Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - GAMG [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - hTERT-RPE1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - JURKAT [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - OE19 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - SuSa [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" "Single Cell Type RNA - Alveolar cells type 1 [NX]" "Single Cell Type RNA - Alveolar cells type 2 [NX]" "Single Cell Type RNA - B-cells [NX]" "Single Cell Type RNA - Basal glandular cells [NX]" "Single Cell Type RNA - Basal keratinocytes [NX]" "Single Cell Type RNA - Bipolar cells [NX]" "Single Cell Type RNA - Cardiomyocytes [NX]" "Single Cell Type RNA - Cholangiocytes [NX]" "Single Cell Type RNA - Ciliated cells [NX]" "Single Cell Type RNA - Club cells [NX]" "Single Cell Type RNA - Collecting duct cells [NX]" "Single Cell Type RNA - Cone photoreceptor cells [NX]" "Single Cell Type RNA - Cytotrophoblasts [NX]" "Single Cell Type RNA - Distal tubular cells [NX]" "Single Cell Type RNA - Ductal cells [NX]" "Single Cell Type RNA - Early spermatids [NX]" "Single Cell Type RNA - Endothelial cells [NX]" "Single Cell Type RNA - Enterocytes [NX]" "Single Cell Type RNA - Erythroid cells [NX]" "Single Cell Type RNA - Exocrine glandular cells [NX]" "Single Cell Type RNA - Extravillous trophoblasts [NX]" "Single Cell Type RNA - Fibroblasts [NX]" "Single Cell Type RNA - Glandular cells [NX]" "Single Cell Type RNA - granulocytes [NX]" "Single Cell Type RNA - Hepatocytes [NX]" "Single Cell Type RNA - Hofbauer cells [NX]" "Single Cell Type RNA - Horizontal cells [NX]" "Single Cell Type RNA - Intestinal endocrine cells [NX]" "Single Cell Type RNA - Ito cells [NX]" "Single Cell Type RNA - Kupffer cells [NX]" "Single Cell Type RNA - Late spermatids [NX]" "Single Cell Type RNA - Leydig cells [NX]" "Single Cell Type RNA - Macrophages [NX]" "Single Cell Type RNA - Melanocytes [NX]" "Single Cell Type RNA - monocytes [NX]" "Single Cell Type RNA - Mucus-secreting cells [NX]" "Single Cell Type RNA - Muller glia cells [NX]" "Single Cell Type RNA - Pancreatic endocrine cells [NX]" "Single Cell Type RNA - Paneth cells [NX]" "Single Cell Type RNA - Peritubular cells [NX]" "Single Cell Type RNA - Proximal tubular cells [NX]" "Single Cell Type RNA - Rod photoreceptor cells [NX]" "Single Cell Type RNA - Sertoli cells [NX]" "Single Cell Type RNA - Smooth muscle cells [NX]" "Single Cell Type RNA - Spermatocytes [NX]" "Single Cell Type RNA - Spermatogonia [NX]" "Single Cell Type RNA - Suprabasal keratinocytes [NX]" "Single Cell Type RNA - Syncytiotrophoblasts [NX]" "Single Cell Type RNA - T-cells [NX]" "Single Cell Type RNA - Undifferentiated cells [NX]" "Single Cell Type RNA - Urothelial cells [NX]" ABCC4 "EST170205, MOAT-B, MOATB, MRP4" ENSG00000125257 "ATP binding cassette subfamily C member 4" O15439 13 95019829-95301475 "Plasma proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "prostate: 35.0" "Cell type enhanced" "Detected in many" 7 "Glandular cells: 38.5;granulocytes: 53.1;Proximal tubular cells: 32.7" "Cancer enriched" "Detected in all" 8 "prostate cancer: 90.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 4 "HEL: 61.8;HMC-1: 67.7;RPTEC TERT1: 18.2" "Low region specificity" "Detected in all" HPA002476 Enhanced Approved "Nucleoli,Golgi apparatus,Plasma membrane" NA NA "Nucleoli, Plasma membrane" "Golgi apparatus" "HPA002476: AB_1844434" "unprognostic (8.77e-2)" "unprognostic (1.94e-2)" "unprognostic (1.48e-1)" "prognostic unfavorable (9.89e-4)" "unprognostic (2.83e-2)" "unprognostic (1.23e-1)" "unprognostic (7.45e-3)" "unprognostic (2.40e-2)" "unprognostic (9.96e-2)" "unprognostic (2.60e-2)" "unprognostic (1.28e-1)" "unprognostic (2.55e-2)" "prognostic favorable (2.25e-10)" "unprognostic (7.44e-3)" "unprognostic (1.67e-1)" "unprognostic (5.55e-2)" "unprognostic (2.35e-2)" 3.2 1.7 3.8 11.8 4.7 2.9 6.2 1.0 4.6 4.4 11.6 10.3 3.9 4.1 5.8 16.4 3.0 8.6 10.3 3.5 5.7 3.9 19.6 1.9 13.8 7.4 6.6 2.2 7.2 3.5 7.0 2.8 1.8 7.4 35.0 7.3 6.0 3.3 5.2 7.6 4.5 7.4 11.1 6.5 3.8 8.2 3.8 7.0 3.4 6.6 3.1 5.8 25.6 13.4 3.6 4.1 1.0 4.8 4.1 3.6 3.4 4.5 8.0 1.3 2.4 2.5 3.3 0.3 3.6 3.7 3.3 2.8 11.1 3.4 2.5 2.4 4.9 2.4 6.2 2.0 1.8 4.1 7.5 3.1 61.8 2.5 2.2 5.1 7.0 67.7 2.5 0.8 2.3 4.8 4.7 4.2 2.8 6.4 0.1 4.4 1.4 1.3 1.1 1.5 5.5 1.9 1.9 3.7 6.6 18.2 10.3 3.3 2.4 1.2 0.2 2.5 1.5 0.0 3.8 6.9 3.5 2.2 2.9 4.3 0.0 0.0 1.0 6.6 4.0 1.7 0.6 1.2 0.4 3.2 1.2 2.7 3.6 2.6 3.6 4.1 2.7 1.6 3.5 1.0 4.1 4.8 0.7 3.3 3.4 3.8 4.7 1.0 4.6 5.7 3.9 6.6 2.2 7.4 7.0 8.9 28.3 3.7 6.2 3.8 0.0 3.1 5.1 6.7 11.4 22.7 21.6 0.1 0.0 5.2 3.2 11.3 1.4 0.0 2.6 0.4 3.9 38.5 53.1 0.0 3.8 0.0 0.0 2.5 1.0 1.7 6.4 6.3 1.7 19.0 3.2 0.3 4.1 9.3 1.8 32.7 0.7 0.0 3.9 0.6 9.1 6.6 0.2 2.2 7.8 3.7 ABCC8 "ABC36, HHF1, HI, HRINS, MRP8, PHHI, SUR, SUR1, TNDM2" ENSG00000006071 "ATP binding cassette subfamily C member 8" Q09428 11 17392498-17476879 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" Transport Receptor "Diabetes mellitus, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.0;pancreas: 25.5;pituitary gland: 26.6" "Group enriched" "Detected in some" 8 "Bipolar cells: 39.2;Intestinal endocrine cells: 21.0" "Cancer enriched" "Detected in some" 9 "pancreatic cancer: 16.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "A549: 4.7;AN3-CA: 3.8;SCLC-21H: 6.7" "Low region specificity" "Detected in all" "CAB011451, HPA042318" Approved Approved "Nucleoli,Golgi apparatus,Cytosol" No NA Nucleoli "Golgi apparatus, Cytosol" "CAB011451: , HPA042318: AB_2677947" "unprognostic (4.30e-2)" "unprognostic (1.02e-1)" "unprognostic (5.09e-2)" "unprognostic (4.73e-2)" "unprognostic (9.48e-3)" "unprognostic (2.23e-1)" "unprognostic (4.46e-3)" "unprognostic (2.53e-3)" "unprognostic (6.04e-2)" "unprognostic (2.34e-2)" "unprognostic (8.72e-3)" "unprognostic (1.13e-1)" "unprognostic (2.22e-2)" "unprognostic (1.96e-2)" "unprognostic (6.88e-5)" "unprognostic (2.72e-2)" "unprognostic (1.85e-1)" 1.3 6.7 4.4 0.8 6.1 0.9 4.0 28.0 12.3 3.0 1.3 2.6 7.7 1.9 3.1 3.7 0.8 1.2 0.9 2.9 5.1 4.8 1.0 0.8 2.9 0.8 3.6 7.2 0.9 25.5 1.0 26.6 1.6 8.5 2.8 1.3 0.7 0.9 8.5 2.3 1.1 1.5 1.3 4.0 0.9 3.5 1.1 2.3 0.0 6.2 0.0 0.8 0.7 0.8 0.1 0.0 0.5 0.0 0.1 0.2 0.0 0.0 4.7 0.1 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.7 0.9 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.5 0.1 0.0 0.0 0.0 0.0 4.4 6.1 28.0 12.3 5.1 4.8 3.6 7.2 8.5 2.3 0.0 0.0 0.0 0.0 0.0 39.2 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.1 0.0 21.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.7 0.0 0.0 0.0 1.2 0.0 1.6 0.0 0.2 0.1 0.0 0.0 0.0 0.1 ABHD14B "CIB, MGC15429" ENSG00000114779 "Abhydrolase domain containing 14B" Q96IU4 3 51968510-51983409 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Proximal tubular cells: 216.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 52.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036444, HPA036642" Supported Approved Nucleoplasm,Nucleoli,Cytosol NA NA 2600000 Nucleoli "Nucleoplasm, Cytosol" "HPA036444: AB_10672221, HPA036642: AB_10672225" "unprognostic (8.97e-2)" "prognostic favorable (6.92e-5)" "unprognostic (1.84e-1)" "prognostic favorable (5.42e-5)" "unprognostic (1.07e-1)" "unprognostic (2.21e-2)" "unprognostic (2.06e-3)" "unprognostic (1.35e-3)" "unprognostic (3.95e-1)" "unprognostic (1.80e-1)" "unprognostic (1.20e-1)" "unprognostic (2.95e-2)" "prognostic favorable (2.93e-5)" "unprognostic (1.16e-1)" "unprognostic (3.55e-1)" "unprognostic (9.70e-2)" "unprognostic (3.70e-2)" 40.0 34.2 6.2 19.8 7.5 11.4 25.2 10.7 7.0 21.9 33.6 8.6 32.1 30.3 19.6 21.7 27.7 22.0 32.9 12.2 6.2 5.8 42.6 78.4 21.5 35.1 7.8 7.3 29.5 45.0 14.2 15.2 11.4 6.7 30.9 20.2 29.1 39.4 35.0 11.7 16.0 58.7 22.6 8.9 23.3 18.7 11.2 6.2 26.0 35.3 15.2 32.5 24.6 16.9 24.9 15.5 12.5 9.4 9.9 27.2 14.0 10.3 8.8 0.7 10.4 28.8 25.7 2.7 4.1 4.8 7.6 8.9 6.5 20.5 11.6 3.3 14.3 3.5 5.2 6.4 5.9 5.8 15.8 6.9 18.3 7.7 25.5 15.5 10.2 18.9 33.2 20.4 7.7 10.5 11.7 9.2 17.7 10.6 18.6 14.7 10.1 4.5 7.8 1.0 11.3 22.6 11.6 1.4 52.4 13.8 4.2 4.4 4.7 10.4 19.4 33.0 1.6 27.9 7.0 8.7 4.0 19.1 9.1 2.4 23.7 11.1 4.8 8.8 32.8 7.0 12.5 9.4 4.2 18.3 7.6 27.2 24.9 23.0 22.4 15.5 18.7 23.4 21.3 0.8 9.9 4.8 11.3 16.3 14.0 6.2 7.5 10.7 7.0 6.2 5.8 7.8 7.3 6.7 6.2 6.0 25.8 75.9 43.7 26.9 12.4 3.2 56.0 24.1 9.1 66.3 13.7 13.4 124.3 28.2 1.4 33.6 100.6 0.0 40.7 15.9 35.2 36.3 50.7 104.1 49.3 7.9 72.9 30.7 50.2 0.5 60.1 36.2 52.3 32.5 83.5 7.7 25.4 66.2 43.9 216.2 37.1 38.8 41.0 0.5 3.4 26.6 9.8 59.8 107.0 52.8 AC118549.1 ENSG00000036549 "ZZ-type zinc finger-containing protein 3 " Q8IYH5 1 77562416-77683419 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 2: 19.0;Proximal tubular cells: 15.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053663, HPA054913, HPA066197" Uncertain Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" No No "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA053663: AB_2682222, HPA054913: AB_2682640, HPA066197: AB_2685635" "unprognostic (1.30e-1)" "unprognostic (4.78e-2)" "unprognostic (2.73e-2)" "unprognostic (2.13e-3)" "unprognostic (5.38e-3)" "unprognostic (8.77e-2)" "prognostic unfavorable (6.96e-5)" "unprognostic (2.91e-1)" "unprognostic (9.67e-2)" "unprognostic (1.35e-1)" "unprognostic (2.83e-1)" "unprognostic (1.91e-1)" "unprognostic (1.71e-1)" "unprognostic (3.96e-1)" "unprognostic (1.95e-1)" "unprognostic (3.05e-2)" "unprognostic (1.43e-1)" 17.8 17.4 20.8 14.1 23.6 11.6 21.6 20.4 20.3 18.1 16.2 16.1 18.3 12.1 18.3 14.3 14.5 15.3 12.1 13.7 16.9 11.7 18.8 20.0 12.3 15.8 24.1 17.8 24.1 14.5 19.0 28.2 13.9 14.4 16.0 13.0 10.5 15.2 16.8 19.0 16.9 12.4 17.0 16.2 11.5 13.5 9.9 23.6 17.9 26.5 8.6 16.0 20.1 14.9 7.9 7.4 5.6 5.1 7.4 10.4 5.0 13.4 6.9 12.7 9.7 11.1 17.7 13.4 17.2 15.9 15.9 17.5 7.7 7.2 17.6 15.5 14.4 18.0 12.4 16.7 11.1 24.1 13.8 13.2 21.8 13.9 9.5 17.1 22.5 6.2 13.5 17.2 17.6 34.4 15.4 16.1 12.2 21.1 13.7 15.4 6.3 11.2 7.0 18.8 7.4 15.7 13.2 21.7 9.0 11.1 14.3 15.9 13.4 10.3 11.8 30.3 9.1 7.1 12.4 13.2 13.8 17.0 22.3 22.1 10.3 14.4 18.7 13.6 19.7 10.5 0.1 4.6 5.6 6.9 5.1 10.4 7.9 8.2 8.1 7.4 7.9 10.2 9.2 0.9 7.4 4.7 5.0 10.4 5.0 20.8 23.6 20.4 20.3 16.9 11.7 24.1 17.8 14.4 23.6 11.9 19.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 12.5 10.4 0.0 11.4 10.0 13.1 0.0 0.0 0.0 0.0 11.1 10.1 0.0 0.0 5.8 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 13.6 0.0 0.0 11.8 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 AC245033.1 ENSG00000260836 15 82536788-82573194 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 11.3" "Group enriched" "Detected in some" 240 "Alveolar cells type 1: 29.8;Alveolar cells type 2: 42.6;Ciliated cells: 20.1;Club cells: 15.9;granulocytes: 11.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "U-2197: 19.0" HPA055060 Uncertain Approved "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum" "Nucleoli, Cytosol" "HPA055060: AB_2682686" "unprognostic (2.91e-2)" 1.5 0.9 5.3 0.9 7.1 0.9 1.3 6.1 11.3 0.9 1.0 1.4 0.0 0.9 0.9 0.9 1.5 0.9 0.9 1.3 3.9 1.6 0.9 1.0 1.1 0.9 3.2 6.1 0.9 1.0 0.9 2.0 1.0 7.3 1.1 1.1 1.9 0.9 0.9 2.0 0.9 1.4 0.9 2.4 1.1 0.9 1.4 1.7 0.0 1.0 0.0 1.0 1.7 0.8 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.0 1.7 0.5 0.0 0.0 0.0 0.7 0.7 19.0 0.3 0.0 0.2 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 5.3 7.1 6.1 11.3 3.9 1.6 3.2 6.1 7.3 1.7 29.8 42.6 0.0 0.0 0.0 0.0 0.0 0.0 20.1 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACADVL "ACAD6, LCACD, VLCAD" ENSG00000072778 "Acyl-CoA dehydrogenase very long chain" P49748 17 7217125-7225273 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019006, HPA020595" Enhanced Supported Nucleoplasm,Nucleoli,Mitochondria NA NA 19000000 Mitochondria "Nucleoplasm, Nucleoli" "HPA019006: AB_1844478, HPA020595: AB_1844479" "unprognostic (4.81e-2)" "unprognostic (2.86e-1)" "unprognostic (2.21e-2)" "unprognostic (1.09e-2)" "unprognostic (6.63e-3)" "unprognostic (1.51e-1)" "unprognostic (1.89e-2)" "unprognostic (1.39e-1)" "unprognostic (1.07e-1)" "unprognostic (3.21e-1)" "prognostic favorable (6.87e-4)" "unprognostic (3.55e-2)" "unprognostic (1.20e-1)" "unprognostic (1.34e-1)" "unprognostic (1.58e-1)" "unprognostic (4.01e-1)" "unprognostic (2.84e-3)" 32.7 69.2 22.8 18.2 21.1 15.1 24.1 19.8 18.4 21.1 44.0 16.5 26.7 51.7 17.4 19.7 31.5 14.2 24.4 118.2 20.2 12.2 35.2 90.0 17.3 9.8 18.5 16.8 15.5 67.8 31.5 32.3 40.2 20.9 22.1 24.2 20.0 27.4 29.0 132.3 20.3 51.2 25.0 15.7 21.9 28.7 11.5 18.6 14.6 29.6 36.9 21.2 22.4 31.8 8.3 32.0 37.9 29.0 11.6 14.9 20.0 33.5 32.1 13.2 18.1 57.0 21.0 25.0 24.7 34.4 28.1 17.5 12.9 30.3 18.0 20.6 51.7 10.1 25.9 8.8 27.0 24.9 56.9 9.1 9.6 22.8 19.7 27.4 9.1 25.0 23.3 24.7 23.5 37.1 43.6 25.3 22.1 12.3 21.9 45.1 12.7 9.4 11.0 6.2 35.2 12.7 13.2 14.6 42.6 62.6 30.6 3.5 8.7 34.8 44.3 20.2 12.9 20.3 14.0 25.1 24.9 18.7 12.6 24.1 20.6 9.6 0.9 45.9 16.1 18.1 6.8 29.0 37.9 13.5 18.0 12.4 8.3 10.9 14.9 32.0 7.6 8.3 10.2 6.3 11.6 12.0 26.0 9.7 20.0 22.8 21.1 19.8 18.4 20.2 12.2 18.5 16.8 20.9 18.6 56.6 73.4 64.0 249.7 77.5 39.6 397.7 150.3 17.4 43.3 191.9 58.9 369.3 157.5 241.9 107.0 71.4 453.8 23.3 66.5 164.5 100.7 311.9 89.7 297.9 171.6 31.8 172.2 51.5 68.0 184.1 115.3 93.1 77.6 423.8 144.6 37.1 129.2 196.4 124.8 276.8 38.8 103.5 102.3 100.5 34.7 76.5 554.7 68.2 215.2 275.4 ACSL3 "ACS3, FACL3, PRO2194" ENSG00000123983 "Acyl-CoA synthetase long chain family member 3" O95573 2 222860934-222944639 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "parathyroid gland: 206.1" "Cell type enhanced" "Detected in all" 9 "Horizontal cells: 494.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 94.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011315, HPA071021" Approved Approved "Nucleoli,Nucleoli rim,Lipid droplets" NA NA "Nucleoli, Nucleoli rim" "Lipid droplets" "HPA011315: AB_1848344, HPA071021: AB_2686335" "unprognostic (1.87e-1)" "unprognostic (5.64e-2)" "unprognostic (2.36e-1)" "unprognostic (9.35e-3)" "unprognostic (7.53e-2)" "unprognostic (2.07e-2)" "prognostic unfavorable (2.75e-4)" "prognostic unfavorable (8.78e-4)" "unprognostic (3.90e-2)" "unprognostic (2.50e-1)" "unprognostic (2.64e-1)" "unprognostic (4.26e-2)" "unprognostic (1.17e-3)" "unprognostic (1.36e-1)" "unprognostic (2.72e-1)" "unprognostic (2.65e-1)" "unprognostic (1.60e-1)" 14.7 17.0 22.8 9.9 26.0 16.3 51.5 19.4 45.9 15.3 16.5 16.1 11.6 12.7 10.9 18.4 28.3 9.0 11.8 22.7 20.9 22.8 17.9 22.3 15.6 10.5 19.6 21.2 11.7 10.3 206.1 8.8 19.1 24.4 44.4 16.7 14.4 34.2 15.5 19.1 11.4 12.7 12.2 22.2 9.7 28.3 13.7 14.2 13.5 17.3 11.2 8.7 14.6 15.4 15.0 22.5 21.8 16.8 16.6 20.1 16.5 10.1 17.9 27.4 29.8 12.0 29.8 7.6 12.9 33.6 15.5 32.7 16.1 26.1 4.8 7.5 12.3 33.5 29.9 5.9 28.7 20.1 8.7 11.2 11.4 14.5 17.9 26.5 7.5 5.6 15.3 40.8 25.6 44.7 11.9 16.8 8.5 21.5 18.6 21.8 21.5 14.6 8.8 13.9 23.0 9.3 8.0 23.2 8.2 22.3 41.6 14.5 10.7 7.6 20.6 94.2 22.1 10.3 18.4 11.6 10.4 16.6 8.9 9.4 6.6 3.2 16.8 11.1 7.1 31.4 16.6 14.6 21.8 20.1 16.8 19.3 11.6 12.8 14.6 15.7 15.0 18.7 16.7 21.8 16.6 15.9 22.5 9.5 16.5 22.8 26.0 19.4 45.9 20.9 22.8 19.6 21.2 24.4 14.2 32.8 58.5 16.4 65.8 41.3 91.7 51.2 40.8 37.5 44.3 34.9 72.6 32.9 6.6 28.6 31.0 38.3 33.1 23.3 27.3 8.4 36.3 113.5 26.5 47.9 33.5 494.2 20.1 36.2 50.2 18.9 24.2 42.9 45.5 32.5 32.3 205.8 32.5 38.6 33.6 12.5 51.8 45.3 51.8 50.2 49.9 42.7 50.7 27.7 46.5 102.1 AEN "FLJ12484, FLJ12562, ISG20L1" ENSG00000181026 "Apoptosis enhancing nuclease" Q8WTP8 15 88621296-88632282 "Predicted intracellular proteins" "Apoptosis, DNA damage" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 39.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048599 Supported "Nucleoplasm,Nuclear membrane,Nucleoli" NA NA "Nucleoplasm, Nucleoli" "Nuclear membrane" "HPA048599: AB_2756313" "unprognostic (8.64e-2)" "unprognostic (1.94e-1)" "unprognostic (2.16e-2)" "prognostic favorable (1.72e-4)" "unprognostic (1.52e-2)" "unprognostic (4.40e-2)" "unprognostic (4.08e-2)" "unprognostic (9.42e-2)" "unprognostic (4.28e-2)" "unprognostic (1.17e-2)" "unprognostic (9.00e-2)" "unprognostic (7.88e-2)" "unprognostic (8.58e-3)" "unprognostic (3.39e-2)" "unprognostic (2.73e-1)" "unprognostic (8.71e-2)" "unprognostic (6.10e-2)" 9.4 10.4 6.5 10.2 7.2 14.8 11.2 2.8 5.0 8.0 7.8 4.9 13.4 5.0 9.3 10.2 8.9 7.0 23.0 8.2 4.7 8.5 7.9 17.4 9.1 15.4 13.1 3.1 11.2 18.8 6.7 21.3 11.0 7.8 11.6 9.1 4.3 14.5 9.1 18.8 5.9 8.0 10.6 9.3 14.2 11.1 14.3 4.6 14.0 16.6 10.9 13.7 12.5 5.4 9.3 4.1 0.6 3.6 3.0 15.0 7.6 4.9 22.1 13.8 11.8 6.1 7.4 29.3 17.7 16.2 13.6 16.8 18.1 9.7 21.3 5.7 9.6 12.3 7.1 50.8 14.3 11.5 5.2 20.0 11.4 8.9 29.9 15.1 9.4 11.5 9.1 12.7 17.0 14.0 4.9 11.4 7.1 17.9 12.1 16.6 11.5 11.6 7.9 33.3 10.3 12.8 15.3 9.8 15.7 5.7 10.7 10.9 10.0 7.1 8.2 13.6 33.0 6.8 10.9 10.3 13.9 19.4 5.6 23.8 23.5 15.7 18.2 12.8 10.6 27.2 0.0 1.8 0.6 5.3 3.1 10.0 9.3 9.1 6.9 4.1 9.3 10.0 8.8 0.4 3.0 3.6 2.4 15.0 7.6 6.5 7.2 2.8 5.0 4.7 8.5 13.1 3.1 7.8 4.6 6.0 7.2 11.2 18.2 16.6 0.4 3.4 10.2 2.7 12.5 1.8 0.0 3.4 3.3 12.4 19.8 4.4 2.9 0.0 6.4 13.5 6.7 23.7 2.3 5.0 4.1 1.6 8.6 1.8 5.9 39.3 4.0 5.1 13.5 20.8 5.8 2.3 9.5 5.8 2.5 5.0 0.8 12.9 17.0 6.3 15.0 24.7 5.1 7.2 6.0 24.5 AGPAT4 "dJ473J16.2, LPAAT-delta" ENSG00000026652 "1-acylglycerol-3-phosphate O-acyltransferase 4" Q9NRZ5 6 161129979-161274061 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.0" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 51.8;Late spermatids: 44.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 19.8;HEL: 14.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053287, HPA060525" Approved Approved "Nucleoli,Golgi apparatus,Vesicles" NA NA "Golgi apparatus" "Nucleoli, Vesicles" "HPA053287: AB_2682101, HPA060525: AB_2684306" "unprognostic (5.69e-2)" "prognostic unfavorable (1.45e-4)" "unprognostic (1.73e-1)" "unprognostic (3.43e-2)" "unprognostic (4.14e-2)" "unprognostic (6.67e-3)" "unprognostic (1.94e-4)" "unprognostic (1.05e-1)" "unprognostic (3.42e-2)" "unprognostic (2.77e-2)" "unprognostic (1.76e-3)" "unprognostic (1.67e-1)" "prognostic unfavorable (4.08e-4)" "unprognostic (1.82e-2)" "unprognostic (8.87e-2)" "unprognostic (3.63e-4)" "unprognostic (5.51e-2)" 5.6 4.2 10.5 3.5 19.1 8.0 4.5 9.6 26.6 5.3 4.2 35.6 1.0 2.6 10.7 4.5 5.2 7.2 8.0 2.9 14.2 11.8 5.2 2.0 6.1 2.0 25.8 12.4 10.0 2.3 1.3 9.8 14.6 27.4 3.7 4.4 0.7 2.7 4.9 2.1 1.9 2.5 8.5 49.0 5.2 3.0 4.2 19.8 0.6 4.8 2.0 2.2 4.0 3.8 1.1 1.9 0.6 3.5 5.8 7.0 2.1 0.3 0.8 19.8 3.9 3.7 7.6 0.8 0.7 0.2 1.5 2.5 1.1 3.5 0.5 1.4 3.1 9.2 0.3 3.6 3.0 1.4 2.2 6.2 14.8 3.5 0.0 2.9 0.1 2.1 9.1 1.5 4.0 2.1 7.1 4.6 2.3 7.3 6.8 1.8 0.0 1.0 1.6 4.7 0.0 7.5 0.0 0.9 0.4 4.3 0.3 11.5 4.4 3.0 1.6 0.8 8.1 0.8 1.0 5.1 2.1 2.6 1.4 3.3 0.5 0.7 0.0 7.8 0.8 1.3 0.0 3.5 0.0 7.0 2.8 2.3 0.4 3.3 4.1 1.9 1.1 1.7 2.7 0.6 5.8 2.5 1.5 2.9 2.1 10.5 19.1 9.6 15.8 14.2 11.8 25.8 12.4 27.4 19.8 3.0 5.6 5.2 4.6 2.9 1.0 4.0 2.5 10.7 5.7 5.2 0.0 16.0 0.0 4.3 51.8 12.2 0.0 0.0 7.0 10.7 11.3 0.8 10.5 0.4 16.7 0.0 1.7 9.8 7.6 44.8 5.5 15.4 3.3 11.8 0.0 4.0 5.9 0.0 8.1 0.3 0.9 19.4 6.2 3.6 2.9 2.3 18.5 7.4 0.0 3.2 AKAP11 "AKAP220, DKFZp781I12161, FLJ11304, KIAA0629, PPP1R44, PRKA11" ENSG00000023516 "A-kinase anchoring protein 11" Q9UKA4 13 42272153-42323267 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039089 Enhanced Approved "Nucleoli,Plasma membrane,Cytosol" NA NA "Nucleoli, Plasma membrane, Cytosol" "HPA039089: AB_10674279" "unprognostic (6.43e-2)" "prognostic unfavorable (9.26e-4)" "unprognostic (4.91e-1)" "unprognostic (6.89e-2)" "unprognostic (1.92e-1)" "unprognostic (7.34e-2)" "unprognostic (1.16e-1)" "unprognostic (1.83e-1)" "unprognostic (7.91e-2)" "unprognostic (2.15e-3)" "unprognostic (3.02e-2)" "unprognostic (1.35e-1)" "unprognostic (7.49e-3)" "unprognostic (7.44e-2)" "unprognostic (1.49e-1)" "unprognostic (6.02e-2)" "unprognostic (1.10e-1)" 11.2 13.6 21.7 10.0 42.3 3.0 11.0 19.9 30.7 17.1 9.1 9.0 5.9 6.9 13.0 15.2 10.2 10.2 9.7 10.4 18.3 17.9 12.9 9.9 10.2 13.4 16.4 22.8 14.6 6.4 11.6 14.5 7.2 20.3 11.1 10.1 6.7 7.6 12.4 5.7 9.1 8.1 13.4 21.4 11.7 9.5 18.1 16.0 5.6 13.3 4.6 12.6 10.4 9.4 3.0 1.6 4.2 1.4 4.8 2.7 0.7 9.4 9.7 11.9 7.0 15.6 19.2 5.2 12.8 10.7 7.8 7.3 10.6 7.9 19.5 5.0 14.3 8.2 11.3 10.3 10.7 14.9 20.7 4.8 5.5 6.7 5.2 12.3 13.6 13.5 14.0 11.1 15.8 13.9 11.4 11.3 9.8 18.0 7.9 15.6 7.1 7.9 4.4 7.0 13.9 4.5 6.6 8.4 9.4 7.7 7.0 5.1 7.4 9.8 6.5 4.5 5.7 5.6 7.4 15.7 13.2 6.9 19.8 9.6 3.0 3.8 10.1 16.8 7.0 9.2 4.2 0.9 1.2 1.7 1.1 2.1 2.7 2.4 1.6 1.0 3.0 2.1 2.1 0.3 4.8 1.4 1.6 2.7 0.7 21.7 42.3 19.9 24.6 18.3 17.9 16.4 22.8 20.3 16.0 23.8 23.3 15.9 13.0 10.9 54.0 42.5 15.3 30.8 40.9 27.9 35.3 3.6 1.7 10.1 7.6 19.9 8.4 23.3 8.1 3.1 16.4 11.4 33.5 19.7 10.7 39.7 20.2 27.6 23.5 9.4 20.1 21.2 8.5 11.8 14.2 66.5 10.8 15.8 31.5 17.7 36.7 19.4 17.9 31.7 33.9 14.8 2.1 15.9 11.2 11.3 AL136454.1 ENSG00000231767 1 192716132-192716653 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 12 "Ciliated cells: 13.4;Club cells: 30.7;Distal tubular cells: 36.5;granulocytes: 33.7" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 7.5;SK-MEL-30: 6.6;THP-1: 7.8" "HPA041344, HPA049132, HPA054087" Uncertain Approved "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA "Nucleoli, Endoplasmic reticulum, Cytosol" "HPA041344: AB_2677422, HPA049132: AB_2680646, HPA054087: AB_2682373" "unprognostic (2.56e-1)" "unprognostic (1.02e-2)" "unprognostic (1.90e-2)" "unprognostic (8.64e-2)" "unprognostic (3.78e-1)" "unprognostic (5.09e-2)" "unprognostic (7.80e-3)" "prognostic favorable (5.72e-4)" "unprognostic (1.59e-1)" "prognostic unfavorable (6.48e-4)" "unprognostic (3.07e-2)" "unprognostic (6.43e-2)" "unprognostic (5.80e-2)" "unprognostic (7.99e-2)" "unprognostic (2.58e-2)" "unprognostic (2.10e-2)" "unprognostic (3.62e-2)" 1.7 0.9 0.3 2.3 0.6 1.9 2.6 0.9 0.9 1.3 0.7 0.0 3.9 2.8 1.8 2.5 0.8 0.7 1.8 0.8 0.5 1.2 0.4 1.3 3.3 1.7 0.2 2.6 7.3 0.0 0.0 0.6 0.8 1.5 0.0 0.4 5.9 4.2 3.4 0.1 1.6 0.6 0.7 3.0 1.2 0.4 1.0 0.2 0.6 2.5 0.8 3.0 2.3 6.1 2.6 1.3 1.9 4.5 7.4 6.4 1.7 0.7 0.5 1.1 0.5 0.0 4.4 0.2 1.0 0.0 0.6 0.0 1.3 0.4 4.4 0.0 0.3 1.8 0.3 0.5 0.0 1.4 0.9 0.8 0.9 3.3 0.4 1.2 2.3 0.5 0.8 0.3 0.0 0.1 0.3 0.4 0.2 1.3 0.0 0.9 1.5 7.5 1.9 0.2 0.4 1.7 0.5 1.0 0.6 2.2 1.4 2.7 0.3 2.7 6.6 0.2 1.7 7.8 0.9 1.1 2.1 1.4 4.0 2.6 1.8 1.5 1.4 1.2 0.2 1.3 1.4 0.7 3.2 1.9 4.6 6.1 5.7 3.5 2.6 5.8 7.4 7.0 0.4 4.5 1.4 2.4 3.6 6.4 8.9 8.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 30.7 1.8 0.0 0.0 36.5 1.4 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 33.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 2.8 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL162231.1 ENSG00000187186 9 34664163-34666112 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 68.6" "Cell type enhanced" "Detected in many" 9 "Collecting duct cells: 34.9;Distal tubular cells: 21.6;Proximal tubular cells: 30.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 28.3" "Low region specificity" "Detected in all" HPA069617 Enhanced Approved "Nucleoli,Endoplasmic reticulum,Vesicles" NA NA Vesicles "Nucleoli, Endoplasmic reticulum" "HPA069617: AB_2686161" "unprognostic (8.20e-3)" "unprognostic (3.13e-1)" "unprognostic (1.17e-2)" "unprognostic (2.03e-1)" "prognostic unfavorable (6.63e-5)" "unprognostic (2.30e-1)" "unprognostic (2.46e-2)" "unprognostic (9.22e-2)" "unprognostic (2.11e-1)" "unprognostic (2.55e-2)" "unprognostic (5.99e-4)" "unprognostic (8.02e-2)" "unprognostic (1.39e-5)" "unprognostic (1.03e-1)" "unprognostic (1.07e-1)" "unprognostic (7.08e-3)" "unprognostic (2.00e-2)" 3.0 6.9 12.1 2.1 21.6 1.8 2.9 6.9 20.2 2.3 1.8 1.9 1.1 2.8 4.0 13.9 1.8 1.8 2.2 9.1 11.8 9.5 4.9 2.5 2.2 1.4 9.6 12.2 7.8 6.2 3.4 13.1 2.3 7.0 3.7 1.2 1.8 4.6 2.1 21.9 2.2 2.0 3.8 5.0 1.0 1.4 68.6 5.3 0.6 3.5 2.0 0.7 1.5 2.5 4.0 11.8 12.0 2.5 3.5 2.9 1.6 0.3 6.0 5.6 7.2 4.6 2.3 5.0 4.8 1.4 3.0 3.5 1.0 2.4 0.0 0.6 3.2 6.0 1.4 3.6 1.7 0.5 12.9 0.6 0.0 28.3 1.7 1.1 2.6 4.5 2.4 2.0 1.8 1.9 4.2 0.8 7.4 3.2 7.4 2.2 0.0 0.5 2.6 4.6 5.3 1.6 0.0 5.3 0.9 5.4 0.0 5.8 9.3 3.4 1.1 8.0 3.3 2.8 7.4 1.1 10.7 14.8 3.4 1.1 7.9 2.6 1.0 13.2 1.5 14.6 12.0 2.5 2.6 1.8 1.3 1.7 4.0 2.3 1.0 0.8 1.6 2.9 1.5 3.5 3.5 0.8 11.8 2.0 1.6 12.1 21.6 6.9 20.2 11.8 9.5 9.6 12.2 7.0 5.3 8.9 9.5 0.0 0.0 0.0 0.0 0.0 0.0 6.7 4.5 34.9 0.0 11.6 21.6 12.0 0.0 0.0 0.0 0.0 9.4 10.4 0.0 0.0 2.3 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 9.0 0.0 0.0 10.8 0.0 0.0 30.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 ANKRD18A "FLJ35740, KIAA2015" ENSG00000180071 "Ankyrin repeat domain 18A" Q8IVF6 9 38571358-38620660 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "bone marrow: 24.4;brain: 11.1;testis: 19.1" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 17.4;Muller glia cells: 13.3;Rod photoreceptor cells: 33.7;Spermatocytes: 25.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HL-60: 16.6" "HPA046346, HPA046695, HPA049923, HPA051288" Uncertain Supported "Nucleoli,Nucleoli rim,Cytosol" NA NA "Nucleoli, Nucleoli rim" Cytosol "HPA046346: AB_2679631, HPA046695: , HPA049923: AB_2680954, HPA051288: AB_2681421" "unprognostic (4.02e-2)" "unprognostic (1.07e-1)" "unprognostic (1.42e-3)" "unprognostic (1.69e-2)" "unprognostic (2.05e-1)" "unprognostic (2.38e-2)" "unprognostic (1.26e-1)" "unprognostic (2.37e-1)" "unprognostic (4.34e-1)" "unprognostic (1.15e-1)" "unprognostic (1.92e-2)" "unprognostic (1.94e-5)" "unprognostic (2.31e-2)" "unprognostic (1.63e-2)" "unprognostic (1.58e-2)" "unprognostic (7.03e-2)" "unprognostic (2.14e-1)" 0.5 0.7 1.4 0.8 9.1 24.4 1.1 0.4 4.1 1.0 2.1 8.5 2.4 0.9 0.7 1.1 1.4 1.2 2.7 1.1 3.0 2.2 1.5 1.2 1.5 0.8 4.8 2.3 0.4 4.1 2.5 3.2 0.7 8.7 1.6 1.5 0.4 0.9 3.9 0.4 2.4 1.5 0.7 11.1 0.5 2.0 19.1 6.9 0.0 3.8 0.0 0.5 0.7 0.8 0.4 0.0 1.1 0.0 0.1 1.7 0.1 4.5 3.5 3.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.5 0.0 1.9 0.0 0.0 0.9 3.4 3.2 0.0 0.0 4.8 0.0 4.8 2.8 0.0 16.6 0.4 0.0 2.3 0.0 3.1 1.7 0.0 7.0 1.6 0.3 0.3 4.3 0.1 0.8 3.6 5.8 2.0 0.0 6.3 6.3 2.1 1.9 1.5 3.0 2.3 0.5 0.1 7.4 2.5 7.9 4.3 0.0 1.3 0.1 0.0 0.3 0.5 0.0 0.0 0.0 2.0 0.0 0.0 1.1 0.5 0.0 0.7 0.0 1.3 0.8 0.0 0.4 0.7 1.7 0.5 0.1 0.0 0.0 1.0 0.1 1.4 9.1 0.4 4.1 3.0 2.2 4.8 2.3 8.7 6.9 0.0 1.0 0.0 1.8 0.6 3.9 6.5 0.0 17.4 5.7 1.8 2.0 0.0 1.7 4.4 4.9 0.0 0.7 0.0 2.0 0.1 0.0 2.0 0.0 0.5 0.1 0.0 4.1 0.0 0.0 1.3 0.6 0.0 0.0 0.0 3.6 13.3 3.7 2.9 0.4 0.1 33.7 0.0 0.1 25.6 2.0 1.5 0.0 0.0 2.3 0.7 ANKRD18B bA255A11.3 ENSG00000230453 "Ankyrin repeat domain 18B" A2A2Z9 9 33524394-33573009 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.9;testis: 26.9" "Group enriched" "Detected in many" 6 "Ciliated cells: 16.0;Early spermatids: 23.8;Muller glia cells: 23.4;Spermatocytes: 37.6" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "cerebellum: 12.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "NB-4: 20.8" "HPA046346, HPA046695, HPA049923, HPA051288" Uncertain Approved "Nucleoli,Nucleoli rim,Cytosol" NA NA "Nucleoli, Nucleoli rim" Cytosol "HPA046346: AB_2679631, HPA046695: , HPA049923: AB_2680954, HPA051288: AB_2681421" "unprognostic (4.71e-2)" "unprognostic (1.85e-1)" "unprognostic (4.85e-3)" "unprognostic (1.00e-2)" "unprognostic (1.13e-1)" "unprognostic (1.17e-2)" "unprognostic (1.29e-4)" "unprognostic (1.45e-2)" "unprognostic (9.84e-2)" "unprognostic (8.65e-2)" "unprognostic (2.54e-4)" "unprognostic (1.01e-2)" "unprognostic (6.43e-5)" "unprognostic (4.89e-2)" "unprognostic (9.75e-4)" "unprognostic (8.25e-2)" "unprognostic (5.18e-2)" 1.5 0.9 4.3 0.1 0.4 0.2 1.3 12.9 3.9 0.3 0.2 0.2 0.1 0.0 0.5 1.0 2.1 1.0 0.9 0.3 2.1 1.3 0.1 0.4 0.7 0.1 1.0 1.4 0.1 0.1 0.1 1.6 1.3 2.6 2.0 0.3 0.2 0.2 0.1 1.4 5.5 0.2 0.1 1.0 0.9 0.0 26.9 0.1 0.1 0.9 1.6 0.7 1.2 1.1 0.5 0.8 0.1 0.2 0.0 0.8 0.1 7.5 8.5 0.7 0.2 0.3 1.4 0.7 1.6 1.7 2.1 2.3 1.6 0.2 0.2 0.4 0.2 2.3 1.7 4.6 1.6 2.9 0.1 4.6 8.2 9.9 3.1 0.0 2.7 0.6 1.1 4.5 2.9 7.6 0.9 3.9 0.0 4.5 2.1 2.6 1.3 0.2 20.8 7.3 0.3 3.7 0.0 10.5 1.5 1.2 1.8 0.2 7.3 3.5 0.4 0.6 6.8 6.0 10.1 3.9 1.7 7.6 3.5 3.0 1.2 0.8 0.1 0.8 0.1 1.2 0.0 0.1 0.1 0.3 0.1 0.7 0.4 0.2 0.6 0.0 0.5 0.4 0.8 0.1 0.0 0.2 0.8 0.1 0.1 4.3 0.4 12.9 3.9 2.1 1.3 1.0 1.4 2.6 0.1 0.0 0.0 0.0 4.4 1.8 2.6 2.4 2.5 16.0 3.4 1.8 0.0 0.0 0.0 0.6 23.8 0.0 0.3 0.0 0.4 0.2 0.0 1.5 0.0 0.0 0.2 0.0 0.0 0.6 0.0 1.6 0.6 0.1 0.0 0.0 1.6 23.4 0.3 1.4 0.7 0.0 4.3 0.0 0.0 37.6 1.7 2.9 0.0 0.0 1.0 3.5 ANKRD49 "FGIF, FLJ20189, GBIF" ENSG00000168876 "Ankyrin repeat domain 49" Q8WVL7 11 94493629-94499583 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040273, HPA048137" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA "Nucleoplasm, Nucleoli" "Golgi apparatus" "HPA040273: AB_10674991, HPA048137: AB_2680279" "unprognostic (1.52e-2)" "unprognostic (2.76e-2)" "unprognostic (1.92e-1)" "unprognostic (5.22e-3)" "unprognostic (1.71e-2)" "unprognostic (1.30e-1)" "unprognostic (9.06e-3)" "unprognostic (1.46e-2)" "unprognostic (7.21e-3)" "unprognostic (1.36e-1)" "unprognostic (1.23e-1)" "unprognostic (4.21e-3)" "prognostic unfavorable (9.96e-4)" "unprognostic (6.32e-3)" "unprognostic (2.82e-1)" "unprognostic (3.40e-2)" "prognostic favorable (6.16e-4)" 9.8 9.0 10.2 10.7 10.8 19.6 12.7 18.6 10.9 15.6 14.8 4.5 9.5 11.2 15.1 19.6 13.2 8.2 7.9 5.7 9.5 6.9 13.3 11.0 10.4 17.5 7.2 8.5 12.3 15.6 9.1 27.9 16.3 7.7 12.6 13.1 7.7 12.1 10.7 7.9 8.8 19.2 9.6 12.5 21.3 12.1 5.3 8.5 22.6 18.0 9.9 19.2 11.9 9.3 20.5 17.7 34.7 15.1 17.3 19.6 10.5 6.4 2.9 7.6 6.5 7.5 9.6 9.2 10.2 9.1 10.7 12.7 14.2 12.7 17.0 15.7 7.2 9.3 14.1 9.2 6.9 8.6 13.3 7.4 14.7 11.4 4.8 8.6 12.9 11.8 6.7 17.4 8.2 11.5 7.9 8.4 15.1 13.9 10.1 7.0 4.4 13.7 23.4 4.4 12.2 7.3 11.1 8.5 8.5 10.1 6.8 7.5 7.8 7.0 7.0 6.3 14.2 14.2 8.7 5.2 9.7 6.8 10.6 5.1 5.9 13.6 18.1 3.2 15.6 5.5 34.7 15.1 12.6 14.9 12.5 16.3 20.5 15.9 13.1 11.4 19.6 19.6 17.9 27.1 17.3 9.3 17.7 19.1 10.5 10.2 10.8 18.6 10.9 9.5 6.9 7.2 8.5 7.7 8.5 11.9 9.4 31.8 9.7 4.9 15.9 5.3 17.8 8.1 17.0 24.4 13.7 25.3 18.3 16.9 4.4 13.5 27.1 46.7 20.0 13.5 13.3 9.6 19.8 16.6 12.2 11.1 12.9 16.0 28.9 1.5 33.1 17.8 10.1 13.6 20.3 20.2 18.8 30.3 22.3 12.6 14.5 25.8 11.8 22.3 18.8 5.9 23.5 35.0 21.1 5.1 ANKS6 "ANKRD14, FLJ36928, NPHP16, SAMD6" ENSG00000165138 "Ankyrin repeat and sterile alpha motif domain containing 6" Q68DC2 9 98731329-98796965 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease mutation, Joubert syndrome, Nephronophthisis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 31.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA008355 Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA008355: AB_2058277" "unprognostic (1.66e-1)" "unprognostic (1.46e-1)" "unprognostic (9.31e-2)" "unprognostic (9.15e-3)" "unprognostic (6.90e-3)" "unprognostic (1.22e-1)" "unprognostic (4.29e-3)" "unprognostic (4.10e-2)" "unprognostic (1.48e-1)" "unprognostic (3.46e-3)" "unprognostic (1.00e-1)" "unprognostic (5.94e-2)" "prognostic favorable (3.44e-5)" "unprognostic (1.40e-1)" "unprognostic (1.02e-1)" "unprognostic (3.95e-2)" "unprognostic (2.68e-1)" 5.0 3.7 5.8 4.3 9.9 1.8 4.8 31.2 9.5 7.3 6.5 9.4 2.6 5.9 6.0 7.4 7.5 7.8 7.7 2.9 6.9 6.1 7.7 1.8 7.2 3.4 10.1 4.4 9.6 18.1 10.0 2.8 2.8 11.4 3.6 7.3 4.2 3.1 3.5 3.3 4.4 5.4 8.9 6.1 2.5 7.7 6.1 9.2 1.8 13.4 2.4 4.5 5.4 6.4 0.9 0.0 0.0 0.1 0.0 2.1 0.2 5.2 7.9 7.3 12.8 6.1 5.0 4.9 3.8 6.6 4.3 5.2 4.3 3.8 9.7 2.9 5.4 6.2 15.6 5.3 6.4 2.3 13.5 5.5 2.3 4.7 1.8 6.0 1.2 1.6 6.1 8.1 5.9 6.0 5.3 4.9 9.0 16.3 2.3 3.3 8.7 0.5 2.5 11.5 23.5 8.6 6.5 18.1 0.7 7.7 3.3 4.7 5.4 1.6 9.4 4.3 6.2 0.0 2.7 4.9 4.5 4.9 12.2 3.7 4.5 7.6 1.6 6.3 4.4 6.4 0.0 0.1 0.0 1.3 0.0 0.7 0.9 0.7 2.1 0.0 0.6 1.8 0.9 0.0 0.0 0.0 0.0 1.1 0.2 5.8 9.9 31.2 9.5 6.9 6.1 10.1 4.4 11.4 9.2 6.0 8.0 2.4 0.7 1.5 6.1 4.4 12.7 5.3 4.5 12.2 7.9 2.3 3.3 3.6 2.9 3.1 4.2 0.0 7.7 2.5 3.4 3.4 1.1 1.5 1.6 0.0 4.7 1.8 1.5 4.9 2.6 1.1 0.0 1.0 6.8 1.4 7.0 3.5 4.2 5.0 0.6 0.0 2.3 4.2 4.9 1.0 0.9 2.1 7.6 2.4 ANXA10 ANX14 ENSG00000109511 "Annexin A10" Q9UJ72 4 168092515-168187690 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "gallbladder: 33.5;stomach 1: 105.3" "Group enriched" "Detected in some" 14 "Exocrine glandular cells: 153.7;Hepatocytes: 62.3;Pancreatic endocrine cells: 198.3" "Group enriched" "Detected in many" 5 "pancreatic cancer: 62.4;stomach cancer: 42.2;urothelial cancer: 19.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "OE19: 72.5;PC-3: 32.8;RT4: 44.3" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA005469, HPA074650" Enhanced Approved Nucleoplasm,Nucleoli,Vesicles NA NA "Nucleoplasm, Nucleoli" Vesicles "HPA005469: AB_1844849, HPA074650: " "unprognostic (2.29e-2)" "unprognostic (8.71e-3)" "unprognostic (2.48e-2)" "unprognostic (1.71e-1)" "unprognostic (4.69e-1)" "unprognostic (2.29e-2)" "prognostic favorable (3.64e-6)" "unprognostic (1.18e-3)" "unprognostic (2.88e-1)" "unprognostic (8.61e-4)" "unprognostic (3.43e-2)" "unprognostic (1.84e-1)" "unprognostic (1.69e-3)" "unprognostic (8.41e-2)" "unprognostic (4.01e-1)" "unprognostic (2.04e-1)" "unprognostic (8.89e-3)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 1.4 0.1 4.2 0.1 0.1 0.5 0.0 33.5 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 1.5 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.4 0.1 0.1 105.3 0.1 0.1 0.1 0.1 0.1 0.1 11.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.1 0.0 2.5 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 72.5 32.8 0.0 0.1 0.0 0.0 44.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 10.2 0.0 2.3 0.0 2.0 0.0 0.0 3.5 7.3 0.0 0.0 0.0 153.7 0.0 0.0 0.6 0.0 62.3 0.0 0.0 0.0 1.3 2.7 0.0 0.0 0.0 0.0 1.0 0.4 0.0 198.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 APOC3 ENSG00000110245 "Apolipoprotein C3" P02656 11 116829706-116833072 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Lipid degradation, Lipid metabolism, Lipid transport, Transport" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "liver: 714.1" "Cell type enriched" "Detected in some" 60 "Hepatocytes: 64257.6" "Cancer enriched" "Detected in many" 643 "liver cancer: 4021.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 19 "CACO-2: 28.5;Hep G2: 77.0" "Not detected" "Not detected" "HPA065365, HPA073918" Supported Approved "Nucleoplasm,Nucleoli,Cell Junctions" "Secreted to blood" NA NA 106000000000 97000000000 Nucleoplasm "Nucleoli, Cell Junctions" "HPA065365: AB_2732733, HPA073918: " "prognostic favorable (3.77e-4)" "unprognostic (2.33e-1)" "prognostic unfavorable (6.87e-5)" "unprognostic (1.60e-2)" "unprognostic (5.21e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 38.7 0.1 0.1 31.7 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.4 714.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 91.3 0.1 0.1 0.3 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 28.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 77.0 0.0 2.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.7 0.9 0.0 0.0 0.3 1.0 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.0 100.1 0.0 0.0 0.0 0.0 858.6 0.0 0.0 0.0 0.0 0.0 3.3 0.0 3.8 0.0 0.0 1074.6 0.4 0.3 0.0 0.0 0.0 64257.6 1.0 0.0 0.0 825.6 1072.7 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 3.2 0.0 0.0 ATP13A3 AFURS1 ENSG00000133657 "ATPase 13A3" Q9H7F0 3 194402672-194498364 "Predicted membrane proteins" Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029471 Approved Approved "Nucleoli,Plasma membrane,Cytosol" NA NA Nucleoli "Plasma membrane, Cytosol" "HPA029471: AB_10600784" "unprognostic (5.07e-2)" "unprognostic (3.53e-2)" "unprognostic (2.94e-1)" "unprognostic (5.31e-2)" "unprognostic (3.20e-2)" "unprognostic (3.55e-1)" "unprognostic (1.57e-1)" "unprognostic (9.87e-2)" "unprognostic (1.32e-1)" "unprognostic (1.51e-1)" "prognostic unfavorable (1.60e-4)" "unprognostic (2.70e-2)" "prognostic unfavorable (1.63e-4)" "unprognostic (1.22e-1)" "unprognostic (1.65e-1)" "unprognostic (1.34e-2)" "unprognostic (3.77e-1)" 27.1 14.4 9.0 20.8 12.7 17.5 22.8 15.3 13.8 12.1 13.4 10.8 17.2 11.4 16.2 13.2 12.4 11.3 17.1 37.8 9.6 8.1 29.7 56.9 22.1 11.6 10.1 8.3 13.2 11.4 37.6 10.6 28.9 10.6 11.8 12.6 12.9 16.7 15.9 11.8 7.7 15.0 12.1 9.0 17.1 16.3 8.8 8.4 18.9 37.1 12.0 12.7 17.8 16.1 1.9 2.4 2.3 2.3 2.2 4.7 1.0 49.1 5.6 10.0 9.5 11.4 17.8 24.4 16.9 18.4 18.4 33.5 30.8 12.0 19.4 50.3 24.3 61.0 16.7 9.6 16.8 42.8 64.7 8.3 10.7 7.4 6.5 19.8 34.8 28.1 8.1 7.5 38.2 24.9 30.2 9.5 12.0 12.3 39.3 22.3 8.4 14.0 6.9 9.5 16.1 9.7 12.8 21.6 11.6 15.6 15.7 15.4 8.1 17.9 18.6 12.5 8.8 35.7 24.4 12.4 22.5 18.7 44.6 31.5 25.9 46.7 34.5 44.6 20.7 15.5 1.8 1.7 2.3 1.8 2.3 2.2 1.9 1.7 2.8 2.4 1.1 2.5 2.5 0.3 2.2 0.9 1.6 4.7 1.0 9.0 12.7 15.3 13.8 9.6 8.1 10.1 8.3 10.6 8.4 47.6 35.1 27.9 35.7 73.3 24.1 34.6 96.8 24.1 37.5 47.1 19.6 25.7 3.3 56.7 1.9 46.6 20.8 0.0 60.7 16.3 46.0 62.6 8.1 112.9 37.1 14.3 29.4 49.1 35.1 1.1 9.5 48.5 59.1 8.2 21.5 10.3 76.7 20.4 12.4 39.8 13.3 12.9 36.0 14.0 7.0 62.2 54.0 20.1 19.9 58.3 ATXN1 "ATX1, D6S504E, SCA1" ENSG00000124788 "Ataxin 1" P54253 6 16299112-16761491 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor, RNA-binding" "Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 108.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 24.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008335, HPA070756" Approved Supported Nucleoplasm,Nucleoli,Cytosol Yes No Nucleoplasm "Nucleoli, Cytosol" "HPA008335: AB_1845129, HPA070756: AB_2686306" "unprognostic (1.01e-1)" "unprognostic (4.77e-2)" "unprognostic (1.23e-1)" "unprognostic (5.64e-3)" "unprognostic (4.54e-1)" "unprognostic (1.95e-2)" "unprognostic (7.74e-2)" "unprognostic (4.51e-2)" "unprognostic (4.06e-1)" "unprognostic (1.11e-2)" "unprognostic (3.87e-2)" "unprognostic (2.69e-2)" "unprognostic (1.41e-3)" "unprognostic (1.67e-3)" "unprognostic (2.33e-1)" "unprognostic (1.06e-1)" "unprognostic (3.29e-3)" 8.1 9.1 17.7 11.9 25.1 5.5 9.1 33.7 29.5 14.8 13.5 12.9 10.3 8.2 20.5 9.8 11.1 11.0 12.1 11.8 18.0 11.0 9.1 10.1 14.8 11.6 21.1 17.7 10.7 10.3 18.4 11.6 10.3 16.4 14.2 8.5 9.8 8.4 14.0 26.3 12.0 8.3 19.1 16.1 11.4 10.3 8.1 25.6 4.6 11.8 12.5 7.4 11.7 11.3 0.4 0.8 4.4 1.7 0.1 2.5 0.8 3.4 2.0 0.7 0.0 3.5 4.8 4.6 3.7 8.7 2.3 2.7 2.1 2.2 0.1 5.0 7.1 3.0 3.2 0.2 2.3 3.3 1.9 3.6 0.5 3.2 6.7 5.7 3.2 5.6 3.7 4.5 4.8 4.1 8.9 4.6 0.7 0.0 4.1 1.9 1.7 0.2 3.6 0.7 1.1 3.3 0.2 4.6 3.0 3.1 5.8 0.2 2.0 3.4 4.3 7.0 7.0 2.8 5.5 7.0 3.2 4.9 3.7 3.3 24.3 13.9 0.1 2.0 3.3 7.8 0.7 1.7 0.4 2.5 1.3 1.9 0.4 1.7 2.4 0.8 0.1 0.2 1.5 4.4 0.1 0.7 0.4 1.3 0.8 17.7 25.1 33.7 29.5 18.0 11.0 21.1 17.7 16.4 25.6 44.7 20.4 14.9 54.4 81.3 39.6 30.2 25.5 22.7 26.1 10.4 94.2 0.3 6.6 15.9 3.6 15.7 12.5 0.0 7.4 3.0 26.7 57.3 38.1 25.3 20.8 36.5 1.2 20.3 33.9 1.8 9.8 33.2 30.4 28.9 12.3 24.2 22.2 13.5 26.5 7.7 108.3 51.8 35.3 0.9 1.3 42.7 0.3 44.9 6.8 52.7 ATXN3 "ATX3, JOS, MJD, SCA3" ENSG00000066427 "Ataxin 3" P54252 14 92044496-92106625 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB021976, HPA024123, HPA069338" Uncertain Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Nucleoplasm, Nucleoli" "Plasma membrane" "CAB021976: , HPA024123: AB_1845133, HPA069338: AB_2686124" "unprognostic (1.06e-2)" "unprognostic (2.93e-1)" "unprognostic (1.22e-1)" "unprognostic (3.67e-2)" "unprognostic (5.76e-2)" "unprognostic (1.57e-1)" "unprognostic (1.42e-1)" "unprognostic (9.85e-3)" "unprognostic (1.69e-1)" "unprognostic (6.75e-2)" "unprognostic (1.04e-2)" "unprognostic (3.06e-2)" "unprognostic (2.03e-2)" "unprognostic (8.94e-3)" "unprognostic (4.22e-1)" "unprognostic (1.64e-1)" "unprognostic (1.11e-1)" 17.8 10.3 10.2 9.1 11.6 14.3 12.8 18.7 12.1 16.0 11.8 12.2 11.9 6.4 17.9 12.4 17.7 9.5 11.2 10.4 9.0 9.9 9.9 16.0 12.3 11.6 16.3 9.5 14.0 10.3 11.9 17.2 11.7 13.8 15.8 11.7 8.6 11.4 10.2 6.1 21.0 8.7 20.6 16.5 12.6 9.0 14.8 14.3 16.2 11.5 12.0 15.6 15.4 13.6 9.8 14.5 11.4 18.8 7.0 8.5 5.3 5.6 11.1 10.1 9.3 14.7 14.4 19.7 6.4 10.5 8.2 11.5 8.1 15.7 11.5 12.8 10.5 9.7 9.9 7.7 14.1 18.2 13.1 2.3 4.9 5.4 11.8 12.1 8.6 8.8 11.6 12.6 14.3 15.0 11.0 12.6 12.9 6.5 8.6 12.4 22.0 9.0 7.8 7.1 18.8 9.2 7.2 18.5 6.5 10.5 12.8 3.4 6.0 15.6 6.6 8.8 14.1 12.3 6.1 6.7 8.1 11.9 5.2 3.4 7.5 12.5 10.6 6.0 8.5 4.7 11.4 13.4 9.4 5.9 14.5 7.0 7.1 6.9 6.5 14.5 9.8 7.6 8.5 11.3 7.0 18.8 8.4 6.8 5.3 10.2 11.6 18.7 12.1 9.0 9.9 16.3 9.5 13.8 14.3 14.9 14.3 18.1 26.1 22.6 32.4 17.3 17.8 12.0 12.5 40.1 47.1 17.4 13.3 17.7 18.3 43.4 11.7 0.0 15.0 23.8 25.4 29.1 23.2 19.1 20.8 25.4 15.4 39.3 27.2 18.5 62.7 31.8 21.9 30.7 16.0 20.6 17.6 17.5 61.2 14.6 45.6 45.3 35.8 30.5 60.9 26.5 21.2 23.0 19.4 25.1 B3GNTL1 B3GNT8 ENSG00000175711 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase like 1" Q67FW5 17 82942155-83051810 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 17.4;Late spermatids: 15.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 17.9;HL-60: 18.6;THP-1: 17.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023585, HPA024547" Supported Approved "Nucleoli,Nucleoli fibrillar center,Vesicles" NA NA "Nucleoli, Nucleoli fibrillar center" Vesicles "HPA023585: AB_2061075, HPA024547: AB_1845240" "unprognostic (1.51e-2)" "unprognostic (9.84e-2)" "unprognostic (4.11e-1)" "unprognostic (2.34e-1)" "unprognostic (1.38e-1)" "unprognostic (8.11e-2)" "unprognostic (2.61e-7)" "unprognostic (9.95e-2)" "unprognostic (2.62e-1)" "unprognostic (1.62e-1)" "unprognostic (8.74e-2)" "unprognostic (2.80e-2)" "unprognostic (4.17e-9)" "unprognostic (2.02e-1)" "unprognostic (1.47e-1)" "unprognostic (1.88e-1)" "unprognostic (3.39e-3)" 3.7 4.3 6.5 7.2 13.9 17.7 4.0 6.4 10.7 4.7 3.6 4.2 1.7 4.7 6.3 6.1 3.7 8.3 3.9 6.2 6.9 4.7 2.9 3.4 4.4 5.6 3.8 7.1 6.6 7.6 1.7 6.1 3.9 7.1 4.6 2.8 3.7 5.6 4.5 5.0 4.4 3.3 5.1 4.4 6.6 4.9 4.0 3.7 6.9 4.4 4.8 3.3 4.3 3.8 3.7 8.8 16.9 5.7 2.4 11.2 3.3 8.2 5.5 0.1 2.7 1.5 4.9 3.4 3.0 2.7 3.5 2.7 3.3 17.9 4.0 5.9 3.7 8.5 1.6 1.4 0.0 3.0 6.2 3.6 8.5 8.2 11.0 5.6 18.6 0.3 1.8 1.5 2.1 3.5 1.7 4.2 6.4 3.7 3.9 2.8 1.8 5.2 7.1 1.3 5.6 4.0 6.8 0.7 0.3 2.0 1.8 1.7 0.6 2.5 1.9 2.5 2.6 0.0 17.9 6.9 6.8 4.6 1.0 5.3 0.8 1.9 3.0 7.5 2.4 0.9 2.6 5.7 0.9 2.7 5.0 4.1 2.8 4.3 3.0 8.8 3.7 3.8 4.6 16.9 2.4 2.5 3.5 11.2 3.3 6.5 13.9 6.4 10.7 6.9 4.7 3.8 7.1 7.1 3.7 3.0 5.0 1.3 1.7 0.9 3.9 1.7 2.5 17.4 6.8 5.2 3.9 5.1 1.7 1.6 11.7 1.5 0.3 0.0 0.8 2.1 3.0 1.5 6.9 1.0 7.2 3.2 1.2 1.8 8.1 15.2 2.8 6.7 1.7 3.6 1.2 1.1 1.9 2.9 4.6 2.2 3.4 0.0 1.2 0.7 4.3 1.5 1.6 6.4 2.7 2.0 BATF3 "JDP1, JUNDM1, SNFT" ENSG00000123685 "Basic leucine zipper ATF-like transcription factor 3" Q9NR55 1 212686418-212699985 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 26.8" "Group enriched" "Detected in many" 4 "Extravillous trophoblasts: 36.2;Macrophages: 24.9;monocytes: 98.2;Smooth muscle cells: 25.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "intermediate monocyte: 18.0;myeloid DC: 16.5;non-classical monocyte: 26.8" "Group enriched" "Detected in many" 36 "dendritic cells: 16.5;monocytes: 26.8" "Cell line enriched" "Detected in some" 12 "HDLM-2: 93.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA075858 Supported Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA075858: " "unprognostic (3.87e-2)" "unprognostic (2.10e-2)" "unprognostic (4.29e-2)" "unprognostic (6.85e-2)" "unprognostic (6.33e-2)" "unprognostic (3.15e-2)" "unprognostic (3.84e-2)" "unprognostic (6.59e-2)" "unprognostic (3.08e-1)" "unprognostic (6.47e-2)" "unprognostic (1.28e-2)" "unprognostic (1.75e-1)" "unprognostic (6.43e-10)" "unprognostic (9.88e-2)" "unprognostic (5.19e-2)" "unprognostic (3.90e-1)" "unprognostic (7.08e-2)" 10.4 1.3 6.7 6.3 9.4 5.4 3.5 0.4 5.2 2.0 2.4 3.3 0.2 1.4 1.8 0.4 1.8 2.6 3.8 4.1 5.5 2.1 2.6 2.3 7.2 8.7 9.5 2.8 3.1 3.2 1.2 1.3 4.6 4.3 2.3 1.6 0.5 2.2 1.2 1.5 1.1 4.3 3.7 4.7 9.5 3.2 1.1 7.1 5.0 2.1 2.6 4.9 3.0 6.0 0.2 16.5 0.6 26.8 0.3 0.4 2.4 0.3 0.9 0.1 0.0 0.0 0.6 0.7 0.5 1.1 1.1 1.2 0.0 0.3 0.0 0.2 0.0 1.8 0.0 1.1 0.2 0.8 93.1 2.2 0.0 0.3 0.0 0.2 4.2 0.6 0.1 0.0 2.2 0.3 0.1 0.0 7.7 0.1 1.1 0.2 0.0 3.2 1.7 0.4 0.0 1.5 0.6 0.4 0.0 1.0 0.0 0.2 0.1 0.3 0.0 0.0 0.4 0.0 3.0 0.0 0.5 2.1 0.1 2.4 0.1 0.2 0.5 1.5 3.8 1.1 0.0 4.1 0.0 0.0 18.0 0.0 0.2 0.0 0.0 16.5 0.0 0.0 0.0 0.6 0.3 26.8 0.0 0.4 2.4 6.7 9.4 0.4 5.2 5.5 2.1 9.5 2.8 4.3 7.1 3.0 1.1 0.5 2.2 5.0 0.1 0.3 0.0 4.0 2.3 0.0 0.0 0.8 0.0 0.7 0.3 5.8 0.0 0.0 0.3 36.2 8.5 6.6 4.7 0.2 4.6 0.0 0.0 6.2 10.5 0.8 0.9 24.9 1.7 98.2 0.0 0.2 1.3 0.0 0.0 0.5 0.4 0.0 25.8 1.1 4.3 2.5 3.8 1.0 0.0 0.9 BMP7 OP-1 ENSG00000101144 "Bone morphogenetic protein 7" P18075 20 57168748-57266629 "Predicted intracellular proteins, Predicted secreted proteins" "Chondrogenesis, Differentiation, Osteogenesis" "Cytokine, Developmental protein, Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 37.0;thyroid gland: 44.3" "Cell type enhanced" "Detected in many" 16 "Cytotrophoblasts: 108.5;Muller glia cells: 38.0;Syncytiotrophoblasts: 47.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 13 "basophil: 2.4" "Lineage enriched" "Detected in single" 13 "granulocytes: 2.4" "Cell line enhanced" "Detected in some" "Daudi: 42.0;MCF7: 48.6;OE19: 22.8;RPMI-8226: 18.6;SK-BR-3: 31.7;U-698: 57.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057757 Approved Nucleoplasm,Nucleoli,Vesicles "Secreted to blood" NA NA 248000 Vesicles "Nucleoplasm, Nucleoli" "HPA057757: AB_2683518" "unprognostic (1.67e-1)" "unprognostic (9.72e-3)" "unprognostic (9.67e-2)" "prognostic unfavorable (2.91e-4)" "unprognostic (2.62e-1)" "unprognostic (1.60e-1)" "unprognostic (1.16e-1)" "unprognostic (1.01e-1)" "unprognostic (6.78e-2)" "unprognostic (4.63e-3)" "unprognostic (4.03e-2)" "unprognostic (1.09e-2)" "unprognostic (3.82e-2)" "unprognostic (4.30e-2)" "unprognostic (1.21e-1)" "unprognostic (5.42e-2)" "unprognostic (1.59e-1)" 1.5 7.2 16.8 2.4 17.5 0.7 2.1 3.8 19.7 9.2 2.3 23.6 6.0 2.7 1.9 17.7 17.2 10.0 1.2 8.5 13.9 9.9 4.5 0.7 1.8 1.6 14.3 11.2 0.8 1.0 0.8 1.9 24.4 12.2 5.0 2.4 37.0 2.6 10.3 1.0 15.5 2.4 1.0 13.8 1.3 4.1 1.4 13.4 1.8 44.3 5.7 4.9 7.8 7.0 0.1 0.1 2.4 0.0 0.0 0.1 0.0 0.0 0.1 5.8 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 1.7 42.0 10.8 0.0 2.2 12.2 1.3 0.0 0.0 0.1 4.6 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 48.6 0.0 0.0 3.0 22.8 0.0 0.0 0.0 18.6 0.0 0.0 0.1 4.6 1.3 31.7 0.1 4.0 0.2 0.1 0.1 0.0 2.9 0.0 0.0 0.0 0.0 57.4 0.0 0.0 0.0 2.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 16.8 17.5 3.8 12.5 13.9 9.9 14.3 11.2 12.2 13.4 6.0 2.1 0.0 11.4 12.2 3.8 12.4 0.0 2.7 2.3 1.8 0.0 108.5 0.0 0.0 3.9 1.5 0.0 0.0 0.0 14.4 10.8 4.9 21.8 0.0 9.3 1.6 2.4 0.0 0.0 3.3 0.3 0.0 3.3 0.0 0.0 38.0 0.0 0.0 0.4 1.6 2.4 0.0 0.9 1.4 1.4 8.4 47.6 0.5 0.2 10.6 BMS1 "BMS1L, KIAA0187" ENSG00000165733 "BMS1, ribosome biogenesis factor" Q14692 10 42782801-42834937 "Disease related genes, Predicted intracellular proteins" "Ribosome biogenesis" "Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036589, HPA043081" Uncertain Enhanced "Nucleoplasm,Nucleoli,Mitotic chromosome" Yes No "Nucleoplasm, Nucleoli, Mitotic chromosome" "HPA036589: AB_10601460, HPA043081: AB_2678305" "unprognostic (1.46e-2)" "unprognostic (4.31e-1)" "unprognostic (7.09e-2)" "unprognostic (3.56e-2)" "unprognostic (3.11e-2)" "unprognostic (7.25e-3)" "prognostic unfavorable (1.06e-6)" "unprognostic (1.47e-1)" "unprognostic (1.20e-1)" "unprognostic (1.89e-2)" "unprognostic (3.81e-3)" "unprognostic (1.32e-2)" "unprognostic (2.16e-3)" "unprognostic (7.03e-2)" "unprognostic (1.80e-1)" "unprognostic (3.43e-1)" "unprognostic (4.82e-2)" 17.8 15.3 10.4 15.8 19.7 17.4 16.2 22.5 20.6 15.5 12.9 13.7 11.2 11.8 23.1 13.4 17.8 14.0 10.0 14.4 10.8 13.3 17.8 16.8 14.1 17.2 12.6 15.4 17.5 16.2 24.7 28.0 15.3 22.8 14.1 15.4 12.3 18.8 14.0 29.9 18.1 13.8 14.7 15.0 18.3 13.5 14.8 13.4 20.7 14.0 17.2 19.2 14.4 15.9 9.8 8.4 3.4 9.1 6.2 11.6 5.6 16.8 14.4 14.0 15.9 10.6 8.8 13.6 14.2 15.0 16.8 14.5 19.8 13.3 9.0 10.1 12.2 9.4 14.8 22.8 18.3 22.1 13.1 16.0 12.0 11.2 16.8 9.2 32.4 11.4 7.9 9.4 18.1 17.6 9.4 12.7 10.5 21.0 9.7 11.9 14.2 18.0 10.7 17.7 11.7 15.3 16.6 14.7 9.6 9.3 14.9 10.7 11.4 12.3 13.8 11.7 15.3 16.7 9.4 15.3 7.9 28.3 15.7 23.0 7.8 9.6 26.3 11.5 24.0 6.0 3.4 5.1 2.9 8.6 9.1 10.2 9.8 10.6 9.3 8.4 7.4 11.6 10.0 0.7 6.2 7.4 4.4 7.5 5.6 10.4 19.7 22.5 20.6 10.8 13.3 12.6 15.4 22.8 13.4 29.8 24.9 24.6 24.5 20.4 21.0 41.4 22.9 68.3 44.3 22.7 9.8 24.5 18.3 25.0 12.0 26.4 7.9 0.0 30.5 25.1 21.9 17.4 20.9 17.1 17.5 20.6 16.1 23.9 18.6 8.1 21.9 21.0 32.1 41.5 10.4 11.4 29.2 7.0 15.6 23.2 25.6 19.4 20.3 35.2 53.5 22.2 20.8 20.0 16.8 36.0 BPGM ENSG00000172331 "Bisphosphoglycerate mutase" P07738 7 134646808-134679813 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Glycolysis "Hydrolase, Isomerase" "Congenital erythrocytosis, Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "placenta: 184.7" "Group enriched" "Detected in all" 5 "Distal tubular cells: 109.5;Erythroid cells: 303.7;Syncytiotrophoblasts: 308.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 38.0;RT4: 61.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016493, HPA028735" Enhanced Approved "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA 69000000 "Nucleoli, Nucleoli rim" Nucleoplasm "HPA016493: AB_1845414, HPA028735: AB_10600791" "unprognostic (2.56e-1)" "prognostic favorable (7.95e-4)" "unprognostic (3.19e-1)" "unprognostic (3.94e-1)" "unprognostic (1.78e-1)" "unprognostic (5.22e-2)" "unprognostic (3.81e-3)" "unprognostic (1.96e-1)" "unprognostic (7.74e-2)" "unprognostic (4.67e-3)" "unprognostic (7.42e-2)" "unprognostic (5.69e-2)" "prognostic favorable (1.54e-8)" "unprognostic (2.18e-1)" "unprognostic (1.35e-1)" "unprognostic (2.73e-1)" "unprognostic (3.78e-2)" 6.1 7.3 13.6 4.5 11.1 37.7 6.9 11.7 11.6 7.1 6.9 9.1 6.1 4.3 5.4 10.2 14.6 4.7 6.9 7.3 12.5 14.2 19.1 8.1 8.0 5.2 13.9 7.8 5.7 5.4 16.5 14.4 184.7 12.4 7.5 5.4 6.7 10.6 10.3 17.7 5.5 6.0 6.6 15.9 8.6 6.8 7.4 8.8 8.5 7.5 22.2 13.3 24.9 9.5 11.6 10.2 28.2 12.8 9.8 14.5 12.8 4.5 5.5 7.4 9.9 8.5 5.0 7.4 13.7 16.6 5.3 8.0 2.2 6.1 5.5 4.1 7.6 10.6 3.7 7.8 7.5 9.4 38.0 6.8 3.2 5.1 2.5 5.8 6.0 4.2 4.9 6.9 10.0 5.5 8.2 19.3 7.0 9.2 7.0 12.6 2.2 9.8 8.4 7.6 9.3 5.3 7.5 5.3 4.0 12.1 61.1 6.3 10.7 6.3 7.7 6.8 8.2 5.1 3.9 14.7 8.5 2.0 11.4 11.1 11.5 13.2 6.9 14.7 5.8 14.5 28.2 9.8 27.6 14.5 12.8 10.4 11.6 9.5 12.7 10.2 10.5 13.2 13.4 18.0 9.8 12.5 6.7 12.0 12.8 13.6 11.1 11.7 11.6 12.5 14.2 13.9 7.8 12.4 8.8 8.9 26.7 14.4 18.4 34.7 20.3 20.5 15.3 29.4 14.8 26.2 2.0 35.3 109.5 38.4 2.2 11.9 5.1 303.7 15.9 28.0 17.1 21.1 24.3 4.3 13.3 19.1 12.6 8.0 7.3 5.1 9.5 11.3 21.9 19.8 3.8 18.6 36.1 3.5 11.3 47.1 11.6 6.5 24.7 27.9 22.5 11.5 308.5 21.5 4.5 13.7 BRWD1 "C21orf107, DCAF19, FLJ11315, N143, WDR9" ENSG00000185658 "Bromodomain and WD repeat domain containing 1" Q9NSI6 21 39184176-39321559 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030943, HPA030944, HPA030945, CAB034184" Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "CAB034184: AB_2243666, HPA030943: AB_2673666, HPA030944: AB_2673667, HPA030945: AB_10670161" "unprognostic (6.00e-2)" "unprognostic (1.35e-1)" "unprognostic (1.96e-1)" "unprognostic (1.31e-1)" "unprognostic (1.27e-1)" "unprognostic (8.39e-3)" "unprognostic (4.94e-2)" "unprognostic (5.01e-2)" "unprognostic (8.90e-2)" "unprognostic (2.26e-1)" "unprognostic (4.82e-3)" "unprognostic (5.45e-2)" "unprognostic (2.58e-3)" "unprognostic (6.48e-2)" "unprognostic (1.19e-1)" "unprognostic (3.88e-2)" "unprognostic (2.56e-2)" 10.9 16.7 33.0 15.4 36.8 13.4 16.3 15.5 40.2 12.3 12.0 14.3 10.5 8.8 13.0 21.1 10.2 11.8 9.9 12.9 29.1 32.9 13.9 21.8 10.0 12.9 24.3 17.7 16.2 17.2 12.8 12.0 15.2 13.4 13.2 11.5 13.0 9.3 11.8 14.6 11.9 9.6 13.1 16.1 9.6 9.9 17.2 10.5 22.4 17.7 9.3 13.2 12.1 11.6 8.5 7.2 11.6 6.1 10.2 11.1 3.8 10.2 4.1 10.1 5.6 6.5 9.8 10.4 5.9 6.9 4.6 5.4 3.9 7.0 32.9 6.2 8.0 5.5 5.1 9.4 6.8 7.3 7.6 7.7 22.3 7.2 7.1 8.2 12.3 6.3 6.7 11.2 6.3 16.0 10.7 6.8 21.0 16.5 16.6 6.4 7.9 8.4 14.5 10.6 12.4 5.8 14.9 7.8 10.4 5.6 6.6 8.0 10.3 12.6 15.2 8.7 3.9 12.9 17.2 7.5 6.1 2.9 3.5 4.4 18.5 12.7 16.0 7.3 13.2 4.8 4.4 5.2 11.6 10.7 6.1 8.3 8.5 9.2 11.0 7.2 6.3 11.1 9.0 5.7 10.2 3.8 6.8 10.3 3.8 33.0 36.8 15.5 40.0 29.1 32.9 24.3 17.7 13.4 10.5 44.7 40.4 19.5 36.5 56.1 63.7 54.9 17.8 49.5 39.8 17.4 110.0 50.0 38.1 24.8 41.9 37.6 30.2 23.3 30.0 38.8 37.9 51.4 31.3 31.6 22.1 69.9 34.0 33.2 35.6 16.8 40.0 27.5 28.7 23.4 35.9 35.9 32.0 28.1 42.1 28.1 103.4 25.8 37.3 85.4 77.1 61.5 83.5 38.9 34.2 55.4 C11orf68 "BLES03, P5326" ENSG00000175573 "Chromosome 11 open reading frame 68" Q9H3H3 11 65916808-65919117 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045938 Uncertain Approved "Nucleoplasm,Nucleoli,Nucleoli rim" No Yes "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA045938: AB_10961633" "unprognostic (3.18e-1)" "unprognostic (3.35e-2)" "unprognostic (2.38e-2)" "unprognostic (4.48e-2)" "unprognostic (1.23e-1)" "unprognostic (9.25e-2)" "unprognostic (1.15e-2)" "unprognostic (9.88e-2)" "unprognostic (5.98e-2)" "unprognostic (9.88e-2)" "unprognostic (2.73e-1)" "unprognostic (1.50e-3)" "prognostic favorable (5.02e-6)" "unprognostic (2.16e-1)" "unprognostic (3.55e-1)" "unprognostic (3.07e-2)" "unprognostic (1.18e-1)" 20.1 13.1 23.5 11.0 23.5 6.9 15.4 44.0 42.9 24.5 19.7 20.0 16.6 13.6 26.3 33.0 19.0 25.3 16.4 24.5 22.9 18.8 13.7 12.1 15.4 17.3 18.3 23.7 32.9 17.6 20.6 11.0 19.5 18.6 23.3 12.9 14.8 24.2 27.5 37.0 19.6 13.1 22.2 15.5 19.0 14.1 21.5 18.5 23.0 21.5 13.1 16.4 22.3 23.1 6.6 3.6 12.6 5.2 4.9 7.5 2.8 20.4 9.2 5.7 6.2 20.2 19.6 4.9 16.4 25.2 21.0 12.9 3.4 23.3 4.2 11.5 24.6 33.7 6.7 4.4 10.1 11.4 6.5 4.4 5.0 6.2 8.9 16.1 3.9 6.7 18.1 15.2 15.2 16.9 21.9 15.6 7.2 6.6 10.6 38.1 9.3 5.2 9.6 5.7 4.5 46.3 7.7 6.5 11.8 11.1 3.9 3.9 6.1 6.3 8.4 15.8 6.2 10.8 3.8 16.8 33.6 16.4 45.6 8.3 7.1 3.1 3.5 19.9 3.0 26.1 8.7 3.5 4.9 7.4 5.2 5.2 4.2 4.8 6.1 2.6 6.6 7.4 7.5 12.6 4.9 2.6 3.6 5.6 2.8 23.5 23.5 44.0 42.9 22.9 18.8 18.3 23.7 18.6 18.5 14.9 6.1 6.7 24.0 13.6 10.2 13.7 15.3 0.0 1.2 15.7 9.8 13.0 6.6 11.6 6.3 10.5 10.0 0.0 10.0 13.3 15.8 19.5 3.5 9.6 12.3 15.9 4.6 16.0 11.5 19.9 19.8 6.6 10.1 14.4 11.6 22.3 13.9 0.0 33.2 5.1 7.2 19.4 12.5 13.9 14.3 11.2 18.3 8.7 8.4 22.4 C15orf61 LOC145853 ENSG00000189227 "Chromosome 15 open reading frame 61" A6NNL5 15 67521068-67530143 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 45.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062820 Approved Nucleoli,Vesicles,Cytosol "Secreted - unknown location" NA NA "Nucleoli, Vesicles" Cytosol "HPA062820: AB_2684874" "unprognostic (1.35e-1)" "unprognostic (9.42e-3)" "unprognostic (2.11e-1)" "unprognostic (5.41e-2)" "unprognostic (2.40e-1)" "unprognostic (2.49e-1)" "unprognostic (1.49e-1)" "unprognostic (3.87e-3)" "unprognostic (8.95e-2)" "unprognostic (4.01e-2)" "unprognostic (1.04e-2)" "unprognostic (8.45e-2)" "prognostic favorable (5.31e-5)" "unprognostic (2.42e-2)" "unprognostic (9.78e-2)" "unprognostic (1.42e-1)" "unprognostic (8.32e-2)" 9.9 10.0 10.8 4.7 18.1 11.0 17.9 14.5 17.2 5.5 6.0 2.4 5.6 7.5 6.3 5.9 5.5 5.2 5.1 21.0 8.7 7.2 8.4 6.4 7.2 7.5 6.9 10.9 7.9 20.7 8.8 10.9 5.8 7.3 7.2 6.4 5.9 7.0 6.4 45.8 8.4 5.0 7.0 5.8 5.0 6.6 25.2 5.5 3.6 7.7 16.9 3.7 4.6 8.0 7.2 7.2 10.7 6.6 5.1 9.8 5.0 4.2 4.6 1.2 5.1 5.4 7.8 3.3 1.9 3.4 3.5 2.8 3.5 3.0 3.6 4.1 2.1 4.1 5.0 4.6 1.3 2.9 2.1 10.9 3.8 3.5 4.6 3.5 4.7 3.2 8.1 3.5 1.1 4.3 2.5 1.6 11.1 4.3 8.0 1.1 2.4 3.8 7.7 1.9 3.4 5.8 5.2 2.6 13.1 2.5 3.0 6.8 5.1 3.3 3.2 5.8 2.3 2.8 7.2 1.6 4.7 7.2 5.9 4.8 7.6 11.0 8.7 2.0 9.2 2.4 8.6 6.6 10.7 7.0 5.2 8.0 7.2 9.2 6.9 6.9 5.6 9.8 7.9 0.8 5.1 4.4 7.2 5.6 5.0 10.8 18.1 14.5 17.2 8.7 7.2 6.9 10.9 7.3 5.5 20.8 9.1 25.1 28.7 59.6 71.3 69.8 20.4 6.7 7.9 15.7 35.3 35.6 68.0 21.1 136.1 26.6 30.6 0.0 25.8 25.7 33.5 30.2 33.5 33.8 26.4 12.7 26.0 17.2 20.2 22.0 38.0 16.0 35.4 7.2 47.0 62.2 24.4 38.6 24.1 54.0 68.8 32.3 28.3 136.2 21.8 53.2 17.2 31.9 43.0 15.6 C1orf109 FLJ20508 ENSG00000116922 "Chromosome 1 open reading frame 109" Q9NX04 1 37681570-37692249 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 44.6;Suprabasal keratinocytes: 54.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027110, HPA027127" Supported Supported Nucleoplasm,Nucleoli,Cytosol NA NA Cytosol "Nucleoplasm, Nucleoli" "HPA027110: AB_10611813, HPA027127: AB_1845628" "unprognostic (1.37e-1)" "unprognostic (3.65e-2)" "unprognostic (2.43e-1)" "unprognostic (3.30e-3)" "unprognostic (1.71e-2)" "unprognostic (7.13e-3)" "prognostic unfavorable (1.76e-7)" "unprognostic (1.93e-1)" "unprognostic (1.48e-2)" "unprognostic (8.38e-2)" "unprognostic (1.73e-1)" "unprognostic (3.79e-3)" "unprognostic (9.96e-2)" "unprognostic (1.66e-2)" "unprognostic (2.25e-1)" "unprognostic (7.96e-3)" "unprognostic (1.69e-1)" 13.8 15.1 12.0 9.3 15.0 9.3 14.5 17.9 20.5 12.9 11.1 11.4 16.2 11.0 15.9 14.3 13.7 13.9 10.5 11.1 13.1 12.9 12.8 12.0 8.8 14.1 13.6 15.0 19.7 19.6 20.5 10.9 14.6 15.9 15.0 7.8 12.9 20.3 14.8 15.2 14.9 8.5 11.6 9.9 10.1 11.1 11.2 12.2 13.1 15.7 9.1 12.6 13.7 12.8 11.4 27.5 3.3 5.0 12.2 16.2 7.5 8.3 9.6 8.3 13.6 7.3 5.2 18.9 10.0 7.1 15.2 11.2 14.6 10.1 11.9 12.1 4.4 7.0 12.2 15.3 10.2 15.6 18.9 17.2 13.5 9.7 9.1 14.1 14.7 8.9 7.1 12.6 14.9 19.5 6.6 7.6 10.5 26.5 14.5 8.6 5.7 14.2 6.5 25.8 8.6 18.5 14.2 17.4 32.5 8.0 7.2 25.1 12.1 8.8 13.7 20.3 8.7 7.7 6.6 5.1 15.3 9.6 12.3 20.3 11.8 13.1 24.3 7.6 14.4 16.0 1.7 5.0 3.3 10.3 3.9 16.1 11.4 12.4 9.9 5.9 10.3 16.2 13.8 0.9 12.2 4.2 27.5 6.2 7.5 12.0 15.0 17.9 20.5 13.1 12.9 13.6 15.0 15.9 12.2 6.0 6.4 16.6 16.0 44.6 9.7 4.5 7.6 6.7 15.9 3.5 9.8 11.8 11.6 8.2 1.2 10.5 4.0 23.3 6.3 11.6 13.5 9.8 11.5 4.9 4.9 15.9 4.1 5.5 4.3 0.2 9.2 4.9 11.8 7.2 4.5 10.1 8.1 7.0 13.1 6.8 12.2 0.0 10.3 10.1 26.6 54.3 6.6 13.8 7.3 9.6 C5orf67 ENSG00000225940 "Chromosome 5 open reading frame 67" F2Z3F1 5 56511567-56606232 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "epididymis: 17.9;kidney: 9.3;retina: 16.3" "Group enriched" "Detected in some" 4 "Collecting duct cells: 1.8;Distal tubular cells: 1.7;Proximal tubular cells: 1.2" "Cancer enhanced" "Detected in single" "thyroid cancer: 0.9" "Region enriched" "Detected in some" 5 "pons and medulla: 6.1" "Cell type enhanced" "Detected in some" "neutrophil: 3.3" "Group enriched" "Detected in many" 5 "dendritic cells: 1.5;granulocytes: 3.3;monocytes: 1.9" "Group enriched" "Detected in some" 7 "CACO-2: 3.2;EFO-21: 9.3;U-266/70: 10.4" HPA054214 Approved Nucleoplasm,Nucleoli,Vesicles NA NA Nucleoli "Nucleoplasm, Vesicles" "HPA054214: " "unprognostic (7.28e-2)" "unprognostic (1.41e-1)" "unprognostic (2.55e-1)" "unprognostic (1.35e-1)" "unprognostic (1.12e-3)" "unprognostic (6.58e-2)" "unprognostic (7.93e-2)" "unprognostic (2.91e-1)" "unprognostic (2.18e-1)" "unprognostic (8.69e-2)" "unprognostic (1.35e-1)" "unprognostic (1.83e-1)" "unprognostic (1.64e-1)" "unprognostic (3.62e-2)" 0.4 0.0 0.2 0.2 1.2 0.4 1.0 0.2 0.2 0.4 0.8 0.4 0.2 1.5 0.6 17.9 0.4 0.4 0.2 0.2 0.6 0.2 9.3 0.2 0.4 0.6 0.7 0.2 0.2 0.2 0.0 0.2 0.2 6.1 0.2 0.0 16.3 1.1 0.2 0.2 0.8 1.6 0.2 0.2 1.5 0.1 0.2 0.2 0.2 2.1 0.2 0.2 0.2 0.2 0.1 1.5 3.3 1.9 0.0 0.4 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.3 0.0 9.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.2 0.0 0.0 0.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.5 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.6 0.0 0.1 0.1 0.0 0.5 0.0 0.0 0.0 3.3 0.0 1.9 1.5 0.4 0.1 0.2 1.2 0.2 0.2 0.6 0.2 0.7 0.2 6.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C8orf34 "vest-1, VEST1" ENSG00000165084 "Chromosome 8 open reading frame 34" Q49A92 8 68330722-68819022 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 15.3;parathyroid gland: 19.9" "Cell type enhanced" "Detected in some" 17 "Alveolar cells type 1: 14.9;Alveolar cells type 2: 16.0;Ciliated cells: 28.1;Club cells: 6.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+: 4.5;HEK 293: 5.8;LHCN-M2: 5.1;RH-30: 5.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044420, HPA053065" Uncertain Supported "Nucleoplasm,Nucleoli,Golgi apparatus" No NA "Nucleoplasm, Nucleoli" "Golgi apparatus" "HPA044420: AB_10963791, HPA053065: AB_2682030" "unprognostic (1.75e-1)" "unprognostic (2.20e-1)" "unprognostic (3.30e-2)" "unprognostic (5.59e-3)" "unprognostic (3.07e-1)" "unprognostic (2.85e-2)" "unprognostic (3.35e-1)" "unprognostic (1.19e-1)" "unprognostic (2.80e-1)" "unprognostic (1.74e-1)" "unprognostic (8.55e-2)" "unprognostic (5.86e-2)" "unprognostic (1.80e-4)" "unprognostic (5.21e-2)" "unprognostic (8.87e-2)" "unprognostic (2.84e-4)" "unprognostic (1.33e-1)" 4.2 0.9 7.4 0.8 10.6 1.1 1.5 9.6 8.4 4.0 0.7 9.6 0.2 0.7 1.5 2.5 2.1 15.3 3.2 1.6 8.9 7.0 1.0 0.7 8.3 0.8 3.7 5.0 1.4 2.1 19.9 2.7 0.9 10.4 3.9 0.9 3.5 1.4 2.2 0.9 1.8 0.8 1.7 3.2 0.8 1.7 1.4 6.7 0.0 1.0 1.1 0.7 1.2 1.1 1.8 2.0 2.9 0.7 1.3 1.8 0.5 0.3 0.0 0.8 0.4 1.2 2.3 0.2 1.4 4.5 0.7 0.6 0.3 0.4 0.2 0.9 1.2 0.2 0.3 0.3 0.8 0.2 0.1 5.8 0.7 1.0 0.4 0.3 0.1 0.5 0.1 0.6 0.8 1.6 0.3 0.1 0.7 0.3 1.0 5.1 0.6 0.1 0.5 2.6 0.0 0.1 0.2 5.4 0.1 0.6 0.4 1.1 0.2 0.3 0.3 0.0 0.6 2.6 0.2 0.1 1.0 0.6 3.4 0.2 0.8 0.0 0.1 0.4 0.3 0.8 2.1 0.7 1.2 1.4 0.3 1.1 1.0 1.2 1.1 0.3 1.8 1.5 1.8 2.9 1.3 0.5 2.0 0.8 0.5 7.4 10.6 9.6 8.4 8.9 7.0 3.7 5.0 10.4 6.7 14.9 16.0 0.0 0.6 1.4 1.2 1.2 0.0 28.1 6.8 0.0 0.0 0.3 0.0 0.3 0.3 0.3 0.0 0.0 0.0 0.2 0.9 1.2 1.1 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.3 0.0 1.7 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.6 0.0 1.0 0.2 0.2 0.6 0.3 0.0 0.0 0.4 C8orf59 ENSG00000176731 "Chromosome 8 open reading frame 59" Q8N0T1 8 85214076-85220421 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044805, HPA071903" Enhanced Nucleoplasm,Nucleoli,Cytosol No No "Nucleoplasm, Nucleoli" Cytosol "HPA044805: AB_2679095, HPA071903: AB_2686469" "unprognostic (1.61e-2)" "unprognostic (2.98e-1)" "unprognostic (4.51e-1)" "unprognostic (1.63e-3)" "unprognostic (2.19e-2)" "unprognostic (1.71e-1)" "unprognostic (1.36e-2)" "unprognostic (1.47e-1)" "unprognostic (1.22e-3)" "unprognostic (1.63e-1)" "unprognostic (1.69e-2)" "unprognostic (2.82e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.03e-2)" "unprognostic (3.16e-2)" "unprognostic (2.29e-1)" "unprognostic (3.84e-3)" 28.1 28.2 25.3 25.3 21.9 33.0 46.1 18.9 26.5 33.0 38.4 12.6 36.3 28.1 32.0 45.5 44.8 28.7 25.8 41.5 20.6 24.1 32.3 47.1 20.8 30.7 26.3 27.2 45.1 35.1 19.5 36.0 27.7 24.4 35.5 27.7 14.7 37.8 36.2 43.9 24.8 37.1 33.7 27.0 32.2 36.9 16.7 25.7 39.1 43.5 53.6 32.0 39.1 35.2 33.3 42.7 21.3 25.3 36.5 38.0 23.9 38.9 19.9 29.6 19.2 18.4 35.7 23.2 26.0 25.0 30.4 30.0 23.2 33.8 9.7 21.5 17.2 28.5 27.2 20.5 28.5 34.3 27.4 22.4 57.6 18.8 34.2 21.8 21.6 26.1 30.2 33.9 19.6 24.8 33.1 25.8 35.0 25.8 24.0 25.2 30.7 47.7 40.6 8.5 88.2 34.8 20.4 24.8 44.2 29.5 25.0 10.0 21.5 19.7 32.4 35.7 37.3 37.3 32.3 19.7 19.4 40.7 21.5 24.6 27.9 32.7 45.8 38.7 27.7 21.5 21.3 20.5 13.4 24.7 25.3 29.5 33.3 32.7 30.1 34.8 29.9 38.0 36.3 5.1 36.5 21.5 42.7 32.1 23.9 25.3 21.9 18.9 26.5 20.6 24.1 26.3 27.2 24.4 25.7 80.4 65.2 124.2 47.1 48.2 25.9 26.3 86.6 147.2 103.5 34.9 9.8 86.5 56.3 152.0 93.6 67.1 76.6 46.7 240.4 102.1 84.3 40.2 75.1 136.0 90.6 22.3 36.9 108.6 132.2 20.6 173.2 92.3 54.0 180.3 112.7 58.4 213.9 84.2 122.0 90.6 33.5 155.2 88.6 128.1 91.8 40.0 64.3 104.7 101.8 39.3 C9orf85 MGC61599 ENSG00000155621 "Chromosome 9 open reading frame 85" Q96MD7 9 71911510-71986054 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050767, HPA076627" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" No No "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA050767: AB_2681229, HPA076627: " "unprognostic (7.81e-2)" "unprognostic (2.80e-1)" "unprognostic (6.21e-2)" "unprognostic (3.04e-1)" "unprognostic (2.89e-2)" "unprognostic (2.87e-2)" "unprognostic (1.99e-2)" "unprognostic (2.34e-1)" "unprognostic (1.01e-1)" "unprognostic (3.05e-1)" "unprognostic (1.27e-1)" "unprognostic (3.48e-1)" "unprognostic (1.10e-2)" "unprognostic (8.10e-2)" "unprognostic (6.60e-2)" "unprognostic (4.02e-1)" "unprognostic (6.18e-2)" 13.4 12.7 15.5 10.1 26.0 8.9 14.7 11.2 18.8 12.8 12.9 18.2 15.0 19.3 14.1 14.3 18.4 11.6 12.0 10.5 14.9 13.8 12.3 13.1 10.4 13.0 24.5 13.3 16.9 14.7 9.8 16.9 13.9 15.2 13.1 13.7 14.3 14.7 9.8 14.6 18.4 16.3 15.2 21.1 10.7 11.2 9.2 21.9 14.5 14.8 15.9 12.9 18.8 15.5 11.3 13.1 16.1 9.9 17.1 14.6 9.3 7.7 5.1 9.1 7.4 9.6 17.4 9.3 10.0 15.5 8.1 7.9 1.1 4.7 12.7 5.1 8.6 8.5 14.3 9.5 9.5 11.2 8.9 4.7 7.8 7.5 6.4 10.3 11.4 6.4 14.1 13.0 8.1 17.8 12.7 9.9 12.3 9.2 8.6 10.2 4.0 13.7 8.0 8.6 12.5 12.6 8.1 15.8 0.3 11.5 11.3 7.6 10.0 4.9 12.7 16.5 10.4 4.5 6.6 8.7 7.5 9.6 16.9 7.3 8.6 14.1 5.8 10.1 8.7 4.8 16.1 8.9 12.6 13.4 9.9 13.7 10.9 11.5 11.5 9.3 11.3 14.0 14.6 9.9 17.1 8.3 13.1 10.5 9.3 15.5 26.0 11.2 18.8 14.9 13.8 24.5 13.3 15.2 21.9 6.0 14.2 13.0 11.4 6.8 10.6 10.8 5.1 9.4 11.4 5.2 7.9 17.8 18.3 12.3 6.1 11.6 23.0 0.0 17.3 15.9 12.4 13.2 18.4 8.7 12.9 4.8 6.3 16.0 12.4 4.5 19.2 13.3 3.3 11.8 17.8 11.2 14.2 17.5 12.4 15.1 11.5 12.9 12.7 13.0 14.2 8.5 9.0 12.2 16.3 17.9 CA13 "CAXIII, FLJ37995, MGC59868" ENSG00000185015 "Carbonic anhydrase 13" Q8N1Q1 8 85220587-85284073 "Enzymes, Predicted intracellular proteins" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 56.7" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 31.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 12.5;OE19: 24.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA024689, CAB025567" Enhanced Approved Nucleoplasm,Nucleoli,Vesicles NA NA 100000 Nucleoli "Nucleoplasm, Vesicles" "CAB025567: , HPA024689: AB_1846004" "unprognostic (1.12e-2)" "unprognostic (2.20e-1)" "unprognostic (1.75e-1)" "unprognostic (9.16e-5)" "unprognostic (2.21e-2)" "unprognostic (2.08e-1)" "unprognostic (9.39e-2)" "unprognostic (7.90e-3)" "unprognostic (1.97e-1)" "unprognostic (1.34e-2)" "unprognostic (3.58e-2)" "unprognostic (3.13e-1)" "prognostic favorable (9.40e-4)" "unprognostic (7.59e-2)" "unprognostic (1.59e-1)" "unprognostic (1.55e-2)" "unprognostic (3.00e-1)" 2.6 2.6 2.0 1.9 3.1 0.5 2.9 2.4 2.4 3.2 18.2 0.8 0.0 14.2 1.8 1.7 6.7 1.4 25.6 5.8 1.6 1.9 10.4 17.1 9.5 2.4 2.0 0.1 2.2 1.6 9.3 6.5 1.0 5.7 2.6 3.7 1.9 7.0 1.0 1.9 7.1 56.7 1.9 5.2 2.2 7.0 0.9 0.9 0.4 10.3 3.9 5.6 2.9 5.2 0.8 2.1 3.2 2.5 0.5 0.5 1.0 0.2 0.3 0.7 0.1 0.5 0.5 0.3 0.8 0.9 0.1 2.4 5.8 4.5 0.3 0.4 1.0 5.1 1.9 1.8 2.3 0.1 1.3 0.8 12.5 1.6 5.3 1.2 0.2 0.5 1.9 0.4 0.2 1.0 1.5 1.3 0.5 3.1 2.4 2.1 0.0 0.2 0.2 0.3 24.6 0.3 0.2 1.8 0.1 6.7 0.2 0.2 0.0 0.4 0.0 1.3 0.9 0.4 0.6 1.2 2.3 3.3 0.1 1.3 1.0 0.4 1.5 4.8 1.8 2.2 3.2 2.5 1.3 0.4 0.7 0.2 0.2 0.2 0.1 2.1 0.8 0.3 0.5 0.9 0.5 0.8 0.9 0.1 1.0 2.0 3.1 2.4 2.4 1.6 1.9 2.0 0.1 5.7 0.9 3.0 7.7 1.4 2.1 1.5 1.5 5.2 5.1 10.7 12.5 12.2 31.4 0.2 8.3 3.2 9.1 2.1 16.9 0.0 1.4 0.2 3.1 2.1 0.0 4.7 0.9 0.0 4.6 9.8 3.0 10.4 0.0 2.2 5.0 0.0 3.2 2.0 3.1 4.9 0.0 16.1 5.1 0.0 1.0 1.2 2.3 2.8 0.2 1.0 3.4 1.8 CAMLG "CAML, GET2" ENSG00000164615 "Calcium modulating ligand" P49069 5 134738501-134752160 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Host-virus interaction" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 658.5;Late spermatids: 1206.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052636, HPA056472" Approved Approved Nucleoplasm,Nucleoli,Vesicles NA NA Vesicles "Nucleoplasm, Nucleoli" "HPA052636: AB_2681893, HPA056472: AB_2683143" "unprognostic (9.23e-2)" "unprognostic (8.54e-2)" "unprognostic (2.95e-1)" "unprognostic (2.21e-1)" "unprognostic (1.07e-1)" "unprognostic (1.07e-2)" "unprognostic (3.68e-2)" "unprognostic (5.41e-3)" "unprognostic (3.07e-1)" "unprognostic (8.54e-2)" "unprognostic (5.34e-3)" "unprognostic (4.58e-2)" "prognostic unfavorable (1.09e-5)" "unprognostic (3.26e-2)" "unprognostic (1.43e-2)" "unprognostic (2.19e-1)" "unprognostic (3.16e-1)" 24.2 29.0 37.6 14.3 32.4 22.7 29.3 28.2 39.3 33.3 32.7 15.5 20.2 26.1 31.7 45.2 21.4 23.0 21.8 22.3 32.4 38.3 20.1 19.7 18.9 18.4 36.2 22.7 53.0 25.7 14.8 21.9 14.0 22.4 27.5 14.3 21.7 15.9 26.2 32.5 19.7 22.2 30.4 26.0 15.1 17.7 36.6 14.0 21.1 21.6 18.5 19.3 40.3 20.0 25.0 16.1 32.1 23.3 16.6 28.6 17.4 9.6 7.5 12.8 23.8 28.5 44.2 5.8 13.7 19.9 10.2 19.4 13.7 14.7 39.3 20.1 9.5 15.9 12.5 10.5 16.7 14.6 18.3 19.5 10.4 13.6 11.1 21.0 5.5 33.0 35.8 18.2 12.6 21.7 33.9 19.3 17.4 6.6 18.3 15.2 10.7 14.5 23.3 6.6 12.0 7.6 16.4 17.0 15.1 17.5 9.4 19.0 13.3 9.8 6.3 32.7 17.2 17.3 11.5 18.4 10.0 6.2 15.2 12.4 17.2 18.6 15.0 16.8 17.4 5.4 32.1 15.2 32.1 18.3 17.3 24.6 25.0 26.4 22.9 16.1 22.4 27.8 26.8 27.6 16.6 23.3 14.7 28.6 17.4 37.6 32.4 28.2 39.3 32.4 38.3 36.2 22.7 22.4 14.0 35.7 31.3 84.3 104.0 148.5 76.2 38.6 76.5 32.1 48.9 40.1 23.6 43.8 77.9 53.1 658.5 74.5 44.2 0.0 78.9 53.3 107.2 105.7 119.1 66.0 62.6 52.4 60.0 81.6 102.8 1206.3 155.6 92.2 91.1 124.4 64.9 79.0 61.6 59.6 124.5 149.1 63.7 97.0 161.7 114.4 74.5 176.2 61.2 108.0 83.2 90.1 CATSPERG "C19orf15, DKFZp434A1022, FLJ46353" ENSG00000099338 "Cation channel sperm associated auxiliary subunit gamma" Q6ZRH7 19 38335775-38370943 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 35.7" "Group enriched" "Detected in many" 7 "Early spermatids: 23.9;Enterocytes: 14.0;Late spermatids: 27.8;Spermatocytes: 31.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.8" "Group enriched" "Detected in many" 5 "granulocytes: 4.8;monocytes: 1.8" "Cell line enhanced" "Detected in some" "BEWO: 4.2;HMC-1: 5.3;MCF7: 4.3" "Low region specificity" "Detected in all" HPA052777 Approved Nucleoplasm,Nucleoli,Cytosol "Secreted in male reproductive system" NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA052777: " "unprognostic (8.50e-5)" "unprognostic (5.12e-2)" "unprognostic (3.57e-3)" "unprognostic (1.51e-1)" "unprognostic (2.63e-1)" "unprognostic (3.18e-1)" "unprognostic (2.60e-1)" "unprognostic (2.87e-3)" "unprognostic (1.00e-1)" "unprognostic (2.92e-2)" "unprognostic (1.06e-1)" "unprognostic (2.50e-1)" "unprognostic (4.37e-4)" "unprognostic (9.99e-2)" "unprognostic (2.01e-1)" "unprognostic (4.61e-2)" "unprognostic (1.07e-3)" 0.9 0.8 2.9 0.8 7.7 1.1 1.3 4.3 5.8 1.2 1.1 6.5 1.9 1.2 1.2 1.8 0.9 1.4 0.9 0.8 3.9 1.0 1.0 1.0 1.1 1.0 7.4 2.2 1.3 1.0 1.0 1.2 0.8 5.2 1.3 1.0 0.4 2.0 1.1 1.0 2.0 1.1 0.9 3.2 0.9 1.0 35.7 6.5 2.2 1.3 0.0 1.0 0.9 3.3 0.1 0.6 4.8 1.8 0.2 0.5 0.2 0.2 0.5 0.2 1.8 0.8 0.0 4.2 0.2 0.0 0.0 0.0 1.3 0.8 0.3 0.0 0.0 0.7 0.6 0.5 0.1 0.0 0.9 0.2 0.1 0.2 0.0 0.1 0.3 5.3 0.0 0.8 0.0 0.5 0.5 0.1 0.8 0.0 1.4 0.0 4.3 0.0 0.0 0.0 1.1 0.8 0.1 0.0 0.8 2.0 0.1 0.4 0.6 0.4 0.9 0.2 0.7 0.4 0.0 0.3 0.0 1.0 0.7 0.0 0.8 0.9 0.0 0.2 0.2 0.0 0.3 0.8 1.8 0.4 0.9 0.2 0.0 0.1 0.2 0.6 0.1 0.5 0.2 4.8 0.2 1.8 0.4 0.3 0.2 2.9 7.7 4.3 5.8 3.9 1.0 7.4 2.2 5.2 6.5 0.0 2.4 1.7 1.9 2.3 1.1 2.4 2.5 0.0 0.0 1.8 0.0 1.0 0.0 0.8 23.9 1.5 14.0 0.0 0.6 0.2 1.5 1.8 1.1 0.5 2.8 1.6 1.7 1.8 0.8 27.8 1.7 2.6 0.0 1.8 1.5 1.9 0.5 3.5 2.1 1.1 1.1 0.0 1.0 31.9 2.7 1.6 1.1 2.5 2.0 1.4 CCDC148 MGC125588 ENSG00000153237 "Coiled-coil domain containing 148" Q8NFR7 2 158171081-158456753 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 5.9;testis: 6.5" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 40.2;Cone photoreceptor cells: 53.0;Early spermatids: 22.4;Rod photoreceptor cells: 29.6" "Low cancer specificity" "Detected in some" "Cell type enriched" "Detected in single" 9 "basophil: 1.9" "Lineage enriched" "Detected in single" 9 "granulocytes: 1.9" "Cell line enhanced" "Detected in some" "CAPAN-2: 6.1;HBF TERT88: 4.3;hTEC/SVTERT24-B: 2.8;RPTEC TERT1: 3.3;SCLC-21H: 4.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042626 Uncertain Uncertain "Nucleoplasm,Nucleoli,Nucleoli rim" No No "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA042626: AB_10806244" "unprognostic (1.88e-1)" "unprognostic (5.90e-2)" "unprognostic (3.31e-2)" "unprognostic (1.94e-4)" "unprognostic (3.29e-1)" "unprognostic (7.65e-2)" "unprognostic (1.23e-1)" "unprognostic (1.32e-1)" "unprognostic (1.09e-1)" "unprognostic (7.98e-2)" "unprognostic (1.84e-1)" "unprognostic (1.18e-1)" "unprognostic (1.42e-2)" "unprognostic (5.77e-2)" "unprognostic (3.35e-2)" "prognostic favorable (2.54e-4)" "unprognostic (6.57e-3)" 0.1 0.5 0.6 0.0 0.8 0.0 1.8 1.9 0.3 1.4 0.0 0.0 0.6 2.4 0.0 3.3 0.4 0.0 0.7 0.8 4.3 0.1 0.6 0.0 0.5 1.3 0.1 5.9 1.9 0.0 0.4 0.0 1.0 0.7 0.0 0.2 0.0 0.0 1.0 0.0 0.0 6.5 1.8 0.0 0.1 0.3 0.0 0.0 1.9 0.0 0.0 0.2 0.0 1.3 0.0 0.8 1.0 0.0 0.0 0.1 0.9 0.0 1.1 2.3 1.1 6.1 0.1 0.1 0.9 0.4 0.5 0.0 0.3 4.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.4 0.4 0.0 0.2 0.0 0.1 0.5 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 3.3 0.4 4.2 0.2 0.3 0.4 0.5 1.3 2.4 0.3 0.0 0.4 0.5 0.1 0.2 0.6 0.7 0.0 1.0 0.0 0.4 1.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 2.2 0.0 9.1 2.0 0.0 40.2 3.4 7.0 53.0 0.0 11.6 5.6 22.4 0.2 0.0 0.0 1.6 0.0 0.5 0.8 0.0 1.0 0.1 4.8 0.0 1.8 0.0 3.8 0.9 0.0 0.0 1.0 0.0 5.2 3.4 0.0 1.8 4.8 29.6 6.5 0.3 7.5 1.5 0.4 0.0 0.0 0.0 1.6 CCDC168 "C13orf40, FLJ40176" ENSG00000175820 "Coiled-coil domain containing 168" Q8NDH2 13 102729369-102759070 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 23.7" "Cell type enriched" "Detected in some" 32 "Early spermatids: 828.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HL-60: 1.6;MOLT-4: 1.3;NB-4: 1.0;THP-1: 2.0" "HPA048184, HPA058793, HPA078547" Uncertain Approved Nucleoli,Centrosome,Cytosol NA NA "Nucleoli, Centrosome" Cytosol "HPA048184: AB_2680303, HPA058793: AB_2683823, HPA078547: " "unprognostic (2.06e-1)" "unprognostic (7.95e-2)" "unprognostic (3.90e-2)" "unprognostic (1.38e-1)" "unprognostic (2.39e-4)" "unprognostic (2.09e-2)" "unprognostic (3.68e-2)" "unprognostic (2.74e-1)" "unprognostic (5.05e-2)" "unprognostic (3.61e-1)" "unprognostic (2.89e-3)" "unprognostic (1.73e-1)" "unprognostic (1.44e-5)" "unprognostic (2.56e-1)" "unprognostic (2.01e-1)" "unprognostic (2.85e-1)" "unprognostic (6.94e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.9 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.7 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.4 0.2 0.7 0.1 0.0 0.0 1.6 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 1.3 1.0 0.0 0.1 0.3 0.4 0.0 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.0 2.0 0.0 0.0 0.1 0.3 0.3 0.0 0.3 0.0 0.0 0.2 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.5 0.0 0.0 3.1 0.0 0.0 3.4 0.0 0.0 0.2 0.0 0.3 828.1 0.0 0.0 0.0 0.3 0.4 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.6 0.8 26.2 2.0 0.0 0.0 2.8 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.1 1.1 1.4 0.0 0.3 0.0 0.0 0.1 CCDC175 C14orf38 ENSG00000151838 "Coiled-coil domain containing 175" P0C221 14 59504539-59576831 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 17.1;pituitary gland: 6.6;testis: 8.2" "Cell type enhanced" "Detected in some" 13 "Ciliated cells: 13.4;Cone photoreceptor cells: 7.9;Early spermatids: 7.0;Rod photoreceptor cells: 11.8;Spermatocytes: 16.5" "Not detected" "Not detected" "Region enriched" "Detected in many" 5 "cerebellum: 17.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 1.6;SCLC-21H: 1.7" HPA004200 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA004200: AB_1078743" "unprognostic (3.64e-3)" "unprognostic (8.05e-2)" "unprognostic (1.13e-1)" "unprognostic (2.21e-1)" "unprognostic (3.83e-1)" "unprognostic (2.02e-2)" "unprognostic (5.98e-2)" "unprognostic (1.27e-1)" 0.2 0.1 0.9 0.2 2.9 0.5 0.2 17.1 3.3 0.2 0.9 1.2 0.0 0.3 0.2 1.0 0.2 1.3 0.5 0.2 0.8 0.5 0.4 0.2 0.5 0.2 0.8 0.9 0.2 0.1 0.3 6.6 0.1 3.0 0.2 1.8 0.6 0.2 0.2 0.2 0.3 0.9 0.2 0.4 0.4 0.2 8.2 1.5 0.0 0.3 0.0 0.2 0.1 0.1 0.0 0.1 0.5 0.1 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.1 0.0 0.4 0.9 2.9 17.1 3.3 0.8 0.5 0.8 0.9 3.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 13.4 1.2 0.0 7.9 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 11.8 0.0 0.0 16.5 1.3 0.0 0.0 0.0 2.6 0.0 CCDC24 MGC45441 ENSG00000159214 "Coiled-coil domain containing 24" Q8N4L8 1 43991359-43996528 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 52.2;Intestinal endocrine cells: 34.9;Spermatocytes: 48.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 6.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 15.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA035424, HPA061710" Uncertain Approved "Nucleoli,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoli, Cytosol" "HPA035424: AB_2674619, HPA061710: AB_2684591" "prognostic favorable (3.06e-5)" "unprognostic (1.47e-1)" "unprognostic (1.13e-2)" "unprognostic (1.05e-1)" "unprognostic (1.65e-2)" "prognostic favorable (3.18e-4)" "prognostic unfavorable (1.70e-4)" "unprognostic (1.92e-2)" "unprognostic (6.38e-2)" "unprognostic (2.81e-1)" "unprognostic (7.00e-3)" "unprognostic (3.00e-1)" "unprognostic (1.74e-2)" "unprognostic (6.91e-2)" "unprognostic (1.51e-1)" "unprognostic (7.84e-2)" "unprognostic (2.15e-3)" 1.8 5.5 9.3 2.6 9.8 1.1 5.1 3.0 9.8 7.2 5.0 3.2 18.9 3.7 4.9 6.6 2.6 20.3 13.1 1.5 6.4 8.0 8.9 3.0 3.2 2.6 5.5 9.6 3.4 6.0 9.6 14.5 2.4 5.2 7.2 4.1 6.5 8.4 14.7 1.5 0.9 3.3 3.4 3.3 3.0 4.9 15.4 1.7 0.6 8.8 1.0 2.5 4.7 2.1 6.8 0.8 1.4 4.0 0.5 0.6 0.5 5.1 3.1 1.4 1.6 1.4 1.0 3.1 0.2 2.2 1.6 2.8 2.0 15.0 4.2 5.9 0.6 4.6 5.3 0.8 7.4 1.5 4.4 1.8 2.1 1.9 0.6 1.6 0.7 3.7 0.3 0.7 5.2 0.5 5.0 1.3 1.6 0.9 1.6 2.2 4.5 0.3 1.6 3.1 4.7 2.6 1.3 0.0 0.8 6.2 2.0 3.4 3.0 4.6 2.6 2.9 3.1 7.8 0.1 0.4 2.4 7.0 1.8 0.7 0.6 2.0 0.9 6.3 0.6 2.0 0.0 0.7 1.4 0.6 4.0 0.3 6.8 0.2 0.2 0.8 3.0 0.0 0.0 0.6 0.5 3.1 0.6 0.0 0.5 9.3 9.8 3.0 9.8 6.4 8.0 5.5 9.6 5.2 1.7 3.0 7.4 0.5 8.2 1.0 8.8 0.8 12.7 52.2 19.4 8.7 5.9 4.7 18.3 7.1 16.4 0.7 6.3 0.0 6.4 1.7 3.3 6.8 2.3 2.1 2.9 3.2 34.9 1.8 3.2 8.5 2.0 1.8 3.3 4.6 12.1 9.5 5.4 8.6 2.8 8.0 14.2 0.0 2.4 48.8 19.5 0.6 2.1 0.0 13.0 8.4 CCDC7 "BIOT2, C10orf68, FLJ13031, FLJ32762" ENSG00000216937 "Coiled-coil domain containing 7" Q96M83 10 32446140-32882874 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "testis: 65.5" "Group enriched" "Detected in many" 8 "Early spermatids: 397.3;Late spermatids: 669.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA075536 Approved "Nucleoli,Mitotic spindle,Cytosol" Yes No Nucleoli "Mitotic spindle, Cytosol" "HPA075536: AB_2686755" "unprognostic (3.43e-3)" "unprognostic (4.75e-2)" "unprognostic (1.85e-1)" "unprognostic (1.01e-2)" "unprognostic (2.69e-2)" "unprognostic (3.75e-3)" "unprognostic (2.65e-5)" "unprognostic (6.95e-2)" "unprognostic (7.57e-2)" "unprognostic (1.55e-1)" "unprognostic (2.44e-3)" "unprognostic (2.84e-2)" "unprognostic (2.95e-5)" "unprognostic (7.56e-2)" "unprognostic (1.92e-1)" "unprognostic (1.23e-1)" "unprognostic (3.71e-2)" 2.1 2.1 3.2 3.8 3.6 2.8 2.2 4.8 3.6 2.3 2.1 4.2 4.3 2.0 3.4 5.1 2.0 1.7 1.9 2.3 2.6 1.9 1.9 1.7 2.0 2.8 4.2 1.5 2.7 2.3 2.1 8.5 1.8 3.0 2.1 2.3 1.8 2.0 3.2 2.0 2.0 1.8 2.1 5.4 2.0 2.0 65.5 3.2 3.4 2.7 0.3 2.2 2.3 2.3 2.4 1.7 0.1 0.6 2.9 5.9 0.5 2.6 2.9 0.8 3.6 2.5 1.9 1.3 2.3 0.9 0.8 2.5 0.6 3.8 1.9 1.2 1.6 2.3 1.3 1.4 1.4 3.2 6.8 0.3 1.1 2.0 0.7 4.3 1.1 1.9 1.8 0.7 1.7 0.7 1.6 1.0 3.0 1.5 6.7 3.3 0.4 0.8 0.6 0.7 1.4 2.8 1.6 3.7 0.3 2.4 0.6 1.9 1.9 0.4 0.5 1.6 1.1 1.9 1.5 3.9 2.0 2.4 2.6 1.3 2.1 1.4 2.0 2.6 7.5 1.1 0.0 0.6 0.1 3.4 0.3 3.3 2.4 5.3 2.9 0.3 1.2 5.9 3.9 0.1 2.9 0.3 1.7 3.5 0.5 3.2 3.6 4.8 3.6 2.6 1.9 4.2 1.5 3.0 3.2 6.0 7.5 0.8 1.0 1.6 8.6 6.7 0.0 1.4 4.5 1.8 3.9 0.6 1.7 3.1 397.3 2.3 1.4 0.0 3.0 1.0 1.2 0.8 11.6 0.0 1.6 0.0 2.9 0.0 0.0 669.2 8.9 2.3 1.7 1.0 2.0 2.7 2.3 0.0 6.7 0.6 25.0 12.9 1.0 70.9 6.1 1.0 0.1 1.5 1.7 0.6 CDCA7L "JPO2, R1, RAM2" ENSG00000164649 "Cell division cycle associated 7 like" Q96GN5 7 21900900-21946084 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 47.9" "Cell type enhanced" "Detected in many" 7 "Spermatogonia: 61.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "eosinophil: 11.8;memory B-cell: 28.6;naive B-cell: 38.5;naive CD4 T-cell: 9.7;plasmacytoid DC: 21.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Region enriched" "Detected in some" 5 "olfactory region: 22.0" "HPA027169, HPA074623" Approved Supported Nucleoplasm,Nucleoli,Cytosol No No "Nucleoplasm, Nucleoli" Cytosol "HPA027169: AB_1856058, HPA074623: " "unprognostic (5.13e-3)" "unprognostic (5.94e-2)" "unprognostic (1.91e-1)" "unprognostic (4.63e-2)" "unprognostic (2.33e-1)" "unprognostic (2.15e-1)" "prognostic unfavorable (4.36e-6)" "unprognostic (4.09e-2)" "unprognostic (2.86e-1)" "unprognostic (3.87e-2)" "unprognostic (3.22e-2)" "unprognostic (2.34e-1)" "prognostic unfavorable (1.98e-4)" "unprognostic (2.00e-1)" "unprognostic (1.60e-1)" "unprognostic (1.73e-1)" "unprognostic (2.83e-3)" 6.2 1.2 3.7 19.9 9.6 24.2 8.0 6.5 4.2 8.4 9.0 7.8 3.9 5.2 11.1 3.6 6.0 7.0 5.4 12.5 3.9 2.5 2.7 4.5 7.3 18.7 6.2 4.0 13.9 17.4 1.0 1.6 2.2 3.7 7.6 10.2 5.8 10.5 8.0 2.7 13.6 8.7 6.6 3.0 9.3 12.7 12.6 5.3 47.9 20.0 5.1 16.5 6.0 9.4 38.5 21.8 11.8 1.3 0.8 9.7 3.3 19.7 6.8 6.4 0.1 3.5 4.5 0.0 16.2 13.9 12.6 17.9 2.5 18.0 41.3 5.3 13.9 25.1 12.2 10.1 16.6 25.5 0.0 6.7 9.9 20.1 1.6 4.5 25.9 0.1 8.3 3.0 9.7 28.5 13.0 24.8 32.3 13.6 0.0 9.7 7.4 32.7 9.3 36.5 3.9 8.4 32.9 22.9 27.5 3.5 3.7 23.5 19.2 7.3 4.5 7.4 8.5 11.0 11.7 10.5 13.8 17.0 23.9 19.5 21.3 14.6 53.4 13.2 35.0 13.5 0.3 0.6 11.8 0.6 0.9 0.1 28.6 1.9 0.9 4.3 38.5 9.7 3.9 1.1 0.8 1.3 21.8 2.7 3.3 3.7 9.6 6.5 4.2 3.9 2.5 6.2 4.0 3.7 5.3 17.9 20.3 28.9 22.5 24.2 0.2 26.3 2.5 6.7 31.8 0.0 2.0 0.5 3.3 6.7 2.6 3.7 1.5 0.0 5.3 0.2 4.3 7.7 8.1 3.4 9.6 12.7 10.3 2.5 10.2 3.6 3.7 3.5 8.5 0.0 26.4 2.4 4.9 3.5 2.5 0.0 2.1 12.9 12.3 2.7 61.1 6.8 0.2 2.5 24.4 3.9 CDCA8 "BOR, DasraB, FLJ12042, MESRGP" ENSG00000134690 "Cell division cycle associated 8" Q53HL2 1 37692418-37709719 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 19.0;lymphoid tissue: 51.6;testis: 44.7" "Cell type enhanced" "Detected in many" 16 "Extravillous trophoblasts: 20.9;Spermatocytes: 82.1;Spermatogonia: 41.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" "HPA028120, HPA028258, HPA028783, CAB040294" Enhanced Supported "Nucleoplasm,Nucleoli,Cytokinetic bridge" Yes Yes Nucleoli "Nucleoplasm, Cytokinetic bridge" "CAB040294: , HPA028120: AB_10670556, HPA028258: AB_10669864, HPA028783: AB_10671092" "unprognostic (8.36e-2)" "unprognostic (2.00e-1)" "unprognostic (8.39e-2)" "unprognostic (7.75e-3)" "unprognostic (2.34e-1)" "unprognostic (5.42e-2)" "prognostic unfavorable (4.93e-10)" "unprognostic (4.30e-3)" "prognostic unfavorable (6.04e-4)" "unprognostic (3.00e-1)" "prognostic unfavorable (8.32e-4)" "unprognostic (3.78e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (6.39e-3)" "unprognostic (2.99e-1)" "unprognostic (3.18e-1)" "unprognostic (1.67e-1)" 1.2 1.4 0.9 12.9 1.7 19.0 1.7 0.8 1.6 1.8 6.0 1.1 0.7 5.3 1.4 1.3 9.6 0.7 2.4 0.8 0.9 0.9 1.3 1.5 2.0 12.2 1.8 1.3 0.9 1.0 0.1 0.8 3.7 1.3 1.0 7.7 0.7 2.1 1.0 0.9 4.0 5.4 1.6 1.2 5.4 3.5 44.7 1.7 51.6 0.9 6.5 14.6 1.6 2.9 2.8 1.8 4.5 5.0 6.3 8.9 2.5 28.4 12.4 23.5 17.0 1.0 2.0 15.8 21.5 10.8 38.0 27.0 19.4 21.3 34.6 8.7 13.7 15.3 16.2 27.0 14.2 40.4 23.0 12.1 31.1 13.3 15.3 0.2 29.9 16.1 0.8 1.0 21.4 19.0 4.3 16.8 24.9 26.2 37.2 27.4 12.7 27.5 18.4 27.2 16.6 17.2 26.9 32.1 19.8 8.6 11.9 20.9 9.2 23.6 11.1 14.5 21.1 16.3 11.4 10.1 18.7 19.9 10.7 33.5 25.3 32.9 47.2 8.8 27.8 21.4 0.0 1.1 1.8 2.5 2.2 4.5 2.8 5.7 3.3 1.0 2.5 1.9 3.8 4.5 6.3 5.0 1.8 8.9 2.5 0.9 1.7 0.8 1.6 0.9 0.9 1.8 1.3 1.3 1.7 0.0 0.3 9.3 0.8 3.0 1.1 0.4 5.1 8.1 0.0 0.0 0.0 2.2 0.0 1.1 0.8 0.2 4.2 0.0 0.6 20.9 0.9 0.6 0.0 1.0 9.5 1.6 3.5 1.8 3.1 2.2 1.4 4.6 1.7 2.8 5.1 0.0 1.6 4.9 1.1 0.5 0.8 19.4 0.0 82.1 41.4 2.4 2.4 3.2 6.3 0.9 CDK5RAP3 "C53, FLJ13660, HSF-27, IC53, LZAP, MST016, OK/SW-cl.114" ENSG00000108465 "CDK5 regulatory subunit associated protein 3" Q96JB5 17 47967810-47981774 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022141, HPA022882, HPA027883" Supported Supported Nucleoli,Vesicles,Cytosol NA NA Cytosol "Nucleoli, Vesicles" "HPA022141: AB_1846426, HPA022882: AB_1846428, HPA027883: AB_10602797" "unprognostic (4.27e-2)" "unprognostic (1.01e-3)" "unprognostic (9.95e-3)" "unprognostic (6.65e-2)" "unprognostic (5.98e-2)" "unprognostic (7.19e-3)" "unprognostic (3.84e-1)" "unprognostic (4.44e-2)" "unprognostic (7.55e-2)" "unprognostic (2.06e-1)" "unprognostic (2.59e-3)" "unprognostic (1.92e-2)" "prognostic unfavorable (3.61e-5)" "unprognostic (8.35e-3)" "unprognostic (2.30e-1)" "unprognostic (9.58e-2)" "prognostic favorable (7.31e-5)" 15.5 19.7 20.8 30.0 38.3 21.2 22.5 35.7 31.9 21.1 21.2 27.1 39.4 24.1 26.2 45.4 20.8 26.1 22.0 14.4 23.2 16.7 23.2 31.0 18.8 22.0 31.3 25.8 28.9 51.9 29.4 41.3 15.4 27.3 24.2 25.5 25.1 44.0 26.4 10.7 16.8 25.8 18.4 18.2 32.3 28.6 40.1 29.5 32.3 29.7 16.5 24.6 20.0 18.5 22.8 26.9 27.2 33.5 22.4 22.3 21.0 21.6 35.0 19.4 34.6 16.2 16.3 34.7 15.8 19.3 16.0 14.8 27.4 21.1 26.1 32.8 16.5 10.9 21.3 12.5 17.8 17.9 38.6 16.6 12.5 41.6 37.1 18.2 14.7 13.9 18.6 15.1 14.4 28.3 19.1 15.5 52.1 14.7 24.3 16.3 41.5 40.0 23.8 11.6 26.0 15.1 21.4 32.6 29.6 15.9 27.3 13.2 31.7 12.3 11.0 15.9 20.3 25.0 19.2 12.4 13.3 11.8 16.0 20.3 31.9 30.1 16.2 16.6 20.4 16.1 9.1 33.5 27.2 20.9 32.7 22.3 22.1 20.0 18.5 26.9 22.8 18.1 19.9 15.7 22.4 32.5 24.4 19.0 21.0 20.8 38.3 35.7 31.9 23.2 16.7 31.3 25.8 27.3 29.5 23.8 60.0 43.9 57.3 29.9 50.5 21.5 53.5 68.3 54.6 38.4 29.5 59.3 43.1 46.8 30.4 31.5 56.4 0.0 58.8 47.0 41.2 53.4 67.1 47.9 55.2 54.0 59.1 22.1 38.3 29.6 37.7 41.1 43.9 48.7 49.8 44.7 36.9 56.1 28.0 39.9 50.6 32.3 28.5 71.6 40.3 22.6 51.5 51.6 47.6 51.4 CDV3 H41 ENSG00000091527 "CDV3 homolog" Q9UKY7 3 133573730-133590261 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 485.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 153.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029761, HPA029762, HPA029763" Enhanced Enhanced "Nucleoli,Plasma membrane,Cytosol" NA NA 220000 Cytosol "Nucleoli, Plasma membrane" "HPA029761: AB_10600193, HPA029762: AB_10611247, HPA029763: AB_10601679" "unprognostic (1.17e-2)" "unprognostic (1.22e-1)" "unprognostic (4.06e-2)" "unprognostic (4.56e-2)" "unprognostic (4.04e-2)" "unprognostic (1.52e-1)" "prognostic unfavorable (5.21e-6)" "unprognostic (1.20e-1)" "unprognostic (3.30e-1)" "unprognostic (8.45e-3)" "unprognostic (3.29e-3)" "unprognostic (1.13e-1)" "unprognostic (2.36e-1)" "unprognostic (7.83e-2)" "unprognostic (1.48e-2)" "unprognostic (9.87e-2)" "unprognostic (7.59e-3)" 46.4 26.5 20.7 45.7 22.4 44.9 38.1 13.2 22.3 25.6 29.5 20.2 16.2 18.5 27.0 26.1 34.1 22.0 25.4 50.5 19.0 18.3 26.2 40.2 34.3 47.6 22.5 20.6 32.8 34.4 25.6 22.5 34.8 24.4 24.6 23.9 18.7 24.6 16.7 106.6 23.1 27.7 33.1 25.4 56.6 31.4 38.2 21.5 61.1 33.9 32.5 52.1 43.8 37.2 10.6 14.2 14.7 11.1 5.3 20.8 4.5 50.8 11.8 20.9 13.8 24.2 29.9 24.8 28.1 36.6 28.2 28.0 29.3 20.5 65.0 42.7 31.4 32.6 22.0 29.9 28.1 52.8 41.5 11.3 38.4 13.0 17.9 37.7 42.7 24.7 28.3 29.5 25.1 67.9 20.0 35.5 19.3 27.6 43.7 40.7 14.6 34.9 24.7 21.1 22.1 15.2 21.3 27.8 52.1 29.6 20.7 16.6 12.5 26.7 19.9 33.4 31.3 64.3 26.2 43.9 30.1 28.4 23.8 27.8 63.8 47.8 153.1 16.8 25.9 17.4 11.5 9.6 14.7 12.2 10.7 12.8 10.6 11.7 12.4 8.5 6.5 9.4 14.4 8.7 5.3 11.1 14.2 20.8 4.5 20.7 22.4 13.2 22.3 19.0 18.3 22.5 20.6 24.4 21.5 53.6 71.1 101.7 142.6 129.7 20.9 78.7 53.5 28.1 42.1 80.3 9.8 43.1 31.5 38.9 281.1 76.6 64.9 0.0 75.3 62.7 68.5 184.4 43.9 86.4 99.8 22.3 45.3 81.0 95.3 485.8 31.7 84.0 52.3 32.5 44.7 88.5 74.6 39.3 33.6 39.1 27.1 25.8 54.6 20.4 24.7 112.0 29.4 62.3 47.8 220.3 CEACAM19 CEAL1 ENSG00000186567 "Carcinoembryonic antigen related cell adhesion molecule 19" Q7Z692 19 44662278-44684359 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 10.7;RPTEC TERT1: 13.7;TIME: 17.7" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA014462, HPA052865" Uncertain Approved Nucleoplasm,Nucleoli,Mitochondria NA NA "Nucleoli, Mitochondria" Nucleoplasm "HPA014462: AB_2669006, HPA052865: AB_2681976" "unprognostic (2.91e-1)" "unprognostic (5.29e-3)" "unprognostic (6.96e-3)" "unprognostic (1.45e-2)" "unprognostic (3.73e-2)" "unprognostic (8.43e-2)" "unprognostic (5.22e-2)" "unprognostic (1.15e-2)" "unprognostic (9.98e-2)" "unprognostic (1.14e-1)" "unprognostic (1.78e-3)" "unprognostic (1.77e-1)" "unprognostic (3.26e-9)" "unprognostic (8.01e-3)" "unprognostic (9.62e-2)" "unprognostic (1.31e-1)" "unprognostic (2.70e-1)" 1.6 2.9 1.1 0.8 1.9 1.0 2.4 4.3 1.7 3.1 2.4 2.7 2.7 1.4 2.4 4.3 2.1 4.1 1.2 1.8 3.3 4.3 3.8 0.6 0.6 4.0 4.7 1.2 3.9 1.8 4.1 3.3 2.9 3.0 12.5 10.8 2.9 3.0 0.9 1.8 2.0 3.0 3.4 1.7 1.0 4.4 1.7 0.5 1.7 1.0 1.0 0.7 0.6 4.2 8.8 1.3 0.9 3.1 3.6 3.3 2.4 3.6 0.8 1.6 0.3 1.0 0.1 0.8 3.2 0.9 5.3 2.2 0.9 0.7 1.2 5.0 0.1 4.6 1.4 3.2 0.2 0.8 1.1 8.7 2.2 5.4 10.7 2.0 0.6 0.3 0.2 1.2 1.0 0.0 0.5 0.8 1.1 1.0 0.0 1.6 0.2 13.7 1.0 1.7 0.4 0.9 0.9 0.8 1.3 1.2 0.3 17.7 0.3 6.1 1.3 0.7 0.1 0.3 0.0 0.4 1.7 1.4 1.7 1.0 0.6 0.6 0.4 0.3 0.5 0.3 0.6 0.2 1.7 0.4 0.7 1.6 1.0 0.5 0.5 0.3 0.6 3.0 2.1 0.0 0.9 1.8 2.6 4.1 2.5 1.4 2.3 0.0 0.0 0.0 0.0 1.6 0.7 3.1 1.7 0.0 2.9 0.1 0.9 1.3 0.0 1.9 0.2 0.0 1.7 4.9 1.2 0.2 2.8 0.5 0.0 0.0 2.6 0.1 3.5 3.5 2.5 0.2 0.5 0.0 2.8 3.2 0.4 5.3 0.0 0.0 2.2 0.9 CERCAM "CEECAM1, CerCAM, GLT25D3" ENSG00000167123 "Cerebral endothelial cell adhesion molecule" Q5T4B2 9 128411751-128437351 "Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 78.1" "Cell type enhanced" "Detected in many" 8 "Extravillous trophoblasts: 48.9;Fibroblasts: 70.1;Melanocytes: 38.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD8 T-cell: 5.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 55.6;ASC TERT1: 59.3;fHDF/TERT166: 50.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021657, HPA051595" Uncertain Approved "Nucleoplasm,Nucleoli,Cell Junctions" "Intracellular and membrane" NA NA "Nucleoplasm, Nucleoli" "Cell Junctions" "HPA021657: AB_1846507, HPA051595: AB_2681545" "unprognostic (2.87e-2)" "unprognostic (1.37e-3)" "unprognostic (1.89e-3)" "unprognostic (2.19e-1)" "unprognostic (4.68e-3)" "unprognostic (7.79e-3)" "unprognostic (3.29e-3)" "unprognostic (5.68e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (5.22e-4)" "unprognostic (1.59e-1)" "unprognostic (5.93e-2)" "prognostic unfavorable (3.33e-16)" "unprognostic (1.34e-2)" "unprognostic (1.04e-1)" "unprognostic (6.05e-3)" "prognostic unfavorable (3.30e-5)" 12.7 5.1 40.0 7.2 65.5 1.6 9.0 10.0 62.1 19.1 6.9 61.2 5.0 4.8 11.4 10.9 8.2 6.0 17.3 8.8 72.8 34.7 4.9 1.8 5.3 2.3 59.5 28.1 14.1 18.8 15.8 21.6 27.4 31.4 11.1 5.2 3.5 13.2 13.6 4.3 8.9 6.0 27.7 78.1 3.3 5.4 5.2 62.1 0.0 6.7 2.4 2.7 15.1 6.6 0.3 2.0 0.3 1.6 1.1 5.3 2.2 9.5 6.1 6.9 7.3 55.6 59.3 5.9 30.9 29.2 8.1 6.1 2.2 0.4 0.0 12.7 50.4 6.9 6.5 3.0 4.1 3.1 2.4 4.9 0.5 5.6 3.3 17.0 1.1 17.3 32.8 2.2 8.8 2.1 33.5 9.1 0.6 2.8 7.6 10.5 18.1 0.4 11.7 0.4 0.4 4.7 0.9 4.8 1.3 3.8 3.6 1.0 1.9 6.9 8.4 3.5 2.3 6.8 2.3 10.1 21.6 5.9 29.6 4.7 8.9 6.9 0.1 20.4 3.4 4.2 0.3 1.1 0.1 3.8 1.6 0.3 0.3 0.3 4.7 1.5 0.1 0.1 5.3 0.3 1.1 0.1 2.0 0.0 2.2 40.0 65.5 10.0 24.5 72.8 34.7 59.5 28.1 31.4 62.1 6.0 13.0 0.0 6.2 7.9 1.1 3.2 0.0 6.7 21.6 10.4 0.0 14.3 0.0 10.7 2.0 7.1 0.0 0.0 2.9 48.9 70.1 3.9 8.1 0.0 5.9 6.4 0.0 18.4 0.6 1.5 22.5 4.7 38.8 1.0 0.0 0.1 6.9 0.0 24.8 0.5 0.7 6.5 15.6 1.0 19.0 3.6 16.4 2.5 0.0 2.0 CHD3 "Mi-2a, Mi2-ALPHA, ZFH" ENSG00000170004 "Chromodomain helicase DNA binding protein 3" Q12873 17 7884806-7912760 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043368, HPA076524" Supported Approved "Nucleoplasm,Nucleoli,Centriolar satellite" No No "Nucleoplasm, Nucleoli, Centriolar satellite" "HPA043368: AB_2678448, HPA076524: AB_2686804" "unprognostic (1.77e-2)" "unprognostic (8.01e-2)" "prognostic unfavorable (2.43e-4)" "prognostic favorable (7.68e-5)" "unprognostic (1.53e-1)" "unprognostic (8.11e-3)" "unprognostic (2.54e-1)" "unprognostic (1.11e-1)" "unprognostic (2.83e-2)" "unprognostic (5.25e-3)" "prognostic favorable (8.36e-4)" "unprognostic (9.11e-2)" "unprognostic (8.31e-2)" "unprognostic (3.98e-2)" "unprognostic (1.50e-1)" "unprognostic (8.90e-3)" "unprognostic (2.20e-3)" 10.4 12.9 31.7 24.3 26.0 18.7 12.5 12.1 28.3 41.1 21.1 4.1 22.5 8.2 46.3 16.1 15.1 25.0 20.0 8.7 30.4 14.2 15.2 2.3 13.1 19.0 8.4 28.4 27.3 15.1 28.5 21.0 8.0 10.7 32.9 11.1 20.7 19.4 23.0 3.3 16.2 14.0 23.3 6.9 14.6 15.8 11.3 5.1 40.6 19.7 7.5 17.7 20.6 28.9 1.6 4.0 4.1 3.5 2.7 7.8 3.6 12.2 30.5 17.9 23.7 21.8 18.3 9.6 14.3 19.2 12.1 13.0 5.9 10.3 34.5 10.9 21.0 9.8 16.6 33.6 15.1 15.3 17.5 19.6 16.7 39.6 0.7 11.7 4.8 32.9 24.1 8.1 16.3 10.9 32.3 22.5 15.8 11.1 0.6 11.3 12.1 13.1 5.5 2.8 12.9 11.3 38.6 21.8 5.2 12.1 29.8 12.2 16.5 35.5 13.8 6.9 5.1 15.9 7.8 28.1 26.3 20.7 6.4 20.5 2.6 0.4 19.5 13.4 13.5 22.4 0.6 2.7 4.1 7.0 1.7 5.5 1.5 6.7 6.6 2.1 1.6 7.8 5.1 2.1 2.7 3.5 4.0 3.6 3.6 31.7 26.0 12.1 28.3 30.4 14.2 8.4 28.4 10.7 5.1 29.8 57.4 11.5 44.3 32.4 61.2 9.7 17.8 24.1 37.5 76.8 7.9 15.1 14.9 21.3 8.9 17.5 12.0 0.0 20.6 16.7 30.0 67.6 38.2 2.1 8.4 42.9 54.5 18.4 21.1 13.0 41.1 14.7 8.5 54.1 12.6 11.3 23.7 7.0 53.7 7.5 15.6 25.8 27.2 12.9 50.5 17.9 13.7 34.6 25.9 53.1 CIPC KIAA1737 ENSG00000198894 "CLOCK interacting pacemaker" Q9C0C6 14 77098097-77117287 "Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 77.7" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 55.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA000644 Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Cytosol" Nucleoli "HPA000644: AB_1079206" "unprognostic (3.93e-2)" "unprognostic (6.71e-2)" "unprognostic (2.62e-2)" "unprognostic (1.10e-1)" "unprognostic (1.55e-1)" "unprognostic (1.85e-1)" "unprognostic (2.41e-1)" "unprognostic (6.67e-3)" "unprognostic (3.73e-2)" "unprognostic (1.74e-1)" "unprognostic (2.31e-2)" "unprognostic (3.20e-1)" "prognostic favorable (1.77e-10)" "unprognostic (2.28e-1)" "unprognostic (2.32e-1)" "unprognostic (1.13e-1)" "unprognostic (1.21e-1)" 8.9 7.3 20.8 5.9 20.7 3.1 11.4 29.0 24.2 12.8 14.1 27.9 9.9 7.5 10.7 10.0 15.5 21.2 6.7 26.1 21.6 17.5 10.4 10.9 7.9 5.8 22.2 14.9 7.1 7.1 15.8 9.4 6.6 20.5 18.3 14.1 10.6 13.3 18.2 77.7 8.6 7.9 11.8 21.6 6.3 7.1 8.0 23.4 3.4 14.4 13.1 7.1 11.4 8.8 11.4 7.2 7.7 6.7 7.6 5.8 4.2 6.2 8.3 17.6 11.8 7.2 5.7 10.9 4.2 6.5 7.4 6.8 6.6 13.4 15.3 4.0 6.6 6.9 9.5 16.4 6.3 10.2 7.9 4.4 10.2 6.3 6.1 6.8 5.6 7.5 6.6 12.6 7.3 4.6 10.0 8.6 12.4 8.8 6.2 5.6 13.5 13.2 6.8 7.4 14.3 7.2 13.3 7.7 9.2 7.6 10.5 25.1 9.3 7.4 12.1 9.7 7.8 18.9 5.7 10.3 4.9 10.5 6.9 5.0 5.5 3.8 7.4 9.3 4.8 10.3 5.8 5.8 2.1 3.7 6.7 5.8 11.4 5.2 3.9 7.2 9.4 5.6 3.9 7.7 7.6 4.8 2.7 5.3 4.2 20.8 20.7 29.0 22.4 21.6 17.5 22.2 14.9 20.5 23.4 14.9 13.6 0.8 7.0 8.0 24.6 44.8 7.6 14.7 14.8 10.4 55.0 5.6 8.3 4.2 8.7 5.8 18.6 0.0 4.7 3.7 6.0 7.5 1.1 23.6 12.8 11.1 16.7 6.7 14.3 9.9 3.7 5.8 8.5 3.6 15.6 18.9 3.9 10.5 13.4 4.9 36.3 12.9 9.5 14.9 6.1 8.5 11.3 3.9 9.5 5.8 CLDND1 "C3orf4, Z38" ENSG00000080822 "Claudin domain containing 1" Q9NY35 3 98497912-98523066 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "blood: 75.9;brain: 227.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029841 Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA029841: AB_10600658" "unprognostic (1.64e-1)" "unprognostic (3.63e-1)" "unprognostic (3.13e-2)" "unprognostic (8.50e-2)" "unprognostic (9.15e-2)" "unprognostic (7.30e-2)" "unprognostic (2.43e-3)" "unprognostic (4.08e-2)" "unprognostic (3.65e-2)" "unprognostic (8.30e-3)" "unprognostic (1.21e-1)" "unprognostic (3.14e-1)" "prognostic unfavorable (5.84e-6)" "unprognostic (5.73e-3)" "unprognostic (6.54e-2)" "unprognostic (3.05e-1)" "unprognostic (1.51e-1)" 14.7 12.4 61.6 10.7 76.1 11.7 14.1 11.9 77.1 14.1 10.4 100.5 3.3 10.0 16.9 12.6 22.6 10.9 14.3 15.9 85.4 52.3 11.0 14.0 12.2 13.6 133.4 28.9 19.1 5.8 7.0 6.7 20.5 72.7 14.6 13.6 4.9 6.8 15.7 9.7 17.6 9.4 18.5 227.4 11.5 7.5 28.5 95.4 4.3 11.5 4.7 14.8 14.7 11.1 19.9 19.7 28.1 18.6 49.5 75.9 28.6 17.9 7.3 22.9 14.0 27.7 21.6 12.5 14.2 19.6 20.0 27.7 14.8 18.3 9.0 19.2 13.6 38.0 24.3 17.6 10.8 35.1 21.2 7.5 18.7 5.2 13.2 22.2 16.8 18.7 25.2 58.3 15.6 16.8 21.5 21.7 17.9 9.3 27.7 28.1 9.4 12.3 11.1 19.9 7.8 15.6 8.3 30.8 11.4 18.7 8.1 8.3 22.8 19.6 6.6 28.1 32.1 6.6 14.3 20.1 26.1 24.1 17.7 18.4 36.7 15.7 14.5 43.6 16.2 33.3 28.1 18.6 19.8 21.7 10.7 40.8 19.9 40.9 39.8 19.7 16.4 16.6 16.9 13.8 49.5 10.5 12.7 75.9 28.6 61.6 76.1 11.9 38.8 85.4 52.3 133.4 28.9 72.7 95.4 32.8 39.6 30.5 103.2 128.0 19.7 48.0 12.7 16.0 23.9 26.2 23.6 44.0 24.9 18.4 58.8 63.1 19.7 46.7 14.2 132.7 70.7 85.5 35.8 18.7 31.6 14.3 27.5 54.0 25.9 62.2 47.8 38.0 108.0 43.3 18.8 28.6 24.0 11.5 43.9 18.2 31.4 51.8 126.4 168.0 50.6 171.8 80.1 103.6 17.1 110.7 CLN6 "FLJ20561, HsT18960, nclf" ENSG00000128973 "CLN6, transmembrane ER protein" Q9NWW5 15 68206992-68257211 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 161.8;Hofbauer cells: 76.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066046, HPA066759" Approved Approved "Nucleoli,Endoplasmic reticulum,Vesicles" NA NA "Endoplasmic reticulum" "Nucleoli, Vesicles" "HPA066046: AB_2685604, HPA066759: " "unprognostic (1.01e-1)" "unprognostic (1.54e-3)" "unprognostic (7.01e-2)" "unprognostic (3.58e-2)" "unprognostic (2.71e-2)" "unprognostic (3.08e-1)" "unprognostic (2.24e-2)" "unprognostic (5.07e-2)" "unprognostic (2.40e-2)" "unprognostic (2.11e-1)" "unprognostic (1.69e-1)" "unprognostic (1.85e-1)" "prognostic favorable (4.87e-4)" "unprognostic (1.22e-2)" "unprognostic (2.22e-1)" "unprognostic (2.49e-1)" "unprognostic (6.78e-2)" 21.2 17.8 11.6 16.5 11.8 29.8 13.9 14.9 20.7 14.4 20.2 13.2 11.6 17.1 11.7 14.3 16.7 12.0 17.1 10.4 11.7 10.8 22.0 29.5 18.8 27.0 11.1 12.2 12.4 19.7 11.7 11.5 18.6 14.3 13.4 18.0 28.6 16.0 17.9 16.3 17.0 18.5 12.4 11.6 26.5 15.7 13.8 9.7 27.7 14.5 18.2 21.7 11.0 10.9 2.9 4.6 9.4 13.4 1.8 4.1 2.7 11.5 28.8 7.5 10.6 4.7 3.8 18.2 11.0 5.3 13.6 11.2 22.2 18.8 18.0 5.5 6.5 10.1 21.5 21.6 10.7 5.4 11.9 26.4 25.9 21.1 16.5 9.6 29.1 18.5 6.7 3.6 10.9 7.5 2.8 9.0 10.3 17.0 36.5 10.4 31.6 13.2 20.9 18.1 20.5 12.3 12.9 23.1 24.5 11.3 30.2 15.5 6.4 12.4 19.4 10.6 5.9 10.4 29.1 5.9 15.3 18.2 11.3 38.9 26.7 29.0 14.7 9.6 35.4 14.8 0.0 7.3 0.4 2.8 11.5 3.8 2.9 2.1 4.1 4.6 2.3 2.7 1.2 9.4 1.8 13.4 3.8 1.9 2.7 11.6 11.8 14.9 20.7 11.7 10.8 11.1 12.2 14.3 9.7 8.9 5.8 12.7 17.8 17.9 161.8 19.9 0.0 0.0 4.5 5.2 15.7 29.2 0.0 3.1 0.2 12.9 13.6 23.3 1.6 44.9 15.2 12.6 9.2 17.7 76.0 20.6 14.6 14.1 18.0 1.3 8.3 11.9 18.6 7.2 15.3 16.9 3.1 20.9 7.8 1.3 31.0 6.5 8.0 0.9 16.8 12.3 18.2 10.9 30.5 14.5 COX10 ENSG00000006695 "COX10, heme A:farnesyltransferase cytochrome c oxidase assembly factor" Q12887 17 14069496-14208677 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Heme biosynthesis" Transferase "Disease mutation, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 34.9" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 89.2;Late spermatids: 61.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032005, HPA032006" Supported Supported Nucleoli,Mitochondria,Cytosol NA NA Mitochondria "Nucleoli, Cytosol" "HPA032005: AB_10603560, HPA032006: AB_10670554" "unprognostic (6.17e-2)" "unprognostic (3.14e-1)" "unprognostic (1.41e-2)" "unprognostic (4.35e-2)" "unprognostic (1.86e-1)" "unprognostic (2.03e-1)" "unprognostic (1.31e-1)" "unprognostic (7.40e-2)" "unprognostic (6.27e-3)" "unprognostic (1.07e-1)" "unprognostic (9.46e-3)" "unprognostic (6.46e-2)" "prognostic favorable (4.32e-6)" "prognostic favorable (8.73e-4)" "unprognostic (8.82e-2)" "unprognostic (1.02e-2)" "unprognostic (8.71e-2)" 5.5 6.9 5.3 5.7 6.5 7.0 5.4 6.5 7.2 4.4 11.8 4.1 2.9 9.7 5.1 3.6 9.4 4.8 3.5 18.9 5.8 3.8 10.0 9.3 5.2 8.4 4.5 2.8 4.9 9.6 7.2 6.4 6.6 5.7 5.2 10.1 5.5 6.7 4.8 34.9 6.0 10.9 7.2 4.0 4.6 7.7 15.5 4.9 5.9 5.2 9.6 7.4 7.2 5.8 11.9 13.6 4.0 14.1 8.8 17.5 9.8 7.3 14.1 5.9 8.4 5.9 5.4 13.3 8.9 6.2 16.3 11.3 12.3 5.4 17.3 7.1 9.0 5.6 14.1 11.9 11.5 13.1 9.3 12.0 10.3 11.3 13.6 10.3 10.6 9.7 7.7 14.5 10.2 13.0 6.5 8.6 12.3 13.9 5.9 7.2 9.1 9.0 7.0 8.9 27.6 7.3 7.6 19.9 12.2 10.2 13.8 4.4 7.4 9.2 12.3 11.0 29.1 6.9 6.0 7.0 7.1 6.0 7.2 11.2 7.2 10.1 7.8 10.7 11.0 8.8 3.0 10.6 4.0 9.9 14.1 10.4 11.9 11.6 10.3 13.6 8.2 12.6 11.9 1.2 8.8 11.9 4.6 17.5 9.8 5.3 6.5 6.5 7.2 5.8 3.8 4.5 2.8 5.7 4.9 0.0 14.3 5.2 7.2 8.7 8.0 89.2 7.6 5.3 4.5 10.4 9.8 16.5 34.9 8.0 33.1 4.9 19.0 0.0 7.5 14.8 5.1 7.4 4.7 8.9 9.4 0.0 12.1 4.9 3.8 61.2 2.0 5.4 5.0 4.6 14.2 2.8 8.6 11.0 6.3 11.4 11.6 0.0 5.1 14.6 15.9 9.2 13.5 5.3 15.1 11.8 CPT2 "CPT1, CPTASE" ENSG00000157184 "Carnitine palmitoyltransferase 2" P23786 1 53196429-53214197 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism, Transport" "Acyltransferase, Transferase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 69.0" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 64.6;Hepatocytes: 80.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028201, HPA028202, HPA028214" Enhanced Approved Nucleoplasm,Nucleoli,Mitochondria Yes No "Nucleoplasm, Mitochondria" Nucleoli "HPA028201: AB_10599177, HPA028202: AB_10599942, HPA028214: AB_10601958" "unprognostic (2.43e-1)" "unprognostic (2.27e-1)" "prognostic favorable (5.27e-4)" "unprognostic (6.48e-2)" "unprognostic (1.88e-1)" "unprognostic (9.34e-2)" "unprognostic (6.48e-2)" "unprognostic (1.75e-2)" "unprognostic (2.86e-1)" "unprognostic (1.67e-1)" "unprognostic (3.00e-2)" "unprognostic (8.97e-2)" "prognostic favorable (1.46e-12)" "unprognostic (4.00e-2)" "unprognostic (2.06e-1)" "unprognostic (1.79e-2)" "unprognostic (2.95e-2)" 7.5 15.5 5.3 6.8 6.1 2.3 6.5 4.0 7.2 5.1 15.4 9.4 10.7 16.6 5.1 7.6 10.5 5.4 11.3 21.4 4.3 4.5 19.8 69.0 6.9 8.3 5.7 3.7 5.3 15.9 10.7 11.5 18.1 6.4 6.0 15.6 13.8 11.8 12.2 13.6 6.0 18.9 5.5 5.2 10.3 10.1 11.2 4.7 9.7 8.3 7.2 10.3 8.0 4.9 5.9 12.4 10.0 13.1 4.8 8.0 6.5 7.7 3.2 7.5 7.3 6.5 3.8 8.5 4.8 4.9 6.9 6.4 1.6 6.5 13.2 7.3 2.2 7.8 7.7 14.0 11.0 5.9 7.3 8.2 7.5 4.3 1.3 9.5 7.1 7.3 8.2 9.4 5.0 4.2 7.7 4.7 11.7 9.6 4.7 4.2 4.5 5.5 5.8 14.0 14.4 8.6 6.4 7.2 13.9 8.6 7.2 11.2 7.6 9.6 12.2 18.1 18.1 14.2 15.2 4.5 3.9 3.1 6.8 3.9 14.5 8.9 8.1 5.0 8.2 5.7 4.1 8.4 10.0 5.1 12.6 6.2 4.5 4.9 5.9 12.4 5.9 8.0 5.5 5.1 4.8 13.1 6.4 7.0 6.5 5.3 6.1 4.0 7.2 4.3 4.5 5.7 3.7 6.4 4.7 11.9 20.8 8.9 5.1 1.5 3.1 12.4 15.3 4.0 3.4 10.4 13.7 64.6 21.6 10.7 1.1 3.6 39.8 0.0 9.3 16.0 2.8 4.8 2.3 80.0 23.6 14.3 13.9 6.7 13.5 2.1 6.4 8.2 6.8 26.2 26.9 10.5 9.8 21.0 4.9 28.3 9.9 6.5 3.2 29.8 16.3 2.3 45.7 7.1 25.3 4.6 CRAMP1 "CRAMP1L, KIAA1426" ENSG00000007545 "Cramped chromatin regulator homolog 1" Q96RY5 16 1612325-1677908 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041752 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol No No Nucleoplasm "Nucleoli, Cytosol" "HPA041752: AB_10796459" "unprognostic (3.67e-1)" "unprognostic (9.97e-2)" "unprognostic (2.72e-1)" "unprognostic (2.23e-1)" "unprognostic (3.41e-2)" "unprognostic (2.25e-3)" "unprognostic (5.78e-4)" "unprognostic (4.17e-2)" "unprognostic (8.53e-3)" "unprognostic (6.01e-2)" "unprognostic (1.55e-2)" "unprognostic (9.93e-2)" "unprognostic (3.86e-3)" "prognostic favorable (4.93e-4)" "unprognostic (8.57e-2)" "unprognostic (2.29e-1)" "unprognostic (1.33e-2)" 8.5 6.4 9.2 10.5 9.3 13.9 11.6 24.2 11.0 8.4 8.8 11.1 5.1 7.2 11.4 8.3 8.6 9.9 6.5 7.2 8.6 5.4 6.5 4.7 9.2 8.0 9.7 10.5 12.3 9.2 10.2 10.9 8.4 9.4 9.8 7.1 9.8 8.4 9.5 8.9 13.7 8.4 8.8 7.9 9.4 8.5 21.9 9.8 18.1 11.8 4.4 7.5 10.6 11.7 0.8 2.1 0.5 0.6 2.5 1.9 0.5 5.3 8.7 11.0 10.4 7.4 7.4 12.8 6.2 5.5 8.5 6.1 8.0 9.1 5.3 6.0 7.1 5.1 9.0 13.2 6.4 7.8 6.4 13.7 8.4 10.0 4.9 5.4 11.8 13.6 6.4 8.7 10.1 8.2 8.1 8.4 12.0 11.2 4.2 4.6 8.8 7.8 7.3 8.8 3.5 5.4 30.3 5.2 9.3 5.6 5.4 11.5 8.2 9.3 7.7 4.9 8.2 6.2 16.4 9.5 8.1 7.9 6.9 7.9 7.1 10.2 13.6 2.8 7.9 7.2 0.4 0.6 0.0 1.9 0.6 0.9 0.8 0.6 0.6 0.3 0.8 0.9 0.9 0.5 2.5 0.2 2.1 0.3 0.5 9.2 9.3 24.2 11.0 8.6 5.4 9.7 10.5 9.4 9.8 14.9 13.4 0.0 4.3 0.0 7.3 0.0 7.6 5.3 15.9 8.7 17.7 3.5 1.7 4.1 21.2 4.3 3.9 0.0 1.6 2.5 3.3 6.1 4.7 3.4 4.4 3.2 2.4 8.6 6.5 7.6 4.0 2.8 0.0 1.8 8.7 4.5 5.3 3.5 6.3 1.4 17.5 6.5 0.0 13.5 19.0 0.0 4.5 6.4 6.4 4.2 CRIP2 "CRP2, ESP1" ENSG00000182809 "Cysteine rich protein 2" P52943 14 105472962-105480170 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "heart muscle: 180.3" "Cell type enhanced" "Detected in many" 9 "Cardiomyocytes: 702.6;Endothelial cells: 478.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory CD4 T-cell: 24.0;T-reg: 29.2" "Group enriched" "Detected in many" 19 "B-cells: 17.9;T-cells: 29.2" "Cell line enhanced" "Detected in many" "A549: 38.5;EFO-21: 39.4;HUVEC TERT2: 36.8;MCF7: 56.5;SK-BR-3: 44.3;T-47d: 37.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042664 Approved Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA 490000 Nucleoli "Nucleoplasm, Plasma membrane" "HPA042664: AB_10797017" "unprognostic (2.68e-1)" "unprognostic (6.53e-3)" "unprognostic (2.11e-3)" "unprognostic (2.19e-1)" "unprognostic (2.39e-1)" "unprognostic (2.14e-1)" "unprognostic (1.63e-2)" "unprognostic (2.56e-1)" "unprognostic (3.20e-3)" "unprognostic (9.68e-2)" "unprognostic (6.96e-2)" "unprognostic (1.14e-1)" "unprognostic (2.04e-2)" "unprognostic (6.25e-2)" "unprognostic (2.35e-2)" "unprognostic (2.39e-2)" "unprognostic (8.26e-3)" 22.8 11.5 27.5 9.1 24.6 1.6 16.9 3.6 30.3 20.2 10.1 9.4 33.7 7.9 15.3 30.6 25.6 29.5 24.5 180.3 22.6 18.7 20.0 6.9 28.5 9.3 13.5 16.9 12.5 12.6 4.3 20.4 29.1 10.4 14.6 3.8 8.8 18.4 28.0 10.7 28.4 9.1 24.9 10.3 13.0 11.3 10.9 7.8 1.0 17.8 23.8 13.3 23.8 17.5 17.9 0.9 0.2 0.5 1.2 29.2 3.4 0.4 38.5 5.6 15.3 0.9 4.0 1.6 1.7 0.4 0.5 0.1 1.2 7.1 0.0 39.4 12.6 0.8 22.0 0.7 9.3 0.0 0.2 0.2 0.0 24.2 14.6 4.1 0.0 3.3 1.9 0.8 0.9 5.3 7.2 36.8 0.0 0.0 0.3 5.5 56.5 0.1 0.1 1.5 7.8 23.1 0.0 0.7 1.6 25.9 0.1 8.5 21.4 2.5 44.3 0.3 0.9 37.9 0.0 14.3 12.8 6.0 0.3 7.1 0.1 0.1 0.1 3.7 0.0 25.7 0.0 0.5 0.0 2.4 0.2 2.3 14.4 24.0 5.3 0.9 17.9 5.9 1.6 0.2 1.2 0.1 0.1 29.2 3.4 27.5 24.6 3.6 30.3 22.6 18.7 13.5 16.9 10.4 7.8 145.9 41.3 6.5 66.0 136.0 2.2 702.6 96.8 105.7 131.9 179.7 3.9 0.9 131.0 90.2 30.6 478.7 0.0 0.0 80.2 15.4 145.8 41.0 7.0 27.0 2.6 89.0 24.2 229.6 13.7 62.0 25.9 11.3 148.5 2.8 0.0 55.2 33.3 0.0 13.8 9.8 3.7 271.7 208.1 5.9 44.5 172.0 26.8 6.4 0.0 77.0 CUTC CGI-32 ENSG00000119929 "CutC copper transporter" Q9NTM9 10 99702558-99756134 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 122.1" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 105.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038619, HPA058231" Enhanced Enhanced Nucleoplasm,Nucleoli,Cytosol No No "Nucleoplasm, Cytosol" Nucleoli "HPA038619: AB_10672649, HPA058231: " "unprognostic (1.25e-2)" "unprognostic (5.92e-2)" "unprognostic (2.70e-1)" "unprognostic (8.66e-2)" "unprognostic (7.39e-2)" "unprognostic (1.39e-1)" "unprognostic (3.55e-3)" "unprognostic (8.67e-2)" "unprognostic (5.36e-2)" "unprognostic (1.81e-1)" "unprognostic (5.87e-2)" "unprognostic (2.06e-1)" "prognostic unfavorable (3.81e-7)" "unprognostic (1.00e-1)" "unprognostic (3.42e-2)" "unprognostic (2.41e-1)" "unprognostic (3.97e-1)" 11.6 4.9 5.7 9.8 8.7 7.9 9.8 3.5 6.5 5.3 5.9 7.2 3.5 4.4 4.9 8.0 6.2 5.1 5.8 13.2 5.9 4.7 5.3 11.0 5.1 7.9 8.6 6.6 4.6 4.5 3.5 3.6 4.5 5.5 6.0 6.4 6.9 5.7 5.4 122.1 5.8 6.2 11.6 7.4 9.2 6.0 14.1 8.3 9.2 4.3 25.1 7.3 13.5 11.4 32.8 24.2 47.1 19.4 25.5 36.3 19.3 9.5 20.5 7.2 21.9 26.8 12.3 3.9 7.8 10.1 7.9 8.9 9.4 7.3 34.7 7.0 13.3 3.9 8.2 14.7 13.0 8.8 10.2 14.0 11.5 9.2 14.8 12.4 21.3 5.6 12.7 8.1 12.6 26.2 9.8 13.5 20.2 10.1 7.7 5.9 6.6 19.1 22.0 7.2 9.7 7.7 13.0 8.5 13.3 8.3 3.9 2.4 5.4 3.6 5.7 9.8 10.4 9.1 12.2 7.5 3.3 4.4 3.6 10.3 12.7 16.5 24.3 10.8 45.8 2.9 26.5 19.4 47.1 27.2 15.2 28.3 32.8 25.9 25.9 21.0 29.0 36.3 27.8 30.8 25.5 18.5 24.2 24.7 19.3 5.7 8.7 3.5 6.5 5.9 4.7 8.6 6.6 5.5 8.3 8.9 12.2 21.9 13.0 10.8 16.5 35.8 10.2 20.1 10.3 5.2 7.9 15.9 18.3 14.6 8.1 21.5 4.9 0.0 15.0 10.7 15.3 11.4 30.0 20.2 18.3 11.1 11.6 22.7 17.8 6.8 12.0 15.9 28.7 27.9 7.8 17.8 10.1 10.1 15.2 24.5 27.1 19.4 15.6 105.8 35.1 9.5 11.3 20.1 9.7 10.7 DCTN6 WS-3 ENSG00000104671 "Dynactin subunit 6" O00399 8 30156297-30183640 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024049, HPA024558" Approved Supported "Nucleoli,Plasma membrane,Cytosol" NA NA "Nucleoli, Cytosol" "Plasma membrane" "HPA024049: AB_1847524, HPA024558: AB_1847525" "unprognostic (1.28e-1)" "unprognostic (8.32e-3)" "unprognostic (1.65e-2)" "unprognostic (1.88e-1)" "unprognostic (1.69e-1)" "unprognostic (7.50e-2)" "prognostic unfavorable (5.51e-4)" "unprognostic (1.26e-1)" "unprognostic (7.84e-2)" "unprognostic (1.08e-2)" "unprognostic (2.38e-2)" "unprognostic (9.26e-2)" "prognostic favorable (5.42e-4)" "unprognostic (1.06e-1)" "unprognostic (3.10e-1)" "unprognostic (7.54e-2)" "unprognostic (1.43e-1)" 29.5 34.6 41.4 15.6 39.4 23.3 32.6 23.6 43.6 21.0 20.6 27.4 15.4 14.2 24.1 27.2 24.1 18.0 20.0 44.5 37.7 35.2 32.8 27.5 20.3 15.3 42.3 36.3 26.3 19.5 31.0 27.7 32.7 41.4 21.9 22.5 16.5 20.3 23.7 20.4 17.5 15.6 26.0 46.2 16.8 19.3 13.9 30.3 15.4 33.7 18.2 17.9 25.7 18.8 7.4 19.8 9.5 15.9 10.2 11.2 6.9 19.1 18.3 23.3 12.2 21.1 29.2 14.9 26.1 30.1 25.4 26.7 11.9 12.8 14.2 28.0 27.2 23.8 14.2 16.1 22.0 30.0 11.4 12.5 20.4 15.8 18.6 16.3 11.5 17.4 24.6 31.4 18.2 19.5 22.1 22.7 20.5 22.8 15.7 27.0 14.5 21.3 16.6 18.9 32.2 11.7 11.4 17.5 12.4 36.1 18.8 38.1 21.6 15.2 18.6 25.8 12.3 18.0 16.3 21.8 13.8 48.3 11.3 18.5 6.7 7.4 18.4 25.5 13.2 24.0 9.5 14.1 4.9 8.6 15.9 9.8 7.4 7.8 10.1 16.8 5.5 9.0 11.2 4.5 10.2 15.1 19.8 8.7 6.9 41.4 39.4 23.6 43.6 37.7 35.2 42.3 36.3 41.4 30.3 23.8 31.2 37.4 81.1 50.8 33.7 73.4 45.9 57.6 37.5 41.8 13.7 76.0 104.5 78.2 11.6 53.1 26.3 0.0 74.2 71.3 55.9 41.2 46.1 41.8 61.9 25.4 39.2 44.2 46.4 7.3 74.8 51.6 65.8 65.9 27.4 43.3 77.1 38.6 70.7 114.8 36.3 51.8 70.0 42.8 48.2 55.6 170.3 40.5 29.2 81.2 DDAH1 DDAH ENSG00000153904 "Dimethylarginine dimethylaminohydrolase 1" O94760 1 85318481-85578363 "Enzymes, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 61.6" "Cell type enhanced" "Detected in many" 8 "Proximal tubular cells: 219.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 1.3;naive B-cell: 1.0" "Lineage enhanced" "Detected in single" "B-cells: 1.3" "Cell line enhanced" "Detected in many" "OE19: 36.9;SH-SY5Y: 35.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006308, HPA071064" Enhanced Approved "Nucleoli,Plasma membrane,Cytosol" NA NA 140000 "Plasma membrane, Cytosol" Nucleoli "HPA006308: AB_1847532, HPA071064: " "unprognostic (1.44e-2)" "unprognostic (2.43e-1)" "prognostic favorable (5.99e-4)" "unprognostic (6.82e-2)" "unprognostic (1.04e-1)" "unprognostic (1.62e-2)" "unprognostic (2.55e-1)" "unprognostic (3.85e-2)" "unprognostic (2.57e-1)" "unprognostic (1.02e-2)" "unprognostic (3.62e-2)" "unprognostic (1.56e-1)" "prognostic favorable (5.21e-6)" "unprognostic (5.37e-2)" "unprognostic (9.06e-2)" "unprognostic (5.81e-2)" "unprognostic (1.56e-2)" 4.3 14.3 43.9 5.8 44.9 0.7 6.6 14.4 37.2 7.7 22.1 20.7 4.3 21.1 6.0 33.8 4.9 18.4 12.2 6.4 29.5 24.1 61.6 39.9 11.8 1.1 24.9 37.0 3.4 13.8 13.0 7.2 3.1 13.8 13.1 21.4 4.1 8.5 6.2 13.8 2.8 19.9 7.4 8.1 4.1 15.6 9.3 11.0 0.0 14.1 1.0 1.2 6.0 3.0 1.3 0.4 0.0 0.0 0.0 0.0 0.0 18.3 2.3 6.5 1.2 10.9 9.2 0.8 21.7 13.2 7.7 8.2 26.1 4.9 0.0 9.1 24.6 7.6 5.3 23.5 4.5 9.9 0.0 9.0 0.0 6.2 9.1 3.9 16.7 1.0 7.7 0.4 6.5 4.1 9.8 12.3 0.0 0.0 1.8 19.8 1.5 0.8 0.0 7.8 36.9 6.8 0.0 15.2 0.2 33.0 13.7 18.3 35.6 2.8 16.5 2.6 9.7 8.9 1.2 24.0 6.8 5.5 1.6 15.1 0.0 0.0 0.0 0.3 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 43.9 44.9 14.4 37.2 29.5 24.1 24.9 37.0 13.8 11.0 32.8 31.3 4.2 4.0 12.2 2.7 11.4 68.8 30.8 13.6 66.3 3.9 1.7 106.1 15.6 17.1 4.5 78.7 0.0 26.7 0.8 23.5 37.8 0.0 94.3 0.9 0.0 32.8 9.2 2.2 18.4 14.7 1.5 11.8 1.0 77.8 59.7 34.2 73.6 70.4 219.6 8.0 12.9 18.9 5.0 5.6 12.5 0.7 3.3 85.4 6.5 DDX18 "Has1, MrDb" ENSG00000088205 "DEAD-box helicase 18" Q9NVP1 2 117814650-117832379 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 90.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035400, HPA041056" Approved Enhanced "Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim, Mitotic chromosome" "HPA035400: AB_10672091, HPA041056: AB_2677277" "unprognostic (1.44e-1)" "unprognostic (2.22e-2)" "unprognostic (5.63e-2)" "prognostic unfavorable (2.64e-4)" "unprognostic (2.06e-1)" "unprognostic (1.77e-3)" "prognostic unfavorable (3.07e-4)" "unprognostic (8.80e-2)" "unprognostic (1.66e-3)" "unprognostic (1.44e-1)" "unprognostic (1.42e-2)" "unprognostic (4.94e-2)" "unprognostic (8.51e-2)" "unprognostic (1.45e-1)" "unprognostic (1.53e-1)" "unprognostic (7.28e-2)" "unprognostic (5.65e-2)" 35.3 21.3 20.5 28.7 26.0 17.4 31.2 27.1 25.6 31.2 27.9 16.7 21.6 20.9 32.0 22.9 27.8 28.5 21.3 22.9 19.6 19.1 32.0 40.3 24.1 35.0 25.5 22.9 36.3 29.5 21.0 25.9 25.0 25.0 25.0 30.3 11.5 24.2 26.6 37.0 24.9 26.3 28.3 30.8 46.5 26.2 22.9 31.1 40.7 31.3 23.9 37.6 37.6 23.7 22.2 20.5 9.4 18.5 17.2 23.6 16.3 22.0 10.0 15.0 13.5 8.9 8.0 24.8 13.1 10.4 18.1 16.0 24.6 14.6 32.5 21.5 10.8 16.8 17.1 29.0 16.9 26.8 16.5 20.3 31.0 9.4 24.7 12.4 41.4 16.2 8.3 15.7 23.0 23.3 9.2 10.8 16.9 33.8 14.1 13.8 13.7 22.6 21.6 37.6 18.7 15.2 19.7 23.4 28.4 12.0 13.1 14.4 24.5 15.2 16.8 17.0 15.9 10.6 22.9 8.3 16.2 23.9 11.4 23.5 16.3 20.2 90.0 11.9 19.6 7.2 6.2 13.8 9.4 16.2 17.3 20.6 22.2 19.3 18.5 12.5 19.1 23.6 20.7 3.6 17.2 18.5 20.5 15.0 16.3 20.5 26.0 27.1 25.6 19.6 19.1 25.5 22.9 25.0 31.1 89.3 53.4 123.6 65.7 171.3 131.1 44.8 122.3 89.7 94.4 115.1 78.5 95.4 99.5 87.4 10.8 105.7 49.3 23.3 99.4 101.8 89.3 52.4 108.5 162.0 78.1 77.9 54.6 103.7 79.2 10.1 98.7 99.7 87.7 93.8 85.3 76.8 106.8 59.6 97.6 93.5 118.7 64.7 108.2 111.4 127.7 140.4 74.3 107.1 93.0 50.8 DDX28 "FLJ11282, MDDX28" ENSG00000182810 "DEAD-box helicase 28" Q9NUL7 16 68021274-68023442 "Enzymes, Predicted intracellular proteins" "Ribosome biogenesis" "Helicase, Hydrolase, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Syncytiotrophoblasts: 83.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041911, HPA053585" Approved Supported Nucleoli,Mitochondria,Cytosol No No "Mitochondria, Cytosol" Nucleoli "HPA041911: AB_10794161, HPA053585: AB_2682200" "unprognostic (8.11e-2)" "unprognostic (1.18e-1)" "unprognostic (6.10e-3)" "unprognostic (8.03e-2)" "unprognostic (1.58e-1)" "unprognostic (8.69e-2)" "unprognostic (8.46e-2)" "unprognostic (9.58e-2)" "unprognostic (2.19e-1)" "unprognostic (7.63e-2)" "unprognostic (8.14e-3)" "unprognostic (8.53e-2)" "prognostic favorable (2.07e-10)" "unprognostic (1.58e-2)" "unprognostic (6.21e-2)" "unprognostic (2.23e-1)" "unprognostic (2.47e-1)" 9.8 12.7 6.2 6.7 8.3 19.7 7.1 6.0 12.9 8.3 7.2 6.4 6.8 5.2 7.5 7.3 9.7 7.1 7.0 9.2 5.2 5.9 8.9 12.4 5.8 18.4 6.4 5.1 8.6 13.3 6.8 4.6 17.1 6.6 6.1 6.0 7.8 6.3 5.2 16.2 9.9 7.9 5.3 3.0 11.1 7.0 11.5 2.7 14.6 10.2 7.3 10.6 8.0 4.8 17.8 18.0 22.9 19.1 17.0 22.9 16.6 6.1 9.2 4.5 5.4 6.3 3.5 10.6 4.2 6.3 10.7 7.6 8.9 9.8 23.2 6.5 5.2 5.8 11.2 6.4 10.2 6.3 3.1 10.6 8.4 4.8 9.2 8.5 13.1 9.0 6.9 11.2 8.8 8.1 3.7 5.9 15.7 14.9 3.6 4.7 13.8 13.7 18.5 11.1 6.3 6.8 13.5 4.2 24.8 7.5 7.2 9.5 6.4 17.2 4.9 9.3 5.4 9.5 14.4 4.2 4.7 4.0 6.7 6.9 8.2 9.9 22.3 5.8 10.1 6.4 17.7 19.1 22.9 15.7 18.8 17.3 12.6 14.6 16.9 18.0 17.8 22.9 16.9 6.3 17.0 18.5 9.0 13.8 16.6 6.2 8.3 6.0 12.9 5.2 5.9 6.4 5.1 6.6 2.7 6.0 5.0 7.5 13.5 8.1 4.8 3.1 2.5 2.7 5.7 3.5 0.0 24.0 11.6 9.5 5.9 6.0 1.7 0.0 8.5 9.4 4.2 3.1 3.5 9.7 15.4 3.2 4.6 4.3 10.3 3.1 4.6 6.6 6.8 11.8 2.8 7.2 7.2 4.5 3.2 14.6 3.4 12.9 4.1 20.6 15.1 9.4 83.5 10.1 5.8 10.3 DDX31 "FLJ13633, FLJ14578, FLJ23349, PPP1R25" ENSG00000125485 "DEAD-box helicase 31" Q9H8H2 9 132592997-132670401 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Intestinal endocrine cells: 23.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020891 Supported "Nucleoli,Golgi apparatus,Vesicles" NA NA Nucleoli "Golgi apparatus, Vesicles" "HPA020891: " "unprognostic (5.71e-2)" "unprognostic (1.76e-2)" "unprognostic (2.56e-1)" "unprognostic (7.91e-2)" "unprognostic (5.79e-2)" "unprognostic (9.94e-2)" "prognostic unfavorable (1.68e-7)" "unprognostic (1.34e-1)" "unprognostic (2.02e-2)" "unprognostic (1.66e-1)" "unprognostic (3.90e-2)" "unprognostic (9.57e-3)" "unprognostic (4.57e-3)" "unprognostic (2.24e-2)" "unprognostic (1.22e-1)" "unprognostic (1.38e-1)" "unprognostic (2.03e-1)" 6.8 6.9 8.2 15.3 11.2 6.0 12.3 18.4 8.5 7.5 6.6 9.4 12.6 5.0 8.9 8.8 9.8 8.8 7.5 5.4 6.3 6.3 8.4 9.2 12.0 15.1 9.1 5.7 16.9 17.3 10.0 8.8 5.8 9.8 9.2 8.0 7.4 12.7 12.6 12.9 14.0 7.2 12.7 12.9 8.7 6.8 15.2 8.3 6.8 22.7 10.8 13.8 7.2 12.6 5.0 4.5 1.9 2.7 3.1 6.9 3.0 7.0 13.2 6.4 8.8 7.9 7.1 12.6 7.6 7.5 12.0 9.2 14.6 14.6 17.7 6.9 7.1 12.5 19.8 20.2 8.9 9.7 10.8 7.5 9.6 11.7 7.6 9.5 17.0 7.8 6.3 12.2 12.3 17.3 4.6 7.8 13.2 17.6 6.9 9.9 15.2 11.8 9.3 15.9 21.0 13.5 12.5 11.4 20.3 10.9 6.8 11.6 8.3 13.9 12.4 10.5 7.8 25.9 5.0 6.6 20.4 9.2 11.5 11.7 3.4 10.7 13.8 7.3 10.8 15.3 0.0 1.9 1.9 5.7 2.7 4.7 4.2 5.5 4.4 4.5 5.0 6.9 5.1 0.3 3.1 1.9 2.8 3.6 3.0 8.2 11.2 18.4 8.5 6.3 6.3 9.1 5.7 9.8 8.3 6.0 5.9 3.4 3.1 4.9 3.4 3.1 0.0 6.7 15.9 7.0 3.9 4.6 1.7 4.1 2.1 3.9 0.7 0.0 4.6 5.8 2.6 4.1 1.1 3.2 4.6 1.6 23.6 3.1 2.4 2.4 16.7 2.8 1.7 4.6 3.7 1.5 4.7 0.0 12.4 4.3 3.1 0.0 2.1 11.2 15.7 5.5 2.5 4.1 5.7 2.6 DDX51 ENSG00000185163 "DEAD-box helicase 51" Q8N8A6 12 132136594-132144335 "Enzymes, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 31.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039503 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA039503: AB_10796328" "unprognostic (2.84e-3)" "unprognostic (1.69e-2)" "unprognostic (1.43e-1)" "unprognostic (2.84e-1)" "unprognostic (8.66e-2)" "unprognostic (4.00e-2)" "prognostic unfavorable (4.73e-4)" "unprognostic (1.13e-1)" "unprognostic (1.42e-1)" "unprognostic (4.88e-1)" "unprognostic (3.05e-3)" "unprognostic (5.31e-2)" "unprognostic (3.97e-2)" "unprognostic (2.48e-1)" "unprognostic (4.69e-2)" "unprognostic (3.28e-1)" "unprognostic (1.65e-3)" 10.5 8.5 12.7 12.7 17.1 17.2 10.3 23.5 18.9 8.8 8.4 11.8 10.6 7.8 11.5 12.2 8.5 12.4 10.0 8.1 11.6 9.9 9.5 7.2 8.9 11.1 10.5 16.9 19.6 14.8 10.1 9.8 7.2 11.8 9.3 7.3 8.9 10.7 12.4 13.8 18.0 8.2 10.4 10.5 10.6 9.3 6.7 12.0 9.5 9.9 7.1 10.4 9.3 8.6 2.5 2.3 2.6 2.1 1.6 2.0 1.0 6.2 10.1 4.2 5.3 4.0 3.9 8.0 4.8 2.9 7.2 3.0 6.2 3.1 10.9 4.2 2.9 1.7 6.6 10.5 7.7 3.5 2.6 10.1 12.9 5.4 2.0 4.9 9.0 7.5 3.4 5.7 4.0 3.6 8.1 3.8 12.2 9.5 3.6 2.1 6.2 11.0 18.5 7.4 5.3 17.4 13.1 5.8 12.1 4.9 5.0 10.3 5.4 5.3 7.5 5.3 3.7 6.6 8.3 6.7 2.7 8.3 6.6 11.1 10.2 5.9 12.8 5.6 6.9 6.3 1.1 2.1 1.2 2.0 1.0 0.7 1.5 1.3 0.9 0.6 2.5 1.2 1.6 2.6 1.6 1.0 2.3 0.6 1.0 12.7 17.1 23.5 18.9 11.6 9.9 10.5 16.9 11.8 12.0 3.0 15.9 3.0 6.8 11.1 27.9 4.0 10.2 4.0 13.6 3.5 23.6 6.0 1.7 4.0 0.9 7.7 3.5 0.0 4.5 4.9 6.5 7.3 5.8 6.4 4.9 31.8 8.1 7.4 6.2 0.7 7.8 5.7 10.1 3.6 8.3 11.1 5.4 7.0 7.8 2.9 27.4 0.0 6.4 5.7 9.4 12.3 3.4 6.9 12.1 5.8 DDX53 "CAGE, CT26" ENSG00000184735 "DEAD-box helicase 53" Q86TM3 X 22999961-23003589 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 33 "testis: 11.5" "Cell type enriched" "Detected in some" 5 "Early spermatids: 47.4" "Cancer enhanced" "Detected in single" "testis cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 4.6;K-562: 6.3;RPMI-8226: 3.3;U-2197: 2.1;U-266/84: 14.1" "Low region specificity" "Detected in many" HPA003186 Supported Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA003186: AB_1078637" "unprognostic (5.76e-1)" "unprognostic (1.12e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.1 0.0 0.4 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 10.0 8.8 0.0 0.0 0.0 0.0 0.0 DDX54 "APR-5, DP97, MGC2835" ENSG00000123064 "DEAD-box helicase 54" Q8TDD1 12 113157174-113185479 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028244, HPA070786" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA "Nucleoplasm, Nucleoli, Golgi apparatus" "HPA028244: AB_10603885, HPA070786: AB_2686311" "unprognostic (1.61e-2)" "unprognostic (1.14e-1)" "unprognostic (1.23e-1)" "unprognostic (8.54e-2)" "unprognostic (8.57e-2)" "unprognostic (6.39e-2)" "prognostic unfavorable (1.39e-4)" "unprognostic (2.23e-2)" "unprognostic (1.03e-1)" "unprognostic (1.08e-1)" "unprognostic (1.01e-1)" "unprognostic (4.83e-2)" "unprognostic (1.15e-1)" "unprognostic (2.29e-2)" "unprognostic (2.01e-1)" "unprognostic (2.22e-1)" "unprognostic (1.24e-1)" 17.2 17.6 9.2 20.7 12.8 25.4 17.2 9.9 13.6 17.9 16.4 12.4 18.1 20.3 18.0 19.4 19.5 17.2 17.9 20.1 8.8 7.9 22.3 28.6 14.0 19.9 8.1 9.4 22.4 27.0 18.3 7.4 22.6 10.0 16.6 9.0 13.4 17.4 13.9 45.4 18.7 19.4 14.8 8.1 22.2 16.1 11.4 8.6 26.6 23.1 21.6 22.2 16.7 17.5 12.1 13.3 8.0 15.2 11.9 13.0 10.0 26.8 28.1 10.5 19.3 7.0 8.5 27.1 14.6 13.6 20.0 11.0 28.9 13.1 34.9 17.2 12.2 14.9 20.0 18.6 19.0 7.6 20.0 22.8 20.9 15.1 19.7 12.4 34.9 24.8 13.9 15.1 19.3 11.9 16.4 16.3 21.2 30.3 12.5 10.2 24.8 30.0 49.8 24.5 18.9 20.0 22.3 15.5 35.6 10.9 28.1 13.6 12.4 20.7 31.8 13.2 9.0 27.3 27.3 12.1 17.0 19.0 20.1 30.4 18.3 20.8 39.2 15.0 19.5 17.8 8.0 10.0 2.3 12.4 15.2 13.0 11.6 11.4 12.2 13.3 12.1 11.8 12.5 0.6 11.9 9.8 10.0 9.4 10.0 9.2 12.8 9.9 13.6 8.8 7.9 8.1 9.4 10.0 8.6 29.8 28.0 32.1 27.0 15.3 20.2 12.4 20.4 10.7 21.6 12.2 2.0 51.4 21.6 35.0 0.9 19.7 30.2 23.3 43.1 46.0 18.7 23.5 24.3 35.5 34.5 25.4 27.1 15.4 31.7 2.1 27.3 23.0 11.8 23.4 28.6 23.8 38.0 38.2 22.6 34.9 18.1 6.5 18.9 15.4 18.9 17.1 60.5 37.3 38.2 32.3 DEPDC7 ENSG00000121690 "DEP domain containing 7" Q96QD5 11 33015864-33033582 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 51.8;liver: 42.2" "Cell type enhanced" "Detected in many" 17 "Basal keratinocytes: 30.9;Early spermatids: 98.0;Extravillous trophoblasts: 40.1;Spermatocytes: 27.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 9.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "LHCN-M2: 27.2;RH-30: 20.6;SiHa: 18.8;U-2197: 17.5" "Low region specificity" "Detected in many" HPA015800 Approved Nucleoplasm,Nucleoli,Cytosol Yes No Nucleoli "Nucleoplasm, Cytosol" "HPA015800: AB_1847610" "unprognostic (2.34e-1)" "unprognostic (5.57e-2)" "unprognostic (1.27e-1)" "unprognostic (2.27e-1)" "unprognostic (2.66e-2)" "unprognostic (7.26e-2)" "prognostic favorable (7.26e-4)" "unprognostic (1.80e-1)" "unprognostic (1.22e-1)" "unprognostic (2.92e-1)" "unprognostic (1.17e-3)" "unprognostic (8.99e-2)" "unprognostic (1.89e-2)" "unprognostic (9.30e-2)" "unprognostic (8.09e-3)" "unprognostic (2.64e-1)" "unprognostic (2.94e-2)" 0.6 0.5 2.0 1.4 4.1 0.9 2.0 0.5 2.6 1.7 15.3 4.3 1.2 14.1 1.2 1.4 3.1 0.8 3.1 0.9 2.6 1.4 10.9 42.2 0.7 0.4 4.0 1.5 1.3 2.7 3.5 0.8 1.2 2.8 1.4 3.1 1.2 1.7 1.0 3.3 3.4 51.8 1.0 3.2 0.5 2.2 15.6 3.3 1.8 0.6 2.0 0.9 0.9 2.4 0.0 4.4 9.0 0.7 3.0 3.1 0.6 4.5 2.5 3.7 1.6 2.0 1.9 2.5 8.2 2.7 5.0 6.8 6.7 0.4 0.0 1.9 8.1 2.3 4.7 5.4 1.9 6.0 0.0 7.5 1.3 7.9 9.4 1.6 4.4 5.6 2.4 2.9 2.9 2.1 2.7 0.0 0.0 3.0 0.0 27.2 0.5 0.0 7.1 2.4 3.8 0.0 0.0 20.6 0.0 1.6 0.6 0.8 2.1 18.8 3.3 16.3 2.7 0.8 2.3 0.0 3.2 5.4 17.5 5.2 0.0 0.0 0.0 1.2 0.0 15.9 4.0 0.7 9.0 0.3 0.2 0.0 0.0 0.6 0.3 4.4 0.0 2.9 3.1 0.0 3.0 0.0 1.8 0.0 0.6 2.0 4.1 0.5 2.6 2.6 1.4 4.0 1.5 2.8 3.3 0.0 0.0 0.0 8.3 30.9 0.0 0.0 0.0 1.4 1.2 0.0 0.0 0.3 3.3 0.4 98.0 0.1 8.6 0.0 0.5 40.1 1.6 0.8 2.3 19.4 2.7 0.0 3.4 2.5 0.3 6.3 1.4 2.4 1.7 1.8 1.0 0.0 1.0 0.0 1.1 11.2 0.0 0.0 1.4 27.7 7.6 6.5 1.3 0.0 2.1 0.7 DIAPH2 "DIA, DIA2, POF, POF2" ENSG00000147202 "Diaphanous related formin 2" O60879 X 96684663-97604997 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Oogenesis" "Developmental protein" "Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 117.7;Syncytiotrophoblasts: 99.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005647, CAB015461, CAB068183, CAB068184" Enhanced Supported "Nucleoli,Endoplasmic reticulum,Vesicles" NA NA "Endoplasmic reticulum, Vesicles" Nucleoli "CAB015461: AB_831223, CAB068183: AB_2665693, CAB068184: AB_2665694, HPA005647: AB_1078657" "unprognostic (5.75e-2)" "unprognostic (4.13e-3)" "unprognostic (1.48e-1)" "prognostic unfavorable (2.16e-5)" "unprognostic (1.58e-1)" "unprognostic (6.48e-2)" "unprognostic (4.06e-1)" "unprognostic (1.07e-2)" "unprognostic (2.41e-1)" "unprognostic (1.43e-2)" "prognostic unfavorable (2.12e-4)" "unprognostic (3.39e-2)" "prognostic unfavorable (3.90e-4)" "unprognostic (6.44e-2)" "unprognostic (3.11e-2)" "unprognostic (6.99e-3)" "unprognostic (6.08e-3)" 25.3 5.7 8.2 16.5 13.6 19.9 12.0 1.6 4.6 17.8 18.5 2.9 15.1 5.5 10.7 9.1 16.3 10.4 12.6 13.0 6.6 3.0 6.1 15.7 16.8 6.9 4.1 4.4 14.2 6.6 8.7 5.5 37.2 7.1 16.0 11.4 4.7 9.4 17.2 19.9 9.3 12.0 18.5 7.3 9.8 9.9 12.3 5.1 9.4 7.5 12.0 4.9 19.8 26.9 2.7 4.3 5.7 5.8 1.4 2.8 1.0 0.0 4.0 1.9 3.9 11.1 18.5 0.0 7.0 7.4 3.8 8.0 3.3 7.6 11.3 5.6 6.0 7.2 0.0 10.4 1.1 4.9 0.3 5.9 0.0 4.9 3.6 9.3 14.6 5.2 9.3 3.7 5.0 15.8 5.1 7.3 8.5 0.0 9.4 7.0 3.2 5.5 6.0 15.4 0.0 5.9 0.0 10.5 0.0 2.1 6.0 0.0 4.0 0.0 2.0 5.6 12.5 1.7 8.0 9.1 8.1 3.7 6.7 4.5 0.1 0.0 9.5 6.8 14.9 4.7 0.0 5.8 5.7 2.3 5.4 1.8 2.7 2.4 2.8 4.3 2.4 1.6 1.5 0.6 1.4 4.5 4.1 1.3 1.0 8.2 13.6 1.6 4.6 6.6 3.0 4.1 4.4 7.1 5.1 29.8 42.7 10.6 4.8 9.6 5.7 19.0 7.6 42.8 18.2 19.2 0.0 41.5 6.6 16.9 60.0 25.2 23.6 0.0 20.1 14.6 25.5 6.7 7.0 23.1 17.8 0.0 23.6 8.0 30.6 117.7 41.7 21.4 8.5 6.4 27.6 12.5 26.4 35.1 19.1 6.1 14.0 25.8 18.6 4.9 12.2 15.9 99.0 12.5 28.1 4.8 DLK2 "EGFL9, MGC2487" ENSG00000171462 "Delta like non-canonical Notch ligand 2" Q6UY11 6 43450352-43456632 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 19.3" "Cell type enriched" "Detected in some" 7 "Basal glandular cells: 79.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 16.5;HBEC3-KT: 9.0;hTCEpi: 27.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA061223, HPA068672, HPA070955" Uncertain Approved Nucleoplasm,Nucleoli,Vesicles No No Nucleoplasm "Nucleoli, Vesicles" "HPA061223: AB_2684454, HPA068672: AB_2686017, HPA070955: " "unprognostic (4.65e-5)" "unprognostic (1.27e-1)" "unprognostic (1.69e-1)" "unprognostic (9.68e-4)" "unprognostic (2.87e-1)" "unprognostic (3.80e-1)" "unprognostic (4.19e-3)" "unprognostic (1.65e-1)" "unprognostic (2.65e-3)" "unprognostic (4.04e-1)" "unprognostic (1.88e-2)" "unprognostic (1.88e-1)" "unprognostic (9.27e-12)" "unprognostic (7.71e-4)" "unprognostic (8.92e-2)" "unprognostic (1.55e-1)" "unprognostic (6.43e-2)" 1.0 1.1 4.5 1.4 7.9 1.7 4.3 12.2 8.2 2.2 0.7 0.9 6.4 1.1 1.4 3.8 10.5 1.1 0.9 1.8 4.1 4.6 0.7 0.7 1.1 1.7 1.5 4.8 1.7 1.5 0.4 0.5 1.3 0.9 10.4 0.5 0.3 12.4 13.0 0.7 19.3 1.0 0.6 1.5 1.5 1.1 1.1 1.2 1.3 0.8 4.7 3.9 2.2 5.3 0.8 1.8 1.0 0.5 2.5 3.2 0.3 5.2 1.9 0.5 7.9 0.0 0.4 1.8 1.9 2.1 2.2 1.0 1.8 0.2 1.0 1.2 0.4 2.7 16.5 5.6 9.0 0.5 1.0 2.1 0.4 0.9 2.8 0.6 0.3 1.1 0.9 27.2 0.6 5.1 0.7 0.0 3.1 0.4 0.8 0.8 2.0 0.4 0.4 0.7 2.0 2.0 1.1 1.0 0.5 0.3 1.8 5.9 0.6 0.6 0.2 0.3 0.4 0.5 1.6 0.5 0.8 2.5 0.6 3.8 1.2 0.3 1.7 0.1 0.7 0.5 0.9 0.4 0.4 0.7 0.3 3.2 0.6 2.2 2.2 0.1 0.8 0.9 0.4 1.0 2.5 0.5 1.8 0.3 0.3 4.5 7.9 12.2 8.2 4.1 4.6 1.5 4.8 0.9 1.2 0.0 0.3 0.0 79.5 9.0 0.6 0.5 0.0 0.0 7.9 0.0 0.0 0.8 0.0 0.1 0.2 0.3 0.0 0.0 0.0 2.1 0.2 4.3 0.0 0.0 0.1 11.1 1.2 0.0 0.0 0.2 0.3 0.0 1.7 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.9 0.0 0.3 1.2 5.5 2.3 0.2 0.0 0.0 3.9 DNAJA2 "CPR3, DNAJ, DNJ3, HIRIP4" ENSG00000069345 "DnaJ heat shock protein family (Hsp40) member A2" O60884 16 46955362-46973788 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049789, HPA060538" Approved Approved "Nucleoli,Intermediate filaments,Cytosol" NA NA 31000 "Nucleoli, Cytosol" "Intermediate filaments" "HPA049789: AB_2680883, HPA060538: AB_2684315" "unprognostic (7.68e-3)" "unprognostic (1.05e-2)" "unprognostic (4.77e-2)" "unprognostic (3.67e-2)" "unprognostic (4.46e-2)" "prognostic unfavorable (2.81e-4)" "unprognostic (1.03e-1)" "unprognostic (4.56e-2)" "unprognostic (1.18e-1)" "unprognostic (1.53e-2)" "unprognostic (5.41e-2)" "unprognostic (2.12e-1)" "prognostic favorable (1.19e-9)" "unprognostic (9.22e-2)" "unprognostic (2.28e-1)" "unprognostic (9.22e-2)" "unprognostic (4.69e-2)" 25.0 29.2 32.3 18.0 36.5 23.6 22.8 29.8 44.2 21.7 21.1 17.1 20.3 22.3 25.6 33.6 23.4 20.3 18.9 37.9 30.5 27.1 31.2 39.0 17.7 21.4 25.5 27.6 26.1 18.9 29.0 18.9 22.1 31.5 25.6 21.9 18.4 19.1 24.9 43.7 22.3 23.8 26.9 21.2 24.1 20.3 33.0 18.7 20.8 25.4 31.8 23.2 24.5 23.5 13.6 10.5 14.5 14.0 14.3 18.9 10.2 11.0 13.1 13.2 11.2 18.1 17.5 20.2 14.4 17.3 21.6 10.3 11.4 11.5 17.7 11.6 15.4 9.3 17.2 21.1 14.8 25.2 4.2 17.6 13.0 6.4 24.1 21.8 19.7 18.2 18.6 17.2 12.5 11.9 19.0 14.9 7.2 14.9 6.0 18.2 12.0 14.1 27.5 20.1 10.1 19.5 16.4 24.3 21.0 26.0 11.7 18.1 11.6 17.0 25.9 15.6 13.6 10.0 15.4 15.3 12.9 8.1 9.2 12.0 14.8 10.1 23.8 13.5 17.1 10.7 13.0 11.5 14.5 11.9 14.0 15.4 13.6 16.1 13.3 10.5 10.4 16.0 15.7 12.1 14.3 12.0 7.4 18.9 10.2 32.3 36.5 29.8 44.2 30.5 27.1 25.5 27.6 31.5 18.7 47.6 31.0 65.5 60.6 112.8 37.1 86.5 28.1 80.3 42.1 38.4 17.7 68.7 76.3 62.0 53.0 41.0 64.6 0.0 54.2 58.1 44.1 43.1 53.1 50.8 51.1 35.0 49.8 31.3 41.3 44.4 46.3 47.7 69.2 64.1 46.0 56.2 58.4 56.1 55.5 78.9 37.8 51.8 68.0 155.1 97.9 105.3 144.2 46.5 47.8 68.8 DNTTIP2 "ERBP, HSU15552, TdIF2" ENSG00000067334 "Deoxynucleotidyltransferase terminal interacting protein 2" Q5QJE6 1 93866283-93879918 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044502, HPA053707" Supported Enhanced "Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim, Mitotic chromosome" "HPA044502: AB_10960277, HPA053707: AB_2682236" "unprognostic (2.95e-3)" "unprognostic (3.84e-2)" "unprognostic (6.21e-3)" "unprognostic (1.12e-2)" "unprognostic (2.41e-1)" "unprognostic (8.92e-2)" "prognostic unfavorable (1.90e-6)" "unprognostic (7.94e-2)" "unprognostic (5.57e-3)" "unprognostic (2.69e-2)" "unprognostic (2.02e-3)" "unprognostic (1.59e-1)" "prognostic unfavorable (7.80e-5)" "unprognostic (2.59e-1)" "unprognostic (8.41e-2)" "unprognostic (2.25e-1)" "unprognostic (1.06e-2)" 14.0 8.5 10.7 7.3 11.4 27.6 10.9 12.0 12.5 12.4 9.4 5.8 7.9 6.1 9.4 14.1 15.1 9.7 9.7 11.4 9.4 10.3 14.5 15.1 12.1 10.7 10.4 10.5 15.9 8.3 9.9 12.1 15.5 17.7 13.0 8.1 4.6 9.0 7.3 24.6 11.7 11.7 11.0 13.2 16.2 9.0 12.0 10.9 15.9 16.2 12.6 10.7 17.3 15.5 11.1 7.2 15.8 11.6 11.9 11.6 8.0 12.4 6.0 6.8 7.1 6.5 5.8 10.3 8.4 6.0 10.1 8.7 6.6 5.6 16.7 11.3 8.8 12.7 7.1 10.8 10.1 14.4 10.1 6.1 13.7 9.9 9.6 6.8 15.3 4.9 6.4 11.0 10.8 9.1 5.1 7.2 5.5 16.1 5.8 13.7 5.4 10.7 10.0 13.0 5.6 9.7 6.2 14.4 6.4 10.3 9.7 8.1 7.3 8.8 13.2 9.2 9.0 5.7 11.1 6.8 8.2 8.6 9.4 14.1 6.1 8.1 13.7 4.8 12.1 5.4 10.9 7.9 15.8 9.6 11.6 11.6 11.1 8.9 8.7 7.2 10.5 8.2 10.4 12.1 11.9 10.7 5.0 8.8 8.0 10.7 11.4 12.0 12.5 9.4 10.3 10.4 10.5 17.7 10.9 53.6 74.1 43.3 98.3 48.3 31.6 69.0 10.2 117.8 117.2 12.2 55.0 44.4 18.3 60.2 28.9 60.6 13.1 23.3 52.7 36.6 31.7 61.4 112.5 16.6 33.8 19.1 8.1 20.9 24.1 7.4 23.9 59.5 21.9 64.1 12.1 30.7 68.6 15.3 24.4 14.7 29.6 19.4 106.0 54.0 70.5 44.3 46.7 46.5 19.7 80.3 DOC2A ENSG00000149927 "Double C2 domain alpha" Q14183 16 30005509-30023270 "Predicted intracellular proteins" Exocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 49.0;testis: 12.6" "Group enriched" "Detected in many" 6 "Ciliated cells: 72.3;Early spermatids: 196.5;Late spermatids: 146.0" "Cancer enhanced" "Detected in many" "renal cancer: 5.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 9.8;SCLC-21H: 26.6;U-937: 12.8" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 4 "amygdala: 13.5;cerebral cortex: 30.8;hippocampal formation: 24.4" HPA065676 Uncertain "Nucleoplasm,Nucleoli,Cell Junctions" NA NA "Cell Junctions" "Nucleoplasm, Nucleoli" "HPA065676: AB_2685528" "unprognostic (1.46e-3)" "unprognostic (3.39e-1)" "unprognostic (2.30e-2)" "unprognostic (1.31e-1)" "unprognostic (4.26e-2)" "unprognostic (1.40e-1)" "unprognostic (3.66e-2)" "unprognostic (9.14e-2)" "unprognostic (3.90e-2)" "unprognostic (2.89e-2)" "unprognostic (1.28e-3)" "unprognostic (5.13e-2)" "unprognostic (8.29e-3)" "unprognostic (1.71e-1)" "unprognostic (2.74e-1)" "unprognostic (2.68e-1)" "unprognostic (2.61e-1)" 1.2 2.7 18.5 1.0 17.5 3.9 2.3 24.0 49.0 1.3 3.1 0.9 0.3 1.7 1.6 2.4 1.1 3.3 1.8 1.0 15.3 8.3 1.6 1.4 3.5 1.4 2.8 27.4 5.7 1.0 1.3 3.2 1.2 13.1 2.5 2.4 0.0 1.6 1.4 1.1 2.0 2.3 1.8 4.2 3.1 1.7 12.6 1.8 0.0 1.6 0.0 1.2 1.4 0.6 0.6 1.1 1.0 0.4 0.2 0.5 0.3 0.7 1.5 1.1 0.8 0.3 0.0 9.8 0.4 0.7 0.5 0.3 4.0 2.7 0.0 0.9 0.4 1.4 0.2 5.0 2.0 0.2 0.1 0.5 0.8 0.5 0.3 0.7 0.9 2.9 1.2 0.8 0.1 1.1 5.0 0.0 3.3 0.3 0.0 0.0 7.8 2.1 3.6 1.5 3.1 4.2 8.0 0.1 0.4 0.5 0.8 26.6 2.1 0.6 2.8 0.2 2.4 2.7 1.7 0.8 0.3 1.5 0.3 0.3 0.5 0.1 0.1 0.3 12.8 0.3 0.8 0.4 0.0 0.0 0.3 0.1 0.5 0.1 0.3 1.1 0.6 0.5 0.5 1.0 0.2 0.0 0.0 0.1 0.3 18.5 17.5 24.0 36.2 15.3 8.3 2.8 27.4 13.1 1.8 0.0 5.8 0.5 3.1 0.6 1.2 0.6 2.5 72.3 12.5 1.8 21.6 0.3 1.7 0.0 196.5 0.7 0.9 0.0 0.0 0.9 0.7 1.8 0.0 0.0 0.4 0.0 1.2 1.8 1.3 146.0 0.6 1.3 1.7 0.0 2.2 3.1 0.0 0.0 1.8 0.0 1.8 0.0 0.3 1.7 4.1 0.6 0.1 0.0 4.1 0.7 DOHH "HLRC1, MGC4293" ENSG00000129932 "Deoxyhypusine hydroxylase" Q9BU89 19 3490822-3500940 "Enzymes, Predicted intracellular proteins" "Hypusine biosynthesis" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041953, HPA076271" Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA Cytosol "Nucleoplasm, Nucleoli" "HPA041953: AB_10795386, HPA076271: " "unprognostic (1.28e-1)" "unprognostic (1.18e-1)" "unprognostic (8.63e-2)" "prognostic favorable (2.24e-4)" "unprognostic (3.66e-1)" "unprognostic (2.01e-2)" "unprognostic (9.45e-2)" "unprognostic (7.26e-2)" "unprognostic (4.65e-2)" "unprognostic (1.13e-1)" "prognostic favorable (3.58e-4)" "unprognostic (9.87e-3)" "unprognostic (1.14e-3)" "unprognostic (4.35e-2)" "unprognostic (1.46e-1)" "unprognostic (1.66e-1)" "unprognostic (3.76e-3)" 8.1 6.5 10.5 6.6 13.0 9.3 3.4 5.5 13.0 3.9 5.5 6.9 2.6 18.9 3.7 4.1 4.1 3.1 4.9 5.1 14.9 9.1 6.0 6.4 4.0 4.5 18.2 6.2 3.8 7.6 3.8 3.9 3.8 8.4 5.1 2.0 3.2 6.0 4.0 23.1 7.0 12.3 2.4 25.5 5.9 7.3 4.2 6.1 4.7 2.9 7.8 4.5 3.1 4.7 11.6 11.0 1.8 6.6 6.9 12.3 4.4 9.2 11.0 1.7 3.6 0.9 1.1 7.4 8.8 1.8 4.3 3.4 15.3 3.8 7.2 6.9 1.3 3.9 9.6 2.7 3.0 0.9 10.6 12.4 7.5 6.2 18.2 3.5 10.0 10.5 1.2 3.0 4.2 1.8 1.5 2.2 8.0 16.3 8.5 1.7 10.5 10.8 11.4 9.8 3.7 14.9 12.3 4.0 10.4 2.6 5.2 10.5 7.7 6.2 5.5 8.8 0.8 7.5 5.5 5.0 5.4 7.4 14.3 16.1 11.3 8.2 9.6 6.4 22.8 6.4 1.1 5.3 1.8 6.2 6.2 8.1 8.1 8.5 12.3 8.7 11.6 12.3 10.4 0.3 6.9 6.6 11.0 9.6 4.4 10.5 13.0 5.5 13.0 14.9 9.1 18.2 6.2 8.4 6.1 6.0 2.1 18.5 14.9 20.9 17.4 7.1 10.2 1.4 2.3 5.2 9.8 25.8 18.3 21.7 7.1 12.1 9.7 0.0 18.5 26.0 13.9 16.8 13.8 8.2 19.0 23.8 12.6 11.1 7.2 17.2 13.0 8.6 18.6 24.4 11.0 13.1 19.1 14.4 14.2 23.9 11.8 0.0 13.7 11.1 12.3 24.1 29.1 12.8 16.1 15.3 DOLK "DK1, KIAA1094, TMEM15" ENSG00000175283 "Dolichol kinase" Q9UPQ8 9 128945530-128947619 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Kinase, Transferase" "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066767, HPA068706" Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA066767: AB_2732751, HPA068706: AB_2732118" "unprognostic (6.35e-2)" "unprognostic (2.69e-1)" "unprognostic (2.63e-1)" "unprognostic (1.30e-3)" "unprognostic (3.55e-1)" "unprognostic (2.81e-3)" "unprognostic (8.90e-3)" "unprognostic (3.26e-1)" "unprognostic (1.02e-1)" "unprognostic (3.01e-1)" "unprognostic (8.83e-3)" "unprognostic (1.83e-2)" "prognostic favorable (5.53e-4)" "unprognostic (3.20e-2)" "unprognostic (1.06e-1)" "prognostic favorable (6.88e-5)" "unprognostic (6.13e-3)" 11.0 20.2 7.9 7.8 13.8 1.4 9.5 7.0 18.6 9.8 8.6 14.9 7.1 8.8 12.4 16.8 10.9 10.8 10.8 12.0 7.6 9.9 17.5 22.0 10.6 10.6 8.1 6.7 13.2 16.9 19.2 8.0 19.5 16.3 12.3 8.0 14.2 15.5 12.8 7.9 11.4 10.9 11.1 5.9 11.6 12.4 22.4 6.0 12.5 11.0 11.9 12.1 10.4 7.3 9.4 14.2 5.6 16.4 9.8 13.7 9.0 5.1 19.3 6.8 10.1 20.2 10.7 9.3 10.8 17.5 13.3 9.9 15.1 8.2 2.8 5.7 15.6 18.8 36.7 9.3 13.5 6.9 4.7 8.1 3.5 13.3 10.9 20.5 3.8 6.3 14.8 12.5 14.3 7.9 7.8 12.9 4.1 8.6 4.6 14.3 25.4 3.1 3.2 8.8 14.8 12.0 3.2 9.0 11.2 11.9 7.8 6.3 7.0 14.3 11.8 6.3 6.7 20.6 5.1 10.7 12.0 4.3 15.1 8.8 4.4 10.8 2.9 11.3 3.5 9.1 2.3 13.5 5.6 10.2 13.3 9.1 9.4 9.2 11.2 14.2 9.2 12.1 12.3 2.1 9.8 16.4 8.1 13.7 9.0 7.9 13.8 7.0 18.6 7.6 9.9 8.1 6.7 16.3 6.0 6.0 2.6 1.5 3.2 1.5 9.0 3.0 7.6 6.7 3.4 7.0 7.9 21.7 0.0 14.1 10.7 8.3 6.2 0.0 12.3 14.0 5.6 3.1 1.1 8.3 11.4 4.8 1.2 17.2 6.9 2.8 11.2 2.7 3.3 1.8 3.8 11.2 10.4 5.8 5.6 7.2 6.5 0.0 4.1 24.0 14.9 1.1 15.2 1.9 5.5 1.7 DPH6 "ATPBD4, MGC14798" ENSG00000134146 "Diphthamine biosynthesis 6" Q7L8W6 15 35217345-35546193 "Enzymes, Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042976, HPA055496" Approved Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" Nucleoplasm "HPA042976: AB_10964890, HPA055496: AB_2682835" "unprognostic (9.78e-2)" "unprognostic (1.45e-1)" "unprognostic (1.92e-1)" "unprognostic (1.14e-1)" "unprognostic (1.82e-1)" "unprognostic (1.45e-2)" "unprognostic (1.60e-1)" "unprognostic (9.94e-2)" "unprognostic (1.76e-1)" "unprognostic (1.49e-3)" "unprognostic (7.92e-3)" "unprognostic (1.13e-1)" "unprognostic (4.65e-6)" "unprognostic (9.70e-2)" "unprognostic (5.61e-2)" "unprognostic (2.18e-2)" "unprognostic (7.44e-2)" 13.3 12.7 8.0 6.8 16.1 6.4 15.3 11.6 15.8 14.7 9.2 15.5 10.8 8.5 23.9 17.1 14.7 11.5 10.5 14.4 7.8 7.2 14.7 11.2 8.7 9.3 9.7 12.0 16.7 19.5 15.8 31.7 11.1 13.4 8.5 10.2 14.6 11.5 14.7 24.9 15.2 8.7 16.8 11.1 8.3 9.6 11.3 10.6 7.1 15.3 16.5 10.0 11.0 11.3 8.4 6.3 0.3 6.5 13.2 10.8 4.4 10.5 5.7 9.6 8.1 1.7 7.9 9.4 4.0 7.0 9.7 5.1 7.6 9.9 3.3 9.8 3.7 11.8 12.2 11.1 11.5 11.6 2.6 7.0 12.3 6.5 12.0 10.3 6.5 8.0 6.6 14.6 3.9 18.9 6.0 9.3 7.1 13.5 13.4 8.9 4.1 8.0 6.1 8.5 16.1 5.3 10.0 9.0 4.5 8.4 13.5 7.0 6.9 7.5 8.4 6.4 5.9 29.0 9.1 2.8 9.5 9.2 9.4 6.3 12.0 19.0 8.3 8.2 11.3 9.0 0.0 6.5 0.3 6.2 6.0 7.7 8.4 8.3 8.6 6.3 6.5 10.8 9.5 0.3 13.2 5.6 5.4 5.4 4.4 8.0 16.1 11.6 15.8 7.8 7.2 9.7 12.0 13.4 10.6 14.9 6.9 12.6 16.6 27.5 31.5 11.0 17.8 5.3 17.0 8.7 37.3 22.9 11.6 12.0 2.1 9.5 10.1 23.3 21.1 18.8 11.6 7.6 3.5 7.3 15.0 17.5 5.2 6.7 10.0 1.6 13.0 10.9 15.1 15.4 6.0 16.6 15.1 7.0 6.3 16.4 22.2 0.0 11.3 8.3 15.1 20.3 18.9 5.0 9.2 11.1 DRGX "DRG11, PRRXL1" ENSG00000165606 "Dorsal root ganglia homeobox" A6NNA5 10 49364181-49396016 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 8 "adrenal gland: 13.9;brain: 8.0" "Cell type enriched" "Detected in single" 4 "Melanocytes: 1.7" "Low cancer specificity" "Detected in single" "Group enriched" "Detected in some" 5 "cerebral cortex: 3.3;midbrain: 2.0;pons and medulla: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RH-30: 8.2;SH-SY5Y: 37.4;U-2197: 13.5" "Region enriched" "Detected in single" 6 "pons and medulla: 4.1" "Low region specificity" "Detected in all" HPA043978 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA043978: AB_10961154" "unprognostic (1.42e-2)" "unprognostic (5.68e-2)" "unprognostic (3.92e-2)" "unprognostic (1.23e-2)" "unprognostic (1.74e-3)" "unprognostic (1.58e-1)" "unprognostic (4.54e-2)" "unprognostic (3.74e-2)" "unprognostic (8.91e-2)" "unprognostic (1.60e-1)" "unprognostic (4.09e-2)" 0.2 13.9 0.0 0.4 0.2 0.3 0.1 0.4 3.3 0.0 0.4 0.8 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.2 0.3 0.0 0.0 0.5 0.1 2.0 0.6 0.0 0.0 0.0 0.9 0.0 4.8 0.0 0.9 0.0 0.0 0.0 0.0 1.3 0.3 0.0 8.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 37.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 13.5 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 3.3 0.2 0.3 2.0 0.6 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DTL "CDT2, DCAF2, L2DTL, RAMP" ENSG00000143476 "Denticleless E3 ubiquitin protein ligase homolog" Q9NZJ0 1 212035553-212107400 "Predicted intracellular proteins" "Biological rhythms, DNA damage, DNA replication, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 10.8;lymphoid tissue: 41.2;testis: 37.2" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 17.8;Erythroid cells: 23.3;Extravillous trophoblasts: 13.2;Spermatocytes: 35.9;Spermatogonia: 19.1" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "memory CD8 T-cell: 1.5;T-reg: 5.2" "Lineage enriched" "Detected in single" 7 "T-cells: 5.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA028016, HPA032023, HPA032031" Uncertain Supported Nucleoplasm,Nucleoli,Cytosol Yes Yes Nucleoplasm "Nucleoli, Cytosol" "HPA028016: AB_10611958, HPA032023: AB_2674114, HPA032031: AB_2674119" "unprognostic (7.61e-2)" "unprognostic (1.01e-3)" "unprognostic (2.14e-2)" "unprognostic (3.05e-2)" "unprognostic (2.19e-1)" "unprognostic (5.31e-2)" "prognostic unfavorable (4.41e-5)" "unprognostic (8.96e-3)" "unprognostic (2.45e-3)" "unprognostic (8.83e-3)" "unprognostic (2.52e-3)" "unprognostic (2.83e-2)" "prognostic unfavorable (1.71e-9)" "unprognostic (5.93e-2)" "unprognostic (2.01e-1)" "unprognostic (1.96e-2)" "unprognostic (2.82e-1)" 1.3 0.7 0.4 5.4 0.6 10.8 1.3 0.4 0.5 1.2 2.8 0.3 0.1 1.7 1.0 0.6 4.0 0.4 1.5 0.6 0.4 0.4 0.8 1.0 1.6 4.4 0.4 0.1 0.6 0.5 0.6 0.7 5.4 0.2 0.6 4.2 0.2 1.1 0.1 0.4 1.6 3.3 1.4 0.4 4.6 1.1 37.2 0.1 41.2 0.9 5.7 7.5 0.9 1.6 0.7 0.3 0.0 0.4 0.6 5.2 0.7 12.6 10.8 18.5 9.2 1.1 2.3 9.1 15.9 9.9 15.1 22.5 6.7 11.2 9.6 6.0 6.1 9.7 9.9 24.4 13.4 21.8 11.6 11.7 15.3 14.3 8.1 0.0 20.1 9.6 1.0 0.4 24.4 13.0 2.7 6.9 17.0 18.2 19.6 17.4 5.1 26.8 9.2 21.4 9.6 12.5 21.3 32.7 18.5 4.3 8.8 11.6 18.2 15.1 14.5 6.5 19.7 12.4 9.2 3.7 15.1 11.3 15.6 17.9 7.2 11.2 22.2 7.6 13.3 14.6 0.0 0.0 0.0 0.6 0.4 0.0 0.7 0.8 1.5 0.3 0.1 0.0 0.3 0.0 0.6 0.0 0.0 5.2 0.7 0.4 0.6 0.4 0.5 0.4 0.4 0.4 0.1 0.2 0.1 0.0 0.0 7.8 0.4 2.1 0.0 6.1 2.5 0.0 1.2 0.0 0.0 7.5 0.0 0.2 17.8 1.8 0.5 23.3 0.0 13.2 1.2 0.2 0.0 0.0 3.9 0.0 0.0 1.3 0.3 7.9 1.1 1.0 0.0 0.0 1.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.0 35.9 19.1 1.5 1.3 1.9 2.9 0.0 DTX3 "FLJ34766, RNF154" ENSG00000178498 "Deltex E3 ubiquitin ligase 3" Q8N9I9 12 57604622-57609804 "Enzymes, Predicted intracellular proteins" "Notch signaling pathway, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Horizontal cells: 66.7" "Cancer enhanced" "Detected in all" "glioma: 54.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "NK-cells: 2.0;T-cells: 5.5" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 31.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059654 Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" No No "Nucleoplasm, Nucleoli" "Golgi apparatus" "HPA059654: AB_2684097" "unprognostic (2.31e-2)" "unprognostic (8.80e-2)" "unprognostic (2.06e-2)" "unprognostic (3.68e-1)" "unprognostic (3.35e-1)" "unprognostic (2.58e-2)" "unprognostic (6.91e-2)" "prognostic favorable (9.87e-4)" "unprognostic (1.84e-1)" "unprognostic (4.26e-2)" "prognostic favorable (1.44e-4)" "unprognostic (8.62e-2)" "unprognostic (5.44e-3)" "unprognostic (7.99e-2)" "unprognostic (8.81e-2)" "unprognostic (9.51e-2)" "unprognostic (3.48e-2)" 7.2 18.8 22.7 9.0 35.2 3.5 9.4 47.8 53.6 17.6 22.8 23.7 11.0 6.7 29.7 30.6 9.7 31.8 14.1 20.5 23.8 19.8 11.4 2.4 12.2 11.0 18.3 28.4 36.3 12.0 23.9 32.7 16.0 22.5 21.1 10.1 20.4 13.2 29.5 10.9 7.9 9.4 28.7 16.9 11.2 11.2 7.8 21.6 6.8 16.8 5.1 8.8 11.8 13.5 0.3 0.6 0.0 0.0 2.0 5.5 1.8 3.1 8.2 24.4 0.0 0.0 0.0 0.1 5.0 12.9 11.0 11.2 4.2 13.2 4.4 7.6 10.8 0.1 5.1 0.0 0.6 7.8 11.0 1.5 2.5 12.6 4.4 18.8 0.0 0.0 9.3 6.1 8.4 0.1 31.5 12.3 0.0 0.0 15.0 8.4 6.8 13.4 0.1 19.2 2.5 0.7 0.0 20.3 0.2 1.0 8.2 17.7 28.1 3.9 1.1 2.4 6.1 14.1 6.7 0.0 14.4 5.8 6.6 7.1 24.6 18.4 0.0 9.2 0.0 7.5 0.0 0.0 0.0 5.5 0.0 1.3 0.3 2.1 2.5 0.2 0.3 1.9 3.5 0.0 2.0 0.0 0.6 4.2 1.8 22.7 35.2 47.8 53.6 23.8 19.8 18.3 28.4 22.5 21.6 14.9 14.1 2.2 9.6 5.6 45.2 9.4 5.1 32.1 15.9 12.2 47.1 0.3 11.6 7.6 1.0 4.5 0.0 0.0 1.7 0.2 9.3 8.6 5.7 0.8 0.6 66.7 15.0 14.1 1.6 1.6 31.7 0.5 3.3 1.0 1.1 25.9 3.3 0.0 29.7 2.9 41.2 45.3 29.3 3.5 4.1 2.5 1.0 10.1 0.3 2.5 E2F5 ENSG00000133740 "E2F transcription factor 5" Q15329 8 85177225-85217158 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Cilium biogenesis/degradation, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "B-cells: 16.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "memory B-cell: 13.3;naive B-cell: 7.6" "Lineage enriched" "Detected in many" 9 "B-cells: 13.3" "Cell line enhanced" "Detected in many" "AF22: 27.5;Daudi: 54.2;U-698: 25.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055723, HPA065441" Supported Nucleoplasm,Nucleoli,Vesicles NA NA Nucleoplasm "Nucleoli, Vesicles" "HPA055723: AB_2682897, HPA065441: " "unprognostic (8.73e-2)" "unprognostic (3.45e-1)" "unprognostic (3.15e-2)" "unprognostic (1.02e-3)" "unprognostic (6.73e-3)" "unprognostic (1.62e-1)" "unprognostic (3.36e-5)" "unprognostic (1.23e-1)" "unprognostic (9.53e-2)" "unprognostic (1.28e-1)" "unprognostic (3.18e-1)" "unprognostic (3.87e-2)" "prognostic unfavorable (1.89e-6)" "unprognostic (2.88e-2)" "unprognostic (3.25e-2)" "unprognostic (3.64e-1)" "unprognostic (2.95e-3)" 3.0 9.0 6.4 22.2 8.1 1.5 5.9 2.6 5.3 5.0 5.9 4.0 3.4 4.6 5.4 7.4 4.7 7.2 6.6 3.2 5.6 5.6 9.0 4.5 5.1 22.4 4.6 2.7 8.3 14.6 12.7 10.6 4.3 3.8 5.1 7.2 3.4 5.7 5.9 1.1 1.7 7.3 3.8 4.5 9.9 5.1 10.5 3.2 13.6 10.2 3.0 26.0 6.0 7.6 13.3 1.4 0.0 0.0 1.1 0.6 0.6 4.9 5.3 27.5 10.2 0.5 0.7 8.8 1.0 2.2 0.8 2.4 3.2 5.8 54.2 3.8 1.1 9.9 1.0 16.0 1.3 1.0 5.6 7.3 5.5 3.0 7.4 4.4 1.6 0.0 1.0 2.2 1.1 3.9 5.4 0.8 5.7 11.5 0.4 1.5 3.2 5.5 3.6 8.8 9.2 4.7 4.4 1.1 5.8 8.9 3.5 3.4 10.6 0.6 1.9 8.1 11.5 11.6 1.7 0.0 1.3 1.0 1.6 3.6 10.2 6.8 25.9 1.5 1.4 2.7 0.0 0.0 0.0 0.1 0.0 0.0 13.3 0.0 0.0 0.1 7.6 0.2 0.4 0.0 1.1 0.0 1.4 0.6 0.6 6.4 8.1 2.6 4.5 5.6 5.6 4.6 2.7 3.8 3.2 0.0 6.2 16.3 2.8 2.1 0.4 1.0 2.5 9.4 3.4 5.2 9.8 2.7 0.0 2.9 5.2 1.5 1.3 0.0 2.1 0.6 3.0 2.7 1.1 2.4 0.4 0.0 7.5 0.6 1.0 2.9 1.4 0.4 3.3 0.0 3.4 4.3 2.8 0.0 1.8 4.9 1.1 0.0 1.7 11.1 3.4 2.5 0.9 1.9 3.7 1.6 E2F8 FLJ23311 ENSG00000129173 "E2F transcription factor 8" A0AVK6 11 19224063-19241620 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 30.3" "Group enriched" "Detected in some" 5 "Ciliated cells: 8.1;Erythroid cells: 23.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "T-reg: 2.9" "Lineage enriched" "Detected in single" 24 "T-cells: 2.9" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA064882, HPA076614" Enhanced Supported Nucleoplasm,Nucleoli,Cytosol No No Nucleoli "Nucleoplasm, Cytosol" "HPA064882: AB_2685381, HPA076614: " "unprognostic (5.62e-2)" "unprognostic (5.24e-2)" "unprognostic (3.17e-2)" "unprognostic (6.99e-3)" "unprognostic (2.86e-2)" "unprognostic (1.66e-2)" "unprognostic (1.29e-5)" "unprognostic (1.94e-2)" "unprognostic (3.90e-3)" "unprognostic (2.41e-1)" "unprognostic (7.29e-4)" "unprognostic (1.16e-2)" "unprognostic (9.13e-8)" "unprognostic (1.02e-3)" "unprognostic (1.37e-1)" "unprognostic (3.81e-1)" "unprognostic (4.28e-3)" 1.0 0.4 0.4 7.2 0.2 11.5 0.3 0.2 0.4 1.6 3.6 0.2 0.2 3.3 1.2 1.4 8.2 0.9 2.0 3.4 0.2 0.2 0.4 0.5 0.8 6.1 0.2 0.2 0.7 0.3 0.0 0.2 4.0 0.2 0.6 4.8 1.2 1.8 0.9 11.5 2.6 4.6 0.7 0.2 2.4 5.1 4.7 0.2 30.3 0.3 8.0 12.5 3.4 2.1 0.0 0.1 0.0 0.0 0.0 2.9 0.4 14.2 4.2 4.4 6.1 0.2 0.6 18.9 7.9 2.2 9.3 10.1 14.7 4.7 14.1 3.3 2.5 5.5 12.6 10.7 1.0 8.4 9.5 8.7 4.9 2.4 4.0 0.0 7.4 11.8 0.2 0.0 1.9 0.6 0.5 13.0 10.1 10.3 13.7 3.7 6.9 14.6 9.3 4.0 16.1 6.0 15.9 8.2 9.5 4.0 9.6 3.8 4.3 3.5 7.0 0.8 2.4 4.8 8.0 2.5 4.5 5.6 11.0 7.1 4.7 9.5 17.9 5.7 14.7 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.4 0.4 0.2 0.2 0.4 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 1.5 0.0 1.0 0.0 2.0 0.0 8.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.4 23.3 0.0 1.4 0.6 0.0 0.0 0.0 2.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.2 3.1 0.3 0.2 0.0 2.6 0.6 EBNA1BP2 "EBP2, NOBP, P40" ENSG00000117395 "EBNA1 binding protein 2" Q99848 1 43164175-43270936 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026512, HPA028277" Approved Enhanced "Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim" "Mitotic chromosome" "HPA026512: AB_1847954, HPA028277: AB_10603664" "unprognostic (9.30e-2)" "unprognostic (2.02e-1)" "unprognostic (1.05e-3)" "unprognostic (2.03e-2)" "unprognostic (8.59e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (4.22e-4)" "unprognostic (7.64e-3)" "unprognostic (2.89e-2)" "unprognostic (1.24e-3)" "unprognostic (7.11e-2)" "unprognostic (1.64e-3)" "unprognostic (4.10e-3)" "unprognostic (3.04e-3)" "unprognostic (1.69e-1)" "unprognostic (3.22e-2)" "unprognostic (1.33e-2)" 18.9 24.8 30.2 22.8 41.1 19.3 27.6 17.7 35.7 18.1 23.6 19.0 15.6 15.4 22.4 40.6 27.8 30.4 15.6 24.9 26.3 25.2 34.0 66.0 18.5 21.9 25.1 29.8 21.8 30.7 24.5 30.0 26.0 29.2 20.3 26.0 16.6 22.3 22.3 28.4 22.8 16.9 24.3 21.6 18.4 19.7 24.8 27.4 18.2 28.8 31.3 25.8 21.5 19.8 26.9 29.6 10.2 22.8 24.1 25.1 17.8 61.7 36.1 13.5 39.1 10.9 12.3 28.0 43.1 21.6 68.9 43.4 40.3 38.6 41.1 34.2 31.3 32.5 44.0 29.2 39.9 75.4 19.4 28.8 28.0 32.5 35.4 19.8 48.5 21.6 9.8 40.4 50.6 41.0 13.2 37.7 28.3 42.3 13.9 33.5 34.0 36.8 29.0 58.7 41.5 33.5 27.0 30.7 46.3 25.3 27.0 26.9 28.9 24.9 46.6 43.2 22.9 19.1 26.5 29.0 26.7 50.3 42.6 70.0 20.6 40.6 50.8 22.1 50.3 53.6 7.5 20.1 10.2 24.0 22.8 25.1 26.9 24.5 24.9 29.6 26.7 22.8 22.8 1.8 24.1 21.6 28.3 24.6 17.8 30.2 41.1 17.7 35.7 26.3 25.2 25.1 29.8 29.2 27.4 32.8 33.2 26.8 68.9 109.3 25.1 28.5 56.0 87.0 48.9 29.6 5.9 95.0 76.3 100.0 109.6 36.8 23.0 70.0 107.4 112.0 52.9 58.1 49.7 127.1 57.6 14.3 23.2 32.5 23.4 70.9 30.8 30.6 52.3 54.1 37.8 44.2 101.2 11.5 36.0 100.9 22.3 38.8 54.7 79.6 103.6 86.9 70.5 23.5 59.7 77.3 ECEL1 "DINE, XCE" ENSG00000171551 "Endothelin converting enzyme like 1" O95672 2 232479827-232487828 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.6;ovary: 57.1" "Group enriched" "Detected in some" 19 "Muller glia cells: 76.3;Peritubular cells: 19.8" "Cancer enhanced" "Detected in many" "endometrial cancer: 12.9" "Region enriched" "Detected in many" 5 "hypothalamus: 28.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "AN3-CA: 30.1;HeLa: 15.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA067560, HPA069756, HPA077424" Approved Supported Approved "Nucleoplasm,Nuclear membrane,Nucleoli" NA NA Nucleoplasm "Nuclear membrane, Nucleoli" "HPA067560: , HPA069756: , HPA077424: " "unprognostic (1.21e-2)" "unprognostic (1.06e-2)" "unprognostic (4.39e-1)" "unprognostic (4.62e-3)" "unprognostic (2.80e-1)" "unprognostic (9.96e-4)" "unprognostic (7.56e-3)" "unprognostic (1.22e-1)" "unprognostic (9.89e-3)" "unprognostic (8.49e-2)" "unprognostic (1.54e-1)" "unprognostic (2.89e-1)" "unprognostic (1.24e-5)" "unprognostic (3.09e-2)" "unprognostic (3.68e-1)" "unprognostic (7.84e-2)" "unprognostic (5.45e-2)" 0.9 2.6 0.5 0.9 4.0 0.2 0.4 0.7 1.2 0.3 0.4 0.5 0.1 0.3 0.6 4.9 0.3 1.7 1.0 1.1 0.1 28.6 1.0 0.7 0.2 1.2 0.3 0.1 57.1 0.6 0.3 8.9 0.4 5.5 0.3 0.2 11.5 0.3 1.2 1.8 0.3 0.3 1.1 4.5 2.0 0.3 0.8 1.6 0.1 0.5 0.3 0.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 30.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.4 0.3 0.0 0.1 0.0 0.4 0.0 0.0 0.0 2.7 0.0 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 4.0 0.7 1.2 0.1 28.6 0.3 0.1 5.5 1.6 0.0 0.0 0.0 0.0 0.0 2.6 1.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.4 0.0 0.0 0.0 0.0 76.3 0.2 0.0 19.8 0.0 1.7 0.0 2.1 0.2 1.7 0.0 0.0 0.0 0.0 0.0 EDN1 ET1 ENSG00000078401 "Endothelin 1" P05305 6 12290363-12297194 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Vasoactive, Vasoconstrictor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 14 "Basal glandular cells: 804.7;Ductal cells: 273.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "non-classical monocyte: 7.9" "Lineage enriched" "Detected in many" 6 "monocytes: 7.9" "Cell line enhanced" "Detected in many" "EFO-21: 109.7;HUVEC TERT2: 72.7;T-47d: 22.4;TIME: 53.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031976, CAB032500, CAB037291" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" "Secreted to blood" NA Yes 9740 "Nucleoli, Golgi apparatus" Nucleoplasm "CAB032500: AB_2096241, CAB037291: AB_259277, HPA031976: AB_10602489" "unprognostic (1.51e-2)" "unprognostic (2.38e-1)" "unprognostic (3.95e-2)" "unprognostic (9.72e-2)" "unprognostic (3.40e-1)" "unprognostic (1.91e-1)" "unprognostic (6.24e-2)" "unprognostic (2.94e-3)" "unprognostic (1.42e-1)" "unprognostic (8.92e-2)" "unprognostic (4.19e-2)" "unprognostic (3.17e-1)" "unprognostic (8.02e-3)" "unprognostic (2.09e-1)" "unprognostic (1.71e-1)" "unprognostic (1.34e-1)" "unprognostic (3.47e-1)" 35.7 1.5 8.4 6.2 30.8 3.6 19.2 3.2 22.0 8.2 9.2 4.2 1.1 9.0 7.2 15.3 10.8 8.6 11.9 5.2 19.0 6.2 5.7 2.8 25.1 6.7 10.9 5.5 4.3 8.2 1.6 1.0 16.0 25.1 5.4 12.9 6.9 9.7 8.5 25.6 8.2 6.7 9.7 13.5 10.2 6.8 4.8 5.6 0.2 2.9 3.8 2.1 5.3 4.1 0.2 0.2 1.2 7.9 0.0 0.2 0.0 1.6 9.2 0.1 0.0 0.0 0.0 0.0 2.9 2.6 2.4 2.0 11.9 1.4 0.0 109.7 1.1 1.5 0.8 0.0 1.7 1.8 0.1 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 1.0 0.4 0.3 0.7 72.7 0.0 0.0 0.0 9.2 0.2 0.0 0.0 0.1 1.6 0.1 0.0 0.8 0.0 5.8 1.5 0.1 0.0 0.3 8.7 0.0 20.3 22.4 0.1 53.8 6.2 4.9 0.1 3.7 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.0 7.9 0.1 0.0 0.0 8.4 30.8 3.2 22.0 19.0 6.2 10.9 5.5 25.1 5.6 160.8 31.6 0.8 804.7 168.7 0.0 2.0 5.1 0.0 46.6 36.6 0.0 1.4 3.3 273.4 11.4 170.8 145.3 0.0 195.7 0.6 8.2 167.4 1.1 0.8 1.7 1.6 15.0 109.2 6.3 10.0 5.2 3.6 8.5 19.0 12.9 0.2 217.0 147.3 0.4 5.7 0.0 6.5 6.2 1.1 0.4 56.3 0.7 5.7 34.9 116.8 EFCAB14 KIAA0494 ENSG00000159658 "EF-hand calcium binding domain 14" O75071 1 46675159-46719064 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 107.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011224, HPA011938" Approved Approved "Nucleoli,Golgi apparatus,Cytosol" NA NA 58000 Cytosol "Nucleoli, Golgi apparatus" "HPA011224: AB_1852314, HPA011938: AB_1852317" "unprognostic (2.44e-1)" "unprognostic (5.90e-2)" "unprognostic (7.53e-2)" "unprognostic (2.36e-1)" "unprognostic (7.34e-2)" "unprognostic (4.55e-2)" "unprognostic (1.39e-2)" "unprognostic (6.06e-2)" "unprognostic (1.73e-1)" "unprognostic (1.66e-1)" "unprognostic (1.21e-2)" "unprognostic (3.00e-1)" "unprognostic (1.13e-3)" "unprognostic (1.00e-2)" "unprognostic (5.77e-2)" "unprognostic (1.94e-1)" "unprognostic (2.46e-1)" 29.4 17.4 29.4 14.3 29.5 6.7 22.5 16.2 24.8 25.3 26.0 40.6 15.6 17.2 23.7 27.3 30.0 22.0 19.7 20.2 27.2 20.5 27.8 24.9 24.0 16.4 31.0 15.2 25.2 16.0 107.1 17.2 25.2 27.3 24.4 24.0 23.0 19.9 24.9 24.7 20.4 26.9 22.5 36.1 24.0 36.4 21.9 30.6 28.7 30.1 13.2 20.2 25.7 20.0 16.6 16.0 30.3 21.1 17.1 28.5 18.3 14.5 8.3 7.1 11.2 34.0 21.4 16.3 15.8 23.3 17.5 18.1 9.9 9.9 11.7 16.5 21.4 23.7 17.6 12.1 17.4 23.8 22.2 7.8 14.6 9.2 4.0 11.7 18.8 28.8 18.9 29.2 13.9 11.6 16.8 21.3 11.4 9.0 16.7 18.0 5.7 12.4 8.5 10.1 17.2 9.4 9.5 19.9 10.2 18.5 29.6 3.7 5.1 19.5 27.6 14.8 20.1 12.3 16.5 19.6 15.0 7.3 17.4 16.0 17.2 23.8 9.4 19.2 16.2 11.0 15.6 18.6 30.3 23.6 21.1 28.5 16.6 20.6 20.2 16.0 16.2 18.0 19.5 12.5 17.1 18.3 12.9 17.8 18.3 29.4 29.5 16.2 24.8 27.2 20.5 31.0 15.2 27.3 30.6 68.5 69.2 34.6 40.1 28.2 30.1 33.2 45.9 45.5 45.5 108.2 29.5 31.8 26.6 31.3 50.1 52.8 51.8 0.0 33.7 27.6 35.0 57.4 96.2 51.2 37.0 44.5 36.2 46.1 67.7 14.4 43.7 41.1 25.3 34.3 62.6 50.2 37.9 57.5 46.7 30.6 17.7 25.8 28.8 37.2 23.3 38.0 49.3 41.5 41.9 98.2 EIPR1 "EIPR-1, TSSC1" ENSG00000032389 "EARP complex and GARP complex interacting protein 1" Q53HC9 2 3188925-3377882 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 43.9;Distal tubular cells: 43.1;Extravillous trophoblasts: 29.7;Hofbauer cells: 29.7;monocytes: 28.9;Proximal tubular cells: 31.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031231, HPA031232, HPA031233, HPA031234" Approved Supported "Nucleoplasm,Nucleoli,Intermediate filaments" NA NA "Nucleoplasm, Nucleoli" "Intermediate filaments" "HPA031231: AB_10669881, HPA031232: AB_10603222, HPA031233: AB_10670026, HPA031234: AB_2673803" "unprognostic (2.16e-1)" "unprognostic (2.22e-1)" "unprognostic (2.71e-1)" "unprognostic (1.66e-1)" "unprognostic (4.27e-2)" "unprognostic (1.22e-1)" "prognostic unfavorable (3.67e-7)" "unprognostic (1.94e-1)" "unprognostic (1.57e-1)" "unprognostic (7.83e-2)" "unprognostic (2.10e-1)" "unprognostic (2.50e-1)" "unprognostic (1.78e-1)" "unprognostic (1.02e-2)" "unprognostic (3.43e-1)" "unprognostic (2.24e-2)" "unprognostic (3.83e-2)" 7.3 12.3 20.1 17.3 24.4 14.2 9.0 26.0 22.9 8.3 11.9 12.1 10.0 10.7 7.7 18.4 14.5 12.0 7.9 10.3 17.7 19.3 12.4 11.4 7.9 15.2 15.1 14.5 5.8 11.6 14.2 20.8 8.0 13.6 7.7 10.9 10.5 9.9 7.4 10.9 9.2 9.3 9.4 12.4 12.0 9.3 9.9 11.5 14.5 20.4 15.5 15.3 11.1 7.7 15.7 23.4 13.9 13.3 16.3 16.9 14.0 10.6 20.1 10.7 12.1 6.8 9.2 24.3 11.2 11.7 13.5 10.3 13.4 13.5 18.7 19.9 11.4 12.8 11.0 8.4 16.2 7.5 14.5 15.9 16.5 12.5 30.9 13.0 16.1 20.6 8.4 14.7 13.7 17.8 7.5 17.1 33.4 18.4 13.0 12.4 19.9 14.9 23.5 12.4 25.2 16.1 17.5 11.4 25.1 16.8 14.8 23.4 27.2 7.9 13.3 12.2 6.0 12.3 15.1 12.0 10.9 5.6 8.9 15.0 14.9 36.0 15.5 12.9 16.8 10.0 13.9 11.8 9.4 16.1 13.3 16.3 13.9 13.4 16.8 21.3 15.7 14.7 15.8 5.0 16.3 11.9 23.4 16.9 14.0 20.1 24.4 26.0 22.9 17.7 19.3 15.1 14.5 13.6 11.5 3.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 8.1 11.4 19.2 0.0 43.9 43.1 25.6 0.0 0.0 0.0 0.0 13.9 29.7 0.0 0.0 3.5 0.0 29.7 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 28.9 0.0 0.0 17.8 0.0 0.0 31.4 0.0 0.0 0.0 0.0 0.0 0.0 22.3 0.0 0.0 0.0 ELAVL1 "Hua, HuR, MelG" ENSG00000066044 "ELAV like RNA binding protein 1" Q15717 19 7958579-8005659 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005256, HPA046298" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA 210000 Nucleoplasm "Nucleoli, Cytosol" "CAB005256: AB_2096342, HPA046298: AB_2679618" "unprognostic (1.19e-1)" "unprognostic (9.66e-3)" "unprognostic (2.46e-2)" "unprognostic (3.98e-1)" "unprognostic (1.04e-1)" "unprognostic (6.37e-3)" "unprognostic (1.81e-2)" "unprognostic (8.44e-2)" "unprognostic (3.75e-2)" "prognostic favorable (4.93e-4)" "unprognostic (2.09e-1)" "unprognostic (1.59e-2)" "unprognostic (7.23e-2)" "unprognostic (6.14e-2)" "unprognostic (1.50e-1)" "unprognostic (1.18e-2)" "unprognostic (1.65e-2)" 19.7 23.8 28.0 22.4 34.1 17.2 22.4 35.4 28.0 23.1 21.4 21.2 19.6 17.9 27.5 19.7 24.4 25.7 16.9 25.2 23.6 17.6 20.8 21.4 19.4 26.5 27.5 22.2 25.7 20.4 29.4 25.4 23.3 26.5 20.4 20.2 19.7 21.2 23.0 27.6 19.2 18.4 30.4 17.7 21.9 19.7 46.7 26.5 40.4 20.6 18.7 30.7 23.4 32.2 17.1 17.6 24.3 14.7 23.2 19.6 9.4 36.1 24.0 40.3 30.3 15.8 15.9 22.7 27.0 22.7 40.2 31.5 34.7 21.1 43.6 38.0 29.6 22.6 25.3 44.9 30.9 34.1 38.9 41.7 38.2 17.7 32.3 23.2 36.2 30.6 19.7 18.6 28.0 17.1 19.1 30.7 33.3 39.2 32.7 27.7 26.8 60.5 29.2 35.9 27.2 30.6 68.1 26.3 28.7 25.5 26.7 29.0 21.2 25.6 25.9 20.4 25.4 29.5 28.6 23.0 37.7 26.4 34.9 46.4 33.4 32.3 45.8 21.1 43.6 32.5 16.4 13.0 24.3 12.2 11.7 12.9 14.0 17.8 19.6 17.6 17.1 16.1 12.4 3.8 23.2 14.7 8.8 13.5 9.4 28.0 34.1 35.4 28.0 23.6 17.6 27.5 22.2 26.5 26.5 23.8 23.9 31.2 59.2 64.3 42.6 27.2 30.6 14.7 13.6 45.4 53.0 76.4 56.3 31.1 188.6 49.4 29.5 0.0 29.2 87.0 49.8 55.0 20.7 78.0 55.5 57.2 40.4 43.0 50.2 108.9 46.6 53.3 49.0 30.7 47.6 43.8 29.8 48.6 53.4 49.4 54.8 51.8 58.0 132.2 59.8 62.0 62.6 49.8 53.0 69.3 ELL3 FLJ22637 ENSG00000128886 "Elongation factor for RNA polymerase II 3" Q9HB65 15 43772600-43777543 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 13.3;lymphoid tissue: 24.2" "Cell type enhanced" "Detected in some" 15 "Ciliated cells: 5.3;Early spermatids: 1.5;Enterocytes: 1.7;Late spermatids: 1.8;Mucus-secreting cells: 2.0;Undifferentiated cells: 2.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "memory B-cell: 5.3;naive B-cell: 8.5" "Lineage enriched" "Detected in many" 7 "B-cells: 8.5" "Cell line enhanced" "Detected in some" "Daudi: 7.9;U-698: 19.2" "Region enriched" "Detected in single" 11 "olfactory region: 2.4" "Not detected" "Not detected" "HPA028938, HPA073494" Approved Supported "Nucleoplasm,Nucleoli,Mitotic chromosome" NA NA "Nucleoplasm, Nucleoli" "Mitotic chromosome" "HPA028938: AB_10795352, HPA073494: " "unprognostic (2.59e-2)" "unprognostic (4.41e-1)" "unprognostic (1.76e-1)" "unprognostic (1.28e-1)" "unprognostic (3.59e-1)" "unprognostic (2.30e-2)" "unprognostic (1.17e-1)" "unprognostic (2.42e-3)" "unprognostic (1.52e-2)" "unprognostic (3.89e-1)" "unprognostic (2.19e-1)" "unprognostic (3.53e-1)" "unprognostic (1.87e-1)" "unprognostic (3.67e-2)" "unprognostic (8.95e-2)" "unprognostic (1.08e-1)" "unprognostic (1.24e-2)" 0.7 1.1 1.0 24.2 0.6 0.4 2.5 4.7 0.6 2.3 10.6 0.5 1.6 4.8 1.0 1.0 5.5 1.3 0.9 0.6 1.0 0.6 1.8 0.5 0.9 7.5 1.3 0.0 1.3 0.7 0.6 1.2 0.8 2.6 2.1 1.8 0.8 2.0 0.7 1.0 7.0 13.3 0.9 0.6 1.5 1.1 12.3 0.5 0.8 1.1 2.8 16.7 1.3 1.7 8.5 1.0 0.1 0.1 0.1 1.2 0.6 0.6 0.1 0.6 0.2 1.6 0.1 0.1 0.2 0.5 0.8 1.3 0.1 0.5 7.9 0.1 0.7 0.1 2.9 0.3 0.0 0.5 0.7 3.4 0.3 2.6 0.8 0.5 0.0 0.0 0.0 0.5 0.2 0.1 0.1 0.3 0.2 0.3 0.0 0.1 1.2 0.3 0.9 0.0 1.1 0.8 0.8 0.1 0.1 0.2 0.0 3.6 0.2 0.3 1.5 0.3 0.1 3.6 0.2 0.1 0.2 0.0 0.3 0.2 0.0 0.0 19.2 0.2 0.7 0.1 0.0 0.1 0.0 0.0 0.0 0.2 5.3 0.5 0.2 0.0 8.5 1.2 0.3 0.1 0.1 0.0 1.0 0.3 0.6 1.0 0.6 4.7 0.6 1.0 0.6 1.3 0.0 2.6 0.5 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 1.7 0.0 0.6 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.0 2.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.9 0.2 0.0 2.0 0.1 ELMOD2 MGC10084 ENSG00000179387 "ELMO domain containing 2" Q8IZ81 4 140524158-140553770 "Predicted intracellular proteins" "Antiviral defense" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047600 Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" Nucleoplasm "HPA047600: AB_2680098" "unprognostic (1.39e-1)" "unprognostic (1.91e-1)" "unprognostic (6.70e-3)" "unprognostic (2.10e-3)" "unprognostic (4.91e-2)" "unprognostic (3.93e-1)" "unprognostic (1.66e-2)" "unprognostic (1.26e-1)" "unprognostic (1.76e-1)" "unprognostic (7.93e-2)" "unprognostic (1.05e-2)" "unprognostic (3.65e-1)" "prognostic favorable (1.17e-8)" "unprognostic (3.17e-1)" "unprognostic (4.03e-1)" "prognostic unfavorable (6.35e-4)" "unprognostic (1.82e-2)" 11.6 20.8 9.2 11.9 14.0 8.5 16.7 14.0 10.6 13.8 17.9 10.4 24.7 14.4 15.4 15.8 13.9 13.9 10.9 18.0 10.4 11.2 20.6 19.3 14.5 13.9 13.6 9.2 13.0 17.2 20.2 24.1 17.3 13.6 15.5 15.2 12.1 13.5 21.2 8.4 10.5 31.0 12.4 14.4 11.6 12.1 9.1 12.3 18.2 19.6 10.5 11.2 12.1 11.6 6.0 10.6 17.0 7.8 7.8 8.6 4.8 6.6 7.4 15.2 11.6 15.9 18.4 9.8 15.8 15.0 8.8 10.6 7.3 14.2 10.9 7.0 9.8 10.7 6.1 14.4 10.0 10.9 10.5 8.5 8.9 5.8 9.4 14.5 13.6 8.0 12.6 16.7 7.4 7.7 13.9 9.6 13.3 11.4 18.0 15.0 4.8 14.8 4.7 8.0 9.7 6.1 17.4 11.7 7.0 12.7 10.6 7.2 26.8 10.3 10.6 11.3 17.8 10.4 5.7 9.6 20.3 7.3 9.4 16.2 18.9 26.8 13.8 14.8 10.8 15.2 2.6 7.2 8.7 7.5 7.8 8.6 3.8 6.9 8.3 6.1 6.0 7.1 7.0 17.0 7.8 5.9 10.6 8.0 4.8 9.2 14.0 14.0 10.6 10.4 11.2 13.6 9.2 13.6 12.3 26.8 15.3 5.2 9.6 8.1 19.0 12.3 5.1 25.4 5.7 17.4 17.7 19.0 1.7 20.2 2.0 11.7 15.3 0.0 22.7 7.3 13.3 8.8 19.6 24.6 17.2 14.3 8.7 11.1 17.4 1.0 12.0 13.4 16.9 11.8 12.5 18.5 21.7 12.2 10.3 15.1 22.8 6.5 6.1 25.6 19.4 10.2 16.8 10.7 10.8 4.8 ELOC "SIII, TCEB1" ENSG00000154582 "Elongin C" Q15369 8 73939169-73972287 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 271.8;Hofbauer cells: 287.3;Pancreatic endocrine cells: 255.4;Proximal tubular cells: 236.7;Syncytiotrophoblasts: 278.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078113 Approved "Nucleoli,Vesicles,Cell Junctions" NA NA 250000 Vesicles "Nucleoli, Cell Junctions" "HPA078113: AB_2686877" "prognostic unfavorable (6.48e-4)" "unprognostic (1.60e-1)" "unprognostic (3.14e-1)" "unprognostic (2.83e-2)" "unprognostic (2.46e-2)" "unprognostic (8.02e-3)" "unprognostic (5.84e-3)" "unprognostic (2.19e-2)" "unprognostic (1.77e-1)" "unprognostic (6.99e-3)" "unprognostic (4.02e-3)" "unprognostic (3.33e-2)" "unprognostic (2.77e-3)" "unprognostic (3.84e-2)" "unprognostic (5.33e-2)" "unprognostic (1.67e-1)" "unprognostic (8.95e-2)" 27.0 29.5 39.1 19.2 37.6 35.4 24.2 25.6 43.3 17.5 19.6 12.2 21.0 13.4 18.2 31.7 24.5 17.2 17.9 50.1 33.9 29.5 28.2 36.1 21.2 35.2 32.5 28.4 17.9 25.5 17.6 20.0 25.7 27.3 19.2 20.6 12.1 16.3 21.0 62.5 16.6 14.5 24.4 33.9 18.7 18.5 51.0 18.8 19.7 19.6 31.9 27.9 19.3 16.7 38.9 55.3 51.7 35.4 32.5 44.9 26.4 43.9 36.0 33.0 23.9 25.3 33.1 23.7 43.7 35.7 42.9 44.1 32.0 38.4 22.4 35.4 38.7 58.0 31.5 36.4 43.6 56.8 25.8 30.2 39.0 38.5 50.6 33.0 25.0 29.3 33.4 35.0 38.8 50.2 31.9 39.8 38.8 34.4 30.1 56.3 32.5 64.3 44.9 30.0 72.1 58.4 23.5 20.8 21.3 46.8 38.6 31.2 29.6 18.3 99.9 40.8 35.8 36.8 27.0 30.4 31.2 35.3 34.1 43.7 34.2 41.8 41.3 37.5 27.4 37.8 51.7 32.2 38.2 31.2 35.4 34.0 38.9 37.5 34.8 34.2 34.0 34.3 34.4 37.7 32.5 33.8 55.3 44.9 26.4 39.1 37.6 25.6 43.3 33.9 29.5 32.5 28.4 27.3 18.8 62.5 90.6 0.0 0.0 0.0 0.0 0.0 0.0 116.4 91.0 113.4 0.0 190.4 225.5 210.9 0.0 0.0 0.0 0.0 197.5 271.8 0.0 0.0 64.0 0.0 287.3 0.0 0.0 0.0 0.0 0.0 0.0 68.7 0.0 196.6 0.0 0.0 255.4 0.0 0.0 236.7 0.0 0.0 0.0 0.0 0.0 0.0 278.0 0.0 0.0 0.0 EMX1 ENSG00000135638 "Empty spiracles homeobox 1" Q04741 2 72916260-72936071 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 14.8;kidney: 27.4" "Group enriched" "Detected in some" 8 "Collecting duct cells: 52.4;Proximal tubular cells: 31.6" "Cancer enhanced" "Detected in some" "renal cancer: 3.7" "Region enhanced" "Detected in many" "cerebral cortex: 14.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.7;CACO-2: 5.7;HEK 293: 12.8;HMC-1: 2.5;RPTEC TERT1: 2.2;U-2 OS: 2.0" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 13 "amygdala: 3.8;cerebral cortex: 11.1;hippocampal formation: 8.6" "HPA006230, HPA006421" Approved Supported "Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim" "Mitotic chromosome" "HPA006230: AB_2667542, HPA006421: AB_1078739" "unprognostic (4.54e-2)" "unprognostic (5.59e-2)" "unprognostic (8.71e-2)" "unprognostic (2.22e-6)" "unprognostic (4.82e-2)" "unprognostic (1.70e-1)" "unprognostic (1.94e-1)" "unprognostic (2.16e-1)" "unprognostic (1.29e-1)" "unprognostic (1.04e-1)" "unprognostic (2.99e-1)" "unprognostic (3.07e-1)" "prognostic favorable (1.54e-6)" "unprognostic (4.08e-2)" "unprognostic (1.44e-1)" "unprognostic (1.08e-3)" "unprognostic (5.02e-2)" 0.2 0.3 5.2 0.2 3.1 0.1 0.1 0.1 14.8 0.1 0.5 0.0 0.8 1.4 0.1 6.0 0.2 0.1 0.1 0.2 5.0 0.4 27.4 0.2 0.1 0.2 0.4 1.5 0.2 0.4 4.8 0.2 0.1 0.0 0.2 0.2 0.0 0.6 0.2 0.2 0.2 1.1 0.1 0.1 0.1 0.3 2.1 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 3.7 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 12.8 0.0 0.0 1.7 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.1 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.3 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 3.1 0.1 14.8 5.0 0.4 0.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 52.4 0.0 0.0 5.0 0.0 0.8 0.0 0.5 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 31.6 0.0 0.0 0.0 1.4 1.1 0.0 0.0 0.0 0.0 0.0 FAM131C "C1orf117, FLJ36766" ENSG00000185519 "Family with sequence similarity 131 member C" Q96AQ9 1 16057769-16073632 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.1" "Cell type enhanced" "Detected in some" 15 "Distal tubular cells: 16.6;Horizontal cells: 36.5;Muller glia cells: 32.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "cerebellum: 41.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 10.8;HEK 293: 7.0;PC-3: 8.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031046 Uncertain Approved "Nucleoli,Intermediate filaments,Cytosol" NA NA "Nucleoli, Intermediate filaments, Cytosol" "HPA031046: AB_2673711" "unprognostic (4.69e-3)" "unprognostic (4.98e-2)" "unprognostic (7.26e-2)" "unprognostic (2.46e-4)" "unprognostic (1.77e-1)" "unprognostic (1.15e-1)" "unprognostic (1.63e-2)" "unprognostic (4.67e-4)" "unprognostic (2.82e-1)" "unprognostic (1.93e-2)" "unprognostic (1.75e-1)" "unprognostic (1.68e-1)" "prognostic favorable (9.33e-6)" "unprognostic (1.93e-1)" "unprognostic (2.29e-1)" "unprognostic (2.82e-2)" "unprognostic (1.44e-1)" 0.7 7.8 5.6 0.6 4.0 0.5 1.1 41.1 9.1 1.1 1.0 7.7 0.0 0.7 1.0 1.4 1.2 1.1 1.4 5.2 5.0 6.5 10.4 2.2 0.6 0.5 10.7 3.8 1.2 7.1 2.0 5.6 0.7 8.7 0.8 0.6 0.8 6.3 1.6 0.6 3.2 0.8 0.9 17.7 0.6 1.6 1.3 4.9 0.0 1.7 0.0 1.4 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 4.3 10.8 0.4 0.6 0.0 0.0 0.0 1.0 0.9 1.2 2.7 0.2 2.4 0.0 0.4 0.5 2.7 1.2 1.4 0.3 0.4 0.0 7.0 0.0 2.4 0.0 0.1 0.0 0.0 0.0 1.7 0.1 0.9 3.8 0.7 0.3 0.0 0.0 0.1 2.2 0.0 0.0 0.5 2.2 8.0 0.0 0.0 4.6 0.8 0.0 1.5 3.1 0.4 1.3 0.3 0.0 0.3 0.0 1.7 0.2 3.8 0.0 0.0 1.7 0.1 0.0 3.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 4.0 41.1 7.1 5.0 6.5 10.7 3.8 8.7 4.9 0.0 0.0 0.0 0.3 0.2 3.5 1.6 2.5 0.0 0.0 8.7 3.9 0.0 16.6 2.6 1.0 0.0 0.0 0.0 0.3 0.0 0.2 0.2 0.0 0.2 0.0 36.5 3.4 0.6 0.0 1.3 0.0 0.0 0.0 4.6 0.0 32.7 0.4 0.0 0.0 0.3 2.0 0.0 0.3 0.6 1.9 1.0 0.0 0.0 0.0 0.4 FAM13A "ARHGAP48, FAM13A1, KIAA0914" ENSG00000138640 "Family with sequence similarity 13 member A" O94988 4 88725955-89111398 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 111.2;Syncytiotrophoblasts: 233.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "dendritic cells: 5.7;monocytes: 6.5;T-cells: 5.2" "Cell line enhanced" "Detected in many" "ASC diff: 32.6" "Low region specificity" "Detected in all" "HPA038108, HPA038109" Uncertain Approved "Nucleoli,Cell Junctions,Cytosol" NA NA "Cell Junctions, Cytosol" Nucleoli "HPA038108: AB_2675837, HPA038109: AB_10672619" "unprognostic (1.14e-1)" "unprognostic (1.53e-2)" "unprognostic (6.29e-2)" "unprognostic (2.53e-1)" "unprognostic (3.20e-1)" "unprognostic (1.07e-1)" "unprognostic (3.79e-1)" "unprognostic (2.81e-1)" "unprognostic (8.20e-2)" "unprognostic (1.75e-1)" "unprognostic (1.46e-3)" "unprognostic (6.36e-2)" "unprognostic (4.71e-1)" "unprognostic (3.49e-3)" "unprognostic (1.90e-2)" "unprognostic (7.44e-2)" "prognostic favorable (4.28e-4)" 58.6 10.8 9.1 11.0 9.3 6.5 19.0 17.9 18.5 15.5 41.0 3.7 7.4 30.5 10.9 12.0 9.3 14.8 10.7 8.8 9.6 5.7 14.0 22.9 13.3 5.3 10.0 6.8 17.8 23.5 45.5 11.2 20.7 11.4 15.9 9.3 11.5 13.3 8.0 8.4 17.5 30.5 15.6 19.4 4.9 13.4 11.1 12.9 3.2 20.4 16.1 4.0 30.4 23.8 0.1 5.7 1.4 6.5 0.7 5.2 2.6 2.4 3.7 5.6 7.3 32.6 13.5 9.2 5.8 7.0 2.3 2.1 3.1 5.8 0.1 2.3 4.1 3.6 1.5 8.2 4.1 5.2 0.3 5.7 4.1 5.2 0.4 9.6 3.4 0.5 12.9 3.4 5.8 2.1 10.1 3.9 1.4 10.6 0.4 4.9 0.1 0.3 1.5 6.9 0.4 3.9 5.6 9.5 2.2 4.2 12.2 14.2 3.8 1.4 4.5 5.4 5.8 3.1 0.1 1.4 6.5 3.6 3.1 3.3 2.0 1.1 0.0 9.6 0.3 3.3 0.1 6.5 0.1 1.8 3.2 1.3 0.1 4.7 0.6 5.7 0.1 5.2 1.3 1.4 0.7 1.0 1.9 2.5 2.6 9.1 9.3 17.9 18.5 9.6 5.7 10.0 6.8 11.4 12.9 11.9 27.5 3.7 19.8 9.0 19.2 22.7 22.9 81.7 46.6 10.4 33.4 57.4 24.9 8.6 2.3 12.5 34.9 0.0 14.6 29.6 23.6 13.3 1.1 111.2 17.5 0.0 4.7 8.0 29.1 2.4 41.7 12.6 18.6 4.6 37.9 26.9 31.2 63.3 31.5 34.7 10.7 0.0 24.2 4.8 6.1 6.8 233.8 6.4 14.6 16.6 FAM212B "C1orf183, FLJ31105, INKA2" ENSG00000197852 "Family with sequence similarity 212 member B" Q9NTI7 1 111680630-111739424 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in single" 10 "Hofbauer cells: 3.6" "Cancer enhanced" "Detected in many" "glioma: 6.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 13 "neutrophil: 19.2" "Lineage enriched" "Detected in many" 13 "granulocytes: 19.2" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 18.2;U-87 MG: 37.5;WM-115: 14.2" "HPA027809, HPA027810, HPA027811" Approved Supported Nucleoplasm,Nucleoli,Vesicles NA NA Nucleoplasm "Nucleoli, Vesicles" "HPA027809: AB_10599616, HPA027810: , HPA027811: AB_10600872" "unprognostic (1.92e-1)" "unprognostic (9.70e-3)" "unprognostic (1.84e-1)" "unprognostic (1.85e-2)" "unprognostic (2.81e-2)" "prognostic favorable (4.51e-5)" "unprognostic (9.96e-4)" "unprognostic (1.15e-1)" "unprognostic (1.36e-2)" "unprognostic (9.50e-3)" "unprognostic (9.92e-5)" "unprognostic (8.66e-2)" "unprognostic (1.31e-3)" "unprognostic (2.84e-1)" "unprognostic (1.42e-1)" "unprognostic (3.03e-3)" "unprognostic (5.07e-2)" 12.1 1.4 14.9 4.6 11.5 4.0 8.6 5.5 22.4 2.6 3.7 2.9 1.5 1.8 4.9 1.8 11.1 7.9 4.7 12.9 13.1 3.5 3.9 1.4 6.9 2.4 4.8 13.4 3.2 1.7 4.5 0.9 9.4 3.9 4.6 3.3 1.8 2.7 6.3 8.3 8.8 2.9 8.1 3.9 6.3 4.9 4.3 3.7 0.5 3.8 3.5 2.9 3.1 3.9 0.4 0.8 19.2 1.4 0.0 0.0 0.4 1.2 1.1 2.1 1.6 10.7 3.8 0.9 0.9 2.0 1.7 4.0 2.1 0.0 0.9 0.4 0.8 0.8 1.1 1.1 2.4 1.5 2.3 1.1 7.4 0.7 1.9 3.6 0.3 1.2 2.6 10.7 18.2 0.8 0.4 4.5 1.1 0.0 1.7 2.0 1.1 0.4 0.3 0.3 0.9 1.0 1.1 9.9 0.3 0.5 1.7 5.6 1.6 0.5 0.0 4.9 2.3 1.4 1.2 1.7 3.8 6.0 2.0 0.7 10.8 1.9 0.9 37.5 1.8 14.2 0.0 1.3 1.0 0.0 1.1 0.0 0.2 0.0 0.0 0.8 0.4 0.0 0.0 19.2 0.0 1.4 0.3 0.0 0.4 14.9 11.5 5.5 22.4 13.1 3.5 4.8 13.4 3.9 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 FAM212B "C1orf183, FLJ31105, INKA2" ENSG00000284755 "Family with sequence similarity 212 member B" 1 111722064-111755824 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 3.4" "Group enriched" "Detected in many" 5 "Early spermatids: 52.0;Late spermatids: 39.5;Sertoli cells: 32.3" "Cell type enriched" "Detected in single" 5 "NK-cell: 3.4" "Lineage enriched" "Detected in single" 5 "NK-cells: 3.4" "Cell line enhanced" "Detected in some" "AF22: 2.5;HHSteC: 3.7;HSkMC: 2.9;LHCN-M2: 3.5;SuSa: 3.5;THP-1: 2.5;U-87 MG: 2.5" "HPA027810, HPA027811" Uncertain Uncertain Nucleoplasm,Nucleoli,Vesicles NA NA "Nucleoplasm, Vesicles" Nucleoli "HPA027810: , HPA027811: AB_10600872" 0.1 0.3 0.1 0.4 2.8 0.2 0.1 0.1 1.7 0.1 0.2 1.5 0.1 0.3 1.7 2.0 0.1 0.0 0.3 0.4 0.1 0.7 0.1 0.5 0.2 0.1 0.1 0.1 1.0 0.0 0.1 1.0 1.6 0.8 1.3 0.1 0.1 1.2 0.1 0.0 1.0 2.5 2.6 2.2 0.0 0.7 1.2 2.6 0.8 0.1 0.1 1.9 0.1 0.1 0.2 0.7 0.1 3.4 0.5 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.2 0.0 3.7 1.5 0.0 2.9 0.0 0.0 0.0 0.0 0.0 1.6 0.2 0.0 3.5 1.3 0.5 1.9 1.8 1.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.8 3.5 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 2.5 2.2 0.0 0.7 0.0 0.0 0.2 0.0 0.2 0.1 0.5 0.3 0.0 0.1 0.3 0.3 0.0 3.4 0.1 0.2 0.2 0.0 0.0 0.0 0.5 3.1 6.2 6.2 0.0 0.0 2.7 0.0 0.0 7.9 0.0 0.0 0.0 52.0 0.0 0.7 0.0 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.0 6.9 1.3 2.8 39.5 2.0 2.0 6.8 0.0 4.6 1.2 0.0 1.1 5.3 0.0 5.9 32.3 6.1 4.2 2.1 3.4 0.0 0.0 0.9 0.6 FAM229B "C6orf225, DKFZp586F0922, LOC619208" ENSG00000203778 "Family with sequence similarity 229 member B" Q4G0N7 6 112087599-112102790 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 118.9" "Group enriched" "Detected in many" 10 "Early spermatids: 2880.3;Late spermatids: 5153.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036068 Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA Nucleoplasm "Nucleoli, Golgi apparatus" "HPA036068: AB_10673495" "unprognostic (1.65e-1)" "unprognostic (9.41e-2)" "unprognostic (4.29e-2)" "unprognostic (4.67e-3)" "unprognostic (3.17e-2)" "unprognostic (2.00e-2)" "unprognostic (2.71e-2)" "unprognostic (1.76e-2)" "unprognostic (5.08e-2)" "unprognostic (2.52e-1)" "unprognostic (1.07e-3)" "unprognostic (4.74e-2)" "prognostic favorable (8.76e-4)" "unprognostic (3.74e-3)" "unprognostic (1.36e-1)" "unprognostic (1.80e-2)" "unprognostic (2.06e-2)" 4.7 7.4 18.4 2.1 16.8 2.0 7.7 5.8 14.8 8.2 4.2 17.3 4.3 2.2 9.6 17.0 3.8 23.7 8.8 16.8 15.7 16.2 11.6 11.0 5.2 2.0 20.7 11.2 10.7 4.3 10.0 15.4 5.2 15.3 7.3 3.1 8.6 3.9 11.0 5.9 1.9 2.3 8.6 21.7 2.3 4.3 118.9 13.6 1.6 9.7 2.6 2.0 4.6 2.6 4.0 3.4 2.7 0.3 5.4 8.1 2.8 1.6 4.2 17.4 8.5 15.4 15.3 0.8 6.4 24.5 9.2 19.5 0.7 4.1 1.3 19.0 11.8 9.6 1.0 3.6 9.3 14.8 0.4 12.0 1.5 1.9 6.5 9.6 3.3 0.8 9.3 6.3 15.2 2.6 21.5 9.0 15.2 2.0 3.4 11.2 0.4 6.2 5.4 4.5 1.2 10.1 9.7 4.3 1.3 13.5 0.2 16.2 6.8 5.1 0.6 9.9 9.8 8.3 3.1 5.1 7.7 3.3 29.4 8.5 2.5 0.1 11.7 12.3 2.8 10.2 0.1 0.1 2.7 4.2 0.0 5.3 2.5 3.7 3.3 0.5 4.0 8.1 7.2 0.4 5.4 0.3 3.4 0.4 2.8 18.4 16.8 5.8 14.0 15.7 16.2 20.7 11.2 15.3 13.6 3.0 10.7 4.7 14.7 7.4 29.1 81.9 22.9 313.2 31.8 48.8 11.8 1.2 112.7 25.4 2880.3 27.2 0.0 0.0 9.2 4.2 30.9 16.9 1.1 39.9 2.7 15.9 2.9 34.4 1.9 5153.7 67.3 6.2 23.6 2.8 0.3 63.3 6.5 0.0 85.2 62.8 30.9 58.2 24.7 416.7 35.0 7.5 0.5 4.4 0.6 7.9 FAM98C FLJ44669 ENSG00000130244 "Family with sequence similarity 98 member C" Q17RN3 19 38403135-38409088 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040930, HPA041730" Approved Approved Nucleoplasm,Nucleoli,Cytosol No No "Nucleoplasm, Nucleoli" Cytosol "HPA040930: AB_10795484, HPA041730: AB_10804114" "unprognostic (3.01e-2)" "unprognostic (6.44e-3)" "unprognostic (5.15e-2)" "unprognostic (1.94e-1)" "unprognostic (3.18e-1)" "unprognostic (8.10e-3)" "unprognostic (3.06e-1)" "unprognostic (2.15e-2)" "unprognostic (2.95e-1)" "prognostic unfavorable (8.51e-5)" "unprognostic (2.82e-2)" "unprognostic (8.91e-3)" "unprognostic (1.01e-1)" "unprognostic (2.37e-3)" "unprognostic (2.43e-1)" "unprognostic (2.96e-1)" "prognostic favorable (5.53e-4)" 10.8 8.9 18.3 9.3 16.9 11.0 9.8 17.0 19.9 8.7 14.2 12.8 9.0 19.6 9.9 7.2 14.3 13.8 9.1 11.6 16.0 13.1 9.1 13.4 8.7 9.5 12.3 16.9 10.2 22.4 10.6 8.1 7.6 13.0 12.5 7.0 8.2 17.7 9.5 2.5 17.0 22.2 6.8 12.7 10.1 19.2 5.4 9.7 5.3 11.8 7.7 11.2 9.4 9.5 6.0 3.2 12.6 3.4 3.3 5.6 1.6 10.9 11.9 1.4 6.9 1.5 5.2 6.1 6.4 5.4 6.3 6.7 2.0 8.0 10.0 7.2 3.7 2.2 5.3 2.7 4.6 1.0 16.1 5.6 3.2 2.0 4.6 6.8 2.8 6.0 5.0 9.6 3.2 5.8 3.5 3.7 16.4 9.0 11.0 3.7 12.1 4.0 2.1 1.0 18.2 12.8 8.3 2.9 5.9 7.7 5.8 2.4 7.1 6.4 11.4 3.8 0.7 8.6 8.7 4.8 2.8 7.8 8.8 7.6 11.9 6.0 4.2 7.4 6.5 4.5 0.0 2.3 12.6 3.1 3.3 4.2 2.6 5.6 4.6 3.2 6.0 4.3 3.4 2.0 3.3 3.4 1.2 4.4 1.6 18.3 16.9 17.0 19.9 16.0 13.1 12.3 16.9 13.0 9.7 8.9 9.9 17.1 21.7 19.2 13.2 4.3 10.2 6.7 5.7 22.7 11.8 10.3 18.3 17.4 5.0 9.3 43.8 0.0 28.7 9.4 10.0 14.8 15.0 11.9 9.9 11.1 24.6 10.4 10.5 2.1 17.3 14.7 21.9 12.6 32.7 11.1 19.7 34.5 17.3 15.9 11.6 12.9 11.4 27.3 41.1 26.1 5.1 20.3 33.5 22.0 FANCG "FAG, XRCC9" ENSG00000221829 "Fanconi anemia complementation group G" O15287 9 35073835-35080016 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Cancer-related genes, Disease mutation, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Extravillous trophoblasts: 17.3;Spermatogonia: 23.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008105, HPA045335" Approved Approved "Nucleoli,Plasma membrane,Cytosol" NA Yes "Plasma membrane, Cytosol" Nucleoli "CAB008105: AB_2231542, HPA045335: AB_2679292" "unprognostic (9.41e-2)" "unprognostic (2.62e-2)" "unprognostic (1.82e-1)" "unprognostic (1.05e-1)" "unprognostic (2.09e-1)" "unprognostic (5.83e-3)" "prognostic unfavorable (2.02e-4)" "unprognostic (8.92e-2)" "unprognostic (1.42e-2)" "unprognostic (2.27e-3)" "unprognostic (9.01e-2)" "unprognostic (5.62e-2)" "prognostic unfavorable (2.38e-7)" "unprognostic (1.14e-2)" "unprognostic (1.59e-1)" "unprognostic (1.24e-1)" "unprognostic (2.10e-1)" 5.8 5.0 4.4 7.1 6.5 14.9 7.5 13.9 8.5 6.2 5.9 5.3 8.4 6.7 6.8 3.2 9.2 8.6 4.7 5.9 7.6 4.0 5.2 4.5 5.1 9.9 8.7 4.4 9.2 17.0 6.7 4.8 7.6 6.6 7.0 5.5 3.5 8.7 9.7 2.9 8.9 6.5 6.4 4.2 8.6 5.8 8.9 7.6 25.6 9.3 4.8 9.2 6.8 6.9 6.8 4.8 8.9 2.5 8.8 9.2 3.4 15.7 19.6 14.4 13.3 3.2 5.1 12.1 11.1 8.0 21.8 21.0 9.3 9.9 15.6 7.7 3.5 15.6 9.7 11.9 10.2 8.4 18.3 7.2 11.2 21.0 5.7 0.9 11.3 12.9 4.2 2.0 19.0 8.6 3.8 11.1 19.2 7.3 21.0 11.0 14.0 19.1 15.6 14.9 11.8 15.1 19.9 16.9 11.0 5.1 6.7 7.0 12.7 7.3 10.4 4.1 6.5 13.5 8.2 6.7 10.4 20.7 13.3 14.9 5.7 10.8 9.4 9.2 8.4 14.2 8.9 0.8 7.7 7.4 2.5 6.5 6.8 6.1 5.7 2.2 6.5 4.8 5.0 1.3 8.8 2.3 4.8 9.2 3.4 4.4 6.5 13.9 8.5 7.6 4.0 8.7 4.4 6.6 7.6 3.0 5.8 5.2 3.6 3.9 4.3 1.0 0.0 0.0 2.3 3.5 3.9 8.2 3.3 3.7 0.3 2.8 1.6 0.0 2.0 17.3 3.8 3.5 13.9 1.0 6.5 4.8 1.7 3.7 0.3 0.4 3.1 2.0 3.3 3.6 3.9 3.5 2.3 3.2 3.9 1.7 3.0 0.0 2.7 10.9 23.7 2.3 5.5 5.3 5.0 3.3 FAU "asr1, FLJ22986, Fub1, Fubi, MNSFbeta, RPS30, S30" ENSG00000149806 "FAU, ubiquitin like and ribosomal protein S30 fusion" "P35544, P62861" 11 65120628-65122473 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059015 Supported Enhanced "Nucleoli,Endoplasmic reticulum,Cytosol" No No "Endoplasmic reticulum, Cytosol" Nucleoli "HPA059015: AB_2683881" "unprognostic (1.81e-3)" "unprognostic (3.47e-2)" "unprognostic (2.89e-1)" "unprognostic (2.91e-1)" "unprognostic (5.73e-2)" "unprognostic (1.63e-3)" "unprognostic (1.97e-1)" "unprognostic (5.40e-2)" "unprognostic (1.26e-1)" "unprognostic (7.06e-3)" "unprognostic (7.77e-2)" "unprognostic (1.14e-1)" "unprognostic (1.61e-2)" "unprognostic (1.13e-1)" "unprognostic (2.11e-1)" "unprognostic (1.13e-3)" "unprognostic (1.45e-2)" 79.7 95.0 90.6 84.9 76.2 186.7 95.4 50.9 80.9 103.6 134.8 77.6 63.4 77.8 84.0 80.5 115.2 100.0 87.2 133.9 70.0 58.9 88.0 162.9 77.5 182.6 78.9 40.8 176.0 202.8 27.5 56.1 73.2 46.6 123.5 53.0 67.8 97.3 76.7 190.8 86.8 93.8 97.5 72.4 130.9 79.2 53.6 53.2 126.8 121.5 83.6 149.5 122.0 136.6 291.3 169.7 90.9 119.0 116.3 253.8 346.5 78.9 52.0 46.0 72.8 45.0 67.3 63.0 45.1 43.9 63.2 40.1 58.8 79.3 94.1 122.5 38.7 42.6 69.8 42.6 60.1 26.3 69.0 65.3 75.8 54.7 80.7 82.8 89.8 83.6 82.9 100.1 54.3 73.9 60.2 48.7 91.0 70.7 111.5 33.4 98.7 103.8 181.4 126.5 59.2 86.7 101.0 36.8 184.5 58.2 44.7 64.0 64.3 35.0 101.3 140.8 28.6 90.5 124.6 46.0 57.2 66.0 88.2 72.0 121.3 115.2 160.1 69.3 70.0 64.7 90.9 119.0 70.6 128.9 107.0 176.1 291.3 212.1 165.5 132.1 281.7 253.8 198.1 78.9 116.3 92.8 169.7 153.8 346.5 90.6 76.2 50.9 80.9 70.0 58.9 78.9 40.8 46.6 53.2 595.5 951.7 2941.4 2547.1 3351.7 327.7 460.8 1579.6 745.5 1039.6 909.0 184.6 1889.5 1737.5 1225.7 710.1 1573.3 1664.2 1027.9 2337.8 2188.3 1714.1 2189.0 1307.1 1658.9 1928.3 179.6 1179.1 1412.4 2371.4 1489.6 2116.5 2866.9 2014.3 2418.4 1788.3 428.5 1806.3 2457.4 1155.5 1844.9 362.4 1099.5 2206.1 745.0 649.0 3667.7 2335.8 2033.7 2040.2 2956.6 FBXL2 "FBL2, FBL3" ENSG00000153558 "F-box and leucine rich repeat protein 2" Q9UKC9 3 33277025-33403662 "Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" Calmodulin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 23.6;Early spermatids: 41.5;Late spermatids: 37.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 8.9;LHCN-M2: 9.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061783 Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Plasma membrane" "Nucleoplasm, Nucleoli" "HPA061783: AB_2684605" "unprognostic (5.73e-2)" "unprognostic (4.47e-2)" "unprognostic (7.92e-2)" "unprognostic (7.21e-2)" "unprognostic (3.68e-1)" "unprognostic (1.59e-1)" "unprognostic (1.10e-2)" "unprognostic (2.09e-1)" "unprognostic (3.16e-1)" "unprognostic (2.00e-1)" "unprognostic (4.31e-2)" "unprognostic (1.06e-1)" "prognostic favorable (3.35e-4)" "unprognostic (3.30e-3)" "unprognostic (9.72e-2)" "unprognostic (4.28e-2)" "unprognostic (5.90e-2)" 3.2 5.2 8.0 2.2 15.0 1.9 4.1 7.2 18.1 3.7 2.9 4.1 1.8 3.2 5.2 8.2 2.3 6.0 3.0 2.7 8.7 11.3 5.5 1.4 4.6 1.8 6.6 13.4 4.5 3.5 7.7 16.1 5.5 13.1 4.3 1.5 6.4 3.1 6.5 1.5 2.9 2.0 3.5 4.5 2.3 2.5 4.3 2.8 0.0 8.6 0.6 1.5 2.6 2.5 1.3 0.9 2.8 1.0 0.9 1.1 0.1 3.9 1.1 1.6 1.8 2.3 3.8 0.6 3.1 2.5 2.8 4.1 0.8 4.7 0.2 0.9 2.0 1.3 1.0 1.4 3.4 1.9 0.4 1.9 0.7 3.2 0.8 2.8 0.3 0.7 1.5 2.5 1.8 1.3 8.9 5.0 2.8 0.9 0.3 9.4 0.4 0.8 0.7 1.2 0.5 0.9 0.1 1.0 0.1 7.1 1.1 2.0 2.0 1.3 0.8 2.3 2.7 2.2 1.2 3.9 1.4 1.3 1.1 1.7 0.4 0.2 0.2 1.3 0.3 0.9 1.5 1.0 0.7 0.9 0.5 0.7 0.5 0.7 0.9 0.3 1.3 1.1 1.1 2.8 0.9 0.7 0.9 0.4 0.1 8.0 15.0 7.2 18.1 8.7 11.3 6.6 13.4 13.1 2.8 3.0 8.2 0.0 5.1 1.0 16.5 2.0 2.5 13.4 4.5 5.2 23.6 0.4 3.3 3.5 41.5 2.2 0.0 0.0 0.3 1.0 3.6 2.9 0.0 0.0 0.4 17.5 0.0 3.1 0.3 37.9 1.4 1.2 1.7 0.0 0.1 6.7 3.4 0.0 3.9 2.1 14.2 6.5 2.9 11.7 7.9 1.0 0.6 1.3 0.0 3.3 FPR1 "FMLP, FPR" ENSG00000171051 "Formyl peptide receptor 1" P21462 19 51745172-51804110 "G-protein coupled receptors, Predicted membrane proteins" Chemotaxis "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 213.3;lymphoid tissue: 64.4" "Cell type enhanced" "Detected in many" 21 "Hofbauer cells: 97.2;Kupffer cells: 262.0;Macrophages: 111.7" "Cancer enhanced" "Detected in all" "glioma: 23.0" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 6 "neutrophil: 213.3" "Lineage enriched" "Detected in many" 6 "granulocytes: 213.3" "Cell line enriched" "Detected in some" 5 "U-87 MG: 35.0" "Not detected" "Not detected" "HPA046550, HPA061744" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA046550: AB_2679694, HPA061744: AB_2684600" "unprognostic (5.54e-2)" "unprognostic (4.16e-2)" "unprognostic (1.88e-1)" "unprognostic (1.22e-1)" "unprognostic (8.50e-2)" "unprognostic (1.38e-1)" "unprognostic (1.96e-1)" "unprognostic (1.14e-1)" "unprognostic (1.15e-1)" "unprognostic (5.48e-3)" "unprognostic (4.59e-2)" "unprognostic (8.34e-2)" "prognostic unfavorable (2.21e-4)" "unprognostic (6.03e-2)" "unprognostic (4.52e-3)" "unprognostic (1.54e-2)" "unprognostic (1.70e-3)" 22.6 3.7 5.2 52.2 12.4 54.5 2.9 1.1 6.3 2.6 2.4 5.9 0.0 1.1 2.3 2.3 3.3 8.4 9.6 11.2 15.7 4.3 6.0 7.5 28.8 58.4 15.5 0.8 1.9 3.5 0.8 2.3 13.0 9.7 1.8 1.2 2.4 2.4 0.9 3.2 1.1 2.2 12.8 14.3 64.4 3.2 2.9 10.1 0.9 2.7 0.7 3.2 7.9 4.6 0.0 8.9 213.3 36.3 0.0 0.0 16.9 0.3 0.5 0.2 0.3 0.4 1.1 0.3 0.2 0.0 0.3 1.0 0.2 0.3 0.6 0.3 0.0 1.9 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.6 2.8 0.2 0.4 2.4 0.1 0.9 0.8 4.2 0.0 0.2 0.1 0.4 7.1 0.5 0.1 0.2 0.2 0.2 0.4 0.2 0.4 0.0 0.6 0.3 0.1 0.2 0.4 0.1 0.3 0.1 0.6 0.6 0.5 1.2 0.3 0.0 1.7 0.1 0.0 0.3 35.0 0.9 0.1 13.0 36.3 10.0 0.0 15.9 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 213.3 0.0 9.5 0.3 0.0 16.9 5.2 12.4 1.1 6.3 15.7 4.3 15.5 0.8 9.7 10.1 14.9 40.8 6.2 0.2 0.6 0.4 0.2 0.0 16.0 28.4 0.0 0.0 0.9 0.0 0.0 1.2 0.4 0.0 0.0 0.0 1.2 0.9 0.2 24.4 1.7 97.2 0.0 0.0 4.3 262.0 1.3 0.3 111.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 6.5 1.0 0.5 0.6 0.0 2.5 0.0 0.0 0.0 FTSJ3 SPB1 ENSG00000108592 "FtsJ RNA methyltransferase homolog 3" Q8IY81 17 63819433-63830012 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055544, HPA062628" Supported Enhanced "Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim" "Mitotic chromosome" "HPA055544: AB_2682843, HPA062628: AB_2684813" "unprognostic (1.33e-1)" "unprognostic (1.41e-1)" "unprognostic (6.60e-2)" "unprognostic (7.82e-2)" "unprognostic (6.45e-2)" "unprognostic (2.92e-1)" "prognostic unfavorable (1.44e-5)" "unprognostic (1.27e-1)" "unprognostic (2.57e-1)" "unprognostic (2.41e-2)" "unprognostic (2.85e-1)" "unprognostic (1.12e-1)" "unprognostic (4.99e-2)" "unprognostic (1.28e-1)" "unprognostic (1.19e-1)" "unprognostic (5.10e-1)" "unprognostic (3.43e-1)" 20.1 19.9 14.2 15.8 18.2 12.5 16.4 13.6 15.2 17.5 17.4 22.4 25.0 12.9 22.7 19.4 17.6 17.3 16.8 19.2 14.8 9.2 24.4 24.9 13.9 17.5 18.9 9.5 22.3 14.6 30.6 13.3 15.4 16.2 19.3 17.1 17.4 16.5 18.1 25.1 21.2 16.2 21.5 17.7 19.8 16.5 13.0 17.8 31.1 22.4 19.7 26.0 18.0 16.8 9.8 13.3 6.5 12.8 12.3 15.1 9.0 20.6 32.6 12.6 17.9 20.4 17.6 19.6 20.7 15.2 23.7 18.9 27.1 13.9 27.6 8.5 12.1 12.5 14.3 23.5 19.7 30.6 4.7 23.5 24.8 23.2 25.2 14.9 31.3 18.1 12.4 15.6 36.8 17.8 12.1 19.7 17.0 24.6 11.3 15.8 34.8 27.5 10.2 34.0 23.3 33.3 24.6 34.7 19.4 15.5 18.9 11.7 45.9 24.4 20.8 14.1 26.3 19.8 10.5 17.7 17.7 24.9 19.7 38.2 27.4 38.5 27.5 15.8 20.9 17.1 4.5 10.8 6.5 11.4 12.8 15.1 9.8 12.2 14.9 13.3 9.8 9.8 12.0 2.4 12.3 9.2 10.1 14.2 9.0 14.2 18.2 13.6 15.2 14.8 9.2 18.9 9.5 16.2 17.8 29.8 23.8 10.4 12.4 12.2 6.9 26.9 20.4 29.4 30.7 14.0 9.8 13.8 11.6 21.2 6.1 18.5 13.1 0.0 29.2 13.7 11.6 9.0 24.2 17.1 12.5 3.2 12.2 9.2 15.2 11.9 22.5 14.0 8.5 20.8 11.2 13.8 23.1 13.6 18.0 21.6 8.6 45.3 17.9 10.4 12.8 11.2 13.6 10.0 16.4 9.1 FXYD1 PLM ENSG00000266964 "FXYD domain containing ion transport regulator 1" O00168 19 35138808-35143109 "Predicted membrane proteins" "Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "heart muscle: 134.1;liver: 137.1;skeletal muscle: 299.8" "Group enriched" "Detected in many" 4 "Fibroblasts: 170.5;Hepatocytes: 393.6;Leydig cells: 398.4;Muller glia cells: 148.5;Peritubular cells: 120.6;Sertoli cells: 116.4;Smooth muscle cells: 231.4" "Cancer enhanced" "Detected in many" "liver cancer: 8.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 11.7" "Group enriched" "Detected in many" 5 "B-cells: 11.7;T-cells: 7.1" "Cell line enhanced" "Detected in some" "ASC diff: 31.0;ASC TERT1: 9.0;HSkMC: 12.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026873 Approved Nucleoplasm,Nucleoli,Cytosol No NA "Nucleoplasm, Cytosol" Nucleoli "HPA026873: AB_1855471" "unprognostic (5.58e-3)" "unprognostic (6.60e-2)" "unprognostic (3.37e-2)" "unprognostic (1.31e-2)" "prognostic unfavorable (6.91e-4)" "unprognostic (1.54e-2)" "unprognostic (1.72e-2)" "unprognostic (3.54e-3)" "unprognostic (8.13e-2)" "unprognostic (5.11e-2)" "unprognostic (8.64e-2)" "unprognostic (2.66e-1)" "prognostic unfavorable (7.59e-8)" "unprognostic (9.97e-3)" "unprognostic (2.25e-1)" "unprognostic (1.65e-1)" "unprognostic (1.92e-2)" 28.2 8.1 35.7 5.2 40.7 2.0 21.8 16.8 34.7 46.5 16.9 25.5 7.1 5.0 26.3 17.9 18.8 31.1 14.8 134.1 23.8 19.9 4.5 137.1 14.1 3.0 36.1 23.7 34.0 6.2 2.1 4.3 8.6 21.5 21.6 7.9 14.1 6.4 20.7 299.8 5.8 7.5 27.7 19.0 6.2 8.4 7.5 14.8 0.0 3.9 29.0 3.5 12.7 23.7 11.7 0.7 1.2 0.7 2.0 7.1 0.7 0.7 0.0 0.0 0.1 31.0 9.0 0.8 3.7 0.1 0.0 0.0 0.0 0.2 2.4 1.0 0.0 0.1 0.6 0.7 0.4 0.0 2.2 0.9 0.4 0.0 1.2 3.5 0.2 0.2 12.8 0.0 0.1 0.3 0.3 0.1 0.1 0.6 2.5 0.1 0.0 0.0 0.5 0.1 1.8 0.4 0.0 0.1 0.6 0.0 0.0 0.2 0.1 0.4 0.1 1.0 0.2 0.1 4.0 0.3 0.0 0.4 0.3 0.0 0.0 0.0 0.3 0.6 0.4 5.1 1.2 0.3 0.0 1.4 0.7 0.9 11.7 4.1 1.7 0.3 6.6 0.8 1.0 0.6 2.0 0.7 0.7 7.1 0.7 35.7 40.7 16.8 34.7 23.8 19.9 36.1 23.7 21.5 14.8 0.0 0.0 3.7 5.1 26.2 1.4 0.3 2.5 5.3 0.0 24.4 3.9 1.3 0.0 0.1 1.2 6.0 1.3 0.0 4.2 1.5 170.5 2.1 0.0 393.6 4.2 0.0 0.0 49.1 11.0 5.1 398.4 4.1 50.6 0.0 0.4 148.5 1.6 2.5 120.6 0.0 7.0 116.4 231.4 3.8 11.7 23.8 2.4 4.9 0.6 2.3 GCLC "GCS, GLCL, GLCLC" ENSG00000001084 "Glutamate-cysteine ligase catalytic subunit" P48506 6 53497341-53616970 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glutathione biosynthesis" Ligase "Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 69.2" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 102.4;Intestinal endocrine cells: 212.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 8.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A549: 49.2;Hep G2: 42.0;OE19: 68.1;RT4: 45.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009569, HPA036359, HPA036360" Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA 3600000 Nucleoplasm "Nucleoli, Cytosol" "CAB009569: AB_675582, HPA036359: AB_10672243, HPA036360: AB_10669789" "unprognostic (8.41e-2)" "unprognostic (1.27e-2)" "unprognostic (5.65e-2)" "unprognostic (2.42e-1)" "unprognostic (1.58e-1)" "unprognostic (2.76e-1)" "unprognostic (2.60e-1)" "unprognostic (7.50e-2)" "unprognostic (9.94e-3)" "unprognostic (4.67e-3)" "unprognostic (1.30e-1)" "unprognostic (5.23e-2)" "prognostic favorable (3.83e-6)" "unprognostic (3.78e-2)" "unprognostic (8.91e-2)" "prognostic unfavorable (8.24e-4)" "unprognostic (2.30e-2)" 15.8 11.1 12.9 9.0 16.0 14.4 13.0 5.4 15.1 6.8 16.2 21.6 8.2 18.9 9.2 5.3 20.0 29.1 14.9 7.4 13.1 10.6 15.4 69.2 12.9 10.1 21.6 12.2 6.2 12.4 6.6 5.4 6.2 13.0 13.0 12.2 5.2 11.2 10.1 7.0 8.6 14.8 11.9 13.6 16.8 14.8 5.2 17.5 3.1 14.1 32.4 10.6 34.4 12.3 1.6 4.2 2.2 1.9 8.0 2.3 0.6 7.3 49.2 4.0 9.5 4.8 2.2 5.4 3.7 6.0 2.8 3.3 7.2 17.1 14.0 7.1 3.3 21.5 10.5 12.3 27.1 3.8 11.0 7.6 9.3 9.5 42.0 5.5 12.3 5.8 3.4 11.5 3.1 14.1 3.7 4.2 12.3 5.1 4.4 1.3 7.7 10.5 4.9 7.5 68.1 4.6 3.5 2.5 12.3 9.1 45.4 11.7 5.7 6.2 10.0 6.5 6.1 6.8 5.8 5.9 2.5 8.8 6.4 5.5 5.9 9.1 8.1 6.3 8.8 4.2 2.2 1.1 0.6 1.2 1.9 0.8 1.6 1.0 2.3 4.2 1.0 0.6 1.3 0.5 8.0 1.8 3.0 1.6 0.6 12.9 16.0 5.4 11.9 13.1 10.6 21.6 12.2 13.0 17.5 0.0 3.7 7.8 42.9 30.9 12.8 17.8 25.5 48.2 47.8 0.0 23.6 5.2 10.0 12.8 1.4 13.5 19.9 46.7 11.0 6.5 8.7 44.8 2.3 102.4 19.8 7.9 212.1 9.2 60.1 1.0 6.1 16.4 8.5 6.4 16.3 13.8 17.1 8.5 8.9 19.8 4.0 12.9 10.3 3.3 8.1 21.8 6.5 10.7 13.8 89.1 GEMIN2 SIP1 ENSG00000092208 "Gem nuclear organelle associated protein 2" O14893 14 39114223-39136973 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015426, HPA046570, HPA057114" Enhanced Supported "Nucleoplasm,Nucleoli,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" Nucleoli "CAB015426: AB_629517, HPA046570: AB_2679703, HPA057114: AB_2683340" "unprognostic (4.53e-1)" "unprognostic (1.56e-1)" "unprognostic (1.52e-1)" "unprognostic (5.07e-3)" "unprognostic (1.04e-1)" "unprognostic (3.52e-2)" "prognostic unfavorable (3.88e-6)" "unprognostic (8.62e-3)" "unprognostic (3.05e-2)" "unprognostic (1.99e-3)" "unprognostic (3.08e-1)" "unprognostic (3.03e-1)" "unprognostic (4.53e-3)" "unprognostic (1.52e-1)" "unprognostic (1.58e-1)" "unprognostic (3.95e-1)" "unprognostic (6.78e-2)" 10.0 8.2 13.2 8.1 16.9 15.2 13.3 15.7 15.2 10.1 9.5 10.9 5.2 11.4 9.3 12.5 10.2 9.9 7.2 12.4 13.8 10.1 8.2 9.2 9.1 14.1 11.0 13.8 11.3 8.5 4.3 16.1 9.0 13.4 8.4 10.9 8.9 7.7 7.7 18.9 10.4 8.0 12.6 12.4 9.5 8.4 13.2 12.8 11.9 9.8 9.9 13.3 11.3 9.6 17.1 15.8 8.9 12.6 11.6 15.5 8.7 11.6 16.7 16.5 12.0 5.8 6.7 8.5 5.5 4.4 14.9 14.8 14.6 13.7 17.2 11.6 4.7 5.3 8.9 22.1 9.4 15.7 8.8 12.9 10.0 10.2 36.2 11.8 15.2 6.6 3.6 9.0 9.4 13.5 4.4 13.0 15.2 11.9 12.6 8.3 23.1 16.6 14.6 11.5 14.1 18.8 15.5 18.0 10.8 8.3 7.6 16.1 3.2 11.7 9.0 6.0 9.4 20.5 6.7 5.3 6.9 10.2 6.7 9.0 13.2 20.5 25.2 3.3 16.2 9.6 8.1 12.3 8.9 14.3 12.6 10.1 15.4 13.2 14.0 15.6 17.1 14.9 15.5 3.4 11.6 10.4 15.8 11.4 8.7 13.2 16.9 15.7 15.2 13.8 10.1 11.0 13.8 13.4 12.8 6.0 3.0 7.5 7.2 7.6 6.3 5.2 2.5 13.4 6.8 5.2 9.8 12.3 10.0 9.9 33.1 8.0 1.8 0.0 5.6 15.4 11.2 5.3 5.7 5.8 10.0 4.8 3.5 9.8 10.0 32.0 8.3 6.6 6.8 7.2 6.7 7.1 6.1 0.0 9.2 11.5 6.4 6.5 5.2 19.3 14.7 6.9 3.2 10.2 8.8 4.2 GFPT1 "GFA, GFAT, GFAT1, GFPT" ENSG00000198380 "Glutamine--fructose-6-phosphate transaminase 1" Q06210 2 69319769-69387254 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Biological rhythms" "Aminotransferase, Transferase" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Mucus-secreting cells: 215.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047240 Approved "Nucleoplasm,Nucleoli,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli" "Nucleoli fibrillar center" "HPA047240: " "unprognostic (4.38e-3)" "unprognostic (8.20e-2)" "prognostic favorable (7.13e-5)" "unprognostic (2.97e-1)" "unprognostic (1.32e-1)" "unprognostic (2.40e-2)" "unprognostic (1.08e-2)" "unprognostic (2.11e-1)" "unprognostic (2.99e-1)" "unprognostic (3.14e-1)" "unprognostic (4.84e-2)" "unprognostic (5.00e-2)" "unprognostic (3.83e-2)" "unprognostic (9.49e-2)" "unprognostic (1.78e-1)" "unprognostic (1.63e-1)" "unprognostic (2.58e-1)" 16.7 11.4 6.4 12.7 7.8 5.6 18.3 7.8 10.1 16.8 27.0 6.4 41.2 14.5 10.1 18.7 11.6 9.5 19.4 11.3 6.0 9.8 17.8 49.1 14.1 4.7 6.5 5.7 11.1 34.9 13.9 39.6 36.5 7.0 17.2 27.5 7.7 39.7 34.0 9.2 6.1 28.2 8.7 6.2 8.2 24.6 13.9 4.8 8.5 35.2 7.7 18.1 10.6 16.2 5.6 4.1 5.9 3.4 4.1 6.8 3.0 9.6 6.7 8.7 5.4 24.2 16.7 18.7 18.5 17.2 8.7 11.1 21.4 8.8 8.7 6.7 17.1 10.9 4.7 10.8 5.6 14.4 7.9 4.1 10.1 5.0 22.1 28.7 6.9 4.0 10.5 27.6 16.9 32.4 12.1 8.1 7.5 8.4 14.2 17.0 5.7 7.2 7.2 11.2 19.9 5.6 7.3 18.0 4.4 14.2 7.7 5.3 3.0 6.9 12.8 24.7 18.7 5.1 4.3 12.4 7.8 10.4 13.3 8.8 10.2 6.8 6.6 12.7 4.7 8.9 5.9 2.8 3.4 6.8 3.2 6.5 5.6 6.1 6.6 3.6 3.4 6.1 5.6 1.3 4.1 3.4 4.1 4.3 3.0 6.4 7.8 7.8 10.1 6.0 9.8 6.5 5.7 7.0 4.8 47.6 43.8 21.6 18.1 25.2 14.6 39.1 43.3 62.9 45.5 41.8 11.8 23.5 14.9 29.0 71.7 15.1 126.6 0.0 78.9 58.2 37.0 83.5 24.2 49.7 15.2 6.4 72.2 19.6 8.8 12.1 21.6 14.3 50.6 39.7 215.3 10.9 58.8 74.8 26.5 24.3 13.7 19.4 31.7 89.0 45.3 18.3 28.7 16.6 120.1 30.1 GJC1 "CX45, GJA7" ENSG00000182963 "Gap junction protein gamma 1" P36383 17 44798448-44830816 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 23 "Sertoli cells: 155.2;Smooth muscle cells: 65.3;Spermatogonia: 32.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA071788 Uncertain "Nucleoli,Cell Junctions,Cytosol" NA NA Nucleoli "Cell Junctions, Cytosol" "HPA071788: " "unprognostic (1.84e-2)" "unprognostic (2.04e-1)" "unprognostic (2.13e-2)" "unprognostic (1.35e-1)" "unprognostic (1.75e-1)" "unprognostic (2.22e-1)" "unprognostic (7.02e-2)" "unprognostic (4.01e-1)" "unprognostic (1.60e-2)" "unprognostic (1.11e-1)" "unprognostic (3.02e-1)" "unprognostic (1.64e-1)" "prognostic unfavorable (3.55e-8)" "unprognostic (5.18e-2)" "unprognostic (2.20e-1)" "unprognostic (8.52e-2)" "prognostic unfavorable (7.83e-4)" 7.3 0.8 2.2 4.1 3.4 1.0 4.7 8.2 4.2 14.8 23.0 2.8 7.0 1.6 24.2 3.1 3.2 5.0 5.4 10.0 3.3 1.8 1.5 0.9 6.5 2.3 2.5 4.0 2.2 1.3 2.6 0.7 28.5 3.4 8.2 2.8 3.7 1.7 17.0 5.4 1.9 4.8 27.5 2.2 0.9 7.8 8.0 2.9 1.4 5.3 2.9 1.7 12.6 10.4 1.2 1.0 4.7 1.0 1.9 1.0 0.4 17.4 9.0 22.7 7.8 3.0 4.7 8.9 19.4 15.3 20.9 22.5 5.2 9.7 0.1 1.0 18.1 28.6 4.5 11.8 6.0 29.4 0.1 8.8 0.1 4.8 0.5 1.8 0.1 0.7 3.2 0.6 15.9 5.3 7.8 7.1 3.9 0.8 0.2 12.1 0.1 2.8 1.7 10.2 0.0 7.7 16.5 28.8 0.1 5.0 7.3 4.3 9.9 2.2 0.1 6.5 15.3 4.7 2.7 5.9 18.5 17.9 8.4 16.5 0.1 4.5 12.9 6.4 0.1 17.3 4.7 1.0 1.1 0.9 0.6 0.8 0.9 0.7 0.6 0.3 1.2 0.9 1.0 3.9 1.9 0.7 1.0 0.6 0.4 2.2 3.4 8.2 4.2 3.3 1.8 2.5 4.0 3.4 2.9 0.0 0.0 0.0 1.6 1.8 1.0 18.1 0.0 0.0 0.0 1.8 2.0 0.3 0.0 1.3 1.3 11.7 0.0 0.0 0.0 2.1 5.7 1.2 0.0 0.0 1.2 12.7 0.0 6.2 0.8 0.0 1.4 0.0 3.3 1.0 0.0 0.4 0.6 0.0 2.1 0.3 1.0 155.2 65.3 10.2 32.0 2.6 0.5 0.0 0.0 1.4 GLI3 "ACLS, GCPS, PAP-A, PAPA, PAPA1, PAPB, PHS, PPDIV" ENSG00000106571 "GLI family zinc finger 3" P10071 7 41960950-42237870 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 31.6" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 20.8;Syncytiotrophoblasts: 28.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 26.6;WM-115: 19.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA005534 Approved Supported Nucleoplasm,Nucleoli,Vesicles NA NA Nucleoplasm "Nucleoli, Vesicles" "HPA005534: AB_1078973" "unprognostic (2.53e-1)" "unprognostic (2.41e-2)" "unprognostic (7.58e-2)" "unprognostic (8.22e-3)" "unprognostic (1.10e-1)" "unprognostic (1.28e-2)" "unprognostic (1.01e-1)" "unprognostic (5.35e-3)" "unprognostic (2.24e-1)" "unprognostic (7.38e-2)" "unprognostic (4.03e-1)" "unprognostic (3.54e-2)" "unprognostic (1.48e-5)" "unprognostic (9.13e-3)" "unprognostic (5.41e-2)" "unprognostic (3.21e-3)" "unprognostic (7.00e-2)" 7.3 2.6 4.6 6.8 5.4 0.3 9.4 0.8 6.4 21.1 13.1 2.9 10.9 1.4 31.6 10.0 7.3 10.8 7.0 2.0 4.2 1.7 2.3 0.7 5.8 2.4 1.8 2.1 17.6 1.5 0.8 1.9 13.4 1.8 10.6 3.8 5.1 3.7 14.3 2.2 9.7 4.2 13.8 0.9 1.8 3.8 2.3 3.0 1.7 6.1 8.7 4.0 6.4 9.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 26.6 0.2 6.9 12.6 1.7 1.6 5.6 4.8 5.6 0.1 0.0 0.0 1.0 11.1 6.2 5.5 3.6 4.3 4.1 0.0 3.3 0.0 3.3 0.0 4.4 0.0 0.1 10.4 6.3 5.0 4.0 2.8 4.4 2.9 0.0 0.1 2.2 2.4 0.3 0.0 12.0 0.0 10.1 6.3 0.1 0.7 0.0 4.4 0.7 0.0 2.6 3.3 2.0 11.4 4.4 0.0 4.6 5.9 8.5 8.2 2.8 0.0 0.0 0.0 4.4 0.1 19.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 4.6 5.4 0.8 6.4 4.2 1.7 1.8 2.1 1.8 3.0 0.0 4.8 0.0 6.8 20.8 1.8 1.4 0.0 1.4 1.2 1.8 0.0 17.7 0.0 0.0 11.6 2.8 0.0 0.0 0.0 12.0 18.1 3.2 1.1 0.0 2.8 0.0 0.0 2.5 0.3 4.3 17.8 0.0 8.5 0.0 0.0 11.8 0.1 0.0 3.2 3.4 0.8 12.9 14.6 0.4 0.9 13.6 28.6 0.0 0.0 3.7 GNAI1 ENSG00000127955 "G protein subunit alpha i1" P63096 7 80133955-80219402 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transport" Transducer "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 195.4;Suprabasal keratinocytes: 187.2;Syncytiotrophoblasts: 153.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "NK-cell: 20.0" "Lineage enriched" "Detected in many" 5 "NK-cells: 20.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022449, HPA042141" Approved Supported Nucleoplasm,Nucleoli,Centrosome NA NA 9000000 Centrosome "Nucleoplasm, Nucleoli" "CAB022449: , HPA042141: AB_2677870" "unprognostic (2.29e-1)" "unprognostic (2.83e-2)" "unprognostic (2.64e-2)" "unprognostic (1.54e-1)" "unprognostic (7.05e-2)" "unprognostic (1.18e-1)" "unprognostic (1.92e-2)" "unprognostic (2.08e-2)" "prognostic unfavorable (5.09e-4)" "unprognostic (9.78e-2)" "unprognostic (1.26e-1)" "unprognostic (4.48e-1)" "unprognostic (9.41e-3)" "prognostic unfavorable (6.47e-4)" "unprognostic (1.12e-1)" "unprognostic (1.94e-2)" "unprognostic (1.53e-1)" 33.2 23.4 17.2 5.4 26.2 1.5 14.4 14.4 33.7 9.4 10.5 36.9 3.0 6.9 10.0 3.0 16.6 9.0 8.6 5.7 23.8 18.3 25.9 13.1 10.3 3.4 40.3 21.9 14.3 5.4 2.5 7.3 30.4 26.2 10.1 9.0 2.8 4.9 9.5 4.2 32.4 5.3 12.2 49.7 5.7 8.3 11.1 32.0 0.9 11.1 3.2 4.6 15.5 9.0 0.1 3.7 2.1 1.5 20.0 2.3 0.7 2.9 20.8 19.0 0.1 23.7 15.2 8.7 12.6 15.2 11.2 13.9 0.0 3.2 0.1 4.1 13.5 9.6 3.0 10.6 12.9 14.9 0.1 9.7 17.8 18.3 1.3 24.0 2.3 3.8 16.3 32.8 6.0 17.3 9.1 7.5 0.0 1.4 0.0 21.0 0.5 0.1 0.1 5.5 0.1 7.5 8.3 7.3 8.9 33.5 10.0 13.9 9.6 13.5 0.2 10.8 16.3 2.6 0.4 13.3 25.1 17.7 5.8 4.7 0.1 0.0 0.1 6.6 1.3 11.1 2.1 0.7 0.7 0.1 0.7 0.0 0.0 0.3 0.2 3.7 0.1 2.3 0.9 0.3 20.0 1.5 0.3 0.2 0.7 17.2 26.2 14.4 25.5 23.8 18.3 40.3 21.9 26.2 32.0 17.9 14.4 0.8 17.7 195.4 3.7 6.1 15.3 36.1 13.6 27.9 0.0 72.1 74.6 6.5 0.9 24.0 2.9 0.0 3.3 66.5 57.4 6.1 27.9 16.8 8.7 25.4 19.1 18.4 1.0 3.5 31.1 5.8 97.8 4.6 7.3 46.1 6.8 7.0 70.0 9.8 5.0 109.9 38.2 6.2 40.1 187.2 153.4 0.0 8.5 14.5 GNAI3 87U6 ENSG00000065135 "G protein subunit alpha i3" P08754 1 109548611-109618321 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division" Transducer "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Cone photoreceptor cells: 329.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022099, HPA042141" Approved Approved Nucleoplasm,Nucleoli,Centrosome NA NA 8400000 Centrosome "Nucleoplasm, Nucleoli" "CAB022099: , HPA042141: AB_2677870" "unprognostic (2.19e-1)" "unprognostic (1.64e-1)" "prognostic favorable (1.62e-4)" "unprognostic (1.44e-2)" "unprognostic (2.59e-1)" "unprognostic (9.45e-3)" "prognostic unfavorable (5.30e-6)" "unprognostic (2.56e-3)" "unprognostic (2.18e-2)" "prognostic favorable (4.59e-4)" "unprognostic (1.83e-3)" "unprognostic (6.91e-2)" "prognostic unfavorable (4.34e-4)" "unprognostic (7.27e-2)" "unprognostic (1.39e-1)" "unprognostic (1.25e-2)" "unprognostic (1.66e-2)" 25.2 13.0 12.3 15.5 11.3 26.4 15.8 12.8 10.7 19.0 14.7 10.3 14.3 12.1 19.7 15.7 34.8 12.5 13.2 9.3 12.3 9.4 18.1 25.8 13.2 23.8 13.1 8.3 18.4 13.7 10.7 11.0 22.4 11.5 17.2 13.8 8.0 16.2 14.4 8.6 27.9 17.0 15.9 12.9 21.6 12.1 14.0 12.0 22.2 12.9 25.2 20.6 20.0 20.4 6.1 9.6 16.8 13.1 5.8 7.2 9.3 14.1 5.0 9.6 5.6 9.2 11.1 7.9 10.7 8.6 10.9 10.9 7.6 4.9 7.6 7.1 11.4 6.7 7.5 9.0 10.9 15.3 8.5 5.5 6.6 8.6 6.5 7.9 10.3 6.1 8.2 9.3 12.6 8.7 7.6 13.1 5.8 8.6 7.5 10.8 9.6 7.9 8.4 9.6 6.8 5.8 5.7 22.6 4.9 12.1 10.8 6.2 10.8 7.5 8.5 11.7 7.8 6.5 9.1 11.8 9.2 12.7 13.8 12.1 8.0 9.0 8.8 15.3 10.2 14.3 8.5 9.1 16.6 6.8 13.1 7.2 6.1 6.7 6.5 9.6 5.0 5.6 6.4 16.8 5.8 12.3 4.3 6.9 9.3 12.3 11.3 12.8 10.7 12.3 9.4 13.1 8.3 11.5 12.0 41.7 29.8 72.9 89.8 134.3 27.1 11.7 28.1 46.8 34.2 55.8 329.9 74.3 54.7 94.8 7.0 65.3 47.7 23.3 88.0 115.2 72.4 62.2 45.1 49.5 96.4 23.8 80.9 47.9 103.4 6.0 45.1 89.9 70.9 77.5 58.1 44.4 82.3 52.6 44.6 40.9 23.4 51.8 82.4 64.2 49.4 164.6 89.4 82.8 47.9 147.8 GNL3L "FLJ10613, GNL3B" ENSG00000130119 "G protein nucleolar 3 like" Q9NVN8 X 54530211-54561071 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036314, HPA036315" Supported Supported Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA036314: AB_10669986, HPA036315: AB_2675055" "unprognostic (9.71e-3)" "unprognostic (6.58e-2)" "unprognostic (6.24e-2)" "unprognostic (1.99e-2)" "unprognostic (1.13e-2)" "unprognostic (1.38e-1)" "unprognostic (2.92e-2)" "unprognostic (5.46e-2)" "unprognostic (8.44e-2)" "unprognostic (9.97e-2)" "unprognostic (4.91e-3)" "unprognostic (7.87e-2)" "unprognostic (8.05e-3)" "unprognostic (2.99e-2)" "unprognostic (1.51e-1)" "unprognostic (1.75e-3)" "unprognostic (1.10e-1)" 12.7 12.9 10.3 16.1 12.3 19.2 12.5 8.6 13.1 10.8 10.2 14.8 10.5 8.5 15.2 10.2 16.3 11.0 10.1 15.3 8.1 8.0 12.0 12.5 13.0 15.5 13.0 10.8 13.2 17.5 15.9 16.9 12.0 10.2 10.6 13.3 12.3 13.3 12.4 24.0 13.2 13.5 15.0 11.5 17.6 11.7 5.9 13.9 20.5 18.0 12.0 18.6 13.7 13.1 17.2 11.4 20.2 15.2 21.8 17.7 11.5 11.2 28.0 5.8 11.9 6.0 4.1 10.7 6.7 4.9 7.6 6.0 23.6 9.3 15.8 13.0 9.7 9.9 11.0 19.3 8.4 10.5 10.9 10.0 15.9 22.4 11.1 4.6 24.6 15.7 5.8 4.1 17.7 10.7 3.1 8.1 9.0 10.3 16.0 7.6 21.8 13.9 5.1 16.7 6.7 15.7 15.0 13.2 15.3 5.7 17.8 9.4 5.7 22.0 13.6 6.3 12.2 17.9 6.3 11.6 13.8 13.8 13.3 11.4 12.0 15.3 20.3 7.1 20.4 15.3 18.9 14.2 15.1 17.7 12.6 16.1 15.0 16.2 15.4 11.4 17.2 12.4 13.0 20.2 21.8 15.2 9.6 8.6 11.5 10.3 12.3 8.6 13.1 8.1 8.0 13.0 10.8 10.2 13.9 11.9 21.0 11.9 2.9 1.1 9.4 7.0 5.1 12.0 18.2 3.5 11.8 6.4 3.3 6.0 0.2 6.0 4.6 0.0 7.6 5.4 3.3 2.8 10.4 3.9 4.4 7.9 3.4 7.4 11.9 0.0 5.2 6.1 0.0 6.4 4.3 3.7 7.8 3.5 2.8 3.3 8.0 6.5 4.1 1.2 7.4 1.8 4.6 8.2 3.9 3.1 GPR137 "C11orf4, GPR137A, TM7SF1L1" ENSG00000173264 "G protein-coupled receptor 137" Q96N19 11 64270062-64289500 "Predicted intracellular proteins, Predicted membrane proteins" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 64.8" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 157.3;Late spermatids: 445.6;Spermatocytes: 157.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 15.7" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062871 Uncertain Approved "Nucleoplasm,Nucleoli,Actin filaments" NA NA "Nucleoplasm, Nucleoli" "Actin filaments" "HPA062871: AB_2684889" "unprognostic (2.25e-1)" "unprognostic (4.21e-2)" "unprognostic (6.81e-2)" "unprognostic (1.06e-1)" "unprognostic (1.29e-3)" "unprognostic (6.37e-2)" "prognostic unfavorable (5.34e-4)" "unprognostic (5.68e-2)" "unprognostic (1.83e-2)" "unprognostic (7.61e-3)" "prognostic favorable (6.18e-4)" "unprognostic (4.95e-2)" "unprognostic (8.66e-3)" "unprognostic (3.67e-3)" "unprognostic (2.28e-1)" "unprognostic (2.13e-1)" "unprognostic (5.41e-1)" 10.3 12.2 18.6 12.8 21.8 10.4 12.0 20.0 23.1 8.9 10.5 13.2 13.8 11.2 9.0 10.4 10.5 13.3 10.3 9.7 18.5 14.3 14.0 14.1 9.3 10.8 15.4 9.1 7.3 9.4 16.4 10.1 28.9 16.5 10.5 5.8 12.4 13.9 12.8 9.9 15.9 11.4 7.1 12.7 11.3 13.6 64.8 14.4 9.9 14.3 5.5 9.3 9.5 16.2 3.9 3.4 15.7 3.0 1.9 3.4 1.4 9.0 20.3 7.0 20.2 13.7 7.3 29.7 10.8 9.1 10.8 7.0 14.9 12.8 9.3 18.8 6.8 19.4 18.2 9.8 6.0 3.1 29.5 12.3 8.9 20.8 9.5 7.8 5.8 17.3 9.1 9.5 9.4 7.2 7.4 5.8 11.2 7.9 22.8 6.4 23.0 6.5 15.8 9.5 7.4 20.2 13.2 7.5 15.1 7.5 12.4 11.2 13.6 13.1 18.0 11.7 7.4 19.7 2.5 9.3 30.0 20.8 22.6 7.8 18.3 33.5 7.8 21.4 5.0 18.2 1.7 3.0 5.3 2.7 2.8 3.4 2.8 2.3 2.0 3.1 3.9 2.6 2.2 15.7 1.9 2.3 3.4 1.6 1.4 18.6 21.8 20.0 23.1 18.5 14.3 15.4 9.1 16.5 14.4 3.0 9.1 11.8 16.0 12.8 13.4 4.4 10.2 9.4 4.5 12.2 11.8 40.6 13.3 33.8 157.3 14.0 21.2 0.0 23.3 58.9 21.7 17.8 2.3 8.9 21.4 19.1 15.5 9.8 9.1 445.6 17.8 11.8 13.5 20.8 13.8 33.6 24.9 14.0 15.2 15.2 6.0 25.8 12.5 157.6 37.2 13.2 100.0 12.8 13.4 18.0 GPR65 "hTDAG8, TDAG8" ENSG00000140030 "G protein-coupled receptor 65" Q8IYL9 14 88005124-88014811 "G-protein coupled receptors, Predicted membrane proteins" Apoptosis "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 30.4;lymphoid tissue: 40.8" "Cell type enhanced" "Detected in many" 19 "granulocytes: 306.4;Kupffer cells: 79.3;monocytes: 79.4;T-cells: 135.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 6.3;HEL: 6.8;HL-60: 8.1;HMC-1: 10.4;RH-30: 13.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA072624, HPA077397" Enhanced Approved Nucleoli,Vesicles,Cytosol NA NA Vesicles "Nucleoli, Cytosol" "HPA072624: , HPA077397: " "unprognostic (8.56e-2)" "unprognostic (8.65e-3)" "unprognostic (1.98e-3)" "unprognostic (3.59e-3)" "unprognostic (3.10e-1)" "unprognostic (3.55e-3)" "unprognostic (1.15e-1)" "unprognostic (3.01e-2)" "unprognostic (3.62e-2)" "unprognostic (1.35e-1)" "unprognostic (1.08e-1)" "unprognostic (1.63e-1)" "prognostic unfavorable (4.99e-4)" "unprognostic (3.79e-1)" "unprognostic (4.46e-3)" "unprognostic (9.03e-2)" "unprognostic (3.80e-1)" 9.8 3.1 1.8 12.1 6.4 15.2 2.3 0.7 3.0 1.9 2.4 0.9 0.9 2.3 2.2 2.2 2.3 2.2 4.1 2.3 6.0 2.1 4.0 6.9 10.6 13.1 8.2 0.0 1.7 1.8 0.8 6.2 3.6 6.3 2.9 2.3 1.2 2.6 0.9 0.9 1.2 7.7 3.3 15.7 40.8 2.5 1.5 6.2 12.5 1.8 2.3 8.9 4.8 2.3 4.3 5.9 19.1 13.7 21.3 30.4 9.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 6.8 0.0 0.0 0.3 8.1 10.4 0.4 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.8 1.1 0.0 0.0 0.0 0.2 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.1 14.6 9.1 19.1 16.5 12.8 30.4 4.3 8.4 12.6 5.9 4.0 4.4 9.7 6.9 21.3 13.7 2.7 4.0 9.4 1.8 6.4 0.7 3.0 6.0 2.1 8.2 0.0 6.3 6.2 3.0 35.3 38.9 0.4 3.8 0.0 0.3 5.1 1.4 2.3 0.0 0.0 0.2 0.0 0.0 5.5 0.1 0.0 0.0 0.0 0.1 1.5 0.2 306.4 1.0 60.2 0.0 0.0 4.3 79.3 1.0 0.6 64.5 3.3 79.4 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 1.3 0.0 0.1 4.5 0.3 135.4 0.0 0.1 GPRC5B RAIG-2 ENSG00000167191 "G protein-coupled receptor class C group 5 member B" Q9NZH0 16 19856691-19886167 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 108.0" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 172.9;Late spermatids: 145.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "naive CD4 T-cell: 6.5" "Lineage enriched" "Detected in many" 4 "T-cells: 6.5" "Cell line enhanced" "Detected in many" "EFO-21: 39.2;HHSteC: 26.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015247 Enhanced Supported Nucleoplasm,Nucleoli,Vesicles NA NA Vesicles "Nucleoplasm, Nucleoli" "HPA015247: AB_1849323" "unprognostic (1.26e-1)" "unprognostic (1.32e-1)" "prognostic unfavorable (9.27e-5)" "unprognostic (2.60e-3)" "unprognostic (3.28e-1)" "unprognostic (2.46e-1)" "unprognostic (3.97e-2)" "unprognostic (5.70e-2)" "unprognostic (1.42e-1)" "unprognostic (2.26e-2)" "unprognostic (2.76e-2)" "unprognostic (1.27e-1)" "prognostic favorable (6.30e-4)" "unprognostic (4.73e-2)" "unprognostic (1.06e-1)" "unprognostic (4.42e-3)" "unprognostic (6.78e-3)" 12.6 4.4 45.2 3.2 55.9 1.0 7.3 22.8 108.0 5.4 2.9 95.1 4.9 4.0 7.1 9.3 5.5 12.7 9.2 22.3 47.8 28.7 12.1 2.7 3.9 4.6 63.1 34.9 13.7 12.7 9.5 3.8 9.3 38.6 6.3 2.3 3.8 20.8 11.5 35.1 2.5 3.3 5.1 61.6 2.2 22.7 19.6 63.1 0.0 7.2 2.6 2.7 6.2 3.0 0.0 0.0 0.0 1.5 0.0 6.5 1.3 0.4 12.6 12.5 2.2 12.9 0.9 2.3 0.1 3.1 1.2 0.8 11.5 0.4 0.0 39.2 0.4 8.2 0.6 9.2 0.0 0.7 0.0 3.3 0.0 0.0 0.0 26.8 0.0 0.0 1.1 0.0 2.1 0.0 3.3 6.1 0.3 2.6 0.2 2.8 0.6 0.0 0.0 13.7 0.0 6.0 3.6 0.0 0.0 0.4 5.8 9.7 0.8 1.4 0.8 11.3 4.1 0.0 0.2 1.2 0.0 1.5 6.1 0.3 0.1 0.0 0.0 0.6 0.1 0.7 0.0 0.1 0.0 0.0 1.5 0.0 0.0 1.6 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.3 0.0 0.0 1.3 45.2 55.9 22.8 40.5 47.8 28.7 63.1 34.9 38.6 63.1 0.0 4.0 0.9 4.6 1.1 30.1 13.4 35.7 5.3 7.9 29.6 0.0 3.9 1.7 47.7 172.9 30.1 0.0 0.0 56.2 1.2 9.7 4.3 0.0 0.0 3.3 0.0 0.0 6.2 1.0 145.0 22.2 1.1 15.1 1.8 0.0 20.5 53.7 0.0 25.1 0.1 5.7 12.9 9.2 2.8 1.5 1.5 2.1 0.0 0.0 1.7 GRAMD2A GRAMD2 ENSG00000175318 "GRAM domain containing 2A" Q8IUY3 15 72159807-72197785 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 24.6;placenta: 49.2" "Cell type enhanced" "Detected in some" 17 "Alveolar cells type 1: 65.5;Cytotrophoblasts: 93.9;Syncytiotrophoblasts: 123.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 7 "myeloid DC: 2.3" "Lineage enriched" "Detected in single" 7 "dendritic cells: 2.3" "Group enriched" "Detected in some" 12 "BEWO: 59.5;SK-BR-3: 27.1" "Low region specificity" "Detected in many" HPA029435 Uncertain Approved "Nucleoli,Nuclear speckles,Cytosol" NA NA "Nucleoli, Nuclear speckles" Cytosol "HPA029435: AB_10601811" "unprognostic (5.70e-2)" "unprognostic (7.55e-2)" "unprognostic (3.33e-1)" "unprognostic (1.24e-1)" "unprognostic (9.51e-3)" "unprognostic (2.95e-1)" "unprognostic (9.96e-2)" "unprognostic (3.90e-3)" "unprognostic (2.80e-1)" "unprognostic (1.96e-1)" "unprognostic (2.62e-1)" "unprognostic (5.77e-2)" "unprognostic (4.45e-1)" "unprognostic (2.35e-1)" "unprognostic (6.33e-2)" "prognostic unfavorable (7.01e-4)" "unprognostic (7.29e-2)" 0.1 0.0 2.0 0.2 4.5 0.0 6.8 1.1 1.0 3.1 0.7 1.2 9.8 0.6 0.4 24.6 1.0 8.2 0.8 0.1 2.9 6.5 1.9 0.1 9.7 0.2 1.1 0.1 1.1 1.0 0.2 0.9 49.2 3.9 1.2 0.5 1.0 1.8 4.0 0.3 1.5 3.6 0.1 1.0 0.1 0.4 0.7 0.9 0.2 7.7 1.3 1.1 0.3 0.6 0.0 2.3 0.0 0.1 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 59.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.0 3.5 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 27.1 0.0 2.1 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 4.5 1.1 1.0 2.9 6.5 1.1 0.1 3.9 0.9 65.5 13.3 0.0 0.0 0.0 0.0 0.0 0.0 18.7 13.6 3.5 0.0 93.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.1 0.0 0.0 1.1 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 123.0 0.0 0.0 0.0 GRWD1 "GRWD, RRB1, WDR28" ENSG00000105447 "Glutamate rich WD repeat containing 1" Q9BQ67 19 48445773-48457022 "Predicted intracellular proteins" "DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042643, HPA055680" Approved Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" No No "Nucleoli, Nucleoli rim" Nucleoplasm "HPA042643: AB_10795510, HPA055680: AB_2682884" "unprognostic (1.19e-1)" "unprognostic (1.47e-1)" "unprognostic (4.99e-2)" "unprognostic (1.00e-1)" "unprognostic (3.46e-1)" "unprognostic (7.77e-2)" "prognostic unfavorable (2.16e-4)" "unprognostic (1.71e-2)" "unprognostic (5.68e-2)" "unprognostic (2.69e-2)" "unprognostic (7.70e-2)" "unprognostic (2.83e-2)" "unprognostic (8.10e-2)" "unprognostic (1.78e-1)" "unprognostic (3.09e-1)" "unprognostic (2.02e-1)" "unprognostic (5.07e-2)" 16.9 15.5 9.2 15.7 11.1 14.8 15.5 12.9 14.1 13.6 14.1 10.4 11.9 15.6 18.7 12.8 20.0 15.0 16.2 16.9 7.8 8.6 13.0 26.3 12.5 17.5 11.0 10.3 19.3 35.5 16.5 10.3 14.7 9.5 13.8 8.0 12.0 18.6 14.4 29.1 18.3 11.5 13.3 8.2 19.4 14.7 13.1 10.9 18.6 17.3 19.0 17.3 14.1 18.0 21.1 18.4 1.4 17.8 17.4 22.6 16.5 17.0 45.1 7.7 14.4 6.3 6.2 6.6 13.3 6.4 19.2 16.1 25.3 12.7 24.4 11.6 8.3 10.8 14.6 19.1 20.6 7.6 18.2 25.8 22.2 15.3 18.0 7.3 20.9 14.3 7.4 11.4 18.1 9.2 4.3 9.5 13.4 31.0 15.4 8.0 17.7 22.0 52.6 20.9 18.2 13.2 27.4 8.6 17.5 8.0 21.1 17.3 9.6 15.0 21.3 6.6 4.8 10.5 10.6 10.1 17.9 15.1 7.8 31.6 15.7 35.9 22.8 6.0 18.9 20.8 0.1 11.0 1.4 19.6 17.8 22.6 21.1 18.1 19.5 18.4 20.4 21.3 19.7 0.8 17.4 13.5 13.6 15.6 16.5 9.2 11.1 12.9 14.1 7.8 8.6 11.0 10.3 9.5 10.9 3.0 17.4 22.9 20.9 41.1 12.6 6.5 15.3 18.7 14.8 12.2 0.0 35.6 19.9 28.0 1.7 18.0 7.3 0.0 15.7 30.6 18.6 13.5 19.6 14.7 21.5 20.6 18.4 11.6 10.7 14.6 15.8 12.4 27.0 35.1 9.0 5.3 18.5 7.0 11.7 15.3 13.0 19.4 20.2 6.1 34.7 35.5 29.3 20.0 13.4 17.6 GSKIP C14orf129 ENSG00000100744 "GSK3B interacting protein" Q9P0R6 14 96363452-96387288 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 63.0" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 337.2;Late spermatids: 220.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043054, HPA046782" Approved Approved "Nucleoli,Golgi apparatus,Vesicles" No No "Golgi apparatus, Vesicles" Nucleoli "HPA043054: AB_2678293, HPA046782: AB_2679803" "unprognostic (3.48e-1)" "unprognostic (1.16e-1)" "unprognostic (1.68e-2)" "unprognostic (5.08e-2)" "unprognostic (1.58e-1)" "unprognostic (1.04e-1)" "unprognostic (6.23e-3)" "unprognostic (1.11e-1)" "unprognostic (9.35e-2)" "unprognostic (1.16e-3)" "unprognostic (6.82e-2)" "unprognostic (2.84e-1)" "unprognostic (8.74e-3)" "unprognostic (4.67e-2)" "unprognostic (1.52e-1)" "unprognostic (1.48e-2)" "unprognostic (2.30e-1)" 6.6 7.1 11.2 8.0 21.9 7.1 6.7 5.1 14.6 6.6 29.5 5.4 6.7 23.5 5.5 6.4 20.8 5.5 7.0 5.2 12.0 9.6 12.8 36.4 5.3 8.7 9.2 9.7 3.6 6.1 4.0 10.8 11.1 10.7 7.1 28.3 8.7 7.8 5.2 5.5 8.5 63.0 8.0 10.4 6.6 11.3 26.4 7.2 9.0 5.8 10.7 10.7 8.2 9.0 20.1 11.2 27.5 16.6 17.8 34.1 14.8 9.6 13.8 15.5 10.5 11.7 13.6 26.3 18.0 13.8 11.9 13.2 10.2 16.4 9.3 11.0 13.6 7.4 10.7 10.1 10.7 17.4 21.9 9.6 3.8 7.9 7.8 10.9 9.9 6.7 11.0 17.2 15.2 15.3 9.4 15.5 10.6 8.4 8.4 15.1 23.9 7.2 8.0 17.2 15.1 17.5 7.3 14.4 8.4 28.0 36.1 5.5 17.7 20.3 19.2 15.6 16.3 14.4 6.4 17.0 5.5 7.1 11.7 5.6 10.0 28.4 7.8 14.1 7.2 8.8 27.5 10.8 24.3 15.5 12.6 24.0 20.1 21.7 18.3 11.2 16.6 21.4 19.8 21.7 17.8 16.6 9.6 34.1 14.8 11.2 21.9 5.1 14.6 12.0 9.6 9.2 9.7 10.7 7.2 11.9 9.0 19.3 19.8 40.2 24.1 14.2 20.4 14.7 5.7 19.2 39.3 37.6 61.3 30.4 337.2 14.6 80.6 0.0 34.7 35.8 17.9 30.7 19.6 15.5 20.9 22.3 26.9 17.8 22.8 220.8 7.5 17.5 18.6 32.5 63.8 16.2 32.2 98.2 7.4 38.6 79.0 19.4 18.4 37.4 36.7 57.6 100.0 26.1 53.7 34.5 GTPBP4 "CRFG, FLJ10686, FLJ10690, NGB, NOG1" ENSG00000107937 "GTP binding protein 4" Q9BZE4 10 988019-1019936 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039618, HPA056468" Uncertain Supported "Nuclear membrane,Nucleoli,Nucleoli rim" No No "Nucleoli, Nucleoli rim" "Nuclear membrane" "HPA039618: AB_10795292, HPA056468: AB_2683141" "unprognostic (2.11e-3)" "unprognostic (3.10e-3)" "unprognostic (7.77e-3)" "prognostic unfavorable (4.57e-4)" "unprognostic (3.72e-2)" "unprognostic (8.91e-3)" "prognostic unfavorable (8.85e-12)" "unprognostic (9.06e-2)" "unprognostic (1.72e-1)" "unprognostic (8.45e-2)" "unprognostic (1.11e-1)" "unprognostic (1.60e-1)" "prognostic unfavorable (2.38e-5)" "unprognostic (7.90e-2)" "unprognostic (2.90e-1)" "unprognostic (2.00e-1)" "unprognostic (3.67e-2)" 19.0 24.6 11.3 13.9 14.9 24.8 14.2 11.6 15.0 11.0 10.5 12.2 10.3 9.6 14.8 10.1 12.2 15.8 8.9 11.9 14.1 11.8 11.8 14.0 9.5 13.8 14.0 10.1 16.3 22.8 12.7 18.3 13.8 15.3 11.1 12.2 8.9 10.3 9.9 24.8 11.4 11.0 14.4 18.1 13.5 12.7 22.9 12.2 14.2 11.9 16.3 16.3 11.6 10.4 10.5 11.3 10.7 14.2 15.8 14.2 7.7 21.0 17.2 14.5 12.7 10.3 12.3 10.4 19.8 6.9 24.3 20.7 25.4 16.4 30.6 6.0 15.7 8.4 16.7 28.6 18.1 28.4 15.1 17.9 33.5 12.4 15.5 16.3 14.5 18.1 15.9 15.4 26.7 18.6 9.9 13.2 23.8 34.3 12.7 22.2 19.4 22.2 13.7 21.1 28.0 11.9 22.1 12.7 21.1 14.4 13.4 7.3 22.0 13.0 16.7 22.9 14.9 23.9 14.5 11.4 11.6 6.4 27.8 24.0 16.5 31.5 38.5 13.0 15.4 9.5 10.7 8.4 3.0 11.6 14.2 13.6 10.5 11.0 11.7 11.3 9.9 12.2 11.8 1.4 15.8 10.8 7.4 14.2 7.7 11.3 14.9 11.6 15.0 14.1 11.8 14.0 10.1 15.3 12.2 53.6 69.5 32.8 58.3 55.6 25.5 29.7 22.9 66.9 108.1 27.9 17.7 41.8 28.2 54.3 49.0 30.8 10.0 23.3 37.9 45.9 31.1 41.3 62.7 24.3 30.8 22.3 21.2 20.9 25.9 13.8 23.0 29.0 21.9 38.7 24.5 27.3 52.1 17.5 27.6 24.0 31.8 19.4 25.8 86.5 85.2 58.7 79.8 24.5 28.6 76.5 GYG2 GN-2 ENSG00000056998 "Glycogenin 2" O15488 X 2828788-2882820 "Enzymes, Predicted intracellular proteins" "Glycogen biosynthesis" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adipose tissue: 76.7;brain: 21.2;breast: 30.4" "Cell type enhanced" "Detected in many" 11 "Hepatocytes: 15.8;Intestinal endocrine cells: 19.5" "Cancer enhanced" "Detected in all" "melanoma: 42.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 17.1;Hep G2: 13.7;NTERA-2: 16.9;SK-MEL-30: 36.5;SuSa: 27.1" "Low region specificity" "Detected in all" "HPA005495, HPA064686" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol No No "Nucleoli, Cytosol" Nucleoplasm "HPA005495: AB_1079035, HPA064686: AB_2685323" "unprognostic (4.45e-2)" "unprognostic (4.21e-2)" "unprognostic (6.41e-3)" "unprognostic (8.50e-2)" "unprognostic (2.07e-3)" "unprognostic (5.16e-1)" "unprognostic (1.74e-2)" "unprognostic (1.18e-1)" "unprognostic (7.43e-3)" "unprognostic (6.74e-2)" "prognostic favorable (3.01e-5)" "unprognostic (9.76e-2)" "unprognostic (6.10e-5)" "unprognostic (1.78e-1)" "unprognostic (5.05e-3)" "unprognostic (5.41e-2)" "unprognostic (6.60e-2)" 76.7 1.4 4.6 1.3 4.6 0.5 30.4 2.1 3.7 2.1 3.5 8.2 0.7 1.2 4.2 0.9 1.0 3.6 1.7 1.7 3.9 2.9 1.4 9.9 0.7 0.7 5.5 2.9 1.9 3.2 0.4 0.5 1.6 12.9 2.7 2.0 4.2 2.8 4.4 0.5 1.2 1.3 2.8 21.2 0.5 2.2 0.8 5.1 0.0 1.3 0.5 0.6 2.9 1.4 1.0 0.6 0.6 0.4 1.2 0.7 0.0 0.0 5.2 17.1 0.0 10.2 0.0 12.4 0.5 3.0 3.0 3.8 12.7 0.3 0.0 1.4 2.1 3.1 0.0 9.6 0.2 2.9 0.1 2.7 0.0 0.2 13.7 3.0 0.0 4.2 3.7 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 3.1 0.8 0.0 0.4 16.9 0.1 0.0 2.8 5.7 0.0 0.0 0.0 0.0 0.3 0.0 0.1 36.5 27.1 1.6 10.4 0.0 0.0 3.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.3 0.2 0.7 0.5 0.4 0.3 0.1 1.0 0.3 0.2 0.6 1.2 0.4 0.6 0.4 0.0 4.6 4.6 2.1 3.7 3.9 2.9 5.5 2.9 12.9 5.1 0.0 0.0 0.0 0.9 0.3 0.9 0.6 2.5 0.0 0.0 0.0 3.9 5.3 5.0 0.8 0.3 0.0 0.2 0.0 3.4 7.0 1.9 1.7 0.0 15.8 0.9 0.0 19.5 0.0 1.3 0.0 0.6 0.0 3.3 0.0 1.3 1.8 2.8 0.0 2.8 2.1 0.0 0.0 0.9 0.3 0.4 0.3 1.9 0.0 2.0 0.5 H1FX "H1X, MGC15959, MGC8350" ENSG00000184897 "H1 histone family member X" Q92522 3 129314771-129316277 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 8 "bone marrow: 381.6;lymphoid tissue: 238.6" "Cell type enhanced" "Detected in all" 6 "Basal glandular cells: 485.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 139.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB012235, HPA040099, HPA068431" Enhanced Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoplasm, Nucleoli, Nucleoli rim" "CAB012235: , HPA040099: AB_2676846, HPA068431: " "unprognostic (1.01e-2)" "unprognostic (1.12e-2)" "unprognostic (4.13e-2)" "unprognostic (8.48e-2)" "unprognostic (6.94e-2)" "unprognostic (2.23e-1)" "unprognostic (4.00e-2)" "unprognostic (1.46e-2)" "unprognostic (1.16e-1)" "unprognostic (5.51e-2)" "unprognostic (5.28e-3)" "unprognostic (1.44e-2)" "unprognostic (2.88e-1)" "unprognostic (1.15e-1)" "unprognostic (2.85e-1)" "unprognostic (3.24e-1)" "unprognostic (2.50e-2)" 23.1 13.1 11.9 19.0 14.5 381.6 33.7 29.0 22.9 30.9 21.0 9.6 13.4 21.1 26.0 19.6 34.5 25.1 24.0 27.5 11.3 11.2 12.9 24.9 30.9 44.2 6.7 16.3 39.0 22.4 18.4 20.5 15.0 6.9 26.2 7.8 18.4 32.3 16.3 30.8 40.5 26.0 19.1 9.6 29.9 29.0 14.2 6.3 238.6 21.9 18.1 20.5 35.6 25.0 5.7 10.8 15.9 5.3 4.8 8.3 2.2 19.9 10.6 20.1 8.7 2.0 2.4 19.1 8.8 6.4 10.5 11.1 6.3 11.0 2.5 9.7 3.1 7.0 20.1 8.4 5.6 1.6 18.3 16.3 7.6 8.2 8.6 8.7 8.8 2.0 4.9 7.7 4.2 9.7 4.7 6.0 35.4 11.7 45.5 1.4 20.9 40.7 17.5 18.8 3.6 12.0 29.4 8.6 23.7 3.2 4.2 32.1 37.2 9.3 4.6 26.6 4.0 18.2 17.8 5.9 8.1 42.6 7.9 7.3 139.5 53.3 21.5 6.6 8.4 8.9 0.4 5.3 15.9 4.3 3.7 4.0 4.4 6.7 5.1 7.4 5.7 8.3 4.3 1.2 4.8 3.3 10.8 5.1 2.2 11.9 14.5 29.0 22.9 11.3 11.2 6.7 16.3 6.9 6.3 14.9 12.8 95.3 485.3 89.5 119.1 25.5 63.7 2.7 3.4 89.0 29.5 60.0 94.5 42.6 7.4 89.9 34.4 70.0 71.0 93.0 97.3 173.5 5.7 38.5 77.7 138.2 153.1 85.3 93.5 8.0 92.0 75.7 118.1 25.2 86.3 209.9 59.2 48.9 48.8 25.1 84.3 122.9 82.1 13.2 36.5 96.0 57.2 72.6 52.5 312.3 HINT3 FLJ33126 ENSG00000111911 "Histidine triad nucleotide binding protein 3" Q9NQE9 6 125956781-125980244 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 65.8" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 260.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027914 Approved Approved Nucleoli,Mitochondria,Cytosol NA NA "Nucleoli, Mitochondria" Cytosol "HPA027914: AB_10602424" "prognostic unfavorable (4.99e-4)" "unprognostic (4.75e-3)" "unprognostic (3.75e-2)" "unprognostic (1.29e-1)" "unprognostic (1.59e-1)" "unprognostic (1.71e-1)" "unprognostic (1.74e-1)" "unprognostic (4.88e-3)" "unprognostic (3.82e-1)" "unprognostic (1.27e-1)" "unprognostic (2.18e-2)" "unprognostic (1.05e-1)" "prognostic favorable (1.05e-6)" "unprognostic (4.09e-2)" "unprognostic (4.76e-2)" "unprognostic (9.56e-2)" "unprognostic (1.64e-1)" 11.4 16.3 27.4 8.0 23.3 7.2 15.6 19.4 24.3 13.1 13.1 24.8 10.6 10.4 11.5 12.6 15.2 11.4 10.9 19.0 28.1 23.0 15.1 18.5 13.9 7.0 28.7 17.0 10.4 12.8 16.3 13.4 12.1 20.7 20.5 12.1 10.3 16.0 16.2 65.8 11.6 10.5 15.2 40.8 6.8 16.0 21.9 17.0 7.7 15.9 16.8 7.4 16.1 8.8 11.0 11.1 15.0 13.2 7.9 9.9 7.0 7.0 5.6 7.8 16.1 3.1 8.4 9.7 7.6 11.0 5.9 6.1 13.6 3.9 15.3 14.2 5.1 13.1 10.6 9.9 6.4 6.9 14.4 12.8 6.4 8.4 11.4 14.4 10.1 10.9 6.6 14.3 5.9 15.0 15.2 8.8 11.4 19.9 10.3 5.8 10.6 8.0 7.3 2.6 14.4 5.4 6.7 5.3 5.1 12.1 12.9 15.7 9.7 6.9 9.9 35.6 5.9 10.0 15.5 6.2 4.0 5.6 19.2 10.8 15.0 17.2 9.7 11.4 9.6 5.1 14.4 13.2 11.4 7.2 8.4 7.8 11.0 9.2 7.5 11.1 10.4 9.9 8.7 15.0 7.9 10.8 6.9 9.1 7.0 27.4 23.3 19.4 24.3 28.1 23.0 28.7 17.0 20.7 17.0 74.5 57.0 16.0 9.5 16.1 22.3 37.6 10.2 24.1 31.8 15.7 7.9 16.0 28.2 27.0 260.9 11.3 12.3 0.0 17.5 5.7 10.8 19.4 9.2 16.3 23.3 6.4 15.6 6.2 14.5 54.5 9.2 17.0 20.3 9.0 22.7 30.7 20.3 28.1 16.3 21.4 23.9 6.5 13.7 89.1 27.7 15.2 22.1 7.0 19.9 17.1 HMGA2 "BABL, HMGIC, LIPO" ENSG00000149948 "High mobility group AT-hook 2" P52926 12 65824131-65966295 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Cell cycle, Cell division, DNA condensation, Growth regulation, Mitosis, Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 25.3" "Cell type enhanced" "Detected in some" 10 "Early spermatids: 15.7;Hofbauer cells: 6.8;Late spermatids: 6.8;Pancreatic endocrine cells: 11.8;Undifferentiated cells: 8.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 63.0;hTERT-RPE1: 46.0;SuSa: 44.3" "Not detected" "Not detected" "CAB017809, HPA039076" Approved Supported "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoplasm, Nucleoli, Nucleoli rim" "CAB017809: , HPA039076: AB_2676335" "unprognostic (2.39e-1)" "unprognostic (6.00e-2)" "unprognostic (2.08e-1)" "unprognostic (3.68e-3)" "unprognostic (5.21e-3)" "prognostic unfavorable (4.79e-4)" "unprognostic (4.05e-3)" "unprognostic (6.17e-3)" "unprognostic (6.71e-2)" "unprognostic (1.16e-1)" "unprognostic (1.54e-6)" "unprognostic (3.33e-2)" "unprognostic (4.55e-5)" "unprognostic (4.22e-2)" "unprognostic (2.53e-1)" "unprognostic (2.53e-2)" "prognostic unfavorable (2.86e-4)" 6.5 0.3 0.5 3.8 0.8 8.1 2.1 0.2 0.6 2.5 7.6 0.4 0.0 2.4 2.7 0.1 1.1 2.4 3.3 0.5 0.3 0.4 1.0 0.4 0.5 0.1 0.3 1.3 2.1 1.7 0.0 1.7 0.3 0.6 0.5 4.6 0.4 0.5 1.8 2.0 0.7 5.1 0.7 1.7 0.8 2.1 25.3 0.0 0.8 1.1 3.0 0.1 0.8 2.8 0.7 0.3 3.8 2.1 1.3 0.7 0.1 9.1 4.0 63.0 9.0 3.0 16.5 0.0 29.1 13.3 5.1 5.1 5.2 3.9 0.0 18.9 1.3 24.0 4.0 10.4 25.1 24.5 0.0 10.9 0.0 0.1 31.5 1.7 0.8 0.1 12.5 1.5 11.0 19.8 46.0 20.1 0.0 0.0 0.1 29.1 0.0 0.0 5.1 36.9 0.8 18.1 2.4 3.1 0.0 13.6 0.0 0.0 0.0 0.0 0.0 16.0 44.3 0.1 0.1 23.5 18.5 5.5 14.1 8.7 0.0 0.0 0.0 22.4 0.0 4.2 3.8 1.0 0.7 0.5 0.6 0.3 0.3 0.4 0.5 0.2 0.7 0.4 0.7 2.5 1.3 2.1 0.3 0.3 0.1 0.5 0.8 0.2 0.6 0.3 0.4 0.3 1.3 0.6 0.0 0.0 1.4 0.0 2.2 0.0 0.0 1.2 0.0 4.0 0.0 0.0 0.0 0.8 0.0 3.0 15.7 0.1 3.3 0.0 0.7 0.3 0.9 0.4 0.0 0.0 6.8 0.0 0.0 0.6 0.0 6.8 0.3 0.0 0.0 0.0 4.7 0.0 11.8 3.5 0.0 0.0 0.0 0.0 0.8 0.5 0.2 0.1 0.7 0.0 8.5 0.9 HSD3B1 "HSD3B, HSDB3, SDR11E1" ENSG00000203857 "Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1" P14060 1 119507198-119515054 "Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Steroid metabolism, Steroidogenesis" "Isomerase, Multifunctional enzyme, Oxidoreductase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "placenta: 231.4" "Group enriched" "Detected in some" 23 "Extravillous trophoblasts: 115.9;Syncytiotrophoblasts: 419.8" "Cancer enhanced" "Detected in single" "urothelial cancer: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "CACO-2: 36.4;SuSa: 16.3" "HPA043261, HPA043264, HPA044028" Supported Approved "Nucleoli,Endoplasmic reticulum,Cytokinetic bridge" NA NA "Nucleoli, Endoplasmic reticulum" "Cytokinetic bridge" "HPA043261: AB_2630368, HPA043264: AB_2678398, HPA044028: AB_2678781" "unprognostic (1.53e-1)" "unprognostic (7.11e-2)" "unprognostic (1.15e-1)" "unprognostic (1.04e-1)" "prognostic favorable (4.59e-5)" 0.1 0.6 0.0 0.0 0.3 0.0 0.7 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.5 0.0 0.0 231.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 4.5 11.9 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 36.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 4.0 0.4 0.5 16.3 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 115.9 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 419.8 0.0 0.0 0.0 HSD3B2 SDR11E2 ENSG00000203859 "Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2" P26439 1 119414931-119423035 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Steroidogenesis "Isomerase, Multifunctional enzyme, Oxidoreductase" "Congenital adrenal hyperplasia, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "adrenal gland: 223.2" "Cell type enhanced" "Detected in some" 17 "Enterocytes: 1.6;Exocrine glandular cells: 1.1;Peritubular cells: 2.5" "Cancer enhanced" "Detected in single" "testis cancer: 0.6" "Region enriched" "Detected in single" 198 "basal ganglia: 19.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 1.5;SH-SY5Y: 1.4;SK-MEL-30: 5.1;SuSa: 1.9;TIME: 1.2;WM-115: 3.2" "HPA043261, HPA043264, HPA044028" Supported Uncertain "Nucleoli,Endoplasmic reticulum,Cytokinetic bridge" NA NA "Nucleoli, Endoplasmic reticulum" "Cytokinetic bridge" "HPA043261: AB_2630368, HPA043264: AB_2678398, HPA044028: AB_2678781" "unprognostic (3.56e-1)" "unprognostic (1.85e-1)" "unprognostic (2.80e-1)" "unprognostic (2.72e-2)" "unprognostic (8.87e-2)" "unprognostic (3.91e-2)" "unprognostic (3.43e-2)" "unprognostic (1.94e-1)" "unprognostic (6.51e-2)" "unprognostic (1.97e-2)" "unprognostic (1.55e-1)" 0.0 223.2 0.0 0.8 19.8 0.0 0.0 0.0 0.0 0.0 0.5 43.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 3.6 0.2 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.5 1.4 0.0 0.0 5.1 1.9 0.0 0.0 1.2 0.2 0.1 0.1 0.7 0.0 0.0 0.0 0.8 0.0 3.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.6 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 HSPB6 "FLJ32389, Hsp20, PPP1R91" ENSG00000004776 "Heat shock protein family B (small) member 6" O14558 19 35754569-35758079 "Predicted intracellular proteins" "Stress response" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 356.8" "Group enriched" "Detected in many" 5 "Leydig cells: 251.7;Peritubular cells: 207.2;Smooth muscle cells: 65.1" "Cancer enhanced" "Detected in all" "stomach cancer: 93.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 189.0;ASC TERT1: 79.8;HHSteC: 64.1;HSkMC: 74.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB001974, HPA044153, HPA054811" Enhanced Supported "Nucleoli,Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA 86000 Cytosol "Nucleoli, Golgi apparatus" "CAB001974: , HPA044153: AB_2678836, HPA054811: AB_2682610" "unprognostic (3.19e-2)" "unprognostic (8.07e-2)" "unprognostic (1.41e-2)" "unprognostic (1.01e-1)" "unprognostic (5.21e-3)" "unprognostic (7.02e-2)" "unprognostic (9.67e-2)" "unprognostic (7.57e-2)" "unprognostic (1.18e-1)" "unprognostic (7.23e-2)" "unprognostic (1.20e-1)" "unprognostic (7.02e-2)" "prognostic unfavorable (1.93e-5)" "unprognostic (3.32e-2)" "unprognostic (6.65e-2)" "unprognostic (5.61e-2)" "prognostic unfavorable (1.43e-6)" 95.3 39.5 3.9 18.3 8.1 1.1 40.5 1.1 6.1 49.7 48.4 3.8 18.6 5.7 42.6 57.4 24.6 33.3 80.6 132.0 4.4 2.4 6.2 3.5 8.7 7.2 5.4 2.8 53.4 5.8 1.7 1.2 12.7 8.1 42.1 8.7 18.2 8.6 35.8 356.8 2.5 14.3 128.2 10.2 1.9 32.4 22.6 4.9 0.0 11.0 153.5 16.4 121.6 23.3 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.2 0.2 189.0 79.8 0.1 8.4 0.1 0.5 0.9 0.1 0.0 0.0 0.0 25.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 64.1 0.0 0.1 74.6 0.0 1.9 0.0 0.2 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 0.0 1.8 0.0 0.1 0.2 0.0 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.9 8.1 1.1 6.1 4.4 2.4 5.4 2.8 8.1 4.9 3.0 1.1 0.0 0.2 1.5 7.4 26.8 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.1 19.2 2.2 0.0 0.0 0.0 2.8 35.4 0.4 0.0 0.0 4.5 0.0 0.0 28.3 0.3 14.1 251.7 2.0 1.7 1.0 0.0 30.6 0.2 0.0 207.2 0.0 2.1 25.8 65.1 2.2 1.2 1.8 4.0 0.0 0.0 0.5 IFI16 "IFNGIP1, PYHIN2" ENSG00000163565 "Interferon gamma inducible protein 16" Q16666 1 158999968-159055155 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Autophagy, Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA002134, CAB016293" Enhanced Supported Nucleoplasm,Nucleoli,Cytosol No No "Nucleoplasm, Nucleoli" Cytosol "CAB016293: AB_627775, HPA002134: AB_1079099" "unprognostic (7.23e-3)" "unprognostic (2.20e-2)" "unprognostic (5.15e-2)" "unprognostic (7.70e-3)" "unprognostic (1.87e-1)" "unprognostic (6.08e-2)" "unprognostic (1.80e-1)" "unprognostic (5.83e-2)" "unprognostic (5.04e-2)" "unprognostic (2.26e-2)" "unprognostic (5.92e-3)" "unprognostic (7.62e-2)" "prognostic unfavorable (1.11e-16)" "unprognostic (5.07e-2)" "unprognostic (4.08e-1)" "unprognostic (7.97e-2)" "unprognostic (1.14e-1)" 64.2 21.0 10.9 42.5 18.0 10.2 34.8 6.7 11.4 28.5 18.6 9.6 7.8 7.5 32.5 21.8 32.8 25.0 33.4 24.8 16.5 7.5 13.3 10.2 32.1 51.0 19.5 6.3 32.6 5.5 3.2 7.0 21.4 18.0 23.0 15.2 10.9 33.6 11.2 14.6 23.7 21.6 29.1 32.2 63.2 11.8 14.2 16.0 81.8 19.1 24.2 41.8 30.9 27.6 28.9 20.8 51.2 21.0 27.9 24.6 16.9 7.0 0.5 2.4 0.1 17.0 56.4 0.0 15.0 40.3 42.3 56.3 0.0 9.1 41.5 12.9 9.2 13.6 20.5 0.3 15.2 16.9 12.8 0.1 10.6 3.1 0.0 31.9 3.6 0.7 53.1 27.3 21.6 30.8 20.3 44.4 36.7 0.2 30.4 23.4 0.0 48.7 3.4 6.5 0.0 5.5 23.0 15.6 47.9 5.9 2.7 1.1 0.0 19.6 0.1 42.6 10.2 0.0 4.3 25.0 10.9 5.1 30.6 6.3 28.4 13.2 39.0 31.3 12.0 26.2 2.5 21.0 0.1 18.9 20.5 16.9 27.6 18.1 19.3 20.8 28.9 11.5 14.6 51.2 27.9 18.5 15.6 24.6 16.9 10.9 18.0 6.7 11.4 16.5 7.5 19.5 6.3 18.0 16.0 35.7 66.1 149.1 95.2 84.3 0.2 6.9 22.9 58.9 119.4 40.1 0.0 3.0 1.7 32.6 4.0 196.0 5.6 0.0 40.2 1.9 91.8 23.0 129.9 2.9 175.9 0.0 11.6 126.4 165.6 4.9 108.7 168.3 79.2 49.5 16.2 31.8 42.0 24.6 49.8 4.4 0.9 84.1 124.0 2.6 1.9 59.6 2.7 201.5 21.7 108.0 ILF3 "DRBP76, MPHOSPH4, MPP4, NF90, NFAR-1" ENSG00000129351 "Interleukin enhancer binding factor 3" Q12906 19 10654261-10692417 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Transcription, Transcription regulation" "DNA-binding, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001897 Supported Enhanced Nucleoplasm,Nucleoli,Mitochondria No No 1100000 "Nucleoplasm, Nucleoli, Mitochondria" "HPA001897: AB_1078703" "unprognostic (2.39e-1)" "unprognostic (9.44e-2)" "unprognostic (1.51e-1)" "unprognostic (1.25e-1)" "unprognostic (7.53e-2)" "unprognostic (5.55e-3)" "unprognostic (1.11e-3)" "unprognostic (2.96e-1)" "prognostic unfavorable (1.57e-4)" "unprognostic (3.45e-2)" "unprognostic (1.04e-1)" "unprognostic (4.38e-2)" "prognostic unfavorable (9.65e-4)" "unprognostic (7.57e-3)" "unprognostic (7.61e-2)" "unprognostic (1.03e-1)" "unprognostic (6.20e-2)" 31.0 39.0 29.6 45.5 26.8 88.2 34.5 48.3 35.2 34.2 30.2 30.8 35.2 30.3 45.4 31.7 40.5 41.9 32.5 34.0 25.5 20.0 28.1 25.6 34.1 44.9 24.7 27.8 52.8 36.8 34.9 34.9 31.8 32.3 34.9 27.3 35.5 35.1 46.2 50.1 37.7 37.2 33.2 33.3 44.5 32.6 54.3 28.0 58.6 43.4 32.4 41.1 38.5 32.1 18.7 18.7 11.5 14.3 15.4 19.4 8.0 45.7 37.3 60.4 55.2 13.1 18.0 35.2 29.3 24.9 49.2 38.6 42.7 26.6 57.2 29.1 26.3 30.1 41.0 65.2 39.6 44.4 36.5 58.0 74.2 32.9 39.8 18.8 53.4 37.1 17.0 17.7 39.0 43.8 18.8 42.0 33.4 63.3 45.0 28.6 37.7 88.5 85.8 72.5 24.2 41.0 65.2 57.5 39.5 19.6 48.6 66.7 48.5 37.7 30.0 21.8 28.6 25.4 34.3 33.7 40.4 38.4 41.8 57.7 38.6 52.8 69.4 22.6 57.1 43.5 11.5 13.4 7.1 19.4 10.4 16.1 14.7 15.9 17.3 16.8 18.7 15.7 16.0 2.1 15.4 14.3 18.7 15.0 8.0 29.6 26.8 48.3 35.2 25.5 20.0 24.7 27.8 32.3 28.0 92.3 128.4 63.8 84.3 76.5 92.4 59.0 50.9 96.4 131.9 40.1 80.5 65.6 23.2 66.6 12.8 60.9 40.0 46.7 69.0 90.4 57.8 80.9 92.6 46.1 63.0 89.0 109.3 33.7 53.5 14.4 70.8 66.0 37.1 46.9 68.0 70.5 72.3 56.1 58.7 38.2 92.6 32.3 67.0 108.6 117.8 67.2 59.3 68.2 82.6 87.0 IQSEC1 "ARF-GEP100, BRAG2, GEP100, KIAA0763" ENSG00000144711 "IQ motif and Sec7 domain 1" Q6DN90 3 12897220-13073117 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 163.4;Cone photoreceptor cells: 182.6;Horizontal cells: 222.5;Rod photoreceptor cells: 119.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 34.9;U-266/84: 31.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038143, HPA038144" Uncertain Supported "Nucleoli,Nucleoli rim,Vesicles" NA NA "Nucleoli, Nucleoli rim, Vesicles" "HPA038143: AB_10697241, HPA038144: AB_2675860" "prognostic unfavorable (3.03e-5)" "unprognostic (1.80e-1)" "unprognostic (6.32e-2)" "unprognostic (3.01e-1)" "unprognostic (8.19e-3)" "unprognostic (2.64e-3)" "unprognostic (5.60e-2)" "unprognostic (1.67e-1)" "unprognostic (3.00e-1)" "unprognostic (1.14e-2)" "prognostic favorable (9.07e-4)" "unprognostic (4.42e-1)" "prognostic favorable (3.58e-6)" "unprognostic (1.50e-1)" "unprognostic (1.12e-1)" "unprognostic (1.00e-3)" "unprognostic (4.65e-2)" 17.8 14.1 27.8 12.3 27.0 32.5 7.1 31.9 41.5 9.5 6.7 18.5 3.5 4.8 8.0 4.7 6.1 8.5 7.4 16.0 25.0 17.8 7.0 11.5 12.4 14.8 16.4 24.8 12.3 13.0 25.7 7.8 13.4 36.7 11.6 4.8 17.0 9.3 10.0 21.0 6.2 7.7 8.4 10.6 20.6 6.9 5.6 15.5 2.6 6.3 4.3 14.0 7.8 5.9 6.2 6.8 12.9 4.0 1.8 3.6 2.3 5.0 6.9 6.2 7.0 5.2 7.2 34.9 5.7 4.7 3.8 2.9 4.7 4.5 10.7 6.6 10.7 4.2 2.8 4.7 3.0 2.8 7.2 9.9 6.3 4.1 20.0 5.7 0.1 2.7 7.1 5.5 7.8 4.4 5.2 3.5 4.4 17.9 11.4 2.6 16.2 4.0 6.8 6.5 4.0 14.1 5.4 2.0 15.4 2.2 6.6 5.4 9.9 4.1 14.4 3.3 5.6 6.1 4.4 9.4 4.2 10.6 3.5 0.7 22.8 31.2 4.2 7.9 3.2 3.3 5.0 3.8 4.8 3.6 4.0 2.7 6.2 2.4 2.7 1.9 6.1 2.4 3.0 12.9 1.8 3.9 6.8 1.7 2.3 27.8 27.0 31.9 41.5 25.0 17.8 16.4 24.8 36.7 15.5 3.0 22.7 41.9 6.8 10.2 106.3 163.4 28.1 12.0 7.9 3.5 182.6 7.8 6.6 5.7 2.1 20.1 2.0 23.3 11.1 36.0 17.8 15.7 14.0 38.5 19.4 222.5 9.8 28.3 52.6 3.4 15.5 24.7 6.8 3.6 13.6 16.7 7.9 0.0 21.2 4.7 119.9 25.8 33.0 1.8 1.5 6.8 18.2 16.2 7.6 10.7 IRAK4 NY-REN-64 ENSG00000198001 "Interleukin 1 receptor associated kinase 4" Q9NWZ3 12 43758944-43789543 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Immunity, Innate immunity" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-937: 32.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016685, CAB022077" Uncertain Approved Nucleoli,Microtubules,Cytosol NA NA Microtubules "Nucleoli, Cytosol" "CAB016685: AB_1618505, CAB022077: " "unprognostic (2.76e-2)" "unprognostic (5.63e-2)" "unprognostic (1.47e-2)" "prognostic favorable (3.46e-5)" "unprognostic (6.15e-2)" "unprognostic (3.50e-3)" "unprognostic (1.44e-2)" "unprognostic (8.49e-2)" "unprognostic (6.44e-3)" "unprognostic (7.50e-2)" "unprognostic (4.00e-3)" "unprognostic (6.29e-2)" "unprognostic (4.52e-2)" "unprognostic (2.95e-1)" "unprognostic (2.31e-1)" "unprognostic (1.84e-1)" "prognostic favorable (4.42e-5)" 18.0 9.4 5.1 15.0 10.4 10.3 11.3 3.7 6.0 10.3 12.2 9.1 12.5 10.2 13.0 14.1 15.0 9.4 10.8 7.6 6.7 5.2 13.3 11.8 12.0 24.0 13.2 3.9 9.3 20.1 9.1 16.1 14.0 9.8 10.5 10.0 11.9 11.9 15.1 4.1 15.2 15.0 11.8 13.0 25.0 12.3 7.1 11.7 30.3 17.0 7.7 18.9 11.1 10.7 5.1 5.8 16.9 6.0 8.8 7.7 4.7 5.3 4.0 2.8 3.7 10.2 17.2 4.0 7.6 5.4 6.0 5.5 3.4 5.2 9.2 7.5 6.3 4.0 4.4 3.1 4.9 8.7 13.2 2.9 8.8 3.1 2.1 5.8 12.1 10.8 9.1 7.8 7.6 4.5 10.6 8.9 9.0 8.1 6.9 16.6 2.9 10.5 6.8 1.0 0.0 4.7 7.0 3.4 4.8 4.7 5.1 2.0 2.0 3.7 4.7 3.6 4.0 5.9 10.8 7.9 7.4 1.4 9.1 5.2 8.4 10.9 8.0 7.7 32.7 4.1 16.9 4.6 9.4 7.4 5.4 7.7 4.0 6.1 6.3 4.5 5.1 5.5 5.9 9.3 8.8 6.0 5.8 7.5 4.7 5.1 10.4 3.7 6.0 6.7 5.2 13.2 3.9 9.8 11.7 17.9 17.0 15.7 9.4 9.6 5.7 4.1 22.9 6.7 10.3 31.4 19.6 12.5 18.3 10.9 12.6 12.4 13.8 0.0 15.4 7.3 9.3 8.1 20.9 7.3 15.2 7.9 3.5 12.9 29.8 16.3 11.5 22.9 10.1 18.0 9.3 9.1 12.5 5.8 10.6 11.3 25.0 6.5 8.6 27.0 12.6 10.3 23.3 41.5 7.8 11.2 JPT1 "ARM2, HN1, HN1A" ENSG00000189159 "Jupiter microtubule associated homolog 1" Q9UK76 17 75135248-75168281 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 109.4;testis: 101.3" "Cell type enhanced" "Detected in many" 13 "Ductal cells: 365.7;Exocrine glandular cells: 382.5;Extravillous trophoblasts: 1210.3;monocytes: 655.6;Pancreatic endocrine cells: 967.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 109.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059729 Approved Supported "Nucleoplasm,Nuclear membrane,Nucleoli" NA NA Nucleoplasm "Nuclear membrane, Nucleoli" "HPA059729: AB_2684114" "unprognostic (1.13e-2)" "unprognostic (1.81e-1)" "unprognostic (1.31e-3)" "unprognostic (3.57e-3)" "unprognostic (6.71e-2)" "unprognostic (2.51e-3)" "prognostic unfavorable (1.58e-7)" "unprognostic (3.58e-2)" "unprognostic (1.37e-1)" "prognostic favorable (4.91e-4)" "unprognostic (1.25e-3)" "unprognostic (8.24e-2)" "prognostic unfavorable (1.77e-7)" "unprognostic (1.83e-1)" "unprognostic (8.99e-2)" "unprognostic (4.84e-2)" "unprognostic (1.51e-1)" 8.0 18.5 15.6 25.9 22.2 23.0 8.1 30.7 25.4 9.4 43.3 4.6 7.7 37.5 6.1 5.4 52.8 4.3 23.7 6.1 17.9 19.6 15.5 12.8 13.9 26.3 11.1 15.0 5.6 6.5 1.2 6.6 29.2 13.7 7.0 23.7 3.3 15.9 17.6 23.7 9.3 51.3 7.3 8.3 26.2 42.5 101.3 4.9 32.6 5.8 28.9 28.7 17.9 17.0 15.4 14.5 109.4 28.4 10.2 28.7 14.6 92.5 92.3 48.6 48.2 10.3 10.6 38.8 48.7 14.5 47.9 36.9 75.5 55.6 26.1 31.3 39.0 50.4 55.4 45.3 60.7 36.2 26.0 57.0 41.9 36.7 74.7 24.2 31.4 40.5 16.2 29.1 39.0 40.1 14.1 87.1 49.7 23.6 53.7 43.8 67.0 100.7 30.7 28.3 76.6 121.7 64.4 58.0 40.4 51.2 58.2 60.4 49.1 69.8 37.0 25.9 53.6 99.1 19.3 50.1 27.5 77.6 38.5 56.6 21.0 33.9 39.0 23.9 29.5 31.3 27.5 18.5 51.6 12.4 26.6 8.9 15.4 17.2 14.9 14.5 8.0 8.2 12.0 109.4 10.2 28.4 9.6 28.7 14.6 15.6 22.2 30.7 25.4 17.9 19.6 11.1 15.0 13.7 4.9 23.8 17.8 0.0 0.0 0.0 0.0 0.0 0.0 30.8 33.0 233.8 0.0 95.9 84.6 365.7 0.0 0.0 0.0 0.0 382.5 1210.3 0.0 0.0 7.0 0.0 299.4 0.0 0.0 0.0 0.0 0.0 0.0 40.7 0.0 655.6 0.0 0.0 967.6 0.0 0.0 121.9 0.0 0.0 0.0 0.0 0.0 0.0 81.0 0.0 0.0 0.0 JRK "jerky, JH8" ENSG00000234616 "Jrk helix-turn-helix protein" 8 142657460-142681968 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Erythroid cells: 23.3;Spermatogonia: 21.3" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052675 Approved "Nucleoplasm,Nucleoli,Nuclear bodies" No No "Nucleoplasm, Nucleoli" "Nuclear bodies" "HPA052675: AB_2681910" "unprognostic (3.65e-2)" "unprognostic (5.30e-2)" "unprognostic (9.67e-2)" "unprognostic (3.90e-3)" "unprognostic (1.27e-1)" "unprognostic (1.84e-2)" "unprognostic (6.58e-6)" "unprognostic (1.05e-1)" "unprognostic (3.87e-1)" "unprognostic (6.90e-2)" "unprognostic (1.84e-1)" "unprognostic (1.11e-1)" "unprognostic (7.50e-2)" "unprognostic (2.07e-1)" "unprognostic (2.53e-1)" "unprognostic (1.22e-2)" "unprognostic (1.69e-2)" 2.6 3.3 6.4 4.0 6.5 1.6 3.7 11.1 7.1 2.8 2.8 6.1 6.8 2.9 5.4 3.6 3.1 4.7 2.6 3.7 4.4 2.9 0.7 2.6 5.3 5.2 5.2 9.6 4.6 5.6 4.4 3.0 4.3 4.5 2.8 5.4 4.1 4.5 6.2 6.5 3.2 4.9 3.5 4.8 4.3 6.1 5.3 4.3 4.2 2.6 6.1 2.6 7.9 4.5 2.3 3.3 2.3 2.0 4.4 1.2 5.5 6.0 7.0 5.7 6.8 10.0 4.4 8.6 3.6 10.6 6.1 5.3 11.5 9.5 3.7 7.1 7.3 7.5 6.2 5.3 5.4 7.2 10.5 9.5 19.0 6.2 2.8 7.3 6.7 6.4 4.7 6.7 3.9 5.3 5.9 11.2 10.1 4.2 8.9 9.5 8.4 4.1 6.0 3.9 8.5 11.1 4.4 5.3 3.7 9.5 12.9 8.6 15.8 6.5 3.7 4.6 6.4 4.6 7.0 8.3 17.7 8.1 4.7 5.6 6.2 5.6 6.2 9.2 7.9 3.3 2.3 2.9 3.1 1.6 1.8 1.4 3.5 3.1 2.3 4.5 4.4 3.5 2.5 2.0 0.8 2.2 2.0 1.2 6.0 0.6 5.1 1.9 0.0 12.9 9.6 7.6 1.4 1.2 7.0 19.6 3.6 3.3 2.7 1.3 6.2 2.3 23.3 2.2 2.1 1.1 3.6 1.1 2.4 2.6 9.5 8.7 10.4 5.6 1.1 10.6 1.9 0.0 1.8 3.1 5.4 4.1 0.0 11.0 2.4 10.2 0.0 1.4 9.8 21.3 0.0 1.8 0.0 4.5 4.1 KAT6A "MOZ, MYST3, RUNXBP2, ZC2HC6A, ZNF220" ENSG00000083168 "Lysine acetyltransferase 6A" Q92794 8 41929479-42051990 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Acyltransferase, Chromatin regulator, Repressor, Transferase" "Cancer-related genes, Mental retardation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017023, HPA063266, HPA065052" Supported Approved "Nucleoli,Nuclear speckles,Cytosol" NA NA "Nuclear speckles" "Nucleoli, Cytosol" "CAB017023: , HPA063266: AB_2684973, HPA065052: AB_2685414" "unprognostic (3.51e-2)" "unprognostic (1.14e-1)" "unprognostic (2.04e-1)" "unprognostic (3.23e-2)" "unprognostic (2.28e-1)" "unprognostic (9.27e-3)" "unprognostic (3.61e-1)" "unprognostic (2.29e-1)" "unprognostic (2.95e-1)" "unprognostic (2.45e-2)" "unprognostic (1.50e-1)" "unprognostic (4.45e-2)" "unprognostic (4.20e-3)" "unprognostic (1.18e-1)" "unprognostic (2.24e-1)" "unprognostic (8.58e-2)" "unprognostic (2.95e-2)" 20.8 10.9 15.3 19.8 20.3 36.8 22.6 29.9 18.7 19.7 14.6 19.4 14.4 10.7 20.6 12.1 16.9 16.5 14.3 13.0 15.5 11.5 12.3 13.6 26.9 28.2 23.2 10.3 27.2 13.1 26.8 22.3 20.9 15.7 14.1 12.0 12.8 15.1 17.0 21.0 25.5 18.0 25.0 22.9 20.4 14.0 14.1 21.7 30.4 17.9 14.3 20.1 16.9 24.2 4.7 1.8 10.9 1.6 3.1 3.9 1.4 13.1 10.8 17.8 11.3 10.0 11.4 6.0 8.8 11.5 10.9 8.5 6.8 6.3 19.5 8.9 8.7 10.6 8.5 13.8 8.4 13.0 10.0 8.1 28.1 6.7 5.1 7.5 14.8 12.9 9.5 9.6 10.1 12.6 8.0 10.5 17.3 23.5 12.4 10.0 5.8 30.0 4.7 6.8 9.9 4.3 24.0 19.9 6.2 5.4 15.1 11.1 9.5 10.3 6.9 7.1 8.4 15.9 6.5 12.2 13.5 9.6 12.0 9.4 10.1 16.4 21.2 7.3 6.7 11.6 3.5 1.6 2.8 3.5 1.2 3.9 2.4 2.6 3.3 1.0 4.7 3.6 2.9 10.9 3.1 1.2 1.8 3.5 1.4 15.3 20.3 29.9 18.7 15.5 11.5 23.2 10.3 15.7 21.7 32.8 30.4 27.2 23.8 44.8 44.6 22.6 25.5 21.4 30.7 12.2 51.1 12.1 3.3 11.8 1.8 50.4 18.7 46.7 10.4 13.1 28.5 21.6 33.6 22.2 14.6 55.6 23.7 43.0 37.4 3.5 26.2 31.3 21.9 8.2 25.7 32.4 13.2 17.5 21.5 9.3 45.4 19.4 33.9 41.9 36.2 53.4 17.6 45.8 18.9 26.1 KCNB2 Kv2.2 ENSG00000182674 "Potassium voltage-gated channel subfamily B member 2" Q92953 8 72537391-72938349 "FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.7;lymphoid tissue: 8.6;pituitary gland: 9.2" "Cell type enriched" "Detected in some" 15 "Cone photoreceptor cells: 249.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HaCaT: 3.2;HDLM-2: 3.1;HEK 293: 7.6;SCLC-21H: 6.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA065970 Approved "Nucleoli,Plasma membrane,Midbody" Yes NA "Plasma membrane" "Nucleoli, Midbody" "HPA065970: AB_2685591" "unprognostic (9.87e-3)" "unprognostic (1.71e-1)" "unprognostic (7.57e-2)" "unprognostic (1.10e-3)" "unprognostic (1.22e-1)" "unprognostic (1.34e-1)" "unprognostic (1.44e-2)" "unprognostic (2.72e-1)" "unprognostic (6.93e-5)" "unprognostic (5.53e-3)" "unprognostic (3.30e-2)" "unprognostic (1.62e-1)" "unprognostic (3.35e-2)" "unprognostic (3.26e-1)" 0.8 1.9 3.8 0.6 5.3 0.4 0.7 0.3 9.7 0.5 0.7 0.0 0.0 1.2 0.4 0.4 1.1 2.1 0.5 0.4 7.1 3.1 0.5 0.4 0.6 0.5 0.9 7.8 0.4 2.4 0.4 9.2 0.5 3.2 0.7 0.7 4.2 0.5 0.5 0.4 0.4 1.6 0.5 1.6 8.6 2.4 1.7 0.4 0.9 0.4 0.0 0.9 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 3.1 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 5.3 0.3 9.7 7.1 3.1 0.9 7.8 3.2 0.4 0.0 0.0 0.0 0.0 0.0 12.9 0.2 0.0 0.0 0.0 1.8 249.4 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 17.1 0.0 0.0 5.0 1.1 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.4 0.0 2.4 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 KDM6A UTX ENSG00000147050 "Lysine demethylase 6A" O15550 X 44873177-45112602 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Cancer-related genes, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000568, HPA001165, HPA002111" Enhanced Approved "Nucleoplasm,Nucleoli,Nucleoli rim" "Intracellular and membrane" NA NA "Nucleoli, Nucleoli rim" Nucleoplasm "HPA000568: AB_1858705, HPA001165: AB_1080541, HPA002111: AB_1858704" "unprognostic (1.73e-3)" "unprognostic (6.86e-3)" "unprognostic (1.45e-2)" "unprognostic (1.36e-1)" "unprognostic (1.72e-1)" "unprognostic (2.65e-2)" "unprognostic (2.58e-3)" "unprognostic (8.22e-3)" "unprognostic (3.23e-1)" "unprognostic (2.44e-1)" "unprognostic (2.56e-1)" "unprognostic (1.07e-1)" "unprognostic (2.73e-1)" "unprognostic (2.24e-2)" "unprognostic (5.18e-2)" "unprognostic (1.26e-1)" "unprognostic (3.16e-2)" 12.3 12.1 16.5 17.6 24.5 47.9 21.4 26.1 22.0 16.9 11.8 16.7 12.0 13.1 22.6 11.3 15.4 16.9 15.2 9.1 18.2 6.5 11.6 13.5 19.7 15.1 28.8 11.3 23.8 14.9 21.3 20.2 13.3 18.3 10.3 11.3 10.3 16.1 12.6 15.1 21.3 17.6 13.5 14.9 18.1 15.0 17.7 26.1 19.1 14.5 6.9 13.6 14.9 22.8 5.5 7.1 15.7 7.5 6.2 7.9 3.5 8.7 7.6 11.3 11.4 8.1 8.4 24.2 6.8 4.8 8.2 8.6 17.9 7.5 5.7 3.7 6.3 17.0 18.8 14.5 12.0 7.6 8.3 15.5 7.1 9.6 6.7 5.7 3.8 20.2 4.5 9.9 13.5 14.1 8.8 6.3 7.0 9.8 14.2 5.1 5.7 7.8 11.2 9.4 6.7 8.8 8.7 10.9 1.0 4.7 16.3 9.7 5.2 21.7 10.9 9.2 24.8 10.6 0.1 5.3 7.8 6.0 7.8 3.5 9.0 10.8 8.6 5.4 4.0 4.5 15.7 3.8 3.5 5.3 7.5 6.0 5.5 7.2 7.9 7.1 3.8 7.0 6.3 7.3 6.2 7.2 3.8 5.6 3.5 16.5 24.5 26.1 22.0 18.2 6.5 28.8 11.3 18.3 26.1 6.0 8.8 5.2 11.3 23.2 6.5 11.4 10.2 5.3 7.9 7.0 13.7 3.8 0.0 6.5 1.0 9.4 18.8 0.0 6.6 4.9 8.9 11.4 2.3 13.9 6.1 23.8 12.6 6.2 8.9 1.1 6.1 9.7 10.1 7.2 14.2 7.4 7.7 14.4 6.7 3.3 8.4 6.5 10.3 5.6 11.7 23.1 9.2 10.1 11.0 16.3 KIAA1755 RP5-1054A22.3 ENSG00000149633 KIAA1755 Q5JYT7 20 38210488-38260772 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.2" "Cell type enhanced" "Detected in some" 16 "Leydig cells: 3.4;Peritubular cells: 7.1;Proximal tubular cells: 2.9" "Cancer enhanced" "Detected in many" "melanoma: 5.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 40.9;ASC diff: 6.2;ASC TERT1: 9.4;WM-115: 10.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA051064 Approved Approved "Nucleoli,Golgi apparatus,Vesicles" NA NA Nucleoli "Golgi apparatus, Vesicles" "HPA051064: AB_2681331" "unprognostic (3.98e-3)" "unprognostic (2.20e-2)" "unprognostic (3.79e-1)" "unprognostic (3.01e-3)" "unprognostic (1.77e-1)" "unprognostic (7.01e-2)" "unprognostic (2.22e-1)" "unprognostic (1.11e-1)" "unprognostic (4.50e-2)" "unprognostic (2.70e-1)" "unprognostic (3.88e-2)" "unprognostic (1.69e-1)" "unprognostic (2.42e-8)" "unprognostic (1.41e-2)" "unprognostic (2.78e-2)" "unprognostic (1.25e-2)" "unprognostic (5.53e-3)" 6.1 2.5 13.6 5.8 27.3 0.7 3.8 4.8 22.1 13.2 8.1 47.2 3.1 2.7 15.5 7.2 5.6 10.0 16.9 11.5 13.9 8.4 4.6 1.7 2.7 4.9 22.7 13.7 14.7 1.5 0.3 3.1 0.4 24.5 7.3 4.7 8.8 6.1 8.2 1.3 1.6 4.5 15.8 20.4 2.8 4.1 2.9 29.2 0.0 2.6 1.6 4.9 6.8 5.4 0.3 0.5 0.9 0.4 0.4 0.7 0.0 1.5 0.2 40.9 0.0 6.2 9.4 0.0 4.0 2.3 0.0 0.0 0.2 1.2 0.0 0.2 1.2 1.3 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.4 0.0 1.2 0.6 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 1.0 0.1 0.0 0.0 0.2 0.0 0.6 0.2 0.7 0.0 0.0 0.0 0.1 0.0 10.3 0.9 0.4 0.1 0.7 0.2 0.5 0.1 0.5 0.6 0.1 0.3 0.4 0.4 0.7 0.4 0.1 0.5 0.0 0.0 13.6 27.3 4.8 15.7 13.9 8.4 22.7 13.7 24.5 29.2 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.8 0.1 0.0 0.0 0.6 0.0 1.3 3.4 0.0 1.7 0.0 0.0 0.0 0.3 0.0 7.1 2.9 0.0 0.0 0.9 0.4 0.2 0.3 0.0 0.0 0.0 0.0 KIF2A "HK2, KIF2" ENSG00000068796 "Kinesin family member 2A" O00139 5 62306162-62537249 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis" "Developmental protein, Motor protein" "Cancer-related genes, Disease mutation, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "monocytes: 152.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004715, HPA004716" Approved Enhanced Nucleoplasm,Nucleoli,Centrosome Yes No 2100000 "Nucleoplasm, Nucleoli, Centrosome" "HPA004715: AB_2667215, HPA004716: AB_1079211" "unprognostic (2.40e-2)" "unprognostic (3.43e-1)" "prognostic favorable (1.70e-4)" "unprognostic (2.74e-2)" "unprognostic (1.43e-1)" "prognostic favorable (5.45e-4)" "prognostic unfavorable (3.17e-6)" "unprognostic (8.77e-3)" "unprognostic (4.69e-2)" "unprognostic (9.10e-2)" "unprognostic (1.85e-1)" "unprognostic (1.34e-1)" "prognostic unfavorable (3.81e-5)" "unprognostic (3.53e-2)" "unprognostic (2.95e-2)" "unprognostic (1.65e-1)" "unprognostic (1.58e-1)" 11.3 9.3 25.4 21.9 26.4 12.4 15.5 15.4 40.1 19.7 13.5 19.4 8.0 10.3 12.9 7.6 14.3 17.5 13.7 7.2 26.2 24.1 8.2 5.8 10.6 29.4 24.9 24.6 13.0 12.3 15.2 14.3 27.8 37.0 10.2 14.5 6.8 10.7 11.9 7.4 7.9 15.8 13.5 34.3 17.4 9.6 39.2 26.4 28.7 13.0 5.6 26.7 17.4 14.8 9.0 8.4 7.1 3.0 15.8 25.4 9.7 17.3 17.4 29.1 25.8 11.0 15.5 23.8 18.6 15.4 20.3 25.8 18.7 19.1 43.1 20.6 16.4 24.0 11.0 22.0 14.9 27.1 43.2 15.4 43.2 16.3 10.2 13.0 23.5 16.5 12.8 9.9 19.7 17.9 11.9 18.5 24.9 30.6 26.3 16.9 13.1 39.4 11.7 16.9 4.2 11.0 29.0 23.0 23.8 9.1 21.1 26.1 21.7 25.3 10.6 13.1 22.5 13.9 13.3 16.0 12.1 20.0 14.0 18.5 24.9 35.9 45.5 14.0 28.4 14.8 7.1 3.0 3.4 20.2 2.6 22.8 9.0 20.3 20.6 4.0 7.8 17.9 18.4 5.3 15.8 1.8 8.4 25.4 9.7 25.4 26.4 15.4 31.2 26.2 24.1 24.9 24.6 37.0 26.4 14.9 13.1 22.3 22.3 14.9 41.8 7.0 7.6 71.0 25.0 19.2 98.2 16.2 11.6 30.0 88.3 17.5 11.4 0.0 27.0 18.7 10.4 29.9 16.3 3.4 13.1 49.3 20.2 14.7 10.2 90.3 12.0 18.7 11.8 152.3 5.1 22.4 23.3 7.4 12.4 13.5 88.2 25.8 13.3 80.2 42.1 8.3 36.7 39.6 9.5 40.0 KIF3B "FLA8, KIAA0359, KLP-11" ENSG00000101350 "Kinesin family member 3B" O15066 20 32277664-32335011 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 100.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007119 Approved Uncertain "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA Nucleoplasm "Nucleoli, Golgi apparatus" "HPA007119: AB_1852498" "unprognostic (1.74e-2)" "unprognostic (2.25e-1)" "unprognostic (5.14e-2)" "unprognostic (1.84e-1)" "unprognostic (2.73e-1)" "unprognostic (2.89e-1)" "unprognostic (1.49e-2)" "unprognostic (2.14e-1)" "unprognostic (9.01e-3)" "unprognostic (9.30e-2)" "unprognostic (1.41e-1)" "unprognostic (1.18e-1)" "prognostic favorable (1.44e-12)" "unprognostic (2.41e-2)" "unprognostic (2.68e-1)" "unprognostic (5.11e-2)" "unprognostic (4.42e-2)" 8.4 11.0 22.9 7.7 30.2 5.5 9.1 17.6 24.6 11.6 13.4 13.3 7.7 14.3 8.8 13.5 5.8 15.4 11.0 6.2 19.9 15.1 26.4 17.8 9.3 7.7 15.1 18.7 10.5 16.9 38.5 18.1 6.4 13.2 9.0 14.2 11.8 8.4 8.6 5.3 5.8 17.1 9.0 16.0 6.8 12.7 15.3 13.7 4.3 14.3 4.1 8.4 8.5 6.5 6.5 3.1 3.7 5.9 2.6 6.6 1.8 22.9 15.6 10.9 13.9 14.5 23.1 11.1 11.4 16.0 13.9 10.9 26.5 12.7 12.4 13.8 21.5 19.8 14.9 13.9 16.9 17.7 5.8 6.3 10.7 12.5 13.0 9.2 9.0 8.2 14.1 12.2 23.9 9.5 11.4 11.2 5.0 6.6 4.9 11.1 10.5 4.1 4.1 5.8 12.3 13.7 3.8 17.9 4.5 14.2 17.0 17.9 15.1 29.8 8.0 11.4 9.5 17.6 7.0 13.6 26.1 17.8 15.1 14.1 8.3 11.9 6.4 25.9 15.8 10.5 1.3 3.1 3.7 6.6 4.2 5.5 6.1 5.0 6.1 1.7 6.5 3.1 4.6 3.2 2.6 5.9 3.1 3.9 1.8 22.9 30.2 17.6 24.6 19.9 15.1 15.1 18.7 13.2 13.7 20.8 25.5 9.3 7.3 6.0 31.6 7.0 35.7 53.5 14.8 12.2 100.1 6.5 3.3 29.6 52.5 12.5 61.3 0.0 33.7 5.2 11.0 13.5 8.1 20.4 7.0 30.2 37.8 13.5 7.3 61.7 12.4 5.9 0.0 4.6 25.9 20.6 28.0 33.1 19.1 19.9 58.5 0.0 6.2 30.1 6.9 4.4 5.5 8.6 21.8 7.8 KNOP1 "101F10.1, C16orf88, FAM191A, TSG118" ENSG00000103550 "Lysine rich nucleolar protein 1" Q1ED39 16 19701934-19718235 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatogonia: 132.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041079, HPA066169" Uncertain Enhanced "Nucleoli,Nucleoli rim,Cytosol" NA NA "Nucleoli, Nucleoli rim" Cytosol "HPA041079: AB_10962350, HPA066169: AB_2685628" "unprognostic (6.55e-3)" "unprognostic (3.96e-1)" "unprognostic (2.16e-2)" "unprognostic (2.42e-2)" "unprognostic (8.57e-3)" "unprognostic (2.35e-1)" "prognostic unfavorable (3.75e-6)" "unprognostic (2.50e-2)" "unprognostic (2.03e-2)" "unprognostic (1.18e-3)" "unprognostic (5.84e-2)" "unprognostic (2.14e-2)" "unprognostic (7.91e-2)" "unprognostic (3.75e-2)" "unprognostic (3.62e-1)" "unprognostic (1.34e-3)" "unprognostic (1.08e-1)" 6.9 7.1 13.9 7.6 34.7 3.9 13.8 11.1 23.7 7.1 9.5 20.9 8.5 8.2 8.5 10.9 10.1 8.1 7.3 6.9 17.0 10.5 6.2 7.6 5.5 9.4 33.1 9.1 12.8 19.6 17.2 6.4 10.3 18.1 8.1 11.1 4.9 13.9 9.8 15.2 15.0 8.2 5.8 21.2 6.4 9.3 10.0 33.2 4.9 7.3 5.8 7.5 8.4 7.7 7.0 5.2 1.6 8.0 4.5 12.8 4.4 12.4 19.2 21.4 16.2 5.3 5.0 11.0 7.7 4.2 7.4 7.5 13.5 10.9 14.9 31.7 4.7 6.5 11.6 16.6 10.6 7.2 10.0 11.6 8.8 10.9 17.7 9.7 13.7 6.9 3.2 15.2 9.7 8.0 6.5 7.8 10.6 26.9 6.7 6.9 16.3 12.1 11.4 41.7 12.4 7.7 26.1 11.5 17.3 7.8 11.9 19.3 16.3 9.6 12.4 12.6 12.8 14.5 9.3 9.0 11.7 12.0 7.1 10.2 9.9 20.5 18.7 6.3 10.5 11.3 0.4 3.5 1.6 4.8 8.0 7.2 6.6 6.9 4.8 4.2 7.0 12.8 7.2 1.0 4.5 7.0 5.2 4.4 4.4 13.9 34.7 11.1 23.7 17.0 10.5 33.1 9.1 18.1 33.2 6.0 16.2 27.4 24.0 10.9 38.4 6.5 40.8 17.4 12.5 36.6 82.5 46.7 39.7 78.4 1.8 39.8 26.2 0.0 57.5 34.0 26.3 21.6 5.8 47.9 31.3 33.4 14.5 23.4 23.1 5.2 56.1 24.0 11.8 27.1 35.8 17.1 64.2 10.5 50.5 25.8 56.7 45.3 37.1 37.0 132.6 14.1 20.6 20.0 51.0 21.1 KYAT3 "CCBL2, KAT3, KATIII, RBM1, RP11-82K18.3" ENSG00000137944 "Kynurenine aminotransferase 3" Q6YP21 1 88935773-88992953 "Enzymes, Predicted intracellular proteins" "Aminotransferase, Lyase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cytotrophoblasts: 59.0;monocytes: 55.9;Syncytiotrophoblasts: 69.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026538, HPA027168" Enhanced Approved "Nucleoli,Cytokinetic bridge,Cytosol" NA NA Cytosol "Nucleoli, Cytokinetic bridge" "HPA026538: AB_1852076, HPA027168: AB_1852078" "prognostic favorable (3.19e-5)" "unprognostic (3.36e-3)" "unprognostic (1.88e-2)" "unprognostic (1.62e-1)" "unprognostic (2.01e-2)" "prognostic favorable (1.86e-4)" "unprognostic (2.61e-1)" "unprognostic (3.61e-3)" "unprognostic (2.11e-1)" "prognostic favorable (2.80e-4)" "unprognostic (1.04e-1)" "unprognostic (3.17e-1)" "prognostic favorable (5.02e-6)" "unprognostic (1.17e-1)" "unprognostic (1.06e-1)" "unprognostic (2.51e-1)" "unprognostic (2.78e-1)" 22.2 26.8 16.6 13.2 19.3 10.6 27.5 14.9 23.5 23.7 17.5 20.0 13.0 19.4 24.1 21.2 27.2 18.9 17.8 13.2 18.6 14.2 27.3 23.8 17.1 17.6 16.9 22.2 27.4 28.6 27.0 19.5 21.9 23.4 19.0 19.6 19.5 21.0 20.7 10.4 22.0 17.2 22.1 14.8 20.7 23.5 15.6 17.2 15.5 24.5 13.4 20.2 25.2 17.7 9.6 17.0 9.2 12.7 11.5 16.7 8.2 20.8 4.4 21.4 7.1 7.7 21.5 18.6 12.8 24.2 16.5 21.5 6.4 7.3 13.8 9.8 9.5 11.0 5.9 6.0 9.9 25.2 8.1 8.6 12.3 4.2 10.5 25.1 17.2 3.4 18.1 10.0 11.3 20.4 10.5 15.9 16.2 15.9 7.3 15.5 6.9 18.4 8.4 12.7 16.1 3.8 18.8 15.0 7.3 34.6 21.3 15.6 19.1 17.0 22.8 11.1 14.3 12.6 4.2 10.6 6.9 4.6 22.1 9.3 9.9 4.9 9.2 3.4 7.7 5.9 5.6 12.7 7.1 9.1 7.9 12.6 9.6 11.8 10.5 17.0 9.3 12.4 10.4 9.2 11.5 10.2 6.3 16.7 8.2 16.6 19.3 14.9 23.5 18.6 14.2 16.9 22.2 23.4 17.2 11.9 8.3 0.0 0.0 0.0 0.0 0.0 0.0 6.7 14.8 12.2 0.0 59.0 21.6 29.8 0.0 0.0 0.0 0.0 33.6 33.1 0.0 0.0 4.7 0.0 21.4 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 55.9 0.0 0.0 21.3 0.0 0.0 26.9 0.0 0.0 0.0 0.0 0.0 0.0 69.8 0.0 0.0 0.0 L3MBTL3 KIAA1798 ENSG00000198945 "L3MBTL3, histone methyl-lysine binding protein" Q96JM7 6 130013699-130141451 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "granulocytes: 38.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 31.5;HUVEC TERT2: 30.6;TIME: 20.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044382, HPA053035" Approved Supported "Nucleoplasm,Nucleoli,Nucleoli rim" Yes No "Nucleoli, Nucleoli rim" Nucleoplasm "HPA044382: AB_2678920, HPA053035: AB_2682021" "unprognostic (2.33e-1)" "unprognostic (9.92e-2)" "unprognostic (1.40e-1)" "unprognostic (7.82e-2)" "unprognostic (4.22e-3)" "unprognostic (1.28e-2)" "unprognostic (4.51e-2)" "unprognostic (1.48e-2)" "unprognostic (2.90e-1)" "unprognostic (2.63e-1)" "unprognostic (7.56e-3)" "unprognostic (1.07e-1)" "unprognostic (8.44e-2)" "unprognostic (3.94e-3)" "unprognostic (2.88e-1)" "unprognostic (2.45e-2)" "unprognostic (1.60e-2)" 8.8 16.7 5.2 16.4 8.2 7.5 7.5 2.4 7.7 17.1 5.6 3.6 9.3 3.1 17.5 14.1 5.7 7.4 6.0 4.1 5.4 5.8 6.1 6.4 7.4 11.4 5.2 5.9 12.1 3.8 8.1 17.0 6.5 5.7 10.3 5.7 4.8 5.8 7.5 5.3 4.3 7.6 9.9 5.4 18.5 4.6 7.5 3.9 25.5 10.2 4.3 12.8 10.4 11.6 10.7 10.8 3.9 14.1 1.7 4.2 0.6 0.8 3.2 7.4 1.1 5.1 6.9 1.5 3.7 7.7 1.5 2.7 3.8 4.0 1.3 5.4 4.8 4.6 3.2 4.2 6.6 2.3 2.9 4.3 8.6 1.6 1.0 2.6 5.1 31.5 4.3 4.8 1.7 5.1 7.6 30.6 4.1 6.2 3.5 3.8 0.3 10.8 0.9 3.5 0.7 1.6 4.0 2.1 0.0 4.9 1.2 0.2 1.0 1.4 0.3 3.0 9.5 7.8 4.5 20.9 2.5 3.5 0.4 2.4 0.6 0.0 2.3 1.2 2.1 2.5 3.9 3.5 3.5 2.7 4.0 2.7 7.6 2.7 3.8 1.3 10.7 2.4 3.0 3.7 1.7 14.1 10.8 4.2 0.6 5.2 8.2 2.4 7.7 5.4 5.8 5.2 5.9 5.7 3.9 3.0 9.2 7.5 4.8 4.5 2.9 2.9 2.5 5.3 3.4 8.7 2.0 10.2 1.7 4.3 18.5 5.6 0.7 0.0 4.9 6.0 6.7 4.2 38.3 4.9 3.3 0.0 3.5 7.4 8.2 1.6 8.9 3.6 1.7 4.6 7.2 5.6 7.5 3.5 5.6 4.3 0.7 6.5 5.1 5.4 6.1 3.9 5.1 10.0 4.1 5.2 LDB2 "CLIM1, LDB1" ENSG00000169744 "LIM domain binding 2" O43679 4 16501541-16898809 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 21 "Endothelial cells: 120.7;Ito cells: 249.8" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 5 "amygdala: 14.5;basal ganglia: 30.3;cerebral cortex: 45.3;hippocampal formation: 16.6;olfactory region: 21.7" "Cell type enriched" "Detected in single" 13 "NK-cell: 5.1" "Lineage enriched" "Detected in single" 13 "NK-cells: 5.1" "Cell line enhanced" "Detected in some" "AF22: 9.7;ASC TERT1: 9.3;fHDF/TERT166: 9.8;HAP1: 18.0;HUVEC TERT2: 34.0;U-138 MG: 13.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB017544, HPA068634" Supported Supported "Nucleoplasm,Nucleoli,Plasma membrane" No NA "Nucleoplasm, Nucleoli" "Plasma membrane" "CAB017544: AB_2137013, HPA068634: AB_2686012" "unprognostic (3.43e-1)" "unprognostic (2.77e-1)" "unprognostic (9.10e-2)" "unprognostic (4.37e-1)" "unprognostic (7.25e-2)" "unprognostic (4.62e-3)" "unprognostic (2.10e-3)" "unprognostic (1.57e-1)" "unprognostic (2.94e-2)" "unprognostic (2.82e-1)" "unprognostic (2.67e-2)" "unprognostic (1.96e-2)" "unprognostic (2.05e-3)" "unprognostic (1.26e-3)" "unprognostic (1.60e-1)" "unprognostic (9.63e-2)" "unprognostic (7.10e-3)" 27.9 9.5 14.5 4.6 30.3 0.4 26.8 1.1 45.3 27.1 6.8 2.7 8.0 4.0 54.9 14.4 9.5 15.6 18.3 18.5 16.6 4.8 14.9 15.0 31.3 6.9 5.5 21.7 11.9 4.6 15.2 5.6 33.7 3.4 10.4 5.4 15.4 6.1 8.6 7.5 5.4 6.8 32.8 4.2 32.9 6.7 6.4 3.4 0.7 17.8 7.5 3.0 14.7 13.3 0.2 0.0 0.3 0.0 5.1 0.0 0.6 0.0 0.0 9.7 0.0 5.6 9.3 0.0 5.3 4.1 0.6 1.5 0.0 0.0 0.0 0.0 9.8 0.0 0.0 18.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 5.2 0.0 6.7 0.0 1.4 34.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 4.5 0.0 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.0 2.8 0.0 0.0 8.9 13.7 0.0 0.7 0.0 4.4 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 5.1 0.0 0.0 0.0 0.6 14.5 30.3 1.1 45.3 16.6 4.8 5.5 21.7 3.4 3.4 0.0 8.5 1.9 0.2 7.7 21.5 9.2 5.1 1.4 0.0 0.0 0.0 0.2 0.0 1.7 1.1 120.7 0.0 0.0 0.2 0.2 22.0 0.3 5.7 1.3 0.3 0.0 0.0 249.8 20.4 1.5 35.4 2.3 8.5 0.0 0.0 9.8 0.3 0.0 47.4 0.0 1.7 6.5 13.4 0.0 0.6 5.9 0.1 5.4 0.0 0.1 LETMD1 "HCCR, HCCR-1, HCCR-2, HCCR1, HCCR2, SLC55A3" ENSG00000050426 "LETM1 domain containing 1" Q6P1Q0 12 51047962-51060424 "Predicted intracellular proteins, Predicted membrane proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074361 Supported Nucleoplasm,Nucleoli,Mitochondria NA NA Mitochondria "Nucleoplasm, Nucleoli" "HPA074361: AB_2686682" "unprognostic (2.16e-1)" "unprognostic (1.47e-1)" "unprognostic (1.08e-1)" "unprognostic (6.55e-2)" "unprognostic (1.25e-1)" "unprognostic (2.11e-1)" "unprognostic (2.20e-2)" "unprognostic (3.05e-3)" "unprognostic (1.48e-2)" "unprognostic (5.05e-2)" "unprognostic (7.86e-2)" "unprognostic (6.57e-2)" "prognostic favorable (3.26e-4)" "unprognostic (4.07e-1)" "unprognostic (7.79e-2)" "unprognostic (2.58e-1)" "prognostic favorable (3.16e-4)" 25.7 27.5 23.0 18.1 31.2 17.1 27.1 23.1 37.5 18.6 26.8 18.8 21.5 31.9 22.9 22.4 16.2 30.0 23.5 16.4 21.2 19.0 29.3 35.1 16.6 18.5 20.6 21.3 34.3 38.6 28.5 20.2 12.3 21.6 19.1 26.1 22.6 28.2 24.0 23.8 18.5 28.5 18.7 21.4 17.5 22.6 15.5 14.3 19.9 34.1 10.7 20.1 20.3 14.8 11.3 7.2 2.9 11.6 8.6 17.1 9.3 7.4 6.7 5.0 13.5 22.8 37.4 5.1 7.7 12.8 8.1 9.2 16.2 15.4 19.7 9.6 8.3 5.9 13.9 10.3 10.4 9.4 7.1 12.9 14.1 9.3 12.7 15.1 12.7 10.3 31.5 33.7 9.6 22.8 24.8 8.2 19.1 14.6 14.3 11.1 11.6 8.9 12.3 3.4 9.3 18.3 7.6 6.1 10.7 10.2 11.4 15.0 6.9 5.8 13.1 17.6 5.3 20.7 11.6 6.2 5.1 5.5 8.4 4.4 13.0 20.2 8.4 9.5 8.3 3.6 2.5 7.3 2.9 8.6 7.8 12.5 11.3 14.2 10.6 7.2 8.1 17.1 15.5 2.4 8.6 11.6 6.4 12.6 9.3 23.0 31.2 23.1 37.5 21.2 19.0 20.6 21.3 21.6 14.3 20.8 22.7 30.4 41.1 44.1 20.2 12.5 22.9 25.4 11.4 22.7 9.8 40.0 77.9 12.6 6.3 19.6 22.0 23.3 28.4 18.9 32.4 29.0 25.3 16.3 26.2 17.5 26.7 20.3 41.0 11.9 30.2 21.2 37.1 17.2 34.4 24.4 16.0 28.1 28.7 31.5 16.5 25.8 38.1 20.6 19.4 38.8 23.3 42.4 49.8 24.8 LHX8 Lhx7 ENSG00000162624 "LIM homeobox 8" Q68G74 1 75128434-75161533 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.5;lymphoid tissue: 5.3;salivary gland: 6.1;tongue: 4.9" "Cell type enhanced" "Detected in single" 26 "Spermatogonia: 2.8" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "basal ganglia: 9.5;thalamus: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "SCLC-21H: 23.8;U-266/70: 8.0" "Region enhanced" "Detected in some" "basal ganglia: 9.9" "Group enriched" "Detected in some" 32 "basal ganglia: 15.3;hypothalamus: 4.4" HPA071806 Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA071806: AB_2686449" "unprognostic (2.28e-2)" "unprognostic (6.23e-2)" "unprognostic (3.85e-3)" "unprognostic (1.52e-9)" "unprognostic (1.64e-1)" "unprognostic (2.13e-1)" "unprognostic (1.06e-2)" 0.0 0.0 0.1 0.0 9.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.8 0.0 2.1 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.6 0.1 0.0 0.3 0.0 3.9 0.0 0.2 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 3.3 0.0 0.5 4.9 5.3 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.8 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.7 0.2 0.0 0.0 8.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.5 0.0 0.5 0.0 1.1 0.0 0.6 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.8 0.0 0.0 0.0 0.0 0.0 LIN28A "CSDD1, FLJ12457, LIN-28, LIN28, ZCCHC1" ENSG00000131914 "Lin-28 homolog A" Q9H9Z2 1 26410778-26429722 "Predicted intracellular proteins" "RNA-mediated gene silencing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 9.8" "Group enriched" "Detected in some" 42 "Early spermatids: 24.2;Late spermatids: 49.8" "Cancer enriched" "Detected in single" 261 "testis cancer: 101.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 7 "NTERA-2: 136.8;SuSa: 50.5" "Not detected" "Not detected" "CAB020785, HPA063074, HPA068814" Enhanced Supported "Nucleoli,Cytosol,Rods & Rings" NA NA Cytosol "Nucleoli, Rods & Rings" "CAB020785: , HPA063074: , HPA068814: " "unprognostic (9.64e-3)" "unprognostic (1.69e-1)" "unprognostic (1.35e-1)" "unprognostic (1.40e-1)" "unprognostic (1.55e-1)" "unprognostic (1.17e-2)" "unprognostic (1.85e-1)" "unprognostic (2.21e-1)" "unprognostic (2.49e-2)" "unprognostic (1.83e-1)" "unprognostic (1.13e-1)" "unprognostic (6.82e-2)" 0.1 0.0 0.1 0.1 0.1 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.5 0.5 0.1 0.1 0.1 0.2 0.3 9.8 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.3 0.6 2.3 0.5 1.0 0.8 0.1 0.0 0.0 13.5 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 136.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.5 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.5 0.7 0.7 0.3 0.4 1.0 0.5 0.6 0.2 1.3 0.8 0.7 2.2 1.0 0.3 0.6 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 49.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.9 0.4 0.1 0.0 0.0 0.0 0.1 LIN28B "CSDD2, FLJ16517" ENSG00000187772 "Lin-28 homolog B" Q6ZN17 6 104936616-105083332 "Predicted intracellular proteins" "RNA-mediated gene silencing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "placenta: 51.9" "Cell type enhanced" "Detected in some" 13 "Cytotrophoblasts: 66.0;Extravillous trophoblasts: 67.8;Syncytiotrophoblasts: 46.7" "Cancer enriched" "Detected in single" 25 "testis cancer: 12.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 2.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 14.1;BEWO: 73.1;Hep G2: 12.2;K-562: 23.6;NTERA-2: 12.9;SuSa: 13.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA036630, HPA061745" Enhanced Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA036630: AB_10669911, HPA061745: AB_2684601" "unprognostic (2.00e-4)" "unprognostic (6.75e-2)" "unprognostic (2.02e-1)" "unprognostic (2.57e-2)" "unprognostic (1.59e-2)" "unprognostic (4.10e-2)" 0.1 0.1 1.2 0.0 0.8 0.3 0.0 0.1 1.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.3 0.0 0.1 0.1 0.1 0.5 0.8 0.0 0.0 0.0 1.0 51.9 1.2 0.0 0.0 0.4 0.1 0.0 0.1 0.2 0.1 0.0 0.2 0.1 0.1 5.8 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.7 0.7 2.1 0.4 0.2 0.5 0.3 0.0 0.9 14.1 2.8 0.0 0.0 73.1 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.8 0.0 8.8 0.0 0.0 0.0 6.8 10.1 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.6 0.3 0.0 0.0 1.5 1.7 12.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 3.3 0.0 0.0 1.1 13.5 0.0 2.9 0.3 0.0 1.5 0.0 0.0 4.3 6.0 0.0 0.0 0.0 0.0 1.6 0.4 0.2 0.5 0.4 0.3 0.5 0.3 0.1 0.2 0.7 0.1 0.2 2.1 0.2 0.4 0.7 0.2 0.3 1.2 0.8 0.1 1.3 0.9 1.3 0.5 0.8 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 5.9 66.0 0.0 0.0 15.5 0.0 0.0 0.0 0.0 67.8 0.0 0.0 0.0 0.0 8.0 1.6 0.0 0.0 0.0 17.9 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.4 6.5 0.0 5.8 9.2 0.0 46.7 0.0 0.0 0.0 LRCH1 "CHDC1, KIAA1016" ENSG00000136141 "Leucine rich repeats and calponin homology domain containing 1" Q9Y2L9 13 46553168-46753040 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 46.4" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021536 Approved Approved "Nucleoli,Actin filaments,Cytosol" NA NA "Actin filaments, Cytosol" Nucleoli "HPA021536: AB_1853258" "unprognostic (7.13e-3)" "prognostic unfavorable (6.24e-4)" "unprognostic (3.59e-2)" "unprognostic (8.93e-2)" "unprognostic (7.50e-2)" "unprognostic (1.37e-1)" "unprognostic (5.16e-2)" "prognostic unfavorable (6.67e-4)" "unprognostic (2.16e-1)" "prognostic unfavorable (5.75e-4)" "unprognostic (1.39e-2)" "unprognostic (1.17e-1)" "prognostic favorable (1.04e-4)" "unprognostic (2.87e-1)" "unprognostic (1.22e-1)" "unprognostic (3.39e-1)" "unprognostic (1.98e-2)" 17.9 5.0 6.5 20.3 5.9 7.2 15.2 46.4 7.2 17.5 14.6 4.6 11.5 7.0 24.6 9.8 10.6 11.9 14.1 8.0 6.3 5.9 13.8 10.9 14.3 13.5 6.6 4.9 9.5 5.1 5.2 13.1 24.1 8.0 12.8 9.3 8.4 11.3 14.5 5.3 18.1 12.0 20.9 8.5 13.7 14.6 5.0 6.0 31.7 7.8 6.4 13.7 16.6 18.3 6.2 2.3 1.8 2.0 5.1 3.6 1.8 4.3 6.3 5.7 5.9 4.2 8.0 14.7 7.5 9.9 9.4 8.9 14.2 7.5 14.0 2.1 7.1 6.1 6.3 4.3 7.6 13.6 14.4 4.1 12.6 2.5 6.6 5.2 8.1 21.6 5.1 6.0 8.6 10.5 7.7 8.0 9.5 2.4 4.3 6.9 8.5 8.7 10.2 3.2 27.7 3.3 4.8 6.2 3.7 17.5 4.6 9.1 9.1 4.2 4.2 11.2 10.6 3.2 11.0 7.6 5.5 3.7 6.8 7.1 0.8 2.1 6.3 6.4 7.2 6.6 1.5 2.0 1.8 3.6 1.6 2.1 5.3 2.7 2.6 1.9 6.2 2.1 2.1 0.7 5.1 1.2 2.3 1.9 1.8 6.5 5.9 46.4 7.2 6.3 5.9 6.6 4.9 8.0 6.0 6.0 6.7 15.1 9.1 33.3 8.2 6.7 25.5 1.4 6.8 21.0 21.6 11.1 8.3 7.2 1.2 25.9 6.9 0.0 3.5 10.0 10.5 7.9 27.6 7.9 11.4 3.2 1.7 16.5 16.7 1.1 12.0 9.9 28.7 5.4 9.7 6.4 9.5 5.8 15.9 7.3 8.9 12.9 21.7 0.7 3.2 29.1 8.1 10.2 6.5 7.8 LRP4 "CLSS, LRP-4, MEGF7, SOST2" ENSG00000134569 "LDL receptor related protein 4" O75096 11 46856868-46918642 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Endocytosis, Wnt signaling pathway" "Developmental protein, Receptor" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.7;skin 1: 33.0" "Cell type enriched" "Detected in many" 4 "Cone photoreceptor cells: 39.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 17.0;SuSa: 13.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA011934, HPA012300" Approved Uncertain Nucleoplasm,Nucleoli,Mitochondria NA NA "Nucleoplasm, Nucleoli, Mitochondria" "HPA011934: AB_1853286, HPA012300: AB_1853288" "unprognostic (1.46e-1)" "unprognostic (4.07e-2)" "unprognostic (2.86e-1)" "unprognostic (1.33e-2)" "unprognostic (4.39e-2)" "unprognostic (9.73e-3)" "unprognostic (5.29e-4)" "unprognostic (8.61e-2)" "unprognostic (2.29e-2)" "unprognostic (2.77e-1)" "unprognostic (1.92e-1)" "unprognostic (1.33e-1)" "unprognostic (7.59e-2)" "unprognostic (7.95e-2)" "unprognostic (2.76e-2)" "unprognostic (9.90e-3)" "unprognostic (6.79e-2)" 1.2 1.9 16.0 1.3 20.3 0.5 2.1 7.3 23.7 3.0 5.4 11.6 0.6 3.9 2.1 1.3 2.4 2.0 2.5 7.2 20.4 5.8 1.2 0.7 3.4 0.5 9.6 12.6 5.4 2.7 9.3 3.3 3.1 14.5 2.7 4.1 1.3 2.1 3.0 4.4 33.0 5.3 2.0 9.7 4.2 9.6 1.6 19.0 0.0 2.9 1.0 0.8 1.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.5 17.0 5.2 10.6 2.9 3.9 0.7 1.5 2.3 2.5 2.2 0.0 0.0 1.1 8.7 2.4 3.0 9.5 5.8 1.8 0.0 7.9 0.8 3.0 5.2 2.2 0.1 1.5 3.6 3.4 3.5 0.9 2.0 1.9 2.1 0.7 0.0 1.3 0.6 0.1 0.2 9.2 0.0 0.7 1.2 5.8 0.0 0.2 2.2 0.0 11.2 0.9 0.0 2.8 13.6 0.2 0.4 0.1 4.6 2.9 5.2 1.6 0.0 0.0 0.3 3.4 0.6 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 20.3 7.3 17.3 20.4 5.8 9.6 12.6 14.5 19.0 0.0 3.4 0.0 2.5 7.2 0.4 4.8 0.0 0.0 2.3 1.8 39.3 1.8 1.7 0.0 0.4 0.7 6.3 0.0 0.3 0.4 4.3 0.3 4.7 0.0 0.2 0.0 0.0 1.3 0.0 0.0 1.7 0.0 1.7 1.0 2.2 8.7 0.5 2.3 1.1 0.2 2.6 0.0 1.2 0.1 0.7 9.5 1.1 0.0 1.8 0.7 LRRC75A "C17orf76, FAM211A, FLJ35696" ENSG00000181350 "Leucine rich repeat containing 75A" Q8NAA5 17 16441577-16492153 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 42.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 12.0;HUVEC TERT2: 3.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028528, HPA065840" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA028528: AB_10600755, HPA065840: " "unprognostic (1.09e-1)" "unprognostic (5.60e-2)" "unprognostic (5.79e-2)" "unprognostic (3.85e-5)" "unprognostic (3.93e-2)" "unprognostic (3.23e-2)" "unprognostic (3.44e-1)" "unprognostic (7.66e-3)" "unprognostic (7.74e-2)" "unprognostic (2.84e-1)" "prognostic favorable (7.46e-5)" "unprognostic (8.36e-2)" "unprognostic (4.28e-3)" "unprognostic (8.84e-2)" "unprognostic (1.82e-1)" "unprognostic (1.17e-3)" "unprognostic (2.06e-1)" 1.0 8.9 5.2 2.8 3.7 1.7 0.6 0.7 6.3 2.2 26.3 1.5 1.4 15.0 1.9 0.5 0.4 0.9 0.5 0.4 4.1 2.4 0.8 0.2 1.6 1.9 1.6 3.2 1.8 1.6 3.7 4.1 1.5 2.1 1.1 10.4 1.9 0.3 1.7 0.4 0.4 42.3 3.0 0.8 6.4 1.3 8.5 0.4 0.5 1.2 0.0 1.9 1.3 0.7 0.8 0.0 0.3 0.6 0.3 0.6 0.2 1.2 1.0 1.2 0.8 0.3 0.5 0.1 0.3 0.8 2.8 2.3 1.1 0.3 0.0 0.8 0.1 0.5 0.4 0.3 0.2 0.1 0.4 0.9 12.0 0.6 0.0 0.4 0.2 0.9 0.0 0.0 0.6 0.0 0.4 3.9 1.3 0.5 0.2 0.0 2.0 1.9 0.8 0.2 2.8 0.1 0.7 0.7 0.1 0.6 0.2 2.3 0.6 0.0 0.2 2.8 0.5 0.2 0.1 0.0 0.3 1.4 0.9 1.5 1.5 0.3 0.2 0.1 0.7 1.0 0.0 0.3 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.6 0.3 0.3 0.6 0.0 0.0 0.2 5.2 3.7 0.7 6.3 4.1 2.4 1.6 3.2 2.1 0.4 38.7 51.3 11.9 7.2 0.0 8.7 0.3 7.6 16.0 36.4 1.8 5.9 13.7 16.6 3.8 5.3 6.0 49.1 23.3 6.1 16.9 3.9 6.4 27.8 8.1 10.5 3.2 23.7 9.2 10.7 5.9 15.3 6.7 0.0 1.8 44.8 16.7 5.7 23.0 10.6 15.2 16.4 12.9 2.3 3.8 6.7 0.0 14.0 8.9 47.2 6.2 LRRN4 "C20orf75, dJ1056H1.1, NLRR4" ENSG00000125872 "Leucine rich repeat neuronal 4" Q8WUT4 20 6040778-6054049 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adipose tissue: 9.5;kidney: 13.0;lung: 36.4" "Cell type enhanced" "Detected in some" 20 "Alveolar cells type 1: 8.9;Alveolar cells type 2: 3.8;Ductal cells: 3.6;Proximal tubular cells: 2.2" "Group enriched" "Detected in many" 7 "lung cancer: 4.6;ovarian cancer: 3.6;renal cancer: 11.7" "Region enriched" "Detected in single" 5 "basal ganglia: 1.1" "Cell type enhanced" "Detected in single" "gdT-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 11 "RPTEC TERT1: 40.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA075974 Uncertain "Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No 32000 "Nucleoli, Nucleoli rim, Mitotic chromosome" "HPA075974: AB_2686770" "unprognostic (6.16e-2)" "unprognostic (1.69e-3)" "unprognostic (2.40e-3)" "unprognostic (9.04e-3)" "unprognostic (5.95e-2)" "unprognostic (1.32e-2)" "unprognostic (2.59e-1)" "unprognostic (8.94e-2)" "unprognostic (2.73e-1)" "unprognostic (2.44e-2)" "unprognostic (2.79e-2)" "unprognostic (4.83e-3)" "unprognostic (1.15e-3)" "unprognostic (2.33e-2)" "unprognostic (6.88e-2)" "unprognostic (2.31e-1)" "unprognostic (9.84e-3)" 9.5 0.1 0.0 2.4 1.1 0.1 0.1 0.0 0.2 0.7 2.2 0.0 0.0 0.1 0.1 2.8 0.1 1.5 0.1 1.1 0.0 0.2 13.0 0.4 36.4 0.1 0.0 0.0 1.6 2.6 0.1 0.0 3.4 0.0 0.1 0.1 0.0 0.1 0.5 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.8 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.4 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.0 0.7 0.0 1.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 40.4 0.0 0.2 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.1 0.8 0.4 0.2 0.9 0.0 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 8.9 3.8 0.0 0.0 0.0 0.0 0.4 0.0 1.4 0.0 1.8 0.0 0.1 0.0 3.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 LYAR "ZC2HC2, ZLYAR" ENSG00000145220 "Ly1 antibody reactive" Q9NX58 4 4267701-4290169 "Predicted intracellular proteins, Transcription factors" "Immunity, Innate immunity, rRNA processing, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 60.2" "Cell type enhanced" "Detected in many" 12 "Spermatocytes: 435.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035880, HPA035881" Enhanced Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" Nucleoplasm "HPA035880: , HPA035881: AB_10669980" "unprognostic (2.81e-1)" "unprognostic (3.79e-1)" "unprognostic (2.64e-2)" "unprognostic (6.22e-3)" "unprognostic (1.44e-1)" "unprognostic (2.97e-2)" "prognostic unfavorable (3.20e-5)" "unprognostic (1.08e-3)" "unprognostic (2.92e-2)" "prognostic favorable (8.82e-4)" "unprognostic (5.05e-2)" "unprognostic (1.59e-2)" "prognostic unfavorable (4.36e-10)" "unprognostic (4.94e-2)" "unprognostic (1.61e-1)" "unprognostic (5.90e-2)" "unprognostic (2.72e-1)" 11.1 5.7 6.8 11.9 10.1 10.9 8.2 7.3 8.0 6.6 6.9 4.3 4.1 5.7 6.9 5.5 11.2 7.1 5.4 10.1 7.0 4.6 5.0 9.9 7.7 13.8 10.9 4.5 11.1 6.3 4.4 15.6 7.1 8.4 7.8 6.8 3.7 5.4 6.4 15.1 5.9 6.2 9.1 7.9 18.2 5.8 60.2 12.0 10.0 6.3 11.9 10.9 10.1 10.4 7.3 7.1 8.9 12.9 10.7 32.8 10.3 13.3 7.0 6.3 9.2 5.5 6.3 10.8 12.2 4.2 12.7 8.8 22.0 17.6 35.9 8.8 5.2 20.5 8.5 23.5 12.7 16.7 6.4 17.3 36.0 6.7 24.6 9.4 41.5 9.8 4.9 8.1 14.6 24.9 3.3 10.9 20.5 48.1 12.0 8.8 13.5 14.1 53.5 31.3 14.2 23.0 21.7 11.5 17.3 5.7 9.3 15.0 6.4 6.6 7.3 12.4 8.4 7.5 12.4 10.2 12.7 10.1 16.5 38.4 8.5 12.8 57.4 8.6 35.1 10.2 8.9 9.7 8.5 28.6 9.6 32.8 7.3 18.9 30.8 7.1 5.7 8.9 19.0 2.8 10.7 12.9 5.3 8.8 10.3 6.8 10.1 7.3 8.0 7.0 4.6 10.9 4.5 8.4 12.0 14.9 30.0 19.7 34.4 106.7 9.4 21.6 12.7 26.8 36.4 1.8 7.9 43.0 8.3 15.1 74.2 29.5 2.8 0.0 17.0 43.6 29.4 25.4 20.8 10.6 32.5 14.3 10.3 8.6 30.8 61.9 31.7 32.1 20.3 19.0 16.0 9.6 22.6 13.9 25.1 5.1 28.7 38.8 35.0 435.9 39.2 101.3 16.9 130.7 24.0 62.3 MAD2L1BP "CMT2, dJ261G23.1, KIAA0110" ENSG00000124688 "MAD2L1 binding protein" Q15013 6 43629540-43640952 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 66.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028729 Supported "Nucleoplasm,Nuclear membrane,Nucleoli" Yes No Nucleoplasm "Nuclear membrane, Nucleoli" "HPA028729: AB_2672752" "unprognostic (2.60e-1)" "unprognostic (2.06e-1)" "unprognostic (3.92e-2)" "unprognostic (6.97e-2)" "unprognostic (6.91e-2)" "unprognostic (6.92e-2)" "unprognostic (5.74e-3)" "unprognostic (2.67e-3)" "unprognostic (3.60e-1)" "unprognostic (7.18e-2)" "unprognostic (1.71e-1)" "unprognostic (6.64e-2)" "unprognostic (4.61e-2)" "unprognostic (1.18e-1)" "unprognostic (3.34e-1)" "unprognostic (1.16e-1)" "unprognostic (3.25e-3)" 12.1 16.6 11.0 13.3 14.4 35.7 13.8 16.5 24.4 12.2 21.3 10.1 6.3 18.1 12.9 14.1 17.0 13.4 13.2 19.2 11.9 12.1 18.3 18.9 11.4 18.2 11.0 12.6 11.3 18.5 11.5 12.8 12.6 14.0 12.6 22.0 13.6 24.2 11.3 25.1 11.9 22.0 12.4 9.8 17.5 16.8 17.6 7.9 29.0 18.9 13.9 19.9 14.3 13.2 27.9 27.6 39.7 22.2 26.8 39.8 21.4 15.9 7.4 11.7 13.0 10.2 11.1 7.1 9.6 15.6 21.4 20.1 15.1 6.5 12.5 5.5 11.3 19.5 10.5 18.2 13.4 16.5 11.4 14.1 15.4 8.2 13.0 11.0 9.0 9.3 11.2 16.5 15.9 9.7 10.8 16.0 10.1 19.7 6.7 14.8 15.0 8.0 16.8 7.2 66.4 9.6 9.3 9.1 11.8 15.2 12.8 14.0 14.2 6.9 10.7 45.4 9.3 12.5 24.2 8.7 11.5 9.6 7.5 15.3 8.7 7.4 29.3 10.4 15.3 12.6 39.7 22.2 25.0 25.7 22.1 25.8 27.9 30.8 28.4 27.6 25.6 32.3 29.0 18.6 26.8 19.9 18.3 39.8 21.4 11.0 14.4 16.5 24.4 11.9 12.1 11.0 12.6 14.0 7.9 23.8 10.1 16.1 16.9 12.8 12.1 10.4 10.2 21.4 21.6 3.5 11.8 18.1 23.2 24.8 36.4 11.3 26.9 23.3 18.5 17.9 15.3 9.1 30.1 11.3 15.5 9.5 16.7 14.7 10.8 27.8 11.2 13.0 27.0 20.8 15.1 12.4 20.4 25.9 11.3 16.5 12.0 25.8 12.2 18.4 18.8 8.4 5.1 15.4 19.2 21.6 MAF1 DKFZp586G1123 ENSG00000179632 "MAF1 homolog, negative regulator of RNA polymerase III" Q9H063 8 144104499-144107611 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024821, HPA058548" Uncertain Supported Nucleoplasm,Nucleoli,Vesicles NA NA Nucleoplasm "Nucleoli, Vesicles" "HPA024821: AB_2671696, HPA058548: AB_2683751" "unprognostic (2.26e-1)" "unprognostic (3.05e-1)" "unprognostic (2.71e-2)" "unprognostic (2.21e-1)" "unprognostic (8.51e-2)" "unprognostic (9.67e-2)" "prognostic unfavorable (7.09e-4)" "unprognostic (6.12e-2)" "unprognostic (4.92e-2)" "unprognostic (5.90e-3)" "unprognostic (9.42e-2)" "unprognostic (6.48e-2)" "unprognostic (9.40e-3)" "unprognostic (9.02e-2)" "unprognostic (2.59e-1)" "unprognostic (2.38e-1)" "unprognostic (3.99e-2)" 26.8 23.2 17.5 18.4 17.5 43.6 35.7 20.5 26.3 27.3 47.2 23.7 22.8 19.5 33.0 22.5 34.4 26.1 33.6 72.5 17.3 15.5 24.1 21.4 21.2 28.2 19.7 18.6 36.3 39.8 25.2 20.8 23.8 14.9 36.8 18.9 23.8 28.7 32.3 114.3 18.7 29.8 50.9 17.2 27.7 28.9 30.2 16.2 35.5 40.4 38.7 22.8 35.2 46.7 48.0 39.9 45.1 34.5 33.2 46.2 32.6 24.2 39.1 18.1 18.1 49.6 24.8 14.7 19.1 31.6 29.9 30.6 14.3 27.1 27.0 32.6 31.9 16.6 15.0 24.6 27.0 22.1 23.8 29.8 29.5 26.9 22.3 33.5 12.5 20.3 21.8 31.7 23.9 45.3 33.5 32.2 19.8 22.7 18.4 17.8 57.9 46.6 23.0 13.6 44.2 105.0 18.7 25.4 28.7 18.7 18.3 26.5 22.1 25.4 33.1 30.9 17.7 22.5 19.2 19.3 14.0 31.9 24.6 24.0 22.3 16.9 12.6 23.2 23.4 9.2 15.8 34.5 45.1 28.5 26.8 32.3 40.1 41.0 46.2 39.9 48.0 44.2 41.4 19.9 33.2 27.0 29.8 29.2 32.6 17.5 17.5 20.5 26.3 17.3 15.5 19.7 18.6 14.9 16.2 14.9 17.0 89.7 75.9 82.5 41.2 46.4 7.6 4.0 3.4 41.8 13.7 87.2 89.5 88.1 49.3 67.4 88.9 70.0 94.2 87.3 63.4 114.9 33.3 25.2 87.3 35.0 89.6 44.8 58.6 27.8 81.7 78.7 74.2 166.9 77.1 55.4 88.3 79.3 87.7 90.2 29.0 97.0 72.8 85.0 43.7 78.4 120.7 94.5 78.4 80.6 MAGED2 "11B6, BCG1, HCA10, JCL-1, MAGE-D2, MAGED, MGC8386" ENSG00000102316 "MAGE family member D2" Q9UNF1 X 54807599-54816012 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Tumor antigen" "Bartter syndrome, Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Peritubular cells: 301.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031572, HPA031573" Approved Enhanced Nucleoplasm,Nucleoli,Cytosol No No "Nucleoplasm, Nucleoli, Cytosol" "HPA031572: AB_10599819, HPA031573: AB_10602181" "unprognostic (1.33e-1)" "unprognostic (8.60e-2)" "unprognostic (3.32e-1)" "unprognostic (1.69e-3)" "unprognostic (4.79e-2)" "unprognostic (3.52e-1)" "unprognostic (2.41e-3)" "unprognostic (1.39e-1)" "unprognostic (2.97e-1)" "prognostic favorable (2.88e-4)" "prognostic favorable (2.82e-4)" "unprognostic (6.34e-2)" "unprognostic (3.55e-3)" "prognostic unfavorable (9.43e-4)" "unprognostic (1.58e-1)" "unprognostic (9.77e-2)" "unprognostic (3.58e-1)" 22.1 38.4 26.9 14.8 26.5 8.2 50.2 24.4 43.0 55.7 27.3 27.8 21.4 16.2 41.1 31.8 21.9 45.9 28.5 40.7 23.8 38.2 42.7 17.3 24.0 13.5 30.3 36.0 79.7 23.5 34.5 57.6 58.6 57.1 63.9 16.4 43.1 32.0 53.7 25.6 16.5 17.6 41.6 24.7 17.5 22.5 21.8 18.3 23.4 45.1 17.3 22.0 31.9 29.2 17.1 11.7 43.1 37.0 28.5 35.5 32.5 5.4 10.0 60.2 18.3 28.7 39.1 11.1 22.5 40.2 17.9 31.8 10.0 13.9 7.6 59.1 45.3 14.7 7.4 17.1 17.0 12.9 13.5 14.2 15.7 11.9 19.5 24.6 4.0 12.1 51.1 7.1 18.1 9.2 36.9 33.9 8.9 3.8 9.3 34.1 15.0 8.9 6.7 22.2 9.5 12.0 5.9 21.6 10.8 24.5 4.1 9.5 24.5 8.9 10.4 52.0 73.5 42.9 6.8 29.2 15.3 23.8 22.7 6.3 6.0 5.0 5.4 22.3 10.6 77.7 43.1 9.1 35.5 35.5 22.4 27.3 16.3 29.4 33.1 11.7 17.1 29.7 34.1 3.4 28.5 37.0 7.2 29.2 32.5 26.9 26.5 24.4 43.0 23.8 38.2 30.3 36.0 57.1 18.3 41.7 33.9 29.8 80.0 37.7 72.3 51.6 53.5 66.9 30.7 73.3 27.5 185.2 208.9 88.2 2.4 76.6 14.7 0.0 47.8 117.1 94.0 95.1 100.4 13.2 60.7 130.3 56.0 66.9 12.9 8.5 216.0 36.3 150.1 64.9 42.6 178.6 48.5 32.3 301.2 111.7 49.9 155.2 150.8 13.5 12.4 30.6 141.5 45.4 24.9 55.9 MAPKBP1 KIAA0596 ENSG00000137802 "Mitogen-activated protein kinase binding protein 1" O60336 15 41774434-41827855 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Nephronophthisis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 48.1" "Cell type enhanced" "Detected in many" 18 "Basal keratinocytes: 48.5;Cone photoreceptor cells: 192.4;Suprabasal keratinocytes: 46.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030832, HPA030833" Approved Supported "Nucleoplasm,Nucleoli,Nucleoli rim" No No "Nucleoli, Nucleoli rim" Nucleoplasm "HPA030832: AB_10601869, HPA030833: AB_2673628" "unprognostic (2.53e-1)" "unprognostic (9.18e-2)" "unprognostic (6.56e-2)" "prognostic favorable (1.47e-4)" "unprognostic (1.16e-1)" "unprognostic (2.22e-1)" "unprognostic (9.84e-3)" "unprognostic (1.32e-1)" "unprognostic (1.52e-1)" "prognostic unfavorable (6.80e-4)" "unprognostic (1.08e-3)" "unprognostic (6.03e-3)" "unprognostic (7.94e-2)" "unprognostic (1.68e-1)" "unprognostic (8.98e-2)" "unprognostic (1.72e-1)" "unprognostic (2.28e-2)" 4.7 6.0 10.6 5.0 13.8 4.4 5.7 48.1 13.9 6.1 5.7 8.8 4.4 10.6 9.3 5.4 12.5 8.0 5.3 4.2 8.6 6.7 3.9 2.3 4.7 4.0 8.6 9.2 15.4 4.3 5.8 9.5 6.1 9.3 5.9 4.3 7.0 5.1 7.1 4.9 26.3 10.5 10.2 6.8 5.7 5.4 19.5 10.7 4.4 8.7 5.2 7.4 8.4 6.6 1.9 1.9 4.3 2.1 2.2 3.3 1.6 4.9 2.6 7.1 6.7 7.9 7.8 4.8 7.1 17.7 6.4 4.7 5.2 1.8 1.2 5.8 5.7 8.9 12.0 6.8 19.7 4.6 4.5 2.0 5.0 8.1 1.7 3.4 3.2 10.3 4.0 15.8 10.2 18.5 10.6 9.4 8.3 3.1 2.3 9.0 1.0 2.6 2.8 0.8 2.9 5.4 2.9 5.1 0.5 3.7 5.6 8.0 4.6 4.1 4.1 3.1 7.6 4.9 2.5 7.4 9.2 4.5 8.9 6.9 5.2 8.5 2.9 6.2 4.3 7.7 4.3 1.3 1.1 3.3 0.7 2.4 1.9 1.9 1.4 1.9 1.8 2.4 2.0 0.7 2.2 2.1 0.7 0.8 1.6 10.6 13.8 48.1 13.9 8.6 6.7 8.6 9.2 9.3 10.7 6.0 13.0 2.2 7.6 48.5 11.4 2.8 2.5 10.7 9.1 3.5 192.4 5.0 0.0 2.7 11.7 7.0 4.0 0.0 3.0 3.5 5.5 3.6 1.1 1.8 3.3 14.3 4.6 4.9 2.1 19.1 6.6 4.6 8.5 4.6 1.4 6.1 3.3 1.5 7.4 0.3 8.2 12.9 3.9 8.1 4.1 46.9 4.5 4.4 2.0 12.1 MBIP ENSG00000151332 "MAP3K12 binding inhibitory protein 1" Q9NS73 14 36298558-36320676 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 61.2" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 202.5;Alveolar cells type 2: 218.5;Club cells: 169.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003388 Supported Supported Nucleoplasm,Nucleoli,Cytosol NA NA Cytosol "Nucleoplasm, Nucleoli" "HPA003388: AB_1079322" "unprognostic (8.79e-2)" "unprognostic (9.92e-2)" "unprognostic (5.07e-2)" "unprognostic (8.66e-2)" "unprognostic (9.85e-2)" "unprognostic (4.71e-2)" "unprognostic (2.71e-1)" "prognostic favorable (1.52e-4)" "unprognostic (5.24e-2)" "prognostic favorable (1.14e-4)" "unprognostic (4.65e-1)" "unprognostic (9.27e-2)" "prognostic favorable (1.25e-4)" "unprognostic (2.95e-1)" "unprognostic (1.12e-1)" "unprognostic (1.74e-3)" "unprognostic (1.09e-1)" 10.4 11.7 11.4 5.7 17.0 15.4 12.9 16.4 14.9 15.4 12.2 11.5 3.6 8.6 14.0 11.3 14.0 9.1 8.6 7.2 10.7 13.0 19.5 15.0 46.2 8.1 9.9 8.9 20.0 9.0 10.4 25.1 9.8 13.3 13.8 11.7 10.1 7.7 8.9 6.0 14.3 13.2 11.0 13.6 9.8 19.0 8.8 11.8 14.4 61.2 4.0 7.9 12.4 9.3 12.0 10.4 5.1 9.3 8.3 17.9 9.6 16.6 8.7 18.7 18.8 18.8 18.2 14.1 14.3 17.8 19.0 20.0 17.8 16.8 15.8 21.9 18.4 10.0 12.8 19.6 13.2 23.4 22.8 14.7 9.2 8.7 30.3 20.5 18.8 10.3 18.6 20.4 12.4 16.1 19.7 11.8 22.2 15.8 19.8 14.0 16.0 18.0 15.3 15.8 14.3 26.0 8.7 16.3 11.0 21.4 12.9 28.0 11.1 11.8 11.4 18.9 16.7 18.6 12.3 9.2 21.2 13.8 15.5 14.7 16.4 18.9 24.8 8.1 9.7 14.6 1.4 9.3 2.0 11.2 6.8 14.1 12.0 13.7 13.8 9.2 8.7 17.9 14.5 5.1 8.3 5.3 10.4 16.1 9.6 11.4 17.0 16.4 14.9 10.7 13.0 9.9 8.9 13.3 11.8 202.5 218.5 10.4 31.7 80.1 24.3 9.4 2.5 50.9 169.5 24.4 2.0 20.7 49.7 17.7 2.7 17.7 14.6 0.0 16.6 17.7 24.9 20.7 12.7 21.2 15.9 87.4 30.2 15.4 9.9 2.5 29.7 14.5 20.3 9.0 12.1 23.6 16.8 17.5 25.5 38.3 22.5 12.9 21.2 42.9 36.4 57.2 16.6 14.9 17.7 12.9 MED21 "SRB7, SURB7" ENSG00000152944 "Mediator complex subunit 21" Q13503 12 27022546-27066343 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 190.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017177 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA017177: AB_1857665" "unprognostic (3.02e-1)" "unprognostic (7.33e-2)" "unprognostic (2.66e-1)" "unprognostic (1.12e-1)" "unprognostic (1.39e-1)" "unprognostic (2.10e-1)" "unprognostic (7.18e-3)" "unprognostic (1.01e-1)" "unprognostic (4.78e-3)" "unprognostic (7.32e-2)" "unprognostic (1.03e-2)" "unprognostic (1.54e-1)" "prognostic favorable (3.74e-8)" "unprognostic (3.18e-2)" "unprognostic (1.96e-1)" "unprognostic (1.71e-2)" "unprognostic (1.42e-2)" 20.7 31.5 20.7 13.3 32.4 31.9 23.9 25.9 31.9 24.8 21.9 18.0 18.8 14.9 25.9 21.7 30.4 20.8 19.6 31.3 19.5 21.9 34.1 18.8 20.8 15.7 21.1 26.2 30.8 17.1 30.3 26.0 19.8 23.6 27.6 20.6 18.3 25.3 24.5 30.7 19.3 17.4 27.3 20.2 16.0 19.6 28.9 22.1 22.1 28.2 28.7 19.9 31.6 27.2 20.1 15.8 35.5 18.6 12.8 28.0 19.1 16.6 17.6 9.3 14.8 20.8 21.0 15.4 19.0 14.3 16.1 21.0 18.4 19.0 11.0 12.1 14.5 23.4 13.8 19.8 17.6 27.8 9.6 17.7 15.8 18.2 11.3 11.6 19.3 11.4 14.8 25.8 19.9 23.9 26.1 23.3 14.9 12.8 14.7 18.1 12.5 16.9 35.6 28.5 21.2 23.3 14.6 59.7 12.4 16.7 19.1 7.1 10.4 23.2 10.0 15.0 37.3 17.7 12.9 16.8 18.0 14.0 22.3 19.2 4.5 9.3 18.1 17.1 21.6 12.1 35.5 17.5 23.9 20.4 18.6 20.8 20.1 24.6 23.9 15.8 16.6 28.0 25.3 14.0 12.8 16.5 12.9 23.8 19.1 20.7 32.4 25.9 31.9 19.5 21.9 21.1 26.2 23.6 22.1 14.9 16.5 22.6 105.7 87.8 9.2 30.8 7.6 12.0 29.6 50.6 0.0 52.6 79.6 36.3 190.1 33.7 16.5 23.3 33.3 49.3 57.0 71.3 18.4 20.0 27.5 12.7 17.1 22.1 17.5 59.3 44.8 27.0 67.4 36.9 17.6 15.1 29.2 17.3 44.6 72.5 13.1 19.4 58.7 92.2 54.3 88.5 51.0 27.7 17.2 125.9 MED27 "CRSP34, CRSP8, MED3, TRAP37" ENSG00000160563 "Mediator complex subunit 27" Q6P2C8 9 131860107-132079908 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Syncytiotrophoblasts: 45.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007002 Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA007002: AB_1078574" "unprognostic (8.81e-2)" "prognostic favorable (1.59e-4)" "unprognostic (2.42e-2)" "unprognostic (2.21e-2)" "unprognostic (9.57e-2)" "unprognostic (1.32e-2)" "unprognostic (1.55e-2)" "unprognostic (6.07e-2)" "unprognostic (6.63e-3)" "unprognostic (1.63e-1)" "unprognostic (8.59e-3)" "unprognostic (5.93e-2)" "unprognostic (7.45e-3)" "unprognostic (9.16e-2)" "unprognostic (1.19e-1)" "unprognostic (1.32e-1)" "unprognostic (4.60e-2)" 11.1 12.1 18.0 9.5 18.1 15.5 11.5 14.0 21.4 10.9 11.7 19.5 10.1 7.8 18.6 23.5 15.5 13.9 9.5 17.5 17.5 11.2 10.4 7.5 10.9 13.5 18.6 19.1 12.7 7.9 10.6 17.8 12.7 17.4 12.7 10.7 16.0 17.7 14.4 15.2 15.7 8.6 16.3 16.1 11.7 10.2 14.7 14.0 17.9 13.2 9.6 15.8 12.3 10.5 12.9 19.8 13.4 18.6 18.0 19.7 11.8 16.1 15.9 18.4 14.6 13.2 12.2 15.5 16.8 22.4 33.8 26.5 23.8 13.1 16.0 11.4 17.5 22.6 29.4 25.4 23.9 22.2 17.2 15.0 12.0 16.7 14.1 19.8 21.5 15.2 13.4 16.5 26.6 27.3 10.7 17.6 23.5 17.5 13.4 24.6 25.7 23.1 12.5 18.7 15.9 27.1 20.4 26.0 19.6 13.6 9.0 34.4 13.9 21.7 11.2 11.2 12.3 17.8 10.1 14.7 34.4 15.1 25.4 25.3 5.4 16.6 28.4 19.1 15.0 23.4 3.5 12.2 13.4 18.9 18.6 15.3 11.6 14.8 18.5 19.2 12.9 12.7 15.5 4.8 18.0 16.0 19.8 19.7 11.8 18.0 18.1 14.0 21.4 17.5 11.2 18.6 19.1 17.4 14.0 14.9 8.5 3.0 11.2 5.4 24.5 5.9 5.1 6.7 10.3 12.2 17.7 28.2 11.6 13.9 12.9 10.6 2.1 0.0 14.5 17.3 8.9 5.1 10.4 4.9 15.2 20.6 5.1 5.5 3.7 5.4 13.3 8.8 6.8 11.8 4.2 23.3 12.9 0.0 15.9 6.0 17.8 6.5 8.3 20.7 22.2 4.4 45.8 10.2 4.7 10.7 MIF4GD "AD023, MGC45027, MIFD, SLIP1" ENSG00000125457 "MIF4G domain containing" A9UHW6 17 75266228-75271227 "Predicted intracellular proteins" "Translation regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 67.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051222 Approved Supported "Nucleoli,Golgi apparatus,Cytosol" NA NA Nucleoli "Golgi apparatus, Cytosol" "HPA051222: AB_2681393" "unprognostic (1.05e-1)" "unprognostic (9.17e-2)" "unprognostic (1.94e-2)" "unprognostic (3.82e-3)" "unprognostic (2.92e-1)" "unprognostic (1.31e-1)" "unprognostic (2.36e-2)" "unprognostic (4.21e-2)" "unprognostic (1.44e-1)" "unprognostic (8.15e-2)" "prognostic favorable (2.70e-4)" "unprognostic (2.18e-1)" "unprognostic (9.20e-2)" "unprognostic (9.88e-2)" "unprognostic (2.29e-1)" "unprognostic (7.12e-2)" "unprognostic (7.31e-2)" 19.0 13.9 10.4 14.5 11.1 30.5 13.3 7.4 14.6 11.9 12.9 20.8 14.2 10.3 16.8 12.8 18.3 13.9 20.4 20.4 10.2 8.2 16.0 15.1 15.1 30.4 12.0 9.9 12.2 16.2 18.2 7.4 15.9 12.0 12.0 11.7 15.5 15.4 11.5 34.4 18.6 14.1 20.4 15.4 22.0 11.7 12.6 10.9 21.8 15.0 20.7 20.9 16.6 12.2 14.1 67.0 11.3 21.5 14.5 17.5 14.4 12.0 21.3 4.7 11.0 7.7 2.3 6.8 3.1 8.8 6.2 4.2 7.5 13.6 18.8 5.6 4.9 7.3 9.6 5.7 10.8 4.7 9.3 14.6 9.3 9.3 6.6 8.5 8.1 10.8 2.2 16.9 4.3 17.7 8.5 12.8 21.2 12.2 23.0 1.6 23.5 25.8 19.4 2.1 13.9 10.4 16.9 6.0 25.6 12.5 6.5 7.1 10.4 6.3 16.6 15.4 11.4 30.8 19.0 4.9 3.2 7.7 4.0 6.1 33.5 8.7 15.8 5.9 14.4 4.2 5.7 21.5 11.3 15.4 11.0 16.2 14.1 12.5 13.7 25.4 13.0 11.4 12.0 3.8 14.5 13.1 67.0 17.5 14.4 10.4 11.1 7.4 14.6 10.2 8.2 12.0 9.9 12.0 10.9 0.0 11.2 26.7 11.3 10.2 3.8 4.0 25.5 13.4 10.3 12.2 0.0 12.2 18.3 40.4 24.1 17.9 11.2 0.0 38.2 7.9 11.3 11.9 32.2 7.2 42.0 1.6 15.0 11.1 45.6 9.9 8.6 38.5 15.1 48.7 15.0 22.4 20.7 21.6 14.9 22.6 5.3 19.4 24.2 20.0 17.4 16.6 7.8 34.5 16.9 11.4 MNX1 "HB9, HLXB9, HOXHB9, SCRA1" ENSG00000130675 "Motor neuron and pancreas homeobox 1" P50219 7 156994051-157010651 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "pancreas: 43.3" "Cell type enhanced" "Detected in some" 15 "Intestinal endocrine cells: 24.1;Mucus-secreting cells: 18.0;Paneth cells: 9.0;Undifferentiated cells: 12.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 11.8;BEWO: 8.8;EFO-21: 11.3;HEK 293: 9.0;RPMI-8226: 24.7;SCLC-21H: 13.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA071717 Approved Nucleoplasm,Nucleoli,Cytosol No NA Nucleoplasm "Nucleoli, Cytosol" "HPA071717: AB_2686437" "unprognostic (2.01e-1)" "unprognostic (1.21e-1)" "unprognostic (1.87e-2)" "unprognostic (3.72e-3)" "unprognostic (8.85e-2)" "unprognostic (1.08e-2)" "unprognostic (2.07e-1)" "unprognostic (4.07e-2)" "unprognostic (5.06e-2)" "unprognostic (8.62e-4)" "unprognostic (1.00e-2)" "unprognostic (3.35e-2)" "unprognostic (2.23e-5)" "unprognostic (1.67e-3)" "unprognostic (5.80e-2)" "unprognostic (5.58e-2)" "unprognostic (1.08e-1)" 0.1 0.0 0.1 0.4 0.2 0.0 0.1 0.2 0.1 0.1 6.0 0.2 0.1 9.0 0.1 0.1 0.3 0.0 7.3 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 43.3 0.0 3.2 0.1 0.2 0.8 3.7 0.1 1.9 0.1 0.1 0.1 7.3 0.1 0.2 0.1 2.7 1.0 0.1 0.2 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.6 3.9 0.0 11.8 0.0 0.0 8.8 0.0 0.0 0.1 0.0 5.1 1.7 0.9 11.3 0.0 0.3 0.2 2.0 1.6 0.9 1.4 9.0 0.0 0.8 2.3 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 4.1 3.7 1.9 0.0 6.6 0.6 0.1 0.0 1.1 0.7 0.0 1.7 24.7 4.4 0.4 13.3 0.0 1.7 1.5 0.2 0.1 3.7 2.9 0.0 0.0 0.0 0.0 0.0 3.7 1.9 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.2 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.9 0.7 0.0 4.3 0.0 2.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 24.1 0.0 0.0 0.0 0.0 0.0 1.7 0.0 18.0 0.0 2.5 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 12.4 0.0 MOB1A "C2orf6, FLJ10788, FLJ11595, Mats1, MOB1, Mob4B, MOBK1B, MOBKL1B" ENSG00000114978 "MOB kinase activator 1A" Q9H8S9 2 74152528-74178898 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "monocytes: 381.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047088, HPA071690" Supported Approved Nucleoplasm,Nucleoli,Cytosol NA NA Cytosol "Nucleoplasm, Nucleoli" "HPA047088: AB_2679927, HPA071690: AB_2686432" "unprognostic (5.32e-2)" "unprognostic (2.45e-1)" "unprognostic (5.38e-2)" "unprognostic (2.62e-1)" "unprognostic (2.19e-1)" "unprognostic (8.19e-2)" "prognostic unfavorable (3.34e-4)" "unprognostic (9.36e-2)" "unprognostic (3.91e-2)" "unprognostic (1.13e-1)" "unprognostic (2.05e-3)" "unprognostic (1.04e-1)" "unprognostic (2.20e-3)" "unprognostic (5.10e-2)" "unprognostic (2.00e-1)" "unprognostic (1.10e-1)" "unprognostic (5.11e-3)" 32.2 18.0 12.2 41.5 16.3 36.6 36.2 10.8 11.3 24.5 21.5 12.6 16.1 19.7 27.1 19.8 28.9 22.0 19.9 20.9 11.0 10.4 34.7 21.4 28.4 65.1 14.7 6.9 28.4 12.6 13.8 11.5 20.9 15.9 21.0 20.7 14.3 18.1 18.8 12.8 22.9 30.2 31.6 21.8 51.1 18.7 17.9 12.8 57.0 25.4 16.9 42.4 29.2 24.6 22.3 22.2 32.3 42.8 20.6 15.9 25.2 21.0 12.1 15.2 16.4 25.1 27.5 18.0 17.0 22.9 22.2 21.9 16.5 15.4 43.3 14.6 21.3 16.5 17.7 19.4 19.4 33.7 30.4 11.6 39.1 8.4 17.4 20.1 33.8 63.2 23.2 19.0 17.7 15.0 16.7 23.2 16.8 16.7 16.1 21.5 11.4 42.4 28.8 14.1 18.1 9.9 29.3 52.4 23.0 19.1 26.4 7.7 10.1 24.1 17.9 15.5 12.0 14.3 16.1 22.0 28.9 15.2 20.2 26.9 12.0 10.6 33.3 19.4 28.9 15.4 30.8 24.0 32.3 14.8 39.0 15.9 22.3 13.3 15.7 22.2 17.2 12.3 14.6 24.0 20.6 42.8 15.5 13.4 25.2 12.2 16.3 10.8 11.3 11.0 10.4 14.7 6.9 15.9 12.8 47.6 54.3 138.1 70.9 121.6 12.3 37.0 43.3 80.3 58.0 78.5 5.9 57.5 77.9 53.0 5.0 60.8 83.6 46.7 46.0 83.4 58.3 90.4 109.5 38.0 153.8 25.4 36.1 63.3 177.0 8.5 57.8 185.9 64.1 381.5 63.9 22.4 63.0 74.8 64.3 137.3 13.0 71.1 74.1 87.4 46.2 115.4 55.5 96.5 62.4 139.8 MOB1B "MOB4A, MOBKL1A" ENSG00000173542 "MOB kinase activator 1B" Q7L9L4 4 70902326-71022449 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Erythroid cells: 70.0;monocytes: 52.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HEL: 34.3" "Low region specificity" "Detected in all" "HPA047088, HPA071690" Supported Approved Nucleoplasm,Nucleoli,Cytosol NA NA Cytosol "Nucleoplasm, Nucleoli" "HPA047088: AB_2679927, HPA071690: AB_2686432" "unprognostic (1.05e-1)" "unprognostic (1.48e-2)" "unprognostic (1.84e-1)" "unprognostic (2.96e-2)" "unprognostic (1.99e-1)" "unprognostic (3.96e-1)" "prognostic unfavorable (4.92e-4)" "unprognostic (2.94e-1)" "unprognostic (1.36e-1)" "unprognostic (3.45e-1)" "unprognostic (1.42e-2)" "unprognostic (1.07e-1)" "unprognostic (1.09e-3)" "unprognostic (2.70e-1)" "unprognostic (1.71e-1)" "unprognostic (1.25e-1)" "unprognostic (7.53e-3)" 9.8 10.1 15.7 17.8 13.0 30.9 11.1 10.4 20.0 10.5 9.7 17.3 4.8 6.1 13.9 8.6 9.9 11.8 9.1 11.1 19.8 10.6 29.3 8.3 20.6 13.4 15.5 18.6 13.8 11.0 18.0 10.9 11.2 12.8 12.7 8.5 8.0 11.1 8.6 10.8 11.2 8.4 14.1 17.4 10.6 10.1 7.6 15.4 52.3 14.4 8.2 12.8 10.8 9.8 0.6 5.3 2.5 3.1 0.7 1.4 1.2 3.9 3.2 12.2 9.9 6.6 8.4 10.0 11.9 6.5 6.7 5.9 4.2 7.6 22.0 5.7 10.5 4.5 2.8 7.5 10.0 16.2 11.6 2.6 34.3 3.6 3.3 6.6 7.5 6.9 6.9 5.5 7.5 6.1 7.5 7.9 11.4 21.0 7.2 10.5 4.2 23.2 4.6 4.0 2.6 4.2 7.5 11.8 3.0 11.1 6.9 4.2 8.1 5.1 2.3 15.9 6.8 5.4 4.8 9.4 18.6 9.5 8.4 4.8 4.6 1.5 9.4 6.5 5.5 8.5 0.8 3.1 2.5 1.3 1.6 1.1 0.5 0.6 0.6 4.0 0.6 0.8 0.7 0.4 0.7 0.9 5.3 1.4 1.2 15.7 13.0 10.4 20.0 19.8 10.6 15.5 18.6 12.8 15.4 23.8 15.5 2.2 5.2 15.9 2.0 14.7 7.6 21.4 12.5 41.8 17.7 4.6 8.3 4.9 0.4 9.5 0.9 70.0 4.0 4.9 11.2 9.8 10.4 6.4 9.9 6.4 36.4 9.8 34.3 1.4 4.0 21.6 10.1 52.3 8.4 6.0 8.0 0.0 8.1 15.9 4.3 25.8 21.7 7.2 9.8 14.9 4.8 5.4 5.6 8.4 MOB2 HCCA2 ENSG00000182208 "MOB kinase activator 2" Q70IA6 11 1469457-1501247 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "smooth muscle: 57.3;urinary bladder: 51.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046313 Uncertain Supported Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA046313: AB_10959882" "unprognostic (5.02e-1)" "unprognostic (5.71e-2)" "unprognostic (6.24e-3)" "unprognostic (4.42e-3)" "prognostic unfavorable (4.64e-4)" "unprognostic (8.30e-2)" "unprognostic (1.06e-3)" "unprognostic (3.06e-2)" "unprognostic (1.77e-1)" "unprognostic (2.80e-2)" "unprognostic (5.30e-2)" "unprognostic (2.87e-1)" "prognostic favorable (2.02e-4)" "unprognostic (2.67e-1)" "unprognostic (8.56e-2)" "unprognostic (9.78e-2)" "unprognostic (1.15e-1)" 9.2 4.2 2.4 17.0 2.5 3.0 12.1 2.5 3.2 14.9 30.9 1.8 6.7 2.5 12.5 8.7 17.3 13.8 26.8 8.1 2.8 1.9 3.2 3.0 4.1 8.2 2.1 2.1 8.6 5.8 6.8 1.8 4.2 2.9 21.2 6.7 4.3 12.9 20.1 7.1 9.4 10.6 57.3 2.5 3.7 9.9 4.2 2.0 2.0 4.3 3.2 4.4 51.8 21.2 10.6 10.8 11.2 12.5 11.6 17.3 9.0 13.9 15.2 9.4 7.6 23.5 16.6 8.7 11.0 16.1 21.2 16.8 9.7 19.2 10.3 8.5 25.9 13.2 17.1 14.5 24.7 13.0 13.8 21.7 7.8 5.5 12.3 15.9 10.2 12.3 13.4 29.8 11.3 13.3 17.1 22.5 13.4 12.6 10.7 10.7 9.9 13.2 17.4 11.6 26.7 14.2 9.6 9.6 10.7 17.7 13.3 17.6 18.7 13.7 17.1 13.2 12.5 7.9 10.2 18.5 13.0 6.6 4.2 6.9 10.6 10.3 10.7 9.0 9.9 9.9 8.2 8.6 11.2 17.3 8.7 14.6 8.2 14.9 13.8 10.8 10.6 12.5 10.5 7.1 11.6 12.5 6.9 12.8 9.0 2.4 2.5 2.5 2.5 2.8 1.9 2.1 2.1 2.9 2.0 6.0 7.7 13.7 25.1 73.0 17.7 11.3 12.7 6.7 5.7 7.0 11.8 26.7 23.2 29.5 22.2 55.0 43.9 70.0 33.6 25.8 27.0 36.5 25.3 7.4 23.5 41.3 20.1 25.8 15.2 9.0 22.2 20.7 54.0 32.5 29.1 18.0 31.2 63.1 48.1 18.3 17.2 84.1 54.6 22.2 39.4 71.6 49.7 45.0 24.3 28.6 MPHOSPH10 "CT90, MPP10, MPP10P, PPP1R106" ENSG00000124383 "M-phase phosphoprotein 10" O00566 2 71130314-71150101 "Predicted intracellular proteins, Predicted membrane proteins" "Ribosome biogenesis, rRNA processing" Ribonucleoprotein "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035059, HPA035060, HPA049907" Enhanced Enhanced "Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim" "Mitotic chromosome" "HPA035059: AB_2674436, HPA035060: AB_10601875, HPA049907: AB_2680947" "unprognostic (3.20e-3)" "unprognostic (1.59e-1)" "unprognostic (8.51e-2)" "unprognostic (5.77e-2)" "unprognostic (1.03e-1)" "unprognostic (1.62e-1)" "unprognostic (3.58e-2)" "unprognostic (1.01e-1)" "unprognostic (6.41e-3)" "unprognostic (6.13e-2)" "unprognostic (3.50e-2)" "unprognostic (1.02e-1)" "prognostic unfavorable (3.89e-7)" "unprognostic (1.24e-1)" "unprognostic (2.91e-1)" "unprognostic (2.47e-1)" "unprognostic (2.23e-2)" 20.5 17.6 21.8 20.2 28.0 21.2 23.7 26.7 25.7 23.5 17.6 12.6 22.0 16.5 22.3 26.7 30.6 19.4 17.1 20.4 21.6 20.3 22.2 27.5 15.5 21.9 30.4 22.7 25.4 20.7 20.0 36.7 18.5 26.3 24.0 18.4 8.1 21.8 28.8 48.4 24.4 16.8 25.0 25.0 22.0 17.6 13.7 29.8 22.3 20.4 26.3 24.4 22.2 22.2 13.5 12.8 8.7 17.3 12.4 17.4 8.4 15.0 11.4 14.7 17.5 13.7 13.0 20.1 16.8 13.4 13.9 10.3 20.4 11.1 21.2 10.6 11.7 10.8 14.1 18.4 11.9 18.6 14.6 14.7 25.4 9.0 46.4 12.0 32.8 20.4 11.1 15.3 11.4 15.3 9.5 11.7 13.3 36.7 16.9 13.8 16.1 26.4 33.3 24.4 21.0 13.0 22.0 23.0 25.0 11.2 16.4 17.9 13.8 11.2 26.1 16.1 13.0 13.2 14.6 12.2 16.5 17.7 15.7 21.2 14.4 16.2 34.7 14.2 27.5 16.5 8.7 9.9 7.2 12.4 13.6 16.0 13.5 15.7 14.8 11.7 12.3 17.4 15.3 1.4 12.4 17.3 12.8 13.2 8.4 21.8 28.0 26.7 25.7 21.6 20.3 30.4 22.7 26.3 29.8 32.8 49.8 36.5 30.0 29.8 35.6 38.2 17.8 38.8 66.0 17.4 3.9 41.6 21.6 35.8 4.3 33.7 11.5 23.3 36.1 40.3 37.1 24.7 46.2 28.1 23.8 17.5 17.2 20.3 16.4 5.3 45.1 24.7 11.8 28.9 19.6 22.1 29.5 10.5 41.1 21.9 47.2 38.8 34.8 57.9 88.6 29.4 27.1 34.8 22.9 28.6 MPPED2 "239FB, C11orf8, D11S302E, dJ1024C24.1, dJ873F21.1, FAM1B, Hs.46638" ENSG00000066382 "Metallophosphoesterase domain containing 2" Q15777 11 30384493-30586872 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "cervix, uterine: 31.0;thyroid gland: 30.0" "Cell type enhanced" "Detected in many" 21 "Cone photoreceptor cells: 269.0;Horizontal cells: 77.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 4.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 19.2;HAP1: 11.4;JURKAT: 10.0;RT4: 8.0;SH-SY5Y: 6.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062575 Approved Nucleoli,Vesicles,Mitochondria NA NA Nucleoli "Vesicles, Mitochondria" "HPA062575: AB_2684797" "unprognostic (9.60e-3)" "unprognostic (6.12e-3)" "unprognostic (3.70e-3)" "unprognostic (4.56e-2)" "unprognostic (5.46e-2)" "unprognostic (5.04e-2)" "unprognostic (1.46e-1)" "unprognostic (2.32e-1)" "unprognostic (1.57e-2)" "unprognostic (1.13e-1)" "unprognostic (7.98e-4)" "unprognostic (6.82e-2)" "unprognostic (2.47e-7)" "unprognostic (3.64e-3)" "unprognostic (2.50e-1)" "unprognostic (2.22e-2)" "unprognostic (2.57e-2)" 2.9 7.0 6.3 1.7 19.3 1.1 5.5 4.6 8.9 31.0 4.2 1.8 4.4 1.5 8.3 7.9 1.6 11.1 1.9 4.6 8.5 9.7 12.2 1.2 1.1 0.9 7.0 6.7 1.2 2.5 5.0 10.7 2.5 11.2 15.6 1.4 7.1 12.1 10.1 5.7 1.0 1.4 5.1 4.6 3.1 1.9 3.8 3.4 9.1 30.0 1.2 1.0 4.7 4.9 1.3 0.7 0.3 0.2 2.0 4.8 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.2 11.4 0.0 0.0 0.0 2.1 0.0 0.2 0.2 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.8 0.0 0.2 3.2 0.1 0.0 0.0 3.1 0.2 0.0 8.0 0.1 6.1 0.0 0.0 3.1 1.3 1.7 0.0 0.1 0.0 1.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.1 0.3 0.2 0.0 0.9 0.0 4.8 0.0 0.0 0.6 0.4 1.3 1.3 0.2 0.2 2.0 0.0 0.7 0.1 0.2 6.3 19.3 4.6 8.8 8.5 9.7 7.0 6.7 11.2 3.4 0.0 2.1 0.0 47.3 0.9 23.4 3.1 0.0 5.3 0.0 43.6 269.0 0.2 21.6 2.9 1.6 5.0 0.0 0.0 0.0 0.1 4.1 21.0 4.7 0.2 3.2 77.9 0.0 0.6 15.9 0.5 0.3 2.3 5.0 0.0 0.0 40.1 0.1 0.0 3.2 2.2 17.1 0.0 1.4 0.1 0.7 1.0 0.5 0.0 0.0 18.4 MRTO4 "C1orf33, dJ657E11.4, MRT4" ENSG00000053372 "MRT4 homolog, ribosome maturation factor" Q9UKD2 1 19251539-19260128 "Predicted intracellular proteins, Ribosomal proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026446 Approved Approved "Nucleoplasm,Nuclear membrane,Nucleoli" Yes No "Nucleoplasm, Nuclear membrane" Nucleoli "HPA026446: AB_10601441" "unprognostic (3.99e-1)" "unprognostic (1.75e-1)" "unprognostic (2.18e-2)" "unprognostic (2.94e-1)" "unprognostic (4.12e-1)" "unprognostic (4.22e-2)" "prognostic unfavorable (1.56e-8)" "unprognostic (7.46e-2)" "unprognostic (5.58e-2)" "unprognostic (2.61e-2)" "unprognostic (2.69e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (4.11e-8)" "unprognostic (5.87e-2)" "unprognostic (1.16e-1)" "unprognostic (2.50e-1)" "unprognostic (3.23e-2)" 17.2 16.5 20.4 16.9 18.5 12.0 21.6 10.7 21.7 12.1 13.8 12.4 10.2 17.5 15.6 15.2 21.6 18.8 11.8 11.7 19.1 15.9 13.6 23.7 10.5 23.0 16.1 19.1 18.7 41.2 10.2 8.8 12.5 15.1 12.2 17.6 10.6 13.2 11.9 22.8 15.3 19.3 17.3 10.0 14.5 13.7 21.6 11.6 14.5 12.9 29.3 22.7 11.4 12.4 14.7 12.8 1.0 8.2 10.6 15.7 7.2 24.3 17.3 14.4 18.8 7.0 11.2 12.7 19.1 10.8 32.7 21.6 24.9 25.3 36.0 16.0 15.8 14.3 19.4 39.7 28.8 33.0 12.8 30.3 26.6 15.5 21.4 8.8 35.1 11.2 9.8 19.1 36.9 19.2 8.7 18.3 16.4 40.2 11.6 19.3 17.8 28.5 25.4 18.4 25.6 26.4 26.8 17.5 27.8 17.8 8.3 23.1 17.0 14.6 20.1 20.1 10.7 14.3 20.7 12.0 17.9 22.2 27.4 32.4 9.5 16.5 47.4 17.4 45.1 28.5 0.7 7.5 0.7 7.9 8.2 15.7 14.7 9.6 10.8 11.4 13.1 13.0 11.6 1.0 10.6 6.2 12.8 6.7 7.2 20.4 18.5 10.7 21.7 19.1 15.9 16.1 19.1 15.1 11.6 6.0 12.6 26.1 38.7 33.2 19.2 9.0 35.7 17.4 23.9 7.0 9.8 42.2 34.9 44.9 14.5 23.3 5.4 0.0 47.2 51.2 28.2 15.4 25.4 14.4 42.9 14.3 20.7 11.6 12.1 27.6 21.3 21.7 18.6 39.7 19.8 19.2 44.4 14.0 19.1 30.1 13.8 19.4 28.8 37.0 43.7 29.4 21.7 14.6 31.2 31.2 MYBPH ENSG00000133055 "Myosin binding protein H" Q13203 1 203167811-203175813 "Predicted intracellular proteins" "Cell adhesion" "Muscle protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "skeletal muscle: 53.8" "Cell type enhanced" "Detected in single" 33 "Alveolar cells type 2: 2.2" "Group enriched" "Detected in many" 7 "glioma: 4.9;head and neck cancer: 20.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 6 "plasmacytoid DC: 6.1" "Lineage enriched" "Detected in many" 6 "dendritic cells: 6.1" "Group enriched" "Detected in some" 5 "CACO-2: 17.6;HSkMC: 34.5;THP-1: 8.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA061383 Enhanced Approved Nucleoplasm,Nucleoli,Mitochondria NA NA "Nucleoplasm, Mitochondria" Nucleoli "HPA061383: AB_2684497" "unprognostic (2.26e-4)" "unprognostic (2.04e-1)" "unprognostic (3.50e-1)" "unprognostic (1.06e-1)" "unprognostic (3.82e-2)" "unprognostic (1.32e-3)" "unprognostic (3.42e-1)" "unprognostic (6.84e-2)" "unprognostic (1.18e-1)" "unprognostic (2.96e-1)" "unprognostic (2.86e-1)" "unprognostic (1.75e-1)" "unprognostic (7.62e-4)" "unprognostic (1.51e-1)" "unprognostic (3.34e-2)" "unprognostic (1.14e-1)" "unprognostic (1.74e-1)" 0.8 0.1 1.1 0.8 0.8 0.3 0.4 0.4 0.6 0.1 0.1 0.0 0.0 0.1 0.4 4.4 3.9 0.2 0.1 0.2 0.4 0.3 1.1 1.5 0.2 0.3 1.3 0.0 0.1 0.2 0.1 0.6 0.3 1.0 4.2 0.1 0.0 8.8 0.1 53.8 0.2 0.1 0.1 0.4 0.4 0.1 0.2 2.1 0.9 3.9 12.7 2.0 0.3 0.8 0.0 6.1 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 4.4 0.0 0.0 0.0 0.0 0.0 17.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 34.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.5 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 6.1 0.0 0.1 1.1 0.8 0.4 0.6 0.4 0.3 1.3 0.0 1.0 2.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 MYLK4 SgK085 ENSG00000145949 "Myosin light chain kinase family member 4" Q86YV6 6 2663629-2750966 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 17 "skeletal muscle: 23.6;tongue: 63.6" "Cell type enhanced" "Detected in some" 6 "Alveolar cells type 1: 3.0;Cholangiocytes: 2.5;Proximal tubular cells: 2.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 6 "HEL: 12.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA015860 Uncertain Approved "Nucleoli,Golgi apparatus,Vesicles" NA NA "Golgi apparatus" "Nucleoli, Vesicles" "HPA015860: AB_2147922" "unprognostic (1.75e-1)" "unprognostic (2.04e-1)" "unprognostic (1.87e-1)" "unprognostic (5.22e-3)" "unprognostic (1.85e-1)" "unprognostic (2.99e-2)" "unprognostic (7.48e-2)" "unprognostic (2.80e-1)" "unprognostic (5.32e-2)" "unprognostic (2.25e-1)" "unprognostic (2.02e-2)" "unprognostic (2.91e-1)" "unprognostic (2.74e-3)" "unprognostic (1.43e-1)" "unprognostic (2.65e-1)" "unprognostic (1.19e-2)" "unprognostic (4.63e-2)" 0.5 0.3 0.3 0.3 0.4 0.4 0.8 1.4 0.7 0.3 0.3 0.3 0.3 0.1 0.3 0.5 1.0 0.2 0.3 1.0 0.5 0.5 2.6 0.3 0.5 0.3 0.4 0.3 0.3 1.1 0.7 0.7 0.4 0.4 0.4 0.1 0.4 2.4 0.4 23.6 0.8 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 1.0 63.6 1.5 0.5 0.3 0.1 0.8 0.3 0.3 0.9 1.4 0.1 0.3 0.2 0.6 1.2 1.0 1.2 0.6 0.7 1.6 0.5 0.4 0.5 1.1 1.1 1.6 0.8 0.2 1.9 0.2 0.5 0.7 0.2 0.6 12.7 0.6 0.1 0.3 0.3 0.6 1.5 0.5 0.1 1.2 0.6 0.5 0.2 0.1 0.1 0.3 0.5 0.1 1.4 0.2 0.4 0.0 0.9 0.0 0.0 0.9 0.3 1.0 0.6 0.3 0.2 0.5 1.1 0.4 0.8 0.7 0.5 0.1 0.2 0.4 0.4 0.2 0.1 0.2 0.3 1.3 0.1 0.1 0.1 0.5 0.0 0.3 0.1 0.2 1.4 0.2 0.1 0.6 0.1 0.3 0.9 0.3 0.8 0.1 0.1 0.3 0.4 1.4 0.7 0.5 0.5 0.4 0.3 0.4 0.3 3.0 0.6 0.0 0.1 0.1 0.8 1.2 2.5 0.0 1.2 0.0 0.0 0.3 0.0 0.1 0.4 0.5 0.0 0.0 0.2 0.0 0.4 0.1 0.0 0.0 0.2 1.6 1.2 0.0 0.3 0.0 0.3 1.0 0.0 1.8 0.0 0.2 0.0 0.0 1.4 2.9 0.2 0.0 0.0 0.0 0.1 0.6 0.2 0.0 0.0 0.1 NBAS NAG ENSG00000151779 "Neuroblastoma amplified sequence" A2RRP1 2 15166909-15561330 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036817 Approved Approved "Nuclear membrane,Nucleoli,Golgi apparatus" NA NA "Golgi apparatus" "Nuclear membrane, Nucleoli" "HPA036817: AB_10670925" "unprognostic (1.72e-1)" "unprognostic (1.69e-1)" "unprognostic (1.22e-1)" "unprognostic (2.36e-1)" "unprognostic (1.32e-1)" "unprognostic (2.45e-1)" "prognostic unfavorable (1.10e-4)" "unprognostic (3.80e-2)" "unprognostic (4.16e-2)" "unprognostic (1.33e-1)" "unprognostic (1.55e-1)" "unprognostic (1.53e-2)" "unprognostic (1.17e-2)" "unprognostic (1.36e-1)" "unprognostic (2.56e-1)" "unprognostic (2.65e-1)" "prognostic unfavorable (5.84e-5)" 16.8 18.1 23.2 16.3 30.9 21.9 22.5 21.5 28.3 21.9 17.1 20.6 17.4 13.3 27.1 23.4 14.1 18.7 13.5 21.6 20.9 21.5 19.1 16.9 15.4 16.3 19.3 20.8 24.1 28.6 34.1 35.5 16.2 24.9 16.9 17.7 16.8 22.9 19.0 26.5 23.4 20.5 21.0 18.1 18.1 19.0 31.4 16.7 23.8 20.1 14.6 20.0 14.4 15.2 5.3 6.0 3.2 8.7 9.4 9.9 3.6 5.5 7.3 8.1 5.6 21.3 23.4 8.4 10.3 11.3 8.0 8.1 7.3 8.0 7.1 2.3 15.6 8.3 6.7 8.8 12.9 9.6 7.0 5.6 27.1 6.5 20.4 21.9 7.0 13.8 15.4 10.3 10.6 17.8 16.6 16.5 10.1 21.0 8.2 12.2 6.8 5.8 15.8 7.0 9.0 7.0 6.2 14.3 8.4 16.6 7.5 4.8 7.8 8.7 7.2 12.9 10.6 5.1 6.4 14.3 10.2 6.3 7.2 7.4 12.2 10.3 10.1 18.1 8.2 9.1 1.4 5.7 3.2 7.6 3.9 9.5 5.3 5.9 9.9 5.2 5.1 5.9 6.1 1.0 9.4 8.7 6.0 6.9 3.6 23.2 30.9 21.5 28.3 20.9 21.5 19.3 20.8 24.9 16.7 17.9 14.4 12.9 8.3 6.5 15.6 26.3 22.9 25.4 13.6 17.4 27.5 9.8 0.0 9.6 29.5 10.5 11.9 0.0 12.1 11.2 8.0 7.9 37.0 7.8 7.7 12.7 7.0 7.4 9.5 46.9 10.6 8.2 5.0 19.0 13.5 15.2 8.1 9.3 15.6 7.7 22.9 0.0 11.7 30.4 16.6 9.8 8.7 11.8 11.0 5.8 NCAPD2 "CAP-D2, CNAP1, hCAP-D2, KIAA0159" ENSG00000010292 "Non-SMC condensin I complex subunit D2" Q15021 12 6493356-6531955 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA condensation, Mitosis" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "lymphoid tissue: 84.1" "Cell type enhanced" "Detected in many" 7 "Erythroid cells: 46.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012423, HPA036947, HPA037363" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA Yes Cytosol "Nucleoplasm, Nucleoli" "CAB012423: , HPA036947: AB_10671367, HPA037363: AB_10672483" "unprognostic (1.51e-1)" "unprognostic (1.88e-1)" "unprognostic (2.20e-1)" "unprognostic (1.31e-2)" "unprognostic (1.03e-2)" "unprognostic (7.84e-2)" "prognostic unfavorable (1.79e-8)" "unprognostic (2.73e-3)" "unprognostic (1.45e-2)" "unprognostic (5.00e-2)" "unprognostic (5.41e-3)" "unprognostic (4.53e-1)" "prognostic unfavorable (1.13e-7)" "unprognostic (4.80e-3)" "unprognostic (1.18e-1)" "unprognostic (4.53e-1)" "unprognostic (8.75e-2)" 6.8 8.8 6.5 24.6 12.7 16.7 7.7 7.7 9.0 8.0 11.3 16.2 7.0 10.6 11.5 8.8 17.7 8.1 6.5 6.2 7.5 5.4 7.0 5.1 7.7 20.4 16.5 6.2 7.7 7.2 9.6 6.3 13.9 8.7 8.2 12.4 8.1 10.5 8.3 7.0 14.8 13.0 8.2 12.7 16.4 9.9 17.2 11.4 84.1 11.4 12.4 24.3 10.9 9.5 5.0 4.8 7.2 2.8 7.8 7.4 3.2 22.1 20.5 22.1 16.0 5.8 6.0 25.8 15.3 12.3 24.8 20.1 18.5 23.6 23.3 4.6 10.0 21.0 19.6 36.4 17.9 47.4 42.2 20.4 21.3 23.5 10.5 2.4 26.4 15.4 3.8 6.7 19.3 19.8 11.4 16.3 15.0 13.5 9.5 21.9 11.0 29.9 17.4 34.5 20.9 16.0 25.6 50.3 12.4 8.3 12.4 9.1 9.6 22.8 10.8 8.1 36.0 4.7 16.6 10.2 16.3 26.8 11.0 29.7 7.4 10.0 33.2 9.6 15.3 20.2 7.2 2.0 3.6 6.3 2.8 5.6 5.0 6.2 7.3 3.0 3.8 7.4 7.2 1.9 7.8 1.9 4.8 7.2 3.2 6.5 12.7 7.7 9.0 7.5 5.4 16.5 6.2 8.7 11.4 6.0 6.1 13.0 3.2 3.2 3.6 2.9 7.6 5.3 3.4 1.8 7.9 6.8 0.0 4.1 14.9 2.6 5.2 46.7 3.3 16.2 3.1 2.8 3.5 2.6 8.6 4.8 1.2 9.2 10.8 20.4 5.5 5.4 0.0 5.4 6.3 10.0 4.5 5.7 5.6 2.0 7.6 0.0 3.6 17.7 10.0 3.0 5.3 6.9 8.0 3.0 NCOA4 "ARA70, DKFZp762E1112, ELE1, PTC3, RFG" ENSG00000266412 "Nuclear receptor coactivator 4" Q13772 10 46005088-46030714 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 100.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 30.2;granulocytes: 100.1;monocytes: 40.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051260, HPA065208" Uncertain Approved "Nucleoli,Golgi apparatus,Cytosol" NA NA Nucleoli "Golgi apparatus, Cytosol" "HPA051260: AB_2681412, HPA065208: AB_2685432" "unprognostic (4.23e-2)" "unprognostic (1.50e-1)" "unprognostic (2.44e-2)" "unprognostic (1.82e-1)" "prognostic favorable (3.26e-4)" "unprognostic (1.34e-1)" "unprognostic (1.80e-1)" "unprognostic (9.34e-2)" "unprognostic (4.67e-2)" "unprognostic (5.22e-2)" "unprognostic (9.16e-2)" "unprognostic (2.04e-2)" "prognostic favorable (8.04e-6)" "unprognostic (1.35e-1)" "unprognostic (4.71e-3)" "unprognostic (1.14e-1)" "unprognostic (2.78e-1)" 18.5 6.9 5.5 9.5 10.0 17.4 10.0 5.5 11.3 10.8 22.5 13.6 5.9 27.0 9.9 9.4 17.0 6.3 9.0 16.6 5.7 20.8 40.9 11.6 11.6 8.7 7.1 11.0 9.1 9.3 9.6 28.4 13.5 14.7 12.4 9.9 12.6 8.5 15.5 6.8 36.4 11.2 9.7 23.8 8.9 6.4 8.1 26.8 13.2 13.9 16.3 13.0 6.4 7.3 30.2 100.1 40.4 13.4 10.9 53.9 31.8 13.5 15.9 16.3 42.1 38.2 39.8 29.3 47.4 28.9 28.4 20.8 23.6 36.0 35.3 47.8 16.2 32.6 16.6 32.3 32.3 25.4 17.1 24.3 18.6 59.4 29.5 61.8 54.3 37.1 32.4 24.6 41.4 30.9 42.5 18.2 26.4 21.7 39.4 14.2 30.0 23.2 9.6 24.6 8.0 17.8 23.1 21.5 34.6 27.1 16.0 10.8 29.6 33.8 29.3 32.9 24.4 30.4 39.1 17.9 21.5 18.9 19.7 16.2 17.3 35.8 22.4 52.1 9.5 69.1 40.4 70.7 10.0 26.8 10.9 7.3 9.4 9.5 30.2 6.6 10.2 8.6 100.1 13.4 30.4 9.3 10.8 53.9 47.6 78.0 32.8 33.2 44.0 13.3 136.0 38.2 50.9 59.1 41.8 27.5 85.3 68.0 41.7 72.4 47.2 113.4 186.9 45.2 92.9 44.2 51.5 191.6 148.1 148.2 19.1 25.8 53.4 209.6 51.8 34.5 96.2 49.0 73.1 41.3 37.9 41.1 57.5 44.6 100.4 11.3 12.9 47.2 22.7 15.1 49.4 132.3 41.5 50.4 45.0 NDP "EVR2, norrin" ENSG00000124479 "NDP, norrin cystine knot growth factor" Q00604 X 43948776-43973504 "Disease related genes, Predicted secreted proteins" "Sensory transduction, Vision, Wnt signaling pathway" "Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 40.4" "Cell type enriched" "Detected in some" 8 "Muller glia cells: 100.6" "Cancer enhanced" "Detected in many" "glioma: 25.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 14 "memory CD4 T-cell: 1.7" "Lineage enriched" "Detected in single" 14 "T-cells: 1.7" "Cell line enriched" "Detected in some" 17 "U-87 MG: 41.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003095 Supported Nucleoplasm,Nucleoli,Vesicles "Secreted to extracellular matrix" NA NA Vesicles "Nucleoplasm, Nucleoli" "HPA003095: AB_1079457" "unprognostic (1.12e-1)" "unprognostic (7.12e-2)" "unprognostic (2.27e-2)" "unprognostic (2.55e-3)" "unprognostic (6.84e-3)" "unprognostic (1.51e-1)" "unprognostic (9.09e-2)" "unprognostic (2.29e-1)" "unprognostic (1.22e-1)" "unprognostic (1.86e-1)" "unprognostic (1.40e-1)" "unprognostic (3.02e-2)" "unprognostic (2.22e-2)" "unprognostic (1.47e-1)" "unprognostic (1.13e-1)" "unprognostic (2.87e-3)" 0.9 0.6 17.3 0.6 18.6 0.5 3.6 14.6 15.0 19.1 0.7 12.6 0.2 0.6 13.6 19.9 0.6 18.0 0.9 1.4 14.0 7.8 0.7 0.5 0.6 0.7 11.0 10.9 40.4 0.6 0.8 0.2 5.3 13.1 6.8 0.7 1.4 0.6 12.4 1.5 1.1 0.6 10.7 7.5 0.6 0.7 1.4 12.2 0.0 1.2 0.0 0.7 1.0 1.7 0.1 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.9 0.0 0.0 0.1 1.1 0.7 0.0 0.0 1.1 0.0 2.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 1.2 0.0 0.0 0.0 41.2 0.4 2.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 17.3 18.6 14.6 15.0 14.0 7.8 11.0 10.9 13.1 12.2 0.0 0.0 0.0 0.0 0.1 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 12.4 0.0 0.0 0.0 0.0 100.6 0.7 0.0 9.2 0.0 3.3 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 NGDN "C14orf120, CANu1, DKFZP564O092, LCP5, lpd-2, NGD" ENSG00000129460 Neuroguidin Q8NEJ9 14 23469688-23509862 "Predicted intracellular proteins" "Translation regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000944 Approved Approved Nucleoplasm,Nucleoli,Mitochondria Yes No "Nucleoli, Mitochondria" Nucleoplasm "HPA000944: AB_1079483" "unprognostic (2.63e-3)" "unprognostic (7.65e-2)" "unprognostic (2.84e-1)" "unprognostic (4.16e-3)" "unprognostic (1.51e-2)" "unprognostic (3.14e-2)" "unprognostic (8.87e-2)" "unprognostic (1.72e-3)" "unprognostic (5.64e-2)" "unprognostic (3.87e-3)" "unprognostic (7.10e-2)" "unprognostic (1.65e-1)" "unprognostic (6.36e-2)" "unprognostic (9.83e-2)" "unprognostic (2.29e-2)" "unprognostic (2.58e-1)" "unprognostic (1.70e-1)" 20.1 17.6 17.2 19.3 23.6 35.7 26.9 28.9 25.8 17.8 17.8 21.2 18.7 15.0 29.1 22.3 17.4 21.7 12.1 14.8 17.6 15.7 20.6 21.0 15.5 20.4 23.5 17.4 27.2 16.6 20.9 20.7 19.7 19.1 19.7 19.4 17.4 24.0 19.9 32.8 22.7 17.9 21.0 21.6 19.7 17.5 19.0 25.2 19.6 23.7 17.2 22.8 17.3 19.7 42.0 26.7 18.9 23.4 35.2 44.6 28.2 11.0 21.9 16.8 15.7 16.3 11.8 22.2 14.6 15.3 31.3 25.4 21.6 20.2 27.4 10.8 13.3 22.2 19.2 33.2 18.1 36.9 18.2 17.5 24.5 13.3 66.7 22.2 32.4 17.5 14.7 23.1 24.6 29.4 12.4 15.8 21.2 27.1 19.6 15.2 26.2 24.1 24.5 21.2 25.4 29.5 19.7 20.1 14.0 20.0 21.0 17.2 19.4 17.3 20.8 23.9 17.8 12.9 20.8 11.9 14.8 17.6 13.9 21.2 24.5 42.5 39.8 6.4 16.6 15.8 17.5 21.5 18.9 31.6 23.4 33.5 42.0 34.3 32.1 25.3 36.6 44.6 35.1 6.6 35.2 22.4 26.7 37.4 28.2 17.2 23.6 28.9 25.8 17.6 15.7 23.5 17.4 19.1 25.2 32.8 26.9 41.2 49.3 62.7 21.0 17.7 17.8 28.1 29.6 26.2 15.7 50.7 28.2 31.1 4.1 34.3 17.4 23.3 31.3 36.0 37.0 25.4 43.9 18.1 26.5 23.8 23.6 16.0 16.4 4.5 32.5 29.5 30.4 36.1 18.8 20.7 28.1 19.9 26.5 27.0 24.7 19.4 38.7 57.2 69.0 59.1 47.8 41.5 22.0 44.2 NIFK "hNIFK, MKI67IP, Nopp34" ENSG00000155438 "Nucleolar protein interacting with the FHA domain of MKI67" Q9BYG3 2 121726945-121736923 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015382, HPA035735, HPA035736, CAB075728, CAB075729" Supported Enhanced "Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim" "Mitotic chromosome" "CAB015382: AB_2142390, CAB075728: AB_2665734, CAB075729: AB_2665735, HPA035735: AB_2674758, HPA035736: AB_2674759" "unprognostic (3.53e-2)" "unprognostic (1.67e-1)" "unprognostic (3.49e-1)" "prognostic unfavorable (5.57e-4)" "unprognostic (1.21e-1)" "unprognostic (4.15e-3)" "prognostic unfavorable (2.92e-6)" "unprognostic (7.74e-3)" "unprognostic (4.63e-2)" "unprognostic (3.21e-2)" "unprognostic (6.02e-3)" "unprognostic (9.50e-2)" "prognostic unfavorable (5.01e-11)" "unprognostic (1.72e-1)" "unprognostic (1.29e-1)" "unprognostic (1.27e-1)" "unprognostic (1.28e-1)" 25.1 18.7 18.4 22.1 19.0 19.9 28.1 14.3 20.8 24.0 17.3 14.8 9.8 16.5 21.4 17.4 28.2 20.3 16.6 15.4 16.1 15.1 24.2 40.1 14.7 30.8 15.8 15.2 32.8 33.7 12.9 28.9 19.8 18.5 21.2 19.7 10.2 16.5 14.2 35.5 22.8 17.9 20.9 18.3 28.1 19.2 18.7 18.0 31.3 23.6 21.3 29.5 26.1 21.0 28.1 25.9 12.5 23.5 27.1 32.9 24.6 28.8 8.7 18.9 18.5 16.6 23.0 22.7 22.7 20.4 28.6 31.3 25.5 14.7 39.7 28.4 17.7 24.8 18.7 40.6 30.7 42.9 24.1 21.5 39.0 12.3 23.8 23.3 35.9 21.6 23.1 35.4 37.8 50.7 13.3 20.5 15.8 43.8 19.8 24.7 14.2 27.5 35.7 46.3 34.5 31.5 26.4 21.2 48.6 25.4 18.1 23.6 24.4 14.3 28.6 49.6 17.9 13.7 30.9 11.8 19.7 32.2 22.2 32.3 23.2 34.9 44.1 15.3 35.5 27.4 12.5 19.8 9.3 22.9 23.5 32.1 27.0 28.2 26.2 25.9 28.1 32.9 30.8 1.3 27.1 20.9 22.6 23.5 24.6 18.4 19.0 14.3 20.8 16.1 15.1 15.8 15.2 18.5 18.0 41.7 23.4 49.1 90.7 87.3 25.6 18.3 15.3 44.2 64.8 14.0 11.8 63.5 39.7 65.3 10.4 41.8 15.2 23.3 39.1 70.0 52.4 39.8 53.1 31.1 49.2 12.7 27.0 22.7 32.3 3.8 53.2 41.0 21.9 45.1 37.8 44.7 45.9 21.0 42.5 40.0 38.4 38.8 44.3 54.8 72.2 88.7 40.8 39.4 44.3 93.5 NLK ENSG00000087095 "Nemo like kinase" Q9UBE8 17 28041737-28196381 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Bipolar cells: 93.3;Cone photoreceptor cells: 145.3;Early spermatids: 243.8;Late spermatids: 250.1;Rod photoreceptor cells: 92.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 32 "basophil: 17.6" "Lineage enriched" "Detected in single" 32 "granulocytes: 17.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018192, HPA056511" Approved Approved "Nucleoplasm,Nucleoli,Cell Junctions" NA NA Nucleoplasm "Nucleoli, Cell Junctions" "HPA018192: AB_1854525, HPA056511: AB_2683160" "unprognostic (7.19e-2)" "unprognostic (1.98e-1)" "unprognostic (5.54e-2)" "unprognostic (5.64e-3)" "unprognostic (2.11e-1)" "unprognostic (1.29e-1)" "unprognostic (1.67e-2)" "unprognostic (2.59e-3)" "unprognostic (2.72e-2)" "unprognostic (4.23e-3)" "unprognostic (1.07e-2)" "unprognostic (1.09e-2)" "unprognostic (5.29e-2)" "unprognostic (1.66e-1)" "unprognostic (3.92e-1)" "unprognostic (5.27e-2)" "unprognostic (6.57e-2)" 6.4 30.5 19.4 10.9 14.1 7.4 7.5 7.5 38.2 6.2 6.7 8.3 14.4 8.3 5.7 8.8 4.5 5.1 8.2 8.5 18.2 12.0 13.0 8.2 7.1 11.7 15.2 23.6 4.6 11.5 20.8 9.4 9.1 7.0 6.7 7.1 12.7 5.8 17.4 4.9 4.5 8.3 4.6 15.3 10.1 7.0 17.4 7.5 10.9 13.2 3.7 11.0 7.2 4.4 0.5 0.3 17.6 0.3 0.1 0.5 0.2 4.6 5.4 13.0 4.5 2.8 3.6 5.8 4.7 4.8 7.8 6.0 27.1 4.2 6.3 7.1 3.8 9.9 4.4 9.2 8.5 9.0 14.6 5.8 24.8 5.0 4.6 4.7 5.2 25.6 4.7 5.3 5.1 6.2 7.6 9.1 18.0 9.5 7.7 7.1 5.5 13.4 6.0 5.0 9.1 2.7 11.2 8.4 4.6 14.2 5.7 9.5 3.6 7.1 6.8 29.1 16.4 10.6 8.3 9.3 5.6 7.6 4.6 9.4 9.0 8.6 6.1 5.5 5.7 6.1 17.6 0.2 0.2 0.3 0.3 0.1 0.5 0.4 0.4 0.2 0.3 0.2 0.5 0.1 0.1 0.3 0.3 0.4 0.2 19.4 14.1 7.5 38.2 18.2 12.0 15.2 23.6 7.0 7.5 20.8 5.9 4.7 3.5 4.7 93.3 23.0 10.2 6.7 4.5 31.4 145.3 2.5 1.7 3.3 243.8 10.6 5.9 0.0 5.5 3.0 3.7 5.4 24.2 8.9 7.2 35.0 27.1 10.4 14.2 250.1 5.2 5.0 15.1 4.6 9.4 9.4 5.7 7.0 2.5 6.3 92.4 12.9 3.9 25.8 9.5 4.3 5.4 5.1 8.3 5.8 NOC2L "DKFZP564C186, NET15, NET7, NIR, PPP1R112" ENSG00000188976 "NOC2 like nucleolar associated transcriptional repressor" Q9Y3T9 1 944204-959309 "Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044258, HPA062195" Approved Enhanced "Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No 420000 "Nucleoli, Nucleoli rim, Mitotic chromosome" "HPA044258: AB_10961284, HPA062195: AB_2684707" "unprognostic (3.18e-2)" "unprognostic (5.84e-2)" "unprognostic (1.59e-1)" "unprognostic (9.54e-3)" "unprognostic (6.75e-2)" "unprognostic (2.31e-3)" "unprognostic (1.94e-3)" "unprognostic (1.36e-2)" "unprognostic (1.51e-1)" "unprognostic (2.17e-1)" "unprognostic (1.51e-1)" "unprognostic (2.78e-1)" "unprognostic (1.20e-3)" "unprognostic (8.62e-2)" "unprognostic (6.25e-2)" "unprognostic (3.44e-2)" "unprognostic (1.52e-1)" 17.7 15.6 13.4 20.5 17.8 23.8 18.2 23.7 27.4 15.0 15.3 15.6 13.5 16.8 19.0 13.5 27.7 18.3 21.8 23.0 15.3 15.3 15.2 36.6 14.0 19.3 18.7 19.0 16.9 26.8 20.8 15.3 15.9 16.7 16.6 11.1 14.0 22.0 16.5 40.0 32.4 14.6 14.7 13.6 17.5 16.4 21.1 18.0 22.7 19.8 29.5 21.8 17.5 18.0 14.3 20.2 11.3 29.0 18.8 18.4 16.0 27.6 27.6 4.9 32.1 9.0 8.0 18.1 20.7 9.7 29.0 15.9 36.6 27.2 31.2 29.4 13.7 24.1 25.4 36.7 30.9 12.3 19.6 41.8 16.5 35.7 31.7 20.3 36.3 16.3 13.1 8.8 31.8 21.3 9.0 14.0 11.1 46.6 14.4 12.8 43.8 23.3 22.0 28.3 20.0 32.8 29.3 20.6 37.8 13.3 11.7 34.7 34.1 27.4 41.5 25.3 7.8 18.5 19.9 16.0 17.3 24.7 18.9 35.3 24.8 26.7 56.4 21.5 51.6 14.4 7.2 17.0 11.3 14.2 25.7 18.4 14.3 13.8 13.6 20.2 11.9 14.3 11.1 1.6 18.8 29.0 13.0 10.9 16.0 13.4 17.8 23.7 27.4 15.3 15.3 18.7 19.0 16.7 18.0 14.9 23.9 46.0 71.4 61.6 53.0 2.8 20.4 20.1 13.6 34.9 58.9 54.4 14.9 44.4 5.6 27.4 17.0 0.0 39.8 56.2 34.7 37.8 12.8 19.8 34.6 42.9 28.8 17.8 23.1 8.1 27.3 24.1 23.6 30.7 23.4 21.7 31.2 17.5 20.1 15.2 68.2 32.3 49.2 36.7 73.9 71.6 49.2 39.9 41.2 60.5 NOC3L "AD24, C10orf117, FAD24, FLJ12820" ENSG00000173145 "NOC3 like DNA replication regulator" Q8WTT2 10 94333226-94362959 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatogonia: 70.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063958, HPA067638, HPA070981" Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" Nucleoplasm "HPA063958: AB_2685160, HPA067638: AB_2685876, HPA070981: AB_2686331" "unprognostic (1.29e-1)" "unprognostic (2.25e-1)" "unprognostic (5.25e-2)" "unprognostic (2.49e-1)" "unprognostic (1.27e-3)" "unprognostic (4.58e-2)" "unprognostic (6.49e-3)" "unprognostic (3.34e-1)" "unprognostic (1.09e-1)" "unprognostic (1.34e-1)" "unprognostic (9.93e-2)" "unprognostic (5.50e-2)" "unprognostic (1.47e-2)" "unprognostic (3.24e-2)" "unprognostic (2.48e-1)" "unprognostic (1.09e-1)" "unprognostic (2.30e-1)" 16.7 13.2 9.2 11.2 14.5 3.7 14.4 10.8 12.7 13.5 8.9 6.0 8.4 6.7 14.1 8.5 14.3 12.1 7.3 8.8 9.3 6.6 11.0 15.0 9.7 14.9 16.4 7.7 15.4 7.8 12.5 18.2 11.0 14.5 12.5 8.2 6.3 9.7 8.9 18.8 11.6 8.4 9.8 16.6 19.8 8.1 14.1 13.1 12.8 15.7 13.6 16.0 16.1 10.6 13.7 4.3 0.5 4.1 7.5 5.8 3.1 17.9 9.8 6.7 21.5 7.0 11.4 7.9 14.4 11.4 19.8 23.0 16.7 12.7 19.5 10.6 7.2 10.2 13.0 19.0 8.6 32.1 13.3 14.2 13.2 8.2 10.7 14.0 20.9 6.0 6.5 8.5 20.8 21.0 12.9 8.8 7.3 20.5 9.9 19.4 6.0 13.1 15.6 14.1 10.5 10.9 5.9 15.3 10.7 11.7 5.6 4.8 11.9 10.3 5.2 15.9 7.8 13.4 8.1 8.5 12.7 12.8 11.5 24.1 9.4 18.8 27.1 11.6 20.3 9.4 0.0 2.4 0.5 4.3 3.9 5.4 13.7 4.4 5.4 4.3 12.6 5.8 5.1 0.1 7.5 4.1 3.8 4.0 3.1 9.2 14.5 10.8 12.7 9.3 6.6 16.4 7.7 14.5 13.1 17.9 10.7 18.7 20.6 21.1 20.3 20.0 10.2 28.1 47.8 21.0 7.9 18.3 21.6 16.6 2.2 24.1 2.0 0.0 11.8 11.5 13.4 12.0 28.8 9.2 11.3 12.7 5.2 13.5 14.5 3.6 17.0 13.1 11.8 25.2 6.0 21.0 12.3 2.9 23.3 18.0 20.6 12.9 21.8 59.0 70.2 19.1 12.7 13.8 8.6 13.5 NOL7 "C6orf90, dJ223E5.2, NOP27, PQBP3, RARG-1" ENSG00000225921 "Nucleolar protein 7" Q9UMY1 6 13615327-13632739 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029185 Supported Supported "Nucleoli,Mitotic chromosome,Mitochondria" Yes Yes "Nucleoli, Mitotic chromosome" Mitochondria "HPA029185: AB_10601274" "unprognostic (8.76e-2)" "unprognostic (8.94e-2)" "unprognostic (8.38e-2)" "unprognostic (1.15e-2)" "unprognostic (3.75e-1)" "unprognostic (5.77e-2)" "unprognostic (2.50e-3)" "unprognostic (1.57e-1)" "unprognostic (4.64e-2)" "prognostic favorable (3.64e-5)" "unprognostic (1.26e-1)" "unprognostic (2.03e-2)" "unprognostic (8.04e-3)" "unprognostic (2.58e-1)" "unprognostic (1.17e-1)" "unprognostic (4.86e-2)" "unprognostic (4.79e-2)" 35.8 40.5 45.2 41.4 42.3 44.9 36.6 26.7 38.7 30.5 36.7 25.9 29.2 37.2 35.2 36.7 38.6 33.0 36.6 53.4 39.9 38.4 56.9 58.6 28.8 36.6 41.6 30.2 42.4 42.6 54.0 40.5 45.6 36.8 39.5 32.4 23.1 42.3 35.6 59.3 30.6 46.4 36.7 47.7 45.2 34.8 32.5 40.4 34.3 49.5 36.9 36.0 43.3 56.0 50.7 45.5 38.3 38.0 28.8 49.6 30.9 29.8 15.5 14.6 21.0 11.4 13.2 29.7 27.4 14.9 25.7 24.4 29.4 12.6 38.5 54.3 16.6 31.4 18.5 22.0 20.7 25.2 21.6 36.0 33.1 15.4 49.4 24.5 49.1 26.1 12.4 21.8 23.5 14.5 13.4 16.7 21.7 51.3 10.5 22.2 19.2 27.9 54.5 19.1 17.5 26.6 30.2 20.8 59.2 25.6 9.9 37.2 23.9 16.0 38.8 35.8 19.0 24.1 17.9 25.3 23.7 22.3 24.3 48.1 24.6 47.7 47.0 13.6 29.1 35.8 16.0 30.2 38.3 31.0 35.3 36.6 50.7 45.5 38.3 35.9 41.4 49.6 37.8 14.0 28.8 38.0 45.5 46.9 30.9 45.2 42.3 26.7 38.7 39.9 38.4 41.6 30.2 36.8 40.4 86.4 58.0 93.0 81.6 80.6 62.4 203.3 63.7 148.5 80.8 54.1 21.6 114.5 104.5 133.3 133.2 97.2 61.4 70.0 226.4 127.6 86.4 80.3 87.8 56.9 100.9 46.1 35.6 46.6 45.5 19.9 76.5 83.5 96.2 155.9 59.8 89.8 148.3 72.9 74.6 135.1 46.0 64.7 96.7 142.1 122.5 79.2 129.9 82.8 73.6 94.7 NOP9 C14orf21 ENSG00000196943 "NOP9 nucleolar protein" Q86U38 14 24299862-24309124 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000850 Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA000850: AB_1078287" "unprognostic (1.39e-1)" "unprognostic (4.64e-2)" "unprognostic (4.57e-3)" "unprognostic (1.85e-1)" "unprognostic (8.28e-2)" "unprognostic (3.54e-1)" "unprognostic (1.69e-2)" "unprognostic (9.37e-2)" "unprognostic (7.22e-2)" "unprognostic (1.40e-1)" "unprognostic (1.09e-1)" "unprognostic (6.77e-2)" "prognostic favorable (9.39e-6)" "unprognostic (7.03e-3)" "unprognostic (3.80e-1)" "unprognostic (1.95e-1)" "unprognostic (1.59e-2)" 12.0 12.9 11.3 11.4 11.4 14.4 10.0 13.3 17.5 11.3 14.4 16.8 9.6 16.5 11.1 10.1 16.6 10.3 13.8 19.4 10.9 10.6 9.7 14.2 9.5 15.1 13.7 10.0 13.3 13.3 20.1 8.9 11.6 10.9 10.8 12.3 13.0 12.5 11.5 29.7 13.5 12.4 12.3 12.3 18.8 10.9 13.0 10.7 11.8 11.2 18.3 14.9 12.1 9.4 1.6 2.1 1.8 5.2 0.4 1.6 1.4 5.0 10.1 8.2 10.3 7.2 6.1 8.2 9.1 6.8 10.7 8.4 7.6 9.0 13.0 5.1 8.2 8.7 13.2 16.3 11.3 11.2 8.2 6.2 9.5 14.0 17.3 5.8 21.8 11.0 6.1 8.8 7.9 7.4 5.8 9.9 7.6 8.1 6.5 7.4 8.7 10.1 8.3 3.7 17.8 13.0 12.7 5.0 8.3 6.6 11.6 8.3 6.4 12.7 14.9 2.8 6.2 6.3 5.8 10.1 7.3 6.0 5.9 8.5 9.1 8.0 9.8 3.9 10.0 5.7 1.4 2.3 1.8 1.5 2.4 1.6 1.2 1.4 0.7 2.1 1.6 1.0 1.0 0.5 0.4 5.2 1.1 1.2 1.4 11.3 11.4 13.3 17.5 10.9 10.6 13.7 10.0 10.9 10.7 3.0 3.5 3.7 3.0 11.1 8.2 0.8 5.1 5.3 9.1 8.7 7.9 5.4 0.0 6.6 2.4 4.1 11.3 23.3 8.7 4.6 4.7 4.7 1.1 16.3 6.5 6.4 10.3 3.7 9.7 0.5 6.1 4.7 0.0 2.8 8.1 3.9 9.7 9.9 4.2 6.5 7.4 6.5 3.1 3.5 6.0 11.8 5.4 3.2 12.1 3.9 NPM3 ENSG00000107833 "Nucleophosmin/nucleoplasmin 3" O75607 10 101781325-101783413 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036295, HPA036296" Approved Approved "Nucleoli,Actin filaments,Cytosol" NA NA "Nucleoli, Actin filaments, Cytosol" "HPA036295: AB_10671244, HPA036296: AB_10672083" "unprognostic (3.41e-2)" "unprognostic (3.70e-2)" "unprognostic (4.33e-2)" "unprognostic (1.75e-1)" "unprognostic (8.06e-2)" "prognostic unfavorable (1.42e-4)" "unprognostic (1.00e-2)" "unprognostic (1.98e-1)" "unprognostic (5.17e-2)" "unprognostic (1.75e-1)" "unprognostic (2.45e-2)" "unprognostic (1.35e-2)" "unprognostic (2.86e-2)" "unprognostic (3.55e-2)" "unprognostic (1.81e-1)" "unprognostic (5.69e-2)" "unprognostic (9.58e-2)" 9.8 17.0 14.3 20.9 8.5 17.2 14.3 1.5 16.8 13.3 12.3 2.4 6.2 6.0 15.7 15.0 22.7 11.7 12.4 8.9 9.9 7.3 13.6 13.7 8.8 26.3 7.3 11.4 17.7 39.0 11.3 11.1 12.0 9.1 11.5 15.1 3.7 13.2 7.1 11.7 14.0 8.7 15.0 4.8 14.7 11.0 16.4 7.7 18.5 9.8 23.7 18.8 13.0 13.9 4.5 8.3 0.1 3.7 7.0 10.4 5.7 17.3 22.1 6.6 43.2 15.1 15.9 6.9 9.4 14.4 14.7 12.5 23.6 22.2 28.8 17.6 10.5 8.0 18.7 36.6 40.0 11.6 12.2 38.0 23.1 10.3 37.9 17.0 52.5 16.9 13.7 19.4 20.3 81.4 7.6 19.2 35.5 28.5 16.0 12.0 32.1 21.9 68.4 11.6 24.3 17.0 17.2 34.6 29.2 14.3 8.6 13.5 8.7 5.9 13.8 26.3 8.4 18.0 10.9 7.5 5.8 18.6 8.6 17.4 6.9 7.1 33.1 8.1 48.9 6.0 0.0 2.7 0.0 3.8 3.7 7.0 4.3 6.3 7.2 6.3 4.5 10.4 10.4 0.1 7.0 0.8 8.3 2.6 5.7 14.3 8.5 1.5 16.8 9.9 7.3 7.3 11.4 9.1 7.7 3.0 5.3 14.5 57.6 55.6 1.3 2.9 20.4 4.0 9.1 34.9 0.0 79.7 66.3 48.2 5.3 26.4 2.6 0.0 35.4 70.4 52.3 31.9 16.1 16.1 61.3 0.0 23.3 13.5 17.1 8.8 25.9 36.7 28.7 12.6 30.0 2.2 35.2 3.5 22.3 41.9 1.9 6.5 31.6 40.9 83.0 43.5 50.8 26.6 45.2 53.9 NPR1 "ANPa, ANPRA, GUCY2A, NPRA" ENSG00000169418 "Natriuretic peptide receptor 1" P16066 1 153678637-153693992 "Enzymes, FDA approved drug targets, Predicted membrane proteins" "cGMP biosynthesis" "Lyase, Receptor, Vasoactive" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 98.4" "Cell type enriched" "Detected in many" 10 "Ito cells: 136.2" "Cancer enhanced" "Detected in all" "ovarian cancer: 39.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "ASC diff: 60.5" "Region enriched" "Detected in many" 5 "olfactory region: 23.0" "Region enhanced" "Detected in single" "olfactory region: 11.1" HPA031087 Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA Nucleoli "Nucleoplasm, Plasma membrane" "HPA031087: AB_10601975" "unprognostic (2.54e-1)" "unprognostic (3.03e-3)" "unprognostic (6.31e-2)" "prognostic unfavorable (3.97e-4)" "unprognostic (1.55e-1)" "unprognostic (6.60e-2)" "unprognostic (1.54e-2)" "unprognostic (2.03e-1)" "unprognostic (2.46e-1)" "unprognostic (3.27e-2)" "prognostic favorable (2.49e-4)" "unprognostic (1.27e-1)" "unprognostic (6.69e-2)" "unprognostic (1.16e-2)" "unprognostic (1.09e-1)" "unprognostic (4.06e-1)" "unprognostic (1.74e-2)" 41.1 4.3 0.5 5.9 0.9 0.1 98.4 0.5 0.8 8.1 8.2 0.3 7.3 1.2 16.8 11.1 8.7 25.0 9.3 19.6 0.9 0.5 28.7 3.7 34.8 8.6 0.7 0.0 19.5 4.2 7.8 4.5 11.8 2.5 4.9 1.5 2.0 2.0 9.0 6.9 3.4 4.6 15.6 2.2 1.2 5.0 6.4 0.2 0.8 7.6 5.1 1.1 11.6 26.5 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 60.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 10.0 0.0 7.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 5.7 0.0 0.0 0.8 0.0 0.0 0.0 0.6 0.0 2.0 0.4 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.5 0.8 0.9 0.5 0.7 0.0 2.5 0.2 0.0 5.8 0.0 0.4 1.3 0.0 4.8 5.1 0.0 0.0 14.0 0.0 0.1 0.0 0.6 8.0 14.2 0.0 0.0 0.0 0.9 3.9 0.4 0.0 1.5 0.2 0.0 0.0 136.2 6.0 7.9 9.5 0.0 0.0 9.0 0.0 0.0 0.7 0.0 3.9 2.8 0.0 0.0 0.9 0.2 0.1 0.9 0.6 0.0 0.0 0.0 NRIP1 RIP140 ENSG00000180530 "Nuclear receptor interacting protein 1" P48552 21 14961235-15065936 "Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 5.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "REH: 41.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029785, HPA046571, HPA060036" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA029785: , HPA046571: AB_2679704, HPA060036: AB_2684193" "unprognostic (5.60e-2)" "unprognostic (1.87e-1)" "unprognostic (5.20e-3)" "unprognostic (4.64e-3)" "unprognostic (7.98e-2)" "unprognostic (2.59e-2)" "unprognostic (2.74e-1)" "unprognostic (2.75e-3)" "unprognostic (8.94e-3)" "unprognostic (1.55e-1)" "unprognostic (2.64e-2)" "unprognostic (1.65e-1)" "unprognostic (1.80e-2)" "unprognostic (6.53e-2)" "unprognostic (1.07e-1)" "unprognostic (2.72e-1)" "unprognostic (2.80e-1)" 29.0 15.0 10.8 12.6 7.5 19.6 18.4 20.8 10.5 23.1 21.2 6.7 8.5 14.5 16.6 13.4 13.1 18.8 9.0 11.8 9.3 5.8 16.0 22.7 9.3 8.9 5.9 7.3 14.4 15.8 8.3 11.2 16.8 7.2 13.9 15.8 12.7 10.3 7.7 36.5 7.6 30.3 17.3 12.9 17.0 8.4 6.8 7.7 22.1 7.3 12.4 5.9 13.0 14.9 2.6 1.7 0.5 1.4 1.2 5.6 0.7 9.7 20.7 16.3 0.0 8.2 5.3 5.8 11.6 5.2 7.8 5.9 3.8 7.7 0.0 6.6 11.0 3.6 5.1 1.0 6.9 15.7 0.0 4.5 14.7 7.2 11.9 4.9 7.4 3.2 6.5 9.7 8.0 9.4 8.1 5.7 2.2 10.4 8.1 5.1 5.5 3.4 0.0 6.6 3.9 6.2 41.5 12.8 0.3 4.5 16.9 1.4 0.0 9.6 5.1 3.9 13.3 12.4 5.6 9.8 6.3 4.2 9.8 4.7 3.9 0.0 0.0 13.8 0.0 3.2 0.0 1.4 0.5 1.0 0.8 5.6 0.9 1.0 1.1 1.7 2.6 1.7 0.6 0.3 1.2 1.4 1.7 0.5 0.7 10.8 7.5 20.8 10.5 9.3 5.8 5.9 7.3 7.2 7.7 44.7 32.8 11.5 54.8 16.6 33.5 15.3 17.8 18.7 61.4 27.9 47.1 13.0 8.3 20.2 11.9 25.5 34.2 0.0 23.8 109.4 21.7 35.8 29.1 42.3 36.7 20.6 36.1 28.3 37.6 14.4 34.8 26.2 8.5 33.3 38.8 58.9 25.8 40.3 25.5 33.6 60.2 32.3 17.0 9.3 2.3 16.4 11.8 7.7 42.0 78.2 NTRK3 TRKC ENSG00000140538 "Neurotrophic receptor tyrosine kinase 3" Q16288 15 87859751-88256768 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.8" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 58.9;Early spermatids: 85.5;Late spermatids: 103.3;Sertoli cells: 51.8;Smooth muscle cells: 37.7" "Cancer enhanced" "Detected in some" "glioma: 2.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 8 "U-138 MG: 48.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009233, HPA027484, HPA048065" Approved Supported "Nuclear membrane,Nucleoli,Nucleoli rim" NA NA 11000000 "Nucleoli, Nucleoli rim" "Nuclear membrane" "CAB009233: AB_632555, HPA027484: AB_2672297, HPA048065: AB_2680245" "unprognostic (1.27e-3)" "unprognostic (1.24e-2)" "unprognostic (1.98e-2)" "unprognostic (2.04e-2)" "unprognostic (1.65e-1)" "unprognostic (3.34e-1)" "unprognostic (3.18e-2)" "unprognostic (2.23e-2)" "unprognostic (2.34e-1)" "unprognostic (3.91e-1)" "unprognostic (2.88e-1)" "unprognostic (1.09e-1)" "unprognostic (5.78e-3)" "unprognostic (6.45e-3)" "unprognostic (1.06e-2)" "unprognostic (1.26e-2)" "unprognostic (2.49e-3)" 20.8 7.4 22.0 2.5 28.1 1.5 6.2 30.4 41.8 7.0 4.0 8.4 1.3 2.0 12.4 6.7 3.4 9.5 3.9 5.5 22.0 11.1 5.1 2.0 5.7 3.1 11.2 18.7 5.1 2.9 1.6 7.9 2.8 14.7 6.8 4.7 8.0 11.5 8.7 1.9 2.9 2.5 7.7 13.7 4.1 3.0 13.8 13.7 0.0 2.5 0.7 4.3 7.1 4.8 0.7 0.4 1.3 0.5 0.5 0.8 0.0 0.0 6.1 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 48.6 0.9 0.0 0.6 0.0 0.0 0.0 1.4 0.0 0.1 1.2 0.5 0.4 0.3 0.1 0.2 0.4 0.3 0.3 0.1 0.7 0.4 0.4 1.3 0.5 0.1 0.4 0.8 0.0 22.0 28.1 30.4 28.9 22.0 11.1 11.2 18.7 14.7 13.7 0.0 0.0 0.0 5.9 0.5 58.9 5.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 85.5 0.7 0.0 0.0 0.0 0.0 1.7 0.6 0.0 0.0 0.9 1.6 0.0 1.8 0.0 103.3 3.1 0.2 0.0 0.0 0.0 8.9 0.0 0.0 25.8 0.0 2.7 51.8 37.7 8.8 1.9 0.1 0.1 0.0 0.0 0.1 NUDT19 RP2 ENSG00000213965 "Nudix hydrolase 19" A8MXV4 19 32691961-32713796 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042761 Uncertain Nucleoplasm,Nucleoli,Cytosol No No "Nucleoplasm, Nucleoli, Cytosol" "HPA042761: " "unprognostic (1.20e-1)" "unprognostic (2.90e-1)" "unprognostic (2.35e-3)" "unprognostic (6.61e-3)" "unprognostic (2.62e-2)" "unprognostic (2.44e-1)" "unprognostic (6.18e-3)" "unprognostic (1.97e-1)" "unprognostic (3.14e-2)" "unprognostic (2.19e-1)" "unprognostic (2.99e-1)" "unprognostic (1.85e-1)" "unprognostic (1.47e-1)" "unprognostic (2.64e-2)" "unprognostic (2.81e-1)" "unprognostic (1.23e-1)" "prognostic favorable (1.35e-4)" 9.9 18.7 7.2 11.1 7.0 10.8 10.7 7.4 7.6 5.6 12.8 6.1 8.4 10.2 6.6 8.8 16.9 6.3 7.6 19.3 6.1 6.5 10.5 16.4 15.9 9.2 6.2 5.5 8.5 18.9 9.5 9.3 6.6 6.1 11.2 10.7 9.4 14.7 11.8 29.5 13.2 12.9 6.9 5.6 8.9 11.3 6.8 6.6 6.8 5.9 13.1 13.0 9.9 8.4 8.4 11.9 9.0 23.6 18.7 14.8 6.5 13.7 16.0 1.8 15.9 5.5 7.2 0.3 7.8 2.9 5.8 5.5 9.0 7.6 0.2 9.4 9.0 4.5 9.0 11.0 9.1 7.7 15.8 6.6 17.8 6.4 3.3 7.6 13.3 5.5 5.8 12.1 4.9 12.0 6.8 8.5 2.8 13.7 10.2 10.4 9.1 0.1 12.3 1.9 3.8 7.6 0.1 3.5 7.7 9.6 10.3 7.2 10.3 13.9 11.9 9.8 3.3 6.5 16.3 6.8 8.1 5.2 8.0 13.9 12.0 10.1 4.5 9.7 12.8 7.4 6.6 17.3 9.0 11.9 21.7 12.8 8.4 12.5 14.8 11.9 5.9 10.0 13.8 3.3 18.7 23.6 9.5 13.8 6.5 7.2 7.0 7.4 7.6 6.1 6.5 6.2 5.5 6.1 6.6 11.9 12.6 8.2 6.5 19.5 12.8 18.7 5.1 4.0 4.5 7.0 11.8 9.8 23.2 2.6 7.7 4.5 9.7 0.0 9.9 9.4 9.4 8.5 1.1 9.3 12.6 3.2 11.6 12.3 12.1 3.1 3.7 10.8 11.8 7.2 13.0 5.5 9.5 14.0 8.9 14.8 26.4 0.0 6.6 1.4 1.9 27.6 6.5 13.3 15.8 7.9 NUP188 KIAA0169 ENSG00000095319 "Nucleoporin 188" Q5SRE5 9 128947699-129007096 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 60.3" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 43.2;Spermatocytes: 41.6;Spermatogonia: 37.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061750, HPA063942" Approved Uncertain Nucleoplasm,Nucleoli,Cytosol No No Nucleoplasm "Nucleoli, Cytosol" "HPA061750: AB_2684602, HPA063942: AB_2685156" "unprognostic (4.64e-1)" "unprognostic (6.91e-3)" "unprognostic (2.36e-1)" "prognostic favorable (5.20e-5)" "unprognostic (9.50e-2)" "unprognostic (4.41e-2)" "unprognostic (1.85e-3)" "unprognostic (1.91e-1)" "unprognostic (1.47e-1)" "unprognostic (1.63e-1)" "unprognostic (7.78e-2)" "unprognostic (4.53e-2)" "unprognostic (1.01e-1)" "unprognostic (4.68e-2)" "unprognostic (2.87e-1)" "unprognostic (2.81e-3)" "unprognostic (3.53e-3)" 10.2 11.1 7.6 12.6 9.2 14.3 14.0 13.3 8.7 9.2 9.3 10.1 9.6 5.8 9.8 6.7 16.6 8.3 7.6 9.2 5.6 6.3 8.1 9.6 13.1 16.6 6.5 6.7 10.8 13.3 12.6 13.6 9.1 7.3 9.5 9.3 11.2 9.9 8.3 10.9 16.4 9.0 11.0 7.7 12.2 9.5 60.3 7.3 26.5 9.2 11.3 17.3 8.5 10.5 6.1 7.9 6.3 10.7 6.0 12.0 7.0 10.9 21.0 17.4 23.7 13.2 13.1 15.6 15.4 12.2 28.3 18.9 25.3 8.8 19.2 5.8 16.9 18.3 32.6 39.0 19.1 21.2 15.4 18.8 17.1 39.2 19.9 8.4 29.2 17.3 9.1 9.0 29.7 15.2 8.3 16.2 25.0 37.5 13.7 19.9 27.8 24.9 11.9 23.3 21.1 20.2 22.9 37.7 19.6 8.7 12.4 24.5 11.8 39.9 15.2 5.9 13.4 16.7 10.8 13.1 23.5 16.7 23.6 27.5 11.7 21.6 26.0 13.7 18.7 17.3 6.3 5.3 1.9 9.3 10.7 12.0 6.1 7.9 9.0 7.9 5.9 8.1 8.6 0.8 6.0 5.9 3.3 9.5 7.0 7.6 9.2 13.3 8.7 5.6 6.3 6.5 6.7 7.3 7.3 0.0 13.0 7.5 5.2 5.8 14.9 2.7 7.6 4.0 2.3 5.2 43.2 6.4 1.7 5.5 10.1 6.8 3.2 0.0 5.6 5.9 6.9 7.5 5.8 3.8 7.4 19.1 8.7 12.9 4.9 3.1 8.9 7.2 1.7 4.6 6.7 7.5 7.5 0.0 11.0 1.9 25.0 25.8 4.2 41.6 37.7 9.8 7.2 7.0 6.0 7.2 ODF3L2 "C19orf19, FLJ40059" ENSG00000181781 "Outer dense fiber of sperm tails 3 like 2" Q3SX64 19 463346-474983 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 26 "skeletal muscle: 12.5;testis: 16.7" "Cell type enriched" "Detected in some" 5 "Late spermatids: 894.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.5;BEWO: 2.2;EFO-21: 3.1;HMC-1: 2.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA067065, HPA067973" Uncertain Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA Nucleoli "Nucleoplasm, Golgi apparatus" "HPA067065: , HPA067973: AB_2685937" "unprognostic (3.75e-4)" "unprognostic (1.79e-2)" "unprognostic (1.83e-3)" "unprognostic (9.69e-3)" "unprognostic (5.88e-2)" "unprognostic (5.65e-2)" "unprognostic (9.32e-2)" "unprognostic (1.35e-1)" "unprognostic (2.34e-2)" "unprognostic (1.77e-2)" "unprognostic (2.13e-2)" "unprognostic (4.06e-2)" "unprognostic (2.02e-5)" "unprognostic (3.13e-3)" "unprognostic (8.99e-2)" "unprognostic (3.05e-1)" "unprognostic (1.99e-1)" 0.4 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.3 0.5 0.0 16.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.5 0.0 0.0 2.2 0.0 0.1 0.1 0.1 0.0 0.0 0.1 3.1 0.0 0.5 0.1 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.3 2.3 0.0 0.3 0.0 0.2 1.1 0.0 0.0 0.6 0.1 0.6 1.0 0.1 0.0 0.8 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.9 0.0 0.5 0.1 0.0 0.0 0.6 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 187.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 894.9 7.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.6 0.0 0.7 0.0 0.1 6.4 5.2 0.0 0.0 0.0 0.0 0.0 OLFM1 "AMY, NOE1, NOELIN, OlfA" ENSG00000130558 "Olfactomedin 1" Q99784 9 135075422-135121179 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 159.5" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 41.2;Horizontal cells: 36.5;Ito cells: 74.3;Leydig cells: 41.1" "Cancer enhanced" "Detected in all" "glioma: 18.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 38 "classical monocyte: 3.4;intermediate monocyte: 5.0;myeloid DC: 5.1;non-classical monocyte: 1.3" "Group enriched" "Detected in many" 51 "dendritic cells: 5.1;monocytes: 5.0" "Cell line enhanced" "Detected in some" "HeLa: 25.5;MCF7: 21.5;NTERA-2: 28.6;OE19: 20.3;SCLC-21H: 41.3;SiHa: 34.2;T-47d: 53.0;U-2197: 23.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057444 Approved Nucleoplasm,Nucleoli,Cytosol "Secreted in brain" NA NA 130000000 Nucleoli "Nucleoplasm, Cytosol" "HPA057444: AB_2683443" "unprognostic (6.77e-2)" "prognostic favorable (7.14e-4)" "unprognostic (1.01e-1)" "unprognostic (3.76e-2)" "prognostic unfavorable (6.58e-4)" "unprognostic (3.08e-1)" "unprognostic (1.30e-1)" "unprognostic (3.69e-3)" "unprognostic (2.67e-1)" "unprognostic (6.04e-2)" "unprognostic (1.58e-3)" "unprognostic (1.87e-1)" "unprognostic (9.46e-3)" "unprognostic (4.60e-2)" "unprognostic (1.51e-1)" "unprognostic (6.20e-2)" "unprognostic (7.53e-4)" 7.7 10.0 80.5 5.0 41.5 0.9 4.7 30.9 159.5 7.4 5.4 4.6 0.7 2.5 6.9 26.4 5.0 4.4 3.8 3.9 77.2 19.1 3.4 2.4 4.7 5.2 18.8 36.5 6.2 5.1 3.6 9.9 1.1 13.5 4.8 5.7 0.9 2.6 7.5 6.1 4.5 3.5 6.9 6.1 5.8 3.9 2.8 2.8 0.3 2.7 0.8 7.1 4.1 6.2 0.0 5.1 0.0 5.0 0.0 0.0 0.6 0.0 1.6 3.2 0.0 0.4 0.3 0.1 0.9 0.0 0.0 0.0 0.0 0.7 0.0 0.2 1.3 13.1 0.6 0.6 0.0 0.0 3.6 0.2 0.0 25.5 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 21.5 0.1 0.0 28.6 20.3 0.0 0.0 0.0 12.0 0.0 0.0 41.3 5.5 34.2 0.1 2.1 2.2 53.0 0.0 0.0 2.0 4.6 23.1 0.0 0.0 0.0 0.1 0.1 0.0 1.1 0.0 3.4 0.0 0.0 5.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.6 80.5 41.5 30.9 119.7 77.2 19.1 18.8 36.5 13.5 2.8 0.0 9.3 0.0 2.8 8.7 20.7 5.8 7.6 0.0 3.4 0.0 41.2 0.0 0.0 7.4 5.8 26.1 0.0 0.0 2.3 0.0 8.2 6.1 2.3 0.5 0.3 36.5 2.4 74.3 4.5 8.9 41.1 2.8 20.3 0.0 1.7 32.6 3.6 2.9 27.6 0.0 12.0 0.0 11.7 0.6 3.4 5.5 0.0 0.0 5.5 0.9 OR1N2 ENSG00000171501 "Olfactory receptor family 1 subfamily N member 2" Q8NGR9 9 122553112-122554214 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" 33 "Cardiomyocytes: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "RT4: 1.1" "Not detected" "Not detected" HPA060968 Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Nucleoli, Plasma membrane" Nucleoplasm "HPA060968: " 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 OSCP1 "C1orf102, NOR1" ENSG00000116885 "Organic solute carrier partner 1" Q8WVF1 1 36415827-36450451 "Predicted intracellular proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 35.8;testis: 49.9" "Group enriched" "Detected in many" 5 "Ciliated cells: 144.6;Early spermatids: 336.5;Spermatocytes: 91.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028436, HPA052655" Approved Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Nucleoplasm, Nucleoli" "Plasma membrane" "HPA028436: AB_10600885, HPA052655: " "unprognostic (3.46e-3)" "unprognostic (7.57e-2)" "unprognostic (4.67e-2)" "prognostic favorable (6.88e-4)" "unprognostic (1.28e-2)" "unprognostic (4.81e-2)" "unprognostic (3.38e-2)" "unprognostic (4.52e-2)" "unprognostic (5.52e-2)" "unprognostic (8.80e-2)" "unprognostic (2.21e-2)" "unprognostic (3.87e-2)" "prognostic favorable (2.18e-6)" "unprognostic (1.20e-1)" "unprognostic (2.04e-2)" "unprognostic (1.02e-2)" "unprognostic (4.20e-2)" 3.9 5.3 6.2 1.5 14.0 1.2 6.0 3.6 12.7 6.2 3.6 6.5 7.5 1.8 6.3 14.1 3.2 35.8 5.5 4.7 6.5 8.9 11.9 1.8 6.7 1.3 4.9 5.3 5.9 6.2 15.7 15.7 8.9 7.8 6.4 2.5 6.7 5.3 6.8 2.4 3.4 1.3 5.0 3.2 0.9 3.5 49.9 3.2 1.3 11.1 3.5 2.4 3.2 2.6 0.8 3.8 0.3 1.7 0.3 3.1 0.8 5.2 5.0 6.2 7.1 7.4 7.2 1.1 3.2 7.8 7.9 5.4 0.1 4.6 1.1 6.0 5.7 5.8 4.1 0.2 6.0 5.1 0.9 4.7 0.0 3.3 0.5 9.1 0.6 0.9 8.1 9.8 11.1 4.9 11.5 5.4 5.0 0.1 1.3 6.2 3.7 2.7 1.9 6.3 2.0 2.1 2.9 2.5 0.9 12.9 1.8 16.6 7.3 5.9 2.8 4.1 6.1 6.1 0.9 4.6 5.7 2.1 10.3 5.3 2.3 2.3 0.5 11.0 0.1 3.8 0.0 0.7 0.0 0.9 1.7 0.0 0.4 0.9 0.7 1.8 0.8 2.2 3.1 0.3 0.3 0.2 3.8 2.2 0.8 6.2 14.0 3.6 12.7 6.5 8.9 4.9 5.3 7.8 3.2 8.9 7.5 0.5 6.7 1.3 5.3 4.7 5.1 144.6 19.4 12.2 15.7 9.8 19.9 11.2 336.5 2.4 0.7 0.0 8.1 2.6 4.1 4.3 0.0 1.9 3.8 4.8 4.7 2.5 0.6 35.1 11.5 1.2 3.3 0.0 2.6 12.3 7.9 4.0 8.5 18.1 18.9 0.0 3.3 91.2 18.9 2.8 16.8 0.7 2.6 3.3 OSER1 "C20orf111, dJ1183I21.1, HSPC207, Osr1, Perit1" ENSG00000132823 "Oxidative stress responsive serine rich 1" Q9NX31 20 44196496-44210791 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 722.5;Late spermatids: 1504.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045125 Approved Approved "Nucleoli,Nucleoli rim,Nuclear speckles" NA Yes "Nucleoli, Nucleoli rim, Nuclear speckles" "HPA045125: AB_10961629" "unprognostic (2.77e-2)" "unprognostic (3.01e-2)" "unprognostic (3.22e-1)" "prognostic unfavorable (2.58e-5)" "unprognostic (1.18e-1)" "unprognostic (6.07e-2)" "unprognostic (8.44e-3)" "unprognostic (3.31e-1)" "unprognostic (1.14e-1)" "unprognostic (8.78e-2)" "unprognostic (8.01e-3)" "unprognostic (9.87e-2)" "unprognostic (3.96e-1)" "unprognostic (2.14e-1)" "unprognostic (2.45e-1)" "unprognostic (8.39e-2)" "unprognostic (1.06e-1)" 18.7 11.8 11.9 18.4 13.3 62.5 20.0 17.8 13.3 19.1 17.2 13.0 13.0 15.1 17.5 17.6 23.5 14.2 13.7 16.9 12.4 10.0 15.0 16.3 17.7 16.9 16.3 10.9 21.4 10.9 19.3 12.5 31.7 13.1 22.6 14.1 12.4 17.0 13.2 46.3 22.3 18.9 23.5 16.9 18.2 14.7 47.4 13.3 15.1 19.0 15.4 17.4 29.6 16.7 28.4 14.6 74.3 21.9 15.1 17.6 19.8 20.4 16.0 11.6 9.1 31.1 22.2 13.5 18.9 28.5 29.8 27.4 38.3 21.2 20.5 18.7 17.2 38.8 27.9 13.2 17.4 25.1 6.9 8.6 6.6 34.5 25.9 18.0 11.3 11.0 26.3 29.3 19.5 35.8 15.5 13.5 12.5 9.7 25.3 16.3 30.6 9.1 13.8 10.6 18.7 16.4 12.7 19.7 14.1 14.8 14.0 11.7 11.8 26.9 35.8 23.9 14.3 18.2 10.2 11.8 24.6 18.9 14.6 16.2 17.2 18.4 19.9 17.4 8.5 12.7 50.2 16.8 27.7 12.7 15.7 13.7 28.4 14.8 12.5 14.6 26.9 17.6 15.9 74.3 15.1 21.9 9.5 17.1 19.8 11.9 13.3 17.8 13.3 12.4 10.0 16.3 10.9 13.1 13.3 17.9 28.4 24.4 119.5 230.4 9.6 33.9 17.8 24.1 22.7 12.2 3.9 33.6 31.5 38.1 722.5 31.5 56.3 0.0 32.0 30.4 33.9 80.1 33.4 26.0 38.1 11.1 47.4 17.2 27.0 1504.1 37.7 43.4 72.6 117.2 30.0 23.4 42.0 45.6 33.2 26.2 14.1 19.4 49.5 76.2 55.8 173.4 145.2 35.9 35.3 99.2 P3H3 "GRCB, HSU47926, LEPREL2" ENSG00000110811 "Prolyl 3-hydroxylase 3" Q8IVL6 12 6828410-6839851 "Enzymes, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Bipolar cells: 28.3;Cone photoreceptor cells: 94.2;Horizontal cells: 41.3;Leydig cells: 46.1;Peritubular cells: 36.0;Rod photoreceptor cells: 26.9" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.1;naive CD4 T-cell: 1.7" "Lineage enriched" "Detected in single" 21 "T-cells: 2.1" "Cell line enhanced" "Detected in many" "BJ: 22.1;hTERT-RPE1: 15.7;NTERA-2: 15.7;U-251 MG: 15.3" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 17.6" HPA043695 Approved Approved "Nucleoli,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane, Cytosol" Nucleoli "HPA043695: AB_10797146" "unprognostic (2.54e-1)" "unprognostic (6.66e-2)" "unprognostic (1.14e-1)" "unprognostic (3.34e-2)" "unprognostic (5.76e-2)" "unprognostic (6.55e-2)" "unprognostic (2.66e-1)" "unprognostic (2.92e-1)" "unprognostic (6.90e-2)" "unprognostic (1.44e-1)" "prognostic favorable (4.91e-4)" "unprognostic (1.29e-1)" "prognostic unfavorable (1.64e-4)" "unprognostic (2.58e-2)" "unprognostic (9.67e-2)" "unprognostic (2.27e-1)" "unprognostic (7.77e-3)" 3.7 3.1 1.2 2.2 2.6 0.3 3.0 10.7 2.5 12.1 2.7 0.0 7.6 1.1 11.0 8.5 2.5 2.1 5.6 4.4 1.2 1.1 0.4 1.6 1.9 0.0 2.2 9.3 3.6 12.1 7.4 2.5 0.8 5.6 0.5 8.1 5.9 6.5 0.5 1.8 1.7 8.8 0.5 1.0 2.8 2.1 0.1 0.0 3.5 1.2 1.4 5.9 4.7 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.8 4.2 7.9 4.9 6.0 0.1 22.1 12.7 7.0 7.7 0.3 0.0 0.0 0.3 8.3 0.2 0.0 2.5 0.2 1.6 0.0 10.6 0.5 2.3 1.0 3.4 0.5 0.0 6.5 0.2 3.4 1.9 15.7 7.4 0.7 2.0 0.0 3.3 0.0 0.0 0.2 15.7 0.0 0.6 0.0 3.9 0.1 0.3 0.0 1.6 6.0 0.0 0.0 2.4 2.1 0.1 0.1 12.9 6.9 10.3 10.6 15.3 0.0 0.1 0.2 5.9 0.0 2.7 0.0 0.0 0.0 0.3 0.0 2.1 0.0 0.0 0.9 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.8 0.0 28.3 9.0 2.5 2.7 3.4 5.2 94.2 0.3 1.7 1.6 0.7 2.3 0.0 0.0 2.3 0.4 7.4 4.6 0.0 0.0 1.2 41.3 1.2 3.7 0.0 1.3 46.1 0.0 0.0 1.8 2.5 4.8 1.9 0.0 36.0 0.3 26.9 6.5 9.2 0.7 0.9 0.0 0.8 0.0 0.4 1.4 PAFAH1B2 ENSG00000168092 "Platelet activating factor acetylhydrolase 1b catalytic subunit 2" P68402 11 117144267-117176894 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051836 Approved Supported "Nucleoli,Plasma membrane,Cytosol" NA NA 1600000 Cytosol "Nucleoli, Plasma membrane" "HPA051836: AB_2681630" "unprognostic (1.08e-2)" "unprognostic (3.14e-2)" "unprognostic (2.07e-2)" "unprognostic (3.88e-2)" "unprognostic (9.94e-2)" "unprognostic (1.21e-3)" "prognostic unfavorable (9.44e-4)" "prognostic unfavorable (3.07e-4)" "unprognostic (1.01e-1)" "prognostic favorable (4.25e-4)" "prognostic unfavorable (7.79e-5)" "unprognostic (8.18e-2)" "unprognostic (1.11e-2)" "unprognostic (9.97e-2)" "unprognostic (3.25e-1)" "unprognostic (2.46e-1)" "unprognostic (1.34e-1)" 21.5 34.1 30.6 19.2 29.7 33.5 32.3 43.5 41.3 21.6 20.2 33.3 12.7 21.1 23.4 22.8 23.3 20.8 19.3 26.2 31.9 36.8 24.6 22.5 20.5 17.7 39.3 31.6 23.6 23.0 23.1 24.2 26.9 39.6 22.2 19.6 17.3 19.3 17.4 14.1 20.8 18.0 19.9 51.6 18.3 21.4 29.9 26.3 15.1 30.9 10.8 20.4 25.9 20.3 26.8 21.6 36.8 35.7 18.9 31.4 26.9 15.0 17.2 19.9 28.7 22.2 15.6 15.5 25.3 22.1 14.1 12.9 31.4 33.2 16.2 36.3 30.3 14.1 24.1 28.9 32.7 18.6 14.5 11.1 41.8 15.7 20.1 19.9 14.4 16.0 17.2 25.9 28.1 35.5 15.4 23.0 9.1 22.1 12.4 21.5 9.6 13.9 21.2 18.2 20.9 13.6 15.6 22.5 17.8 21.5 23.5 22.2 29.4 29.2 22.1 9.6 17.6 24.6 12.4 36.8 25.8 17.1 12.6 17.9 3.9 6.0 21.8 10.4 27.7 21.6 32.1 30.8 26.7 24.2 33.3 28.2 26.8 28.0 25.3 21.6 25.4 29.3 31.4 36.8 18.9 35.7 15.8 19.5 26.9 30.6 29.7 43.5 37.8 31.9 36.8 39.3 31.6 39.6 26.3 26.8 33.3 41.0 38.7 108.6 36.9 31.1 68.8 17.4 26.1 62.8 45.2 36.3 39.7 52.6 7.3 54.4 31.6 0.0 34.5 77.2 42.9 53.9 18.5 39.2 38.5 44.5 79.3 57.7 59.6 8.9 42.0 55.7 47.2 49.5 37.2 33.5 72.8 46.7 32.2 44.8 33.5 12.9 46.4 45.1 75.6 101.4 45.7 38.5 39.1 38.8 PBDC1 "CXorf26, MGC874" ENSG00000102390 "Polysaccharide biosynthesis domain containing 1" Q9BVG4 X 76172936-76178204 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003155 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA 88000 Nucleoplasm "Nucleoli, Cytosol" "HPA003155: AB_1078592" "unprognostic (6.95e-2)" "unprognostic (9.85e-2)" "unprognostic (1.02e-2)" "unprognostic (3.78e-2)" "unprognostic (2.09e-1)" "unprognostic (2.51e-2)" "unprognostic (2.47e-3)" "unprognostic (7.23e-2)" "unprognostic (1.78e-1)" "unprognostic (1.56e-3)" "unprognostic (8.82e-3)" "unprognostic (3.64e-1)" "unprognostic (1.39e-2)" "unprognostic (1.05e-1)" "unprognostic (4.98e-2)" "prognostic favorable (8.57e-4)" "unprognostic (1.62e-1)" 24.9 25.4 12.7 15.1 14.3 28.9 17.1 15.3 14.9 21.3 31.5 10.0 14.8 28.5 21.3 18.4 26.9 15.1 14.2 14.7 12.5 12.5 36.3 39.1 16.6 17.0 17.6 8.8 23.1 16.1 15.2 22.8 21.9 15.0 22.3 20.9 10.3 18.0 14.3 19.2 19.5 48.9 22.3 22.7 23.8 17.8 8.4 14.6 21.1 22.5 21.2 18.2 20.8 17.6 28.1 24.0 17.0 27.8 27.1 30.6 17.1 12.1 17.7 15.2 10.4 19.5 19.5 13.1 21.6 18.5 19.9 17.2 16.9 16.8 16.6 14.6 21.8 24.8 17.5 25.3 24.2 26.0 12.3 16.0 12.3 9.9 25.3 30.7 36.1 18.1 15.5 19.9 27.2 23.3 12.1 25.3 6.0 17.4 8.3 24.3 14.2 17.0 26.5 42.2 30.2 27.8 14.6 16.0 2.1 29.1 22.5 8.9 11.5 9.5 15.9 0.1 20.5 9.7 13.6 21.7 14.9 14.9 17.7 19.7 14.6 25.8 9.9 16.5 12.7 11.7 6.7 17.6 17.0 30.6 25.6 22.2 28.1 27.5 29.7 22.5 23.7 28.2 26.9 3.3 27.1 27.8 24.0 22.5 17.1 12.7 14.3 15.3 14.9 12.5 12.5 17.6 8.8 15.0 14.6 32.8 23.2 24.8 69.4 47.1 21.4 36.9 33.1 33.5 30.7 38.4 13.7 48.2 41.4 60.7 1.0 28.6 58.6 0.0 54.4 49.7 36.0 52.4 50.7 46.4 62.6 7.9 26.5 19.6 30.5 1.1 44.3 40.9 43.9 80.2 37.2 21.5 53.5 34.8 36.4 66.3 19.3 51.8 41.1 2.3 16.4 61.6 46.0 44.5 46.0 68.1 PCDH1 pc42 ENSG00000156453 "Protocadherin 1" Q08174 5 141853111-141879246 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 37.9;Exocrine glandular cells: 40.1;Pancreatic endocrine cells: 44.8;Urothelial cells: 43.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.2;naive CD8 T-cell: 1.6" "Lineage enriched" "Detected in single" 6 "T-cells: 2.2" "Cell line enhanced" "Detected in many" "CAPAN-2: 29.5;HaCaT: 36.8;HUVEC TERT2: 19.3;OE19: 26.1;RT4: 25.2;TIME: 25.1;WM-115: 17.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047720, HPA050538" Enhanced Approved "Nucleoplasm,Nucleoli,Cell Junctions" NA NA 270000 "Nucleoplasm, Cell Junctions" Nucleoli "HPA047720: AB_2680130, HPA050538: AB_2681162" "unprognostic (4.67e-2)" "unprognostic (1.79e-1)" "unprognostic (5.30e-2)" "unprognostic (4.61e-3)" "unprognostic (5.03e-2)" "unprognostic (4.16e-2)" "prognostic unfavorable (4.96e-5)" "unprognostic (1.98e-2)" "unprognostic (4.87e-2)" "unprognostic (1.31e-1)" "prognostic unfavorable (3.61e-4)" "unprognostic (2.43e-1)" "prognostic favorable (7.55e-5)" "unprognostic (2.05e-1)" "unprognostic (4.16e-2)" "unprognostic (3.13e-2)" "unprognostic (1.91e-1)" 22.4 4.5 14.8 7.4 17.6 1.4 19.0 16.1 25.6 8.3 22.2 7.3 11.4 20.6 7.0 7.0 26.9 9.7 6.8 8.9 11.6 7.4 14.9 13.0 18.9 3.4 8.8 16.9 2.5 11.0 1.3 5.2 32.5 9.2 11.1 14.4 6.0 23.7 12.3 7.4 17.3 15.8 7.5 7.5 1.6 22.8 1.5 9.8 0.0 9.1 3.9 8.8 8.6 11.7 0.0 0.0 0.3 0.0 0.0 2.2 0.5 6.2 0.3 2.6 2.9 0.1 0.0 1.9 0.0 0.0 0.0 0.0 1.5 29.5 0.0 15.2 0.2 0.3 36.8 3.4 2.7 0.0 0.0 0.1 0.0 0.1 0.0 2.4 0.0 0.1 0.0 6.2 0.0 0.4 6.3 19.3 0.0 0.0 3.1 0.0 5.0 0.1 0.0 11.2 26.1 5.0 0.1 0.0 4.2 2.1 25.2 0.3 0.6 0.1 8.1 6.5 7.9 6.5 0.1 25.1 0.0 0.2 0.0 2.3 0.0 0.0 0.0 0.2 0.0 17.8 0.0 0.0 0.3 2.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.4 0.5 14.8 17.6 16.1 25.6 11.6 7.4 8.8 16.9 9.2 9.8 0.0 4.0 0.0 10.2 0.9 9.1 2.2 22.9 4.0 2.3 12.2 0.0 0.6 3.3 13.6 0.3 21.8 37.9 0.0 40.1 0.2 1.6 22.4 0.0 26.0 0.2 25.4 7.5 6.2 1.9 0.8 0.6 0.5 0.0 0.0 17.6 4.0 44.8 19.3 0.4 5.1 0.4 12.9 15.1 0.2 0.2 2.3 16.8 0.0 14.7 43.0 PCDHAC1 ENSG00000248383 "Protocadherin alpha subfamily C, 1" Q9H158 5 140926369-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "parathyroid gland: 33.3" "Cell type enhanced" "Detected in some" 27 "Alveolar cells type 1: 6.0;Bipolar cells: 1.7;Ciliated cells: 1.4;Rod photoreceptor cells: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 8.7;EFO-21: 3.7;hTCEpi: 11.3;PC-3: 6.4;SCLC-21H: 5.0" "Low region specificity" "Detected in all" HPA052775 Approved Nucleoplasm,Nucleoli,Vesicles No No "Nucleoplasm, Nucleoli" Vesicles "HPA052775: AB_2681942" "unprognostic (2.52e-1)" "unprognostic (1.06e-1)" "unprognostic (3.32e-3)" "unprognostic (9.52e-3)" "unprognostic (1.36e-1)" "unprognostic (9.63e-2)" "unprognostic (4.27e-2)" "unprognostic (2.51e-2)" "unprognostic (1.17e-1)" "unprognostic (6.24e-2)" "unprognostic (2.09e-1)" "unprognostic (3.64e-3)" "unprognostic (1.04e-3)" "unprognostic (3.25e-3)" "unprognostic (1.35e-1)" "unprognostic (2.96e-1)" "unprognostic (3.29e-2)" 0.3 0.4 0.9 0.3 1.0 0.0 0.0 2.0 2.8 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.9 0.0 1.0 1.6 0.2 0.1 0.8 1.0 1.1 0.0 1.5 33.3 1.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.8 0.8 0.4 0.0 0.0 0.2 0.1 0.5 0.2 0.2 0.1 0.0 0.0 8.7 1.2 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.7 0.0 1.1 0.0 0.3 1.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 11.3 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.1 6.4 0.0 0.0 0.0 0.5 0.4 5.0 2.4 0.0 0.7 0.0 1.2 0.5 0.0 0.0 0.6 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.5 0.2 0.2 0.1 0.0 0.0 6.0 0.3 0.0 0.0 0.0 1.7 0.3 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 PDGFRL PRLTS ENSG00000104213 "Platelet derived growth factor receptor like" Q15198 8 17576433-17644071 "Disease related genes, Predicted secreted proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 14.3" "Cell type enhanced" "Detected in many" 11 "Fibroblasts: 36.0;Leydig cells: 69.0;Peritubular cells: 66.4" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 1.4;neutrophil: 1.4" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "AN3-CA: 49.5;BJ hTERT+: 40.1;HSkMC: 21.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA052801 Approved "Nucleoplasm,Nucleoli,Golgi apparatus" "Secreted - unknown location" NA NA "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA052801: AB_2681956" "unprognostic (1.25e-1)" "unprognostic (1.73e-1)" "unprognostic (5.10e-2)" "unprognostic (1.59e-2)" "unprognostic (7.39e-3)" "unprognostic (1.31e-1)" "unprognostic (1.32e-1)" "unprognostic (6.54e-2)" "unprognostic (3.86e-1)" "unprognostic (7.46e-2)" "unprognostic (1.63e-1)" "unprognostic (6.72e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.58e-3)" "unprognostic (1.26e-1)" "unprognostic (4.47e-3)" "unprognostic (6.00e-3)" 7.7 0.4 0.5 0.1 0.9 0.0 14.3 0.6 0.5 8.0 1.3 0.0 3.6 2.0 0.3 5.8 2.6 1.2 0.3 0.4 0.4 0.3 0.7 0.0 0.4 11.6 1.6 2.3 2.0 1.5 0.9 0.0 1.4 1.1 3.3 1.8 0.6 6.3 0.5 0.2 1.0 0.9 8.3 0.0 0.9 2.0 0.0 0.9 1.4 1.4 0.0 0.0 0.1 0.0 4.5 0.2 49.5 1.5 0.6 3.2 0.9 40.1 1.8 8.0 0.2 0.0 0.0 0.2 0.6 6.0 0.0 2.7 0.2 1.0 0.0 3.0 0.0 1.4 1.0 3.8 0.0 0.0 21.9 0.0 2.2 0.0 0.0 3.3 0.4 0.0 0.6 0.2 3.2 0.0 0.1 2.4 0.2 0.7 0.0 0.0 0.1 0.2 2.9 0.1 0.3 0.3 0.3 0.8 3.0 0.1 0.0 0.6 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 2.2 0.0 0.4 11.7 0.4 2.2 0.0 0.0 3.4 0.0 0.0 14.1 0.0 2.5 19.2 2.7 0.1 0.0 6.4 17.2 36.0 1.7 0.0 0.0 2.7 0.0 1.2 2.5 0.0 3.1 69.0 0.3 10.1 2.8 1.0 1.3 4.9 0.0 66.4 0.0 0.4 0.0 6.1 0.5 1.0 8.7 8.1 0.0 0.2 0.3 PELI1 ENSG00000197329 "Pellino E3 ubiquitin protein ligase 1" Q96FA3 2 64092652-64144454 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 105.7" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 199.1;Suprabasal keratinocytes: 190.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 33.9" "Group enriched" "Detected in all" 4 "granulocytes: 33.9;monocytes: 9.2" "Cell line enhanced" "Detected in many" "CACO-2: 21.8;U-698: 54.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053182 Uncertain Approved "Nucleoplasm,Nucleoli,Intermediate filaments" NA NA "Nucleoplasm, Nucleoli, Intermediate filaments" "HPA053182: AB_2682072" "unprognostic (3.33e-2)" "unprognostic (3.43e-2)" "unprognostic (1.79e-2)" "prognostic unfavorable (5.33e-4)" "unprognostic (1.91e-2)" "unprognostic (3.12e-3)" "unprognostic (6.73e-3)" "unprognostic (8.01e-3)" "unprognostic (4.16e-2)" "unprognostic (3.52e-3)" "unprognostic (5.99e-3)" "unprognostic (3.33e-1)" "prognostic unfavorable (5.67e-6)" "unprognostic (6.72e-2)" "unprognostic (6.22e-2)" "unprognostic (8.88e-2)" "unprognostic (1.03e-1)" 15.7 5.1 10.0 15.1 20.5 105.7 22.3 15.1 8.9 9.9 14.5 11.0 3.3 9.9 14.5 7.1 26.4 8.0 14.9 11.6 11.3 6.8 6.7 8.6 20.1 16.8 15.6 5.2 4.8 6.2 11.0 14.8 13.7 10.8 7.6 11.8 6.0 12.3 8.5 4.5 17.5 17.3 8.4 15.0 17.8 10.2 7.8 12.8 19.9 6.3 10.2 19.3 14.1 14.8 3.9 2.3 33.9 9.2 1.3 5.0 2.5 1.3 1.0 14.0 9.3 1.6 1.2 3.2 1.8 2.0 1.6 2.6 21.8 1.5 17.9 4.4 0.6 0.6 2.1 4.2 3.9 3.3 4.4 3.3 1.6 0.7 3.5 4.9 1.7 3.2 1.6 3.1 2.4 8.4 1.7 9.2 6.9 1.0 4.5 1.4 0.1 3.8 2.5 9.1 4.1 0.6 4.8 4.8 10.2 6.7 4.0 6.4 9.0 1.3 2.1 4.8 4.5 1.1 1.2 6.5 1.5 2.2 1.5 2.6 10.4 1.0 54.2 0.8 1.6 4.1 5.1 6.5 6.3 0.4 6.1 0.7 3.9 2.2 0.9 2.3 2.4 2.7 1.1 33.9 1.3 9.2 0.2 5.0 2.5 10.0 20.5 15.1 8.8 11.3 6.8 15.6 5.2 10.8 12.8 26.8 45.1 22.4 65.1 199.1 0.9 5.1 10.2 30.8 55.7 5.2 0.0 1.4 1.7 4.5 8.5 42.7 37.0 0.0 23.1 6.5 25.9 43.3 14.0 6.8 19.1 3.2 24.6 36.2 52.6 7.8 1.4 57.1 106.3 13.6 22.2 4.5 18.2 28.1 1.8 7.7 1.8 0.0 48.4 6.1 7.8 190.1 3.3 11.5 27.3 104.0 PELI2 ENSG00000139946 "Pellino E3 ubiquitin protein ligase family member 2" Q9HAT8 14 56117814-56301526 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 4 "cerebellum: 21.4" "Cell type enhanced" "Detected in many" "neutrophil: 9.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 19.3;JURKAT: 24.9;MOLT-4: 21.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053182 Uncertain Approved "Nucleoplasm,Nucleoli,Intermediate filaments" NA NA "Nucleoplasm, Nucleoli, Intermediate filaments" "HPA053182: AB_2682072" "unprognostic (3.26e-1)" "unprognostic (2.25e-1)" "unprognostic (9.21e-2)" "unprognostic (8.94e-3)" "unprognostic (1.57e-1)" "unprognostic (1.68e-1)" "unprognostic (2.53e-2)" "unprognostic (3.36e-3)" "unprognostic (1.81e-1)" "unprognostic (2.68e-2)" "unprognostic (1.18e-1)" "unprognostic (2.14e-1)" "prognostic favorable (1.53e-6)" "unprognostic (3.64e-1)" "unprognostic (2.15e-1)" "unprognostic (5.43e-2)" "unprognostic (2.22e-1)" 12.3 3.3 5.2 5.6 4.6 16.5 8.7 21.4 6.5 7.5 9.4 5.4 9.7 11.1 9.3 7.1 4.7 5.9 11.5 3.4 4.6 4.5 9.7 3.1 7.3 4.8 5.2 3.9 16.0 38.9 1.7 5.5 3.3 4.4 8.2 4.2 9.2 7.6 12.4 3.8 6.5 12.6 17.7 5.8 6.6 14.1 10.0 4.2 38.2 4.9 3.4 2.6 13.3 14.9 0.9 2.0 9.0 3.0 0.5 0.8 1.1 0.0 1.8 5.1 0.0 2.8 4.2 0.1 0.7 2.4 0.5 0.0 0.1 0.4 0.1 2.4 1.4 0.0 0.5 3.9 0.0 0.2 1.2 1.4 4.4 7.9 0.0 2.4 0.6 19.3 2.7 0.2 0.0 0.0 2.8 0.9 24.9 3.2 0.0 0.5 0.0 21.6 0.2 8.3 0.0 0.7 10.6 0.3 0.9 2.1 8.7 10.2 0.0 0.4 0.0 5.7 3.3 0.0 3.5 0.3 1.5 2.6 0.4 2.5 0.4 0.0 0.5 2.7 3.0 1.5 1.4 3.0 3.5 0.5 1.6 0.8 0.2 0.6 0.3 2.0 0.9 0.4 0.3 9.0 0.5 1.2 0.5 0.0 1.1 5.2 4.6 21.4 4.4 4.6 4.5 5.2 3.9 4.4 4.2 0.0 7.7 2.7 11.0 12.7 30.0 1.9 7.6 14.7 10.3 12.2 27.5 0.0 3.3 4.4 2.3 10.9 8.4 0.0 12.2 0.1 5.6 7.0 5.7 0.8 1.1 20.6 6.9 11.1 16.5 4.1 15.8 11.1 16.9 2.8 7.4 10.0 8.6 3.7 17.0 8.8 18.5 12.9 22.1 1.4 27.2 15.9 0.1 3.5 3.0 9.7 PELI3 MGC35521 ENSG00000174516 "Pellino E3 ubiquitin protein ligase family member 3" Q8N2H9 11 66466327-66477337 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Horizontal cells: 20.6;Intestinal endocrine cells: 25.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033750, HPA038875, HPA062281" Uncertain Approved Nucleoplasm,Nucleoli,Vesicles NA NA "Nucleoplasm, Vesicles" Nucleoli "CAB033750: AB_2161361, HPA038875: AB_2676249, HPA062281: AB_2684735" "unprognostic (1.15e-1)" "unprognostic (1.58e-1)" "unprognostic (3.04e-1)" "unprognostic (1.43e-1)" "unprognostic (1.02e-2)" "unprognostic (1.89e-2)" "unprognostic (1.30e-2)" "unprognostic (1.94e-1)" "unprognostic (1.35e-1)" "unprognostic (1.19e-1)" "unprognostic (2.19e-3)" "unprognostic (7.91e-3)" "prognostic favorable (8.19e-4)" "unprognostic (1.59e-1)" "unprognostic (1.44e-1)" "unprognostic (1.91e-1)" "unprognostic (3.01e-2)" 6.7 9.5 14.5 3.8 17.0 1.8 7.4 19.6 33.1 7.4 8.3 6.7 6.4 4.8 10.3 9.1 10.6 8.2 10.1 7.7 17.4 13.5 4.6 3.2 7.1 4.3 13.0 12.5 15.3 9.9 21.5 8.3 3.8 15.8 11.5 2.9 6.4 10.4 22.3 10.8 11.2 4.7 11.3 6.2 5.0 5.8 6.2 7.8 0.3 8.5 2.7 3.4 9.0 11.8 3.3 3.3 1.3 6.8 1.2 3.1 1.4 15.5 6.6 5.4 4.2 8.6 3.4 4.3 5.0 6.5 4.8 4.1 9.6 3.5 3.9 5.0 5.4 8.6 8.4 3.5 6.3 2.0 7.6 3.1 1.0 5.4 2.8 5.4 0.8 7.6 3.2 7.1 4.9 1.7 7.0 1.0 5.2 1.8 6.1 2.0 9.5 3.2 2.4 3.4 8.2 6.8 10.8 3.9 4.1 2.6 5.0 6.5 3.6 2.5 7.2 17.0 2.4 8.4 4.2 2.7 4.2 6.5 18.3 4.1 5.6 3.2 2.1 8.9 2.5 3.5 1.3 2.5 0.4 2.5 1.8 2.0 2.8 2.1 3.1 3.3 3.3 2.2 1.8 0.1 1.2 6.8 1.0 2.4 1.4 14.5 17.0 19.6 33.1 17.4 13.5 13.0 12.5 15.8 7.8 6.0 1.3 0.0 3.4 1.4 12.1 6.2 2.5 0.0 0.0 0.0 9.8 1.9 1.7 2.7 3.7 2.5 0.0 0.0 2.1 1.7 3.1 2.0 0.0 2.4 2.9 20.6 25.4 1.8 0.6 5.6 6.9 3.2 0.0 2.8 0.5 5.5 1.9 0.8 9.2 2.2 8.5 6.5 4.8 1.9 3.2 0.3 0.2 0.0 0.6 1.6 PFDN1 PFD1 ENSG00000113068 "Prefoldin subunit 1" O60925 5 140245039-140303121 "Predicted intracellular proteins, Predicted membrane proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006499 Approved Approved "Nucleoli,Plasma membrane,Cytosol" NA NA 10000 "Plasma membrane, Cytosol" Nucleoli "HPA006499: AB_1079596" "unprognostic (2.73e-1)" "unprognostic (1.48e-1)" "unprognostic (1.37e-1)" "unprognostic (3.00e-2)" "unprognostic (6.11e-2)" "unprognostic (5.66e-3)" "prognostic unfavorable (8.81e-5)" "unprognostic (2.12e-2)" "unprognostic (2.19e-1)" "unprognostic (1.89e-1)" "unprognostic (1.50e-1)" "unprognostic (2.33e-1)" "unprognostic (4.10e-1)" "unprognostic (8.60e-3)" "unprognostic (2.53e-1)" "unprognostic (3.53e-2)" "unprognostic (3.00e-1)" 36.1 24.8 39.5 18.8 38.8 26.4 25.8 28.5 48.7 23.1 27.0 29.3 15.8 20.9 28.2 29.6 26.8 22.5 18.6 46.7 38.2 34.7 32.7 20.2 24.2 21.6 38.8 35.3 20.6 18.1 26.5 19.9 26.9 45.6 24.3 23.0 19.8 23.1 24.4 69.5 20.9 22.0 32.1 37.1 23.1 19.2 19.6 24.1 23.7 24.4 28.7 25.5 23.0 19.2 38.9 36.3 45.6 46.4 39.5 45.1 37.2 39.1 18.4 32.8 18.9 21.5 22.1 31.7 53.6 26.7 41.2 45.9 39.1 25.1 26.4 54.2 28.5 43.1 14.6 23.8 52.6 48.6 27.9 24.0 23.4 18.8 25.2 25.3 48.1 18.4 23.5 28.0 35.0 36.9 26.7 45.2 31.1 20.9 17.3 34.6 17.5 32.7 33.0 21.7 16.0 27.6 23.2 46.7 19.4 46.0 18.0 18.6 19.6 40.1 35.3 30.6 32.1 24.1 28.5 58.1 29.1 28.9 17.1 47.9 16.9 43.3 68.4 29.4 31.8 33.7 43.2 31.1 45.6 33.4 46.4 35.3 38.9 38.4 38.4 36.3 35.9 38.5 34.6 5.1 39.5 44.1 33.9 45.1 37.2 39.5 38.8 28.5 48.7 38.2 34.7 38.8 35.3 45.6 24.1 62.5 27.0 57.4 56.0 33.8 39.1 71.1 56.0 54.9 56.9 62.8 43.2 99.5 104.5 108.2 2.6 70.9 60.6 70.0 88.5 69.1 54.6 45.1 52.1 56.2 74.9 23.8 44.7 68.2 54.4 9.4 48.3 63.8 70.9 117.2 33.8 53.2 101.0 51.8 49.1 83.4 38.8 64.7 38.1 20.0 47.7 30.6 71.6 50.7 39.3 59.1 PGAM2 PGAM-M ENSG00000164708 "Phosphoglycerate mutase 2" P15259 7 44062727-44065587 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Glycolysis "Hydrolase, Isomerase" "Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 12 "heart muscle: 111.6;skeletal muscle: 379.1;tongue: 119.0" "Group enriched" "Detected in many" 13 "Early spermatids: 421.0;Late spermatids: 1332.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "eosinophil: 1.2;neutrophil: 1.1;plasmacytoid DC: 1.3;T-reg: 1.7" "Group enriched" "Detected in many" 4 "dendritic cells: 1.3;granulocytes: 1.2;T-cells: 1.7" "Cell line enriched" "Detected in some" 9 "SCLC-21H: 39.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA043801, HPA050314, HPA060173" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol NA NA 60000000 Nucleoplasm "Nucleoli, Cytosol" "HPA043801: , HPA050314: AB_2732558, HPA060173: AB_2684215" 1.4 0.8 2.0 0.4 2.2 0.4 0.5 6.9 2.1 0.5 0.5 3.6 0.0 0.6 0.5 9.1 6.1 0.6 0.7 111.6 2.1 3.2 0.8 0.4 0.4 0.4 4.2 1.6 0.5 0.6 0.6 1.3 0.4 2.0 1.9 0.4 2.3 7.6 0.5 379.1 0.4 0.4 0.4 3.2 0.5 0.5 16.7 1.1 4.8 1.5 119.0 4.8 0.4 0.0 0.3 1.3 1.2 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.0 4.3 0.0 0.2 0.2 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.3 0.1 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 1.3 1.7 0.2 2.0 2.2 6.9 2.1 2.1 3.2 4.2 1.6 2.0 1.1 0.0 0.0 0.5 0.2 1.0 4.3 0.0 0.0 0.0 0.0 0.0 9.8 0.0 68.0 0.0 421.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 22.0 0.0 0.3 1332.7 7.2 0.4 1.7 0.0 0.0 3.8 0.2 0.2 5.6 1.9 4.2 25.8 3.1 30.5 5.6 0.5 0.0 0.0 0.2 0.4 PHLDA1 "DT1P1B11, PHRIP, TDAG51" ENSG00000139289 "Pleckstrin homology like domain family A member 1" Q8WV24 12 76025447-76033932 "Cancer-related genes, Predicted intracellular proteins" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "salivary gland: 142.4" "Cell type enhanced" "Detected in many" 12 "Basal glandular cells: 1037.1;Smooth muscle cells: 353.3;Urothelial cells: 680.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 2.4;MAIT T-cell: 3.9;memory CD4 T-cell: 2.5;memory CD8 T-cell: 2.5;non-classical monocyte: 2.5;T-reg: 4.1" "Group enriched" "Detected in many" 7 "monocytes: 2.5;T-cells: 4.1" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 65.6;RPTEC TERT1: 51.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016160, HPA019000, HPA063520" Enhanced Supported "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" Nucleoplasm "CAB016160: AB_628117, HPA019000: AB_1855309, HPA063520: AB_2685028" "unprognostic (9.09e-2)" "unprognostic (2.27e-2)" "unprognostic (2.03e-1)" "unprognostic (4.51e-3)" "unprognostic (2.33e-1)" "unprognostic (2.60e-3)" "unprognostic (1.40e-1)" "unprognostic (4.18e-2)" "unprognostic (2.21e-1)" "unprognostic (1.16e-1)" "unprognostic (5.21e-3)" "unprognostic (5.03e-2)" "unprognostic (1.21e-1)" "unprognostic (3.34e-2)" "unprognostic (2.32e-1)" "unprognostic (1.29e-1)" "unprognostic (4.55e-3)" 13.2 15.9 9.4 8.4 12.1 9.0 13.5 6.4 15.7 11.5 4.5 11.1 4.8 3.4 7.1 3.1 33.3 5.1 20.0 9.6 8.2 7.9 13.8 33.2 14.2 3.0 8.4 5.6 10.8 8.8 2.6 6.0 7.1 10.0 4.8 5.5 24.9 142.4 6.5 3.3 6.3 7.0 7.6 9.7 14.6 10.8 2.3 10.1 2.5 18.0 13.2 19.9 17.0 17.8 0.3 0.1 0.4 2.5 0.3 4.1 0.6 12.7 15.3 12.0 6.6 5.6 11.7 0.8 10.8 29.2 4.9 6.8 8.4 15.6 0.0 3.2 4.5 16.3 6.5 0.3 18.1 10.6 1.9 0.2 0.3 0.7 14.3 8.2 0.3 3.3 3.6 13.3 20.4 40.6 65.6 11.8 0.0 1.0 0.3 25.1 1.6 0.0 1.6 4.4 7.7 23.6 0.0 3.1 0.3 51.5 28.9 0.8 2.3 1.8 0.1 35.1 15.6 7.7 0.1 10.9 16.8 1.6 19.5 10.6 0.1 0.0 0.0 28.4 0.1 20.9 0.3 0.1 0.2 2.4 0.2 3.9 0.3 2.5 2.5 0.0 0.2 0.5 0.6 0.4 0.3 2.5 0.1 4.1 0.6 9.4 12.1 6.4 7.7 8.2 7.9 8.4 5.6 10.0 10.1 11.9 17.2 2.7 1037.1 173.4 1.5 29.5 10.2 6.7 22.7 29.6 2.0 4.8 71.3 68.6 1.0 95.1 0.7 0.0 35.8 6.3 85.4 57.9 80.5 117.3 97.6 1.6 112.7 23.9 10.8 1.3 8.6 53.3 271.7 41.5 10.3 90.9 162.8 3.5 14.5 32.7 4.0 265.1 353.3 0.5 0.4 66.0 6.2 23.0 8.0 680.5 PIN4 "EPVH, PAR14, PAR17" ENSG00000102309 "Peptidylprolyl cis/trans isomerase, NIMA-interacting 4" Q9Y237 X 72181353-72302926 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA-binding, Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 68.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054483, HPA064504" Approved Supported "Nucleoplasm,Nucleoli,Mitotic chromosome" Yes No "Nucleoplasm, Nucleoli" "Mitotic chromosome" "HPA054483: AB_2682503, HPA064504: AB_2685274" "unprognostic (2.47e-1)" "unprognostic (6.97e-3)" "unprognostic (1.65e-1)" "unprognostic (3.77e-2)" "unprognostic (8.42e-2)" "unprognostic (1.30e-2)" "unprognostic (1.14e-2)" "prognostic favorable (6.37e-4)" "unprognostic (1.56e-1)" "unprognostic (2.13e-2)" "unprognostic (2.49e-1)" "unprognostic (9.54e-2)" "unprognostic (2.09e-3)" "unprognostic (1.92e-1)" "prognostic favorable (2.58e-4)" "unprognostic (3.34e-3)" "prognostic favorable (2.66e-4)" 14.4 11.3 15.0 8.0 14.7 6.1 18.8 10.7 16.2 9.7 9.7 8.4 6.7 9.5 11.6 19.3 8.9 8.7 30.7 11.2 15.2 12.2 15.6 23.2 7.9 7.9 12.9 11.0 12.7 8.1 8.0 9.2 9.8 10.0 10.4 11.1 6.6 30.7 37.1 68.7 7.3 9.6 9.2 12.4 16.7 9.3 4.7 6.9 9.7 12.9 40.1 9.1 7.8 9.2 28.9 26.8 23.4 23.6 22.4 33.4 22.7 15.4 18.1 19.0 12.9 13.0 10.9 10.1 10.6 12.2 13.0 13.4 9.1 11.5 4.6 31.0 10.9 17.6 11.0 16.8 18.6 16.1 11.7 37.8 7.9 21.6 23.9 7.2 12.5 6.7 7.3 10.3 14.2 4.9 14.7 13.2 14.2 13.3 20.6 9.7 18.7 10.9 21.1 13.5 17.6 16.4 10.9 15.1 13.7 16.5 10.8 12.2 21.7 12.4 5.8 10.9 14.6 9.0 11.5 13.2 5.9 9.1 16.2 7.7 7.1 7.6 7.7 17.0 12.6 6.4 21.9 23.3 23.4 26.8 23.6 26.4 28.9 28.3 25.5 22.8 26.4 29.3 29.4 9.7 22.4 21.8 26.8 33.4 22.7 15.0 14.7 10.7 16.2 15.2 12.2 12.9 11.0 10.0 6.9 62.5 35.0 52.8 54.1 38.4 26.9 74.7 81.5 84.3 51.2 113.4 7.9 137.4 154.2 102.6 10.6 70.5 117.6 23.3 102.2 92.0 70.9 50.1 55.5 238.7 95.4 27.0 88.9 80.4 73.2 6.2 69.0 61.7 57.3 68.5 76.9 55.6 124.5 101.7 76.4 218.0 33.7 84.1 78.3 14.4 39.1 40.9 100.9 62.3 82.1 54.0 PINX1 "FLJ20565, Gno1, LPTL, LPTS, MGC8850, PinX1, Pxr1" ENSG00000254093 "PIN2/TERF1 interacting telomerase inhibitor 1" Q96BK5 8 10764963-10839884 "Predicted intracellular proteins" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Syncytiotrophoblasts: 40.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023139, HPA023146" Uncertain Supported Nucleoplasm,Nucleoli,Mitochondria NA NA Nucleoli "Nucleoplasm, Mitochondria" "HPA023139: AB_1855384, HPA023146: " "unprognostic (4.01e-1)" "prognostic favorable (2.45e-5)" "unprognostic (7.80e-3)" "unprognostic (3.35e-2)" "unprognostic (4.10e-1)" "unprognostic (4.61e-2)" "unprognostic (1.83e-2)" "unprognostic (3.40e-2)" "unprognostic (9.73e-3)" "unprognostic (2.49e-1)" "unprognostic (1.40e-1)" "unprognostic (4.37e-1)" "unprognostic (2.59e-1)" "unprognostic (1.13e-1)" "unprognostic (1.45e-1)" "unprognostic (1.45e-1)" "unprognostic (2.08e-2)" 14.3 14.4 9.9 16.0 13.9 14.8 13.8 14.5 16.5 12.6 14.2 12.6 7.1 11.5 15.7 8.9 19.3 10.7 9.3 11.7 10.6 10.1 13.1 19.4 11.2 19.2 13.2 10.9 16.1 17.2 7.6 10.7 13.3 17.6 11.4 12.0 15.6 14.9 8.5 21.2 19.0 11.3 15.9 11.1 14.8 11.7 24.0 9.7 18.7 12.4 17.8 19.6 11.5 14.3 9.8 8.8 4.4 8.4 8.9 16.0 8.4 6.4 8.7 9.4 8.9 8.0 6.5 10.8 9.9 4.5 10.9 7.4 9.1 5.7 17.4 3.5 5.3 13.4 13.1 23.8 18.3 14.1 7.0 7.1 7.3 6.1 9.8 9.0 7.8 4.6 5.4 11.7 8.6 16.1 3.9 15.1 11.9 23.1 10.8 10.7 7.7 25.5 9.8 21.6 28.3 9.7 20.9 11.5 15.9 8.1 8.0 7.8 8.1 6.6 7.9 21.7 12.0 8.4 9.7 9.1 6.6 14.3 8.4 12.7 4.9 12.7 31.7 6.8 14.8 14.9 1.5 6.8 4.4 12.5 8.4 16.0 9.7 10.9 13.1 8.8 9.8 15.0 11.6 0.4 8.9 7.3 6.8 12.3 8.4 9.9 13.9 14.5 16.5 10.6 10.1 13.2 10.9 17.6 9.7 3.0 4.1 9.9 14.8 23.7 5.2 3.3 7.6 10.7 9.1 3.5 11.8 14.9 10.0 0.0 29.6 11.4 4.0 0.0 0.0 9.6 8.0 5.2 13.9 6.6 14.3 3.2 8.1 11.6 4.0 22.3 8.6 9.6 6.8 0.0 3.9 6.2 0.0 4.8 6.0 8.2 21.5 0.0 6.2 24.9 25.1 25.0 40.3 11.7 7.7 8.0 PKMYT1 "MYT1, PPP1R126" ENSG00000127564 "Protein kinase, membrane associated tyrosine/threonine 1" Q99640 16 2968024-2980539 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 19.5;lymphoid tissue: 42.8;testis: 61.4" "Group enriched" "Detected in many" 6 "Extravillous trophoblasts: 39.8;Spermatocytes: 108.0;Spermatogonia: 40.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 5 "T-reg: 4.4" "Lineage enriched" "Detected in single" 5 "T-cells: 4.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA068860 Supported "Nucleoplasm,Nucleoli,Golgi apparatus" NA Yes "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA068860: AB_2686050" "unprognostic (7.82e-2)" "unprognostic (8.70e-2)" "unprognostic (5.93e-2)" "unprognostic (2.04e-2)" "unprognostic (4.54e-2)" "unprognostic (1.44e-1)" "prognostic unfavorable (8.33e-4)" "prognostic unfavorable (3.37e-4)" "unprognostic (4.52e-2)" "unprognostic (2.15e-1)" "unprognostic (1.61e-2)" "unprognostic (7.95e-3)" "unprognostic (0.00e+0)" "unprognostic (1.09e-3)" "unprognostic (9.13e-2)" "unprognostic (1.96e-1)" "unprognostic (5.91e-2)" 0.9 0.7 0.7 9.4 0.6 19.5 1.3 2.6 0.8 1.3 2.9 0.3 0.5 1.9 0.8 1.5 7.2 0.2 1.5 1.4 0.7 0.7 0.8 1.0 1.3 6.2 0.8 0.2 0.3 1.3 0.0 0.7 4.3 0.4 0.6 0.8 0.3 1.3 0.2 1.6 3.4 3.2 0.6 1.0 4.4 2.7 61.4 0.2 42.8 0.3 9.2 12.7 0.7 2.0 0.8 0.4 0.3 0.5 0.4 4.4 1.0 24.9 17.5 6.8 9.8 0.1 0.3 18.6 19.4 4.6 12.3 11.8 13.6 14.8 15.6 8.7 2.1 7.3 32.1 4.8 6.2 2.2 20.0 15.7 7.9 15.8 11.9 0.0 8.8 22.5 0.2 0.5 7.3 2.0 1.5 2.5 17.3 22.7 27.7 4.0 37.4 24.6 24.5 11.2 11.7 9.3 26.9 15.3 30.2 2.3 5.5 13.0 13.8 9.4 24.5 7.3 3.9 14.0 17.6 2.3 16.6 21.0 24.2 20.3 21.0 15.6 26.8 6.3 11.8 19.2 0.0 0.4 0.3 0.3 0.3 0.0 0.8 0.5 0.5 0.4 0.0 0.0 0.0 0.1 0.4 0.5 0.1 4.4 1.0 0.7 0.6 2.6 0.8 0.7 0.7 0.8 0.2 0.4 0.2 0.0 1.4 0.0 0.8 2.3 0.1 0.4 2.5 0.0 2.3 1.8 5.9 3.0 0.0 1.1 11.2 0.3 0.2 0.0 0.5 39.8 0.4 0.5 0.0 0.2 10.2 0.0 1.7 0.0 1.3 7.5 0.3 1.3 0.0 1.0 1.2 0.3 0.3 0.0 0.4 0.0 6.7 0.0 0.0 108.0 40.5 0.5 6.2 0.7 3.5 0.4 PLPP4 "DPPL2, PPAPDC1, PPAPDC1A" ENSG00000203805 "Phospholipid phosphatase 4" Q5VZY2 10 120456954-120589855 "Enzymes, Predicted membrane proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.5;kidney: 12.6" "Cell type enhanced" "Detected in some" 11 "Cholangiocytes: 12.7;Distal tubular cells: 6.6;Early spermatids: 7.1;Late spermatids: 7.9;Leydig cells: 17.8;Peritubular cells: 7.4;Proximal tubular cells: 7.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 22 "eosinophil: 2.2" "Lineage enriched" "Detected in single" 22 "granulocytes: 2.2" "Group enriched" "Detected in some" 4 "hTERT-RPE1: 62.8;U-251 MG: 34.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045188 Approved Approved "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" Nucleoplasm "HPA045188: AB_2679246" "unprognostic (8.19e-2)" "unprognostic (2.94e-2)" "unprognostic (8.86e-2)" "unprognostic (1.90e-3)" "unprognostic (3.45e-1)" "unprognostic (2.92e-2)" "unprognostic (2.69e-1)" "unprognostic (2.26e-3)" "unprognostic (1.55e-1)" "unprognostic (8.62e-3)" "unprognostic (2.70e-3)" "unprognostic (1.89e-1)" "unprognostic (2.40e-3)" "unprognostic (3.49e-2)" "unprognostic (3.75e-2)" "unprognostic (1.11e-1)" "unprognostic (1.21e-3)" 0.6 1.7 11.4 1.2 13.6 4.9 3.1 11.6 18.2 3.4 1.2 12.1 1.0 0.7 1.7 2.7 0.9 1.2 11.3 0.7 15.9 17.4 12.6 2.8 0.5 0.6 15.5 6.0 0.6 0.6 0.4 0.5 0.6 26.5 3.0 0.8 0.0 2.0 6.1 0.4 1.7 0.8 1.5 19.1 0.5 1.2 11.1 12.5 0.0 1.5 0.0 0.5 0.8 0.7 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.8 1.7 1.0 0.0 1.0 0.0 0.0 8.0 6.3 0.1 0.7 0.1 0.9 1.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.8 0.0 62.8 6.5 0.0 0.7 1.6 0.7 0.0 0.0 0.0 0.7 0.0 2.0 0.0 0.0 0.0 3.3 0.0 0.6 0.1 0.5 0.0 0.5 3.5 1.4 0.0 9.0 7.2 4.0 0.3 34.8 0.0 0.0 0.0 6.6 0.0 1.9 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 13.6 11.6 10.0 15.9 17.4 15.5 6.0 26.5 12.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 12.7 0.0 0.0 3.5 0.0 0.0 6.6 0.0 7.1 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 1.9 0.0 0.0 2.5 0.0 7.9 17.8 0.0 0.0 0.0 0.0 0.0 1.5 0.0 7.4 7.6 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.3 PNPLA3 "adiponutrin, ADPN, C22orf20, dJ796I17.1, FLJ22012, iPLA2epsilon" ENSG00000100344 "Patatin like phospholipase domain containing 3" Q9NST1 22 43923739-43964488 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Hydrolase, Transferase" "Disease mutation, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "liver: 31.1;retina: 39.3" "Group enriched" "Detected in some" 6 "Bipolar cells: 37.1;Cholangiocytes: 15.3;Cone photoreceptor cells: 17.7;Hepatocytes: 42.7;Rod photoreceptor cells: 34.3" "Cancer enhanced" "Detected in many" "liver cancer: 4.9" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 13.5;LHCN-M2: 15.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA058058 Approved Approved Nucleoli,Mitochondria,Cytosol NA NA Nucleoli "Mitochondria, Cytosol" "HPA058058: AB_2683590" "unprognostic (4.74e-3)" "unprognostic (4.52e-2)" "unprognostic (1.76e-1)" "unprognostic (2.31e-1)" "unprognostic (1.36e-2)" "unprognostic (1.89e-1)" "unprognostic (8.93e-2)" "unprognostic (1.02e-1)" "unprognostic (2.63e-1)" "unprognostic (2.93e-1)" "unprognostic (2.33e-2)" "unprognostic (1.05e-1)" "unprognostic (1.39e-3)" "unprognostic (2.52e-3)" "unprognostic (5.91e-2)" "unprognostic (2.02e-2)" "unprognostic (1.01e-1)" 2.8 0.4 0.5 0.7 1.0 0.3 4.0 0.3 2.4 0.8 1.3 0.4 0.0 1.0 0.5 1.9 0.4 1.1 0.5 0.9 0.8 0.6 4.6 31.1 1.4 0.4 0.3 1.8 0.5 0.2 0.6 0.2 0.4 2.2 0.2 0.2 39.3 0.9 0.2 2.2 5.3 0.6 0.2 0.5 0.6 0.3 0.5 0.3 0.0 0.2 0.0 0.3 0.2 0.4 1.2 0.7 1.8 0.6 0.9 0.8 0.0 3.9 1.3 13.5 5.5 3.8 4.3 0.4 2.4 1.4 3.3 7.2 3.9 7.1 0.0 2.1 4.0 1.9 3.4 8.4 3.9 2.8 0.0 0.7 0.2 3.2 7.2 6.2 0.0 0.2 4.9 3.1 10.6 0.5 5.7 0.4 0.1 0.0 0.0 15.3 0.6 0.2 0.0 9.2 0.4 0.0 0.0 7.3 0.1 1.5 0.2 1.2 0.1 2.7 1.1 3.8 2.4 4.2 4.6 0.4 1.3 4.1 0.1 0.1 0.0 0.0 0.0 11.6 0.0 4.8 1.5 0.6 0.4 0.5 0.4 0.3 0.7 0.4 0.3 0.2 1.2 0.6 0.8 1.8 0.9 0.3 0.7 0.2 0.0 0.5 1.0 0.3 2.4 0.8 0.6 0.3 1.8 2.2 0.3 0.0 0.0 0.0 0.5 0.3 37.1 1.1 15.3 0.0 0.0 0.0 17.7 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.4 0.0 42.7 0.6 0.0 1.7 0.6 2.6 0.0 0.3 0.0 1.7 0.0 0.5 1.3 1.5 0.0 0.7 5.0 34.3 0.0 0.0 0.4 0.7 0.1 0.0 0.0 0.0 0.4 POMT2 LGMD2N ENSG00000009830 "Protein O-mannosyltransferase 2" Q9UKY4 14 77274956-77320884 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital muscular dystrophy, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003663 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA003663: AB_1079655" "unprognostic (2.15e-1)" "unprognostic (1.07e-2)" "unprognostic (7.92e-2)" "unprognostic (3.37e-2)" "unprognostic (1.48e-1)" "unprognostic (1.31e-1)" "prognostic unfavorable (2.40e-4)" "unprognostic (7.10e-3)" "unprognostic (1.17e-1)" "unprognostic (1.68e-1)" "unprognostic (6.89e-3)" "unprognostic (1.94e-3)" "unprognostic (8.50e-3)" "unprognostic (1.37e-1)" "unprognostic (2.44e-1)" "unprognostic (6.75e-3)" "unprognostic (3.46e-2)" 6.7 10.8 10.4 6.8 11.4 3.8 7.7 12.5 13.3 6.8 6.3 18.0 9.8 4.6 6.9 17.1 5.7 8.7 6.9 7.7 9.3 7.7 8.1 8.3 6.2 3.0 11.7 6.2 7.6 10.6 14.7 16.1 11.4 9.7 7.3 5.8 8.2 10.1 12.3 17.0 4.3 4.6 7.8 8.4 5.2 5.6 30.9 14.4 2.5 11.5 4.9 3.8 5.7 5.0 1.4 1.9 0.8 1.9 0.0 1.7 0.4 10.4 13.4 13.0 14.7 9.3 7.5 10.4 9.2 7.6 13.8 11.8 6.6 9.4 3.1 7.5 8.6 19.1 11.7 6.1 9.2 9.6 4.6 8.3 1.9 6.6 5.4 11.4 2.1 6.3 7.6 9.8 12.9 12.6 9.6 8.0 3.1 4.9 7.3 9.0 20.6 3.6 10.1 3.7 14.5 11.3 3.5 12.7 2.8 14.3 7.7 11.0 10.8 6.0 10.2 7.7 8.9 10.5 4.4 6.6 10.4 16.4 12.0 8.0 4.8 9.4 1.4 5.3 3.2 9.1 0.0 0.4 0.0 1.7 1.9 0.4 1.4 0.0 0.3 0.9 0.2 0.1 0.0 0.8 0.0 0.8 1.9 0.0 0.4 10.4 11.4 12.5 13.3 9.3 7.7 11.7 6.2 9.7 14.4 6.0 3.2 2.2 2.3 2.7 6.5 4.0 5.1 0.0 0.0 1.8 15.7 5.0 0.0 6.6 8.0 2.8 3.9 0.0 6.4 8.6 6.0 3.5 2.3 4.4 4.8 7.9 17.2 3.1 2.4 12.1 1.7 2.2 1.7 3.6 3.0 8.2 5.8 1.9 3.9 3.0 15.0 0.0 3.9 9.8 8.5 1.6 4.8 0.0 2.6 1.4 PPDPF "C20orf149, dJ697K14.9, exdpf" ENSG00000125534 "Pancreatic progenitor cell differentiation and proliferation factor" Q9H3Y8 20 63520724-63522206 "Predicted intracellular proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Distal tubular cells: 2540.0;Paneth cells: 2816.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 18.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040929 Approved Nucleoplasm,Nucleoli,Microtubules Yes No "Nucleoplasm, Microtubules" Nucleoli "HPA040929: AB_10794155" "unprognostic (3.75e-2)" "unprognostic (5.39e-2)" "unprognostic (4.37e-2)" "unprognostic (9.03e-2)" "unprognostic (1.07e-1)" "unprognostic (2.38e-2)" "unprognostic (2.03e-2)" "unprognostic (2.42e-1)" "unprognostic (3.43e-2)" "unprognostic (1.91e-1)" "unprognostic (2.00e-1)" "unprognostic (4.20e-1)" "prognostic favorable (3.91e-4)" "unprognostic (1.04e-1)" "unprognostic (1.03e-1)" "unprognostic (4.20e-1)" "unprognostic (2.09e-2)" 63.9 19.9 42.2 46.0 43.0 36.5 38.8 22.3 55.1 54.3 78.6 61.5 43.5 41.3 39.9 46.0 112.6 44.7 67.3 53.2 32.9 31.0 72.1 28.4 56.5 42.8 44.5 34.9 45.6 69.5 15.4 35.0 22.2 48.7 75.3 32.2 58.8 143.7 54.1 116.1 86.2 48.5 61.8 72.0 40.0 120.2 49.0 21.6 28.7 48.0 73.3 87.9 68.6 65.2 5.8 3.4 18.9 4.5 2.4 5.2 3.4 44.6 13.9 9.5 19.2 10.8 18.2 30.7 27.5 8.9 36.0 14.2 25.4 26.9 9.6 37.1 18.3 13.7 47.3 4.8 31.4 5.8 17.1 9.5 3.9 13.0 4.8 29.7 0.0 20.6 17.9 63.4 9.1 12.7 11.9 14.1 12.2 16.1 22.7 13.1 60.8 45.7 0.4 10.3 35.8 80.8 20.9 21.5 19.4 25.7 18.4 32.6 24.9 27.3 44.1 18.9 6.6 63.0 26.2 23.2 30.4 34.6 40.2 22.7 18.1 14.2 6.5 21.5 11.3 19.8 1.9 2.4 18.9 5.2 3.1 4.3 4.6 4.6 4.8 2.9 5.8 4.1 4.5 1.1 2.4 4.5 3.4 5.0 3.4 42.2 43.0 22.3 55.1 32.9 31.0 44.5 34.9 48.7 21.6 291.8 201.0 276.1 613.6 510.4 42.1 61.0 749.1 294.5 174.0 910.7 11.8 432.7 2540.0 793.9 185.5 235.8 2093.0 327.1 669.9 547.6 555.3 988.2 330.2 190.7 548.2 47.7 765.2 266.4 322.1 856.1 344.3 360.7 1130.3 1110.9 1414.5 95.8 744.2 2816.1 271.2 1340.7 49.4 194.1 670.9 133.9 288.9 814.8 346.3 385.8 996.5 1073.4 PPP1R1C Inhibitor-1-like ENSG00000150722 "Protein phosphatase 1 regulatory inhibitor subunit 1C" Q8WVI7 2 181954241-182131398 "Predicted intracellular proteins" "Cell cycle, Cell division" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 7.5;heart muscle: 27.8" "Cell type enhanced" "Detected in many" 15 "Early spermatids: 106.6;Late spermatids: 139.1;Spermatocytes: 41.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.0;HAP1: 1.2;JURKAT: 1.1;MOLT-4: 2.1;SiHa: 1.3;SuSa: 1.2;U-266/70: 1.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA055043 Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA Nucleoplasm "Nucleoli, Golgi apparatus" "HPA055043: AB_2797251" "unprognostic (1.70e-1)" "unprognostic (3.15e-1)" "unprognostic (4.54e-3)" "unprognostic (1.08e-2)" "unprognostic (1.36e-1)" "unprognostic (1.01e-1)" "unprognostic (2.44e-2)" "unprognostic (3.77e-2)" "unprognostic (6.57e-2)" "unprognostic (6.59e-3)" "unprognostic (1.13e-1)" "unprognostic (7.98e-2)" "unprognostic (3.70e-2)" "unprognostic (1.00e-3)" "unprognostic (7.68e-2)" "unprognostic (3.07e-2)" "unprognostic (9.75e-3)" 0.2 0.1 0.7 0.1 3.5 0.1 0.2 3.5 1.8 0.1 0.2 3.0 0.0 0.2 0.2 0.1 0.3 0.2 0.5 27.8 1.5 1.1 0.2 1.2 0.3 0.2 0.8 0.6 0.1 0.6 0.1 0.4 0.2 7.5 1.4 0.2 0.5 0.5 0.2 4.3 0.2 0.7 0.1 2.5 0.2 0.4 0.6 1.3 0.0 0.2 3.3 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.4 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.3 0.4 2.1 0.0 0.5 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 1.3 0.2 0.3 1.2 0.2 0.0 0.0 0.0 0.6 0.0 0.0 1.9 0.0 0.2 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 3.5 3.5 1.8 1.5 1.1 0.8 0.6 7.5 1.3 11.9 5.4 0.0 0.5 0.2 0.8 34.2 10.2 1.4 11.4 3.5 0.0 2.7 1.7 2.3 106.6 0.0 0.0 0.0 9.8 5.6 0.7 0.1 0.0 17.9 0.5 0.0 5.8 0.0 0.3 139.1 5.5 0.0 3.3 6.4 0.3 6.0 14.6 0.0 0.7 0.5 1.9 0.0 0.5 41.8 2.0 0.3 2.1 0.0 0.7 0.9 PPP1R3D PPP1R6 ENSG00000132825 "Protein phosphatase 1 regulatory subunit 3D" O95685 20 59936668-59940297 "Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 6.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-BR-3: 20.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041146 Approved Approved Nucleoli,Vesicles,Mitochondria NA NA "Vesicles, Mitochondria" Nucleoli "HPA041146: AB_10793870" "unprognostic (2.50e-3)" "unprognostic (3.55e-3)" "unprognostic (6.90e-2)" "unprognostic (1.23e-1)" "unprognostic (7.23e-2)" "unprognostic (5.87e-2)" "unprognostic (5.73e-2)" "unprognostic (2.39e-3)" "unprognostic (5.54e-2)" "unprognostic (3.27e-1)" "unprognostic (3.52e-2)" "unprognostic (1.20e-1)" "unprognostic (1.48e-2)" "prognostic favorable (9.14e-4)" "unprognostic (4.71e-2)" "unprognostic (1.47e-2)" "unprognostic (5.71e-2)" 8.2 6.1 9.3 8.2 9.5 9.9 17.2 8.6 9.5 9.1 8.2 6.4 7.1 9.5 9.0 6.5 13.3 7.4 6.5 11.3 8.4 7.8 7.8 2.0 10.0 16.8 9.5 5.4 8.8 17.5 13.3 12.1 9.8 9.3 12.0 5.6 7.6 9.1 11.2 12.9 9.1 10.1 7.1 8.9 11.2 9.6 4.7 6.6 4.0 8.0 8.8 8.9 9.1 8.8 0.7 1.2 6.0 3.5 0.8 1.0 0.4 4.0 2.5 1.7 3.5 3.9 4.1 14.4 5.4 5.8 6.6 3.2 3.9 5.6 1.7 6.7 4.5 4.1 12.0 3.5 3.8 4.3 3.9 2.8 4.5 3.3 2.1 3.6 1.8 12.7 2.9 10.6 2.3 2.0 3.5 3.6 1.1 0.8 0.4 4.2 6.3 1.5 5.9 1.2 7.7 6.0 1.9 0.8 2.6 4.4 6.6 3.3 2.0 6.7 20.3 5.8 3.4 7.4 6.6 3.8 3.9 1.6 4.1 0.8 1.4 3.5 0.4 2.9 6.5 2.4 0.6 1.6 6.0 1.0 0.7 0.9 0.7 0.7 0.8 1.2 0.6 0.9 0.6 4.2 0.8 3.5 0.5 1.0 0.4 9.3 9.5 8.6 9.5 8.4 7.8 9.5 5.4 9.3 6.6 8.9 0.3 2.4 4.4 1.1 6.1 4.7 7.6 4.0 4.5 5.2 2.0 12.2 5.0 1.9 0.3 5.8 4.2 0.0 2.7 3.7 2.6 5.9 5.7 0.2 4.6 12.7 1.7 9.2 8.9 0.0 2.8 3.4 5.0 1.0 3.1 10.3 3.0 6.5 4.2 5.0 10.8 6.5 4.0 0.2 4.3 2.8 4.1 7.5 2.8 7.8 PRDM5 PFM2 ENSG00000138738 "PR/SET domain 5" Q9NQX1 4 120684919-120922870 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 57.4;Late spermatids: 22.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 25 "eosinophil: 9.1;neutrophil: 6.7" "Lineage enriched" "Detected in single" 29 "granulocytes: 9.1" "Cell line enhanced" "Detected in many" "U-266/84: 15.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051406 Enhanced Supported "Nucleoplasm,Nucleoli,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" Nucleoli "HPA051406: AB_2681472" "unprognostic (7.74e-2)" "unprognostic (8.45e-3)" "unprognostic (3.15e-3)" "unprognostic (1.09e-1)" "unprognostic (7.20e-2)" "unprognostic (9.30e-2)" "unprognostic (3.28e-2)" "unprognostic (4.52e-2)" "unprognostic (5.09e-2)" "unprognostic (8.71e-2)" "unprognostic (6.29e-2)" "unprognostic (4.13e-1)" "unprognostic (3.00e-2)" "unprognostic (4.91e-4)" "unprognostic (2.34e-1)" "unprognostic (1.29e-1)" "unprognostic (5.56e-3)" 5.0 5.9 3.5 3.6 3.9 4.6 5.4 1.9 5.4 9.3 5.2 2.7 6.3 1.9 8.6 7.0 3.3 7.7 6.1 5.0 3.2 3.1 3.1 0.8 7.4 2.7 3.4 4.2 15.2 10.3 19.3 12.5 5.0 6.1 7.7 4.4 9.4 3.3 6.8 2.2 2.7 3.2 9.5 6.2 3.3 4.1 5.0 3.3 0.5 8.4 5.1 2.3 5.8 14.1 0.0 0.0 9.1 0.0 0.0 0.3 0.0 1.8 2.9 6.6 0.1 4.0 8.3 7.8 3.9 8.6 4.0 3.5 3.7 1.1 0.4 1.1 5.2 3.8 0.0 0.0 0.8 5.3 0.0 1.1 2.4 2.6 0.2 4.3 8.1 0.1 5.8 2.6 2.8 3.6 3.7 2.9 1.0 0.0 12.1 4.9 0.3 1.2 0.0 4.9 0.6 2.2 0.0 7.7 5.0 1.4 0.0 1.2 5.3 0.0 0.1 0.8 3.6 5.5 3.4 1.1 0.2 2.4 4.1 3.8 11.2 15.6 0.0 3.0 0.0 3.0 0.1 0.0 9.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 6.7 0.0 0.0 0.0 0.0 0.0 3.5 3.9 1.9 5.4 3.2 3.1 3.4 4.2 6.1 3.3 11.9 3.5 0.5 2.5 1.4 9.5 7.3 0.0 2.7 5.7 1.8 7.9 0.8 1.7 1.8 57.4 4.9 0.0 0.0 2.1 2.1 4.4 2.0 2.3 0.0 0.7 0.0 3.5 3.7 0.3 22.0 8.1 0.8 1.7 0.0 2.7 8.2 1.9 0.0 8.9 0.0 8.0 6.5 3.6 5.0 3.3 1.5 0.5 0.0 2.4 0.6 PRIMA1 PRIMA ENSG00000175785 "Proline rich membrane anchor 1" Q86XR5 14 93718298-93788481 "Predicted membrane proteins" "Neurotransmitter degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 26.2" "Cell type enriched" "Detected in some" 11 "Muller glia cells: 33.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 7.5;Hep G2: 4.8;NTERA-2: 3.0;SCLC-21H: 13.2;SH-SY5Y: 7.5" "Region enhanced" "Detected in many" "basal ganglia: 16.2" "Low region specificity" "Detected in all" "HPA046671, HPA060047" Approved Approved "Nucleoli,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoli, Cytosol" "HPA046671: AB_2679744, HPA060047: AB_2684194" "unprognostic (3.60e-2)" "unprognostic (1.97e-1)" "unprognostic (7.54e-2)" "prognostic unfavorable (6.99e-5)" "unprognostic (1.03e-2)" "unprognostic (3.73e-2)" "unprognostic (1.07e-1)" "unprognostic (5.81e-2)" "unprognostic (2.93e-1)" "unprognostic (1.05e-1)" "unprognostic (8.94e-2)" "unprognostic (6.61e-3)" "prognostic unfavorable (2.62e-7)" "unprognostic (2.33e-2)" "unprognostic (2.67e-1)" "unprognostic (7.94e-4)" "unprognostic (4.57e-3)" 4.6 6.0 4.2 5.9 16.7 0.4 2.4 4.5 8.2 7.7 26.2 21.7 4.2 4.6 7.9 7.9 13.7 10.7 3.3 4.8 5.8 3.3 1.2 0.7 1.0 0.7 20.2 4.0 6.9 1.2 0.6 0.3 2.2 15.5 8.6 7.6 9.9 4.6 10.2 0.7 2.1 11.6 14.9 24.3 0.7 12.1 1.8 14.7 0.0 1.3 0.9 4.4 4.7 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 7.5 0.0 0.0 0.2 0.4 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 13.2 7.5 0.4 0.0 0.0 0.5 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 16.7 4.5 8.2 5.8 3.3 20.2 4.0 15.5 14.7 0.0 0.0 0.0 1.0 0.5 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.1 0.0 0.0 3.1 0.0 0.4 2.6 0.0 0.0 0.0 0.0 33.7 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.2 0.3 0.0 0.0 0.0 0.1 PRRG2 PRGP2 ENSG00000126460 "Proline rich and Gla domain 2" O14669 19 49580646-49591015 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 38.8;Paneth cells: 31.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 11.7;OE19: 13.8;RT4: 9.0;SK-BR-3: 10.5;T-47d: 11.4;U-266/84: 13.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010702 Approved Approved Nucleoplasm,Nucleoli,Cytosol No NA "Nucleoplasm, Nucleoli" Cytosol "HPA010702: AB_1079693" "unprognostic (2.25e-2)" "unprognostic (1.04e-1)" "unprognostic (3.46e-2)" "unprognostic (1.04e-2)" "unprognostic (1.04e-1)" "unprognostic (7.55e-2)" "unprognostic (5.60e-1)" "unprognostic (1.55e-1)" "unprognostic (1.14e-1)" "unprognostic (1.77e-1)" "unprognostic (1.51e-1)" "unprognostic (1.67e-1)" "prognostic favorable (3.82e-9)" "unprognostic (4.89e-2)" "unprognostic (1.46e-1)" "unprognostic (6.58e-3)" "unprognostic (3.68e-2)" 0.9 0.4 0.5 1.1 0.6 0.0 4.8 1.1 1.3 4.0 14.3 0.4 17.5 8.3 1.9 9.6 13.7 3.3 9.8 0.7 0.5 0.4 15.0 12.1 5.2 0.4 0.7 0.4 1.9 13.4 13.8 16.1 8.6 0.7 5.4 5.3 0.7 24.9 14.6 1.2 10.1 23.2 1.4 0.5 1.0 7.1 1.7 0.4 2.1 21.9 9.8 7.8 4.2 4.2 1.2 4.2 2.1 0.9 0.0 1.4 0.4 8.4 0.3 0.2 0.7 1.0 0.0 3.6 0.2 0.0 0.3 0.3 1.7 11.7 0.5 1.3 0.1 0.2 6.8 0.2 6.6 0.3 0.8 0.9 0.4 0.5 0.6 0.7 0.3 0.9 0.7 5.8 0.2 0.2 0.6 2.6 0.7 0.2 0.6 0.0 1.8 0.1 0.7 0.5 13.8 1.1 0.2 0.3 6.6 5.2 9.0 1.9 0.2 1.0 10.5 0.1 0.9 11.4 0.1 0.4 0.7 0.5 0.3 0.1 4.1 13.7 0.4 0.1 0.2 0.3 0.0 0.9 0.4 1.4 0.1 0.7 1.2 0.6 0.6 0.1 0.7 0.8 0.7 2.1 0.0 0.7 4.2 0.6 0.4 0.5 0.6 1.1 1.3 0.5 0.4 0.7 0.4 0.7 0.4 6.0 12.0 1.3 12.1 3.7 1.9 0.8 10.2 4.0 9.1 12.2 2.0 11.6 3.3 27.3 0.7 6.2 38.8 0.0 29.0 5.4 0.8 11.8 2.3 4.9 2.1 4.8 15.5 0.6 3.2 0.0 0.3 2.3 1.7 12.6 13.9 0.8 24.3 31.6 0.0 12.1 3.7 0.0 1.8 0.5 1.5 4.1 10.6 0.8 14.2 12.8 PRY "PRY1, PTPN13LY" ENSG00000169789 "PTPN13-like, Y-linked" O14603 Y 22490397-22514637 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "blood: 1.9;epididymis: 2.3;testis: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 6 "memory CD4 T-cell: 1.9" "Lineage enriched" "Detected in single" 20 "T-cells: 1.9" "Cell line enhanced" "Detected in some" "A549: 3.1;HDLM-2: 2.3;SK-MEL-30: 1.5" "HPA046366, HPA059887" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA046366: AB_2679639, HPA059887: " 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRY2 PTPN13LY2 ENSG00000169807 "PTPN13-like, Y-linked 2" O14603 Y 22071756-22096007 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 1.4;testis: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.4;naive CD4 T-cell: 1.1" "Lineage enriched" "Detected in single" 14 "T-cells: 1.4" "Cell line enhanced" "Detected in single" "SK-MEL-30: 3.6" "HPA046366, HPA059887" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA046366: AB_2679639, HPA059887: " 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PSTK "C10orf89, MGC35392" ENSG00000179988 "Phosphoseryl-tRNA kinase" Q8IV42 10 122954381-122997513 "Enzymes, Predicted intracellular proteins" "Protein biosynthesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037780, HPA037781" Approved Approved "Nucleoli,Nuclear bodies,Actin filaments" No No "Actin filaments" "Nucleoli, Nuclear bodies" "HPA037780: AB_2675662, HPA037781: AB_10670530" "unprognostic (8.95e-3)" "unprognostic (5.51e-3)" "unprognostic (1.37e-1)" "unprognostic (7.39e-4)" "unprognostic (5.21e-2)" "unprognostic (4.08e-3)" "unprognostic (1.60e-2)" "unprognostic (5.92e-4)" "unprognostic (3.55e-2)" "unprognostic (1.16e-1)" "unprognostic (6.22e-3)" "unprognostic (7.10e-3)" "unprognostic (2.39e-1)" "unprognostic (4.50e-2)" "unprognostic (4.92e-2)" "unprognostic (3.02e-2)" "unprognostic (5.55e-4)" 2.8 5.6 7.0 2.5 8.8 12.5 8.8 4.3 10.4 5.8 4.3 10.5 4.7 4.6 5.4 11.4 3.7 5.6 3.5 4.7 7.5 7.3 5.5 10.6 2.8 4.0 8.8 8.7 3.8 5.4 4.2 7.2 3.7 9.3 5.6 4.3 3.8 4.3 3.6 6.8 3.8 3.8 5.4 8.7 2.9 3.0 11.1 8.6 2.9 6.8 1.4 3.6 4.8 3.2 6.5 7.4 6.3 5.5 6.6 10.0 6.0 5.4 3.9 2.1 1.0 2.5 4.7 2.6 2.1 5.2 4.6 5.6 5.6 4.9 5.5 5.1 3.8 2.9 3.0 1.0 4.7 5.4 3.0 10.4 3.8 0.9 4.4 6.0 7.7 4.6 5.3 8.1 4.2 8.1 4.3 3.2 5.0 5.2 8.6 6.8 8.2 2.7 4.8 4.7 2.3 5.6 5.5 3.6 5.1 6.9 3.4 2.2 2.4 4.6 5.3 7.7 2.4 2.5 0.6 3.8 3.6 3.4 1.4 5.2 3.2 1.7 7.6 3.3 5.3 1.4 0.0 5.5 6.3 8.9 3.3 10.0 6.5 6.9 8.4 7.4 5.8 9.2 9.4 0.6 6.6 3.9 7.0 4.2 6.0 7.0 8.8 4.3 10.4 7.5 7.3 8.8 8.7 9.3 8.6 8.9 8.2 3.4 4.6 3.9 8.1 4.4 12.7 8.1 4.5 5.2 7.9 6.8 8.3 3.9 20.0 3.1 1.7 0.0 5.6 2.2 4.1 3.4 2.3 5.1 4.2 4.8 4.1 4.3 1.3 2.6 4.9 3.0 5.0 5.4 2.3 8.5 3.4 3.4 5.3 6.4 9.6 0.0 4.7 16.8 13.8 4.1 8.0 5.7 3.8 2.6 PTMS ParaT ENSG00000159335 Parathymosin P20962 12 6765516-6770952 "Predicted intracellular proteins" Immunity "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 12.9;eosinophil: 3.3;plasmacytoid DC: 4.2" "Group enriched" "Detected in many" 6 "dendritic cells: 4.2;granulocytes: 12.9" "Cell line enhanced" "Detected in many" "HDLM-2: 84.1" HPA038186 Approved Approved "Nucleoplasm,Nucleoli,Nucleoli rim" No No 31000 "Nucleoli, Nucleoli rim" Nucleoplasm "HPA038186: AB_10673042" "unprognostic (3.11e-2)" "unprognostic (1.31e-3)" "unprognostic (1.76e-1)" "unprognostic (3.57e-2)" "unprognostic (1.09e-1)" "unprognostic (2.83e-1)" "unprognostic (1.13e-1)" "unprognostic (2.47e-1)" "unprognostic (4.16e-1)" "unprognostic (1.01e-1)" "unprognostic (8.69e-3)" "unprognostic (2.52e-1)" "prognostic unfavorable (6.18e-5)" "unprognostic (1.02e-1)" "unprognostic (3.21e-1)" "unprognostic (2.35e-3)" "unprognostic (1.55e-2)" 47.0 24.7 45.4 23.5 54.9 7.5 79.3 54.0 40.3 46.0 58.1 7.9 32.4 17.8 71.3 24.9 43.7 36.5 30.8 21.8 31.7 20.0 43.4 155.3 50.7 19.4 11.1 28.6 72.9 18.3 45.8 21.0 26.3 17.9 58.7 19.1 26.6 22.7 58.1 22.6 29.9 24.4 62.5 17.7 20.8 28.3 16.1 15.3 9.5 28.3 29.8 13.0 44.4 81.6 0.1 4.2 12.9 0.3 0.2 1.3 0.3 6.1 27.1 46.7 43.7 25.2 21.2 16.9 26.7 30.0 24.4 21.0 17.2 25.2 2.3 20.1 48.6 20.5 12.9 27.1 24.9 9.7 84.1 36.8 3.0 16.0 5.9 28.6 0.7 7.2 20.1 10.1 17.5 36.2 37.4 27.3 1.2 21.3 6.2 22.2 15.4 1.1 4.9 44.5 13.1 29.4 0.5 12.2 5.1 19.2 1.2 14.3 46.5 29.3 11.0 22.9 34.4 10.0 3.1 37.0 33.6 46.8 4.6 24.4 5.4 2.6 3.2 26.1 2.0 24.5 12.9 0.3 3.3 1.3 0.1 0.6 0.1 0.1 1.2 0.3 0.0 0.0 0.2 1.0 0.2 0.0 4.2 0.5 0.3 45.4 54.9 54.0 40.3 31.7 20.0 11.1 28.6 17.9 15.3 0.0 19.7 44.0 264.1 257.1 332.2 6.9 79.0 10.7 12.5 146.5 188.5 124.4 198.9 34.5 5.5 262.5 134.0 116.8 29.5 354.7 255.9 393.3 54.0 544.5 395.5 109.7 492.9 234.5 56.9 9.0 453.3 138.5 215.9 116.4 209.5 249.7 32.6 106.6 650.6 469.2 250.9 588.6 361.9 5.8 34.1 217.8 136.5 54.3 187.5 139.3 PURG "PURG-A, PURG-B" ENSG00000172733 "Purine rich element binding protein G" Q9UJV8 8 30995802-31033715 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.7" "Group enriched" "Detected in some" 7 "Bipolar cells: 11.8;Early spermatids: 11.1;Horizontal cells: 19.1;Late spermatids: 16.8;Muller glia cells: 11.3" "Cancer enhanced" "Detected in some" "glioma: 1.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 8.7;JURKAT: 6.1;NTERA-2: 6.8;SH-SY5Y: 8.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047746 Enhanced Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" Nucleoli "HPA047746: AB_2680145" "unprognostic (3.37e-1)" "unprognostic (2.15e-1)" "unprognostic (6.69e-2)" "unprognostic (7.33e-3)" "unprognostic (3.65e-2)" "unprognostic (1.78e-1)" "unprognostic (3.51e-3)" "unprognostic (1.10e-2)" "unprognostic (1.49e-1)" "unprognostic (1.62e-1)" "unprognostic (4.79e-2)" "unprognostic (8.72e-2)" "unprognostic (1.46e-3)" "unprognostic (1.03e-1)" "unprognostic (1.27e-1)" "unprognostic (1.83e-2)" "unprognostic (5.30e-2)" 1.3 1.9 11.0 1.2 10.3 0.6 0.9 14.7 13.5 2.4 1.0 2.4 0.5 1.0 5.6 2.6 1.5 1.6 3.0 1.6 9.4 6.2 1.7 0.7 1.4 1.3 4.9 7.3 1.6 0.7 0.6 3.9 1.5 6.2 1.9 1.1 1.7 1.6 2.6 1.0 0.9 1.0 5.0 4.5 2.5 1.3 8.1 6.4 0.0 0.8 0.0 1.0 1.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.2 0.1 0.0 0.0 0.2 0.4 0.7 1.8 0.0 0.0 0.2 0.0 0.0 3.0 0.0 2.9 0.0 1.0 0.0 4.4 1.6 0.0 0.2 0.0 0.0 0.2 1.3 0.0 1.3 0.0 1.0 4.3 6.1 0.4 0.5 0.2 0.0 0.9 0.0 6.8 0.0 0.3 2.2 1.2 0.0 0.0 0.0 1.2 8.2 0.0 0.0 0.0 3.3 0.0 0.0 2.6 2.9 3.7 0.0 0.4 0.3 0.0 0.2 2.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 10.3 14.7 8.9 9.4 6.2 4.9 7.3 6.2 6.4 0.0 0.0 0.0 0.0 0.0 11.8 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 11.1 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 19.1 0.0 0.0 0.0 16.8 0.6 0.0 0.0 0.0 0.0 11.3 0.0 0.0 1.4 0.0 1.8 0.0 0.3 1.7 1.1 0.0 0.0 0.0 0.0 0.0 PVALB D22S749 ENSG00000100362 Parvalbumin P20472 22 36800684-36819479 "Predicted intracellular proteins" "Muscle protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 125.0;parathyroid gland: 137.5" "Group enriched" "Detected in some" 10 "Distal tubular cells: 543.8;Horizontal cells: 1442.9" "Group enriched" "Detected in many" 10 "breast cancer: 14.2;renal cancer: 59.5;urothelial cancer: 12.3" "Region enhanced" "Detected in all" "cerebellum: 125.0" "Cell type enriched" "Detected in single" 6 "neutrophil: 3.4" "Lineage enriched" "Detected in single" 6 "granulocytes: 3.4" "Cell line enriched" "Detected in single" 198 "RPMI-8226: 134.1" "Region enriched" "Detected in many" 5 "cerebellum: 2377.5" "Low region specificity" "Detected in all" "CAB002515, HPA048536" Enhanced Approved "Nucleoplasm,Nucleoli,Cell Junctions" No NA Nucleoplasm "Nucleoli, Cell Junctions" "CAB002515: AB_563948, HPA048536: AB_2680433" "unprognostic (4.41e-2)" "unprognostic (1.60e-1)" "unprognostic (9.75e-2)" "unprognostic (1.79e-3)" "unprognostic (7.80e-2)" "unprognostic (2.49e-2)" "unprognostic (2.52e-2)" "unprognostic (6.53e-2)" "unprognostic (2.37e-1)" "unprognostic (2.24e-1)" "unprognostic (1.61e-1)" "unprognostic (2.13e-1)" "unprognostic (5.21e-2)" "unprognostic (6.92e-2)" "unprognostic (1.91e-1)" "unprognostic (1.65e-2)" "unprognostic (8.99e-3)" 0.9 0.8 1.2 0.9 3.9 0.8 4.3 125.0 47.2 0.8 0.8 6.6 0.0 0.8 1.1 0.9 0.8 0.8 0.9 0.8 4.5 9.4 16.7 1.8 1.2 1.2 28.6 2.5 0.8 0.8 137.5 0.2 1.2 22.9 0.9 0.9 27.3 1.2 1.0 5.0 0.8 0.8 0.9 12.6 1.2 0.9 1.1 1.2 0.0 0.9 0.0 1.4 1.2 1.0 0.0 0.5 3.4 0.4 0.0 0.3 12.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 134.1 0.0 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 3.4 0.0 0.0 0.5 0.3 12.2 1.2 3.9 125.0 47.2 4.5 9.4 28.6 2.5 22.9 1.2 0.0 0.0 0.0 0.0 0.0 39.1 0.2 0.0 0.0 0.0 36.6 9.8 0.2 543.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 10.5 0.0 40.7 1442.9 0.0 40.5 3.7 0.0 0.6 0.9 0.0 0.0 0.0 41.2 0.0 0.0 0.0 0.8 104.1 0.0 0.0 0.0 0.6 0.0 0.3 1.0 0.0 0.0 PYCARD "ASC, CARD5, TMS-1" ENSG00000103490 "PYD and CARD domain containing" Q9ULZ3 16 31201485-31203450 "Predicted intracellular proteins" "Apoptosis, Immunity, Inflammatory response, Innate immunity" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 130.8" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 312.0;Hofbauer cells: 375.8;Kupffer cells: 516.6;Macrophages: 364.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 37.8;classical monocyte: 90.4;eosinophil: 71.4;intermediate monocyte: 87.5;myeloid DC: 66.8;neutrophil: 130.8;non-classical monocyte: 85.0;plasmacytoid DC: 61.0" "Group enriched" "Detected in all" 6 "dendritic cells: 66.8;granulocytes: 130.8;monocytes: 90.4" "Cell line enhanced" "Detected in many" "MCF7: 34.5;NB-4: 54.4;THP-1: 40.1;U-937: 24.9" "CAB006853, CAB015948, HPA049074, HPA054496" Enhanced Supported Nucleoplasm,Nucleoli,Cytosol NA NA 1100000 Nucleoplasm "Nucleoli, Cytosol" "CAB006853: , CAB015948: , HPA049074: AB_2680621, HPA054496: AB_2682506" "unprognostic (1.00e-3)" "unprognostic (2.62e-2)" "unprognostic (2.40e-1)" "unprognostic (4.67e-3)" "unprognostic (3.34e-1)" "unprognostic (1.87e-1)" "unprognostic (5.29e-2)" "unprognostic (2.88e-2)" "unprognostic (3.12e-1)" "unprognostic (2.33e-1)" "unprognostic (6.52e-3)" "unprognostic (3.88e-2)" "prognostic unfavorable (6.09e-7)" "unprognostic (4.45e-3)" "unprognostic (2.51e-1)" "unprognostic (3.61e-2)" "unprognostic (6.97e-2)" 11.6 4.4 3.6 16.7 4.6 22.4 8.6 3.6 3.3 8.2 26.8 6.8 4.1 38.7 5.4 7.9 20.7 6.8 8.5 6.6 2.4 2.6 5.6 6.8 15.0 32.8 6.4 1.8 6.6 6.1 1.3 3.2 6.6 4.0 9.7 4.4 4.7 9.6 5.6 3.5 31.2 29.9 3.5 6.4 34.1 13.3 3.7 3.3 20.6 5.5 22.3 26.3 7.9 11.8 17.1 66.8 130.8 90.4 16.0 16.0 53.1 5.7 13.5 0.1 0.0 1.3 3.0 0.1 2.8 4.0 1.8 1.2 0.0 7.2 2.4 0.0 2.7 0.0 16.0 0.7 10.7 0.0 17.3 0.0 2.2 1.6 4.4 4.6 20.1 16.0 4.0 5.6 0.8 0.1 0.0 3.9 0.0 9.9 3.7 0.5 34.5 0.0 54.4 3.7 2.3 0.0 17.5 0.0 7.6 0.1 5.6 0.1 0.0 2.4 0.0 2.7 0.0 3.3 40.1 2.6 0.1 0.2 2.4 0.0 0.1 0.0 0.0 1.4 24.9 0.0 37.8 90.4 71.4 15.1 87.5 9.5 17.1 12.7 15.5 66.8 15.2 8.9 12.3 130.8 16.0 85.0 61.0 16.0 53.1 3.6 4.6 3.6 3.3 2.4 2.6 6.4 1.8 4.0 3.3 20.8 28.2 73.7 67.5 65.8 0.1 2.8 28.1 36.1 29.6 24.4 0.0 46.3 5.0 83.5 0.3 38.6 312.0 23.3 50.3 8.9 26.7 26.8 108.5 3.0 375.8 0.0 56.6 41.7 516.6 1.5 43.7 364.0 92.8 16.2 110.6 0.0 56.2 271.9 21.2 1.4 0.6 25.8 23.3 0.3 1.1 143.2 14.9 75.0 247.3 42.2 RAC1 "p21-Rac1, Rac-1, TC-25" ENSG00000136238 "Rac family small GTPase 1" P63000 7 6374523-6403977 "Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins" Hydrolase "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB035994, HPA047820" Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA 44000000 "Nucleoplasm, Cytosol" Nucleoli "CAB035994: , HPA047820: AB_2680167" "unprognostic (8.66e-3)" "unprognostic (2.47e-1)" "unprognostic (4.00e-1)" "unprognostic (2.40e-2)" "unprognostic (1.88e-3)" "unprognostic (4.06e-2)" "prognostic unfavorable (1.74e-5)" "prognostic unfavorable (4.59e-4)" "unprognostic (1.59e-1)" "unprognostic (2.04e-1)" "prognostic unfavorable (4.57e-5)" "unprognostic (3.63e-1)" "prognostic unfavorable (2.11e-4)" "unprognostic (1.95e-1)" "unprognostic (2.11e-2)" "unprognostic (4.13e-2)" "unprognostic (8.72e-3)" 45.2 35.0 71.0 28.4 64.0 24.4 46.5 42.1 93.0 48.7 58.9 75.5 22.5 51.6 48.7 49.5 93.4 47.2 40.0 48.4 73.8 59.8 47.8 42.9 45.6 38.3 76.7 60.9 45.1 29.2 51.0 25.2 55.8 54.9 40.5 64.0 37.2 43.3 48.9 57.4 58.6 49.8 57.3 88.2 35.0 49.7 28.1 47.1 41.3 40.9 42.8 50.7 52.2 54.0 11.0 32.0 49.1 31.9 7.3 11.8 10.7 75.1 34.1 35.3 38.3 41.9 53.5 21.1 42.4 52.1 56.6 57.7 33.5 71.1 21.2 27.5 59.1 58.6 53.6 37.6 51.4 72.5 9.9 31.2 21.3 27.6 24.1 50.4 19.2 17.4 35.6 46.0 40.7 45.7 43.1 49.8 21.0 38.0 16.8 60.9 54.8 10.5 45.2 63.2 38.3 40.9 18.7 35.9 31.1 72.7 47.7 26.8 45.1 29.9 109.6 34.0 42.1 61.8 57.8 52.2 37.2 56.0 45.5 48.9 12.8 14.0 20.0 34.3 36.7 70.4 7.6 31.9 16.4 7.2 22.2 4.5 11.0 8.1 9.2 32.0 11.0 9.8 6.5 49.1 7.3 22.1 18.2 11.8 10.7 71.0 64.0 42.1 93.0 73.8 59.8 76.7 60.9 54.9 47.1 137.0 112.5 192.8 745.4 829.8 84.3 183.1 481.6 92.3 104.6 338.5 23.6 691.3 454.3 121.1 58.5 522.9 706.2 303.7 149.3 914.8 466.9 1152.5 132.3 288.4 738.1 138.2 323.2 535.2 736.9 43.7 441.0 745.3 435.3 408.4 531.5 280.9 231.2 471.0 444.5 611.5 54.4 472.1 495.6 210.1 328.6 1004.1 707.0 194.1 436.1 1582.5 RBM20 ENSG00000203867 "RNA binding motif protein 20" Q5T481 10 110644397-110839469 "Disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 45.9;skeletal muscle: 20.9" "Cell type enriched" "Detected in some" 8 "Cardiomyocytes: 137.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 5.7;HEL: 4.8;K-562: 4.6;RH-30: 15.7;SH-SY5Y: 14.6;SuSa: 5.0;T-47d: 8.8" "Region enhanced" "Detected in some" "olfactory region: 4.6" "Not detected" "Not detected" "HPA035806, HPA070358" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" Yes No "Nucleoplasm, Nucleoli, Golgi apparatus" "HPA035806: AB_10672097, HPA070358: " "unprognostic (2.43e-1)" "unprognostic (8.24e-3)" "unprognostic (5.81e-2)" "unprognostic (1.27e-2)" "unprognostic (1.03e-1)" "unprognostic (2.03e-2)" "unprognostic (2.75e-2)" "unprognostic (5.47e-3)" "unprognostic (1.33e-1)" "unprognostic (2.78e-2)" "unprognostic (4.14e-3)" "unprognostic (1.44e-1)" "unprognostic (2.39e-3)" "unprognostic (3.34e-1)" "unprognostic (3.35e-2)" "unprognostic (1.20e-1)" "unprognostic (6.46e-2)" 1.7 0.1 0.4 0.6 1.9 0.1 2.2 0.5 1.5 0.9 2.6 1.3 0.0 0.2 2.5 7.5 3.6 1.9 2.3 45.9 0.6 0.2 1.1 0.1 0.5 0.1 0.3 1.3 2.4 13.7 0.9 1.2 1.4 1.4 1.0 0.5 4.3 6.3 0.7 20.9 0.7 1.0 2.1 0.6 0.1 0.6 0.9 1.4 0.0 0.7 3.4 0.5 1.8 3.2 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.0 1.5 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.1 0.1 0.0 0.0 2.3 5.7 4.8 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.2 0.0 0.0 0.0 0.4 0.0 1.4 0.0 15.7 0.0 0.0 0.0 0.1 14.6 0.1 0.0 0.6 5.0 8.8 0.0 0.0 0.3 0.5 0.0 0.0 0.4 0.1 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.5 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.4 1.9 0.5 1.5 0.6 0.2 0.3 1.3 1.4 1.4 0.0 0.0 0.0 0.2 0.1 1.3 137.1 0.0 17.4 0.0 0.0 2.0 1.0 1.7 0.0 0.7 0.6 0.4 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.4 4.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 12.7 1.4 2.3 6.5 1.9 0.0 0.5 0.0 2.6 0.0 0.0 0.1 RBM34 KIAA0117 ENSG00000188739 "RNA binding motif protein 34" P42696 1 235131183-235161457 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028606 Approved Supported "Nucleoplasm,Nucleoli,Mitotic chromosome" Yes No Nucleoli "Nucleoplasm, Mitotic chromosome" "HPA028606: AB_10601494" "unprognostic (4.53e-2)" "unprognostic (3.64e-2)" "unprognostic (7.30e-2)" "unprognostic (3.68e-2)" "unprognostic (1.28e-1)" "unprognostic (2.32e-2)" "unprognostic (6.57e-4)" "unprognostic (2.98e-2)" "unprognostic (5.65e-3)" "unprognostic (2.02e-2)" "unprognostic (1.38e-1)" "unprognostic (1.13e-1)" "unprognostic (1.69e-8)" "unprognostic (8.50e-2)" "unprognostic (1.85e-1)" "unprognostic (8.73e-2)" "unprognostic (7.09e-4)" 15.8 10.5 17.2 16.4 18.1 30.6 14.8 15.5 22.3 11.0 13.5 10.6 7.0 16.7 10.9 15.2 15.4 9.9 11.3 15.2 13.4 11.6 19.4 14.2 11.5 20.0 16.9 9.9 13.9 13.5 6.6 24.9 14.7 20.9 13.5 12.6 7.6 18.3 11.2 22.2 17.9 17.6 10.9 17.9 14.6 13.1 28.8 17.3 17.5 14.7 10.9 17.1 14.1 16.0 34.2 27.2 38.0 19.2 25.3 35.5 22.7 12.0 9.1 9.5 12.1 7.2 13.0 23.6 12.8 8.9 11.5 11.1 12.3 13.8 20.8 13.9 7.7 9.2 18.1 11.3 11.7 11.1 18.8 18.4 15.6 6.5 8.5 14.4 24.6 15.3 11.4 13.5 10.7 7.4 10.6 9.2 20.8 22.1 10.7 14.5 6.9 21.4 21.2 27.6 16.6 6.5 20.1 10.5 24.0 11.9 9.2 11.8 21.5 17.7 11.3 28.9 6.9 24.6 26.8 9.6 11.7 10.2 16.1 25.6 13.0 21.0 22.0 13.7 16.5 18.2 38.0 16.9 20.4 23.7 19.2 28.2 34.2 27.3 30.4 17.2 26.3 26.0 29.9 8.2 25.3 19.1 27.2 35.5 22.7 17.2 18.1 15.5 22.3 13.4 11.6 16.9 9.9 20.9 17.3 17.9 10.9 5.1 5.4 2.9 3.3 2.6 5.1 16.0 11.4 3.5 9.8 5.2 5.0 5.6 5.6 3.5 3.6 0.0 5.4 3.7 3.5 4.5 22.0 3.0 2.9 0.0 7.5 5.5 6.8 4.4 3.7 4.3 3.3 9.0 2.6 4.1 7.1 2.9 5.3 7.9 4.9 0.0 5.2 6.1 5.3 3.3 5.1 11.4 3.7 5.7 REXO2 "CGI-114, DKFZP566E144, SFN" ENSG00000076043 "RNA exonuclease 2" Q9Y3B8 11 114439386-114450279 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038450, HPA038451" Enhanced Supported "Nucleoli,Focal adhesion sites,Mitochondria" NA NA 390000 Mitochondria "Nucleoli, Focal adhesion sites" "HPA038450: AB_10672516, HPA038451: AB_10697391" "unprognostic (3.26e-3)" "unprognostic (2.36e-2)" "prognostic favorable (6.51e-4)" "unprognostic (6.84e-3)" "unprognostic (5.80e-3)" "unprognostic (1.06e-1)" "unprognostic (1.40e-3)" "unprognostic (1.78e-1)" "unprognostic (8.18e-3)" "unprognostic (2.49e-2)" "unprognostic (2.17e-3)" "unprognostic (1.02e-1)" "unprognostic (1.73e-2)" "unprognostic (6.75e-2)" "unprognostic (1.23e-1)" "unprognostic (7.69e-2)" "prognostic unfavorable (6.70e-4)" 21.8 31.1 13.5 15.8 14.2 16.2 30.0 14.9 12.6 31.4 36.0 11.2 24.0 8.4 38.4 24.8 33.5 17.7 23.9 64.3 13.3 10.5 35.7 28.6 20.1 13.9 17.0 13.1 28.5 27.7 61.2 24.9 45.0 15.3 32.0 17.7 11.6 61.6 22.8 27.8 22.7 15.8 44.6 15.7 18.6 31.5 29.6 14.5 9.9 20.0 25.2 15.2 34.9 40.6 15.5 28.6 19.0 7.9 18.1 30.5 12.2 27.8 16.2 6.3 16.9 50.7 53.8 15.0 47.3 37.0 23.9 30.5 42.6 47.7 15.3 47.7 41.7 36.3 17.8 14.1 41.8 39.5 14.9 10.9 16.9 22.4 26.5 66.7 12.3 5.4 37.2 40.1 30.2 32.1 42.0 42.7 15.9 31.2 9.4 53.5 6.6 8.9 15.5 19.4 22.3 28.7 7.9 20.6 55.8 34.2 22.7 11.2 7.0 21.7 16.8 19.9 27.5 34.1 6.5 40.4 30.8 36.8 23.7 28.9 7.4 8.8 25.9 21.2 29.1 16.4 19.0 6.0 8.8 14.3 7.9 16.5 15.5 21.6 17.9 7.8 11.7 19.9 16.1 1.5 18.1 7.9 28.6 30.5 12.2 13.5 14.2 14.9 12.6 13.3 10.5 17.0 13.1 15.3 14.5 98.3 49.6 36.3 126.2 123.4 12.0 342.7 43.3 89.7 68.2 90.7 2.0 149.0 235.4 121.0 59.3 101.2 22.2 93.5 62.0 153.2 153.3 156.6 32.2 67.6 83.4 4.8 77.7 89.6 17.6 35.4 195.1 39.5 229.5 53.3 64.2 27.2 110.2 31.6 166.2 264.0 6.7 51.8 115.4 227.9 71.1 142.2 225.1 37.4 70.7 116.6 REXO5 NEF-sp ENSG00000005189 "RNA exonuclease 5" Q96IC2 16 20806429-20849668 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 18 "blood: 33.9;testis: 119.4" "Cell type enhanced" "Detected in some" 7 "Ciliated cells: 2.7;Club cells: 2.3;Cytotrophoblasts: 1.7;Extravillous trophoblasts: 2.0;Hofbauer cells: 1.9;monocytes: 2.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 15 "basophil: 33.9" "Lineage enriched" "Detected in single" 39 "granulocytes: 33.9" "Cell line enhanced" "Detected in many" "K-562: 24.4;U-266/70: 25.2" "Low region specificity" "Detected in all" "HPA040755, HPA040868, HPA066145" Approved Approved "Nuclear membrane,Nucleoli,Endoplasmic reticulum" NA NA "Nuclear membrane" "Nucleoli, Endoplasmic reticulum" "HPA040755: AB_10965790, HPA040868: AB_10963549, HPA066145: " "unprognostic (2.39e-1)" "unprognostic (2.09e-3)" "unprognostic (1.09e-2)" "unprognostic (1.15e-1)" "unprognostic (1.68e-1)" "unprognostic (5.63e-2)" "unprognostic (9.15e-2)" "unprognostic (6.24e-2)" "unprognostic (2.26e-1)" "unprognostic (1.80e-2)" "unprognostic (8.24e-2)" "unprognostic (4.72e-2)" "unprognostic (2.42e-4)" "unprognostic (1.01e-2)" "unprognostic (8.23e-2)" "unprognostic (2.00e-1)" "unprognostic (6.93e-2)" 0.8 0.7 0.7 1.4 1.9 2.6 1.0 1.0 1.0 0.4 0.6 0.6 0.2 0.7 0.9 0.8 0.6 1.1 0.7 1.1 0.6 0.5 0.5 0.5 0.6 0.7 0.4 1.2 0.8 0.6 3.3 0.4 0.4 0.6 1.4 0.8 0.7 0.8 0.7 0.4 0.6 0.6 0.7 0.3 0.3 1.6 119.4 0.4 4.1 0.3 0.5 0.9 0.8 0.6 0.0 0.3 33.9 0.2 0.8 0.7 0.1 6.4 3.6 5.7 2.5 2.3 4.8 1.9 4.3 4.8 4.8 5.3 2.7 5.6 3.9 6.9 3.6 3.3 3.2 4.3 1.9 5.0 4.1 3.1 6.5 5.4 3.7 0.5 9.6 9.5 2.2 0.8 5.6 7.3 2.1 1.6 0.0 24.4 17.5 11.7 8.3 1.5 7.2 3.1 2.5 3.7 7.8 10.8 7.0 1.4 2.2 5.1 5.7 4.0 5.5 1.4 1.7 9.3 8.2 0.8 3.5 3.2 4.7 5.1 25.2 17.0 1.5 7.4 12.4 3.4 33.9 0.2 2.2 0.1 0.0 0.2 0.0 0.2 0.2 0.3 0.0 0.0 0.1 0.1 0.8 0.1 0.1 0.7 0.1 0.7 1.9 1.0 1.0 0.6 0.5 0.4 1.2 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 2.3 0.0 0.0 1.7 0.0 1.3 0.0 0.0 0.0 0.0 1.3 2.0 0.0 0.0 1.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 1.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 RGS12 ENSG00000159788 "Regulator of G protein signaling 12" O14924 4 3293028-3439913 "Plasma proteins, Predicted intracellular proteins" Transcription "GTPase activation, Repressor, Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 37.2" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 118.6;Suprabasal keratinocytes: 96.1;Urothelial cells: 169.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054646, HPA067421" Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA054646: AB_2682555, HPA067421: AB_2685836" "unprognostic (2.08e-1)" "unprognostic (1.71e-3)" "unprognostic (7.50e-2)" "unprognostic (4.18e-2)" "unprognostic (1.65e-1)" "prognostic favorable (7.03e-4)" "unprognostic (3.43e-2)" "unprognostic (1.93e-1)" "unprognostic (1.76e-1)" "unprognostic (9.02e-2)" "unprognostic (1.70e-2)" "unprognostic (2.13e-1)" "prognostic favorable (8.43e-4)" "unprognostic (2.54e-1)" "unprognostic (2.60e-1)" "unprognostic (5.92e-2)" "unprognostic (1.11e-2)" 4.7 4.4 20.7 4.1 22.0 2.3 4.4 10.2 37.2 5.4 2.9 10.2 1.5 5.3 6.4 5.6 13.5 7.5 4.4 4.7 13.4 5.6 4.4 6.7 6.5 3.4 12.3 16.3 8.9 3.1 3.1 6.1 4.1 9.4 6.8 2.2 3.1 6.5 5.7 6.8 20.6 4.6 3.0 18.9 4.1 3.2 5.5 9.9 4.3 3.8 3.4 3.6 5.5 7.9 1.0 1.5 1.6 3.9 0.4 1.3 0.7 4.0 5.1 10.3 7.4 3.5 2.7 4.3 4.3 3.5 4.5 3.3 4.1 2.4 1.0 2.7 3.8 6.6 3.9 2.0 13.9 1.5 0.1 1.6 0.4 2.9 10.0 3.1 0.3 5.7 2.3 9.5 2.3 3.2 4.1 9.9 3.6 4.7 0.2 4.1 3.4 0.7 10.8 4.9 2.3 4.9 10.2 4.0 3.3 2.3 12.0 11.7 12.0 2.7 1.9 9.1 2.6 4.7 6.9 7.4 8.8 5.8 1.8 4.6 5.1 4.0 2.3 5.1 6.0 6.2 1.0 1.2 0.3 0.9 3.9 0.3 0.2 0.8 0.5 1.5 1.0 1.3 0.5 1.6 0.4 3.7 0.8 0.6 0.7 20.7 22.0 10.2 37.2 13.4 5.6 12.3 16.3 9.4 9.9 6.0 8.3 0.5 118.6 75.0 19.0 7.5 15.3 29.4 20.5 5.2 27.5 5.3 3.3 9.0 3.8 21.1 5.1 0.0 9.2 1.0 10.0 34.2 13.9 22.7 19.8 9.5 14.3 25.8 6.1 4.2 13.8 19.0 16.9 5.4 9.9 38.9 11.1 0.0 7.4 18.1 18.7 0.0 8.8 20.2 14.9 96.1 5.6 4.5 8.0 169.4 RGS6 ENSG00000182732 "Regulator of G protein signaling 6" P49758 14 71932439-72566529 "Predicted intracellular proteins" "GTPase activation, Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.8" "Group enriched" "Detected in some" 9 "Early spermatids: 155.9;Late spermatids: 221.8" "Group enriched" "Detected in some" 7 "glioma: 3.1;thyroid cancer: 1.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 1.6;T-reg: 1.2" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 7 "HEL: 8.3;Karpas-707: 30.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003067 Uncertain Approved Nucleoplasm,Nucleoli,Vesicles NA NA Nucleoplasm "Nucleoli, Vesicles" "HPA003067: AB_1079807" "unprognostic (7.18e-2)" "unprognostic (7.78e-2)" "unprognostic (1.00e-1)" "unprognostic (6.85e-2)" "unprognostic (5.61e-2)" "unprognostic (3.80e-2)" "unprognostic (1.24e-4)" "unprognostic (7.83e-2)" "unprognostic (2.03e-1)" "unprognostic (8.17e-2)" "unprognostic (1.30e-1)" "unprognostic (2.06e-2)" "unprognostic (8.64e-2)" "unprognostic (5.11e-2)" "unprognostic (8.06e-3)" "unprognostic (2.10e-1)" "unprognostic (3.68e-2)" 6.9 0.8 8.6 1.1 11.1 2.0 4.9 4.0 18.0 7.9 1.8 2.8 0.3 0.8 2.7 4.2 1.0 3.6 1.9 15.7 3.7 7.5 3.3 0.6 1.7 0.5 15.4 9.3 2.3 0.6 10.9 2.6 4.6 20.8 0.7 1.8 1.3 1.3 2.5 1.7 1.4 1.4 2.2 5.2 1.5 0.8 13.9 2.4 0.0 8.5 0.3 1.0 1.1 1.3 0.5 0.4 1.6 0.2 0.6 1.2 4.1 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 8.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 30.0 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.6 0.6 0.0 0.4 1.2 4.1 8.6 11.1 4.0 18.0 3.7 7.5 15.4 9.3 20.8 2.4 0.0 0.0 0.0 0.0 0.2 1.4 19.7 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 155.9 0.7 0.0 0.0 0.2 0.1 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 221.8 1.7 0.0 0.0 8.2 0.0 0.0 0.0 0.0 7.1 0.1 0.4 12.9 20.2 1.2 1.0 0.1 0.7 0.0 0.0 0.4 RHOJ "ARHJ, FLJ14445, RASL7B, TCL" ENSG00000126785 "Ras homolog family member J" Q9H4E5 14 63204114-63293219 "Predicted intracellular proteins" Angiogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 18 "Endothelial cells: 65.7;Ito cells: 34.4;Peritubular cells: 15.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 15.6;HUVEC TERT2: 90.5;TIME: 24.0;WM-115: 26.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003050 Uncertain Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Plasma membrane" "Nucleoplasm, Nucleoli" "HPA003050: AB_1079812" "unprognostic (7.24e-2)" "unprognostic (1.72e-1)" "unprognostic (4.37e-2)" "unprognostic (2.42e-1)" "unprognostic (6.71e-2)" "unprognostic (1.77e-2)" "unprognostic (2.89e-1)" "unprognostic (2.33e-2)" "unprognostic (2.19e-1)" "unprognostic (3.04e-3)" "unprognostic (1.42e-2)" "unprognostic (7.07e-2)" "prognostic unfavorable (1.31e-4)" "unprognostic (3.50e-3)" "unprognostic (4.84e-2)" "unprognostic (1.86e-2)" "unprognostic (1.06e-3)" 17.0 2.9 11.4 6.4 12.0 0.2 14.3 7.3 15.8 15.1 12.0 3.4 7.9 5.8 22.8 14.7 12.4 15.6 20.0 13.0 11.3 4.6 7.3 4.0 18.6 7.0 8.0 9.8 11.9 3.6 3.3 6.5 7.3 6.8 15.9 8.8 14.8 7.2 11.8 5.8 6.0 8.4 25.3 5.4 9.4 9.4 4.7 8.5 0.0 13.1 13.9 3.9 16.9 9.2 1.2 0.9 2.6 0.8 1.4 0.6 0.1 0.0 0.0 15.6 0.0 0.0 0.0 0.0 2.5 10.5 0.9 1.5 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.9 8.9 90.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.5 0.2 0.0 0.0 24.0 0.0 0.2 0.2 1.4 0.0 0.0 0.0 0.0 0.0 26.0 1.0 0.8 0.6 0.5 0.4 0.3 0.7 0.4 0.4 0.2 1.2 0.6 0.6 2.6 1.4 0.2 0.9 0.2 0.1 11.4 12.0 7.3 15.8 11.3 4.6 8.0 9.8 6.8 8.5 0.0 2.2 0.0 0.2 5.3 0.0 2.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.4 0.4 65.7 0.0 0.0 0.7 0.0 11.6 0.5 0.0 0.0 0.1 0.0 0.0 34.4 1.0 0.5 10.9 1.7 3.3 0.0 0.0 9.1 0.1 0.0 15.2 0.0 0.2 6.5 8.0 0.1 0.4 4.3 0.1 0.0 0.0 0.5 RIMS3 "NIM3, RIM3" ENSG00000117016 "Regulating synaptic membrane exocytosis 3" Q9UJD0 1 40620679-40665657 "Predicted intracellular proteins" "Exocytosis, Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 47.7" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 10.7;Late spermatids: 23.5;Muller glia cells: 12.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "MAIT T-cell: 1.8;plasmacytoid DC: 4.6" "Group enriched" "Detected in many" 9 "dendritic cells: 4.6;T-cells: 1.8" "Cell line enhanced" "Detected in many" "Daudi: 37.3;JURKAT: 13.2;SH-SY5Y: 17.7;U-87 MG: 16.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055285 Approved Nucleoplasm,Nucleoli,Mitochondria NA NA "Nucleoli, Mitochondria" Nucleoplasm "HPA055285: AB_2682771" "unprognostic (3.51e-3)" "unprognostic (7.18e-3)" "unprognostic (4.44e-3)" "unprognostic (1.44e-4)" "unprognostic (3.70e-1)" "unprognostic (2.88e-2)" "unprognostic (1.44e-5)" "unprognostic (2.41e-1)" "unprognostic (1.53e-1)" "unprognostic (2.87e-1)" "unprognostic (2.54e-1)" "unprognostic (7.93e-2)" "unprognostic (1.09e-1)" "unprognostic (2.19e-1)" "unprognostic (3.25e-2)" "unprognostic (3.11e-2)" "unprognostic (2.19e-2)" 1.3 7.2 13.6 2.2 19.2 3.7 3.1 21.5 47.7 1.4 3.4 3.4 0.0 1.1 3.0 2.2 2.9 2.1 1.3 1.5 7.8 17.4 1.4 0.7 3.1 2.0 7.4 22.3 2.5 1.1 4.0 0.5 3.8 4.9 3.2 3.8 2.0 2.0 4.1 0.6 2.7 1.7 4.8 3.4 1.7 2.5 3.1 4.4 0.7 2.8 0.0 2.8 1.7 1.0 0.1 4.6 0.1 0.3 0.1 1.8 0.1 1.9 0.7 2.9 3.1 0.1 0.0 0.4 0.0 0.0 0.5 0.6 0.3 0.6 37.3 0.0 0.0 1.4 0.3 1.9 0.3 0.3 6.4 0.9 2.1 0.2 1.0 0.1 0.3 1.7 0.0 1.5 0.1 0.1 0.1 0.1 13.2 1.8 1.4 0.0 3.4 5.5 0.2 1.8 0.3 0.2 2.5 2.6 6.9 0.5 0.5 10.0 17.7 0.4 1.8 1.2 4.0 0.4 10.4 0.0 0.3 3.0 0.0 0.5 0.3 2.7 8.2 16.3 0.6 0.3 0.1 0.0 0.0 0.1 0.0 1.8 0.0 0.5 0.2 0.2 0.1 0.0 0.2 0.0 0.1 0.3 4.6 0.4 0.1 13.6 19.2 21.5 47.7 7.8 17.4 7.4 22.3 4.9 4.4 6.0 0.0 0.0 0.2 0.5 6.3 1.4 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.7 10.7 0.1 1.7 0.0 1.3 0.1 0.3 0.4 1.1 0.0 2.4 4.8 0.0 0.0 2.1 23.5 0.0 1.1 0.0 1.0 1.9 12.8 2.3 0.8 0.7 0.3 0.6 0.0 2.2 3.3 1.1 0.1 0.2 0.0 0.6 0.1 RIN2 RASSF4 ENSG00000132669 "Ras and Rab interactor 2" Q8WYP3 20 19886521-20002457 "Disease related genes, Predicted intracellular proteins" Endocytosis "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Hofbauer cells: 81.6;Ito cells: 94.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 6 "dendritic cells: 1.2;granulocytes: 2.2;monocytes: 3.3" "Cell line enhanced" "Detected in many" "PC-3: 25.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034641 Approved Approved "Nucleoli,Golgi apparatus,Cytosol" NA NA Cytosol "Nucleoli, Golgi apparatus" "HPA034641: AB_10671230" "unprognostic (8.23e-3)" "unprognostic (8.09e-3)" "unprognostic (3.71e-2)" "unprognostic (1.97e-1)" "unprognostic (3.12e-2)" "unprognostic (3.86e-2)" "unprognostic (1.61e-2)" "unprognostic (3.69e-2)" "unprognostic (2.69e-2)" "unprognostic (1.78e-3)" "unprognostic (2.49e-1)" "unprognostic (6.27e-2)" "prognostic favorable (8.34e-6)" "unprognostic (3.10e-1)" "unprognostic (2.08e-2)" "unprognostic (8.02e-3)" "unprognostic (3.63e-2)" 19.2 6.7 9.9 6.1 8.7 4.0 24.4 4.3 10.2 11.7 21.6 9.5 7.6 10.5 12.7 6.6 11.1 9.7 14.7 13.7 10.0 6.2 12.2 4.6 26.8 4.3 8.3 4.4 12.7 5.1 4.2 4.9 16.7 9.3 8.0 10.4 16.5 12.0 11.3 10.9 6.6 23.4 13.2 7.7 17.5 6.5 3.5 9.9 0.3 13.1 5.5 3.7 9.9 15.6 0.3 1.2 2.2 3.3 0.1 0.3 0.4 3.4 11.4 2.1 6.8 12.5 7.7 7.1 2.8 11.8 3.0 1.7 5.4 3.1 0.0 12.4 7.1 5.7 12.7 0.1 18.1 3.3 1.4 0.0 0.0 2.0 0.4 2.8 0.0 0.0 11.2 3.1 5.7 6.3 6.8 16.2 0.0 0.0 0.2 9.0 2.5 0.0 0.2 0.3 1.6 25.3 0.1 7.6 1.8 3.9 4.9 1.8 0.4 2.7 11.2 0.0 2.2 1.0 0.9 17.5 6.3 1.4 3.7 4.7 0.0 0.0 0.0 4.0 0.0 1.0 0.6 3.3 0.2 0.2 2.7 0.2 0.2 0.2 0.2 1.2 0.3 0.3 0.3 2.2 0.1 2.8 0.6 0.1 0.4 9.9 8.7 4.3 10.2 10.0 6.2 8.3 4.4 9.3 9.9 59.6 13.7 4.7 21.9 37.3 5.7 26.6 10.2 13.4 15.9 29.6 7.9 3.8 36.5 15.5 0.6 37.6 17.0 0.0 30.1 5.9 38.6 19.7 0.0 3.8 81.6 6.4 13.8 94.5 62.1 0.8 17.8 36.0 20.3 4.6 16.1 26.2 24.4 7.0 14.5 34.2 0.7 0.0 17.4 0.0 0.1 47.2 5.9 2.5 18.9 24.1 RPL10A "Csa-19, L10A, NEDD6" ENSG00000198755 "Ribosomal protein L10a" P62906 6 35468408-35470785 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053803 Approved Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA 360000 "Endoplasmic reticulum, Cytosol" Nucleoli "HPA053803: AB_2682268" "unprognostic (5.47e-2)" "unprognostic (8.02e-2)" "unprognostic (1.45e-1)" "unprognostic (3.37e-1)" "unprognostic (3.40e-2)" "unprognostic (1.36e-1)" "unprognostic (3.34e-2)" "unprognostic (4.74e-2)" "unprognostic (1.52e-2)" "unprognostic (1.18e-1)" "unprognostic (1.37e-2)" "unprognostic (9.66e-2)" "prognostic unfavorable (3.77e-4)" "unprognostic (2.21e-2)" "unprognostic (1.40e-1)" "unprognostic (1.16e-1)" "unprognostic (9.72e-2)" 55.0 41.7 35.5 80.8 28.0 79.0 96.9 25.3 37.6 71.5 76.4 22.8 62.3 35.0 91.2 62.5 88.7 91.0 72.6 45.2 28.1 23.1 45.4 71.1 44.8 94.0 28.5 38.0 155.3 141.2 18.6 35.6 56.6 25.6 86.5 55.2 34.7 104.5 66.1 98.5 92.9 47.2 56.8 27.3 51.4 55.5 33.2 20.1 70.6 62.0 121.6 76.5 77.4 86.4 165.3 104.4 8.5 62.8 101.1 186.5 235.1 66.6 68.9 78.3 73.6 117.4 214.2 88.8 69.1 142.3 97.5 77.8 99.6 64.6 200.2 63.8 93.6 47.9 59.2 105.5 157.7 81.0 69.4 92.9 76.8 63.8 139.1 174.0 112.0 64.1 249.0 185.0 71.4 239.9 158.1 142.7 100.7 90.5 99.0 110.5 117.8 118.1 136.2 82.2 105.4 60.8 93.6 75.5 154.9 123.2 110.4 55.3 81.0 42.5 97.8 195.2 66.0 105.8 204.3 82.3 31.9 57.7 42.3 86.9 62.6 101.9 132.2 40.0 130.7 57.0 8.5 62.8 5.9 82.7 61.2 146.9 165.3 137.8 106.1 104.4 146.8 186.5 145.8 6.1 101.1 52.4 98.5 104.4 235.1 35.5 28.0 25.3 37.6 28.1 23.1 28.5 38.0 25.6 20.1 497.3 826.2 3505.8 4941.4 4796.5 207.9 239.4 1668.8 799.0 1510.5 567.0 68.7 3327.1 2528.3 1289.0 177.8 1494.7 980.5 513.9 2845.5 4591.2 2345.1 3300.9 883.5 1243.6 1940.9 103.3 1454.5 1261.4 1687.0 354.9 2330.6 2284.0 2282.6 2326.4 2431.8 212.5 2052.4 1855.2 1390.9 2230.9 177.0 756.7 2794.2 210.8 382.0 5789.4 3433.4 2382.6 3597.4 4457.4 RPL13 "BBC1, D16S444E, L13" ENSG00000167526 "Ribosomal protein L13" P26373 16 89560657-89566828 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051702 Approved Enhanced "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA 53000 "Nucleoli, Endoplasmic reticulum, Cytosol" "HPA051702: AB_2681579" "unprognostic (5.41e-3)" "unprognostic (1.69e-1)" "unprognostic (1.14e-2)" "prognostic favorable (6.26e-4)" "unprognostic (1.57e-2)" "unprognostic (3.68e-2)" "unprognostic (7.38e-2)" "unprognostic (2.37e-1)" "unprognostic (2.70e-1)" "unprognostic (1.44e-2)" "unprognostic (2.14e-1)" "unprognostic (7.57e-2)" "prognostic unfavorable (6.64e-4)" "unprognostic (4.34e-2)" "unprognostic (7.10e-2)" "unprognostic (1.14e-1)" "unprognostic (9.30e-2)" 82.5 56.0 46.7 105.0 38.4 112.7 150.9 37.7 44.0 114.5 114.9 31.3 76.9 65.5 118.4 85.4 144.0 98.4 101.6 85.2 38.6 32.1 60.8 118.3 90.4 385.1 38.8 37.4 231.3 255.8 36.5 57.5 66.0 27.0 136.2 44.4 43.0 267.3 87.6 197.4 137.7 66.7 90.2 44.8 104.7 71.1 106.5 24.6 135.0 102.4 129.6 98.6 109.3 156.8 277.8 163.1 26.9 96.9 120.7 299.0 355.4 67.5 75.1 53.4 86.5 96.1 160.2 111.9 42.7 92.6 89.3 36.3 113.4 104.8 95.0 88.2 72.4 35.5 94.0 63.4 112.3 44.6 26.6 176.0 32.3 41.9 150.3 205.8 39.2 39.5 194.0 239.4 57.2 144.3 145.7 93.0 120.4 98.7 54.2 68.5 211.6 107.4 308.2 109.2 133.6 79.9 160.2 56.6 133.5 108.4 56.8 75.3 110.2 59.1 77.3 128.1 35.2 152.0 233.4 54.2 57.7 62.3 50.8 58.5 82.2 77.2 96.9 75.3 138.7 60.5 26.9 96.9 15.3 129.1 74.9 239.2 252.5 234.3 176.5 116.8 277.8 299.0 230.2 10.7 120.7 56.7 163.1 163.7 355.4 46.7 38.4 37.7 44.0 38.6 32.1 38.8 37.4 27.0 24.6 1676.5 3076.1 8572.3 13242.6 11129.2 658.9 392.1 3263.7 1810.8 3433.9 1533.6 178.7 5497.3 3942.5 3304.0 3376.6 4985.3 2353.5 1588.5 9512.5 8594.0 5542.1 9230.0 2503.8 3991.9 4585.6 235.2 2827.6 3949.3 6200.5 9204.7 7634.3 6835.9 5176.0 5670.1 5289.2 713.9 6690.8 4380.2 3433.2 5399.2 577.3 2050.2 5882.2 1406.9 1082.9 14135.8 5156.1 7058.2 8155.8 12161.4 RPL18 L18 ENSG00000063177 "Ribosomal protein L18" Q07020 19 48615328-48619536 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 5 "NB-4: 559.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046572 Approved Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA 100000 "Endoplasmic reticulum, Cytosol" Nucleoli "HPA046572: AB_2679705" "unprognostic (2.12e-2)" "unprognostic (1.86e-2)" "unprognostic (7.30e-2)" "unprognostic (2.57e-2)" "unprognostic (3.48e-3)" "unprognostic (4.76e-2)" "unprognostic (3.21e-3)" "unprognostic (2.80e-1)" "unprognostic (2.39e-1)" "unprognostic (9.15e-2)" "unprognostic (6.15e-2)" "unprognostic (1.80e-1)" "prognostic unfavorable (1.21e-4)" "unprognostic (2.40e-1)" "unprognostic (3.04e-2)" "unprognostic (6.36e-2)" "unprognostic (1.27e-2)" 56.2 57.3 50.3 79.1 40.8 122.4 84.9 35.2 51.1 89.8 76.6 44.8 60.8 66.1 100.6 56.1 129.6 78.2 99.2 43.4 38.3 33.1 56.4 101.9 62.1 194.1 40.3 27.0 206.5 260.5 19.8 57.1 74.8 26.8 100.5 39.6 54.6 136.7 62.3 78.8 108.6 60.5 69.1 39.7 88.7 64.0 45.8 28.6 114.9 115.8 116.5 122.2 91.2 90.5 137.1 84.5 19.0 57.5 71.1 144.1 148.6 58.3 91.0 33.5 58.2 34.2 67.5 49.0 26.8 44.7 55.7 46.9 82.1 54.3 85.4 28.2 25.6 21.1 48.4 30.4 61.0 21.2 36.4 105.9 30.9 42.6 78.4 69.2 43.0 48.3 79.5 89.5 29.8 40.2 40.8 54.7 62.6 43.6 75.3 34.9 74.1 67.6 559.5 53.4 76.1 45.4 70.8 27.0 77.4 45.0 72.2 47.7 62.1 24.2 85.4 81.0 16.2 48.0 83.8 31.2 41.3 45.9 25.6 61.5 62.6 72.9 50.9 26.0 66.4 48.6 19.0 57.5 12.2 65.7 47.6 115.3 130.3 116.4 88.1 79.2 137.1 144.1 113.9 8.6 71.1 37.3 84.5 89.6 148.6 50.3 40.8 35.2 51.1 38.3 33.1 40.3 27.0 26.8 28.6 550.9 838.5 3591.6 3815.8 3969.4 373.7 225.2 1370.7 546.0 953.2 671.7 135.5 3294.6 1175.5 1414.5 62.6 1818.4 1578.0 724.2 3930.9 4507.0 2016.4 3365.3 983.1 1161.9 1943.0 127.1 1609.4 1403.2 2086.4 135.2 3008.2 2285.6 2161.1 2417.6 2644.1 668.4 2833.8 2163.8 1372.2 1352.6 310.0 1015.4 2447.3 225.6 356.8 4859.7 3460.6 2407.5 3173.8 4275.2 RPL22L1 ENSG00000163584 "Ribosomal protein L22 like 1" Q6P5R6 3 170864875-170870483 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 101.9" "Low region specificity" "Detected in all" "HPA048060, HPA056207, HPA068294" Uncertain Approved "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" Nucleoplasm "HPA048060: AB_2732544, HPA056207: AB_2683065, HPA068294: AB_2732781" "unprognostic (1.99e-1)" "unprognostic (3.45e-1)" "unprognostic (2.59e-1)" "unprognostic (1.45e-2)" "unprognostic (1.94e-1)" "unprognostic (2.31e-3)" "unprognostic (1.01e-2)" "unprognostic (9.50e-2)" "unprognostic (1.97e-1)" "prognostic favorable (8.60e-5)" "unprognostic (1.17e-3)" "unprognostic (4.52e-2)" "prognostic unfavorable (5.13e-12)" "unprognostic (5.12e-2)" "unprognostic (3.55e-1)" "unprognostic (1.23e-1)" "unprognostic (6.96e-2)" 17.2 14.6 8.9 28.1 9.5 36.0 21.5 6.0 9.3 14.3 15.7 5.3 6.6 8.4 12.2 12.3 33.6 15.3 11.8 11.3 7.4 8.5 11.4 64.3 18.8 31.4 10.1 5.7 18.6 71.6 1.9 12.1 10.5 10.7 14.7 15.7 6.4 15.7 14.0 17.7 19.4 13.7 12.2 11.5 37.5 17.4 9.7 8.9 17.9 15.2 32.5 27.8 18.9 15.9 24.1 24.2 1.9 7.6 13.1 13.8 3.5 15.8 17.9 5.8 67.6 17.3 101.9 17.8 16.1 37.2 13.1 8.5 7.6 3.7 49.0 3.7 15.0 41.1 4.1 14.4 41.1 7.3 2.9 2.6 4.4 2.2 17.1 70.0 9.0 6.5 74.0 84.0 4.1 44.6 20.5 44.5 27.2 3.1 3.1 71.8 20.1 65.7 5.1 90.9 6.1 3.2 88.2 2.1 7.5 32.5 35.3 0.9 4.9 1.6 8.1 7.0 3.3 11.3 8.0 20.6 2.5 19.3 5.0 22.4 5.0 3.5 7.8 45.9 5.5 52.1 1.0 4.8 1.9 6.8 5.7 13.8 24.1 10.0 9.0 5.1 17.9 6.7 7.4 1.0 13.1 7.6 24.2 6.3 3.5 8.9 9.5 6.0 8.1 7.4 8.5 10.1 5.7 10.7 8.9 8.9 36.6 274.9 201.6 175.5 13.0 14.5 53.5 57.6 92.1 19.2 3.9 84.0 56.3 132.5 30.8 89.5 76.2 23.3 199.7 252.2 105.2 161.6 105.0 90.9 170.2 7.9 138.8 87.8 140.5 29.1 129.2 89.6 74.2 57.7 130.6 34.1 350.4 115.2 83.8 69.0 18.4 45.3 94.8 47.6 26.2 216.6 82.3 126.9 150.6 274.6 RPL26 L26 ENSG00000161970 "Ribosomal protein L26" P61254 17 8377516-8383250 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 586.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030449, CAB037301" Supported Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" Nucleoli "CAB037301: AB_796168, HPA030449: AB_10602125" "unprognostic (2.02e-2)" "unprognostic (3.73e-1)" "unprognostic (2.12e-1)" "unprognostic (2.76e-1)" "unprognostic (6.82e-2)" "unprognostic (1.39e-1)" "unprognostic (1.10e-1)" "unprognostic (3.95e-1)" "unprognostic (6.59e-3)" "unprognostic (1.16e-1)" "unprognostic (1.12e-1)" "unprognostic (7.15e-2)" "unprognostic (1.96e-3)" "unprognostic (2.73e-1)" "unprognostic (1.08e-1)" "unprognostic (5.44e-2)" "unprognostic (2.38e-1)" 122.5 64.5 70.2 102.5 49.8 132.2 170.4 44.4 52.4 127.6 131.6 34.8 68.1 53.1 76.4 97.0 161.2 87.6 98.6 68.1 54.8 42.5 100.6 138.3 97.5 117.5 61.6 32.6 183.0 586.0 32.2 41.1 82.2 47.7 129.0 84.0 41.5 95.3 87.4 170.8 106.3 98.6 103.6 62.9 129.0 75.9 53.0 45.1 104.9 131.6 145.8 107.9 154.7 127.6 154.9 120.8 25.1 92.1 93.0 158.2 165.0 103.5 95.3 93.8 111.0 177.2 291.8 91.7 90.0 133.9 122.3 92.4 100.7 53.4 181.0 103.5 106.6 50.0 115.1 119.2 184.4 144.0 67.6 214.8 70.6 105.2 116.1 207.2 104.9 91.7 248.7 369.2 101.2 304.3 172.0 150.5 104.1 79.9 54.6 128.4 71.3 115.6 143.5 88.1 108.9 63.3 115.5 95.3 112.6 164.3 77.9 39.0 83.3 48.5 90.6 208.1 86.7 92.7 140.5 94.3 49.5 61.8 68.2 157.5 43.9 51.2 79.1 81.0 149.3 73.3 25.1 92.1 18.2 89.9 78.3 130.5 154.9 134.3 116.8 120.8 140.1 158.2 136.0 10.9 93.0 69.5 104.5 111.3 165.0 70.2 49.8 44.4 52.4 54.8 42.5 61.6 32.6 47.7 45.1 833.7 960.0 5357.4 2721.4 4954.5 234.8 252.2 2797.5 959.6 1909.7 952.6 125.7 3974.4 3344.0 2212.2 695.5 2535.1 1389.0 1425.0 4263.0 6092.8 2980.6 2437.9 1777.7 2307.8 2989.4 128.7 2198.5 2802.7 4762.9 1400.7 4423.2 3635.2 3033.3 3719.6 3654.9 300.8 3633.9 3236.9 2028.4 4497.4 340.9 1487.5 2382.4 569.4 578.1 6200.9 3820.5 3284.3 5356.2 2887.4 RPL26L1 RPL26P1 ENSG00000037241 "Ribosomal protein L26 like 1" Q9UNX3 5 172958729-172969771 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 73.6" "Cell type enhanced" "Detected in all" 4 "Early spermatids: 286.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030449 Approved Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" Nucleoli "HPA030449: AB_10602125" "unprognostic (3.02e-1)" "unprognostic (1.41e-1)" "unprognostic (3.39e-2)" "unprognostic (4.12e-2)" "unprognostic (1.31e-1)" "prognostic unfavorable (2.49e-4)" "unprognostic (2.04e-3)" "unprognostic (2.45e-1)" "unprognostic (7.51e-2)" "unprognostic (5.86e-3)" "unprognostic (3.18e-1)" "unprognostic (1.06e-1)" "unprognostic (7.17e-2)" "unprognostic (2.55e-1)" "unprognostic (1.90e-1)" "unprognostic (1.14e-1)" "unprognostic (2.14e-3)" 11.2 23.0 17.9 14.7 17.9 18.0 15.2 10.5 21.1 13.1 12.8 8.2 14.4 13.5 14.5 21.6 18.1 14.7 11.9 19.5 20.7 16.8 20.0 25.9 10.5 16.7 16.2 18.0 14.1 25.5 9.1 15.4 14.2 16.3 12.1 14.6 11.5 18.4 16.7 19.0 9.7 10.8 14.0 12.8 13.3 12.2 73.6 11.8 20.0 16.2 18.2 14.9 13.1 11.9 19.7 40.0 17.5 36.2 14.6 21.7 20.9 29.6 26.9 24.4 33.5 16.9 17.9 31.6 28.4 16.7 41.1 36.7 32.8 32.0 22.3 73.0 38.9 43.8 19.3 40.2 56.3 38.0 28.5 52.3 16.5 31.5 40.1 33.2 24.0 14.7 22.3 23.8 42.3 29.7 16.7 23.5 22.0 22.6 18.8 29.2 65.8 29.3 38.0 15.5 13.8 42.8 21.4 37.8 29.6 23.9 18.7 24.6 15.1 26.0 23.9 37.7 16.3 29.3 25.9 24.7 47.0 26.1 27.4 21.2 16.9 26.3 41.8 37.0 30.2 27.8 7.8 36.2 15.5 14.3 31.4 18.3 19.7 17.4 19.6 40.0 15.1 14.5 18.4 17.5 14.6 26.8 27.5 21.7 20.9 17.9 17.9 10.5 21.1 20.7 16.8 16.2 18.0 16.3 11.8 38.7 26.2 23.1 45.5 43.4 14.3 38.4 50.9 62.9 35.2 55.8 17.7 94.5 154.2 102.8 286.5 45.0 32.9 93.5 97.7 103.7 39.0 47.6 25.5 104.6 100.3 14.3 38.7 41.7 51.6 40.1 35.1 50.7 49.0 97.4 42.9 42.9 113.2 38.6 38.5 146.6 13.9 19.4 39.1 214.9 161.4 46.2 66.0 27.7 55.4 43.0 RPL29 "HIP, HUMRPL29, L29, RPL29P10" ENSG00000162244 "Ribosomal protein L29" P47914 3 51993600-51995942 "Predicted intracellular proteins, Ribosomal proteins" "Heparin-binding, Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 434.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA069064 Approved Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA "Nucleoli, Endoplasmic reticulum, Cytosol" "HPA069064: AB_2686077" "unprognostic (3.77e-3)" "unprognostic (2.72e-1)" "unprognostic (2.18e-1)" "unprognostic (2.32e-3)" "unprognostic (2.89e-3)" "unprognostic (5.46e-2)" "unprognostic (6.79e-3)" "unprognostic (1.79e-1)" "unprognostic (2.16e-1)" "unprognostic (5.06e-2)" "unprognostic (1.17e-1)" "unprognostic (1.40e-1)" "unprognostic (2.16e-2)" "unprognostic (1.98e-1)" "unprognostic (9.99e-2)" "unprognostic (6.25e-2)" "unprognostic (7.56e-2)" 91.6 61.7 42.5 64.6 33.0 110.2 111.0 30.1 39.7 102.4 98.1 30.3 57.1 53.6 59.6 72.8 124.7 76.0 68.7 72.1 33.8 26.0 55.7 122.9 64.8 219.4 36.0 26.0 150.1 434.1 16.3 34.3 50.7 26.3 91.1 41.2 38.9 103.7 54.8 160.8 102.5 73.8 80.2 38.1 83.9 59.7 58.7 25.2 85.9 83.3 123.3 92.4 88.5 87.1 137.9 98.1 32.8 80.0 74.8 132.2 202.9 69.9 91.0 70.2 107.0 125.2 196.8 99.0 78.3 96.8 107.6 89.5 108.3 107.5 195.7 34.1 79.5 65.9 63.7 101.2 166.6 51.5 79.6 137.7 101.3 117.7 180.6 148.5 146.9 97.8 240.5 236.9 79.3 141.3 123.3 120.4 87.9 79.0 150.3 79.2 159.8 127.5 191.1 116.5 106.6 154.5 59.3 77.3 189.8 137.5 146.3 56.8 110.8 58.5 135.2 133.7 46.8 101.2 251.4 104.3 60.4 81.1 93.1 116.7 98.1 139.0 139.2 79.9 176.2 79.8 32.8 80.0 22.6 68.8 61.7 115.0 137.9 112.2 87.6 98.1 128.2 132.2 109.9 10.8 74.8 48.4 82.8 100.8 202.9 42.5 33.0 30.1 39.7 33.8 26.0 36.0 26.0 26.3 25.2 175.7 330.0 3392.7 4367.8 3531.6 218.0 72.2 1398.7 310.5 437.9 675.2 96.2 2332.5 1848.6 1477.5 867.6 2040.8 1839.8 957.8 3975.0 4390.8 2112.5 3132.4 683.0 1270.4 2074.0 101.7 1376.0 1509.4 2270.2 3389.8 3344.0 2646.2 2103.8 1980.2 2585.2 359.2 2990.7 2489.9 1488.6 2639.2 288.1 1125.4 2454.4 526.4 450.8 4436.8 2053.3 2519.7 3632.3 5133.1 RPL34 L34 ENSG00000109475 "Ribosomal protein L34" P49207 4 108620566-108630412 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 400.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035139 Uncertain Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA "Nucleoli, Endoplasmic reticulum, Cytosol" "HPA035139: AB_10602925" "unprognostic (1.49e-2)" "unprognostic (2.06e-1)" "unprognostic (6.97e-2)" "prognostic favorable (2.76e-5)" "unprognostic (2.45e-1)" "unprognostic (1.10e-1)" "unprognostic (2.78e-1)" "unprognostic (8.22e-2)" "unprognostic (7.14e-2)" "unprognostic (2.12e-2)" "unprognostic (1.80e-1)" "unprognostic (1.32e-1)" "unprognostic (3.72e-3)" "unprognostic (6.17e-2)" "unprognostic (8.96e-3)" "unprognostic (2.71e-1)" "unprognostic (1.19e-2)" 68.5 52.6 65.9 77.6 63.7 118.0 165.2 43.7 52.9 82.0 70.1 25.5 57.5 47.3 106.0 111.1 76.4 75.2 61.9 59.2 53.7 41.4 60.2 98.4 56.1 110.1 54.6 49.7 157.4 305.1 17.8 68.3 63.8 59.0 74.3 61.0 35.2 129.9 60.2 87.1 77.6 57.6 87.5 57.5 70.8 60.3 43.2 32.2 63.3 82.2 109.5 95.4 67.6 102.3 300.5 153.8 56.2 116.4 134.2 331.0 400.6 59.2 43.3 78.7 111.9 170.9 270.5 77.5 91.6 116.4 75.6 63.3 109.7 105.5 180.4 55.2 89.0 37.8 42.3 84.6 142.9 99.3 66.5 135.5 75.3 91.0 167.9 143.9 188.8 84.4 240.5 204.2 61.7 140.4 146.0 135.9 100.8 131.9 103.6 124.5 115.1 115.6 230.6 90.3 132.9 87.7 106.2 84.6 109.2 157.8 100.0 84.5 108.2 37.4 218.5 128.3 65.5 72.6 172.7 100.3 51.9 70.4 54.2 80.9 77.4 100.9 145.4 70.7 118.0 63.4 56.2 116.4 35.6 122.0 86.8 207.8 300.5 247.8 165.5 121.2 257.1 331.0 244.9 24.9 134.2 74.9 153.8 176.2 400.6 65.9 63.7 43.7 52.9 53.7 41.4 54.6 49.7 59.0 32.2 1313.2 2435.5 8127.2 9688.6 11162.7 321.1 1043.1 4914.6 1694.4 3137.0 2053.6 70.7 5336.7 5859.0 3087.8 1166.8 4211.1 1851.3 2850.1 7573.3 5633.2 3960.7 4740.0 3107.4 4896.8 3604.2 146.2 2618.2 5127.8 6804.9 1575.7 6923.4 6371.5 5538.7 4548.4 5463.9 625.8 5524.0 4699.4 3790.7 6994.4 382.0 1882.0 3701.7 706.0 481.2 13381.8 5336.0 5116.7 7038.7 7765.2 RPL7 "humL7-1, L7" ENSG00000147604 "Ribosomal protein L7" P18124 8 73290267-73295789 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 536.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 638.4" HPA058373 Approved Approved "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA 170000 "Endoplasmic reticulum, Cytosol" Nucleoli "HPA058373: AB_2683694" "unprognostic (3.75e-1)" "unprognostic (3.60e-2)" "unprognostic (6.99e-2)" "unprognostic (1.80e-1)" "unprognostic (2.37e-2)" "unprognostic (7.32e-2)" "unprognostic (1.45e-2)" "unprognostic (3.41e-2)" "unprognostic (8.31e-2)" "unprognostic (4.78e-2)" "unprognostic (1.76e-1)" "unprognostic (3.09e-1)" "unprognostic (1.63e-2)" "unprognostic (9.89e-2)" "unprognostic (5.52e-2)" "unprognostic (3.14e-1)" "unprognostic (2.31e-1)" 54.7 36.5 54.6 37.9 49.3 67.6 86.9 55.9 54.1 57.5 46.2 36.4 41.0 33.6 54.9 50.6 59.5 50.6 26.5 36.7 32.1 22.0 46.4 67.6 40.3 53.3 55.9 20.5 125.8 87.5 22.9 67.7 33.4 55.0 43.6 44.9 44.1 51.8 36.6 61.9 72.7 37.0 49.5 46.9 46.5 51.2 135.1 54.9 33.7 42.6 69.0 66.6 50.8 58.5 338.1 231.5 66.1 171.7 205.0 464.0 536.3 99.7 72.5 78.0 93.8 159.2 204.1 76.7 109.7 88.2 75.0 59.2 87.2 104.6 296.9 89.8 88.4 51.2 95.8 102.9 140.1 117.1 79.8 85.4 162.5 94.9 89.7 95.7 114.5 83.4 191.0 165.6 69.4 217.2 138.4 121.5 100.9 144.9 112.7 106.4 84.7 181.7 175.2 90.9 182.4 78.0 122.9 89.3 115.7 116.9 100.1 108.0 78.7 51.5 638.4 153.6 67.0 161.3 150.6 114.0 57.7 88.3 73.3 101.3 65.2 92.3 191.6 60.3 142.3 94.7 66.1 171.7 41.1 179.1 138.9 322.3 338.1 314.4 232.5 231.5 282.6 464.0 327.0 22.3 205.0 118.6 192.4 237.0 536.3 54.6 49.3 55.9 54.1 32.1 22.0 55.9 20.5 55.0 54.9 759.3 1377.6 4083.1 8227.6 7155.0 251.0 580.3 2023.0 1007.8 1723.2 1244.0 117.8 3979.6 4725.1 2246.6 1393.0 2953.4 897.4 1004.5 4388.5 6073.2 3431.1 4195.6 1418.7 1830.9 2853.5 89.0 1556.2 2090.7 3232.1 609.0 3931.9 3610.7 3514.2 2982.9 2652.3 679.5 3206.0 2051.6 2172.0 4500.4 280.8 1435.8 4545.3 828.4 372.8 8292.9 4080.0 3000.7 4416.0 6170.5 RPL8 L8 ENSG00000161016 "Ribosomal protein L8" P62917 8 144789765-144792587 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 323.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045095, HPA050165" Enhanced Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA 240000000 "Nucleoli, Endoplasmic reticulum, Cytosol" "HPA045095: AB_2679213, HPA050165: AB_2681038" "unprognostic (2.52e-2)" "unprognostic (2.13e-2)" "unprognostic (2.09e-1)" "unprognostic (1.04e-2)" "unprognostic (1.67e-1)" "unprognostic (9.84e-2)" "prognostic unfavorable (7.22e-4)" "unprognostic (4.48e-2)" "unprognostic (1.41e-1)" "unprognostic (1.54e-1)" "unprognostic (9.28e-2)" "unprognostic (1.92e-1)" "unprognostic (1.19e-3)" "unprognostic (1.79e-2)" "unprognostic (1.77e-1)" "unprognostic (2.31e-1)" "unprognostic (4.13e-2)" 65.9 45.5 32.1 53.7 34.7 120.1 115.2 31.0 61.9 63.9 78.4 26.4 51.1 95.2 106.4 57.1 76.0 51.2 68.9 78.7 27.2 23.6 48.2 62.6 54.5 169.4 29.0 28.8 125.7 349.6 11.8 45.2 38.4 28.8 61.3 15.7 45.6 174.7 57.3 202.1 89.0 82.8 84.9 29.2 79.7 96.4 48.9 17.0 61.2 73.2 103.2 72.8 64.7 100.0 174.8 117.5 31.1 82.7 77.9 136.8 251.3 120.9 142.8 10.2 44.4 11.5 26.1 98.2 87.7 16.5 26.9 19.1 124.7 65.5 162.8 126.9 10.3 8.9 73.3 13.4 30.5 4.9 70.7 162.5 96.5 110.0 87.9 28.7 63.2 52.7 28.1 34.8 12.1 20.7 12.7 19.7 35.6 130.0 37.8 11.4 323.4 90.3 85.7 95.4 33.2 162.0 88.5 59.1 153.0 14.3 91.8 62.5 104.4 84.2 45.9 120.4 4.3 106.3 61.3 78.7 35.7 135.8 74.4 105.3 69.1 58.9 140.8 71.0 105.2 48.8 24.1 80.3 31.1 70.5 82.7 117.9 166.8 119.3 86.9 117.5 174.8 136.8 105.0 9.8 77.9 78.5 64.5 113.8 251.3 32.1 34.7 31.0 61.9 27.2 23.6 29.0 28.8 28.8 17.0 792.1 1172.5 3639.8 5704.0 5720.2 400.0 926.5 1594.9 667.9 1239.8 975.3 253.3 3837.7 3756.8 1939.3 708.6 1998.1 1895.6 1261.4 5072.3 5914.7 2684.9 4292.9 1005.1 1181.4 2697.5 157.3 1633.5 1478.1 2282.6 2004.1 2891.5 2666.3 3338.7 2696.1 3081.8 500.6 3359.4 2949.4 1346.4 3180.5 483.0 1060.7 3222.8 573.1 569.6 7189.2 3651.1 2078.6 4568.6 6042.4 RPL9 L9 ENSG00000163682 "Ribosomal protein L9" P32969 4 39452521-39458949 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA003372 Approved Approved Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA 24000 "Endoplasmic reticulum, Cytosol" Nucleoli "HPA003372: AB_1079843" "unprognostic (1.08e-3)" "unprognostic (2.14e-1)" "unprognostic (1.24e-1)" "unprognostic (8.06e-3)" "unprognostic (5.59e-2)" "unprognostic (1.27e-2)" "unprognostic (3.16e-2)" "unprognostic (2.14e-1)" "unprognostic (8.58e-2)" "unprognostic (6.68e-2)" "unprognostic (2.50e-2)" "unprognostic (7.85e-2)" "prognostic unfavorable (7.34e-4)" "unprognostic (1.34e-1)" "unprognostic (2.10e-2)" "unprognostic (1.97e-1)" "unprognostic (1.06e-2)" 52.6 35.2 42.2 73.9 44.4 179.1 202.3 35.7 51.6 63.0 59.8 34.5 42.2 69.8 50.4 226.8 49.9 48.1 69.7 58.2 42.3 27.6 47.4 73.2 35.8 48.7 34.7 51.7 158.5 126.2 37.4 44.7 38.7 42.5 47.8 59.1 31.7 93.7 71.4 66.3 62.9 38.8 49.5 34.0 45.2 46.5 56.9 25.9 36.0 63.2 70.1 59.0 46.0 56.6 118.3 72.5 26.2 41.4 63.0 145.0 148.9 3.2 2.8 122.9 2.8 6.6 9.0 4.8 57.9 87.4 72.3 54.8 8.1 65.7 143.5 6.6 58.2 57.3 65.4 5.5 6.3 79.1 52.3 115.6 4.5 24.2 7.8 8.6 9.3 38.0 11.9 181.8 4.4 83.1 107.6 5.5 5.8 109.7 67.0 5.0 4.3 77.9 9.9 109.8 79.6 3.9 71.9 123.2 4.9 89.9 3.8 4.6 49.0 2.0 47.5 7.4 118.9 104.9 6.8 4.1 3.1 4.6 84.1 8.0 103.0 144.6 124.7 83.4 87.3 3.3 26.2 41.4 12.3 52.1 40.1 101.2 118.3 102.2 71.4 57.2 103.8 145.0 111.7 6.9 63.0 31.2 72.5 77.0 148.9 42.2 44.4 35.7 51.6 42.3 27.6 34.7 51.7 42.5 25.9 616.4 695.5 3946.9 4635.1 3670.9 362.7 367.2 1765.6 426.9 687.0 673.4 151.2 2652.9 2316.1 1697.3 1288.9 2348.7 1394.0 817.7 3813.6 4743.2 2040.6 3407.8 885.2 1749.4 2435.4 187.5 1780.1 1927.4 2668.8 1161.7 4462.6 2606.9 1756.2 2952.2 2900.0 510.1 3233.5 2563.6 2250.5 2828.8 405.3 1487.5 2143.4 695.4 462.3 4086.9 2843.5 2427.5 4009.2 4396.5 RPS11 S11 ENSG00000142534 "Ribosomal protein S11" P62280 19 49496365-49499689 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049719 Uncertain Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" Nucleoli "HPA049719: AB_2680860" "unprognostic (1.49e-3)" "unprognostic (3.71e-2)" "unprognostic (1.22e-1)" "unprognostic (1.50e-2)" "unprognostic (5.89e-3)" "unprognostic (3.57e-1)" "unprognostic (1.04e-2)" "unprognostic (4.10e-1)" "unprognostic (1.58e-1)" "unprognostic (1.47e-1)" "unprognostic (5.68e-2)" "unprognostic (1.49e-1)" "prognostic unfavorable (3.50e-7)" "unprognostic (5.19e-2)" "unprognostic (1.04e-1)" "unprognostic (2.18e-1)" "unprognostic (1.71e-3)" 103.0 76.8 80.6 187.8 68.7 161.8 165.7 50.4 75.3 138.6 134.1 43.2 105.8 67.0 149.4 132.4 142.8 132.3 133.0 135.9 63.2 53.5 84.3 105.7 101.9 354.2 71.5 64.2 242.4 490.0 41.7 89.7 72.2 63.4 116.6 103.4 72.7 193.2 104.0 223.4 140.8 88.1 198.4 69.9 132.6 96.3 67.2 48.3 137.3 119.0 190.7 169.5 145.6 230.6 232.4 173.3 45.1 96.7 91.3 161.6 231.8 109.9 171.4 130.3 201.2 188.4 285.3 87.3 93.6 185.0 133.4 127.9 118.7 91.9 269.9 58.4 127.4 58.2 74.2 153.6 185.5 131.5 115.1 266.6 163.2 112.8 170.5 176.0 288.2 121.3 283.0 302.6 89.1 229.4 226.9 192.4 166.1 161.1 143.9 143.9 122.9 134.5 217.1 120.3 276.2 176.8 129.7 165.0 143.5 191.4 259.9 139.2 185.8 63.7 214.8 139.2 132.5 69.8 299.8 110.2 106.0 95.2 51.4 123.1 144.1 219.0 191.9 44.1 198.6 90.3 45.1 96.7 29.9 95.6 82.8 127.6 232.4 137.5 110.9 144.1 221.1 161.6 135.7 25.9 91.3 70.6 173.3 109.8 231.8 80.6 68.7 50.4 75.3 63.2 53.5 71.5 64.2 63.4 48.3 777.2 1364.0 2990.9 2041.9 2385.3 290.8 613.7 1123.6 1019.8 1465.0 450.1 135.5 1657.4 1031.2 1067.3 717.3 1435.9 1074.1 934.5 2445.2 2866.6 1515.8 1592.1 1273.2 1366.5 1658.3 89.0 1443.9 1317.9 2294.0 1350.9 2974.6 2278.1 1459.3 1700.6 2280.4 469.1 1978.0 1439.5 1446.5 1386.6 340.6 860.2 1282.2 599.4 586.0 2983.4 1970.5 1736.0 2339.2 2255.1 RPS17 "MGC72007, RPS17L, RPS17L1, RPS17L2, S17" ENSG00000182774 "Ribosomal protein S17" P08708 15 82536750-82540564 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 149.0" "Low region specificity" "Detected in all" HPA055060 Approved Approved "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA 39000 "Endoplasmic reticulum, Cytosol" Nucleoli "HPA055060: AB_2682686" "unprognostic (3.37e-3)" "unprognostic (1.49e-1)" "unprognostic (2.06e-2)" "unprognostic (6.90e-2)" "unprognostic (2.04e-1)" "unprognostic (1.63e-2)" "unprognostic (2.29e-1)" "unprognostic (2.32e-1)" "unprognostic (1.46e-1)" "unprognostic (1.28e-1)" "unprognostic (4.49e-2)" "unprognostic (2.19e-1)" "prognostic unfavorable (1.78e-4)" "unprognostic (2.83e-1)" "unprognostic (5.40e-2)" "unprognostic (2.09e-1)" "unprognostic (2.31e-1)" 40.1 37.3 23.9 41.5 28.0 78.5 93.7 20.5 39.7 41.3 35.4 18.0 32.7 12.0 34.4 69.6 58.2 48.5 36.3 36.2 24.9 16.0 33.0 56.8 30.4 75.5 22.2 22.4 100.0 160.7 8.0 28.1 28.7 29.1 32.2 54.1 21.2 64.2 38.1 47.5 60.8 33.0 54.2 26.6 40.9 38.1 29.3 19.2 36.1 38.5 85.2 82.2 34.1 55.8 42.1 34.6 12.5 19.7 26.5 48.5 63.4 10.4 75.5 24.4 15.8 41.3 57.4 18.9 5.7 10.6 18.1 16.6 107.6 34.5 14.9 10.7 23.1 32.1 33.1 58.8 58.3 32.6 9.1 149.0 2.6 78.0 72.2 56.4 13.2 14.4 73.9 107.7 22.3 76.5 48.5 38.3 39.2 10.2 39.9 27.8 84.1 16.9 46.6 36.7 67.8 60.3 11.4 6.2 26.8 53.9 95.3 17.8 11.5 2.3 32.0 31.5 42.3 38.9 40.7 9.9 28.2 20.6 17.4 12.6 12.0 18.6 13.0 23.1 34.1 15.4 12.5 19.7 4.5 16.6 17.2 43.6 39.9 41.3 26.8 27.2 42.1 48.5 42.4 2.5 26.5 14.8 34.6 23.7 63.4 23.9 28.0 20.5 39.7 24.9 16.0 22.2 22.4 29.1 19.2 756.3 1289.8 2965.8 4861.9 38.4 77.5 373.2 1826.7 922.1 1902.9 167.5 47.1 3046.0 462.6 1389.5 55.8 1090.9 569.4 1962.4 2604.1 5603.8 1698.1 3804.0 863.8 2556.7 2408.0 39.7 929.1 1950.1 2775.5 119.3 4074.2 1038.9 28.7 2043.3 2571.6 141.3 2469.3 1560.6 1761.1 737.0 85.0 1164.2 222.0 396.6 646.1 55.8 2855.8 2041.0 4254.9 4758.2 RPS19BP1 "FLJ21770, MGC52010" ENSG00000187051 "Ribosomal protein S19 binding protein 1" Q86WX3 22 39529093-39532855 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042874 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA Yes "Nucleoli, Cytosol" Nucleoplasm "HPA042874: AB_10793988" "unprognostic (2.44e-1)" "unprognostic (1.67e-1)" "unprognostic (7.79e-2)" "unprognostic (5.07e-3)" "unprognostic (1.65e-1)" "unprognostic (1.94e-1)" "prognostic unfavorable (3.71e-4)" "unprognostic (1.65e-1)" "unprognostic (5.68e-2)" "unprognostic (8.31e-2)" "unprognostic (7.00e-2)" "unprognostic (6.73e-2)" "unprognostic (1.04e-1)" "unprognostic (6.11e-2)" "unprognostic (1.65e-1)" "unprognostic (2.34e-1)" "unprognostic (4.32e-2)" 32.8 38.8 38.9 29.5 30.6 36.9 47.5 24.2 34.7 26.4 28.0 19.2 40.6 31.4 18.8 25.2 24.1 18.0 25.0 30.5 38.9 28.4 30.8 40.7 22.5 29.4 40.3 27.0 23.4 45.0 15.4 18.8 21.9 31.9 31.6 14.4 19.2 65.2 35.4 55.0 19.8 30.9 28.5 31.1 27.1 32.6 28.8 24.6 16.3 40.8 28.0 23.7 24.3 54.5 64.2 73.5 67.3 57.7 42.8 60.3 50.5 20.9 25.9 12.5 17.6 14.1 9.2 26.3 24.1 19.6 21.1 16.8 28.7 13.9 26.2 25.2 14.2 17.2 17.0 19.6 24.7 7.3 37.7 62.7 25.2 22.0 25.3 20.6 36.8 32.9 13.8 18.7 18.1 22.2 11.4 14.3 19.9 28.1 19.0 13.3 23.2 17.6 36.7 21.7 46.7 49.7 28.1 16.3 39.4 22.1 20.8 27.9 15.6 19.5 31.1 43.3 8.0 22.4 29.8 16.9 17.6 40.2 19.6 31.4 33.1 30.4 40.7 23.9 25.6 41.1 42.1 57.7 67.3 53.4 52.1 49.2 62.0 54.4 55.2 46.3 64.2 53.2 54.1 63.4 42.8 42.0 73.5 60.3 50.5 38.9 30.6 24.2 34.7 38.9 28.4 40.3 27.0 31.9 24.6 41.7 44.3 107.2 91.0 121.8 95.6 68.3 109.5 34.8 36.4 92.5 49.1 134.1 184.1 166.7 17.8 129.5 196.8 46.7 167.0 202.1 94.9 166.3 69.2 175.1 185.7 33.4 136.9 111.1 105.7 22.2 126.8 125.3 102.9 172.3 137.0 80.8 187.2 164.9 118.5 232.2 81.9 77.6 104.0 59.0 146.0 129.4 110.1 136.4 130.8 112.7 RPS25 S25 ENSG00000118181 "Ribosomal protein S25" P62851 11 119015712-119018691 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031801, HPA078683" Approved Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA 54000 "Endoplasmic reticulum, Cytosol" Nucleoli "HPA031801: AB_10610419, HPA078683: " "unprognostic (1.60e-2)" "unprognostic (1.79e-1)" "unprognostic (2.12e-1)" "unprognostic (1.40e-1)" "unprognostic (8.32e-2)" "unprognostic (1.78e-2)" "unprognostic (1.55e-2)" "unprognostic (8.47e-2)" "unprognostic (5.23e-2)" "unprognostic (1.54e-2)" "unprognostic (2.36e-2)" "unprognostic (7.75e-3)" "prognostic unfavorable (3.00e-7)" "unprognostic (1.16e-1)" "unprognostic (1.07e-1)" "unprognostic (8.58e-2)" "unprognostic (2.20e-1)" 72.3 68.1 54.9 99.5 60.7 117.7 140.7 38.1 62.2 84.9 69.4 26.8 87.7 53.5 79.6 93.4 92.9 68.0 78.6 87.3 44.4 41.7 58.6 76.5 88.4 256.5 57.1 48.1 190.0 274.5 34.3 67.5 52.5 54.3 77.1 52.2 41.6 113.5 131.7 173.6 82.0 57.7 125.4 68.3 80.7 68.3 35.3 47.3 78.5 83.9 128.8 86.4 112.2 110.6 136.6 83.3 30.0 43.2 64.7 166.9 150.1 39.1 22.5 48.5 48.5 65.3 101.1 39.8 53.0 47.7 31.3 27.3 59.5 68.7 99.1 92.7 36.9 37.1 54.4 42.9 57.0 35.7 48.7 46.8 141.1 19.9 49.9 50.7 100.2 44.1 91.0 101.7 29.9 74.7 98.9 56.9 80.2 73.3 59.8 43.5 80.7 78.3 137.7 50.0 99.7 54.5 68.7 50.9 107.6 57.8 34.5 35.6 67.8 28.2 87.8 54.8 57.4 70.6 109.3 54.0 30.7 35.7 31.1 50.8 50.7 41.3 81.9 21.3 99.7 36.2 30.0 43.2 27.1 75.8 42.5 120.7 136.6 133.4 102.4 69.1 112.6 166.9 128.2 11.7 64.7 37.2 83.3 88.7 150.1 54.9 60.7 38.1 62.2 44.4 41.7 57.1 48.1 54.3 47.3 753.4 1471.8 4134.9 3644.0 3526.8 272.7 156.5 1931.2 1062.7 1885.9 884.5 108.0 3031.7 2773.7 1545.4 1495.6 2111.7 1048.3 1191.4 2746.5 3534.5 2149.5 2685.4 1909.4 2155.6 2228.4 127.1 1279.9 2210.4 2932.5 2021.0 3541.3 3243.7 2073.4 4078.5 2284.3 466.6 2362.4 1995.5 1610.5 3361.8 311.5 1312.9 2458.2 606.9 848.3 4074.2 3057.4 2507.2 2899.2 3437.7 RPS26 S26 ENSG00000197728 "Ribosomal protein S26" P62854 12 56041351-56044676 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043961, HPA055803" Uncertain Enhanced "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" Nucleoli "HPA043961: AB_10963579, HPA055803: AB_2682927" "unprognostic (1.59e-1)" "unprognostic (1.40e-1)" "unprognostic (3.36e-1)" "unprognostic (9.58e-2)" "unprognostic (3.74e-1)" "unprognostic (7.84e-3)" "unprognostic (1.53e-1)" "unprognostic (1.65e-1)" "unprognostic (2.25e-1)" "unprognostic (3.76e-2)" "unprognostic (2.49e-1)" "unprognostic (3.03e-1)" "unprognostic (2.06e-2)" "unprognostic (1.41e-1)" "unprognostic (4.40e-2)" "unprognostic (2.18e-1)" "unprognostic (7.99e-2)" 36.5 66.6 33.3 29.0 48.8 39.2 49.7 23.8 73.7 44.5 45.6 34.9 20.5 20.0 35.9 50.4 49.9 43.5 28.4 39.8 25.8 24.8 61.8 154.3 29.5 56.0 31.4 26.2 75.8 80.4 25.6 29.7 28.7 45.1 35.4 49.1 28.5 38.0 41.1 62.2 50.9 57.5 36.9 30.0 51.6 40.3 47.0 32.5 47.3 58.4 60.0 78.4 46.7 41.2 93.0 69.8 29.8 42.8 63.6 107.4 108.8 53.4 65.8 75.0 27.8 103.9 154.2 75.2 54.5 81.0 90.9 53.2 101.0 24.2 119.3 34.5 57.5 30.0 25.2 84.2 46.9 62.3 47.2 135.1 63.0 43.9 60.2 96.0 40.9 34.6 93.3 150.3 47.9 54.6 35.9 69.0 85.6 42.9 39.8 73.5 82.9 30.6 74.3 73.6 65.4 149.1 41.7 22.5 73.4 75.9 54.2 28.2 48.8 21.3 47.2 30.9 23.3 41.7 45.8 22.3 22.6 46.3 28.8 43.7 34.3 65.6 64.4 25.1 81.7 28.9 29.8 41.4 27.1 74.6 42.8 83.8 93.0 97.8 81.8 55.3 79.8 107.4 99.3 17.0 63.6 38.2 69.8 101.7 108.8 33.3 48.8 23.8 73.7 25.8 24.8 31.4 26.2 45.1 32.5 208.4 201.5 1424.8 560.8 1563.9 119.2 23.8 1184.7 333.3 536.9 408.2 58.9 1212.8 824.0 801.2 63.2 800.7 1808.5 1004.5 2275.1 2554.3 1158.0 914.2 500.2 1753.2 1234.1 71.5 826.4 935.4 838.0 37.7 273.5 701.1 1386.7 874.7 1010.7 278.9 1348.0 1392.2 208.2 969.4 134.7 304.0 900.2 204.7 313.7 1585.9 1428.5 824.9 1127.8 1109.2 RPS27 "MPS-1, MPS1, S27" ENSG00000177954 "Ribosomal protein S27" P42677 1 153990755-153992155 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 778.4;lymphoid tissue: 769.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066851 Approved "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" Nucleoli "HPA066851: AB_2685737" "prognostic favorable (9.69e-4)" "unprognostic (1.40e-1)" "unprognostic (2.34e-1)" "unprognostic (1.35e-1)" "unprognostic (1.01e-2)" "unprognostic (1.28e-1)" "unprognostic (8.62e-2)" "unprognostic (5.88e-3)" "unprognostic (2.05e-2)" "unprognostic (5.04e-2)" "unprognostic (2.55e-2)" "unprognostic (6.81e-2)" "prognostic unfavorable (4.86e-7)" "unprognostic (1.53e-1)" "unprognostic (1.71e-1)" "unprognostic (2.44e-1)" "unprognostic (8.81e-2)" 120.7 72.5 74.9 188.7 118.6 186.7 268.2 51.3 91.4 172.5 114.2 35.9 136.4 58.1 169.0 135.6 107.5 129.0 144.1 176.5 59.6 50.1 98.6 102.5 167.8 769.0 92.1 76.0 317.8 227.2 44.6 91.5 67.5 71.2 117.6 113.6 63.5 248.2 116.1 243.8 160.1 115.9 254.3 65.6 159.3 111.5 119.0 81.9 118.2 113.0 224.0 270.9 162.9 286.0 720.2 296.5 132.9 139.9 324.1 750.5 778.4 103.7 121.7 160.9 87.6 378.8 373.5 99.8 125.8 301.7 169.5 153.2 243.8 114.7 236.3 105.7 181.5 56.5 104.6 141.7 208.3 143.3 114.7 182.7 93.1 161.4 158.1 251.1 206.9 122.8 362.6 409.8 134.8 248.4 252.8 138.9 197.5 113.6 128.5 160.9 260.8 222.5 131.0 194.8 347.8 177.5 142.6 117.8 183.8 156.6 210.3 85.5 190.7 72.1 254.0 218.7 229.1 141.6 415.8 82.0 58.6 97.1 93.4 125.7 258.2 263.2 286.4 101.7 116.2 80.3 132.9 139.9 68.1 393.0 138.9 473.7 720.2 594.4 502.0 179.5 637.3 750.5 579.6 32.4 324.1 127.0 296.5 397.8 778.4 74.9 118.6 51.3 91.4 59.6 50.1 92.1 76.0 71.2 81.9 2045.7 3610.2 12664.6 4456.3 11098.6 390.9 812.1 5699.4 2137.4 3923.0 2044.8 182.6 5213.2 3755.2 3414.7 2254.7 2990.8 2165.3 4461.9 9085.2 5382.4 5444.6 3827.3 4020.8 6408.4 3759.0 181.1 2910.0 5208.2 8634.5 6446.8 6571.4 6944.5 5609.6 8769.4 6097.0 734.9 5926.8 6112.7 3330.7 4371.1 465.9 2690.5 3231.1 1566.2 1451.5 12519.6 5337.4 8309.1 7958.0 4025.9 RPS27A "S27A, Uba80, UBCEP80" ENSG00000143947 "Ribosomal protein S27a" P62979 2 55231903-55235853 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033319, HPA041344, HPA049132, HPA054087" Supported Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA "Nucleoli, Endoplasmic reticulum, Cytosol" "CAB033319: AB_793618, HPA041344: AB_2677422, HPA049132: AB_2680646, HPA054087: AB_2682373" "unprognostic (7.32e-2)" "unprognostic (1.41e-2)" "unprognostic (1.11e-1)" "unprognostic (3.20e-3)" "unprognostic (2.16e-1)" "unprognostic (9.75e-2)" "prognostic unfavorable (2.26e-4)" "unprognostic (1.39e-1)" "unprognostic (1.65e-2)" "unprognostic (2.46e-1)" "unprognostic (6.89e-2)" "unprognostic (1.70e-1)" "prognostic unfavorable (2.60e-6)" "unprognostic (1.09e-1)" "unprognostic (8.82e-2)" "unprognostic (1.47e-1)" "unprognostic (3.60e-1)" 54.1 45.0 46.8 66.0 85.5 111.5 120.1 33.3 77.9 74.5 60.0 21.4 43.0 37.3 66.0 57.8 68.3 61.4 51.2 47.1 57.0 32.7 71.1 172.7 43.9 84.3 42.4 68.3 167.1 88.9 20.7 53.7 57.1 52.1 57.7 52.5 25.3 70.5 46.9 101.9 69.1 52.5 46.3 40.4 77.1 58.9 48.6 36.4 62.8 64.0 144.0 82.1 52.1 71.1 194.8 130.9 42.2 62.9 122.8 253.3 267.6 106.0 61.7 67.7 112.4 94.5 180.5 129.4 83.7 96.3 91.9 58.2 115.1 120.4 148.5 141.5 79.8 54.7 100.8 97.7 114.4 107.5 125.9 113.1 136.8 66.4 153.9 137.5 204.0 93.8 162.3 227.7 61.6 168.3 153.5 124.6 92.0 122.0 136.4 105.0 83.0 119.2 245.7 162.6 130.4 79.0 113.8 172.4 175.6 103.9 101.6 89.5 71.0 57.4 250.0 186.5 110.1 111.1 174.3 118.6 84.3 128.3 75.2 141.6 122.8 85.1 96.5 120.6 173.6 83.9 42.2 62.9 24.1 129.3 59.1 183.5 194.8 197.3 154.8 91.1 179.3 253.3 206.8 14.4 122.8 52.5 130.9 120.7 267.6 46.8 85.5 33.3 77.9 57.0 32.7 42.4 68.3 52.1 36.4 1182.1 2168.7 6366.0 7790.9 7391.5 428.3 362.3 2830.5 1535.1 2713.9 1326.0 202.2 4414.5 3436.8 2947.8 844.4 3491.0 1693.7 1752.0 6390.1 5764.5 3524.5 5396.1 2833.4 2701.0 3058.4 206.6 1979.6 3107.2 4338.7 1140.7 4705.1 4812.5 3451.8 4888.3 3292.1 886.8 4792.0 3026.5 2708.4 4047.2 553.4 1616.9 4201.8 922.6 805.1 7807.0 4507.9 4717.9 5337.4 6552.6 RPS27L ENSG00000185088 "Ribosomal protein S27 like" Q71UM5 15 63125872-63158021 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Proximal tubular cells: 1955.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066851 Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" Nucleoli "HPA066851: AB_2685737" "unprognostic (4.62e-2)" "unprognostic (5.81e-2)" "unprognostic (1.38e-1)" "prognostic favorable (9.08e-6)" "unprognostic (1.75e-1)" "unprognostic (7.24e-2)" "unprognostic (1.42e-3)" "unprognostic (2.98e-1)" "unprognostic (6.38e-2)" "unprognostic (1.80e-1)" "unprognostic (2.19e-3)" "unprognostic (2.51e-1)" "unprognostic (1.97e-2)" "unprognostic (5.31e-2)" "unprognostic (1.36e-1)" "unprognostic (1.97e-3)" "unprognostic (5.10e-3)" 46.8 64.2 21.3 19.8 29.7 18.2 53.6 16.3 23.4 29.4 58.5 15.5 30.4 46.0 30.2 49.3 40.4 27.0 38.3 47.1 22.8 22.2 61.0 75.2 31.7 23.4 32.6 19.2 26.5 65.9 19.2 38.8 35.6 43.9 56.2 55.3 18.3 99.8 46.0 47.1 18.1 80.4 54.8 39.9 28.2 41.9 15.7 27.3 19.4 53.9 25.7 19.8 55.0 36.3 34.5 30.9 51.5 47.6 27.2 75.4 38.3 16.5 46.4 42.1 11.3 61.6 73.0 42.2 52.4 37.4 11.5 28.2 8.5 23.1 15.6 18.8 50.1 20.6 6.4 14.2 25.8 19.5 11.5 19.2 12.8 39.2 60.7 70.9 10.2 35.7 57.1 34.7 26.1 19.8 87.6 65.3 9.8 11.8 15.7 96.0 23.0 13.1 15.9 12.4 21.2 13.6 10.2 20.2 17.6 32.4 33.6 6.1 9.3 19.0 8.0 37.1 88.4 17.8 23.7 69.0 61.2 57.6 13.2 23.2 17.7 15.0 13.8 64.9 28.2 55.1 51.5 34.3 40.0 27.5 35.9 33.9 34.5 41.6 32.0 30.9 26.9 32.9 33.1 11.4 27.2 47.6 30.8 75.4 38.3 21.3 29.7 16.3 23.4 22.8 22.2 32.6 19.2 43.9 27.3 89.3 200.0 257.3 226.5 226.9 32.3 318.9 598.7 234.2 153.6 389.0 45.2 244.0 766.0 754.9 35.9 230.2 819.3 233.6 678.9 1142.2 251.0 333.1 292.5 900.4 483.1 12.7 274.1 300.8 377.4 21.8 291.4 318.2 442.1 1587.0 624.8 110.3 1030.5 691.6 279.7 1955.0 68.4 258.7 357.4 142.8 82.2 216.4 196.7 234.3 638.5 176.3 RPS3A "MFTL, S3A" ENSG00000145425 "Ribosomal protein S3A" P61247 4 151099573-151104652 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" Differentiation "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 440.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047100, HPA053454" Approved Enhanced "Nucleoli,Endoplasmic reticulum,Cytosol" No No 63000 "Nucleoli, Endoplasmic reticulum, Cytosol" "HPA047100: AB_2679931, HPA053454: AB_2682156" "unprognostic (6.24e-3)" "unprognostic (3.45e-2)" "unprognostic (1.79e-1)" "unprognostic (1.16e-1)" "unprognostic (1.79e-2)" "unprognostic (5.46e-2)" "prognostic unfavorable (6.56e-4)" "unprognostic (1.17e-1)" "unprognostic (1.16e-2)" "unprognostic (1.01e-1)" "unprognostic (6.41e-2)" "unprognostic (1.27e-1)" "unprognostic (6.81e-3)" "unprognostic (2.36e-1)" "unprognostic (1.96e-1)" "unprognostic (2.00e-1)" "unprognostic (3.39e-1)" 71.7 46.9 48.4 69.2 47.7 124.7 160.3 40.4 43.5 114.1 98.4 30.4 61.9 45.0 75.3 84.4 142.8 73.3 53.9 51.1 36.8 33.3 72.8 94.2 79.4 102.5 42.6 43.5 179.5 143.8 18.1 49.3 70.5 38.0 113.3 62.4 39.0 113.8 48.5 116.8 97.1 73.5 62.0 43.1 94.2 64.2 61.9 30.7 120.4 126.8 111.6 90.6 111.4 86.3 211.6 187.7 44.3 92.8 142.9 282.7 440.7 80.5 59.3 113.1 111.1 145.6 285.0 115.5 85.9 132.7 121.8 75.4 114.6 117.8 365.6 43.0 93.6 43.0 53.5 114.6 143.5 115.8 80.5 110.9 78.9 73.3 132.3 168.6 187.3 81.9 211.3 296.1 74.9 199.3 172.0 144.4 137.0 126.9 191.5 144.6 120.4 202.3 222.6 106.1 129.0 45.9 148.2 110.4 122.3 141.0 97.9 108.8 107.7 38.6 141.4 189.2 83.4 94.6 227.8 87.6 59.6 78.9 65.7 94.5 148.9 239.5 223.9 76.5 136.8 70.6 44.3 92.8 27.2 120.6 74.5 203.9 211.6 203.1 157.9 156.5 185.7 282.7 226.9 15.1 142.9 62.1 187.7 145.5 440.7 48.4 47.7 40.4 43.5 36.8 33.3 42.6 43.5 38.0 30.7 902.2 1351.4 4981.2 6887.5 5470.3 389.5 334.4 1689.1 1088.1 1918.8 783.4 113.9 3954.4 3630.9 1946.8 1331.3 2405.0 1231.3 1425.0 3246.4 6519.9 2822.1 4092.8 1400.9 1318.9 2985.4 154.1 2072.9 2006.5 3842.5 3230.8 4100.5 4536.3 3092.4 3236.3 3439.0 634.6 3016.2 2304.0 2436.9 3691.6 432.9 1739.7 3595.7 655.4 688.2 5905.5 3840.1 4239.4 5672.4 6561.2 RPS6KA3 "CLS, HU-3, MRX19, RSK, RSK2" ENSG00000177189 "Ribosomal protein S6 kinase A3" P51812 X 20149911-20267519 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Stress response" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 69.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003221, CAB003853, CAB013520" Approved Supported Nucleoplasm,Nucleoli,Cytosol No No Nucleoplasm "Nucleoli, Cytosol" "CAB003853: AB_562343, CAB013520: AB_2533378, HPA003221: AB_1853553" "unprognostic (1.87e-2)" "unprognostic (1.03e-1)" "unprognostic (1.80e-2)" "unprognostic (4.26e-2)" "unprognostic (3.53e-1)" "unprognostic (1.11e-1)" "unprognostic (1.15e-2)" "unprognostic (1.61e-3)" "unprognostic (1.02e-1)" "unprognostic (1.57e-1)" "unprognostic (5.04e-1)" "unprognostic (1.07e-1)" "unprognostic (1.04e-1)" "unprognostic (4.49e-3)" "unprognostic (3.91e-1)" "unprognostic (1.09e-1)" "unprognostic (2.22e-1)" 19.7 12.5 9.9 23.0 12.5 8.2 16.5 15.2 12.1 11.4 23.2 4.4 22.1 13.7 12.4 10.1 13.6 12.7 15.7 21.3 9.7 8.8 14.1 25.8 21.6 34.0 9.9 10.0 12.7 14.0 36.6 9.8 11.0 10.2 14.5 18.8 7.7 14.3 11.3 45.2 11.7 23.7 16.1 11.7 25.8 11.8 4.8 9.7 29.4 13.5 15.0 18.2 20.3 19.0 4.2 8.6 12.5 6.9 8.3 11.3 2.7 12.9 22.7 8.6 4.4 8.4 14.8 2.6 11.2 17.1 8.4 11.6 25.7 16.7 8.5 3.9 11.8 12.3 9.2 9.8 9.5 15.7 7.1 7.8 10.0 14.3 69.0 8.6 19.5 10.4 9.4 7.6 13.2 16.7 7.4 30.4 9.0 6.6 24.4 8.8 6.1 12.6 6.0 6.2 16.9 13.7 6.7 18.2 9.8 7.3 10.9 4.0 3.9 15.1 4.6 16.4 11.2 0.0 5.8 16.9 9.2 6.4 29.1 6.3 19.5 11.9 9.5 17.4 9.7 21.7 12.5 4.7 9.5 6.3 6.9 11.3 2.9 7.3 6.9 7.0 4.2 5.0 6.0 7.5 8.3 6.9 8.6 3.5 2.7 9.9 12.5 15.2 12.1 9.7 8.8 9.9 10.0 10.2 9.7 41.7 68.2 18.2 31.8 48.3 33.6 19.4 38.2 21.4 51.2 15.7 21.6 3.3 3.3 23.3 0.1 48.1 43.4 0.0 26.0 5.7 28.8 47.0 42.8 61.1 20.6 12.7 24.0 29.4 46.1 1.1 12.0 60.4 35.4 20.8 53.4 26.6 30.0 46.0 19.8 23.7 8.7 19.4 35.0 3.3 7.7 48.6 3.0 56.7 46.1 54.2 RPS6KA6 RSK4 ENSG00000072133 "Ribosomal protein S6 kinase A6" Q9UK32 X 84058346-84187907 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 20.7" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 19.9;Collecting duct cells: 17.4;Cone photoreceptor cells: 23.6;Intestinal endocrine cells: 24.0;Rod photoreceptor cells: 18.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NTERA-2: 11.0;PC-3: 11.9;RH-30: 14.6;SH-SY5Y: 11.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA002852, HPA003904" Uncertain Supported Nucleoplasm,Nucleoli,Mitochondria NA NA "Nucleoplasm, Mitochondria" Nucleoli "HPA002852: AB_1079854, HPA003904: AB_1079853" "unprognostic (1.17e-1)" "unprognostic (1.02e-2)" "unprognostic (3.44e-1)" "unprognostic (4.93e-4)" "unprognostic (1.71e-1)" "unprognostic (3.04e-3)" "unprognostic (2.09e-2)" "unprognostic (2.50e-1)" "unprognostic (2.86e-1)" "unprognostic (4.88e-2)" "unprognostic (3.38e-3)" "unprognostic (2.88e-1)" "unprognostic (2.12e-9)" "unprognostic (4.44e-3)" "unprognostic (1.30e-2)" "unprognostic (2.34e-2)" "unprognostic (8.49e-3)" 0.7 2.9 5.9 1.0 12.2 0.0 2.3 4.7 5.1 3.1 4.5 1.1 20.7 1.7 2.7 4.0 1.5 4.0 1.9 1.2 5.1 2.9 9.2 0.9 0.8 0.2 1.5 3.3 4.9 3.4 13.5 9.1 0.5 4.4 4.3 3.7 1.5 3.0 15.0 1.4 2.3 2.0 1.7 1.0 0.6 2.4 2.6 2.7 0.8 14.5 0.9 0.6 3.3 2.3 1.2 0.8 2.4 0.5 0.7 2.8 0.1 0.0 3.7 3.6 0.0 3.4 3.4 0.0 7.7 4.1 3.4 2.9 2.8 3.0 0.0 0.0 4.1 0.0 0.1 9.1 6.1 8.1 0.0 4.6 0.0 0.1 0.0 3.1 0.0 0.0 1.9 0.0 0.0 3.8 3.8 0.8 0.0 0.0 0.2 2.7 0.0 1.3 0.1 11.0 0.0 11.9 0.0 14.6 0.0 0.6 8.5 0.0 11.7 0.0 4.2 0.0 5.2 2.0 0.0 0.0 0.1 4.4 0.0 0.0 0.5 0.0 0.0 1.0 0.0 0.0 2.4 0.4 0.5 0.5 0.3 0.4 1.2 0.4 0.7 0.8 0.6 0.4 0.4 1.1 0.7 0.5 0.4 2.8 0.1 5.9 12.2 4.7 5.1 5.1 2.9 1.5 3.3 4.4 2.7 8.9 2.4 2.0 4.4 0.2 19.9 2.0 12.7 6.7 3.4 17.4 23.6 2.1 1.7 0.4 0.4 0.6 3.4 0.0 1.1 0.6 0.3 7.4 0.0 1.5 0.2 1.6 24.0 1.3 0.0 0.0 4.0 0.0 0.0 0.0 5.0 2.8 1.3 2.9 5.6 3.3 18.2 0.0 0.6 3.7 6.3 0.4 1.9 0.0 5.3 4.2 RRP7A "CGI-96, Rrp7" ENSG00000189306 "Ribosomal RNA processing 7 homolog A" Q9Y3A4 22 42509968-42519802 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001586, HPA046768" Approved Approved "Nucleoplasm,Nucleoli,Cell Junctions" NA NA "Nucleoplasm, Nucleoli" "Cell Junctions" "HPA001586: AB_1078506, HPA046768: AB_2679796" "unprognostic (8.46e-2)" "unprognostic (3.30e-3)" "unprognostic (5.96e-2)" "unprognostic (3.21e-3)" "unprognostic (9.71e-3)" "unprognostic (2.92e-1)" "prognostic unfavorable (1.21e-5)" "unprognostic (6.73e-2)" "unprognostic (3.00e-1)" "unprognostic (2.28e-1)" "unprognostic (2.41e-1)" "unprognostic (3.22e-2)" "unprognostic (9.53e-3)" "unprognostic (8.02e-2)" "unprognostic (2.12e-1)" "unprognostic (4.66e-2)" "unprognostic (1.71e-2)" 10.4 12.9 19.9 15.4 26.6 16.5 13.5 18.5 20.9 12.8 12.2 15.1 9.4 10.2 12.0 47.3 15.1 18.9 12.0 11.1 17.5 14.8 14.0 18.1 11.3 21.5 14.8 9.3 21.2 12.0 16.6 10.3 17.7 17.4 17.8 10.8 12.6 15.2 14.6 13.5 14.9 13.3 11.9 11.7 15.6 12.0 11.2 18.6 17.4 11.6 8.7 16.4 10.7 11.0 26.2 30.5 17.4 27.5 15.2 18.4 20.3 13.0 18.4 10.1 11.9 6.5 4.3 20.5 11.1 6.7 14.4 12.2 23.4 7.5 21.8 5.7 7.9 8.0 14.5 11.6 15.5 6.2 5.5 23.7 11.8 12.8 12.6 6.2 28.3 10.2 5.5 7.8 19.5 9.9 5.2 8.7 11.7 16.6 6.3 8.5 26.5 27.2 11.6 8.4 10.4 13.4 47.4 10.4 9.6 7.5 16.0 5.5 3.9 8.2 23.6 10.8 5.4 9.6 12.8 6.5 11.0 14.2 8.4 11.3 9.7 7.2 25.6 9.2 10.9 15.8 10.0 23.5 17.4 18.4 26.4 17.7 20.5 16.1 16.8 18.1 26.2 17.7 16.5 4.7 15.2 27.5 30.5 13.5 20.3 19.9 26.6 18.5 20.9 17.5 14.8 14.8 9.3 17.4 18.6 20.8 35.8 52.9 72.3 38.9 26.5 14.2 25.5 34.8 33.0 21.0 15.7 80.7 14.9 65.2 48.5 37.9 36.0 23.3 23.4 117.3 32.9 62.0 46.2 29.2 83.7 25.4 25.3 31.3 37.8 94.1 20.4 49.8 32.1 146.1 29.9 22.2 58.6 42.1 17.3 34.2 28.7 6.5 26.9 30.9 22.8 33.1 100.7 41.5 40.0 87.7 RRP8 "KIAA0409, NML" ENSG00000132275 "Ribosomal RNA processing 8" O43159 11 6595075-6603620 "Predicted intracellular proteins" "rRNA processing, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038487, HPA057562" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli, Cytosol" "HPA038487: AB_10672518, HPA057562: AB_2683468" "unprognostic (9.01e-2)" "unprognostic (5.84e-2)" "unprognostic (2.53e-1)" "unprognostic (1.10e-2)" "unprognostic (1.92e-1)" "unprognostic (1.72e-1)" "prognostic unfavorable (3.10e-7)" "unprognostic (4.64e-2)" "unprognostic (2.48e-1)" "unprognostic (2.79e-1)" "unprognostic (1.41e-1)" "unprognostic (6.23e-2)" "unprognostic (3.81e-3)" "unprognostic (2.71e-1)" "unprognostic (1.24e-1)" "unprognostic (1.81e-1)" "unprognostic (1.87e-2)" 13.8 11.9 13.9 15.8 14.8 32.1 17.9 18.1 15.3 15.9 24.9 16.1 10.5 14.0 15.5 21.3 13.8 11.9 15.4 16.2 16.0 10.3 13.3 24.7 14.3 16.0 18.4 13.6 12.4 12.7 12.0 12.3 12.8 14.2 19.8 14.4 11.8 10.9 19.7 18.6 15.5 12.8 19.5 11.0 17.7 15.1 12.3 18.6 11.8 14.2 9.7 16.6 20.2 13.9 13.3 14.4 20.3 12.0 14.4 13.8 10.2 10.1 10.2 4.1 5.2 8.5 7.4 5.8 5.2 6.6 12.2 11.5 10.4 12.0 14.3 5.2 5.0 9.0 10.3 11.6 9.3 13.0 6.8 16.6 6.7 12.2 11.8 9.8 12.2 9.4 6.3 12.1 5.8 10.6 8.1 12.5 6.7 13.3 8.4 9.6 12.6 11.8 18.2 10.0 17.9 9.2 10.6 3.3 3.2 11.4 8.2 6.3 7.4 7.5 15.4 8.6 7.0 8.4 10.7 6.4 11.6 5.3 11.2 10.1 9.4 8.4 13.6 9.8 12.3 7.4 20.3 11.0 10.7 13.7 11.8 13.2 10.9 13.5 12.6 14.4 13.3 13.3 13.8 4.4 14.4 12.0 11.0 12.6 10.2 13.9 14.8 18.1 15.3 16.0 10.3 18.4 13.6 14.2 18.6 20.8 12.9 13.7 14.7 20.6 17.1 18.3 7.6 10.7 15.9 8.7 13.7 19.6 10.0 15.6 5.3 16.6 10.9 23.3 13.9 17.0 14.6 9.7 17.3 19.1 16.3 3.2 6.9 9.8 8.4 10.4 12.0 12.0 8.5 19.8 12.8 13.3 18.6 13.3 9.2 16.5 27.4 0.0 20.9 21.2 17.2 23.7 16.7 14.9 15.9 12.2 RSAD1 FLJ11164 ENSG00000136444 "Radical S-adenosyl methionine domain containing 1" Q9HA92 17 50478800-50485975 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA022436, HPA022967, HPA024459" Approved Approved "Nucleoli,Mitotic chromosome,Mitochondria" NA NA Mitochondria "Nucleoli, Mitotic chromosome" "HPA022436: AB_2180789, HPA022967: AB_1856484, HPA024459: " "unprognostic (8.21e-2)" "unprognostic (4.11e-3)" "unprognostic (3.72e-2)" "unprognostic (1.83e-2)" "unprognostic (3.49e-2)" "unprognostic (2.93e-2)" "unprognostic (6.01e-2)" "unprognostic (1.07e-2)" "unprognostic (2.52e-1)" "unprognostic (1.13e-2)" "prognostic favorable (5.04e-4)" "unprognostic (1.06e-1)" "unprognostic (1.65e-2)" "unprognostic (4.89e-2)" "unprognostic (2.95e-1)" "unprognostic (7.85e-2)" "unprognostic (3.22e-2)" 13.5 22.2 16.1 16.8 23.9 8.9 14.1 32.2 20.3 16.8 13.1 12.7 13.5 13.9 13.8 15.1 8.8 12.9 13.6 25.7 13.7 11.6 18.5 28.2 14.0 16.6 19.0 13.7 20.9 46.0 20.3 12.9 10.1 16.3 12.8 14.9 12.6 21.4 14.0 37.0 13.5 12.0 13.7 23.6 16.7 16.0 8.8 19.1 11.6 15.8 20.9 14.0 11.7 12.4 7.4 5.8 3.8 4.6 6.7 10.9 5.1 5.7 19.7 9.5 15.6 16.3 13.3 3.4 10.2 9.9 13.1 11.1 19.5 7.4 15.7 22.6 7.1 13.0 5.5 10.7 14.2 11.3 17.3 19.5 21.1 8.8 18.9 11.4 12.7 14.9 9.7 15.7 8.7 16.9 10.9 12.7 38.8 16.3 15.0 10.9 13.5 21.2 9.3 3.8 24.6 21.3 8.7 10.9 14.2 15.8 8.8 5.2 17.8 2.6 12.2 13.1 12.6 18.4 13.0 8.9 13.7 14.6 10.4 11.9 23.5 16.4 6.1 10.3 18.2 9.5 1.1 4.1 3.8 9.5 4.6 9.9 5.1 8.2 9.4 5.1 7.4 10.9 10.5 0.0 6.7 4.3 5.8 6.2 5.1 16.1 23.9 32.2 20.3 13.7 11.6 19.0 13.7 16.3 19.1 3.0 12.5 11.2 4.6 9.0 12.3 23.6 12.7 1.4 6.8 15.7 2.0 15.8 19.9 10.9 7.3 13.7 8.7 0.0 25.4 9.6 10.3 5.5 3.5 15.8 14.2 7.9 24.2 6.7 7.8 5.4 14.4 9.6 16.9 10.8 12.6 30.7 11.1 3.5 10.3 8.7 7.4 12.9 12.4 8.4 21.2 8.7 8.5 13.1 13.0 2.8 RSL24D1 "C15orf15, HRP-L30-iso, L30, RPL24, RPL24L" ENSG00000137876 "Ribosomal L24 domain containing 1" Q9UHA3 15 55180806-55197067 "Predicted intracellular proteins, Ribosomal proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062724, HPA063392" Enhanced Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA062724: AB_2684850, HPA063392: AB_2685002" "unprognostic (3.40e-2)" "unprognostic (3.00e-1)" "unprognostic (3.83e-1)" "unprognostic (7.28e-2)" "unprognostic (3.80e-2)" "unprognostic (1.07e-3)" "unprognostic (6.71e-3)" "unprognostic (1.15e-1)" "unprognostic (6.56e-3)" "unprognostic (1.34e-1)" "unprognostic (6.19e-3)" "unprognostic (7.22e-2)" "unprognostic (1.13e-1)" "unprognostic (4.44e-1)" "unprognostic (4.54e-2)" "unprognostic (4.95e-1)" "unprognostic (2.41e-1)" 27.7 24.3 26.7 23.4 28.8 76.1 47.8 35.7 29.9 40.6 32.2 10.0 25.6 18.1 34.5 26.6 34.2 26.4 21.4 25.3 25.1 25.3 24.3 26.7 27.0 35.8 25.4 25.8 54.7 37.8 15.0 23.2 22.4 24.1 44.3 20.5 11.2 25.8 21.3 47.2 19.3 21.1 50.4 27.5 28.6 28.8 24.2 20.6 39.5 43.1 36.9 27.4 61.9 49.6 29.1 27.0 11.4 24.1 22.7 45.1 47.7 16.1 16.4 18.1 23.7 14.2 26.8 14.7 17.1 19.2 14.4 18.4 15.7 9.9 50.4 15.5 12.3 14.1 19.8 23.8 19.8 19.4 24.5 14.8 25.8 13.2 19.5 32.8 48.5 16.9 22.7 42.0 14.4 41.9 23.3 17.8 37.9 48.6 36.6 16.7 16.5 26.5 42.8 22.3 33.1 14.8 21.2 22.7 75.9 21.6 15.0 25.7 30.8 7.9 22.3 55.4 15.0 21.4 71.8 12.4 11.9 13.9 13.8 24.4 35.3 53.9 50.1 18.5 48.1 19.9 11.4 23.8 11.4 19.6 23.4 31.1 29.1 29.5 24.3 27.0 22.5 45.1 34.0 6.0 22.7 24.1 21.1 32.4 47.7 26.7 28.8 35.7 29.9 25.1 25.3 25.4 25.8 24.1 20.6 92.3 65.6 256.3 349.8 515.7 83.5 63.5 89.2 77.6 80.8 80.3 21.6 138.6 242.1 170.0 67.8 119.6 46.1 70.0 234.1 222.4 198.3 186.8 150.0 57.1 128.0 14.3 134.4 79.8 196.0 28.6 188.4 183.5 269.9 194.8 102.0 68.6 201.1 134.0 140.4 191.4 51.1 155.2 258.6 71.0 148.8 456.4 145.9 187.5 118.2 292.9 SAMD15 "C14orf174, FAM15A, FLJ35963" ENSG00000100583 "Sterile alpha motif domain containing 15" Q9P1V8 14 77376689-77391497 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 29.1;testis: 22.1" "Group enriched" "Detected in many" 7 "Ciliated cells: 65.6;Cone photoreceptor cells: 58.9;Early spermatids: 61.5;Late spermatids: 75.0;Rod photoreceptor cells: 75.7;Spermatocytes: 45.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 2.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "MCF7: 10.8" "Low region specificity" "Detected in many" "HPA030673, HPA030677" Enhanced Approved "Nucleoplasm,Nuclear membrane,Nucleoli" NA NA "Nucleoplasm, Nuclear membrane, Nucleoli" "HPA030673: AB_10600655, HPA030677: AB_10599938" "unprognostic (1.09e-1)" "unprognostic (1.65e-1)" "unprognostic (3.76e-2)" "unprognostic (1.15e-1)" "unprognostic (1.02e-2)" "unprognostic (1.38e-2)" "unprognostic (3.70e-3)" "unprognostic (5.20e-2)" "unprognostic (5.76e-2)" "unprognostic (1.11e-1)" "unprognostic (3.83e-3)" "unprognostic (6.19e-2)" "unprognostic (2.53e-3)" "unprognostic (6.87e-3)" "unprognostic (9.90e-2)" "unprognostic (3.73e-3)" "unprognostic (1.76e-2)" 0.8 1.3 5.3 0.5 6.7 0.9 1.5 0.8 3.3 1.2 0.7 2.2 3.1 0.6 1.5 7.5 0.7 6.2 1.5 0.6 3.7 2.9 6.0 0.6 1.8 1.9 1.4 3.1 3.2 2.7 5.2 29.1 0.5 7.9 1.3 0.5 4.4 0.8 1.1 0.5 0.8 0.6 0.6 1.5 0.7 0.7 22.1 2.3 0.1 6.9 0.0 1.8 1.9 0.7 0.6 0.2 2.3 0.5 0.6 0.4 0.1 3.6 4.9 1.9 4.1 0.5 2.1 1.8 1.5 1.3 4.0 3.6 3.5 3.3 4.0 1.6 1.5 3.5 3.5 1.4 2.0 5.5 0.3 0.7 0.6 1.4 0.9 0.2 0.7 4.3 2.0 1.3 3.4 0.4 1.7 2.7 2.0 0.4 1.2 1.6 10.8 0.9 0.4 0.8 0.9 1.6 1.7 1.9 0.2 6.9 2.0 4.3 2.7 5.1 0.8 0.7 0.8 6.4 1.2 1.0 3.7 2.2 3.9 1.9 0.7 3.3 2.6 4.7 0.2 1.9 0.7 0.5 1.2 0.2 0.1 0.1 0.2 0.2 0.1 0.2 0.6 0.3 0.4 2.3 0.6 0.5 0.1 0.4 0.1 5.3 6.7 0.8 3.3 3.7 2.9 1.4 3.1 7.9 2.3 0.0 0.0 0.0 0.4 0.2 9.7 0.8 2.5 65.6 2.3 0.0 58.9 0.2 1.7 2.4 61.5 0.3 0.0 0.0 0.6 0.2 0.6 0.5 0.0 0.0 0.1 3.2 3.5 0.0 0.0 75.0 1.4 0.0 0.0 0.0 0.0 4.8 1.0 0.0 0.0 3.4 75.7 0.0 0.3 45.6 6.0 0.0 0.2 0.0 0.0 0.1 SAPCD2 "C9orf140, p42.3" ENSG00000186193 "Suppressor APC domain containing 2" Q86UD0 9 137062124-137070588 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.4" "Cell type enhanced" "Detected in some" 7 "Basal keratinocytes: 3.8;Mucus-secreting cells: 6.4;Paneth cells: 4.9;Undifferentiated cells: 4.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "classical monocyte: 1.7" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA044154 Approved Supported Nucleoplasm,Nucleoli,Cytosol NA Yes Cytosol "Nucleoplasm, Nucleoli" "HPA044154: AB_10959464" "unprognostic (3.68e-2)" "unprognostic (9.85e-2)" "unprognostic (1.13e-1)" "unprognostic (1.11e-1)" "unprognostic (2.80e-2)" "unprognostic (1.27e-1)" "unprognostic (5.42e-8)" "prognostic unfavorable (5.88e-4)" "unprognostic (8.33e-2)" "unprognostic (7.47e-2)" "unprognostic (1.22e-2)" "unprognostic (1.45e-1)" "unprognostic (9.83e-7)" "unprognostic (4.37e-3)" "unprognostic (4.62e-1)" "unprognostic (3.82e-2)" "unprognostic (1.35e-2)" 1.0 0.4 11.5 10.5 7.0 3.3 2.6 1.4 14.4 2.5 6.2 10.1 0.0 7.6 1.0 0.4 7.8 0.8 5.4 0.4 9.6 7.5 1.2 0.4 2.7 4.7 8.0 3.8 0.3 0.8 0.3 0.4 1.8 5.4 5.4 3.5 0.0 7.3 0.4 0.4 5.4 7.7 1.0 7.0 2.7 4.6 1.5 2.7 9.2 0.6 3.5 10.0 1.0 1.9 0.5 0.8 0.5 1.7 0.0 0.4 0.4 16.0 8.7 3.4 10.2 0.1 0.2 18.5 2.6 1.8 2.8 1.3 16.4 7.4 16.8 8.6 1.3 2.6 22.8 10.8 3.0 0.6 11.5 12.4 7.3 9.6 18.3 0.0 8.3 12.7 0.0 0.5 1.0 1.8 0.7 4.6 8.6 10.1 7.6 0.8 37.7 2.4 22.4 6.4 37.2 19.8 25.6 13.1 18.6 3.5 4.6 17.9 10.6 10.2 28.6 3.9 0.8 23.1 15.8 2.9 2.6 8.8 7.7 13.0 2.6 7.6 8.1 6.0 9.9 8.1 0.2 1.7 0.0 0.0 0.5 0.4 0.5 0.3 0.0 0.8 0.2 0.1 0.0 0.5 0.0 0.8 0.2 0.3 0.4 11.5 7.0 1.4 6.1 9.6 7.5 8.0 3.8 5.4 2.7 0.0 0.0 0.0 0.6 3.8 0.0 1.1 0.0 0.0 1.2 0.0 0.0 0.7 1.7 0.3 0.0 0.0 0.4 0.0 0.0 2.7 0.6 2.1 0.0 0.0 2.5 0.0 0.0 0.6 3.0 0.0 0.0 1.8 0.0 0.0 6.4 0.6 0.3 4.9 0.0 0.0 0.5 0.0 0.3 0.0 1.2 2.4 0.5 1.0 4.5 0.5 SCN5A "CDCD2, CMD1E, CMPD2, HB1, HB2, HBBD, HH1, ICCD, IVF, LQT3, Nav1.5, PFHB1, SSS1" ENSG00000183873 "Sodium voltage-gated channel alpha subunit 5" Q14524 3 38548057-38649673 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Calmodulin-binding, Ion channel, Sodium channel, Voltage-gated channel" "Atrial fibrillation, Brugada syndrome, Cardiomyopathy, Disease mutation, FDA approved drug targets, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "heart muscle: 67.3" "Cell type enriched" "Detected in some" 5 "Cardiomyocytes: 66.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "LHCN-M2: 22.0;RH-30: 18.3" "Group enriched" "Detected in some" 5 "amygdala: 3.2;basal ganglia: 10.5;hypothalamus: 7.0" "Low region specificity" "Detected in many" HPA063346 Supported "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Plasma membrane" "Nucleoplasm, Nucleoli" "HPA063346: " "unprognostic (9.29e-4)" "unprognostic (4.05e-2)" "unprognostic (9.95e-2)" "unprognostic (1.74e-1)" "unprognostic (9.21e-2)" "unprognostic (1.24e-2)" "unprognostic (1.15e-1)" "unprognostic (1.48e-1)" "unprognostic (7.36e-2)" "unprognostic (8.48e-2)" "unprognostic (7.12e-3)" "unprognostic (5.28e-2)" "unprognostic (1.16e-4)" "unprognostic (4.85e-3)" "unprognostic (1.09e-1)" "unprognostic (5.35e-2)" "unprognostic (4.95e-3)" 0.3 0.2 1.3 0.2 0.3 0.4 0.6 0.1 2.3 2.0 0.4 0.0 0.4 0.3 0.9 0.8 0.2 0.4 0.3 67.3 0.5 0.7 0.1 0.1 0.2 0.1 0.1 0.3 0.6 0.2 0.1 0.8 0.3 0.0 1.3 0.2 1.2 0.3 1.6 5.5 0.2 0.3 0.4 0.1 0.2 0.2 0.5 0.0 0.0 0.3 0.1 0.1 0.8 1.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.1 0.8 0.4 0.0 0.1 0.3 2.7 0.0 0.0 0.0 0.9 0.9 2.7 0.0 0.4 0.0 1.2 0.7 0.0 0.1 0.1 0.0 0.1 0.5 0.0 0.5 0.0 1.7 3.6 0.4 0.0 0.0 22.0 1.1 0.0 0.0 2.0 0.0 0.0 0.0 18.3 0.0 0.0 2.4 0.3 2.4 0.0 0.0 0.0 0.7 0.0 0.0 4.4 0.0 4.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.1 2.3 0.5 0.7 0.1 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.2 3.1 66.1 0.0 0.0 0.0 0.0 13.7 0.1 0.0 0.1 1.0 0.4 0.0 0.0 0.0 0.2 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.7 0.0 0.4 0.3 0.9 0.0 0.0 0.0 0.0 1.0 SDHAF2 "C11orf79, FLJ20487, PGL2, SDH5" ENSG00000167985 "Succinate dehydrogenase complex assembly factor 2" Q9NX18 11 61430042-61447529 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" Chaperone "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039464, HPA039732" Supported Approved Nucleoli,Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" Nucleoli "HPA039464: AB_10962146, HPA039732: AB_10962868" "unprognostic (5.31e-2)" "unprognostic (1.12e-2)" "unprognostic (3.13e-1)" "unprognostic (1.30e-2)" "unprognostic (1.40e-1)" "unprognostic (6.71e-2)" "unprognostic (1.98e-3)" "unprognostic (9.06e-2)" "unprognostic (2.17e-1)" "unprognostic (2.09e-3)" "unprognostic (4.21e-3)" "unprognostic (1.50e-1)" "unprognostic (1.81e-2)" "unprognostic (3.61e-1)" "unprognostic (1.78e-1)" "unprognostic (1.45e-1)" "unprognostic (4.48e-2)" 23.7 33.0 22.2 22.4 27.2 34.1 24.8 19.9 33.8 20.5 22.1 23.4 21.0 22.3 23.3 33.5 25.3 25.8 21.1 32.5 20.8 26.9 26.8 39.1 19.9 36.7 24.3 25.0 25.7 22.7 23.3 38.4 26.7 25.2 26.1 24.9 32.0 28.1 21.5 31.4 22.9 27.9 26.6 20.8 32.2 24.3 19.2 21.1 36.1 27.0 20.2 30.9 24.0 19.2 31.3 23.2 44.6 25.4 32.7 43.7 26.7 15.4 22.3 13.2 9.2 19.2 15.7 10.3 12.0 17.4 16.3 12.5 20.8 16.7 15.6 22.1 17.4 22.2 16.8 17.2 17.1 17.5 23.1 16.3 13.4 18.3 30.0 20.0 15.8 18.8 19.4 20.9 17.7 17.3 11.6 26.2 16.8 15.4 20.1 19.6 34.2 16.1 35.9 20.4 15.9 32.8 17.4 17.1 28.8 23.2 23.0 14.2 17.7 16.5 19.3 33.4 14.1 30.1 18.9 16.3 16.6 13.5 19.7 14.2 12.4 19.3 19.9 16.1 14.1 17.4 41.9 25.4 44.6 32.4 22.8 38.4 31.3 35.9 34.7 20.3 29.9 39.5 38.4 37.0 32.7 17.9 23.2 43.7 26.7 22.2 27.2 19.9 33.8 20.8 26.9 24.3 25.0 25.2 21.1 32.8 38.1 35.3 31.0 18.3 14.0 20.5 12.7 32.1 21.6 27.9 5.9 61.5 46.4 50.2 11.4 29.8 27.1 23.3 52.7 47.1 28.8 26.8 31.2 37.0 45.9 14.3 32.8 36.8 33.7 13.8 29.1 32.1 42.2 81.2 28.5 36.7 49.4 31.7 29.0 38.3 14.1 32.3 24.7 15.8 23.5 19.6 83.3 44.5 23.9 29.9 SETD7 "KIAA1717, KMT7, SET7, SET7/9, Set9" ENSG00000145391 "SET domain containing lysine methyltransferase 7" Q8WTS6 4 139495941-139606699 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 64.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058111 Enhanced Enhanced "Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim" "Mitotic chromosome" "HPA058111: AB_2683607" "prognostic unfavorable (8.28e-4)" "unprognostic (7.07e-2)" "unprognostic (4.04e-1)" "unprognostic (2.07e-1)" "unprognostic (2.92e-1)" "unprognostic (4.82e-2)" "unprognostic (1.48e-2)" "unprognostic (2.04e-1)" "unprognostic (1.71e-2)" "unprognostic (9.10e-2)" "unprognostic (6.44e-2)" "unprognostic (7.75e-2)" "unprognostic (1.37e-1)" "unprognostic (6.16e-3)" "unprognostic (1.17e-1)" "unprognostic (6.92e-2)" "unprognostic (6.56e-3)" 26.1 13.2 12.0 9.6 12.3 5.7 26.3 10.2 16.2 27.9 17.7 17.9 11.0 4.8 23.8 12.0 18.3 13.8 16.9 25.2 13.0 10.0 7.2 30.7 12.1 6.9 18.0 10.1 13.3 13.8 26.8 9.3 12.0 15.4 22.8 10.2 12.4 13.7 13.9 56.4 14.2 9.9 33.3 19.0 11.8 17.7 10.6 16.5 2.9 10.3 15.2 9.9 24.2 30.1 2.3 6.8 1.8 5.6 0.5 5.6 1.6 9.0 11.7 4.5 2.6 26.5 22.9 9.9 21.5 22.4 11.0 9.3 6.9 12.4 21.1 8.5 36.2 7.6 4.6 14.9 17.0 17.9 10.4 10.5 2.9 15.3 0.2 13.1 10.1 4.5 19.8 19.9 17.5 18.7 14.0 13.9 9.0 1.7 32.9 14.0 15.1 6.6 1.5 2.2 13.3 7.7 6.2 15.5 12.1 10.7 8.3 17.4 5.8 14.3 21.3 5.1 4.5 8.4 9.2 22.5 19.5 13.9 23.2 17.8 28.4 27.2 13.4 22.5 10.2 9.3 1.0 5.6 0.5 0.6 3.2 4.1 1.8 1.8 1.8 6.8 2.3 0.8 0.5 1.8 0.5 4.8 3.5 5.6 1.6 12.0 12.3 10.2 16.2 13.0 10.0 18.0 10.1 15.4 16.5 6.0 13.1 3.4 10.9 15.2 6.6 35.4 17.8 4.0 6.8 8.7 11.8 21.9 0.0 20.5 0.9 24.7 1.8 23.3 18.1 14.4 19.2 35.1 2.3 64.4 18.3 7.9 1.2 36.8 29.7 3.5 21.3 18.3 10.1 7.2 11.2 13.3 21.5 0.0 26.5 3.9 12.6 19.4 21.0 3.2 1.9 19.3 38.6 5.0 9.9 14.2 SF3B3 "KIAA0017, RSE1, SAP130, SF3b130" ENSG00000189091 "Splicing factor 3b subunit 3" Q15393 16 70523788-70577670 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041134, HPA042986" Supported Supported "Nucleoplasm,Nucleoli,Nucleoli rim" No No "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA041134: AB_2677317, HPA042986: AB_10960386" "unprognostic (3.39e-2)" "unprognostic (1.53e-1)" "unprognostic (7.47e-2)" "unprognostic (1.87e-1)" "unprognostic (2.05e-2)" "unprognostic (3.59e-2)" "unprognostic (1.06e-2)" "unprognostic (7.67e-2)" "unprognostic (2.07e-1)" "unprognostic (2.29e-1)" "unprognostic (6.97e-2)" "unprognostic (2.29e-1)" "unprognostic (3.28e-2)" "unprognostic (1.60e-1)" "unprognostic (8.76e-2)" "unprognostic (7.91e-2)" "unprognostic (1.73e-1)" 23.8 21.1 11.8 22.1 23.2 24.7 22.4 24.9 26.9 23.4 20.6 20.9 15.6 17.1 27.5 13.9 31.8 22.1 15.6 20.1 14.0 12.8 17.0 19.0 18.4 28.5 16.9 15.0 33.3 22.5 34.0 26.8 19.9 16.5 18.4 16.4 20.2 22.6 17.3 30.9 28.9 18.8 20.1 15.4 21.0 17.9 15.5 15.9 47.7 25.1 17.2 31.9 23.7 25.0 23.2 21.4 16.4 18.8 21.0 25.9 19.7 18.7 19.7 25.6 17.9 12.7 11.8 19.3 17.8 15.3 23.3 18.9 20.1 15.1 25.2 14.4 13.9 13.9 22.1 27.0 15.2 37.7 8.1 18.9 19.6 16.2 21.3 8.6 27.6 23.2 11.2 11.1 26.0 19.2 14.9 13.9 14.8 26.7 9.0 18.5 23.2 24.2 13.6 23.5 11.9 11.3 42.8 19.9 28.3 7.5 25.9 22.3 16.5 58.0 9.2 9.0 11.2 19.9 13.7 14.2 17.3 19.0 13.3 18.7 10.2 22.3 67.6 11.5 17.7 16.1 11.5 15.8 16.4 23.1 18.8 25.4 18.6 21.8 24.2 21.4 23.2 25.9 22.0 5.4 21.0 17.9 12.0 24.0 19.7 11.8 23.2 24.9 26.9 14.0 12.8 16.9 15.0 16.5 15.9 23.8 22.6 29.8 20.4 19.9 34.7 26.8 15.3 13.4 17.0 22.7 13.7 28.1 6.6 18.9 6.0 22.6 16.5 0.0 19.7 29.6 17.4 18.3 17.3 20.2 20.4 38.1 20.3 17.8 20.0 7.9 31.4 16.3 16.9 15.4 20.5 20.0 21.1 14.0 31.1 13.9 24.9 6.5 14.4 21.8 37.3 22.8 21.3 22.0 26.4 23.0 SH2D7 LOC646892 ENSG00000183476 "SH2 domain containing 7" A6NKC9 15 78077808-78104909 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 7 "testis: 37.1" "Group enriched" "Detected in some" 4 "Early spermatids: 17.9;Late spermatids: 23.2" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.1;AN3-CA: 2.8;BEWO: 2.6;HEK 293: 2.0;SCLC-21H: 2.4;SH-SY5Y: 4.4;SuSa: 2.3" "Low region specificity" "Detected in all" "HPA051320, HPA058382, HPA076728" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA051320: AB_2681439, HPA058382: , HPA076728: " "unprognostic (1.22e-2)" "unprognostic (4.31e-2)" "unprognostic (2.24e-1)" "unprognostic (1.24e-2)" "unprognostic (2.53e-1)" "unprognostic (1.42e-1)" "unprognostic (2.99e-2)" "unprognostic (7.26e-2)" "unprognostic (1.38e-1)" "unprognostic (8.63e-3)" "unprognostic (4.73e-2)" "unprognostic (2.92e-1)" "unprognostic (2.32e-3)" "unprognostic (5.15e-3)" "unprognostic (1.01e-1)" "unprognostic (1.26e-1)" "unprognostic (1.04e-1)" 0.1 0.2 0.6 0.5 0.4 0.0 0.1 0.5 0.5 0.1 4.3 0.1 0.1 5.0 0.1 0.1 0.1 0.0 1.0 0.2 0.4 0.4 0.1 0.1 0.6 0.1 0.3 0.1 0.1 0.3 0.0 0.2 0.3 0.1 0.2 0.5 0.2 0.2 0.1 0.1 0.1 4.2 0.1 0.3 0.1 0.3 37.1 0.1 0.2 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.1 2.1 2.8 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 1.1 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.3 0.0 0.0 0.2 0.0 0.0 1.5 0.1 0.0 1.1 1.4 0.0 0.0 0.4 2.4 4.4 0.4 0.6 0.2 2.3 0.1 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.4 0.5 0.5 0.4 0.4 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 17.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 5.1 0.0 0.0 23.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 2.5 0.0 0.0 0.0 SIRT2 SIR2L ENSG00000068903 "Sirtuin 2" Q8IXJ6 19 38878555-38899862 "Cancer-related genes, Predicted intracellular proteins" "Autophagy, Cell cycle, Cell division, Differentiation, Immunity, Innate immunity, Meiosis, Mitosis, Neurogenesis, Transcription, Transcription regulation" Transferase "Cancer-related genes, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 86.6;skeletal muscle: 108.7" "Cell type enhanced" "Detected in all" 6 "Early spermatids: 174.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004573, HPA011165" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" Nucleoplasm "CAB004573: AB_2188600, HPA011165: AB_1856900" "unprognostic (2.15e-2)" "unprognostic (2.24e-2)" "unprognostic (2.88e-1)" "prognostic unfavorable (7.20e-7)" "unprognostic (3.75e-3)" "unprognostic (1.28e-2)" "unprognostic (2.85e-2)" "unprognostic (2.44e-3)" "unprognostic (2.73e-1)" "unprognostic (4.83e-2)" "unprognostic (2.97e-3)" "unprognostic (1.02e-1)" "unprognostic (1.90e-1)" "unprognostic (3.60e-2)" "unprognostic (1.19e-1)" "unprognostic (8.73e-2)" "unprognostic (1.70e-1)" 14.1 11.0 30.2 8.1 36.0 10.7 9.1 14.3 38.8 11.0 8.4 78.1 4.0 9.3 9.7 7.8 17.1 12.9 10.7 20.3 36.9 23.5 9.0 12.0 10.8 8.8 52.3 20.5 17.3 9.5 10.1 6.2 7.7 40.8 9.8 7.6 5.8 14.9 11.2 108.7 13.7 9.3 12.8 86.6 9.9 9.0 7.9 46.3 3.2 10.1 23.4 8.9 10.6 7.1 13.2 21.5 28.0 33.0 16.6 23.5 22.1 8.2 5.2 4.4 11.1 25.6 17.6 3.0 6.1 10.9 9.5 12.3 9.3 5.3 2.9 13.3 11.3 7.3 4.5 8.1 13.1 5.8 13.2 8.4 5.6 5.9 5.6 18.1 3.9 12.4 18.4 15.8 7.8 9.4 11.8 16.7 9.4 5.2 22.9 14.5 4.7 7.8 3.0 0.7 14.1 7.3 10.4 12.6 8.0 7.7 7.4 11.3 5.1 7.1 9.5 6.7 3.9 4.3 10.1 15.8 12.9 2.8 19.9 9.0 9.4 4.5 6.6 10.3 9.8 11.9 19.5 27.3 28.0 23.5 33.0 14.6 12.2 11.4 16.1 21.1 13.2 7.5 12.5 20.7 16.6 25.8 21.5 15.5 22.1 30.2 36.0 14.3 38.8 36.9 23.5 52.3 20.5 40.8 46.3 14.9 20.8 11.4 27.5 45.8 26.8 30.8 7.6 29.4 20.5 12.2 33.4 28.9 31.5 27.0 174.5 26.3 34.2 23.3 15.3 12.8 23.1 19.4 25.3 16.2 56.7 28.6 16.8 23.9 33.7 57.6 28.7 34.2 43.9 14.4 20.4 20.6 21.1 18.6 38.5 23.3 27.0 19.4 35.0 12.7 5.9 52.6 35.4 43.6 15.8 22.6 SLBP HBP ENSG00000163950 "Stem-loop binding protein" Q14493 4 1692800-1712555 "Predicted intracellular proteins" "mRNA processing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Spermatocytes: 268.0;Spermatogonia: 323.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019254, HPA061670" Supported Supported Nucleoplasm,Nucleoli,Cytosol Yes Yes Nucleoplasm "Nucleoli, Cytosol" "HPA019254: AB_1856951, HPA061670: AB_2684581" "unprognostic (1.81e-2)" "unprognostic (6.80e-3)" "unprognostic (2.05e-2)" "unprognostic (1.59e-1)" "unprognostic (1.94e-1)" "unprognostic (7.09e-3)" "prognostic unfavorable (2.29e-5)" "unprognostic (5.53e-2)" "unprognostic (1.94e-2)" "unprognostic (1.13e-2)" "unprognostic (9.81e-3)" "unprognostic (9.55e-3)" "unprognostic (4.58e-2)" "unprognostic (7.31e-2)" "unprognostic (1.95e-1)" "unprognostic (1.44e-1)" "unprognostic (7.07e-2)" 19.8 18.1 26.9 30.4 28.0 60.7 27.5 23.8 30.0 19.3 19.3 14.2 20.7 16.3 20.4 21.9 25.0 19.0 15.8 17.9 25.1 26.5 23.7 21.2 18.7 43.9 19.9 24.0 23.1 17.8 13.0 19.5 27.7 16.0 20.0 21.3 17.9 24.7 21.2 15.1 24.7 17.0 20.5 17.1 26.1 18.2 50.6 12.4 52.4 24.9 17.7 42.8 23.7 26.6 24.4 24.1 45.3 29.8 19.8 36.1 30.4 29.4 12.1 17.5 18.4 15.5 17.7 18.2 25.9 22.2 31.5 31.9 25.0 34.4 38.9 15.5 21.4 37.2 18.1 35.1 23.5 37.0 15.9 19.0 48.8 15.1 25.1 19.2 45.1 23.8 12.2 18.9 23.9 15.9 18.3 17.9 26.1 34.9 38.5 38.5 10.6 69.4 41.1 21.8 31.1 21.6 52.3 28.6 24.6 30.3 22.4 19.9 15.3 22.0 14.3 15.3 24.7 23.7 29.8 15.1 26.5 15.2 27.9 40.3 22.4 40.7 93.0 24.8 38.7 26.0 9.3 29.8 21.8 23.6 22.3 21.4 24.4 30.8 33.2 24.1 18.0 26.5 25.1 45.3 19.8 19.8 19.1 36.1 30.4 26.9 28.0 23.8 30.0 25.1 26.5 19.9 24.0 16.0 12.4 14.9 16.8 53.9 86.5 93.4 17.7 7.1 25.5 8.1 7.9 34.9 23.6 121.4 91.2 43.6 64.1 31.8 21.2 23.3 27.3 39.1 59.3 64.3 23.1 26.1 70.1 23.8 34.4 29.4 34.0 32.9 40.9 44.4 62.4 61.3 27.5 27.6 30.6 23.0 41.4 37.4 11.4 12.9 49.1 268.0 323.2 92.5 37.4 59.9 37.5 71.2 SMAD2 "JV18-1, MADH2, MADR2" ENSG00000175387 "SMAD family member 2" Q15796 18 47808957-47931146 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Cone photoreceptor cells: 200.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025507, HPA067203, CAB073546" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli, Cytosol" "CAB025507: , CAB073546: , HPA067203: AB_2685803" "unprognostic (1.55e-1)" "unprognostic (2.49e-1)" "unprognostic (1.43e-2)" "unprognostic (9.82e-3)" "unprognostic (9.88e-2)" "unprognostic (1.06e-1)" "prognostic unfavorable (9.44e-5)" "unprognostic (1.91e-2)" "unprognostic (7.59e-2)" "unprognostic (1.41e-3)" "unprognostic (6.46e-2)" "unprognostic (4.91e-2)" "unprognostic (9.20e-3)" "unprognostic (2.68e-1)" "unprognostic (6.13e-2)" "unprognostic (3.20e-2)" "unprognostic (6.28e-2)" 38.5 39.2 29.0 26.2 25.9 19.6 31.4 19.5 28.9 28.8 34.2 29.4 28.9 21.5 26.6 26.3 33.5 28.8 25.7 31.1 26.1 27.1 26.4 20.9 28.3 23.8 30.9 24.3 36.6 28.1 25.7 24.4 34.8 28.6 27.8 29.8 31.7 29.7 28.7 33.9 28.0 26.4 34.6 35.4 34.1 26.3 29.2 26.2 60.7 46.1 23.6 31.5 35.1 35.7 12.0 21.8 28.9 24.7 24.5 25.9 19.7 22.2 32.0 19.5 18.9 31.2 38.2 22.3 24.3 29.2 25.4 29.7 12.2 21.4 34.6 17.5 30.8 35.6 24.6 21.9 27.1 34.1 37.6 11.2 29.4 48.3 19.8 36.4 40.8 30.1 28.2 35.0 21.7 50.3 29.6 28.0 28.2 13.6 29.0 31.2 14.5 28.0 19.6 9.6 1.1 7.6 20.5 28.5 23.6 57.0 38.4 18.1 21.2 29.2 20.1 23.8 19.9 15.2 27.2 31.3 37.7 21.8 10.2 17.6 28.5 27.3 30.2 26.1 27.9 27.5 28.9 22.6 25.0 16.9 24.7 21.2 12.0 23.1 20.9 21.8 9.4 25.8 19.8 22.7 24.5 20.8 15.5 25.9 19.7 29.0 25.9 19.5 28.9 26.1 27.1 30.9 24.3 28.6 26.2 41.7 29.7 22.0 39.2 48.3 44.4 40.0 40.8 30.8 45.5 73.3 200.3 37.8 33.2 31.7 53.8 44.7 32.0 46.7 38.2 33.2 34.3 51.4 20.8 22.6 38.9 33.4 49.0 57.7 52.1 97.0 38.6 38.2 49.0 44.1 42.5 37.9 37.5 24.6 50.2 32.1 82.1 32.3 35.9 26.3 39.6 54.1 58.1 38.1 35.7 55.8 SMIM20 "C4orf52, MITRAC7, PNX" ENSG00000250317 "Small integral membrane protein 20" Q8N5G0 4 25861830-25929874 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016552 Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Cytosol" Nucleoli "HPA016552: AB_1859536" "unprognostic (1.18e-1)" "unprognostic (3.73e-2)" "unprognostic (1.78e-1)" "unprognostic (6.52e-3)" "unprognostic (1.55e-2)" "unprognostic (2.12e-1)" "unprognostic (1.20e-3)" "unprognostic (7.01e-2)" "unprognostic (2.46e-1)" "unprognostic (1.02e-1)" "unprognostic (5.42e-2)" "unprognostic (2.86e-1)" "prognostic favorable (8.97e-5)" "unprognostic (5.51e-2)" "unprognostic (5.84e-2)" "unprognostic (1.53e-1)" "unprognostic (5.12e-3)" 14.9 20.5 21.8 15.6 26.7 7.1 25.0 11.4 28.0 12.9 16.4 8.3 12.8 24.1 13.7 46.4 11.9 15.1 22.5 33.7 17.9 16.2 27.1 22.7 18.5 26.0 19.2 14.3 19.5 50.0 8.7 10.0 9.5 22.8 13.6 16.1 11.3 20.4 15.7 51.3 6.9 23.8 24.0 22.6 12.7 18.8 17.7 13.5 9.3 21.3 15.3 14.5 14.5 15.9 27.1 21.4 13.3 20.3 18.1 31.1 18.2 12.9 10.9 14.6 14.1 16.2 35.4 19.6 12.7 15.4 10.9 14.0 9.6 23.1 21.4 22.1 14.0 22.7 3.8 17.0 16.2 15.3 12.1 13.5 12.3 7.9 18.3 27.6 14.6 8.2 25.0 32.6 13.9 21.2 21.4 8.4 14.5 19.7 7.0 13.4 8.3 15.8 24.9 27.6 17.3 16.3 13.1 19.1 13.7 24.3 9.5 18.9 17.6 8.1 5.7 27.9 16.8 11.8 20.9 13.9 11.9 14.1 13.3 16.1 13.8 11.3 22.4 18.0 15.6 15.0 13.3 18.2 8.4 15.7 20.3 20.5 27.1 22.7 19.7 20.5 26.8 31.1 24.7 9.2 18.1 15.2 21.4 23.2 18.2 21.8 26.7 11.4 28.0 17.9 16.2 19.2 14.3 22.8 13.5 8.9 35.3 39.7 30.7 19.5 7.0 54.2 58.6 29.4 35.2 34.9 7.9 53.4 111.0 55.9 8.3 17.8 60.0 0.0 54.3 51.6 39.2 34.0 10.4 52.1 61.7 1.6 18.6 19.0 49.0 18.9 34.8 47.0 42.2 36.1 53.7 55.6 48.1 35.1 45.3 134.2 16.1 71.1 36.2 42.9 40.5 16.9 36.6 25.9 63.5 25.3 SMPDL3A "ASM3A, ASML3a, FLJ20177, yR36GH4.1" ENSG00000172594 "Sphingomyelin phosphodiesterase acid like 3A" Q92484 6 122789049-122809720 "Predicted intracellular proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 208.6;Proximal tubular cells: 122.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 10 "basophil: 31.2" "Lineage enriched" "Detected in many" 10 "granulocytes: 31.2" "Cell line enhanced" "Detected in many" "ASC diff: 22.3;hTCEpi: 18.3;OE19: 28.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030148 Uncertain Approved Nucleoplasm,Nucleoli,Mitochondria "Secreted to blood" No No 22000000 "Nucleoplasm, Nucleoli, Mitochondria" "HPA030148: AB_10601591" "unprognostic (2.60e-1)" "unprognostic (1.22e-1)" "prognostic favorable (6.11e-4)" "unprognostic (1.23e-1)" "unprognostic (1.15e-1)" "unprognostic (8.30e-3)" "unprognostic (3.37e-1)" "unprognostic (1.46e-1)" "unprognostic (1.83e-1)" "unprognostic (1.53e-1)" "unprognostic (1.39e-1)" "unprognostic (7.72e-2)" "unprognostic (2.27e-2)" "unprognostic (3.44e-2)" "unprognostic (8.46e-2)" "unprognostic (1.17e-2)" "unprognostic (1.11e-1)" 8.8 15.9 4.0 8.3 5.4 8.1 24.9 9.7 9.9 35.3 46.7 3.8 8.0 19.2 10.0 9.8 9.6 5.1 8.5 11.9 4.5 4.1 20.1 36.9 13.0 29.1 4.7 5.6 6.2 24.6 16.1 7.0 23.2 6.5 19.6 28.5 7.6 9.5 13.7 56.1 32.1 63.6 10.9 4.9 37.7 13.1 3.8 3.2 3.3 7.2 18.0 7.6 18.7 24.3 0.1 0.4 31.2 3.2 0.0 0.0 0.5 0.1 1.2 3.0 1.4 22.3 10.1 9.6 5.0 13.5 1.5 3.3 1.6 1.3 0.0 0.7 3.1 4.1 2.4 0.8 2.5 1.3 0.0 2.6 1.1 5.1 4.2 14.3 0.0 0.0 12.3 18.3 1.4 2.7 6.0 2.7 0.0 1.8 0.0 6.2 4.4 0.0 0.1 0.5 28.0 3.9 0.0 5.3 0.1 7.4 2.0 2.2 0.0 0.7 9.1 12.7 2.0 1.5 0.7 5.2 3.0 1.7 0.3 3.2 0.0 0.0 0.0 4.3 2.3 6.7 31.2 1.7 0.4 0.0 1.9 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 3.2 0.0 0.0 0.5 4.0 5.4 9.7 9.9 4.5 4.1 4.7 5.6 6.5 3.2 3.0 16.2 2.2 20.4 47.7 2.8 3.6 22.9 5.3 3.4 5.2 3.9 117.9 48.0 19.1 0.1 5.8 208.6 0.0 22.5 35.4 27.9 13.5 9.3 67.1 54.3 3.2 46.8 24.5 86.5 1.1 14.4 9.9 33.7 1.0 51.3 11.4 17.1 87.7 13.4 122.4 5.9 12.9 8.3 0.9 3.9 66.5 96.2 4.3 33.0 12.8 SNAPC3 "MGC132011, MGC33124, PTFbeta, SNAP50" ENSG00000164975 "Small nuclear RNA activating complex polypeptide 3" Q92966 9 15422704-15465953 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 98.3;Late spermatids: 162.5;Spermatocytes: 125.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053145, HPA066031" Supported "Nucleoplasm,Nucleoli,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" Nucleoli "HPA053145: AB_2682055, HPA066031: AB_2685600" "unprognostic (2.62e-1)" "unprognostic (4.26e-1)" "unprognostic (5.42e-3)" "unprognostic (2.09e-1)" "unprognostic (4.93e-3)" "unprognostic (6.08e-2)" "unprognostic (5.60e-3)" "unprognostic (4.15e-2)" "unprognostic (1.68e-2)" "unprognostic (1.67e-2)" "unprognostic (1.12e-2)" "unprognostic (2.64e-2)" "unprognostic (1.36e-3)" "unprognostic (3.07e-1)" "unprognostic (2.63e-1)" "unprognostic (4.38e-2)" "unprognostic (2.09e-2)" 9.8 18.5 18.7 10.3 21.1 4.6 10.4 26.3 21.2 17.9 13.2 10.4 10.3 11.6 16.5 15.5 12.6 10.8 10.8 17.5 18.0 14.0 12.3 8.6 10.0 11.2 15.2 16.3 17.4 11.1 12.8 18.4 16.7 21.8 13.3 14.6 9.6 10.5 11.3 19.3 13.7 14.2 12.8 15.2 12.8 10.5 14.7 15.9 11.9 11.3 6.8 10.8 12.9 15.1 12.2 7.7 5.0 21.2 5.0 8.2 5.5 3.9 5.1 10.8 4.1 8.7 9.1 6.3 6.2 2.8 3.7 4.4 2.4 1.7 2.8 2.4 3.9 5.2 2.4 5.7 2.9 4.6 13.1 6.7 10.1 10.8 3.3 4.3 2.2 7.8 5.9 5.9 2.6 3.0 15.7 6.8 6.7 2.8 4.6 8.4 1.2 2.7 7.2 3.4 3.0 13.5 5.5 1.3 1.5 6.4 2.4 11.6 8.2 2.1 1.9 1.4 9.9 4.6 4.6 5.6 6.2 2.5 2.6 7.9 6.1 7.3 3.5 4.0 3.0 2.8 3.4 10.1 5.0 5.7 16.7 5.5 9.9 5.7 5.1 7.7 12.2 8.2 7.9 1.2 5.0 21.2 6.3 7.9 5.5 18.7 21.1 26.3 21.2 18.0 14.0 15.2 16.3 21.8 15.9 17.9 11.0 17.8 12.4 8.5 19.2 37.1 5.1 13.4 5.7 19.2 29.5 10.6 11.6 16.6 98.3 16.4 21.6 0.0 8.2 10.8 16.4 10.3 17.3 12.4 13.8 33.4 14.5 19.0 22.1 162.5 31.4 10.0 18.6 17.2 14.1 15.1 11.3 27.7 28.7 24.2 17.8 12.9 21.7 125.8 27.9 10.5 8.1 17.1 16.2 10.2 SNX10 ENSG00000086300 "Sorting nexin 10" Q9Y5X0 7 26291895-26374329 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Transport" "Disease mutation, Osteopetrosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 67.6;brain: 39.0;liver: 37.4" "Cell type enhanced" "Detected in many" 7 "Distal tubular cells: 242.1;Hofbauer cells: 146.8;Kupffer cells: 156.1;Macrophages: 186.4;Muller glia cells: 262.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 67.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 27.2;U-937: 22.3;WM-115: 77.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015605, HPA064782" Approved Supported Nucleoplasm,Nucleoli,Microtubules NA NA "Nucleoplasm, Microtubules" Nucleoli "HPA015605: AB_1857342, HPA064782: AB_2685349" "unprognostic (6.42e-2)" "unprognostic (2.72e-3)" "unprognostic (2.45e-1)" "unprognostic (7.62e-2)" "prognostic unfavorable (1.16e-4)" "unprognostic (6.92e-2)" "unprognostic (2.48e-3)" "unprognostic (4.51e-2)" "unprognostic (4.87e-1)" "unprognostic (9.36e-2)" "unprognostic (1.59e-1)" "unprognostic (2.56e-1)" "prognostic unfavorable (8.06e-5)" "unprognostic (1.12e-2)" "unprognostic (3.21e-1)" "unprognostic (8.59e-2)" "unprognostic (1.50e-1)" 17.7 8.7 20.2 18.6 17.9 20.9 6.7 13.2 39.0 2.9 3.3 2.1 0.1 2.5 5.4 0.8 1.8 1.9 5.2 1.3 22.2 32.7 21.3 37.4 22.4 18.0 27.8 20.8 1.0 5.0 0.6 3.0 8.9 36.2 2.2 3.9 1.8 1.4 1.5 0.9 1.0 3.6 5.4 15.4 22.1 2.3 3.0 2.1 3.8 1.9 0.1 13.6 6.3 1.8 16.3 20.1 67.6 30.9 9.0 5.6 11.6 13.9 1.3 0.0 2.6 0.0 0.0 15.2 0.0 1.0 0.0 0.0 0.1 4.7 6.1 11.0 0.0 9.6 0.4 3.5 0.9 0.0 8.4 3.3 0.6 0.1 9.2 0.0 13.0 2.3 0.1 1.4 0.0 1.1 0.0 0.2 7.9 0.3 0.0 0.0 2.4 5.4 13.7 4.0 0.1 1.3 0.0 0.0 0.3 27.2 3.0 6.0 1.8 3.0 2.2 15.8 5.0 4.0 18.6 0.0 0.0 3.3 0.0 3.4 4.7 3.7 4.1 0.1 22.3 77.5 8.2 29.2 0.7 4.0 30.9 3.8 16.3 2.8 3.4 20.1 14.5 1.5 2.6 67.6 9.0 30.1 7.4 5.6 11.6 20.2 17.9 13.2 39.0 22.2 32.7 27.8 20.8 36.2 2.1 3.0 17.1 49.9 1.0 4.7 17.7 1.6 20.4 1.4 7.9 22.7 2.0 11.6 242.1 51.3 0.9 5.6 2.6 23.3 23.5 64.7 3.6 2.8 31.1 90.6 146.8 33.4 9.1 2.5 156.1 0.7 1.1 186.4 8.5 49.5 2.5 262.3 22.1 0.0 0.0 123.2 20.4 0.0 3.3 1.6 28.0 2.6 24.0 38.8 9.7 0.9 SNX29 "FLJ12363, RUNDC2A" ENSG00000048471 "Sorting nexin 29" Q8TEQ0 16 11976737-12574289 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 333.8;Early spermatids: 117.2;Horizontal cells: 87.4;Late spermatids: 346.9;Rod photoreceptor cells: 256.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "naive B-cell: 19.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008889, HPA062810" Approved Approved "Nucleoli,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoli, Cytosol" "HPA008889: AB_1079856, HPA062810: " "unprognostic (2.50e-1)" "unprognostic (4.12e-2)" "unprognostic (1.60e-2)" "unprognostic (1.36e-1)" "unprognostic (1.33e-1)" "unprognostic (9.82e-3)" "unprognostic (2.29e-2)" "unprognostic (1.12e-1)" "unprognostic (5.38e-2)" "unprognostic (2.18e-2)" "unprognostic (7.44e-2)" "unprognostic (6.08e-2)" "prognostic favorable (1.38e-7)" "unprognostic (3.85e-3)" "unprognostic (4.54e-2)" "unprognostic (1.83e-1)" "prognostic unfavorable (1.03e-4)" 11.4 5.5 8.2 9.8 14.4 10.7 8.3 13.2 11.9 9.4 6.7 22.7 5.2 3.3 9.6 9.1 9.9 11.1 6.4 6.6 9.0 8.1 24.5 3.6 8.7 14.8 13.7 9.1 13.7 4.8 32.1 16.1 10.0 14.4 5.4 4.9 15.4 6.9 6.8 11.7 8.2 5.8 12.2 18.5 10.8 6.1 16.9 13.1 12.5 8.6 4.9 19.2 9.8 7.4 19.2 5.8 3.0 5.7 1.0 4.3 1.4 3.1 1.8 2.8 2.3 16.9 13.9 3.7 6.8 18.7 2.8 3.1 0.3 3.6 11.7 9.1 10.5 1.8 2.7 1.8 4.3 4.1 4.5 1.9 1.5 1.6 4.0 3.2 1.6 4.3 12.7 2.8 4.1 1.8 4.2 4.9 3.9 2.4 3.3 2.8 4.2 3.1 1.9 1.6 2.0 1.7 7.0 3.6 9.4 12.5 2.9 3.4 2.8 7.7 4.6 1.6 2.5 2.6 2.0 7.4 5.0 2.0 3.7 1.3 19.2 14.6 7.3 9.2 1.8 3.1 3.0 5.7 1.2 1.7 3.7 2.1 8.3 3.6 2.2 2.0 19.2 4.3 3.1 2.0 1.0 1.8 5.8 3.1 1.4 8.2 14.4 13.2 11.9 9.0 8.1 13.7 9.1 14.4 13.1 11.9 19.3 51.4 5.6 13.6 52.7 9.5 5.1 16.0 13.6 15.7 333.8 15.9 18.3 3.8 117.2 11.2 3.4 0.0 2.5 4.2 17.2 3.4 41.5 5.0 24.8 87.4 12.6 16.5 21.8 346.9 19.8 27.4 11.8 11.8 3.6 21.7 5.8 3.5 14.5 32.0 256.7 6.5 10.8 21.5 7.6 13.6 14.3 9.6 3.3 4.6 SNX30 ATG24A ENSG00000148158 "Sorting nexin family member 30" Q5VWJ9 9 112750838-112881671 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 65.1;Erythroid cells: 46.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019346 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli, Cytosol" "HPA019346: AB_2286395" "unprognostic (1.67e-2)" "unprognostic (1.38e-1)" "unprognostic (1.08e-1)" "unprognostic (3.61e-1)" "unprognostic (3.61e-1)" "unprognostic (3.69e-1)" "unprognostic (8.05e-3)" "unprognostic (2.04e-3)" "unprognostic (4.48e-2)" "unprognostic (3.59e-3)" "unprognostic (3.39e-2)" "unprognostic (1.48e-1)" "prognostic favorable (1.01e-7)" "unprognostic (4.48e-3)" "unprognostic (1.18e-1)" "unprognostic (7.51e-2)" "unprognostic (1.41e-2)" 4.9 4.4 12.2 7.7 12.6 8.3 7.7 18.1 18.5 10.9 11.1 25.6 3.6 7.9 6.4 4.1 5.3 3.8 5.4 3.4 14.2 12.0 23.7 5.2 23.4 8.8 14.8 12.8 6.9 5.2 6.9 6.3 5.1 14.7 4.1 11.7 4.9 7.1 4.3 2.6 5.7 8.9 7.5 20.3 7.4 4.7 12.7 11.8 2.3 3.1 2.6 8.7 5.4 4.6 0.7 4.2 1.5 5.1 0.8 1.7 1.6 6.0 3.8 6.6 5.2 8.3 7.6 5.5 5.2 10.9 4.4 4.2 13.5 1.4 10.1 4.4 13.4 7.9 7.2 7.9 3.1 6.9 3.2 3.7 3.1 3.4 5.4 6.0 3.1 5.6 6.2 4.3 6.8 5.1 11.2 3.8 2.6 4.8 5.8 5.9 4.2 2.0 3.6 7.2 9.8 4.0 4.3 15.4 2.6 8.6 10.6 9.8 3.1 6.8 9.4 13.0 7.0 7.0 5.6 4.2 6.6 7.0 19.3 4.4 15.1 13.9 4.8 8.5 2.9 12.8 0.0 5.1 1.5 0.8 2.0 1.7 0.0 0.8 1.0 4.2 0.7 0.7 0.6 0.7 0.8 2.1 0.7 1.6 1.6 12.2 12.6 18.1 18.5 14.2 12.0 14.8 12.8 14.7 11.8 6.0 65.1 0.0 1.9 7.2 5.7 3.8 5.1 1.4 9.1 5.2 9.8 0.4 5.0 2.1 5.3 3.0 12.4 46.7 2.8 1.6 5.7 3.1 6.9 5.9 11.9 7.9 4.6 12.3 19.7 6.3 5.2 12.5 20.3 1.0 9.7 2.6 3.4 17.3 7.4 33.2 2.7 0.0 1.4 5.5 10.5 9.7 0.3 3.8 8.6 5.4 SPG11 "FLJ21439, KIAA1840" ENSG00000104133 "SPG11, spatacsin vesicle trafficking associated" Q96JI7 15 44562696-44663678 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Hereditary spastic paraplegia, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040412, HPA040947" Approved Supported "Nucleoli,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoli "HPA040412: AB_10795418, HPA040947: AB_10796232" "unprognostic (1.10e-1)" "unprognostic (1.74e-1)" "unprognostic (2.39e-1)" "unprognostic (1.98e-3)" "unprognostic (1.99e-1)" "unprognostic (9.31e-2)" "unprognostic (2.91e-1)" "unprognostic (2.32e-1)" "unprognostic (6.71e-2)" "unprognostic (2.26e-3)" "unprognostic (2.58e-2)" "unprognostic (9.19e-2)" "prognostic favorable (6.28e-5)" "unprognostic (8.73e-2)" "unprognostic (2.48e-1)" "unprognostic (3.72e-1)" "unprognostic (6.06e-2)" 23.8 24.6 16.6 26.4 22.2 25.8 23.4 21.2 21.2 20.8 26.0 31.7 25.8 17.9 18.6 28.1 22.9 19.0 20.2 19.3 16.1 15.2 22.0 25.1 22.6 26.9 26.3 15.6 20.5 25.5 33.4 25.9 15.7 22.1 22.3 21.6 18.7 22.7 26.6 19.0 31.8 26.2 21.5 22.1 39.2 22.8 22.1 23.1 35.8 30.9 12.6 26.0 23.0 19.4 12.8 7.1 13.6 13.0 6.7 8.3 3.8 8.0 5.5 14.1 13.7 22.0 21.7 10.1 8.5 10.9 8.3 10.7 6.6 7.9 5.9 10.6 11.3 14.4 18.5 9.7 13.0 8.2 17.8 5.9 13.6 13.0 10.0 15.5 13.6 12.6 16.5 14.9 6.8 19.7 13.1 11.7 10.5 17.3 15.4 11.7 7.0 6.0 12.5 7.4 24.9 7.5 8.0 11.8 6.5 17.7 21.1 9.2 10.8 9.3 14.8 7.9 12.1 14.1 18.6 12.8 11.1 5.5 13.7 10.2 15.3 13.5 11.9 11.4 18.0 11.3 6.0 8.8 12.3 7.8 10.2 8.3 10.9 6.5 5.8 6.9 12.8 5.4 6.4 13.6 6.7 13.0 7.1 6.6 3.8 16.6 22.2 21.2 21.2 16.1 15.2 26.3 15.6 22.1 23.1 41.7 17.4 28.3 13.4 8.2 22.1 15.9 17.8 44.2 29.6 26.2 45.2 13.6 5.0 16.4 24.2 10.8 26.7 0.0 14.7 8.5 12.9 17.8 26.5 19.5 17.6 15.9 19.3 23.9 45.3 24.1 16.4 30.5 13.5 84.8 28.1 15.6 16.1 17.3 13.1 14.6 21.7 6.5 8.9 40.8 24.7 9.7 7.8 23.0 25.1 17.9 SPOCD1 "FLJ25348, PPP1R146" ENSG00000134668 "SPOC domain containing 1" Q6ZMY3 1 31790422-31816051 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 28.9;urinary bladder: 13.7" "Cell type enhanced" "Detected in some" 19 "Ductal cells: 9.9;Hofbauer cells: 13.9;Pancreatic endocrine cells: 18.9;Urothelial cells: 44.4" "Group enriched" "Detected in many" 7 "glioma: 13.9;urothelial cancer: 5.6" "Region enhanced" "Detected in many" "pons and medulla: 8.2" "Cell type enriched" "Detected in single" 15 "neutrophil: 1.9" "Lineage enriched" "Detected in single" 15 "granulocytes: 1.9" "Cell line enhanced" "Detected in many" "BJ hTERT+: 18.9;hTEC/SVTERT24-B: 19.7;RT4: 33.2;TIME: 17.3;U-87 MG: 32.7" "Low region specificity" "Detected in some" "HPA031713, HPA031714, HPA031715" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol NA NA Cytosol "Nucleoplasm, Nucleoli" "HPA031713: AB_10604099, HPA031714: AB_2674007, HPA031715: AB_2674008" "unprognostic (7.78e-2)" "unprognostic (2.58e-2)" "unprognostic (1.85e-3)" "unprognostic (2.70e-3)" "unprognostic (1.29e-2)" "unprognostic (1.56e-2)" "unprognostic (2.15e-3)" "unprognostic (2.60e-2)" "unprognostic (3.51e-1)" "unprognostic (2.18e-1)" "unprognostic (3.01e-2)" "unprognostic (3.00e-1)" "unprognostic (0.00e+0)" "unprognostic (1.97e-1)" "unprognostic (1.06e-1)" "unprognostic (1.54e-2)" "prognostic favorable (4.05e-5)" 28.9 0.5 1.8 5.1 1.6 0.3 1.6 0.4 3.9 2.0 0.7 1.5 0.1 1.6 2.4 2.8 0.3 2.1 1.6 0.4 1.2 1.6 0.5 0.2 12.9 0.9 2.6 0.3 1.8 0.1 0.1 1.6 3.5 8.2 1.8 0.9 1.8 0.1 0.3 0.4 0.1 0.9 2.4 3.1 1.9 1.1 11.9 0.6 0.1 0.4 0.8 0.2 13.7 2.1 0.0 0.0 1.9 0.1 0.0 0.0 7.3 10.7 0.3 0.0 0.0 0.2 1.5 0.5 14.1 18.9 13.7 9.2 0.2 0.6 0.1 1.9 15.9 5.6 1.4 0.0 0.2 4.3 0.0 0.0 0.0 1.9 0.0 0.6 0.0 0.2 6.9 0.2 19.7 0.6 11.1 9.3 0.7 0.2 0.2 8.1 0.0 0.1 0.0 0.2 0.1 0.3 0.0 1.4 0.0 0.0 33.2 0.0 0.0 0.3 0.0 0.9 0.4 8.2 0.0 17.3 14.5 1.4 9.3 5.3 0.0 0.1 0.0 32.7 0.0 2.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 7.3 1.8 1.6 0.4 0.6 1.2 1.6 2.6 0.3 8.2 0.6 0.0 5.9 0.0 4.0 0.1 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.2 0.0 9.9 0.2 0.1 0.0 0.0 8.9 0.5 0.4 1.7 1.1 0.0 13.9 0.0 1.7 0.6 0.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 18.9 0.0 0.4 0.0 0.0 0.0 1.4 0.0 4.3 0.0 0.2 0.0 0.0 44.4 SRSF5 "HRS, SFRS5, SRP40" ENSG00000100650 "Serine and arginine rich splicing factor 5" Q13243 14 69726900-69772005 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043484, HPA056523" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA043484: AB_10797143, HPA056523: AB_2683164" "unprognostic (2.08e-3)" "prognostic favorable (7.91e-4)" "unprognostic (1.89e-1)" "unprognostic (1.19e-1)" "unprognostic (1.19e-1)" "unprognostic (1.79e-2)" "unprognostic (1.86e-1)" "unprognostic (2.06e-2)" "unprognostic (3.32e-2)" "unprognostic (1.61e-1)" "unprognostic (9.30e-3)" "unprognostic (1.07e-3)" "unprognostic (2.37e-2)" "unprognostic (1.13e-1)" "unprognostic (1.42e-1)" "unprognostic (2.42e-1)" "unprognostic (1.00e-2)" 66.6 60.1 67.1 60.9 74.4 131.5 70.3 111.7 88.8 54.3 63.3 67.8 77.1 42.6 71.3 74.6 66.3 79.3 50.1 48.5 66.2 43.0 40.5 60.8 69.4 63.3 86.4 62.1 76.6 41.0 56.4 124.8 59.2 74.0 59.0 54.7 69.2 68.5 75.6 76.0 78.1 74.1 59.7 68.6 66.5 62.0 35.3 75.6 47.8 70.8 52.3 69.1 69.6 55.8 41.2 37.4 60.8 45.1 30.8 38.2 24.4 70.0 20.5 50.2 22.6 31.0 26.9 27.9 33.8 36.4 27.6 29.3 25.7 45.0 72.6 17.9 45.8 28.4 33.5 38.0 48.3 32.6 62.0 20.9 54.7 54.9 28.1 36.1 51.0 41.5 55.7 30.8 31.8 34.1 41.5 38.2 63.2 38.0 43.3 17.1 56.9 58.6 34.6 29.4 55.3 18.9 50.3 23.9 27.9 35.1 86.3 26.2 37.4 57.3 34.8 43.6 31.4 37.9 43.0 47.2 16.2 43.4 17.6 31.6 42.1 27.5 117.5 38.1 43.5 22.2 39.0 24.1 37.2 37.3 43.4 38.2 41.2 33.2 33.4 26.2 40.6 33.2 31.5 60.8 30.8 45.1 37.4 27.4 24.4 67.1 74.4 111.7 88.8 66.2 43.0 86.4 62.1 74.0 75.6 235.2 245.0 272.6 618.6 122.6 370.2 163.3 193.6 401.5 253.6 174.5 225.8 335.9 271.9 173.3 146.9 251.5 417.9 163.5 148.9 193.0 195.8 288.7 459.5 204.3 193.9 357.6 290.6 219.1 193.0 84.2 319.9 251.8 126.5 254.3 249.3 292.6 182.8 399.8 251.0 172.0 307.5 271.7 240.9 175.1 136.3 127.2 626.6 371.3 207.8 495.2 SS18L2 KIAA-iso ENSG00000008324 "SS18 like 2" Q9UHA2 3 42581840-42595114 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047377 Uncertain Approved Nucleoplasm,Nucleoli,Mitochondria Yes No "Nucleoli, Mitochondria" Nucleoplasm "HPA047377: AB_2680020" "unprognostic (4.09e-3)" "unprognostic (1.90e-3)" "unprognostic (1.54e-1)" "unprognostic (1.19e-1)" "unprognostic (2.36e-1)" "unprognostic (1.57e-1)" "unprognostic (1.64e-2)" "prognostic favorable (7.03e-4)" "unprognostic (6.55e-2)" "unprognostic (4.51e-2)" "unprognostic (2.62e-2)" "unprognostic (2.94e-2)" "unprognostic (1.09e-3)" "unprognostic (1.44e-1)" "unprognostic (1.09e-1)" "unprognostic (1.96e-1)" "unprognostic (2.24e-3)" 12.7 11.6 24.5 17.8 26.4 29.9 20.8 25.2 23.8 14.0 14.8 14.4 9.1 19.4 9.1 20.6 16.6 10.6 11.8 10.8 23.5 20.6 15.8 26.2 11.9 34.8 20.5 15.9 13.5 29.0 10.9 16.1 10.7 17.4 22.2 15.5 11.3 18.6 10.8 10.1 14.9 19.3 8.4 24.0 19.7 15.6 6.4 14.9 20.4 18.7 14.7 32.0 16.0 11.1 48.0 30.0 32.8 25.9 31.0 53.5 32.9 16.1 7.4 14.9 13.5 19.2 15.6 9.3 10.5 12.0 15.7 17.8 14.2 14.8 22.1 9.6 7.2 16.5 9.1 17.8 14.7 17.3 11.0 20.8 24.0 14.5 23.8 13.8 31.3 18.9 12.2 9.5 12.6 11.9 10.9 17.1 19.7 21.7 33.4 12.6 15.3 22.0 38.9 23.6 21.8 18.2 11.7 10.9 30.7 17.4 20.4 8.4 12.0 8.9 14.0 14.1 16.8 18.3 29.3 10.0 9.2 15.1 22.1 19.1 24.3 38.4 37.5 13.6 34.4 8.8 19.0 23.5 32.8 38.4 25.9 51.6 48.0 50.5 45.3 24.9 40.8 43.9 44.1 31.1 31.0 19.2 30.0 53.5 32.9 24.5 26.4 25.2 23.8 23.5 20.6 20.5 15.9 17.4 14.9 11.9 11.8 77.1 64.6 95.1 14.4 16.1 38.2 14.7 15.9 26.2 7.9 47.4 48.0 38.3 2.3 39.4 43.1 23.3 43.1 65.4 37.6 63.9 45.0 58.7 58.5 22.3 52.9 28.3 37.6 2.5 31.9 41.0 49.0 61.3 42.2 24.6 41.3 53.7 14.9 68.9 23.5 12.9 39.1 13.2 24.0 120.8 31.2 95.9 48.0 96.2 STK33 ENSG00000130413 "Serine/threonine kinase 33" Q9BYT3 11 8391868-8594289 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 34.4" "Cell type enhanced" "Detected in many" 12 "Ciliated cells: 245.0;Late spermatids: 113.1;Rod photoreceptor cells: 83.4;Spermatocytes: 126.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "memory B-cell: 7.1;naive B-cell: 4.4" "Lineage enriched" "Detected in many" 5 "B-cells: 7.1" "Cell line enhanced" "Detected in many" "Daudi: 14.0;hTERT-RPE1: 14.2;Karpas-707: 13.1;SCLC-21H: 14.7;U-251 MG: 14.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA015742, HPA056855" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA015742: AB_1857592, HPA056855: AB_2683257" "unprognostic (2.57e-2)" "unprognostic (2.80e-1)" "unprognostic (2.23e-3)" "unprognostic (2.76e-3)" "unprognostic (3.57e-1)" "unprognostic (1.40e-1)" "unprognostic (7.28e-2)" "unprognostic (3.85e-4)" "unprognostic (1.23e-1)" "unprognostic (8.06e-2)" "unprognostic (1.33e-3)" "unprognostic (9.46e-2)" "prognostic favorable (4.89e-6)" "unprognostic (2.39e-2)" "unprognostic (1.37e-1)" "unprognostic (3.49e-2)" "unprognostic (2.90e-2)" 0.9 6.1 4.7 1.6 7.5 1.1 0.6 6.1 4.4 5.4 5.3 6.8 7.7 2.6 9.6 15.3 2.3 30.7 4.5 11.4 6.6 6.1 7.7 0.4 5.3 2.3 4.9 2.7 10.3 4.6 20.4 29.9 0.3 17.7 5.3 1.3 14.8 1.6 8.9 2.6 0.3 2.5 7.0 6.7 1.2 4.4 34.4 4.6 4.5 14.6 1.5 1.8 3.7 1.4 7.1 0.7 0.0 0.0 0.2 1.4 0.3 0.0 2.0 9.7 0.0 0.0 0.0 0.0 1.7 1.9 4.2 3.9 1.1 0.0 14.0 7.3 0.3 5.5 0.0 4.3 1.3 3.7 0.0 11.9 0.0 2.6 3.3 1.6 7.8 0.0 0.4 0.0 0.1 0.0 14.2 0.3 6.9 0.0 13.1 0.1 0.0 0.2 0.0 6.9 0.0 0.0 5.2 1.3 8.8 3.8 0.0 14.7 3.9 0.0 0.0 0.1 2.7 0.0 0.8 0.0 0.0 6.6 0.1 14.8 3.1 12.4 0.2 4.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 7.1 0.0 1.4 0.0 4.4 0.0 1.1 0.0 0.2 0.0 0.7 0.2 0.3 4.7 7.5 6.1 4.4 6.6 6.1 4.9 2.7 17.7 4.6 17.9 12.6 5.4 1.1 0.0 19.2 34.4 10.2 245.0 47.8 19.2 66.8 0.1 3.3 7.5 72.9 1.3 0.0 0.0 4.4 2.7 0.3 0.2 1.1 0.0 0.2 1.6 8.7 0.0 0.0 113.1 4.0 0.4 0.0 0.0 1.3 30.6 4.5 0.0 15.9 11.9 83.4 0.0 0.2 126.9 25.1 0.0 0.0 0.0 2.9 0.0 SURF2 ENSG00000148291 "Surfeit 2" Q15527 9 133356552-133361169 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 50.1" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 358.5;Late spermatids: 675.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 43.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044340, HPA052213, HPA059710" Approved Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" No No "Nucleoli, Nucleoli rim" Nucleoplasm "HPA044340: AB_2678900, HPA052213: AB_2681763, HPA059710: " "unprognostic (1.53e-1)" "unprognostic (6.10e-3)" "unprognostic (1.24e-3)" "unprognostic (2.25e-2)" "unprognostic (2.50e-1)" "unprognostic (6.27e-2)" "unprognostic (1.92e-2)" "unprognostic (2.01e-1)" "unprognostic (1.05e-1)" "unprognostic (1.85e-1)" "unprognostic (5.46e-3)" "unprognostic (8.28e-2)" "unprognostic (1.07e-3)" "unprognostic (1.09e-2)" "unprognostic (3.15e-2)" "unprognostic (1.12e-1)" "unprognostic (2.86e-1)" 8.3 9.2 15.8 9.0 13.2 8.2 10.7 13.1 14.5 5.7 8.8 7.4 10.8 13.2 6.4 12.0 11.0 10.7 11.2 8.9 13.4 11.0 14.3 12.0 6.5 12.1 13.1 8.7 9.0 17.5 7.1 11.3 5.9 10.3 7.7 5.7 7.7 14.2 8.8 11.5 14.8 11.4 6.9 9.4 8.6 9.3 50.1 6.6 10.6 10.1 14.9 9.8 6.5 8.3 17.5 15.6 13.1 16.2 13.2 26.9 14.1 7.2 12.5 5.3 6.5 3.8 3.0 11.1 3.7 3.3 5.9 3.1 17.1 6.0 7.2 5.4 2.4 5.1 19.9 8.3 9.0 2.7 6.9 11.5 5.7 14.3 6.3 7.7 9.3 4.3 3.6 10.7 8.4 12.4 2.1 2.7 8.9 9.0 5.0 4.0 43.6 9.6 6.2 16.6 17.4 24.2 10.7 7.9 16.9 5.0 8.3 19.7 9.9 8.2 13.8 11.0 3.4 14.7 4.4 5.1 9.0 9.1 9.2 13.1 6.2 12.3 7.8 5.7 5.6 9.0 13.1 16.2 12.0 17.8 16.2 23.1 15.6 21.9 20.2 13.8 17.5 20.8 19.7 7.1 13.2 11.6 15.6 26.9 14.1 15.8 13.2 13.1 14.5 13.4 11.0 13.1 8.7 10.3 6.6 11.9 7.8 21.6 25.7 74.8 17.9 12.4 45.9 48.2 17.0 21.0 2.0 33.0 89.5 56.4 358.5 19.4 48.7 0.0 70.1 21.0 22.4 21.1 9.2 21.5 25.8 12.7 35.1 20.3 25.9 675.3 24.2 22.4 40.5 27.9 17.1 13.2 50.2 28.1 23.0 64.0 18.9 64.7 32.0 140.5 86.5 77.0 21.4 26.1 23.8 17.8 SYCE3 C22orf41 ENSG00000217442 "Synaptonemal complex central element protein 3" A1L190 22 50551112-50562905 "Predicted intracellular proteins" "Cell cycle, Cell division, Meiosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 61.5" "Group enriched" "Detected in many" 6 "Early spermatids: 349.3;Spermatocytes: 429.3;Spermatogonia: 109.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 4 "neutrophil: 8.0" "Lineage enriched" "Detected in many" 4 "granulocytes: 8.0" "Cell line enhanced" "Detected in many" "CAPAN-2: 8.8;Karpas-707: 7.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA047813 Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA "Nucleoplasm, Nucleoli, Golgi apparatus" "HPA047813: AB_2797234" "unprognostic (2.55e-1)" "unprognostic (2.52e-1)" "unprognostic (2.06e-2)" "unprognostic (2.64e-1)" "unprognostic (1.33e-1)" "unprognostic (1.63e-1)" "unprognostic (1.73e-2)" "unprognostic (2.22e-1)" "unprognostic (2.98e-3)" "unprognostic (1.68e-2)" "unprognostic (4.05e-2)" "unprognostic (3.43e-2)" "unprognostic (4.81e-2)" "unprognostic (2.57e-1)" "unprognostic (1.60e-1)" "unprognostic (1.55e-2)" "unprognostic (5.20e-2)" 0.4 0.4 0.7 0.5 0.9 0.1 0.7 0.2 0.6 0.2 0.4 0.5 0.4 0.1 0.2 1.1 0.2 0.8 0.6 0.1 0.5 0.7 1.0 0.8 0.4 0.9 0.9 0.3 0.1 0.2 0.2 0.4 0.4 0.7 0.1 0.0 0.2 0.7 0.1 0.0 0.2 0.0 0.5 0.7 0.1 0.2 61.5 0.4 0.0 1.1 0.2 0.3 0.7 0.0 0.5 1.9 8.0 1.3 0.0 0.3 0.3 0.4 0.7 0.1 0.3 0.6 0.5 0.4 0.5 0.0 0.0 0.0 0.0 8.8 0.4 3.2 0.0 1.8 0.0 0.9 1.0 0.0 0.0 0.5 0.0 0.6 0.0 4.0 0.0 1.6 2.3 2.0 0.3 1.4 0.5 0.0 1.8 0.0 7.4 0.4 3.3 0.0 0.0 0.3 3.7 0.0 0.0 0.0 3.9 1.2 2.6 0.8 2.3 0.0 2.2 1.4 0.3 2.1 1.8 0.0 0.7 0.8 0.0 0.1 1.9 0.4 1.1 0.9 0.3 0.2 0.0 1.3 1.5 0.0 1.1 0.3 0.0 0.0 0.0 1.9 0.5 0.0 0.2 8.0 0.0 0.9 0.0 0.0 0.3 0.7 0.9 0.2 0.6 0.5 0.7 0.9 0.3 0.7 0.4 0.0 0.0 0.0 0.4 0.1 0.5 0.4 5.1 0.0 0.0 1.8 0.0 4.2 3.3 1.3 349.3 0.1 0.3 0.0 0.6 2.6 0.1 0.3 0.0 1.6 1.4 0.0 0.0 0.6 1.2 52.2 10.0 0.0 0.0 4.6 0.0 0.9 1.2 0.0 6.7 2.1 0.4 45.3 0.0 429.3 109.7 0.1 3.1 0.0 0.3 0.9 SYDE2 FLJ13815 ENSG00000097096 "Synapse defective Rho GTPase homolog 2" Q5VT97 1 85156873-85201046 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 15 "Alveolar cells type 1: 47.6;Cone photoreceptor cells: 51.1;Rod photoreceptor cells: 133.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BEWO: 16.4;SK-BR-3: 8.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027138, HPA058378" Uncertain Approved "Nucleoli,Nucleoli rim,Golgi apparatus" No No "Nucleoli, Nucleoli rim, Golgi apparatus" "HPA027138: AB_1857686, HPA058378: AB_2683696" "unprognostic (1.68e-1)" "unprognostic (8.90e-2)" "unprognostic (2.34e-2)" "unprognostic (3.43e-3)" "unprognostic (2.50e-1)" "unprognostic (6.98e-2)" "unprognostic (3.84e-3)" "unprognostic (6.47e-3)" "unprognostic (4.39e-2)" "unprognostic (1.85e-1)" "unprognostic (3.88e-2)" "unprognostic (4.05e-1)" "unprognostic (2.96e-3)" "unprognostic (1.57e-1)" "unprognostic (8.76e-2)" "unprognostic (7.51e-2)" "unprognostic (6.69e-2)" 2.5 1.8 1.1 2.6 1.7 0.6 3.8 0.6 2.2 3.5 11.4 0.5 2.0 2.5 3.8 2.6 5.6 2.3 7.7 5.4 2.8 0.9 4.7 6.4 9.1 3.4 0.9 2.4 3.3 9.9 8.4 5.1 5.0 0.9 5.0 2.6 7.2 3.9 2.5 2.4 1.9 9.2 13.3 0.9 1.0 6.0 3.3 1.0 0.6 5.2 1.0 0.8 6.0 9.6 0.3 0.1 1.4 0.1 0.3 0.7 0.2 2.2 0.7 0.7 0.8 2.5 0.8 16.4 2.5 1.6 1.5 2.4 4.3 0.8 0.0 0.8 1.6 3.0 4.3 8.1 1.1 2.4 0.9 2.3 2.0 1.7 1.5 3.0 1.3 0.5 1.1 1.3 1.2 1.1 1.0 0.3 1.5 2.5 0.0 1.2 3.1 1.3 0.2 4.2 1.7 0.9 0.0 4.4 0.5 1.2 5.7 0.1 0.0 1.8 8.9 2.6 3.9 2.0 1.8 0.3 1.9 4.3 0.0 2.5 0.0 0.3 0.9 0.2 0.9 1.7 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.6 0.1 0.0 0.3 0.7 0.3 1.4 0.3 0.0 0.1 0.0 0.2 1.1 1.7 0.6 2.2 2.8 0.9 0.9 2.4 0.9 1.0 47.6 7.7 0.0 8.1 7.3 4.6 21.2 2.5 2.7 10.3 1.8 51.1 7.9 6.6 1.6 2.4 1.8 3.3 0.0 4.0 3.8 5.4 4.5 1.1 6.0 1.3 0.0 18.5 3.1 0.3 0.9 2.0 1.4 18.6 2.8 3.3 6.4 3.2 0.0 2.5 4.6 133.9 0.0 2.0 11.5 7.2 4.0 2.2 2.2 3.7 3.8 TACSTD2 "EGP-1, GA733-1, M1S1, TROP2" ENSG00000184292 "Tumor associated calcium signal transducer 2" P09758 1 58575423-58577773 "Disease related genes, Predicted membrane proteins" "Sensory transduction, Vision" "Tumor antigen" "Amyloidosis, Corneal dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 103.9;salivary gland: 56.4" "Cell type enhanced" "Detected in many" 15 "Basal glandular cells: 5162.0;Glandular cells: 2977.4;Urothelial cells: 7434.9" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "eosinophil: 12.4" "Group enriched" "Detected in many" 65 "dendritic cells: 3.7;granulocytes: 12.4;monocytes: 3.2" "Cell line enhanced" "Detected in some" "A-431: 75.7;CAPAN-2: 102.7;HaCaT: 102.9;RT4: 35.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043104, HPA055067, CAB072852" Enhanced Supported "Nucleoli,Vesicles,Plasma membrane" NA NA "Plasma membrane" "Nucleoli, Vesicles" "CAB072852: , HPA043104: AB_10960710, HPA055067: AB_2682687" "unprognostic (1.80e-2)" "unprognostic (3.08e-1)" "unprognostic (3.67e-3)" "unprognostic (1.22e-1)" "unprognostic (5.70e-2)" "unprognostic (2.15e-2)" "unprognostic (1.19e-1)" "unprognostic (1.79e-1)" "unprognostic (1.99e-1)" "unprognostic (1.03e-2)" "unprognostic (1.71e-2)" "unprognostic (7.91e-2)" "prognostic favorable (3.99e-4)" "unprognostic (7.10e-2)" "unprognostic (2.55e-1)" "unprognostic (6.91e-3)" "unprognostic (2.50e-1)" 0.0 0.0 0.0 0.0 0.0 0.7 17.1 0.0 0.0 23.1 0.0 0.0 1.7 2.6 103.9 2.7 0.9 0.0 0.0 0.0 10.4 0.0 8.0 0.0 0.0 0.0 9.0 0.0 0.0 1.5 15.7 0.0 56.4 12.6 0.0 42.1 0.0 0.0 0.0 0.0 7.3 0.0 0.1 20.6 17.7 36.1 0.0 3.7 12.4 3.2 0.0 0.0 1.8 75.7 0.0 0.0 0.1 0.0 0.0 29.0 0.0 0.0 0.0 0.0 0.0 102.7 0.0 9.9 6.4 0.0 102.9 0.0 18.8 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 28.2 0.0 1.1 0.0 4.3 0.0 0.0 0.1 0.0 16.3 0.0 0.1 0.0 16.7 0.1 0.0 0.0 0.0 13.8 35.5 0.0 0.0 3.3 27.4 0.1 0.3 17.9 0.1 4.6 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.2 12.4 0.0 0.1 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 1.8 321.6 110.2 1.3 5162.0 1324.0 0.0 0.3 287.9 277.1 312.8 1212.6 0.0 74.9 36.5 1546.3 0.0 14.3 0.4 0.0 1122.5 4.7 23.0 2977.4 8.1 0.6 7.6 0.0 0.0 0.6 0.3 0.0 0.0 32.3 108.0 54.1 2.9 0.0 1294.2 4.0 0.0 3.3 0.0 0.0 47.2 0.5 0.9 1339.0 65.6 0.0 0.9 7434.9 TAOK2 "KIAA0881, MAP3K17, PSK, PSK1, TAO1, TAO2" ENSG00000149930 "TAO kinase 2" Q9UL54 16 29973641-29992261 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Ito cells: 44.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010650 Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Cytosol" Nucleoli "HPA010650: AB_1080204" "unprognostic (7.30e-2)" "unprognostic (1.78e-1)" "prognostic unfavorable (2.51e-4)" "prognostic favorable (3.87e-5)" "unprognostic (8.46e-2)" "unprognostic (2.14e-3)" "unprognostic (6.08e-2)" "unprognostic (1.12e-3)" "unprognostic (1.01e-2)" "unprognostic (1.60e-1)" "prognostic favorable (4.78e-4)" "unprognostic (3.85e-3)" "prognostic favorable (3.66e-4)" "unprognostic (7.42e-3)" "unprognostic (3.17e-1)" "unprognostic (7.47e-2)" "unprognostic (1.37e-1)" 27.8 24.1 26.2 15.1 26.7 12.3 17.7 29.2 30.6 13.5 13.6 21.5 11.8 18.5 16.8 13.0 12.4 14.1 15.1 17.6 25.0 18.2 13.9 10.4 23.0 14.4 22.1 22.7 15.8 16.3 26.2 18.7 22.5 20.7 13.6 9.6 15.0 17.1 15.9 22.8 20.0 19.3 14.8 14.9 26.3 16.0 21.2 20.2 14.0 15.9 9.8 11.5 12.8 18.0 2.6 3.3 4.8 2.8 2.0 3.2 2.0 11.2 21.5 11.8 18.6 13.9 9.3 18.1 20.7 11.1 14.0 13.1 17.2 15.1 12.2 17.6 14.9 9.4 17.6 10.7 10.4 7.6 18.9 22.7 13.1 21.7 17.2 10.1 12.9 25.3 10.9 9.1 14.9 6.0 9.8 23.4 11.7 11.8 12.4 13.3 20.8 15.0 18.3 11.4 8.4 14.5 27.7 17.1 11.3 8.8 10.6 13.9 11.2 11.8 15.8 6.2 7.9 19.8 14.6 32.6 24.2 11.2 17.1 11.9 18.1 11.6 11.5 14.8 14.8 17.6 1.3 2.8 1.5 2.9 2.7 3.1 2.0 2.9 2.6 1.8 2.6 1.6 1.4 4.8 2.0 1.4 3.3 3.2 2.0 26.2 26.7 29.2 30.6 25.0 18.2 22.1 22.7 20.7 20.2 8.9 11.5 2.2 4.2 9.5 13.3 8.1 5.1 4.0 7.9 8.7 37.3 6.7 1.7 7.6 3.1 27.6 23.3 0.0 10.2 4.8 9.3 5.8 3.5 9.7 8.4 9.5 12.6 44.2 12.4 2.1 11.5 5.5 6.8 4.6 14.9 8.7 12.7 14.2 12.0 6.4 19.2 6.5 7.6 21.1 17.2 8.4 10.1 9.2 13.3 5.7 TAS2R5 T2R5 ENSG00000127366 "Taste 2 receptor member 5" Q9NYW4 7 141790217-141791367 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 8.8" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTCEpi: 10.6" HPA053742 Approved "Nucleoplasm,Nucleoli,Cytoplasmic bodies" NA NA "Nucleoplasm, Nucleoli" "Cytoplasmic bodies" "HPA053742: " "unprognostic (5.48e-3)" "unprognostic (3.90e-3)" "unprognostic (6.07e-2)" "unprognostic (8.00e-3)" "unprognostic (7.56e-2)" "unprognostic (4.87e-2)" "unprognostic (1.90e-1)" "unprognostic (1.71e-1)" "unprognostic (2.65e-2)" "unprognostic (1.67e-1)" "unprognostic (3.13e-5)" "unprognostic (1.13e-2)" "unprognostic (8.29e-7)" "unprognostic (1.29e-1)" "unprognostic (3.28e-1)" "unprognostic (6.92e-2)" "unprognostic (1.39e-2)" 1.0 1.0 0.4 1.4 1.1 0.2 3.2 4.9 0.7 2.5 0.9 0.8 2.8 6.1 1.1 3.0 0.8 0.8 0.6 0.7 1.0 0.5 1.1 1.2 0.4 4.6 1.5 0.1 2.9 1.0 1.7 1.2 1.6 1.0 2.6 8.8 1.7 1.2 1.2 1.9 0.7 1.4 1.7 1.2 1.3 2.4 1.0 0.6 0.5 0.2 0.4 1.4 0.1 0.5 0.2 1.4 0.6 0.9 2.7 1.7 0.6 0.6 0.5 0.9 2.1 0.4 1.1 0.9 0.3 0.0 0.3 1.5 0.8 0.3 0.6 1.7 0.3 1.2 2.7 0.9 1.7 1.3 2.3 10.6 1.2 2.9 3.0 1.0 1.5 2.6 0.4 0.1 1.7 0.6 3.9 1.3 0.2 0.3 0.2 0.1 2.8 0.4 0.7 2.0 1.3 0.3 0.4 0.2 1.7 0.1 0.4 0.3 1.0 0.7 0.6 1.2 1.9 0.4 1.4 0.8 0.8 0.5 0.5 0.2 0.0 1.0 0.0 0.0 0.9 0.3 0.4 0.0 1.0 0.9 1.4 0.0 0.4 0.0 0.6 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TGDS "SDR2E1, TDPGD" ENSG00000088451 "TDP-glucose 4,6-dehydratase" O95455 13 94574051-94596257 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Lyase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 42.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039927, HPA040857" Approved Approved Nucleoplasm,Nucleoli,Cytosol Yes No Nucleoplasm "Nucleoli, Cytosol" "HPA039927: AB_10795238, HPA040857: AB_10794867" "unprognostic (4.07e-2)" "unprognostic (3.56e-1)" "unprognostic (2.66e-2)" "unprognostic (2.76e-1)" "unprognostic (1.27e-1)" "unprognostic (2.25e-2)" "unprognostic (1.60e-1)" "unprognostic (2.87e-1)" "unprognostic (9.99e-2)" "unprognostic (1.96e-1)" "unprognostic (9.17e-2)" "prognostic unfavorable (2.48e-4)" "unprognostic (5.51e-2)" "unprognostic (1.13e-2)" "unprognostic (2.26e-1)" "unprognostic (1.71e-2)" "unprognostic (1.09e-1)" 11.1 12.2 7.9 11.4 11.8 5.8 13.4 8.0 7.8 11.9 9.0 9.0 13.4 11.1 13.7 13.2 10.3 10.5 8.7 7.7 7.0 7.0 11.8 31.9 7.8 12.5 11.8 6.8 13.9 14.1 6.2 24.3 10.8 10.1 10.5 10.6 15.4 12.5 12.7 7.6 7.9 11.1 10.3 12.6 11.9 9.8 7.2 12.6 27.1 15.8 8.9 12.5 10.9 9.2 9.9 8.0 10.5 7.0 10.4 17.4 6.7 7.4 3.1 5.2 4.7 7.7 6.2 6.5 6.8 6.5 6.4 6.2 8.5 7.3 11.4 6.9 4.7 4.2 4.7 9.2 5.3 6.6 9.0 3.6 9.2 3.6 7.9 9.8 31.4 6.3 7.2 4.2 3.6 10.3 5.1 5.9 8.4 9.0 4.0 5.8 4.5 8.6 16.2 6.9 12.0 4.0 7.3 5.3 6.7 8.1 3.3 7.4 4.1 5.1 10.8 19.0 9.1 4.8 17.1 5.5 2.6 6.8 3.9 5.6 9.1 4.9 42.1 7.0 11.7 7.0 10.5 5.3 9.6 9.6 6.2 14.5 9.9 11.3 10.5 8.0 7.3 17.4 12.4 1.5 10.4 7.0 7.1 12.5 6.7 7.9 11.8 8.0 7.8 7.0 7.0 11.8 6.8 10.1 12.6 11.9 5.0 15.6 9.5 2.2 4.5 4.7 0.0 10.7 10.3 7.0 2.0 12.9 8.3 9.8 1.1 6.3 5.5 0.0 8.0 15.4 12.0 9.9 10.5 19.8 10.0 1.6 5.2 9.2 7.6 0.4 13.3 9.6 8.5 12.6 8.1 6.3 8.2 7.0 7.8 13.3 4.0 25.8 6.4 12.0 10.4 3.1 8.7 8.7 8.0 8.7 THAP3 ENSG00000041988 "THAP domain containing 3" Q8WTV1 1 6624866-6635586 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067114 Approved Approved Nucleoplasm,Nucleoli,Mitochondria No No Nucleoplasm "Nucleoli, Mitochondria" "HPA067114: AB_2685782" "unprognostic (1.82e-2)" "unprognostic (9.63e-2)" "prognostic unfavorable (1.33e-4)" "unprognostic (2.89e-2)" "unprognostic (2.87e-1)" "unprognostic (1.61e-1)" "unprognostic (2.14e-3)" "unprognostic (1.13e-1)" "unprognostic (2.70e-1)" "unprognostic (4.63e-2)" "unprognostic (3.50e-3)" "unprognostic (4.30e-2)" "unprognostic (1.11e-2)" "unprognostic (4.51e-2)" "unprognostic (1.08e-1)" "unprognostic (2.67e-1)" "unprognostic (2.26e-3)" 14.2 17.2 16.4 11.4 16.8 12.9 31.4 21.5 20.3 16.5 16.6 13.8 11.8 12.0 15.2 13.6 11.8 16.3 11.9 19.0 16.0 14.5 17.2 17.3 10.8 15.5 18.1 14.1 23.7 28.8 12.1 14.2 11.4 17.6 17.0 7.2 11.5 24.8 16.7 20.9 14.2 11.4 12.7 13.0 15.3 12.0 11.9 16.3 11.6 22.6 9.0 12.9 17.2 21.6 22.2 18.0 10.6 14.7 17.0 22.0 15.0 9.9 9.4 8.6 12.4 14.3 12.9 8.3 9.0 11.8 24.0 15.0 12.6 6.3 8.8 12.2 9.9 8.9 7.9 13.6 8.0 8.4 15.1 22.3 10.1 12.6 11.2 17.9 7.1 10.5 12.0 10.3 15.1 13.3 14.7 10.3 15.5 10.2 11.4 8.8 6.9 12.4 16.2 7.4 11.7 16.0 11.9 10.5 12.7 10.7 2.4 11.4 12.9 11.0 15.2 20.8 7.5 9.7 12.9 9.3 12.8 7.7 8.7 14.0 12.9 13.7 11.6 10.8 15.4 7.2 10.2 14.7 10.6 20.1 11.7 20.2 17.1 19.7 20.8 18.0 22.2 22.0 18.5 9.0 17.0 9.1 16.4 19.3 15.0 16.4 16.8 21.5 20.3 16.0 14.5 18.1 14.1 17.6 16.3 0.0 6.9 9.8 10.6 12.5 10.9 5.6 7.6 14.7 3.4 8.7 5.9 12.9 16.6 9.6 5.3 14.0 11.6 23.3 9.0 15.6 14.6 13.0 5.7 10.0 13.4 4.8 7.5 10.4 13.2 2.3 17.3 8.3 10.1 22.6 7.7 9.8 9.8 8.4 21.9 15.1 6.9 12.9 20.6 8.1 16.0 12.9 13.7 9.2 11.5 13.7 TICAM1 "MGC35334, PRVTIRB, TICAM-1, TRIF" ENSG00000127666 "Toll like receptor adaptor molecule 1" Q8IUC6 19 4815932-4831704 "Disease related genes, Predicted intracellular proteins" "Antiviral defense, Apoptosis, Host-virus interaction, Immunity, Inflammatory response, Innate immunity" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Urothelial cells: 129.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA042460 Uncertain Uncertain "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Nucleoplasm, Nucleoli" "Plasma membrane" "HPA042460: AB_10806240" "unprognostic (2.09e-2)" "unprognostic (1.48e-1)" "unprognostic (1.86e-2)" "prognostic favorable (4.81e-4)" "unprognostic (3.52e-2)" "unprognostic (2.88e-2)" "unprognostic (7.60e-3)" "prognostic unfavorable (3.48e-4)" "unprognostic (9.86e-2)" "unprognostic (1.59e-1)" "unprognostic (6.16e-2)" "unprognostic (2.82e-1)" "unprognostic (4.43e-2)" "unprognostic (2.30e-2)" "unprognostic (5.02e-2)" "unprognostic (3.53e-2)" "unprognostic (6.48e-2)" 10.5 6.9 7.3 9.4 9.5 18.2 9.4 5.9 15.8 10.2 15.4 7.0 3.4 20.3 8.3 5.2 35.6 8.0 11.4 7.7 5.9 5.4 11.0 15.2 14.1 9.0 6.4 6.1 8.0 14.8 4.2 7.8 6.8 7.1 8.2 5.2 6.1 11.8 5.7 15.3 15.8 21.3 5.2 6.5 11.6 15.2 2.8 6.5 4.4 8.5 12.1 21.7 9.3 13.3 5.3 5.0 7.8 9.1 1.5 3.1 5.4 21.3 4.2 0.0 3.7 3.2 4.1 2.0 7.0 7.3 5.7 6.4 4.3 7.7 14.6 4.0 8.1 5.7 14.6 2.0 7.4 2.2 15.6 3.9 3.6 8.5 4.1 9.0 1.3 9.5 6.6 9.3 7.1 5.2 4.4 5.9 5.1 7.8 3.1 3.1 8.0 3.6 0.7 0.6 3.8 16.9 8.1 0.9 9.5 5.1 6.7 2.9 5.5 4.3 13.1 7.2 0.0 5.9 3.0 11.6 7.0 4.8 17.6 10.6 12.7 11.1 10.1 8.1 5.0 5.3 7.8 5.3 2.3 2.6 7.8 2.4 5.3 2.6 3.0 5.0 4.0 1.7 1.0 1.6 1.5 9.1 3.6 3.1 5.4 7.3 9.5 5.9 15.8 5.9 5.4 6.4 6.1 7.1 6.5 6.0 11.1 7.8 63.8 61.6 0.7 2.1 17.8 4.0 9.1 5.2 0.0 5.3 6.6 27.1 0.0 10.5 58.5 0.0 15.3 9.5 9.3 51.3 10.4 12.5 12.1 1.6 28.0 11.1 8.6 0.0 3.4 18.8 13.5 23.4 15.2 0.8 36.4 38.6 4.9 7.0 0.2 6.5 8.9 0.3 1.1 62.2 2.9 7.9 11.0 129.1 TIFA "MGC20791, T2BP, T6BP, TIFAA" ENSG00000145365 "TRAF interacting protein with forkhead associated domain" Q96CG3 4 112274542-112285903 "Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Syncytiotrophoblasts: 66.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 46.1;U-266/70: 28.9;U-698: 39.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA045889 Approved Approved Nucleoplasm,Nucleoli,Cytosol NA Yes "Nucleoplasm, Nucleoli" Cytosol "HPA045889: AB_10963785" "unprognostic (2.41e-2)" "unprognostic (2.47e-2)" "unprognostic (4.13e-2)" "unprognostic (3.23e-2)" "unprognostic (2.86e-1)" "unprognostic (4.98e-3)" "unprognostic (1.05e-1)" "unprognostic (2.25e-1)" "unprognostic (2.48e-2)" "unprognostic (2.14e-2)" "unprognostic (4.60e-3)" "unprognostic (5.26e-2)" "unprognostic (6.44e-3)" "unprognostic (1.52e-1)" "unprognostic (2.56e-1)" "unprognostic (2.99e-1)" "unprognostic (8.49e-3)" 5.7 6.4 3.3 16.7 3.8 19.2 7.4 6.1 4.5 7.0 3.9 2.0 8.4 3.4 3.6 2.3 14.3 4.0 4.2 7.9 4.7 2.1 4.1 14.6 6.7 22.9 5.4 1.6 9.2 32.2 4.1 3.3 7.4 3.9 6.6 3.7 5.4 21.3 4.5 4.0 9.0 8.7 4.7 4.0 20.3 7.1 3.0 4.8 12.5 14.8 7.8 23.2 7.2 7.3 23.2 7.0 11.3 3.8 9.1 17.7 6.1 7.0 1.8 2.6 4.4 3.2 2.6 5.3 5.6 10.6 3.6 6.1 0.9 6.3 21.5 4.6 2.2 5.3 2.1 3.6 4.3 7.5 17.4 2.1 2.1 4.3 2.0 2.2 6.7 2.9 3.5 2.4 3.8 4.2 6.1 5.6 6.0 2.1 46.1 4.7 3.5 11.8 3.7 0.5 4.3 2.3 20.6 6.7 14.3 7.9 4.8 6.1 6.3 4.5 9.5 2.2 1.2 4.0 9.7 4.2 5.7 6.7 4.7 4.4 28.9 26.5 39.8 5.3 4.5 4.1 2.9 3.8 2.0 6.3 2.7 10.3 21.2 11.7 11.0 7.0 23.2 5.4 6.6 11.3 9.1 3.2 6.5 17.7 6.1 3.3 3.8 6.1 4.5 4.7 2.1 5.4 1.6 3.9 4.8 17.9 20.6 34.4 9.9 18.9 1.0 14.1 10.2 6.7 11.4 12.2 0.0 42.8 16.6 12.7 0.0 14.5 5.8 0.0 21.2 17.8 22.6 27.2 3.5 8.5 16.0 0.0 8.6 4.9 10.7 0.0 8.3 11.2 32.1 6.4 7.0 11.3 12.9 3.6 10.3 6.3 0.6 6.5 13.4 0.9 3.0 22.7 66.4 27.3 6.5 10.7 TLDC1 KIAA1609 ENSG00000140950 "TBC/LysM-associated domain containing 1" Q6P9B6 16 84476421-84554033 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Cone photoreceptor cells: 115.8;Rod photoreceptor cells: 65.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 29.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041020 Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA Cytosol "Nucleoplasm, Nucleoli" "HPA041020: AB_10794184" "unprognostic (8.35e-3)" "unprognostic (4.27e-2)" "unprognostic (1.48e-1)" "unprognostic (5.45e-2)" "unprognostic (1.49e-2)" "unprognostic (3.39e-3)" "unprognostic (5.97e-4)" "prognostic unfavorable (1.03e-5)" "unprognostic (3.94e-1)" "unprognostic (2.85e-2)" "prognostic unfavorable (7.05e-5)" "unprognostic (2.92e-2)" "unprognostic (6.78e-3)" "unprognostic (9.87e-2)" "unprognostic (1.83e-1)" "unprognostic (1.56e-2)" "unprognostic (2.16e-2)" 5.5 4.9 7.6 7.1 10.7 1.8 7.3 8.1 11.5 8.1 7.1 6.3 5.2 6.0 14.0 8.8 24.4 6.9 6.5 4.7 6.3 4.5 7.6 5.1 6.4 6.1 5.0 9.4 8.7 5.2 11.3 4.4 15.8 10.7 7.8 7.8 12.9 7.7 6.1 4.5 11.0 9.3 10.7 4.0 5.4 6.8 8.1 3.4 8.3 7.6 6.5 10.0 10.4 12.1 3.3 2.7 13.6 3.5 3.1 8.7 2.6 14.7 10.4 9.1 4.9 4.2 7.4 4.3 10.9 9.8 11.3 3.3 5.9 17.9 2.0 5.9 21.0 8.3 16.5 2.5 29.3 14.9 1.1 2.2 1.6 5.1 5.1 5.2 1.2 5.1 5.1 12.7 10.5 13.9 9.2 4.7 5.9 2.7 2.5 7.6 3.5 1.1 1.2 2.8 7.7 3.6 4.5 2.3 0.7 10.0 8.3 3.0 2.1 9.9 7.1 4.9 10.0 10.2 2.0 11.5 7.9 3.6 4.2 4.5 2.0 3.5 5.4 4.7 0.6 2.7 13.6 3.1 4.4 3.8 2.7 3.7 3.3 6.8 5.5 2.7 2.7 7.6 4.7 3.1 3.1 3.5 0.8 8.7 2.6 7.6 10.7 8.1 11.5 6.3 4.5 5.0 9.4 10.7 3.4 3.0 4.5 2.7 8.9 2.1 14.1 3.3 5.1 8.1 6.8 12.2 115.8 28.9 5.0 15.5 1.4 5.8 13.6 0.0 7.5 8.8 5.1 7.2 4.7 1.5 7.3 4.8 2.9 5.5 4.8 1.2 7.5 2.7 3.3 10.8 4.5 8.1 14.4 7.0 5.3 6.1 65.7 0.0 5.1 4.6 3.9 3.0 39.4 3.2 4.8 20.0 TNNT2 "CMD1D, CMH2, CMPD2" ENSG00000118194 "Troponin T2, cardiac type" P45379 1 201359008-201377762 "Candidate cardiovascular disease genes, Disease related genes, Predicted intracellular proteins" "Muscle protein" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 241 "heart muscle: 679.2" "Cell type enriched" "Detected in many" 289 "Cardiomyocytes: 11884.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 18 "RH-30: 189.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB015371, HPA015774, HPA017888" Enhanced Uncertain "Nucleoplasm,Nucleoli,Focal adhesion sites" No No 50000 "Nucleoplasm, Nucleoli" "Focal adhesion sites" "CAB015371: AB_630390, HPA015774: AB_1858354, HPA017888: AB_1858355" "unprognostic (1.45e-1)" "unprognostic (2.74e-1)" "unprognostic (2.33e-4)" "unprognostic (1.85e-1)" "unprognostic (7.29e-2)" "unprognostic (1.79e-1)" "unprognostic (1.80e-1)" "unprognostic (1.24e-1)" "unprognostic (1.42e-1)" "unprognostic (2.91e-2)" "unprognostic (1.38e-1)" "unprognostic (8.63e-2)" "unprognostic (5.50e-3)" "unprognostic (2.94e-1)" "unprognostic (1.61e-1)" "unprognostic (4.76e-2)" "unprognostic (9.98e-2)" 0.1 0.3 0.1 0.1 0.7 0.0 0.8 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 1.2 679.2 0.9 0.0 1.9 0.0 0.7 0.3 0.1 1.1 0.1 0.3 0.0 0.2 0.7 0.1 0.7 0.0 0.0 0.2 0.1 2.0 1.3 0.0 2.8 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 2.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.1 0.0 0.0 0.4 0.5 0.0 0.0 189.8 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 10.5 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 2.1 0.9 0.0 0.1 1.1 0.1 0.0 3.0 4.0 0.0 1.1 3.1 1.0 11884.8 0.0 0.0 1.2 1.8 0.0 2.3 0.0 0.5 9.4 0.0 1.6 0.0 0.3 0.9 41.1 0.5 0.0 0.0 2.7 0.0 0.0 0.0 0.0 13.6 0.6 0.0 0.0 4.6 0.5 0.0 0.7 0.8 1.1 0.8 0.5 0.0 0.4 0.0 0.2 6.4 3.5 0.0 2.8 1.4 TOX4 "C14orf92, KIAA0737, LCP1" ENSG00000092203 "TOX high mobility group box family member 4" O94842 14 21476597-21499175 "Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Syncytiotrophoblasts: 222.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017880, HPA027551" Approved Approved Nucleoplasm,Nucleoli,Vesicles NA NA Nucleoplasm "Nucleoli, Vesicles" "HPA017880: AB_1845573, HPA027551: AB_10601701" "unprognostic (9.56e-2)" "unprognostic (2.54e-2)" "unprognostic (2.81e-1)" "unprognostic (7.46e-2)" "unprognostic (9.30e-2)" "unprognostic (1.23e-1)" "prognostic unfavorable (3.46e-4)" "unprognostic (8.05e-3)" "unprognostic (2.58e-1)" "unprognostic (5.00e-2)" "unprognostic (3.23e-2)" "unprognostic (2.94e-1)" "prognostic favorable (8.38e-5)" "unprognostic (1.84e-1)" "unprognostic (2.48e-1)" "unprognostic (9.03e-2)" "unprognostic (2.48e-3)" 16.5 15.1 18.0 13.4 24.7 18.8 16.9 19.9 29.8 19.8 17.3 21.0 10.9 12.7 18.9 16.2 21.8 15.6 14.7 19.2 17.0 18.4 14.3 15.8 15.8 13.7 19.3 15.9 17.0 17.0 23.2 15.5 21.3 25.3 15.6 15.9 16.0 19.7 19.2 46.0 20.2 20.0 20.5 17.3 14.7 16.9 18.0 13.3 19.5 17.7 16.6 21.6 18.2 14.4 18.4 23.7 34.1 19.9 19.1 21.4 17.6 13.1 14.0 11.7 11.0 17.0 16.3 15.6 12.8 25.3 27.3 26.4 13.5 16.0 8.0 9.0 21.0 21.8 16.0 19.1 19.7 35.0 14.1 7.7 8.9 9.5 18.7 22.0 16.5 14.7 21.2 20.4 21.4 20.6 18.7 19.3 15.3 11.0 13.8 19.4 11.2 16.2 9.1 6.5 19.7 22.1 14.6 12.1 9.3 12.7 16.8 10.8 11.1 12.6 13.5 11.0 16.2 12.8 6.3 12.6 13.8 13.0 12.4 11.2 18.2 19.6 18.0 6.7 8.0 14.6 25.2 19.6 27.0 17.3 19.9 18.6 17.0 15.3 16.2 17.7 18.4 16.4 17.9 34.1 19.1 17.7 23.7 21.4 17.6 18.0 24.7 19.9 29.8 17.0 18.4 19.3 15.9 25.3 13.3 62.5 50.7 37.3 55.5 77.5 75.7 44.9 30.6 56.2 53.4 43.6 27.5 65.5 53.0 41.6 55.4 48.4 49.5 0.0 45.0 53.5 45.5 50.9 59.0 40.3 38.8 39.7 66.1 33.2 39.0 26.6 45.1 51.1 37.1 54.1 38.1 47.5 41.6 40.7 41.4 44.0 47.2 32.3 52.0 104.2 54.7 77.7 222.3 66.1 37.7 58.6 TP53TG5 "C20orf10, CLG01, dJ453C12.5" ENSG00000124251 "TP53 target 5" Q9Y2B4 20 45372563-45407889 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 35.4" "Group enriched" "Detected in some" 98 "Early spermatids: 648.4;Late spermatids: 205.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CACO-2: 5.3" "Low region specificity" "Detected in all" "HPA041979, HPA058510, HPA077455" Enhanced Supported "Nucleoli,Nucleoli rim,Mitotic chromosome" NA NA "Nucleoli, Nucleoli rim" "Mitotic chromosome" "HPA041979: AB_2677778, HPA058510: , HPA077455: " "unprognostic (2.86e-1)" "unprognostic (1.28e-1)" "unprognostic (2.18e-1)" "unprognostic (3.40e-3)" "unprognostic (1.70e-1)" "unprognostic (1.63e-3)" "unprognostic (2.29e-3)" "unprognostic (3.10e-3)" "unprognostic (9.26e-2)" "unprognostic (3.56e-2)" "unprognostic (1.72e-5)" "unprognostic (2.09e-2)" "unprognostic (7.46e-2)" "unprognostic (1.48e-1)" "unprognostic (1.46e-1)" "unprognostic (4.72e-4)" "unprognostic (1.41e-1)" 0.1 0.1 0.2 0.2 2.0 0.8 0.1 0.1 1.5 0.1 0.1 1.9 0.0 0.0 0.1 0.5 0.1 0.1 0.3 0.2 0.4 0.1 0.1 0.1 0.1 0.4 4.1 1.0 0.2 0.1 0.0 0.1 0.0 1.2 0.1 0.0 0.0 0.2 0.0 0.2 0.3 0.3 0.0 0.8 0.2 0.2 35.4 2.1 0.0 0.3 0.0 0.0 0.1 0.1 0.3 0.4 0.3 0.1 0.0 1.1 0.0 1.0 2.0 1.1 3.1 0.0 0.0 1.0 0.5 0.0 0.0 0.0 5.3 0.9 0.8 0.8 0.0 0.7 2.1 0.0 0.0 0.0 0.3 0.9 1.2 2.5 1.6 0.0 1.5 1.2 0.0 0.0 0.0 0.0 0.7 0.0 1.2 1.1 0.4 0.0 1.4 1.0 0.9 0.3 0.8 0.8 0.0 0.6 0.7 0.0 1.2 1.3 1.0 2.8 1.2 0.7 0.4 3.0 0.3 2.0 3.9 1.2 2.4 0.7 0.9 1.0 0.1 2.0 0.7 1.2 0.0 0.1 0.0 0.3 0.1 1.1 0.0 0.3 0.0 0.1 0.3 0.3 0.4 0.3 0.0 0.1 0.4 0.2 0.0 0.2 2.0 0.1 0.9 0.4 0.1 4.1 1.0 1.2 2.1 0.0 0.0 0.0 0.5 0.1 0.6 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 648.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 205.9 4.4 0.0 0.0 0.0 0.1 0.0 0.0 0.3 4.2 0.0 1.0 0.0 1.7 1.8 2.0 1.0 0.0 0.0 0.0 0.8 TRA2A "AWMS1, htra-2-alpha, tra2a" ENSG00000164548 "Transformer 2 alpha homolog" Q13595 7 23504780-23532041 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054018 Uncertain Supported Nucleoplasm,Nucleoli,Vesicles NA NA Nucleoli "Nucleoplasm, Vesicles" "HPA054018: AB_2682344" "unprognostic (2.55e-2)" "unprognostic (2.16e-1)" "unprognostic (1.24e-1)" "unprognostic (6.77e-3)" "unprognostic (8.05e-2)" "unprognostic (3.41e-2)" "prognostic unfavorable (2.07e-5)" "unprognostic (1.28e-2)" "unprognostic (2.50e-2)" "unprognostic (4.64e-2)" "unprognostic (1.87e-3)" "unprognostic (6.04e-2)" "prognostic unfavorable (1.79e-6)" "unprognostic (1.46e-2)" "unprognostic (1.52e-2)" "unprognostic (8.74e-2)" "unprognostic (1.36e-3)" 23.4 29.4 27.8 29.5 34.1 70.6 27.4 38.1 27.5 30.3 22.9 29.0 31.6 19.8 32.7 34.5 29.4 25.9 17.6 18.7 28.6 29.3 21.3 21.8 28.6 32.2 35.8 18.5 36.8 27.4 14.9 46.6 24.4 28.2 26.4 30.1 23.7 21.9 26.7 15.7 31.6 22.6 35.2 30.4 33.8 21.1 25.9 37.3 35.6 24.7 20.5 38.0 25.0 31.8 15.5 23.9 20.4 23.0 14.7 21.7 8.2 19.3 21.4 33.3 52.1 17.9 11.3 21.5 24.7 11.7 24.8 20.5 17.6 26.6 36.6 14.3 18.3 29.6 32.2 39.9 23.0 31.3 22.0 23.3 22.4 23.7 27.8 18.7 26.1 21.1 13.3 15.9 18.7 23.5 22.5 28.2 16.3 43.5 18.0 28.1 18.9 31.5 43.8 29.9 24.0 22.2 36.1 26.3 21.9 28.7 28.0 28.9 23.5 23.1 26.7 16.5 25.7 21.0 29.4 25.4 19.8 28.3 18.1 28.6 20.1 25.1 30.0 17.0 35.6 26.3 11.5 14.9 18.5 21.7 23.0 18.7 15.5 20.3 19.8 16.8 14.4 17.7 20.9 20.4 14.7 20.4 23.9 20.0 8.2 27.8 34.1 38.1 27.5 28.6 29.3 35.8 18.5 28.2 37.3 56.6 68.2 70.3 85.9 92.7 49.7 37.0 48.4 77.6 60.3 83.7 49.1 76.6 21.6 48.0 48.5 63.2 67.9 70.0 38.1 71.1 87.2 68.2 83.3 62.7 48.6 35.0 113.5 70.0 86.5 17.7 60.1 73.9 54.0 60.5 57.4 42.4 49.0 80.7 63.6 32.1 101.0 71.1 79.3 92.3 54.5 98.9 98.6 97.5 61.7 73.5 TRIM60 "FLJ35882, RNF129, RNF33" ENSG00000176979 "Tripartite motif containing 60" Q495X7 4 165031953-165041744 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "placenta: 5.0;testis: 6.6" "Cell type enhanced" "Detected in some" 11 "Cytotrophoblasts: 4.8;Extravillous trophoblasts: 8.2;Spermatocytes: 3.8;Spermatogonia: 6.4;Syncytiotrophoblasts: 4.7" "Cancer enriched" "Detected in single" 103 "testis cancer: 5.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 8 "BEWO: 18.0" "Not detected" "Not detected" "HPA035809, HPA035810, HPA061496" Uncertain Uncertain Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA035809: AB_2674794, HPA035810: AB_10601827, HPA061496: AB_2684540" "unprognostic (1.10e-1)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.7 1.1 0.2 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.4 0.1 0.2 1.1 0.2 0.3 0.0 0.5 0.3 0.2 1.1 0.1 0.1 0.7 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.5 0.0 1.4 0.0 0.0 0.0 4.8 0.0 0.0 1.6 0.0 0.0 0.0 0.0 8.2 0.2 0.2 0.0 0.8 0.4 0.0 0.0 0.0 2.2 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.3 0.0 0.0 3.8 6.4 0.3 4.7 0.5 0.0 0.0 TSG101 "TSG10, VPS23" ENSG00000074319 "Tumor susceptibility 101" Q99816 11 18468336-18527232 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Growth regulation, Host-virus interaction, Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004283, HPA006161" Approved Supported "Nucleoli,Plasma membrane,Cytosol" NA NA 14000 Cytosol "Nucleoli, Plasma membrane" "CAB004283: AB_671392, HPA006161: AB_1080408" "unprognostic (1.42e-1)" "unprognostic (7.91e-2)" "unprognostic (2.11e-1)" "unprognostic (6.77e-2)" "unprognostic (1.82e-1)" "unprognostic (2.72e-3)" "prognostic unfavorable (3.74e-6)" "unprognostic (5.67e-2)" "unprognostic (2.08e-1)" "unprognostic (2.00e-2)" "unprognostic (4.15e-3)" "unprognostic (4.27e-2)" "prognostic favorable (5.52e-6)" "unprognostic (1.92e-2)" "unprognostic (1.02e-1)" "unprognostic (4.02e-3)" "unprognostic (1.06e-1)" 24.7 30.5 18.4 14.2 25.5 23.5 27.6 22.7 25.9 22.5 23.1 23.7 21.6 20.5 25.8 27.7 34.3 23.9 18.4 31.8 17.7 20.6 33.4 29.0 20.1 23.4 21.6 21.4 23.2 39.5 33.2 23.5 38.5 24.6 21.9 28.4 19.4 25.4 22.4 44.5 27.3 25.7 23.1 21.7 20.5 23.0 33.7 20.2 27.5 32.3 37.1 25.5 24.2 25.5 20.5 18.2 42.3 29.2 14.3 22.0 22.2 14.4 23.8 21.1 14.6 25.0 26.2 19.7 22.4 30.3 27.5 27.2 16.3 7.6 19.5 13.8 25.0 29.6 22.2 21.0 20.3 30.5 27.4 25.7 12.1 12.6 24.0 32.2 18.1 20.9 22.6 41.4 14.3 39.0 29.0 22.5 18.9 19.6 16.6 33.2 26.0 11.4 19.7 13.0 31.3 24.2 10.3 21.4 16.2 18.4 20.6 15.1 27.0 21.5 18.1 28.6 22.1 18.0 18.2 12.1 18.5 11.3 38.4 16.6 10.7 20.5 15.5 19.0 10.1 23.5 42.3 19.5 40.7 14.9 21.7 15.0 20.5 14.4 15.9 18.2 18.0 15.4 16.4 34.5 14.3 29.2 15.4 22.0 22.2 18.4 25.5 22.7 25.9 17.7 20.6 21.6 21.4 24.6 20.2 59.6 51.0 42.1 71.0 37.8 39.6 60.3 56.0 107.1 37.5 41.8 23.6 165.8 106.1 92.2 31.6 49.6 64.6 46.7 89.0 89.6 50.5 62.3 42.8 34.8 70.2 35.0 59.1 46.6 42.2 12.6 52.0 49.4 54.0 107.4 58.3 78.3 101.0 58.3 40.7 95.2 33.9 45.3 45.3 142.6 153.8 42.3 247.6 44.5 43.7 75.7 TSPYL6 ENSG00000178021 "TSPY like 6" Q8N831 2 54253184-54256272 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 54 "testis: 41.1" "Group enriched" "Detected in some" 9 "Spermatocytes: 27.4;Spermatogonia: 22.4" "Cancer enriched" "Detected in single" 27 "testis cancer: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 66 "K-562: 13.4" "HPA034699, HPA034700" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA034699: AB_2674288, HPA034700: AB_10670159" "unprognostic (8.21e-2)" "unprognostic (4.25e-1)" "unprognostic (1.06e-2)" "unprognostic (1.00e-1)" "unprognostic (5.54e-6)" "unprognostic (4.50e-2)" "unprognostic (1.77e-1)" "unprognostic (5.73e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 41.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 13.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 27.4 22.4 0.0 0.0 0.0 0.0 0.0 TSSK3 "SPOGA3, STK22C" ENSG00000162526 "Testis specific serine kinase 3" Q96PN8 1 32351521-32364312 "Enzymes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "testis: 68.1" "Group enriched" "Detected in some" 52 "Early spermatids: 242.3;Late spermatids: 839.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HeLa: 9.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA037516 Approved "Nucleoplasm,Nucleoli,Nuclear bodies" NA NA "Nucleoplasm, Nucleoli" "Nuclear bodies" "HPA037516: AB_2675517" "unprognostic (5.71e-2)" "unprognostic (1.42e-1)" "unprognostic (2.32e-1)" "unprognostic (1.37e-1)" "unprognostic (7.69e-2)" "unprognostic (2.02e-4)" "unprognostic (2.06e-1)" "unprognostic (1.98e-3)" "unprognostic (2.05e-2)" "unprognostic (1.11e-1)" "unprognostic (1.46e-2)" "unprognostic (9.20e-2)" "unprognostic (1.02e-3)" "unprognostic (1.11e-2)" "unprognostic (1.51e-1)" "unprognostic (1.88e-1)" "unprognostic (2.68e-3)" 1.1 2.0 0.8 1.7 0.8 8.2 1.1 3.9 0.8 1.3 0.9 0.8 1.4 2.5 1.8 2.9 0.8 1.3 1.0 0.9 0.8 0.0 0.9 1.3 1.4 2.4 0.8 0.8 2.0 1.2 0.0 0.8 0.8 1.0 1.0 0.0 0.8 1.4 0.8 1.7 3.4 2.9 0.8 0.8 3.4 1.2 68.1 0.8 0.8 1.3 0.8 0.8 0.9 1.1 0.6 0.1 0.1 0.7 0.3 2.3 0.1 2.3 2.3 6.0 3.5 0.0 1.2 5.4 0.7 1.1 0.0 0.0 0.5 1.2 1.2 0.9 0.0 1.0 3.7 0.0 0.0 0.0 3.5 7.2 2.7 9.8 3.7 4.4 1.1 3.4 0.1 0.9 0.0 1.3 6.3 0.0 4.6 3.1 5.8 0.0 0.6 1.4 1.5 1.5 0.4 1.2 1.9 1.7 4.4 0.0 1.9 1.8 3.8 0.8 2.8 4.1 4.4 1.9 2.7 2.9 2.1 3.4 3.0 2.4 8.5 2.8 1.8 3.7 3.9 0.5 0.0 0.1 0.0 1.1 0.7 0.0 0.0 0.2 0.0 0.1 0.6 2.3 0.9 0.1 0.3 0.5 0.0 0.0 0.1 0.8 0.8 3.9 0.8 0.8 0.0 0.8 0.8 1.0 0.8 0.0 0.3 0.0 0.4 0.1 0.1 0.3 0.0 1.4 0.0 0.0 0.0 0.2 0.0 0.2 242.3 0.0 0.0 0.0 0.6 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.6 0.0 839.4 8.6 0.0 0.0 0.0 0.3 0.9 0.2 0.0 8.9 0.6 1.4 6.5 0.0 10.3 3.8 0.0 0.2 0.0 0.2 0.2 TTC3 "DCRR1, RNF105, TPRD, TPRDI, TPRDII, TPRDIII" ENSG00000182670 "Tetratricopeptide repeat domain 3" P53804 21 37073226-37203112 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016810, HPA023964, HPA036304" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol No No "Nucleoplasm, Nucleoli" Cytosol "HPA016810: AB_1858434, HPA023964: AB_1858435, HPA036304: AB_2675049" "unprognostic (3.90e-2)" "unprognostic (1.65e-1)" "unprognostic (1.19e-1)" "unprognostic (1.22e-1)" "unprognostic (1.53e-1)" "unprognostic (1.37e-2)" "unprognostic (8.52e-2)" "unprognostic (9.29e-2)" "unprognostic (8.71e-2)" "unprognostic (1.61e-1)" "unprognostic (2.05e-2)" "unprognostic (1.99e-1)" "unprognostic (9.10e-2)" "unprognostic (1.02e-1)" "unprognostic (1.60e-1)" "unprognostic (1.39e-1)" "unprognostic (6.74e-2)" 22.9 22.1 34.0 18.7 36.5 12.0 23.4 39.2 40.0 34.9 20.6 15.9 26.7 13.0 21.6 33.3 15.3 19.5 19.0 21.5 29.1 16.5 21.4 17.0 15.4 14.3 17.7 27.5 34.5 25.8 27.4 50.4 15.2 34.7 28.9 19.9 16.1 24.5 25.4 21.6 16.1 16.8 21.6 21.7 13.6 21.3 19.5 19.9 19.7 35.4 11.1 15.1 23.3 18.9 10.6 12.8 4.8 5.7 9.1 18.6 3.8 21.7 7.8 36.3 6.8 35.0 51.1 12.6 24.0 29.9 10.8 14.7 10.2 11.0 18.8 8.4 40.2 10.1 7.2 10.9 14.8 15.3 19.9 7.8 38.0 11.6 13.4 12.8 21.2 12.3 26.4 9.1 11.0 9.8 21.8 16.0 16.7 22.8 22.1 20.3 16.8 20.6 5.5 10.3 14.5 13.2 27.6 17.4 9.9 12.6 16.9 27.7 21.1 29.8 17.1 15.4 8.7 19.4 8.3 20.9 15.5 6.2 19.0 9.0 22.2 15.9 18.8 25.6 21.2 11.7 2.9 4.4 4.8 9.1 4.8 13.6 9.5 10.6 12.3 7.9 10.6 18.6 11.3 0.7 9.1 5.7 12.8 7.2 3.8 34.0 36.5 39.2 40.0 29.1 16.5 17.7 27.5 34.7 19.9 116.1 118.5 109.7 81.2 58.5 344.6 127.3 56.0 75.0 101.2 71.5 214.0 39.6 140.9 74.9 160.4 67.6 60.1 0.0 65.5 79.7 132.8 164.9 62.4 80.5 56.3 311.4 182.6 102.5 80.0 149.3 194.5 74.4 200.8 61.3 133.8 187.6 72.0 84.2 245.4 81.7 228.9 51.8 103.8 264.1 280.4 54.8 44.1 76.7 118.3 90.4 TULP3 TUBL3 ENSG00000078246 "Tubby like protein 3" O75386 12 2877223-2941140 "Predicted intracellular proteins, Predicted secreted proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015285, HPA018496" Uncertain Supported "Nucleoplasm,Nucleoli,Plasma membrane" "Secreted - unknown location" NA NA "Nucleoplasm, Nucleoli" "Plasma membrane" "HPA015285: AB_1858460, HPA018496: AB_2669889" "unprognostic (5.33e-2)" "unprognostic (1.57e-1)" "unprognostic (4.80e-2)" "prognostic favorable (2.99e-4)" "unprognostic (2.45e-1)" "unprognostic (1.78e-2)" "prognostic unfavorable (7.97e-5)" "unprognostic (2.44e-1)" "unprognostic (4.09e-2)" "unprognostic (1.73e-1)" "unprognostic (1.50e-1)" "unprognostic (3.37e-1)" "prognostic unfavorable (7.18e-4)" "unprognostic (7.52e-2)" "unprognostic (1.94e-1)" "unprognostic (2.36e-2)" "unprognostic (3.19e-2)" 14.0 12.0 8.1 6.9 12.9 2.4 13.0 21.2 11.1 22.7 13.6 19.6 12.6 5.3 27.7 11.7 14.1 20.9 11.5 12.7 12.1 5.3 12.1 6.5 9.5 7.2 11.0 7.7 37.1 6.8 13.5 15.4 12.7 10.9 12.5 8.1 17.2 9.8 14.0 9.9 19.8 7.0 17.5 9.7 7.3 11.7 13.2 13.8 4.4 13.3 6.3 9.2 11.6 28.4 3.5 2.8 0.6 1.5 4.8 6.3 1.7 9.1 7.8 14.9 12.3 15.0 22.4 14.1 14.4 24.2 15.6 17.3 9.9 8.5 6.8 2.2 21.2 13.3 7.7 8.8 9.3 18.1 8.8 6.5 4.1 9.7 6.3 19.4 4.3 4.7 13.1 11.0 23.6 32.3 19.2 12.0 8.7 3.8 6.4 13.0 8.2 6.4 3.8 20.1 7.3 5.8 6.9 14.6 2.5 9.8 7.7 3.8 10.0 12.6 7.5 8.2 28.4 9.4 4.3 9.6 11.5 13.9 23.3 13.9 2.0 2.4 5.9 11.6 2.4 17.5 0.0 1.5 0.5 4.0 1.5 6.3 2.9 3.1 4.0 1.3 3.5 3.8 5.2 0.6 4.8 0.8 2.8 5.5 1.7 8.1 12.9 21.2 11.1 12.1 5.3 11.0 7.7 10.9 13.8 6.0 8.0 4.2 14.7 18.0 5.6 5.0 12.7 52.2 17.0 1.8 2.0 7.8 19.9 14.2 2.5 13.6 3.2 0.0 6.4 8.8 23.1 19.1 0.0 3.8 4.6 38.1 3.5 19.0 2.2 2.4 37.7 4.7 18.6 9.0 5.0 46.7 9.7 0.0 23.3 13.5 9.5 38.8 23.7 30.7 52.5 17.7 9.7 5.3 5.6 11.1 TYW1 "FLJ10900, MGC23001, MGC60291, RSAFD1, TYW1A, YPL207W" ENSG00000198874 "TRNA-yW synthesizing protein 1 homolog" Q9NV66 7 66995173-67239519 "Enzymes, Predicted membrane proteins" "tRNA processing" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA013568, HPA014118, HPA015535, HPA043136, HPA047029, HPA047052, HPA052097" Approved Approved "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA013568: AB_2668852, HPA014118: AB_2668941, HPA015535: AB_1856487, HPA043136: AB_2678333, HPA047029: AB_2679909, HPA047052: AB_2679918, HPA052097: AB_2681723" "unprognostic (1.53e-1)" "unprognostic (5.49e-3)" "unprognostic (1.62e-1)" "unprognostic (3.05e-2)" "unprognostic (1.84e-2)" "unprognostic (2.20e-1)" "unprognostic (1.83e-2)" "unprognostic (1.79e-1)" "unprognostic (1.47e-1)" "prognostic unfavorable (1.73e-4)" "unprognostic (4.86e-2)" "unprognostic (1.30e-1)" "unprognostic (1.85e-2)" "unprognostic (4.70e-2)" "unprognostic (1.60e-1)" "unprognostic (1.36e-2)" "unprognostic (1.79e-2)" 15.4 19.1 10.2 12.3 15.4 11.9 15.1 14.9 15.3 18.8 12.9 21.2 18.2 14.1 22.7 15.3 12.0 15.5 10.8 12.9 10.8 9.8 15.2 17.7 11.1 15.5 14.1 10.8 19.4 23.9 22.9 28.0 13.2 14.5 14.9 16.5 17.8 15.3 14.7 26.2 14.4 12.8 14.0 13.9 15.1 12.6 13.7 13.4 19.7 19.0 13.6 23.3 15.3 15.2 9.6 8.3 3.6 9.1 11.2 11.8 5.3 10.6 13.6 8.3 17.2 12.5 8.7 9.7 11.4 8.7 9.0 8.5 15.5 13.9 18.5 17.5 10.5 12.7 12.6 17.2 14.0 13.1 14.5 13.2 8.0 11.3 10.5 12.4 18.4 10.6 8.9 14.2 12.2 18.8 7.1 8.2 13.5 21.0 11.2 10.3 10.5 11.6 15.5 14.6 18.0 12.2 13.2 11.6 23.3 12.2 10.8 12.8 12.7 13.7 26.6 11.4 16.6 18.1 13.1 9.6 10.4 7.4 8.2 15.5 11.3 15.9 22.3 8.5 17.4 14.3 2.0 7.0 3.6 8.6 7.8 11.7 8.5 9.4 9.8 8.3 9.6 11.5 11.8 2.0 11.2 9.1 6.6 6.8 5.3 10.2 15.4 14.9 15.3 10.8 9.8 14.1 10.8 14.5 13.4 6.0 15.4 4.5 4.9 9.3 9.0 8.1 10.2 9.4 4.5 10.4 3.9 16.5 0.0 6.6 5.5 6.7 4.7 0.0 6.0 10.7 7.7 4.9 33.5 12.5 6.9 3.2 4.6 6.7 4.3 3.1 7.8 8.9 8.5 10.0 12.1 7.7 6.1 3.5 7.8 2.1 11.7 19.4 7.1 17.0 22.7 14.8 12.7 8.5 9.7 2.8 TYW1B "LINC00069, MGC87315, NCRNA00069, RSAFD2" ENSG00000277149 "TRNA-yW synthesizing protein 1 homolog B" 7 72558744-72828198 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 9.8;Rod photoreceptor cells: 8.1" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA013568, HPA014118, HPA043136, HPA047029, HPA047052, HPA052097" Approved Approved "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA013568: AB_2668852, HPA014118: AB_2668941, HPA043136: AB_2678333, HPA047029: AB_2679909, HPA047052: AB_2679918, HPA052097: AB_2681723" "unprognostic (2.61e-1)" "unprognostic (3.54e-1)" "unprognostic (1.92e-1)" "unprognostic (1.64e-1)" "unprognostic (1.91e-2)" "unprognostic (6.22e-3)" "unprognostic (3.88e-2)" "unprognostic (1.64e-2)" "unprognostic (1.19e-2)" "unprognostic (8.96e-3)" "unprognostic (5.78e-2)" "unprognostic (2.90e-2)" "unprognostic (4.33e-4)" "unprognostic (1.02e-1)" "unprognostic (2.41e-1)" "unprognostic (1.85e-1)" "unprognostic (5.90e-2)" 2.7 1.6 1.8 4.5 3.8 4.4 4.2 6.0 3.3 5.6 2.9 5.8 7.4 1.5 6.0 5.2 3.4 4.1 1.5 2.3 1.9 3.1 7.9 2.9 2.4 3.9 1.7 10.1 5.7 2.0 11.6 3.0 3.4 4.1 4.4 4.7 4.1 5.9 4.4 2.5 2.9 3.6 4.7 3.0 3.1 7.2 3.8 6.0 5.9 1.8 6.0 3.1 1.1 7.5 5.4 5.7 3.5 2.4 3.0 0.9 2.3 2.5 1.0 2.0 1.6 0.5 1.1 1.2 0.5 1.1 1.1 8.0 4.2 7.3 0.7 0.8 1.0 1.1 1.9 0.8 1.3 7.9 2.3 0.7 1.2 4.7 0.8 7.4 2.1 3.8 0.6 1.3 0.9 0.7 0.7 1.6 10.0 7.7 1.1 1.0 2.4 3.8 1.8 3.1 4.6 1.4 5.5 2.6 1.1 0.8 1.8 0.9 1.5 8.4 4.3 3.3 2.1 2.6 3.2 1.8 4.3 9.7 1.4 6.7 8.1 8.3 0.5 2.1 9.7 4.0 3.5 5.7 3.0 1.8 2.8 7.5 2.0 1.8 1.4 5.2 2.3 2.7 4.3 2.4 1.7 5.4 2.0 0.9 0.0 1.3 4.7 1.8 0.0 3.4 4.8 2.5 2.7 1.2 0.0 9.8 3.5 0.0 2.0 3.3 1.4 1.2 0.0 0.6 1.5 2.1 1.6 1.1 1.5 2.9 1.6 0.0 1.3 1.5 0.4 0.9 0.7 0.0 2.8 2.3 1.6 1.0 0.3 0.7 0.5 8.1 0.0 1.7 5.5 5.1 0.0 1.6 2.2 1.1 0.9 UBE2R2 "CDC34B, FLJ20419, MGC10481, UBC3B" ENSG00000107341 "Ubiquitin conjugating enzyme E2 R2" Q712K3 9 33817567-33920404 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Early spermatids: 295.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 21.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061000, HPA074334" Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA061000: AB_2684408, HPA074334: " "unprognostic (1.51e-1)" "unprognostic (1.50e-1)" "unprognostic (7.08e-2)" "unprognostic (1.53e-1)" "unprognostic (6.55e-2)" "unprognostic (5.15e-2)" "prognostic unfavorable (4.37e-4)" "unprognostic (1.82e-3)" "unprognostic (4.61e-3)" "unprognostic (3.05e-3)" "unprognostic (2.22e-2)" "unprognostic (4.19e-1)" "unprognostic (2.01e-2)" "unprognostic (4.18e-2)" "unprognostic (1.22e-1)" "unprognostic (5.72e-2)" "unprognostic (1.43e-1)" 26.1 19.7 29.4 19.7 26.8 13.9 39.3 23.7 32.3 25.6 24.1 27.9 16.3 28.0 26.1 18.4 25.3 22.3 21.8 29.2 25.5 20.3 22.1 34.5 23.0 27.1 30.5 23.2 29.8 44.5 15.7 13.9 24.6 21.6 21.0 21.4 19.3 18.7 20.8 56.1 28.1 25.7 28.5 24.2 21.6 20.8 34.5 29.6 36.7 19.5 22.5 25.7 35.8 30.5 3.3 4.2 21.9 11.6 5.0 2.1 2.4 16.5 18.1 35.0 15.2 19.3 31.5 10.8 14.7 20.5 17.3 17.3 14.5 12.4 14.1 6.0 20.5 12.6 7.4 18.3 16.8 19.0 23.2 9.7 12.2 20.0 18.4 27.5 14.4 13.3 26.7 25.0 14.1 26.8 27.7 29.0 17.0 11.4 15.2 17.1 9.6 27.1 38.0 19.9 14.2 15.1 25.3 10.6 7.3 18.3 12.5 16.4 19.7 17.2 15.4 11.0 23.2 13.5 17.6 21.7 16.7 15.2 11.5 13.6 9.7 9.1 19.8 15.9 8.4 35.9 12.4 7.5 4.1 2.0 7.5 1.3 3.1 1.9 1.6 4.2 3.3 1.9 1.7 21.9 5.0 11.6 2.6 2.1 2.4 29.4 26.8 23.7 32.3 25.5 20.3 30.5 23.2 21.6 29.6 20.8 30.7 29.5 39.6 93.8 61.0 106.8 56.0 22.7 25.0 21.0 13.7 52.6 13.3 43.8 295.7 77.1 60.6 23.3 59.7 65.2 54.0 68.4 12.7 72.1 68.5 57.2 69.2 77.3 105.2 195.4 62.2 81.9 33.7 49.5 57.3 87.1 69.4 38.6 71.5 49.6 30.1 58.2 41.9 90.2 66.2 105.3 69.2 30.5 49.0 79.7 UBLCP1 "CPUB1, MGC10067" ENSG00000164332 "Ubiquitin like domain containing CTD phosphatase 1" Q8WVY7 5 159263081-159286040 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039615 Approved Supported "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA039615: AB_10674425" "unprognostic (1.25e-1)" "unprognostic (3.10e-1)" "unprognostic (6.04e-3)" "unprognostic (3.45e-2)" "unprognostic (7.08e-2)" "unprognostic (6.82e-2)" "prognostic unfavorable (4.46e-5)" "unprognostic (4.01e-1)" "unprognostic (2.14e-2)" "unprognostic (1.98e-1)" "unprognostic (1.91e-2)" "unprognostic (5.43e-2)" "unprognostic (1.16e-1)" "unprognostic (1.87e-1)" "unprognostic (1.18e-1)" "unprognostic (6.39e-2)" "unprognostic (2.51e-2)" 17.1 16.0 16.7 18.4 19.7 16.7 16.3 20.2 33.0 18.5 12.5 12.2 11.4 9.8 22.5 13.1 22.2 14.7 14.5 13.1 20.9 19.1 17.5 14.4 17.8 24.1 19.7 22.7 16.8 12.6 18.0 23.9 19.6 36.7 14.7 14.7 10.9 15.4 17.6 15.3 14.2 13.8 19.5 20.4 22.2 13.3 24.2 15.4 26.8 14.4 16.1 30.1 18.8 16.8 11.9 10.8 21.9 13.9 25.5 19.2 8.2 14.6 10.7 22.2 24.1 23.1 21.4 13.1 16.0 24.5 16.5 22.0 8.7 10.2 13.1 17.7 20.0 23.7 11.2 13.7 30.8 28.8 26.2 13.5 10.1 9.4 7.9 29.2 22.8 15.9 18.9 28.9 14.9 29.9 13.2 15.6 13.9 13.8 17.8 22.9 4.7 12.3 6.9 15.4 7.3 6.5 15.7 21.8 15.3 16.3 11.3 11.8 15.7 16.2 10.8 37.7 14.0 11.4 15.2 16.7 17.0 14.2 8.8 20.2 14.3 14.3 20.0 18.0 15.8 25.1 21.9 6.5 16.1 16.6 13.5 18.6 11.9 15.8 17.3 8.5 10.9 18.5 19.2 19.4 25.5 13.9 10.8 16.9 8.2 16.7 19.7 20.2 33.0 20.9 19.1 19.7 22.7 36.7 15.4 11.9 38.2 22.7 8.2 14.2 9.9 12.2 10.2 34.8 30.7 14.0 3.9 27.7 29.9 18.9 3.4 20.0 9.5 46.7 21.7 14.9 21.7 11.4 43.9 14.0 33.1 19.1 10.3 30.7 42.1 2.2 19.0 27.8 16.9 25.2 14.0 17.9 18.8 8.6 23.3 23.8 13.4 19.4 14.4 70.2 48.5 18.1 14.9 21.7 13.9 7.9 UBXN8 "D8S2298E, REP8, UBXD6" ENSG00000104691 "UBX domain protein 8" O00124 8 30732247-30767006 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 30.6" "Group enriched" "Detected in many" 4 "Early spermatids: 162.1;Hepatocytes: 56.2;Late spermatids: 132.0" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017725, HPA077538" Enhanced Supported "Nucleoplasm,Nucleoli,Endoplasmic reticulum" "Intracellular and membrane" NA NA "Endoplasmic reticulum" "Nucleoplasm, Nucleoli" "HPA017725: AB_1847462, HPA077538: AB_2686844" "unprognostic (3.00e-2)" "unprognostic (2.30e-1)" "prognostic favorable (6.13e-4)" "unprognostic (7.71e-2)" "unprognostic (2.24e-1)" "unprognostic (1.03e-1)" "unprognostic (2.41e-1)" "unprognostic (1.84e-2)" "unprognostic (1.90e-1)" "unprognostic (5.13e-2)" "unprognostic (1.58e-1)" "unprognostic (1.06e-2)" "prognostic unfavorable (5.25e-5)" "unprognostic (2.49e-1)" "unprognostic (1.96e-1)" "unprognostic (1.51e-1)" "unprognostic (6.88e-2)" 5.0 5.3 3.9 1.4 4.8 1.4 4.3 1.5 9.2 3.0 3.5 4.0 6.7 3.1 3.8 14.3 4.1 3.6 3.8 2.8 5.7 8.2 21.5 2.1 3.9 7.6 4.0 30.6 10.3 6.2 3.5 6.2 6.2 4.8 4.7 1.6 1.8 6.1 1.7 4.1 2.9 2.9 7.1 5.7 3.3 11.5 6.1 0.9 9.1 2.8 2.3 2.9 3.7 6.0 8.2 1.0 6.1 3.3 8.4 3.4 7.6 7.7 5.6 5.8 9.1 12.2 6.3 13.7 8.0 7.5 9.2 12.2 2.8 12.2 11.3 11.1 12.4 6.8 1.1 7.6 11.6 6.4 12.5 34.3 6.3 14.9 13.7 7.8 19.4 9.6 7.9 12.0 5.9 6.4 6.5 5.6 33.5 9.2 16.5 7.2 7.9 6.0 10.8 22.8 5.8 9.5 5.4 8.5 12.8 10.0 3.2 8.1 3.8 11.3 24.7 7.0 8.4 13.6 8.3 8.5 3.7 3.8 12.7 4.0 12.5 9.2 7.6 12.6 12.1 0.0 6.0 0.7 8.4 6.1 7.3 6.0 4.5 8.0 6.7 2.9 4.4 7.4 1.0 3.3 3.0 8.2 4.3 3.4 3.0 8.0 3.0 4.1 0.0 1.9 3.2 15.3 1.4 5.7 14.0 19.6 20.6 6.6 7.1 162.1 6.2 6.3 0.0 4.5 16.0 9.4 4.1 13.9 56.2 19.0 11.1 8.2 27.0 14.2 132.0 13.3 6.9 0.0 10.0 6.4 6.6 3.9 3.5 9.2 22.0 1.8 6.5 3.9 14.1 20.4 0.0 12.7 7.2 10.0 2.4 UCHL5 "CGI-70, INO80R, UCH37" ENSG00000116750 "Ubiquitin C-terminal hydrolase L5" Q9Y5K5 1 193012250-193060080 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005908, HPA006069" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Cytosol" Nucleoli "HPA005908: AB_1858585, HPA006069: " "unprognostic (3.66e-2)" "unprognostic (3.84e-3)" "unprognostic (5.17e-2)" "unprognostic (5.98e-2)" "unprognostic (1.20e-2)" "unprognostic (1.20e-1)" "unprognostic (3.50e-2)" "unprognostic (7.41e-2)" "unprognostic (1.96e-2)" "unprognostic (1.04e-3)" "unprognostic (3.44e-3)" "unprognostic (6.92e-2)" "unprognostic (6.41e-3)" "unprognostic (1.51e-1)" "unprognostic (7.15e-2)" "prognostic unfavorable (7.10e-5)" "unprognostic (4.33e-2)" 15.7 18.3 20.1 16.1 26.2 16.0 18.2 30.1 34.8 10.9 17.7 11.5 12.6 19.0 12.5 14.7 26.1 10.7 11.9 22.0 21.6 20.6 21.6 28.3 12.4 19.9 21.3 29.4 13.4 24.8 15.6 16.2 17.8 33.3 17.8 18.8 10.3 19.3 12.9 29.1 16.7 18.0 13.9 20.1 17.3 14.0 9.9 17.5 20.0 15.1 19.1 23.0 14.8 14.8 22.5 20.8 23.8 21.1 35.6 30.9 20.9 33.6 18.7 16.2 16.6 9.5 9.6 19.3 19.8 10.1 19.0 16.5 17.7 22.9 26.4 19.2 11.0 11.5 20.9 21.6 25.6 25.2 27.2 15.5 31.3 24.2 23.4 15.2 49.1 17.6 8.9 11.4 27.3 24.2 8.7 18.7 26.6 68.6 21.6 16.1 27.2 36.1 18.2 15.0 23.1 11.8 21.0 18.2 51.4 17.7 19.8 16.5 20.3 17.8 25.8 27.6 17.9 21.0 24.8 12.2 17.8 5.4 18.0 31.5 16.8 26.0 29.8 10.7 30.6 30.3 23.8 16.5 19.0 28.3 19.5 30.9 22.5 25.9 26.9 19.4 18.0 28.2 30.5 10.0 35.6 21.1 20.8 24.8 20.9 20.1 26.2 30.1 34.8 21.6 20.6 21.3 29.4 33.3 17.5 8.9 24.6 13.7 12.3 21.6 18.3 68.2 15.3 26.8 29.6 26.2 41.2 31.3 38.1 21.6 1.8 20.4 19.5 0.0 24.6 27.1 16.4 17.3 53.3 22.2 24.8 23.8 10.4 18.4 20.3 3.4 13.8 24.5 16.9 19.8 18.3 25.7 20.3 7.0 16.3 30.8 41.8 19.4 17.0 14.0 16.8 26.2 21.1 27.7 20.6 10.5 UFD1 UFD1L ENSG00000070010 "Ubiquitin recognition factor in ER associated degradation 1" Q92890 22 19449910-19479215 "Predicted intracellular proteins, Transporters" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 105.1;Ductal cells: 98.8;Exocrine glandular cells: 123.6;monocytes: 132.6;Pancreatic endocrine cells: 115.9;Syncytiotrophoblasts: 142.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 131.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030286, HPA030287" Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Cytosol" Nucleoli "HPA030286: , HPA030287: AB_10601830" "unprognostic (2.52e-1)" "unprognostic (5.41e-2)" "unprognostic (1.95e-3)" "unprognostic (7.61e-2)" "unprognostic (3.50e-2)" "unprognostic (2.70e-2)" "prognostic unfavorable (2.59e-4)" "unprognostic (9.79e-2)" "unprognostic (1.60e-1)" "unprognostic (1.02e-3)" "unprognostic (8.82e-2)" "unprognostic (1.73e-2)" "prognostic unfavorable (4.50e-8)" "unprognostic (1.45e-1)" "unprognostic (1.08e-1)" "unprognostic (1.46e-1)" "unprognostic (1.30e-2)" 27.8 28.0 22.7 24.3 38.0 38.7 23.9 25.3 30.4 21.1 28.9 23.3 24.7 21.7 32.8 40.3 31.6 21.3 21.7 35.6 21.9 22.9 28.0 46.6 24.6 34.8 44.3 15.9 22.4 34.7 22.5 22.6 31.6 33.0 21.7 27.7 21.9 26.7 24.4 57.9 27.3 24.7 28.3 39.7 26.7 26.2 31.8 29.9 37.8 27.8 26.9 31.7 23.9 23.7 27.7 35.3 53.5 42.8 31.1 67.6 37.5 31.8 23.2 19.8 30.0 16.3 11.5 15.2 26.4 26.4 36.5 33.8 25.7 13.9 22.3 20.5 22.1 16.8 27.7 23.2 23.1 31.8 41.0 24.5 23.5 16.4 20.3 15.5 37.2 32.1 10.5 23.8 31.1 15.3 10.7 29.2 11.8 131.8 43.0 22.2 46.3 23.9 22.8 14.2 40.2 19.7 29.1 46.9 8.6 22.4 30.1 16.3 18.3 20.7 22.5 20.7 21.6 13.5 17.9 31.7 30.8 41.9 25.6 28.3 18.4 36.6 29.0 25.9 19.0 28.1 39.8 29.0 47.8 36.1 42.8 34.7 27.7 41.6 37.3 25.5 23.9 35.9 35.1 53.5 31.1 41.1 35.3 67.6 37.5 22.7 38.0 25.3 30.4 21.9 22.9 44.3 15.9 33.0 29.9 23.8 34.6 0.0 0.0 0.0 0.0 0.0 0.0 50.9 30.7 26.2 0.0 105.1 71.3 98.8 0.0 0.0 0.0 0.0 123.6 90.9 0.0 0.0 25.6 0.0 79.3 0.0 0.0 0.0 0.0 0.0 0.0 26.0 0.0 132.6 0.0 0.0 115.9 0.0 0.0 61.9 0.0 0.0 0.0 0.0 0.0 0.0 142.5 0.0 0.0 0.0 UPF3B "HUPF3B, MRX62, RENT3B, UPF3BP1, UPF3BP2, UPF3BP3, UPF3X" ENSG00000125351 "UPF3B, regulator of nonsense mediated mRNA decay" Q9BZI7 X 119805311-119852998 "Disease related genes, Predicted intracellular proteins" "mRNA transport, Nonsense-mediated mRNA decay, Transport" RNA-binding "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001592, HPA001800, HPA001882" Approved Enhanced Nucleoplasm,Nucleoli,Cytosol No No Cytosol "Nucleoplasm, Nucleoli" "HPA001592: AB_2666373, HPA001800: AB_1080476, HPA001882: AB_1080474" "unprognostic (1.79e-1)" "unprognostic (5.41e-2)" "unprognostic (1.21e-2)" "unprognostic (3.64e-3)" "unprognostic (8.58e-2)" "unprognostic (1.20e-1)" "prognostic unfavorable (1.52e-6)" "unprognostic (6.61e-2)" "prognostic unfavorable (5.39e-4)" "unprognostic (5.74e-2)" "unprognostic (4.51e-2)" "unprognostic (8.63e-3)" "prognostic unfavorable (1.44e-7)" "unprognostic (8.67e-2)" "unprognostic (1.04e-1)" "unprognostic (2.34e-1)" "unprognostic (8.95e-2)" 9.7 10.3 19.4 11.5 21.9 14.5 10.8 34.1 24.0 10.2 13.0 9.3 12.8 14.2 14.6 13.5 13.0 8.8 8.4 7.8 16.9 17.5 10.0 12.4 9.0 17.2 16.5 21.7 14.8 8.7 14.3 26.7 10.5 17.2 12.4 13.2 9.1 9.7 14.4 14.5 18.6 11.1 14.2 21.7 12.9 9.9 15.0 21.0 9.9 12.5 11.5 18.3 12.6 12.9 17.5 10.0 7.1 5.9 7.9 8.1 2.7 11.9 7.2 15.1 12.2 6.9 4.5 9.7 11.5 6.5 9.0 8.0 13.5 8.6 21.5 9.8 4.8 12.9 11.4 19.5 6.9 11.5 12.2 14.3 19.9 24.0 7.1 7.9 21.5 9.9 3.9 5.3 15.4 18.8 8.2 8.3 12.9 19.2 18.0 7.5 14.5 15.1 27.0 29.1 15.3 19.8 14.8 17.3 15.8 7.3 6.0 20.1 13.9 23.5 9.5 17.2 16.4 5.0 12.6 7.2 9.4 7.2 15.0 24.3 9.9 11.0 29.1 7.5 31.7 10.9 7.1 5.3 6.8 7.5 5.1 5.7 13.8 7.0 5.9 3.8 17.5 7.6 8.1 5.9 7.9 5.9 10.0 7.8 2.7 19.4 21.9 34.1 24.0 16.9 17.5 16.5 21.7 17.2 21.0 29.8 25.5 28.9 28.2 33.5 47.9 17.1 15.3 42.8 47.8 24.4 53.0 33.2 5.0 27.3 107.2 24.5 27.1 0.0 22.8 39.7 29.2 18.5 57.7 19.2 25.4 27.0 26.6 20.3 15.4 17.6 28.1 32.2 23.6 49.5 21.8 39.5 18.6 31.7 30.8 12.4 94.7 12.9 36.2 32.2 32.4 33.2 53.8 34.8 32.2 21.3 USF3 KIAA2018 ENSG00000176542 "Upstream transcription factor family member 3" Q68DE3 3 113648385-113696646 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029243, HPA029245" Uncertain Uncertain Nucleoplasm,Nucleoli,Centrosome NA NA "Nucleoplasm, Nucleoli" Centrosome "HPA029243: AB_10611114, HPA029245: AB_10600443" "unprognostic (2.80e-2)" "unprognostic (2.80e-1)" "unprognostic (4.21e-2)" "unprognostic (7.80e-2)" "unprognostic (2.25e-2)" "unprognostic (1.96e-2)" "unprognostic (3.53e-1)" "unprognostic (2.62e-2)" "unprognostic (2.93e-1)" "unprognostic (1.53e-2)" "unprognostic (8.74e-2)" "unprognostic (1.30e-1)" "prognostic favorable (1.74e-6)" "unprognostic (1.23e-1)" "unprognostic (1.97e-1)" "unprognostic (3.28e-1)" "unprognostic (5.55e-2)" 9.0 5.1 8.8 11.0 7.3 13.8 11.4 13.9 7.5 7.2 12.2 5.3 5.4 4.8 5.8 13.3 7.0 6.3 5.3 8.1 7.6 5.5 12.7 24.0 6.1 9.2 6.3 5.6 6.9 10.8 14.4 8.9 4.9 6.5 6.2 6.7 6.4 8.3 5.4 28.7 11.4 14.7 8.3 11.2 12.0 7.3 4.8 6.9 13.3 7.1 11.5 8.9 6.1 6.0 5.9 5.1 6.9 3.7 2.6 3.1 1.4 5.2 4.0 5.0 4.7 12.1 4.7 3.4 2.1 3.4 2.1 2.0 3.7 2.2 9.3 3.9 5.4 3.4 3.3 5.3 4.2 4.0 2.8 2.2 6.6 2.5 6.1 3.6 12.1 7.4 6.7 7.7 3.9 4.4 3.2 5.0 7.1 3.1 5.0 4.4 7.4 6.7 6.7 3.6 7.1 4.1 2.9 3.9 3.7 7.5 7.4 2.4 3.6 5.1 2.9 6.1 3.6 3.9 9.0 6.8 3.3 7.2 1.8 3.0 5.8 3.2 11.1 3.8 5.1 2.4 4.1 2.4 3.5 3.1 2.8 2.3 2.2 2.2 2.3 1.7 5.9 2.7 2.8 6.9 2.6 3.7 5.1 1.1 1.4 8.8 7.3 13.9 7.5 7.6 5.5 6.3 5.6 6.5 6.9 20.8 10.8 4.8 9.6 0.0 20.4 0.0 10.2 22.7 11.4 24.4 13.7 6.7 21.6 7.4 4.6 10.8 9.7 0.0 10.3 3.1 5.4 14.9 4.7 36.5 6.7 12.7 5.8 20.3 16.4 9.1 12.0 10.4 0.0 3.6 13.2 11.3 10.2 16.5 13.1 18.7 17.2 6.5 0.0 9.5 3.9 0.0 12.1 13.4 13.3 17.8 USP36 "FLJ12851, KIAA1453" ENSG00000055483 "Ubiquitin specific peptidase 36" Q9P275 17 78787381-78841441 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012082, HPA012395, HPA052860" Uncertain Supported Enhanced "Nucleoli,Nucleoli rim,Nuclear speckles" NA NA "Nucleoli, Nucleoli rim" "Nuclear speckles" "HPA012082: AB_1858682, HPA012395: , HPA052860: AB_2681974" "unprognostic (1.94e-2)" "unprognostic (2.80e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (5.18e-5)" "unprognostic (9.35e-2)" "unprognostic (1.98e-1)" "unprognostic (2.50e-3)" "unprognostic (1.35e-1)" "unprognostic (2.04e-1)" "unprognostic (1.33e-1)" "unprognostic (1.68e-2)" "unprognostic (2.78e-2)" "unprognostic (1.31e-2)" "unprognostic (1.45e-1)" "unprognostic (1.81e-1)" "unprognostic (4.03e-3)" "unprognostic (1.78e-1)" 26.3 23.4 12.9 21.3 16.0 36.5 28.1 28.3 17.4 17.2 16.4 25.4 19.2 12.3 25.1 22.2 14.6 18.0 21.9 17.4 10.4 11.2 15.9 16.4 20.0 17.2 17.5 16.0 41.3 33.6 19.6 30.0 23.4 14.6 21.0 15.1 20.4 21.8 45.5 19.5 29.3 15.1 25.2 14.5 18.2 17.3 20.8 13.7 12.8 19.3 11.2 22.2 24.6 18.1 6.7 12.4 8.9 5.3 5.6 8.8 2.5 16.0 19.4 5.7 10.6 12.3 13.7 11.0 13.2 13.4 12.7 8.6 18.8 8.1 20.5 6.7 11.7 13.8 11.8 13.4 9.8 22.8 4.9 20.3 18.7 28.3 19.6 12.7 20.5 10.3 11.9 16.3 18.1 40.6 9.8 11.0 9.3 14.9 21.7 10.4 12.3 18.6 20.8 8.8 12.0 15.6 14.4 12.6 13.8 8.0 17.0 16.9 10.3 9.5 44.3 24.0 13.0 11.4 13.1 9.3 30.1 14.0 17.5 23.3 16.1 6.3 25.3 11.8 16.0 9.4 8.9 3.9 3.1 7.6 5.3 8.8 6.4 7.2 6.4 2.3 6.7 8.0 7.7 5.7 5.6 3.3 12.4 4.8 2.5 12.9 16.0 28.3 17.4 10.4 11.2 17.5 16.0 14.6 13.7 11.9 41.5 16.3 21.0 45.9 31.4 13.5 15.3 12.0 26.1 14.0 31.4 6.9 5.0 8.7 12.1 20.4 6.8 0.0 8.3 8.9 25.9 22.8 19.7 12.4 34.2 25.4 17.7 12.3 20.6 6.1 10.9 34.8 28.7 10.8 13.6 17.3 10.7 8.6 11.7 4.1 32.5 6.5 22.7 14.2 10.6 37.9 10.8 30.5 14.0 20.4 UTY "KDM6AL, KDM6C" ENSG00000183878 "Ubiquitously transcribed tetratricopeptide repeat containing, Y-linked" O14607 Y 13248379-13480673 "Predicted intracellular proteins" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 37.7" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 60.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 14.9;U-266/84: 11.4;U-698: 14.9" "HPA000568, HPA001165" Supported Approved "Nucleoplasm,Nucleoli,Nucleoli rim" "Intracellular and membrane" NA NA Nucleoplasm "Nucleoli, Nucleoli rim" "HPA000568: AB_1858705, HPA001165: AB_1080541" "unprognostic (7.52e-2)" "unprognostic (6.60e-2)" "unprognostic (4.04e-6)" "unprognostic (6.47e-2)" "unprognostic (9.34e-2)" "unprognostic (2.00e-2)" "unprognostic (9.17e-2)" "unprognostic (1.53e-2)" "unprognostic (1.29e-1)" "unprognostic (1.41e-2)" "unprognostic (2.82e-1)" "unprognostic (2.67e-2)" "unprognostic (1.46e-2)" 5.3 5.1 3.0 15.4 10.3 9.0 5.1 6.1 11.0 0.4 8.4 18.0 18.4 4.3 0.4 16.5 7.2 0.4 6.5 4.7 3.5 3.4 5.0 6.9 11.9 19.0 3.3 0.0 0.5 15.1 0.4 6.3 5.9 13.0 14.0 10.6 16.8 10.9 16.1 9.3 7.4 10.1 18.6 4.8 17.4 5.7 6.7 0.0 37.7 6.3 10.3 22.0 7.2 0.0 6.1 4.8 6.6 3.8 9.9 6.7 1.3 0.0 1.8 0.0 0.0 0.0 0.0 6.6 3.3 5.7 3.7 5.7 0.0 0.0 9.0 0.0 3.8 0.0 0.0 0.0 0.0 5.3 4.9 0.0 14.9 0.1 0.0 4.9 0.0 0.0 6.0 5.9 0.0 0.0 0.0 0.0 3.1 0.0 0.0 4.1 0.0 5.1 0.1 0.0 0.0 0.0 0.0 2.4 4.0 4.1 6.1 3.7 0.0 0.0 0.0 10.7 6.8 0.0 3.2 4.3 6.6 0.0 0.0 2.3 10.2 11.4 14.9 0.6 0.0 0.0 1.8 2.8 5.8 4.7 3.4 6.7 5.0 4.6 3.6 3.0 6.1 6.5 4.7 6.6 9.9 3.8 4.8 5.3 1.3 3.0 10.3 6.1 11.0 3.5 3.4 3.3 0.0 13.0 0.0 14.9 22.3 25.2 17.2 10.1 30.4 5.2 2.5 10.7 13.6 17.4 60.9 8.5 0.0 2.9 0.3 7.7 1.0 0.0 0.0 2.7 7.6 12.2 15.1 0.0 2.4 35.0 1.7 8.6 13.3 0.9 10.0 15.3 8.5 10.8 0.0 18.3 2.5 0.0 11.0 1.3 38.6 0.0 6.2 1.8 5.9 13.4 11.1 21.3 0.0 16.0 VASN SLITL2 ENSG00000168140 Vasorin Q6EMK4 16 4371848-4383528 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Fibroblasts: 108.9;Peritubular cells: 57.3;Sertoli cells: 97.0;Smooth muscle cells: 96.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 12 "U-2197: 126.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011246, HPA016992" Uncertain Approved Nucleoplasm,Nucleoli,Mitochondria "Secreted - unknown location" NA Yes 2400000000 Mitochondria "Nucleoplasm, Nucleoli" "HPA011246: AB_1858720, HPA016992: AB_2732418" "unprognostic (2.20e-1)" "unprognostic (2.75e-1)" "unprognostic (9.22e-2)" "prognostic unfavorable (6.24e-5)" "unprognostic (2.35e-3)" "unprognostic (8.91e-3)" "unprognostic (3.15e-3)" "unprognostic (5.92e-2)" "unprognostic (2.22e-1)" "unprognostic (1.24e-2)" "unprognostic (1.08e-1)" "unprognostic (1.28e-1)" "unprognostic (1.81e-1)" "unprognostic (8.82e-3)" "unprognostic (4.23e-2)" "unprognostic (4.95e-3)" "unprognostic (5.27e-2)" 22.4 10.2 4.9 7.7 6.7 3.8 28.6 1.6 6.5 19.9 5.1 5.6 6.4 5.1 14.3 13.6 16.2 9.9 10.2 12.9 4.4 1.8 21.6 14.1 17.2 5.2 2.7 2.9 21.0 9.8 1.7 5.9 30.2 4.8 12.9 2.0 33.6 7.9 13.1 7.0 16.0 4.0 9.4 3.6 7.9 6.5 14.7 3.5 0.0 15.2 5.5 8.2 16.6 19.0 0.3 0.2 0.4 0.0 0.0 0.2 0.0 0.3 0.5 0.0 0.0 2.8 3.2 1.2 5.3 5.2 1.6 2.7 0.3 0.6 0.0 1.9 3.5 0.2 0.0 0.0 0.1 0.2 1.2 0.1 0.1 1.5 1.6 10.2 0.0 0.0 3.3 0.0 4.0 0.1 2.7 0.0 0.0 0.2 0.0 0.2 1.8 0.0 0.4 0.3 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.1 0.9 2.5 4.2 0.0 0.2 0.9 0.2 0.0 4.9 1.3 126.7 0.6 0.0 0.0 0.0 1.5 0.0 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 4.9 6.7 1.6 6.5 4.4 1.8 2.7 2.9 4.8 3.5 6.0 12.5 0.9 6.0 8.5 0.0 12.9 35.7 1.4 3.4 22.7 0.0 3.0 6.6 10.3 1.0 3.3 0.2 0.0 2.6 6.4 108.9 7.4 3.5 12.9 2.8 0.0 0.0 4.9 0.3 1.8 46.3 1.2 13.5 0.0 0.4 16.3 17.4 0.0 57.3 12.5 0.7 97.0 96.8 0.5 5.1 6.6 8.4 1.8 0.2 3.3 VEPH1 "FLJ12604, KIAA1692" ENSG00000197415 "Ventricular zone expressed PH domain containing 1" Q14D04 3 157259742-157533619 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 38.1;pituitary gland: 70.3" "Cell type enhanced" "Detected in many" 18 "Alveolar cells type 1: 247.1;Alveolar cells type 2: 124.4;Early spermatids: 67.1;Late spermatids: 63.8" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 5 "cerebellum: 2.2;pons and medulla: 5.5" "Cell type enhanced" "Detected in single" "neutrophil: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ hTERT+: 24.5;hTERT-RPE1: 26.3;HUVEC TERT2: 65.1;TIME: 38.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA026645 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli, Cytosol" "HPA026645: AB_1858741" "unprognostic (4.35e-2)" "unprognostic (1.42e-2)" "unprognostic (2.44e-1)" "unprognostic (3.58e-1)" "unprognostic (5.17e-2)" "unprognostic (3.30e-3)" "unprognostic (2.87e-3)" "unprognostic (2.22e-1)" "unprognostic (3.52e-2)" "unprognostic (1.75e-3)" "unprognostic (3.57e-3)" "unprognostic (1.99e-2)" "prognostic favorable (7.75e-9)" "unprognostic (2.03e-1)" "unprognostic (2.57e-1)" "unprognostic (1.15e-4)" "unprognostic (7.49e-2)" 0.5 16.0 0.3 0.2 0.3 1.1 1.4 2.2 3.5 1.9 0.4 0.7 2.0 0.2 0.4 12.1 0.2 3.4 1.1 0.4 0.8 0.5 20.7 0.6 38.1 0.1 0.7 0.1 1.1 8.6 0.7 70.3 1.6 5.5 1.2 0.3 17.7 6.9 4.9 0.2 0.7 0.2 0.1 0.3 2.3 0.6 1.7 0.2 0.1 1.1 0.5 0.6 0.5 0.8 0.0 0.0 1.5 0.7 0.0 0.0 5.1 1.8 0.2 4.3 0.0 2.5 9.4 0.0 11.0 24.5 3.3 4.8 0.3 1.7 0.0 4.3 11.8 0.5 0.0 0.1 0.2 18.3 0.0 0.0 1.8 0.2 0.0 0.8 0.0 0.0 2.7 0.1 14.0 2.8 26.3 65.1 0.0 0.6 0.0 8.9 0.2 0.0 0.0 1.7 0.5 1.6 0.0 0.3 0.0 1.6 0.9 0.1 0.0 0.3 0.5 4.3 0.0 18.9 0.0 38.7 13.1 0.4 4.5 15.1 0.0 0.0 0.0 10.5 0.0 3.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 5.1 0.3 0.3 2.2 0.4 0.8 0.5 0.7 0.1 5.5 0.2 247.1 124.4 0.0 0.2 1.5 0.0 0.3 12.7 14.7 26.1 29.6 2.0 1.6 39.7 5.5 67.1 0.0 0.0 0.0 8.7 0.1 0.4 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 63.8 1.4 0.4 27.0 1.0 0.2 0.8 2.0 2.8 0.4 24.1 0.3 0.0 0.0 0.3 0.6 0.4 0.0 0.0 0.6 0.1 VPS51 "ANG2, ANG3, C11orf2, C11orf3, FFR" ENSG00000149823 "VPS51, GARP complex subunit" Q9UID3 11 65089324-65111860 "Predicted intracellular proteins" "Lipid transport, Protein transport, Transport" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039650, HPA061447" Uncertain Approved "Nucleoli,Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" Nucleoli "HPA039650: AB_10673147, HPA061447: AB_2684521" "unprognostic (2.36e-2)" "unprognostic (7.58e-2)" "unprognostic (8.35e-2)" "unprognostic (1.56e-1)" "unprognostic (2.11e-2)" "unprognostic (1.64e-1)" "unprognostic (9.72e-2)" "unprognostic (1.52e-1)" "unprognostic (2.58e-1)" "unprognostic (1.17e-1)" "unprognostic (2.03e-3)" "unprognostic (1.56e-1)" "prognostic favorable (2.41e-9)" "unprognostic (7.77e-3)" "unprognostic (4.63e-2)" "unprognostic (2.85e-1)" "unprognostic (2.18e-1)" 22.1 19.5 17.5 19.4 24.3 30.3 21.7 29.8 33.8 23.4 30.9 16.9 22.4 31.2 27.7 15.5 22.9 20.9 25.0 27.7 15.9 13.0 18.5 24.7 16.6 35.0 14.5 19.2 53.2 77.6 22.9 14.5 21.7 15.9 22.0 15.7 17.2 54.2 18.4 39.4 32.0 27.7 24.4 13.2 20.5 30.3 17.5 12.6 36.5 34.7 24.4 21.9 24.6 22.4 15.6 14.8 9.9 10.5 21.8 19.8 10.5 21.8 24.2 11.9 14.5 5.3 13.2 22.2 8.6 17.7 17.6 13.1 17.5 29.0 38.2 24.8 16.7 9.1 18.8 12.5 19.4 6.4 22.2 18.9 22.8 24.6 16.8 17.4 24.6 20.9 22.7 13.3 13.0 10.8 14.0 19.3 17.9 23.1 27.5 7.1 29.8 32.9 24.6 19.2 9.9 18.5 20.6 5.7 46.1 12.0 24.6 19.8 27.2 6.4 36.8 21.5 7.4 30.0 12.3 15.6 11.9 10.5 14.8 12.3 35.1 27.2 21.4 13.3 8.9 8.5 7.0 10.0 9.9 13.3 10.5 15.5 15.3 18.5 19.8 14.8 15.6 16.9 14.7 6.3 21.8 10.3 13.4 11.9 10.5 17.5 24.3 29.8 33.8 15.9 13.0 14.5 19.2 15.9 12.6 17.9 45.0 65.3 52.1 43.6 62.1 5.6 35.7 5.3 12.5 29.6 27.5 63.6 53.0 43.3 65.8 40.2 144.6 0.0 103.8 66.7 40.9 44.2 38.0 45.2 39.6 63.5 91.9 45.4 49.7 145.2 49.5 26.5 47.2 65.9 97.4 47.8 56.6 144.0 51.2 58.6 41.1 25.8 45.3 35.7 31.3 47.9 96.5 55.8 135.4 40.9 VSIG4 Z39IG ENSG00000155659 "V-set and immunoglobulin domain containing 4" Q9Y279 X 66021738-66040125 "Plasma proteins, Predicted membrane proteins" "Complement alternate pathway, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 31 "Hofbauer cells: 772.9;Kupffer cells: 436.3;Macrophages: 389.0" "Cancer enhanced" "Detected in all" "glioma: 88.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 26 "classical monocyte: 13.9;intermediate monocyte: 8.1;myeloid DC: 13.1" "Group enriched" "Detected in many" 30 "dendritic cells: 13.1;monocytes: 13.9" "Cell line enhanced" "Detected in some" "BEWO: 1.2;HMC-1: 1.1;NB-4: 3.1;SH-SY5Y: 1.1;U-937: 2.7" "Low region specificity" "Detected in many" "HPA003903, CAB026000" Enhanced Uncertain "Nucleoli,Plasma membrane,Cytosol" NA NA 41000000 "Plasma membrane, Cytosol" Nucleoli "CAB026000: , HPA003903: AB_1858776" "unprognostic (6.87e-3)" "unprognostic (4.79e-2)" "prognostic unfavorable (1.34e-4)" "unprognostic (3.19e-1)" "unprognostic (1.30e-2)" "unprognostic (1.53e-2)" "unprognostic (9.37e-3)" "unprognostic (1.24e-1)" "unprognostic (3.10e-1)" "unprognostic (1.37e-3)" "unprognostic (1.06e-1)" "unprognostic (2.77e-1)" "prognostic unfavorable (1.95e-6)" "unprognostic (3.70e-2)" "unprognostic (5.45e-2)" "unprognostic (3.37e-2)" "unprognostic (3.47e-2)" 67.1 28.1 15.9 17.6 16.6 2.6 19.0 1.8 10.4 6.3 18.0 5.6 1.0 9.2 6.1 14.2 9.3 28.7 15.5 15.9 11.5 3.5 18.5 22.9 61.4 37.0 17.9 3.4 8.2 8.2 3.7 7.9 52.4 12.0 10.9 12.6 8.1 11.3 4.0 10.5 4.0 14.6 39.9 16.7 28.5 9.4 13.5 17.8 0.0 10.7 1.7 1.8 14.4 9.0 0.1 13.1 0.4 13.9 0.0 0.2 3.3 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.5 0.0 0.0 0.1 3.1 0.2 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.8 1.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.3 0.1 0.4 0.0 0.0 0.8 2.7 0.0 0.0 13.9 0.0 0.0 8.1 0.0 0.0 0.0 0.2 13.1 0.1 0.0 0.0 0.4 0.0 0.2 0.0 0.0 3.3 15.9 16.6 1.8 10.1 11.5 3.5 17.9 3.4 12.0 17.8 3.0 17.3 3.0 0.1 2.1 0.0 0.8 7.6 8.1 5.7 0.0 0.0 4.4 0.0 0.0 5.8 1.9 0.0 0.0 0.0 3.7 3.8 0.2 3.5 2.4 772.9 0.0 0.0 5.5 436.3 13.2 1.4 389.0 3.3 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 6.5 0.2 0.2 0.9 1.5 10.3 0.0 0.0 0.2 WASHC2A "bA56A21.1, bA98I6.1, FAM21A, FAM21B, FLJ10824" ENSG00000099290 "WASH complex subunit 2A" Q641Q2 10 50067888-50133506 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 1: 35.7;Ciliated cells: 76.3;Club cells: 42.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA047844, HPA060975, HPA061022" Supported Supported Nucleoli,Vesicles,Cytosol NA NA Vesicles "Nucleoli, Cytosol" "HPA047844: AB_2680177, HPA060975: AB_2684401, HPA061022: AB_2732656" "unprognostic (2.46e-1)" "unprognostic (1.11e-3)" "unprognostic (8.82e-2)" "unprognostic (3.28e-1)" "unprognostic (2.75e-1)" "unprognostic (6.51e-3)" "prognostic unfavorable (6.75e-5)" "unprognostic (4.60e-2)" "unprognostic (2.85e-2)" "unprognostic (2.37e-2)" "unprognostic (9.04e-2)" "unprognostic (2.73e-2)" "unprognostic (1.18e-1)" "unprognostic (2.57e-1)" "unprognostic (2.95e-1)" "unprognostic (1.85e-2)" "unprognostic (4.40e-2)" 24.0 21.0 15.8 31.4 19.3 24.7 27.1 22.5 18.3 19.1 21.2 16.2 12.6 19.4 22.8 15.3 15.7 15.5 14.4 42.9 17.6 13.9 26.1 12.1 20.7 20.2 15.3 15.8 22.5 14.0 21.2 27.0 17.7 22.0 16.7 23.0 13.1 17.5 16.5 15.5 19.2 21.3 16.8 14.6 27.4 16.2 9.4 14.8 27.0 21.4 9.8 20.2 18.4 27.4 6.6 9.0 11.7 13.9 9.0 12.5 8.8 11.1 5.4 9.2 10.8 37.6 21.0 7.5 13.1 27.8 19.5 20.8 12.5 16.7 9.8 8.2 19.5 18.3 12.2 13.3 11.0 19.3 9.4 9.7 7.0 10.8 12.5 26.2 11.9 12.2 21.6 13.9 21.3 13.5 20.5 14.7 8.4 11.3 9.9 23.4 7.9 6.5 19.5 7.5 7.1 25.5 10.0 13.4 5.8 13.4 12.8 3.2 9.9 12.2 11.3 17.4 14.2 14.0 8.2 21.5 10.0 8.4 28.1 10.7 10.3 20.3 8.4 21.9 21.9 4.0 1.2 10.7 11.7 12.0 13.9 12.5 6.6 10.2 11.0 9.0 6.5 10.2 7.4 5.1 9.0 8.2 5.3 10.4 8.8 15.8 19.3 22.5 18.3 17.6 13.9 15.3 15.8 22.0 14.8 35.7 22.0 0.0 0.0 0.0 0.0 0.0 0.0 76.3 42.1 14.0 0.0 6.6 0.0 14.2 0.0 0.0 0.0 0.0 13.5 5.7 0.0 0.0 14.0 0.0 16.2 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 10.0 0.0 0.0 12.2 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 WASHC2C "Em:AC012044.3, FAM21C, KIAA0592" ENSG00000172661 "WASH complex subunit 2C" Q9Y4E1 10 45727200-45792961 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 32.8;Alveolar cells type 2: 26.2;Ciliated cells: 45.5;Collecting duct cells: 22.7;granulocytes: 27.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA047844, HPA060975, HPA061022" Supported Supported Nucleoli,Vesicles,Cytosol NA NA Vesicles "Nucleoli, Cytosol" "HPA047844: AB_2680177, HPA060975: AB_2684401, HPA061022: AB_2732656" "unprognostic (7.50e-2)" "unprognostic (2.32e-2)" "unprognostic (1.13e-1)" "unprognostic (1.06e-1)" "unprognostic (4.51e-2)" "unprognostic (5.98e-3)" "prognostic unfavorable (1.35e-5)" "prognostic favorable (4.69e-4)" "unprognostic (1.26e-1)" "unprognostic (5.02e-2)" "unprognostic (1.00e-3)" "unprognostic (1.51e-1)" "unprognostic (2.24e-1)" "unprognostic (1.48e-1)" "unprognostic (1.09e-1)" "unprognostic (1.73e-1)" "unprognostic (2.00e-2)" 17.2 15.8 10.0 33.6 15.7 30.1 27.2 24.9 17.1 16.7 15.8 10.7 15.9 12.2 18.3 17.0 12.3 13.2 13.6 23.2 14.2 10.2 20.6 12.8 17.3 14.8 16.0 8.4 20.2 10.1 22.7 16.5 13.4 16.2 13.4 18.5 13.0 15.3 24.0 17.1 14.8 17.0 15.8 14.0 15.5 12.5 10.1 15.3 19.4 14.9 13.2 14.6 19.3 14.8 10.7 11.4 17.2 20.3 12.2 13.4 11.6 11.2 12.2 9.9 11.3 25.9 23.0 6.0 13.3 21.9 15.7 15.2 7.4 11.1 9.3 9.1 19.6 15.0 10.3 11.1 6.1 15.9 8.7 9.2 9.6 15.2 5.7 27.5 9.6 12.0 21.7 14.8 17.0 12.8 15.5 16.2 7.9 15.3 7.4 19.3 5.9 6.4 16.7 7.2 6.8 1.9 8.1 14.6 4.8 11.7 17.8 4.8 10.9 15.4 7.8 18.6 10.6 10.5 9.7 27.2 8.2 8.8 21.7 8.9 10.5 16.2 9.3 11.6 23.2 4.3 12.5 16.9 11.0 13.0 18.2 12.5 10.7 10.8 13.4 11.4 9.6 10.8 9.7 17.2 12.2 20.3 8.4 10.1 11.6 10.0 15.7 24.9 17.1 14.2 10.2 16.0 8.4 16.2 15.3 32.8 26.2 0.0 0.0 0.0 0.0 0.0 0.0 45.5 21.6 22.7 0.0 6.2 3.3 10.9 0.0 0.0 0.0 0.0 12.1 5.4 0.0 0.0 27.9 0.0 16.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 18.0 0.0 0.0 10.6 0.0 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 WDFY3 "ALFY, KIAA0993, ZFYVE25" ENSG00000163625 "WD repeat and FYVE domain containing 3" Q8IZQ1 4 84669610-84966391 "Disease related genes, Predicted intracellular proteins" Autophagy "Developmental protein" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.3" "Group enriched" "Detected in many" 23 "dendritic cells: 1.1;granulocytes: 4.3;monocytes: 1.5" "Cell line enhanced" "Detected in many" "TIME: 31.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042734, HPA048572" Approved Approved "Nucleoli,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoli, Plasma membrane" "HPA042734: AB_2678135, HPA048572: AB_2680447" "unprognostic (7.14e-2)" "unprognostic (6.02e-2)" "unprognostic (7.68e-2)" "unprognostic (1.60e-1)" "unprognostic (1.84e-2)" "unprognostic (2.48e-1)" "unprognostic (2.86e-2)" "unprognostic (3.36e-1)" "unprognostic (1.01e-1)" "unprognostic (4.33e-2)" "unprognostic (3.36e-1)" "unprognostic (7.12e-2)" "prognostic favorable (3.64e-5)" "prognostic unfavorable (9.35e-4)" "unprognostic (2.79e-1)" "unprognostic (4.41e-2)" "unprognostic (4.95e-2)" 10.1 15.2 17.2 7.5 18.7 13.1 9.0 17.9 18.6 9.6 8.3 17.6 4.8 3.6 11.5 6.9 9.4 9.3 9.0 7.3 17.3 6.5 21.3 5.8 7.9 2.4 22.8 9.5 14.7 9.0 24.0 14.6 11.8 17.0 9.2 5.9 8.6 9.8 8.1 13.7 10.9 5.6 8.7 14.8 7.5 7.8 8.0 21.4 0.4 12.1 3.2 2.6 14.2 6.6 0.0 1.1 4.3 1.5 0.0 0.0 0.3 6.5 4.5 8.1 4.5 14.5 11.4 5.1 6.3 6.7 6.6 6.0 5.0 5.4 0.0 6.5 10.4 7.0 3.3 8.7 6.9 8.4 4.5 2.7 4.1 4.9 3.0 5.5 3.2 7.8 8.3 6.3 8.6 8.7 8.0 20.9 3.4 4.1 20.0 12.0 4.7 3.1 0.7 4.2 6.3 2.2 4.6 6.5 0.9 11.4 8.6 9.6 4.5 7.7 8.6 4.3 8.1 4.4 8.0 31.7 8.7 8.7 4.8 7.9 0.0 0.0 0.0 5.9 2.8 9.5 0.0 1.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 4.3 0.0 0.5 0.0 0.0 0.3 17.2 18.7 17.9 18.6 17.3 6.5 22.8 9.5 17.0 21.4 17.9 11.7 1.5 8.3 13.1 41.7 15.5 15.3 10.7 12.5 15.7 33.4 9.5 1.7 8.5 6.7 16.9 4.6 0.0 6.2 5.5 12.3 13.0 0.0 7.6 17.1 27.0 8.7 22.1 39.6 7.7 17.0 17.4 6.8 5.4 7.0 26.8 8.9 5.8 23.0 14.9 41.9 25.8 15.6 7.4 7.8 14.1 12.1 0.5 6.6 10.0 WDR12 "FLJ10881, YTM1" ENSG00000138442 "WD repeat domain 12" Q9GZL7 2 202874782-203014798 "Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036389 Uncertain Approved "Nucleoli,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoli "HPA036389: AB_10670716" "unprognostic (1.08e-2)" "unprognostic (3.59e-1)" "unprognostic (8.17e-2)" "unprognostic (3.59e-3)" "unprognostic (1.24e-2)" "unprognostic (9.40e-3)" "prognostic unfavorable (2.57e-6)" "unprognostic (1.52e-1)" "unprognostic (6.14e-2)" "unprognostic (4.78e-2)" "unprognostic (4.58e-2)" "unprognostic (1.50e-1)" "unprognostic (1.69e-1)" "unprognostic (5.21e-2)" "unprognostic (2.66e-1)" "unprognostic (9.69e-3)" "unprognostic (4.48e-2)" 5.8 9.7 7.2 5.5 16.1 6.7 7.6 11.5 15.2 5.9 6.2 6.5 3.7 8.9 7.1 7.0 8.0 6.7 5.0 8.4 6.8 8.6 11.1 8.7 4.2 6.4 7.4 8.9 7.3 5.7 6.7 8.0 6.6 12.6 4.9 8.7 6.7 5.4 5.2 11.0 7.7 6.0 7.4 6.2 5.3 5.6 17.1 8.2 9.6 7.1 5.1 7.5 5.8 5.6 5.4 6.9 3.6 5.0 3.6 5.9 3.0 4.4 4.7 5.4 10.1 10.2 8.8 9.8 6.7 5.4 8.4 8.1 11.8 6.2 8.0 6.2 5.4 7.4 5.6 14.6 10.8 13.4 4.0 9.0 13.6 7.5 13.9 6.6 17.7 8.4 7.9 7.8 9.9 19.7 5.6 8.7 8.8 21.3 5.3 9.1 5.1 12.1 10.4 12.3 5.9 11.9 8.8 8.4 12.6 9.1 5.3 9.5 8.3 5.3 7.0 8.2 9.8 4.1 11.7 6.9 7.5 6.1 6.2 7.4 7.0 10.4 13.5 7.4 12.1 7.4 3.6 4.7 2.0 4.2 5.0 5.9 5.3 4.0 4.3 6.0 5.4 5.2 5.0 2.1 3.6 4.5 6.9 4.3 3.0 7.2 16.1 11.5 15.2 6.8 8.6 7.4 8.9 12.6 8.2 8.9 16.3 6.0 16.7 18.2 9.1 22.5 10.2 17.4 17.0 5.2 2.0 21.5 13.3 14.9 8.1 10.6 10.0 0.0 9.1 29.0 15.4 7.7 15.0 13.6 15.8 14.3 5.2 8.0 9.1 6.6 15.8 9.5 1.7 8.2 9.1 5.8 12.6 3.5 14.5 29.9 7.8 12.9 15.1 35.1 32.6 15.2 18.0 10.2 17.2 16.0 WDSUB1 "FLJ36175, UBOX6, WDSAM1" ENSG00000196151 "WD repeat, sterile alpha motif and U-box domain containing 1" Q8N9V3 2 159235793-159286799 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036840, HPA058172" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA036840: AB_10670926, HPA058172: AB_2683628" "unprognostic (1.37e-2)" "prognostic favorable (3.35e-4)" "unprognostic (2.56e-1)" "unprognostic (7.33e-3)" "unprognostic (3.44e-2)" "unprognostic (9.65e-2)" "prognostic unfavorable (2.67e-4)" "unprognostic (2.76e-3)" "unprognostic (4.90e-3)" "unprognostic (1.10e-1)" "unprognostic (1.07e-2)" "unprognostic (6.75e-2)" "unprognostic (3.46e-3)" "unprognostic (8.49e-2)" "unprognostic (1.72e-1)" "unprognostic (1.00e-2)" "unprognostic (2.87e-2)" 10.3 14.2 9.7 6.6 12.7 10.9 14.8 18.9 14.0 10.3 8.5 8.9 10.6 5.8 9.8 22.1 11.1 11.8 9.9 11.5 9.7 10.6 27.7 8.2 10.7 16.1 11.5 7.0 16.4 15.5 19.4 23.8 15.7 9.2 11.3 9.2 16.0 11.8 8.7 7.7 8.2 7.7 9.9 9.5 10.5 9.0 7.7 10.2 8.5 22.2 6.1 9.2 10.0 15.0 9.8 10.3 2.8 9.3 16.2 13.0 6.2 6.1 4.6 4.2 6.6 7.6 8.8 14.2 4.8 9.5 8.8 15.5 9.9 10.0 8.2 5.1 7.2 15.1 3.7 11.7 4.4 12.4 3.2 9.7 8.4 5.3 10.0 9.3 7.1 11.7 5.1 16.4 10.8 8.9 16.9 7.2 10.9 11.1 6.2 8.3 6.3 5.1 13.2 5.7 10.4 9.9 8.0 6.2 4.4 10.1 8.9 7.8 5.1 5.0 6.5 11.2 20.4 5.0 12.6 3.0 6.3 4.6 8.8 4.6 3.2 5.3 7.6 11.1 8.9 3.9 2.7 9.3 2.8 13.0 7.0 9.8 9.8 5.2 8.1 10.3 8.9 6.3 7.4 0.6 16.2 6.3 9.7 2.6 6.2 9.7 12.7 18.9 14.0 9.7 10.6 11.5 7.0 9.2 10.2 11.9 5.0 6.7 7.4 4.7 6.4 10.7 10.2 17.4 9.1 19.2 2.0 20.1 29.9 7.2 3.0 6.6 5.1 0.0 3.1 7.7 8.8 6.6 11.5 1.7 15.4 4.8 5.2 6.2 13.9 2.1 11.8 9.5 5.0 3.6 5.5 6.0 4.7 9.0 10.6 17.4 8.9 0.0 7.1 10.5 20.2 5.5 19.2 10.1 7.0 5.1 ZBED9 "Buster4, FLJ31087, KIAA1925, SCAND3, ZFP38-L, ZNF305P2, ZNF452" ENSG00000232040 "Zinc finger BED-type containing 9" Q6R2W3 6 28570535-28616212 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 13.2;testis: 17.6" "Group enriched" "Detected in many" 4 "Early spermatids: 17.9;Spermatocytes: 27.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 7.8;hTCEpi: 7.1;K-562: 12.5;U-266/84: 6.0" HPA007246 Uncertain Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA Nucleoli "Nucleoplasm, Golgi apparatus" "HPA007246: AB_1080727" "unprognostic (1.01e-1)" "unprognostic (5.16e-5)" "unprognostic (1.88e-1)" "unprognostic (1.27e-4)" "unprognostic (3.96e-2)" "unprognostic (9.46e-3)" "unprognostic (3.40e-1)" "unprognostic (2.73e-2)" "unprognostic (4.24e-2)" "unprognostic (2.34e-3)" "unprognostic (8.21e-3)" "unprognostic (4.31e-1)" "unprognostic (2.42e-2)" "unprognostic (1.14e-2)" "unprognostic (7.66e-3)" "unprognostic (3.92e-2)" "unprognostic (1.59e-1)" 0.8 1.8 2.6 0.4 7.2 0.4 2.3 9.5 4.7 2.3 1.1 0.3 9.3 0.7 1.6 7.5 1.0 3.1 0.7 1.2 2.4 2.3 2.3 3.2 1.9 0.5 1.3 2.9 4.1 3.4 3.2 6.9 3.0 3.5 3.4 1.5 0.8 2.4 13.2 0.5 0.7 0.8 1.1 0.8 0.6 1.0 17.6 0.7 0.0 4.1 0.0 0.6 1.4 1.2 0.5 0.7 1.1 0.7 0.4 1.4 0.2 1.8 1.8 1.9 0.0 0.0 0.0 2.3 0.4 0.0 0.4 1.2 0.0 1.2 0.0 7.8 0.1 3.8 1.0 0.0 2.1 0.4 0.0 5.2 0.5 1.2 1.8 1.3 0.0 0.0 1.1 7.1 0.1 3.5 1.1 0.0 0.0 12.5 0.0 0.1 1.4 0.0 0.1 1.8 0.0 0.9 0.7 0.8 0.1 2.0 2.2 2.0 4.9 0.0 2.0 0.0 2.8 0.0 0.6 0.0 0.0 2.2 0.0 1.2 0.0 6.0 0.0 0.0 0.0 0.0 0.6 0.3 0.3 0.3 0.4 0.1 0.2 0.4 0.4 0.2 0.5 1.4 1.0 1.1 0.4 0.7 0.7 0.1 0.2 2.6 7.2 9.5 4.7 2.4 2.3 1.3 2.9 3.5 0.7 0.0 2.7 0.0 0.8 0.0 1.6 1.6 5.1 1.4 1.2 0.0 2.0 2.0 1.7 1.7 17.9 0.0 0.4 0.0 1.2 1.1 0.4 1.1 0.0 1.6 0.3 0.0 1.2 0.0 0.0 3.2 2.3 0.0 0.0 0.0 1.4 1.1 0.6 0.0 0.0 0.7 1.1 0.0 0.0 27.7 2.9 0.0 0.8 0.0 0.9 0.6 ZBTB14 "ZFP161, ZNF478" ENSG00000198081 "Zinc finger and BTB domain containing 14" O43829 18 5289019-5297053 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050758, HPA070819" Uncertain Supported Nucleoplasm,Nucleoli,Cytosol No No Nucleoplasm "Nucleoli, Cytosol" "HPA050758: AB_2681226, HPA070819: AB_2686316" "unprognostic (5.28e-2)" "unprognostic (4.37e-2)" "unprognostic (4.25e-2)" "unprognostic (2.66e-1)" "unprognostic (1.27e-1)" "unprognostic (1.85e-2)" "unprognostic (2.95e-2)" "unprognostic (8.64e-2)" "unprognostic (1.19e-3)" "unprognostic (4.72e-3)" "unprognostic (3.25e-2)" "unprognostic (1.49e-1)" "unprognostic (3.70e-2)" "unprognostic (2.03e-1)" "unprognostic (2.53e-1)" "unprognostic (3.73e-1)" "unprognostic (2.90e-2)" 11.2 9.1 13.1 11.6 13.4 6.8 10.8 24.3 12.8 8.7 8.7 10.7 10.8 7.2 12.5 14.9 10.8 9.3 10.3 7.1 13.1 10.2 9.8 11.3 11.0 19.5 14.5 7.6 14.2 12.1 12.8 8.7 8.5 7.3 9.8 8.7 10.3 9.8 11.1 6.9 11.8 12.7 7.5 16.4 17.4 9.8 10.8 8.2 30.8 15.9 7.0 18.1 11.2 11.8 10.1 8.6 14.3 8.2 7.5 13.4 7.6 7.1 9.5 12.5 9.2 9.4 12.4 8.3 7.1 10.6 10.1 8.9 9.1 9.4 25.1 6.3 8.6 11.6 6.7 9.1 10.7 10.2 4.9 4.9 9.9 8.7 8.3 6.6 12.4 12.0 9.9 9.1 7.0 6.6 10.9 15.6 18.2 6.3 8.3 10.2 7.8 18.6 8.3 11.0 8.9 4.9 11.1 8.0 7.2 8.5 8.8 11.1 10.9 10.9 7.2 11.5 13.0 8.6 14.3 8.7 13.1 10.9 10.1 10.6 5.3 5.3 15.5 13.8 10.7 11.5 10.9 5.7 14.3 9.9 8.2 9.9 8.3 12.7 11.4 8.6 10.1 13.4 12.7 1.3 7.5 7.3 6.5 7.9 7.6 13.1 13.4 24.3 12.8 13.1 10.2 14.5 7.6 7.3 8.2 6.0 4.1 11.1 1.3 2.2 6.5 2.8 2.5 1.4 1.2 5.2 0.0 4.0 5.0 4.2 0.8 6.3 4.0 0.0 2.9 4.9 4.5 2.5 16.1 5.7 6.2 4.8 1.2 9.2 5.9 1.7 5.5 5.2 1.7 4.6 5.1 8.2 3.2 4.2 5.3 4.0 5.8 0.0 4.1 0.7 11.7 2.6 1.8 4.4 4.4 0.6 ZC3H14 "FLJ11806, NY-REN-37, UKp68" ENSG00000100722 "Zinc finger CCCH-type containing 14" Q6PJT7 14 88562909-88627596 "Disease related genes, Predicted intracellular proteins" RNA-binding "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 73.1" "Group enriched" "Detected in many" 5 "Early spermatids: 961.1;Late spermatids: 410.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049798, HPA053510" Enhanced Enhanced "Nucleoli,Nucleoli rim,Nuclear speckles" NA NA "Nuclear speckles" "Nucleoli, Nucleoli rim" "HPA049798: AB_2680888, HPA053510: AB_2682174" "unprognostic (5.80e-3)" "unprognostic (2.25e-1)" "unprognostic (1.35e-2)" "unprognostic (7.39e-2)" "unprognostic (2.06e-1)" "unprognostic (1.91e-1)" "unprognostic (6.47e-3)" "unprognostic (9.57e-2)" "unprognostic (7.21e-3)" "unprognostic (2.77e-3)" "unprognostic (4.83e-2)" "unprognostic (1.50e-2)" "prognostic favorable (7.08e-4)" "unprognostic (2.09e-1)" "unprognostic (8.23e-2)" "unprognostic (3.71e-1)" "unprognostic (4.25e-2)" 13.5 12.6 16.2 10.8 16.4 9.7 13.3 23.4 19.6 14.0 15.3 14.3 17.5 10.6 17.2 15.5 12.4 15.8 10.4 12.3 14.8 8.4 15.2 24.9 13.9 9.1 16.1 16.3 17.1 19.4 19.3 24.1 14.8 16.0 14.9 16.6 11.3 18.0 16.3 15.4 13.6 15.2 14.8 11.2 9.4 12.7 73.1 14.1 9.3 19.4 8.2 11.4 16.2 12.8 13.3 17.4 21.7 21.1 18.5 17.7 13.3 16.4 31.8 29.2 23.1 23.2 22.5 29.6 25.3 23.0 36.0 31.8 22.6 26.0 23.0 18.3 25.7 19.8 20.3 20.6 23.6 49.1 19.4 15.5 11.2 22.7 18.4 23.3 24.6 14.7 18.0 27.8 28.1 28.2 24.6 23.4 21.1 21.9 10.6 32.5 35.1 22.2 13.6 18.6 25.9 28.1 19.4 37.3 10.0 24.3 29.7 21.9 19.6 31.6 36.2 17.7 25.2 33.0 16.1 17.2 43.8 26.8 18.4 25.1 13.6 11.8 25.7 21.5 12.0 20.0 12.9 16.0 21.7 15.9 20.0 17.7 13.3 15.5 17.5 17.4 12.0 14.7 14.7 2.9 18.5 21.1 9.5 13.2 13.3 16.2 16.4 23.4 19.6 14.8 8.4 16.1 16.3 16.0 14.1 113.2 41.2 16.2 22.0 20.1 59.3 19.0 25.5 75.0 46.6 19.2 72.6 40.8 29.9 22.1 961.1 18.2 22.3 0.0 19.9 23.4 21.3 22.4 43.9 29.7 17.6 62.0 30.5 23.4 10.4 410.4 36.5 14.0 5.0 13.6 27.9 35.0 19.9 14.0 44.6 24.5 76.1 12.9 27.6 125.8 76.6 17.2 34.0 17.5 29.2 13.6 ZCCHC2 "C18orf49, FLJ20222, FLJ20281, KIAA1744" ENSG00000141664 "Zinc finger CCHC-type containing 2" Q9C0B9 18 62523007-62587709 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "salivary gland: 99.1" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 114.5;Late spermatids: 110.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040943 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" Nucleoplasm "HPA040943: AB_10795496" "unprognostic (9.32e-2)" "unprognostic (1.68e-1)" "unprognostic (1.17e-1)" "unprognostic (2.84e-3)" "unprognostic (1.40e-1)" "unprognostic (4.07e-2)" "unprognostic (4.79e-2)" "unprognostic (2.60e-1)" "unprognostic (1.93e-1)" "unprognostic (8.25e-2)" "unprognostic (2.32e-2)" "unprognostic (1.30e-1)" "unprognostic (5.12e-2)" "unprognostic (2.45e-1)" "unprognostic (3.72e-2)" "unprognostic (1.46e-1)" "unprognostic (1.29e-1)" 12.6 5.0 6.8 7.0 7.5 22.8 16.0 8.0 6.8 7.5 8.5 6.0 5.3 6.8 6.9 7.1 6.5 7.4 9.0 8.5 5.3 5.7 5.8 23.0 10.1 7.6 8.1 5.7 8.8 6.3 7.8 8.5 8.2 5.5 8.1 5.8 4.5 99.1 5.9 16.8 11.3 7.5 7.6 5.6 8.9 6.5 13.4 8.9 10.8 7.8 4.3 6.4 11.0 19.3 1.6 1.0 4.9 1.6 0.6 2.0 0.4 6.0 5.2 4.5 8.9 13.8 5.9 8.6 3.4 5.2 8.3 8.3 2.8 3.7 17.0 4.6 5.7 6.8 10.2 14.5 7.6 3.4 11.7 6.8 4.4 12.1 19.0 4.7 8.5 6.5 5.8 9.9 5.2 9.8 6.0 15.5 7.7 4.7 5.7 2.7 4.9 5.5 3.6 2.9 4.4 5.2 7.4 4.8 0.1 5.7 6.1 5.7 3.5 5.8 13.1 5.1 8.5 4.6 6.8 6.6 8.1 5.6 3.2 4.9 2.2 4.3 7.3 6.1 3.6 3.0 0.0 1.0 2.4 1.7 1.6 1.2 0.5 1.1 1.5 0.3 1.6 2.0 1.3 4.9 0.6 0.3 1.0 1.2 0.4 6.8 7.5 8.0 6.8 5.3 5.7 8.1 5.7 5.5 8.9 23.8 19.7 4.2 13.1 23.7 27.6 18.8 15.3 9.4 14.8 15.7 51.1 6.3 3.3 5.4 114.5 20.9 7.7 0.0 5.3 10.1 7.6 13.8 2.3 28.0 12.5 41.3 12.1 17.8 39.8 110.8 7.5 21.1 6.8 4.6 13.2 9.2 4.8 10.5 7.4 4.3 19.1 6.5 15.3 11.5 6.6 16.2 5.7 7.5 10.3 10.5 ZEB2 "KIAA0569, SIP-1, SIP1, ZFHX1B" ENSG00000169554 "Zinc finger E-box binding homeobox 2" O60315 2 144364364-144524583 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Disease mutation, Epilepsy, Hirschsprung disease, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 76.6" "Cell type enhanced" "Detected in many" 10 "Horizontal cells: 626.1;Kupffer cells: 357.2;Macrophages: 271.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 39.1;THP-1: 46.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003456 Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA003456: AB_10603840" "unprognostic (1.02e-1)" "unprognostic (2.08e-1)" "unprognostic (1.12e-1)" "unprognostic (2.42e-1)" "unprognostic (4.12e-1)" "unprognostic (4.17e-2)" "unprognostic (3.69e-1)" "unprognostic (3.77e-2)" "unprognostic (5.83e-2)" "unprognostic (7.90e-2)" "unprognostic (1.33e-1)" "unprognostic (1.62e-1)" "prognostic unfavorable (6.04e-5)" "unprognostic (1.11e-2)" "unprognostic (1.73e-2)" "unprognostic (7.45e-2)" "unprognostic (1.32e-2)" 30.2 23.7 48.0 27.8 42.4 55.5 16.6 6.7 36.6 29.4 12.3 72.9 3.4 11.3 15.6 11.1 14.4 11.1 22.6 22.5 52.5 28.8 9.9 11.6 20.7 19.6 54.4 26.4 37.5 3.6 5.0 3.1 31.5 37.6 10.9 16.3 15.7 5.7 12.5 9.6 7.7 12.8 17.2 76.6 32.6 9.3 8.2 38.7 1.9 8.3 7.5 12.4 21.5 14.8 5.0 12.7 9.7 21.6 3.6 10.7 7.4 0.4 0.5 22.5 0.0 26.9 13.7 0.0 9.2 9.4 10.4 10.1 0.0 0.2 1.7 0.0 10.0 2.8 0.1 3.8 0.0 13.0 9.6 2.6 39.1 1.6 0.0 6.1 6.7 31.1 11.2 0.2 12.9 6.2 8.8 7.8 0.0 10.9 1.1 12.2 0.0 0.0 20.5 3.2 0.0 0.5 11.5 15.5 0.0 0.1 0.2 0.2 5.9 1.1 0.0 24.3 7.5 0.0 46.5 12.1 12.0 0.2 23.3 2.9 12.7 0.0 1.9 17.9 20.2 32.2 9.7 21.6 5.7 10.7 20.8 1.0 4.4 1.4 5.3 12.7 5.0 1.1 4.0 7.5 3.6 19.5 10.2 0.3 7.4 48.0 42.4 6.7 35.6 52.5 28.8 54.4 26.4 37.6 38.7 6.0 25.8 45.8 1.2 22.0 178.1 50.1 2.5 6.7 18.2 5.2 3.9 1.3 1.7 0.6 2.0 23.8 0.0 23.3 0.7 1.6 146.0 1.5 150.5 2.1 126.8 626.1 0.0 81.0 357.2 4.0 111.7 271.2 97.8 46.9 0.0 84.2 0.2 0.0 62.6 7.3 8.6 181.1 167.0 2.3 7.0 17.1 3.9 99.2 0.0 2.0 ZMYM4 "KIAA0425, MYM, ZNF198L3, ZNF262" ENSG00000146463 "Zinc finger MYM-type containing 4" Q5VZL5 1 35268967-35422058 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051301, HPA054802" Approved Approved Nucleoplasm,Nucleoli,Cytosol No No Nucleoplasm "Nucleoli, Cytosol" "HPA051301: AB_2681431, HPA054802: AB_2682605" "unprognostic (8.95e-2)" "unprognostic (6.80e-2)" "unprognostic (1.51e-2)" "unprognostic (1.76e-2)" "unprognostic (1.06e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (9.75e-9)" "unprognostic (9.76e-2)" "unprognostic (4.35e-3)" "unprognostic (4.44e-2)" "unprognostic (6.70e-2)" "unprognostic (4.98e-2)" "prognostic unfavorable (8.10e-4)" "unprognostic (1.18e-1)" "unprognostic (2.04e-1)" "unprognostic (9.18e-2)" "unprognostic (2.21e-1)" 16.6 15.9 17.9 17.3 22.1 13.6 19.7 28.1 24.7 22.0 14.8 17.1 18.3 10.2 19.8 18.2 15.0 17.9 15.7 13.1 17.6 19.0 15.8 14.4 14.1 15.0 15.8 14.6 27.0 15.7 26.1 22.6 19.6 22.2 21.0 13.6 18.2 18.0 26.8 15.9 12.9 12.5 16.6 15.2 16.0 15.4 36.3 13.6 26.7 21.6 13.0 18.8 17.2 14.7 4.2 9.8 3.5 8.2 9.6 4.4 2.5 12.8 10.4 32.1 16.2 9.4 20.4 11.8 15.3 23.1 18.7 24.4 11.2 12.9 23.9 9.4 19.1 9.1 8.3 22.2 11.3 27.0 13.5 15.4 29.2 12.2 9.5 17.0 25.0 13.2 15.4 10.1 18.1 17.2 15.6 20.7 13.3 31.8 6.6 22.6 7.7 21.1 13.9 26.7 6.7 10.0 23.7 20.6 11.6 13.4 17.0 18.5 18.0 18.4 13.5 20.9 21.1 10.9 19.0 24.9 17.4 18.1 7.6 16.4 7.2 13.4 18.4 12.6 19.1 16.6 2.4 5.0 3.5 4.3 7.1 4.4 4.2 4.2 3.8 4.8 3.7 4.1 3.9 1.0 9.6 8.2 9.8 3.1 2.5 17.9 22.1 28.1 24.7 17.6 19.0 15.8 14.6 22.2 13.6 11.9 15.0 11.0 16.2 10.2 27.2 29.5 35.7 22.7 22.7 26.2 29.5 12.4 5.0 19.4 48.6 21.1 5.3 0.0 20.5 10.2 15.8 19.3 13.9 16.1 11.2 22.3 21.5 17.2 18.4 69.6 24.5 13.7 5.0 13.6 13.8 20.1 18.6 9.0 21.5 9.1 33.8 19.4 15.5 22.9 10.4 9.9 11.8 11.7 12.2 24.5 ZNF106 "SH3BP3, ZFP106, ZNF474" ENSG00000103994 "Zinc finger protein 106" Q9H2Y7 15 42412823-42491123 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 64.8;skeletal muscle: 111.1" "Cell type enriched" "Detected in all" 9 "Cardiomyocytes: 1626.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 48.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054267 Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA054267: AB_2682431" "unprognostic (2.15e-2)" "unprognostic (3.31e-1)" "unprognostic (7.10e-2)" "unprognostic (2.61e-2)" "unprognostic (4.01e-2)" "unprognostic (1.34e-1)" "unprognostic (9.32e-2)" "unprognostic (2.49e-1)" "unprognostic (3.96e-1)" "unprognostic (1.33e-2)" "unprognostic (2.27e-1)" "unprognostic (2.07e-1)" "unprognostic (1.76e-3)" "unprognostic (8.71e-2)" "unprognostic (1.78e-1)" "unprognostic (4.36e-1)" "unprognostic (4.09e-3)" 14.9 5.4 8.8 6.6 10.4 9.0 10.3 6.3 9.1 7.1 7.8 4.5 4.5 3.9 7.4 6.3 12.7 5.4 6.1 64.8 9.2 6.3 6.4 3.7 7.8 6.0 7.6 6.4 6.6 4.4 8.4 7.1 5.0 11.9 7.8 5.6 11.3 6.0 5.7 111.1 4.3 5.9 10.9 8.0 6.3 6.0 5.7 7.2 3.4 5.7 46.9 6.8 7.0 17.7 8.3 10.8 48.5 19.6 3.9 5.1 4.5 14.4 8.4 14.7 16.2 37.2 32.8 9.0 11.8 11.2 10.3 11.0 19.7 4.2 9.7 10.5 14.4 11.8 16.6 15.2 12.0 15.8 15.7 7.3 18.6 19.6 7.0 10.7 22.2 11.1 24.7 8.1 15.7 17.5 9.2 16.5 12.2 22.0 1.3 16.7 5.7 8.5 5.4 6.2 11.4 8.6 8.1 26.7 5.3 5.4 16.3 9.4 5.0 23.8 11.2 13.2 12.0 10.3 14.5 24.9 11.1 17.1 14.7 17.2 8.1 15.6 36.4 9.9 17.8 19.2 19.9 19.6 7.6 5.1 15.9 4.5 6.7 4.2 4.2 10.5 8.3 3.8 3.4 48.5 3.9 18.5 10.8 3.8 4.5 8.8 10.4 6.3 9.1 9.2 6.3 7.6 6.4 11.9 7.2 125.0 90.2 37.8 49.6 34.2 58.0 1626.8 56.0 188.7 61.4 27.9 90.3 31.5 34.9 37.0 133.3 49.8 30.9 23.3 36.8 30.7 62.9 79.6 42.8 32.7 46.8 33.4 38.7 57.1 104.1 80.0 34.8 64.4 62.4 28.9 28.5 43.3 51.2 23.0 87.0 34.8 75.4 45.3 46.4 55.4 37.4 26.1 25.6 29.4 33.7 64.4 ZNF121 "D19S204, ZHC32, ZNF20" ENSG00000197961 "Zinc finger protein 121" P58317 19 9560353-9584533 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA054961 Uncertain Approved Nucleoplasm,Nucleoli,Centrosome NA NA "Nucleoplasm, Centrosome" Nucleoli "HPA054961: AB_2682651" "unprognostic (3.06e-1)" "unprognostic (9.38e-3)" "unprognostic (9.51e-2)" "unprognostic (7.49e-2)" "unprognostic (3.07e-2)" "unprognostic (3.91e-3)" "unprognostic (3.68e-2)" "unprognostic (1.76e-1)" "unprognostic (6.80e-3)" "prognostic favorable (6.59e-5)" "unprognostic (9.36e-2)" "unprognostic (1.76e-3)" "prognostic unfavorable (1.01e-4)" "unprognostic (8.75e-3)" "unprognostic (2.83e-1)" "unprognostic (1.06e-1)" "prognostic favorable (5.75e-5)" 13.8 8.9 10.4 11.0 12.3 21.0 14.0 16.1 11.8 10.6 8.9 6.2 12.5 6.7 9.4 10.0 16.5 12.4 7.6 10.3 10.3 5.0 9.2 13.2 14.6 13.0 13.6 6.3 13.8 12.5 22.3 20.2 8.3 11.0 11.8 10.6 5.3 14.1 13.7 9.4 18.6 12.3 12.3 14.8 12.4 11.1 6.2 13.0 12.2 11.3 10.4 12.1 15.8 12.7 6.0 4.6 2.9 4.5 7.1 6.8 1.8 7.7 5.0 6.0 12.5 2.8 3.3 9.3 2.7 2.4 4.0 5.0 8.7 3.4 8.8 7.7 2.1 2.2 7.7 12.2 7.1 5.7 4.2 19.8 27.5 12.3 7.7 3.5 13.6 13.8 4.5 6.3 4.0 10.5 3.6 2.9 9.7 9.8 15.0 2.9 6.5 10.1 31.3 14.8 3.1 8.7 6.5 8.2 6.1 3.9 33.0 10.7 5.4 5.3 5.2 3.1 12.5 4.3 4.4 4.2 12.8 7.2 4.4 6.9 16.0 8.7 10.4 3.5 8.0 4.4 2.9 3.6 2.1 5.5 4.4 6.8 4.0 4.9 5.1 4.1 6.0 6.1 6.8 2.8 7.1 4.5 4.6 4.3 1.8 10.4 12.3 16.1 11.8 10.3 5.0 13.6 6.3 11.0 13.0 6.0 8.0 14.1 29.6 20.0 6.5 9.7 7.6 10.7 17.0 8.7 11.8 10.7 6.6 9.0 1.1 7.1 3.3 23.3 4.7 9.4 7.3 18.2 14.0 9.6 4.6 6.4 13.1 9.2 8.9 0.4 5.8 9.2 8.5 1.8 9.2 2.5 9.4 3.5 7.8 4.2 7.0 6.5 6.6 5.4 11.3 27.7 8.8 13.8 12.3 32.8 ZNF354A "EZNF, HKL1, KID-1, KID1, TCF17" ENSG00000169131 "Zinc finger protein 354A" O60765 5 178694605-178730702 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 29.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052043 Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA052043: AB_2681706" "unprognostic (2.79e-1)" "unprognostic (3.44e-2)" "unprognostic (7.06e-3)" "unprognostic (1.78e-3)" "unprognostic (1.38e-1)" "unprognostic (1.32e-1)" "unprognostic (3.25e-2)" "unprognostic (1.41e-1)" "unprognostic (7.66e-3)" "prognostic favorable (8.28e-4)" "unprognostic (4.06e-2)" "unprognostic (4.55e-2)" "prognostic unfavorable (3.45e-6)" "unprognostic (8.71e-2)" "unprognostic (4.13e-1)" "unprognostic (1.13e-1)" "unprognostic (1.07e-2)" 14.0 7.0 13.0 12.1 13.6 14.2 14.2 13.3 14.4 12.6 15.0 6.7 11.4 7.1 13.7 13.3 10.4 11.7 9.8 14.5 13.2 9.3 18.0 6.2 10.8 12.7 16.7 16.1 10.9 15.0 11.7 14.1 14.0 13.4 13.3 10.0 7.1 8.8 15.1 11.9 12.3 10.6 13.6 12.9 17.1 10.4 14.0 14.4 13.1 15.1 8.6 14.2 17.0 25.1 5.7 5.3 15.0 5.8 6.0 6.4 3.6 4.3 3.4 7.1 18.8 12.4 10.1 29.4 5.0 6.7 7.0 7.5 5.0 7.3 5.8 6.6 4.5 12.9 8.6 2.6 21.3 10.8 7.7 8.1 1.7 4.2 0.6 9.4 0.0 4.9 7.9 13.7 6.1 12.5 9.0 6.6 7.9 1.4 0.0 10.1 8.7 8.7 5.8 6.2 4.0 8.8 6.5 1.2 3.6 6.5 4.4 7.8 8.5 6.3 7.2 9.7 9.8 5.9 8.5 5.1 7.9 5.2 4.5 4.2 1.9 4.0 3.6 0.2 1.3 9.9 4.4 5.8 14.5 5.1 3.8 6.4 5.7 4.6 5.7 5.3 3.6 5.3 3.8 15.0 6.0 3.9 1.9 4.1 3.6 13.0 13.6 13.3 14.4 13.2 9.3 16.7 16.1 13.4 14.4 11.9 6.1 3.2 10.0 4.4 8.9 5.5 0.0 12.0 10.3 7.0 13.7 10.6 11.6 9.8 9.2 8.0 2.1 0.0 6.6 10.6 6.1 5.3 5.8 0.8 8.0 6.4 4.6 6.2 8.2 3.2 6.4 7.8 10.1 3.6 2.2 7.4 6.7 0.0 9.9 13.5 9.7 6.5 9.2 22.3 9.8 4.8 10.2 10.9 4.3 6.9 ZNF404 ENSG00000176222 "Zinc finger protein 404" Q494X3 19 43872363-43901385 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 6 "Alveolar cells type 2: 5.6;granulocytes: 6.9;Horizontal cells: 4.8" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 8.6;U-2 OS: 31.2" "Low region specificity" "Detected in all" "HPA032014, HPA063607" Uncertain Supported "Nucleoli,Nucleoli rim,Intermediate filaments" NA Yes "Nucleoli, Nucleoli rim" "Intermediate filaments" "HPA032014: AB_10602591, HPA063607: AB_2732705" "unprognostic (3.76e-3)" "unprognostic (3.41e-1)" "unprognostic (1.11e-2)" "unprognostic (4.32e-3)" "unprognostic (8.92e-2)" "unprognostic (2.82e-1)" "unprognostic (1.64e-2)" "unprognostic (2.68e-2)" "unprognostic (7.47e-2)" "unprognostic (1.26e-1)" "unprognostic (2.03e-5)" "unprognostic (1.46e-2)" "unprognostic (3.79e-3)" "unprognostic (2.89e-2)" "unprognostic (1.59e-1)" "unprognostic (2.12e-1)" "unprognostic (4.80e-3)" 0.9 2.2 4.6 0.7 4.8 0.1 2.6 5.8 4.8 1.5 2.5 0.2 2.0 10.9 1.2 3.7 2.2 6.0 4.6 4.4 1.5 1.0 1.8 3.1 6.0 7.5 0.8 2.6 8.2 2.6 4.6 1.6 2.6 2.2 1.5 2.9 1.0 1.8 7.0 3.9 1.9 3.4 2.6 1.2 1.5 1.1 1.9 0.9 1.9 0.4 2.1 1.9 0.6 2.3 0.3 2.4 0.3 6.0 8.6 1.4 3.2 1.6 2.0 2.8 0.2 0.8 0.0 3.4 1.5 0.0 0.3 0.4 1.6 2.8 0.3 2.3 0.8 0.0 0.9 2.2 0.2 0.6 5.1 3.9 1.5 1.4 7.0 1.7 0.0 0.1 0.0 1.9 0.2 0.0 0.0 1.9 0.1 0.5 0.0 1.3 0.4 2.0 1.5 1.3 1.0 1.3 0.6 1.6 4.5 0.1 0.9 0.7 2.9 31.2 2.6 1.8 4.1 5.3 0.0 4.1 0.0 1.6 0.0 0.3 1.9 0.7 0.0 0.8 0.9 1.4 0.0 0.4 1.9 1.9 1.5 0.0 2.1 0.4 0.9 1.3 0.6 0.0 5.6 0.0 0.5 0.0 3.7 4.0 0.0 1.4 0.0 0.0 0.0 1.2 0.0 0.5 0.9 0.4 0.2 0.0 0.2 1.0 0.8 0.6 6.9 0.0 0.6 4.8 2.4 1.3 0.3 0.0 0.9 0.1 0.0 0.0 0.6 3.5 0.2 0.0 3.2 0.3 2.5 0.0 1.0 1.6 1.9 0.0 0.8 0.0 0.8 0.6 ZNF461 "GIOT-1, MGC33911" ENSG00000197808 "Zinc finger protein 461" Q8TAF7 19 36637192-36666853 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 26.8;Alveolar cells type 2: 31.6;Club cells: 21.6;granulocytes: 31.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA021139 Uncertain Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA021139: AB_10961418" "unprognostic (8.37e-3)" "unprognostic (2.23e-1)" "unprognostic (1.74e-1)" "prognostic unfavorable (3.64e-4)" "unprognostic (2.08e-2)" "unprognostic (6.32e-2)" "unprognostic (5.60e-2)" "unprognostic (1.57e-1)" "unprognostic (1.79e-3)" "unprognostic (2.11e-1)" "unprognostic (7.01e-3)" "unprognostic (2.43e-2)" "unprognostic (1.51e-1)" "unprognostic (4.21e-2)" "unprognostic (4.54e-2)" "unprognostic (5.86e-2)" "unprognostic (5.11e-3)" 6.0 8.7 8.1 5.6 12.3 6.3 7.2 13.5 12.0 7.1 5.9 8.5 4.7 1.5 10.2 7.1 5.2 7.6 5.8 5.0 6.9 7.5 6.8 5.1 5.4 6.9 7.0 8.6 10.8 4.0 7.9 12.1 8.7 8.7 6.7 4.7 5.7 4.8 6.3 4.1 5.9 5.4 8.5 7.4 7.9 5.4 8.1 9.2 5.9 10.6 3.1 7.6 6.2 7.3 3.3 2.3 1.0 2.3 2.2 6.2 1.6 2.9 5.3 4.0 5.1 2.8 6.3 2.5 3.1 3.5 4.9 6.8 0.9 1.3 0.4 6.7 4.4 4.8 0.5 2.8 3.4 5.3 5.4 4.0 4.6 0.7 2.0 4.5 3.9 5.6 3.9 6.2 1.6 4.4 5.8 3.0 2.5 0.2 0.4 4.9 3.1 6.1 1.0 2.3 0.4 2.0 0.4 3.9 0.9 1.5 6.7 4.7 6.7 0.3 2.3 4.2 4.3 2.5 1.5 3.0 3.0 3.8 1.9 3.8 8.8 13.0 1.6 0.0 0.8 3.8 0.0 0.8 1.0 2.5 2.3 3.1 2.8 4.1 6.2 2.3 3.3 3.1 2.2 0.1 2.2 0.4 0.7 3.5 1.6 8.1 12.3 13.5 12.0 6.9 7.5 7.0 8.6 8.7 9.2 26.8 31.6 1.3 1.7 3.0 5.5 1.6 5.1 14.7 21.6 3.5 0.0 2.4 1.7 1.2 17.7 3.4 0.2 0.0 0.8 2.4 3.0 1.7 31.3 1.0 1.5 3.2 2.9 4.3 2.2 4.1 0.9 1.9 0.0 0.0 1.0 1.9 0.7 0.0 1.8 1.5 3.2 0.0 3.1 7.7 4.2 3.0 2.4 4.3 1.2 1.5 ZNF571 HSPC059 ENSG00000180479 "Zinc finger protein 571" Q7Z3V5 19 37554782-37594790 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 61.8" "Cell type enhanced" "Detected in many" 4 "granulocytes: 15.0;Rod photoreceptor cells: 16.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA054762 Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Nucleoplasm, Nucleoli" "Plasma membrane" "HPA054762: " "unprognostic (1.16e-1)" "unprognostic (3.01e-2)" "unprognostic (3.92e-2)" "unprognostic (1.19e-1)" "unprognostic (5.21e-2)" "unprognostic (1.88e-2)" "unprognostic (1.19e-1)" "unprognostic (9.03e-4)" "unprognostic (5.77e-2)" "unprognostic (9.82e-2)" "unprognostic (1.22e-3)" "unprognostic (3.90e-2)" "unprognostic (2.14e-2)" "unprognostic (8.93e-2)" "unprognostic (2.62e-1)" "unprognostic (4.89e-2)" "unprognostic (2.71e-4)" 6.5 6.7 8.6 3.2 12.9 6.1 12.5 12.5 12.8 5.9 4.2 9.8 4.4 2.3 6.7 8.7 3.9 6.0 4.5 4.2 10.4 7.2 6.4 4.2 4.1 4.4 15.3 9.4 8.5 3.8 11.5 12.2 4.8 13.4 7.1 3.4 5.1 3.6 4.5 3.5 7.1 3.7 7.7 14.3 4.8 3.5 8.5 15.8 3.7 61.8 3.3 5.0 6.6 5.3 9.4 4.1 4.9 1.3 3.7 8.4 3.2 1.8 1.0 6.3 9.1 4.7 4.8 2.0 2.7 4.4 6.6 8.2 1.9 1.7 9.6 8.6 2.8 4.6 2.4 2.0 2.9 11.0 2.1 7.9 5.1 2.7 1.1 5.4 1.9 5.8 2.6 5.3 6.3 5.8 4.7 1.3 8.7 2.4 0.8 5.3 1.7 9.6 2.1 15.8 2.9 3.5 4.8 3.0 5.1 9.1 11.6 13.6 9.5 6.4 2.1 3.2 13.2 9.7 1.3 0.8 3.0 3.9 3.3 6.9 7.7 15.8 13.2 0.5 0.8 6.6 1.8 0.8 4.9 6.7 1.3 6.1 8.7 6.3 6.5 2.7 9.4 7.8 8.4 1.5 3.7 1.2 4.1 4.2 3.2 8.6 12.9 12.5 12.8 10.4 7.2 15.3 9.4 13.4 15.8 0.0 1.3 4.5 1.1 1.5 9.3 1.1 2.5 4.0 5.7 5.2 9.8 1.8 3.3 1.7 10.5 2.5 0.8 0.0 1.4 1.3 2.3 1.7 15.0 0.8 1.4 12.7 1.2 2.5 1.3 2.5 4.0 1.3 5.0 0.0 2.1 4.5 0.8 0.0 2.5 2.6 16.6 12.9 1.7 7.2 5.7 2.3 1.0 6.2 1.3 0.5 ZNF668 FLJ13479 ENSG00000167394 "Zinc finger protein 668" Q96K58 16 31060843-31074320 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 31.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043048 Uncertain Approved "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" Nucleoplasm "HPA043048: AB_10962503" "unprognostic (2.71e-2)" "unprognostic (4.95e-2)" "unprognostic (6.42e-2)" "unprognostic (1.48e-1)" "unprognostic (3.27e-1)" "unprognostic (7.20e-3)" "unprognostic (6.73e-5)" "unprognostic (4.03e-2)" "unprognostic (1.37e-1)" "unprognostic (1.84e-1)" "unprognostic (7.71e-3)" "prognostic unfavorable (6.24e-4)" "unprognostic (1.72e-3)" "unprognostic (2.00e-1)" "unprognostic (2.23e-1)" "unprognostic (4.83e-3)" "unprognostic (7.25e-2)" 7.1 8.2 8.2 8.9 10.0 18.5 5.9 11.1 15.4 8.3 10.2 6.6 5.1 11.8 9.4 5.6 8.0 6.1 9.6 5.1 8.6 7.4 5.9 6.9 7.3 8.6 7.6 5.2 5.7 10.6 4.6 6.7 10.1 9.2 8.1 4.2 4.9 7.2 7.6 12.6 9.0 10.3 9.5 6.5 8.6 8.8 10.0 6.1 16.9 5.4 8.8 7.5 6.6 6.5 5.6 7.3 8.6 4.8 8.4 13.9 5.4 3.6 12.6 2.8 7.0 3.0 3.1 9.7 10.4 7.6 5.2 4.4 5.7 5.1 5.9 8.4 6.1 3.3 6.7 1.9 5.6 1.3 7.5 8.2 3.6 7.8 9.1 3.7 5.7 9.1 3.8 2.3 9.0 1.8 1.7 3.8 6.5 6.8 3.7 9.5 12.4 12.0 12.3 10.1 2.6 10.7 16.0 21.3 8.6 2.8 8.1 9.9 11.7 6.6 9.3 3.2 1.1 7.1 8.3 6.4 13.1 5.4 9.9 4.5 6.2 10.2 8.3 8.7 6.0 8.4 7.6 4.8 8.6 13.9 4.7 9.2 5.6 4.1 8.4 7.3 4.4 4.5 5.6 1.7 8.4 3.8 3.9 4.3 5.4 8.2 10.0 11.1 15.4 8.6 7.4 7.6 5.2 9.2 6.1 0.0 5.1 2.2 2.6 7.4 2.9 0.5 5.1 1.4 2.3 0.0 0.0 5.4 6.6 8.2 31.1 3.1 6.3 0.0 4.1 9.5 6.0 2.2 4.6 1.8 6.0 11.1 4.6 3.7 3.2 12.7 5.8 4.4 3.3 4.6 3.8 4.8 6.4 4.2 14.2 4.7 1.9 0.0 2.5 2.9 13.3 7.8 5.8 6.4 4.7 1.7 ZNF678 MGC42493 ENSG00000181450 "Zinc finger protein 678" Q5SXM1 1 227563543-227677443 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA028507 Uncertain Approved Nucleoli,Mitochondria,Cytosol Yes No "Mitochondria, Cytosol" Nucleoli "HPA028507: AB_10603567" "unprognostic (1.76e-2)" "unprognostic (3.01e-2)" "unprognostic (1.68e-1)" "unprognostic (1.39e-1)" "unprognostic (1.20e-2)" "unprognostic (4.42e-3)" "unprognostic (3.92e-2)" "unprognostic (4.64e-2)" "unprognostic (1.59e-2)" "unprognostic (2.19e-2)" "unprognostic (2.50e-1)" "unprognostic (1.64e-1)" "unprognostic (3.54e-6)" "unprognostic (1.39e-1)" "unprognostic (4.18e-1)" "unprognostic (1.10e-1)" "unprognostic (4.88e-4)" 9.0 7.6 8.2 6.6 16.2 7.1 8.8 19.4 10.8 9.3 7.2 6.7 7.1 5.4 9.2 6.2 6.1 7.7 7.4 7.4 8.9 6.3 6.4 5.3 7.8 9.8 12.7 8.2 9.9 12.6 7.2 19.4 9.7 8.9 10.6 10.8 4.6 7.6 6.3 6.2 5.2 6.6 7.5 14.2 9.5 7.6 8.7 15.5 12.0 12.7 5.1 9.1 8.2 9.4 6.6 3.2 7.1 1.1 2.2 3.2 1.5 2.0 3.2 11.9 13.5 1.5 3.4 7.2 2.7 2.7 4.1 4.4 2.6 2.6 8.3 7.2 1.2 2.2 4.0 7.0 1.8 6.8 3.5 13.4 3.9 2.5 1.6 2.7 6.6 10.6 3.0 3.4 2.5 5.3 3.1 3.9 9.3 9.9 13.1 4.5 1.7 9.1 2.3 10.4 3.0 5.4 7.1 7.7 3.2 3.0 6.5 5.1 9.9 4.1 4.9 2.0 6.1 6.8 8.4 2.5 5.1 4.9 4.6 5.6 4.2 9.6 9.1 2.1 1.2 5.3 7.1 1.1 1.3 2.5 0.3 3.0 6.6 2.5 1.4 2.1 4.5 2.2 3.2 0.2 2.2 0.7 3.2 2.7 1.5 8.2 16.2 19.4 10.8 8.9 6.3 12.7 8.2 8.9 15.5 3.0 5.3 4.7 3.6 2.1 11.6 3.6 5.1 5.3 4.5 3.5 3.9 1.8 1.7 3.3 0.6 4.7 1.5 0.0 4.4 2.1 3.4 5.6 3.5 1.6 1.4 1.6 9.2 3.7 3.7 0.2 6.9 2.2 0.0 1.8 3.9 4.2 2.9 4.5 2.5 1.1 6.7 0.0 2.1 7.2 10.0 0.5 1.1 7.5 2.6 3.4 ZNF691 Zfp691 ENSG00000164011 "Zinc finger protein 691" Q5VV52 1 42846573-42852477 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062527 Approved Approved Nucleoplasm,Nucleoli,Vesicles NA NA Nucleoplasm "Nucleoli, Vesicles" "HPA062527: AB_2684791" "unprognostic (4.34e-2)" "unprognostic (4.05e-2)" "unprognostic (1.09e-1)" "unprognostic (4.32e-2)" "unprognostic (4.86e-2)" "unprognostic (5.50e-2)" "prognostic unfavorable (7.33e-6)" "unprognostic (1.40e-3)" "unprognostic (2.65e-3)" "unprognostic (5.12e-2)" "prognostic favorable (6.25e-5)" "unprognostic (1.24e-1)" "unprognostic (1.06e-2)" "unprognostic (1.41e-1)" "unprognostic (1.78e-1)" "unprognostic (1.00e-1)" "unprognostic (1.05e-1)" 7.8 14.6 13.6 11.2 15.5 2.9 15.6 10.8 14.4 12.9 12.6 18.3 14.1 8.8 16.9 21.8 9.1 14.2 8.4 11.4 11.9 9.8 14.2 24.1 9.9 16.0 12.2 12.1 18.6 13.4 19.2 17.3 12.7 12.3 16.8 10.2 12.3 15.2 18.5 10.9 12.8 10.6 13.5 11.9 17.7 10.8 13.9 14.8 17.9 19.3 6.4 16.8 11.8 10.0 20.5 12.5 18.2 11.2 18.4 19.3 12.8 4.5 6.3 12.8 10.5 11.6 8.9 1.6 5.4 6.5 8.8 8.8 4.4 6.6 11.1 8.4 5.0 4.4 8.0 12.3 7.1 7.6 19.8 12.4 11.6 17.3 7.9 8.6 4.4 2.5 7.7 8.7 11.0 9.1 10.8 8.9 11.0 11.2 4.8 8.6 3.6 13.2 5.9 19.1 4.9 4.7 9.0 16.1 7.6 8.2 4.3 9.2 9.2 5.5 10.0 9.3 20.0 5.5 15.2 4.6 8.8 9.3 4.9 5.8 11.7 9.2 3.2 6.2 5.4 7.4 18.2 11.2 16.0 12.2 9.7 15.7 15.9 16.4 16.4 11.1 20.5 15.8 15.7 6.3 18.4 10.0 12.5 19.3 12.8 13.6 15.5 10.8 14.4 11.9 9.8 12.2 12.1 12.3 14.8 6.0 2.4 3.0 2.1 1.5 2.4 5.7 5.1 4.0 2.3 5.2 3.9 5.4 6.6 3.9 3.0 3.6 1.7 0.0 3.3 4.4 4.0 2.4 4.7 6.4 6.4 1.6 2.9 6.2 3.3 2.5 6.6 3.5 1.7 3.6 2.7 5.2 2.4 2.9 6.7 6.8 4.2 0.0 3.9 9.1 6.4 0.6 2.7 6.4 2.3 1.0 ZNF787 ENSG00000142409 "Zinc finger protein 787" 19 56087366-56121280 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 52.1;Cone photoreceptor cells: 104.1;Rod photoreceptor cells: 60.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 43.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035140 Supported Approved Nucleoplasm,Nucleoli,Mitochondria NA NA Nucleoplasm "Nucleoli, Mitochondria" "HPA035140: AB_10602358" "unprognostic (1.97e-2)" "unprognostic (5.86e-2)" "unprognostic (8.77e-2)" "unprognostic (1.62e-1)" "unprognostic (1.08e-1)" "unprognostic (2.24e-1)" "unprognostic (1.46e-2)" "unprognostic (2.17e-1)" "unprognostic (3.19e-2)" "unprognostic (1.54e-1)" "unprognostic (4.83e-2)" "unprognostic (1.26e-1)" "unprognostic (1.27e-1)" "unprognostic (1.31e-2)" "unprognostic (1.86e-1)" "unprognostic (1.10e-1)" "unprognostic (1.96e-3)" 7.4 8.0 4.3 7.8 5.2 18.8 7.1 4.7 7.0 8.0 9.8 5.1 8.5 12.8 5.8 6.5 9.8 8.7 8.7 10.2 4.0 4.3 6.4 18.0 6.9 7.7 4.8 4.0 8.7 13.9 3.3 6.6 4.8 4.6 10.0 3.9 7.9 9.6 7.2 28.2 9.3 10.5 6.8 3.1 14.9 11.0 6.8 4.6 4.8 10.0 8.2 5.7 8.7 10.1 3.0 5.5 4.9 2.1 1.2 1.6 0.7 12.0 11.9 3.9 8.1 1.1 2.5 10.1 6.2 2.4 4.3 4.8 7.0 7.5 8.6 0.4 2.6 3.8 9.5 2.4 5.0 1.9 11.4 43.9 13.7 6.0 10.5 6.3 13.1 12.0 3.3 5.0 3.5 6.2 2.6 3.1 4.9 16.3 9.7 2.5 7.6 8.1 16.5 12.3 11.1 22.4 10.2 5.7 10.9 4.3 8.0 14.9 14.4 6.6 13.0 11.5 2.3 8.0 18.6 6.7 16.1 11.5 6.7 17.1 20.6 15.1 8.3 9.3 8.8 7.5 1.7 2.1 2.6 1.2 1.5 1.6 2.3 0.8 1.0 2.2 3.0 1.3 0.7 4.9 1.2 1.4 5.5 1.3 0.7 4.3 5.2 4.7 7.0 4.0 4.3 4.8 4.0 4.6 4.6 11.9 2.4 6.7 8.9 5.5 52.1 9.0 12.7 0.0 4.5 10.4 104.1 2.9 1.7 5.9 1.5 6.7 15.4 0.0 14.2 4.0 5.0 8.6 5.7 28.4 7.5 33.4 8.7 12.9 6.5 2.9 4.6 6.8 1.7 4.6 17.1 29.5 12.9 15.3 4.2 3.7 60.0 6.5 6.2 2.5 7.9 6.4 1.6 3.2 16.9 11.7 ZNF793 ENSG00000188227 "Zinc finger protein 793" Q6ZN11 19 37506939-37548762 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 29.5;Early spermatids: 32.2;Horizontal cells: 46.1;Rod photoreceptor cells: 33.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 11.5;RT4: 9.8;U-266/70: 17.0;U-266/84: 11.3" HPA034781 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA034781: AB_10602784" "unprognostic (4.80e-2)" "unprognostic (4.70e-2)" "unprognostic (3.26e-1)" "unprognostic (7.13e-2)" "unprognostic (4.08e-2)" "unprognostic (5.72e-2)" "unprognostic (1.05e-2)" "unprognostic (3.80e-2)" "unprognostic (2.22e-1)" "unprognostic (2.69e-3)" "unprognostic (4.16e-3)" "unprognostic (1.03e-4)" "unprognostic (4.94e-3)" "unprognostic (1.38e-1)" "unprognostic (4.62e-1)" "unprognostic (1.24e-2)" "unprognostic (8.12e-3)" 3.1 7.7 12.5 4.9 11.9 2.1 6.4 22.1 14.0 6.4 4.2 12.8 4.6 3.0 9.3 6.9 5.2 6.7 4.6 6.8 10.3 8.0 6.2 1.1 3.3 5.6 8.3 10.0 14.1 4.0 15.7 18.4 4.5 11.2 7.5 6.0 8.1 3.6 5.8 3.7 10.7 3.6 6.1 10.1 5.6 5.3 12.3 9.6 2.1 11.0 3.2 4.9 4.9 5.7 4.0 2.1 7.2 1.6 4.0 2.8 1.4 0.1 0.2 4.2 11.5 0.9 0.9 0.2 3.3 0.2 0.7 0.3 0.2 1.3 2.9 5.5 1.7 1.0 0.4 0.3 2.9 0.3 0.8 4.2 0.3 0.4 0.3 2.1 0.2 2.6 3.4 2.6 0.6 0.1 0.3 0.1 0.3 0.1 0.5 0.5 3.2 0.3 0.4 6.9 0.0 0.3 0.1 0.1 0.6 2.9 9.8 3.1 6.7 0.2 0.2 0.0 8.1 6.4 0.3 0.4 0.1 1.8 0.3 3.3 17.0 11.3 0.3 0.0 0.2 0.5 7.2 1.6 1.2 1.5 0.6 2.3 2.0 2.8 2.5 1.2 4.0 1.9 2.4 4.2 4.0 0.6 2.1 2.2 1.4 12.5 11.9 22.1 14.0 10.3 8.0 8.3 10.0 11.2 9.6 3.0 7.2 0.8 3.4 3.0 28.0 7.3 12.7 6.7 5.7 12.2 29.5 4.8 3.3 3.1 32.2 6.3 1.4 0.0 1.3 3.6 3.1 2.6 2.3 0.4 0.8 46.1 8.6 6.2 0.0 7.7 4.6 2.0 0.0 1.8 3.4 16.2 1.6 0.0 9.6 1.5 33.5 0.0 5.1 5.4 6.4 2.9 1.6 4.3 3.4 1.4 ZNF800 ENSG00000048405 "Zinc finger protein 800" Q2TB10 7 127346790-127431924 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023090, HPA052194" Approved Supported "Nucleoli,Nucleoli rim,Cytosol" NA NA "Nucleoli, Nucleoli rim" Cytosol "HPA023090: AB_1859457, HPA052194: AB_2681757" "unprognostic (2.93e-2)" "unprognostic (1.10e-1)" "unprognostic (2.27e-1)" "unprognostic (3.34e-2)" "unprognostic (1.39e-1)" "unprognostic (1.23e-2)" "unprognostic (6.19e-2)" "unprognostic (2.45e-2)" "unprognostic (1.23e-3)" "unprognostic (1.37e-1)" "unprognostic (9.43e-2)" "unprognostic (8.99e-2)" "unprognostic (7.04e-2)" "unprognostic (1.32e-1)" "unprognostic (1.08e-1)" "unprognostic (2.53e-2)" "unprognostic (8.96e-3)" 17.5 11.2 10.8 14.4 11.7 61.7 18.7 18.6 12.7 11.9 11.9 6.3 12.8 10.3 14.6 10.4 15.4 13.5 11.6 9.5 10.2 5.9 8.9 14.4 16.5 20.7 13.5 9.2 15.2 15.3 16.2 18.6 10.8 12.6 10.5 10.5 7.1 15.1 16.1 14.9 22.7 14.8 11.5 15.7 15.2 13.1 19.1 12.8 22.4 12.7 10.9 13.8 14.4 15.5 14.2 12.0 16.9 6.8 18.9 17.2 5.9 9.1 4.8 5.7 9.8 8.2 11.0 5.4 8.9 10.5 9.2 8.9 4.4 8.8 15.6 5.5 8.4 9.9 6.7 9.2 9.5 12.7 13.7 5.4 10.0 4.9 4.1 10.3 13.7 19.3 9.3 8.8 10.1 13.7 7.7 9.7 9.7 12.4 16.1 9.9 7.0 15.2 9.9 4.7 8.5 6.4 9.5 7.9 10.3 6.7 11.6 8.1 8.5 8.8 34.9 11.3 8.1 4.1 9.4 10.4 15.5 4.9 10.2 10.4 19.4 8.5 22.6 11.5 12.5 12.8 16.9 6.8 10.1 13.3 6.3 14.0 12.0 10.0 13.5 7.0 14.2 16.4 17.2 6.0 18.9 6.6 12.0 13.8 5.9 10.8 11.7 18.6 12.7 10.2 5.9 13.5 9.2 12.6 12.8 35.7 19.7 27.4 41.3 39.8 25.9 12.6 15.3 16.0 21.6 12.2 21.6 9.7 10.0 20.7 27.0 23.3 24.9 23.3 16.7 8.6 17.5 40.1 28.8 12.9 12.9 73.1 15.5 23.4 26.2 8.6 25.0 26.7 27.0 27.9 22.6 16.6 19.9 25.9 29.7 10.5 26.1 25.8 25.8 97.4 48.6 41.9 18.4 33.8 20.0 57.6 ZNF860 ENSG00000197385 "Zinc finger protein 860" A6NHJ4 3 31981771-31991628 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 20.2" "Cell type enhanced" "Detected in some" 9 "B-cells: 3.4;Ciliated cells: 6.7;Club cells: 4.5;Intestinal endocrine cells: 3.4;Syncytiotrophoblasts: 3.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 61 "memory B-cell: 9.1;naive B-cell: 6.4" "Lineage enriched" "Detected in single" 71 "B-cells: 9.1" "Cell line enriched" "Detected in many" 4 "BEWO: 31.9" HPA063386 Uncertain Approved "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" Nucleoplasm "HPA063386: AB_2684999" "unprognostic (1.19e-1)" "unprognostic (2.46e-2)" "unprognostic (2.88e-1)" "unprognostic (1.64e-2)" "unprognostic (1.51e-1)" "unprognostic (8.01e-2)" "unprognostic (1.23e-2)" "unprognostic (1.94e-2)" "unprognostic (3.15e-1)" "unprognostic (4.15e-3)" "unprognostic (1.51e-2)" "unprognostic (6.38e-2)" "unprognostic (1.30e-4)" "unprognostic (9.51e-2)" "unprognostic (1.59e-1)" "unprognostic (8.74e-2)" "unprognostic (3.75e-3)" 2.0 1.0 0.7 11.2 1.0 0.1 2.8 0.8 1.5 4.3 1.1 0.0 1.7 0.3 4.1 4.9 6.2 1.9 3.6 1.3 0.6 1.6 7.2 0.4 3.7 8.3 1.6 0.6 1.8 0.6 0.1 5.5 8.1 1.1 6.0 1.6 1.6 5.6 2.6 0.4 2.3 3.7 6.7 0.5 9.6 1.1 2.2 0.0 0.5 1.8 4.2 20.2 6.4 3.6 9.1 0.0 0.1 0.0 0.0 0.0 0.2 2.1 0.7 0.0 1.6 0.0 0.0 31.9 0.2 0.1 0.2 0.2 2.1 2.5 2.3 2.3 0.0 1.0 1.9 0.7 3.1 0.2 0.0 0.3 0.0 3.2 1.0 0.0 0.0 0.0 0.1 1.4 0.2 6.1 0.2 0.6 0.0 0.0 0.0 0.3 1.8 0.0 0.0 0.8 5.6 3.4 0.0 0.0 0.1 7.2 0.9 0.2 0.0 0.5 3.8 0.0 1.6 2.9 0.0 1.2 0.2 2.6 0.0 0.2 0.0 0.0 3.6 0.3 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 1.0 0.8 1.5 0.6 1.6 1.6 0.6 1.1 0.0 0.0 0.0 3.4 0.4 0.8 0.2 0.6 0.0 6.7 4.5 0.0 0.0 1.4 0.0 0.0 0.0 1.1 0.0 0.0 0.5 3.0 0.5 0.9 0.0 0.0 0.3 0.0 3.4 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.9 0.2 0.0 0.4 1.1 0.0 0.0 0.3 0.1 0.1 0.3 3.5 0.0 0.3 0.6